smiles,-logKd/Ki,description,chembl_id
CC(=O)NC(CCC(=O)[O-])C(=O)[O-],0.4,,
C[NH2+]CCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,0.45,,
CC(=O)N1CCCC(C)C1,0.4899999999999999,,
Nc1cccc(C(=O)[O-])c1,0.4899999999999999,,
CC(=O)Nc1nnc(S(N)(=O)=O)s1,0.5999999999999999,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
[NH3+]C(CF)(Cc1c[nH]c2ccccc12)C(=O)[O-],0.75,,
CSCCC([NH3+])C(=O)[O-],0.82,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],0.82,,
OCC(O)CO,0.96,"This molecule appears as a colorless to brown colored liquid. Combustible but may require some effort to ignite. This molecule is a triol with a structure of propane substituted at positions 1, 2 and 3 by hydroxy groups. It has a role as an osmolyte, a solvent, a detergent, a human metabolite, an algal metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a mouse metabolite and a geroprotector. It is an alditol and a triol. This molecule is an intermediate in carbohydrate and lipid metabolism. This molecule is a Non-Standardized Chemical Allergen. The physiologic effect of glycerin is by means of Increased Histamine Release, and Cell-mediated Immunity, and Increased IgG Production. This molecule is a trihydroxyalcohol with localized osmotic diuretic and laxative effects. This molecule elevates the blood plasma osmolality thereby extracting water from tissues into interstitial fluid and plasma. This agent also prevents water reabsorption in the proximal tubule in the kidney leading to an increase in water and sodium excretion and a reduction in blood volume. Administered rectally, glycerin exerts a hyperosmotic laxative effect by attracting water into the rectum, thereby relieving constipation. In addition, glycerin is used as a solvent, humectant and vehicle in various pharmaceutical preparations. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Microchloropsis, Ramalina usnea, and other organisms with data available. This molecule is an important component of triglycerides (i.e. fats and oils) and of phospholipids. glycerol is a three-carbon substance that forms the backbone of fatty acids in fats. When the body uses stored fat as a source of energy, glycerol and fatty acids are released into the bloodstream. The glycerol component can be converted to glucose by the liver and provides energy for cellular metabolism.",CHEMBL692
C[NH2+]CCCCC([NH3+])C(=O)[O-],1.0,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,1.0,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,1.0,,
NC(=[NH2+])NCCCO,1.01,,
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,1.11,"This molecule is an odorless white powder. Bitter taste. (NTP, 1992) This molecule is an aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge. It has a role as an EC 1.5.1.3 (dihydrofolate reductase) inhibitor, a xenobiotic, an environmental contaminant, a drug allergen, an antibacterial drug and a diuretic. It is a member of methoxybenzenes and an aminopyrimidine. This molecule is an antifolate antibacterial agent that inhibits bacterial dihydrofolate reductase (DHFR), a critical enzyme that catalyzes the formation of tetrahydrofolic acid (THF) - in doing so, it prevents the synthesis of bacterial DNA and ultimately continued bacterial survival. This molecule is often used in combination with [sulfamethoxazole] due to their complementary and synergistic mechanisms but may be used as a monotherapy in the treatment and/or prophylaxis of urinary tract infections. It is structurally and chemically related to [pyrimethamine], another antifolate antimicrobial used in the treatment of plasmodial infections. This molecule is a Dihydrofolate Reductase Inhibitor Antibacterial. The mechanism of action of trimethoprim is as a Dihydrofolate Reductase Inhibitor, and Cytochrome P450 2C8 Inhibitor, and Organic Cation Transporter 2 Inhibitor. This molecule is a synthetic derivative of trimethoxybenzyl-pyrimidine with antibacterial and antiprotozoal properties.  As a pyrimidine inhibitor of bacterial dihydrofolate reductase, trimethoprim binds tightly to the bacterial enzyme, blocking the production of tetrahydrofolic acid from dihydrofolic acid.  The antibacterial activity of this agent is potentiated by sulfonamides. (NCI04)",CHEMBL22
O=C([O-])CCC(=O)[O-],1.24,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],1.24,,
NC(=[NH2+])NCC([NH3+])C(=O)[O-],1.26,,
NC(=[NH2+])NCC([NH3+])C(=O)[O-],1.26,,
O=C1OC(C(O)CO)C(O)=C1O,1.28,This molecule is a natural product found in Pisum sativum and Hippophae with data available.,CHEMBL1161421
OCC1OC(OC2(CO)OC(CO)C(O)C2O)C(O)C(O)C1O.OCC1OC(OC2(CO)OC(CO)C(O)C2O)C(O)C(O)C1O,1.3,,
NC(=O)CCC([NH3+])C(=O)[O-],1.3,,
O=C([O-])CC(=O)[O-],1.3,,
[NH3+]CC(=O)N1CCCC1C(=O)[O-],1.31,,
[NH3+]CC(=O)NCC(=O)[O-],1.35,,
[NH3+]C(CO)(CO)CO,1.35,,
CC(=O)C(N)=O,1.36,,
CC(O)CC(C)(C)O,1.4,"This molecule is an oily colorless liquid with a mild sweet odor. Floats and mixes slowly with water. (USCG, 1999) These molecules is a glycol in which the two hydroxy groups are at positions 2 and 4 of 2-methylpentane (isopentane). This molecule is a natural product found in Nicotiana tabacum with data available.",CHEMBL2104293
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],1.4,,
O=C([O-])CC(=O)[O-],1.4,,
O=C([O-])C(=O)[O-],1.4,,
O=C([O-])c1cccs1,1.4,,
CC(=O)NC1C(O)CC(O)(C(=O)[O-])OC1C(O)C(O)CO,1.43,,
[NH3+]CCCCC([NH3+])C(=O)[O-],1.44,,
[NH3+]CCCCc1ccccc1,1.44,,
[NH3+]CCCc1ccccc1,1.49,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(OC3(C(=O)[O-])CC(O)C(NC(C)=O)C(C(O)C(O)CO)O3)C2O)C1O,1.49,,
O=C([O-])CCCC(=O)[O-],1.52,,
O=C([O-])C(O)C(O)C(=O)[O-],1.54,,
OCC1(F)OCC(O)C(O)C1O,1.55,,
OCC1OC(OC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O,1.59,,
CCOC(=O)C(=O)N1CCCCC1,1.6,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],1.6,,
O=S(=O)(O)CC[NH+]1CCOCC1,1.64,,
COC1(C(=O)[O-])CC(O)C(NC(C)=O)C(C(O)C(O)C[NH3+])O1,1.66,,
CC1OC(O)C(O)C(O)C1O,1.66,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL273741
OCC1OC(SC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,1.68,,
C=C1CN(C2OC(CO)C(O)C2O)C(=O)NC1=O,1.68,,
CCC(=O)[O-],1.7,,
O=C([O-])c1ccccc1O,1.7,,
OCC1(O)OCC(O)C(O)C1O,1.7,This molecule is a natural product found in Apium graveolens with data available.,CHEMBL23954
Cn1c(=O)c2c(ncn2C)n(C)c1=O,1.71,"This molecule appears as odorless white powder or white glistening needles, usually melted together. Bitter taste. Solutions in water are neutral to litmus. Odorless. (NTP, 1992) These molecules is a trimethylxanthine in which the three methyl groups are located at positions 1, 3, and 7. A purine alkaloid that occurs naturally in tea and coffee. It has a role as a central nervous system stimulant, an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor, an adenosine receptor antagonist, an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor, a ryanodine receptor agonist, a fungal metabolite, an adenosine A2A receptor antagonist, a psychotropic drug, a diuretic, a food additive, an adjuvant, a plant metabolite, an environmental contaminant, a xenobiotic, a human blood serum metabolite, a mouse metabolite, a geroprotector and a mutagen. It is a purine alkaloid and a trimethylxanthine. This molecule is a drug of the methylxanthine class used for a variety of purposes, including certain respiratory conditions of the premature newborn, pain relief, and to combat drowsiness. This molecule is similar in chemical structure to [Theophylline] and [Theobromine]. It can be sourced from coffee beans, but also occurs naturally in various teas and cacao beans, which are different than coffee beans. This molecule is also used in a variety of cosmetic products and can be administered topically, orally, by inhalation, or by injection.  The caffeine citrate injection, used for apnea of the premature newborn, was initially approved by the FDA in 1999. According to an article from 2017, more than 15 million babies are born prematurely worldwide. This correlates to about 1 in 10 births. Premature birth can lead to apnea and bronchopulmonary dysplasia, a condition that interferes with lung development and may eventually cause asthma or early onset emphysema in those born prematurely. This molecule is beneficial in preventing and treating apnea and bronchopulmonary dysplasia in newborns, improving the quality of life of premature infants. This molecule is a Central Nervous System Stimulant and Methylxanthine. The physiologic effect of caffeine is by means of Central Nervous System Stimulation. This molecule is xanthine alkaloid that occurs naturally in seeds, leaves and fruit of several plants and trees that acts as a natural pesticide. This molecule is a major component of coffee, tea and chocolate and in humans acts as a central nervous system (CNS) stimulant. Consumption of caffeine, even in high doses, has not been associated with elevations in serum enzyme elevations or instances of clinically apparent liver injury. This molecule is a methylxanthine alkaloid found in the seeds, nuts, or leaves of a number of plants native to South America and East Asia that is structurally related to adenosine and acts primarily as an adenosine receptor antagonist with psychotropic and anti-inflammatory activities. Upon ingestion, caffeine binds to adenosine receptors in the central nervous system (CNS), which inhibits adenosine binding. This inhibits the adenosine-mediated downregulation of CNS activity; thus, stimulating the activity of the medullary, vagal, vasomotor, and respiratory centers in the brain. This agent also promotes neurotransmitter release that further stimulates the CNS. The anti-inflammatory effects of caffeine are due the nonselective competitive inhibition of phosphodiesterases (PDEs). Inhibition of PDEs raises the intracellular concentration of cyclic AMP (cAMP), activates protein kinase A, and inhibits leukotriene synthesis, which leads to reduced inflammation and innate immunity. This molecule is a natural product found in Camellia sinensis, Claviceps sorghicola, and other organisms with data available. This molecule is the most widely consumed psychostimulant drug in the world that mostly is consumed in the form of coffee. Whether caffeine and/or coffee consumption contribute to the development of cardiovascular disease (CVD), the single leading cause of death in the US, is unclear. The literature indicates a strong relationship between boiled, unfiltered coffee consumption and elevated cholesterol levels; however, there is a critical gap in the literature regarding the effects of coffee or caffeine consumption on fibrinogen or CRP, which is an independent predictor of CVD risk. Available studies are limited by small samples sizes, inclusion of only men (or few women) and unrepresented age or ethnic groups. There is a critical need for controlled laboratory and epidemiological studies that include fibrinogen and CRP markers of CVD risk before conclusions can be drawn regarding the health effects of caffeine and/or coffee in a normal, healthy population of men and women. (A11723). The relationship between caffeine consumption and various illnesses such as cardiovascular disease and cancer remains equivocal. Prudence might dictate that pregnant women and chronically ill individuals exercise restraint in their use of caffeine, although research suggests relatively low or nonexistent levels of risk associated with moderate caffeine consumption. (A7827). There is extensive evidence that caffeine at dietary doses increases blood pressure (BP). However, concern that the drug may contribute to cardiovascular disease appears to have been dampened by (1) the belief that habitual use leads to the development of tolerance, and (2) confusion regarding relevant epidemiologic findings. When considered comprehensively, findings from experimental and epidemiologic studies converge to show that BP remains reactive to the pressor effects of caffeine in the diet. Overall, the impact of dietary caffeine on population BP levels is likely to be modest, probably in the region of 4/2 mm Hg. At these levels, however, population studies of BP indicate that caffeine use could account for premature deaths in the region of 14% for coronary heart disease and 20% for stroke. (A7828). This molecule is a purine alkaloid that occurs naturally in coffee beans. At intake levels associated with coffee consumption, caffeine appears to exert most of its biological effects through the antagonism of the A1 and A2A subtypes of the adenosine receptor. Adenosine is an endogenous neuromodulator with mostly inhibitory effects, and adenosine antagonism by caffeine results in effects that are generally stimulatory. Some physiological effects associated with caffeine administration include central nervous system stimulation, acute elevation of blood pressure, increased metabolic rate, and diuresis. This molecule concentrations in coffee beverages can be quite variable. A standard cup of coffee is often assumed to provide 100 mg of caffeine, but a recent analysis of 14 different specialty coffees purchased at coffee shops in the US found that the amount of caffeine in 8 oz (=240 ml) of brewed coffee ranged from 72 to 130 mg.This molecule in espresso coffees ranged from 58 to 76 mg in a single shot. (A7829). This molecule is a member of the methylxanthine family of drugs, and is the most widely consumed behaviourally active substance in the western world. A number of in vitro and in vivo studies have demonstrated that caffeine modulates both innate and adaptive immune responses. For instance studies indicate that caffeine and its major metabolite paraxanthine suppress neutrophil and monocyte chemotaxis, and also suppress production of the pro-inflammatory cytokine tumor necrosis factor (TNF) alpha from human blood. This molecule has also been reported to suppress human lymphocyte function as indicated by reduced T-cell proliferation and impaired production of Th1 (interleukin [IL]-2 and interferon [IFN]-gamma), Th2 (IL-4, IL-5) and Th3 (IL-10) cytokines. Studies also indicate that caffeine suppresses antibody production. The evidence suggests that at least some of the immunomodulatory actions of caffeine are mediated via inhibition of cyclic adenosine monophosphate (cAMP)-phosphodiesterase (PDE), and consequential increase in intracellular cAMP concentrations. Overall, these studies indicate that caffeine, like other members of the methylxanthine family, is largely anti-inflammatory in nature, and based on the pharmacokinetics of caffeine, many of its immunomodulatory effects occur at concentrations that are relevant to normal human consumption. (A7830).",CHEMBL113
Nc1ccc(C(=O)[O-])cc1O,1.72,,
CC(OC1OC(CO)C(O)C(O)C1O)C([NH3+])C(=O)[O-],1.72,,
OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC1C(O)C2O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O,1.72,,
OCC1NC(=NO)C(O)C(O)C1O,1.74,,
C=C1CN(C2CCC(CO)O2)C(=O)NC1=O,1.74,,
CC(=O)NC1C(O)CC(OCC2OC(O)C(O)C(O)C2O)(C(=O)[O-])OC1C(O)C(O)CO,1.77,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,1.79,,
OCC1CC(O)C(O)C(OC2C(CO)OC(O)C(O)C2O)O1,1.8,,
[NH3+]CCc1c[nH]cn1,1.8,,
OCC1OC(OC2(CO)OC(CO)C(O)C2O)C(O)C(O)C1O,1.82,,
NC(=[NH2+])c1ccccc1,1.82,,
O=C([O-])C(O)C(O)C(=O)[O-],1.82,,
[NH3+]C1(C(=O)[O-])CCCC1,1.82,,
[NH3+]CCNc1nnc(-c2ccc(F)c(F)c2Nc2ccc(I)cc2F)o1,1.82,,
[NH3+]Cc1ccccc1-n1cccn1,1.82,,
CC(=O)NC1C(O)OC(CO)C(O)C1O,1.84,"This molecule is a N-acyl-hexosamine. This molecule is under investigation for the other of GNE Myopathy. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655).",CHEMBL83479
O=C(NCc1ccccc1)c1cccc(OC2OC(CO)C(O)C(O)C2O)c1,1.85,,
[NH3+]Cc1ccc(CO)cc1,1.85,,
[NH3+]C1CC1c1ccccc1,1.88,,
O=C([O-])CCC1CCCCC1,1.88,,
[NH3+]C(Cc1ccccc1)C(=O)[O-],1.9,,
Cc1cc(N)c(N)cc1Cl,1.9,,CHEMBL3237625
CC(C)CC([NH3+])C(=O)[O-],1.91,,
Nc1ccc(OC2OC(CO)C(O)C(O)C2O)cc1,1.92,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C1O,1.92,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(COC3(C(=O)[O-])CC(O)C(NC(C)=O)C(C(O)C(O)CO)O3)C(O)C(O)C2O)C1O,1.92,,
O=C([O-])C(O)C(O)c1ccc(F)cc1,1.94,,
c1ccc2c(c1)CC[NH2+]C2,1.95,,
[NH3+]CCc1ccccc1,1.96,,
O=C1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O,1.98,,
NC(=[NH2+])Nc1ccc(C=O)cc1,2.0,,
CC(=O)Nc1ccc(C(=O)[O-])cc1NC(=O)CO,2.0,,
NC(=[NH2+])c1ccccc1,2.0,,
CS(=O)(=O)Nc1ccc(C(=O)[O-])cc1,2.0,,
C[NH+](C)CCCCC([NH3+])C(=O)[O-],2.0,,
CCc1c(C)[nH]n(-c2nnn[nH]2)c1=O,2.0,,CHEMBL1213368
O=C([O-])Cc1cccc(O)c1,2.0,,
CNC(=O)C1CC(O)CN1C(C)=O,2.0,,
Nc1csc2nccnc12,2.0,,
Cc1onc(-c2ccccc2Cl)c1C(=O)NCC(=O)[O-],2.0,,
CC1C=NC(=O)NC1=O,2.0,,
Cc1cn(C2CC(O)C(CO)O2)c(=O)[nH]c1=O,2.0,"This molecule is a pyrimidine 2'-deoxyribonucleoside. This molecule is a natural product found in Penicillium commune, Fritillaria thunbergii, and other organisms with data available.",CHEMBL6497
CSCCC(NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCC[NH3+])NC(=O)C1CCCN1C(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)[O-],2.04,,
COC1OC(CO)C(SC2OC(CO)C(SC)C(O)C2O)C(O)C1O,2.05,,
O=C([O-])c1ccccc1S,2.05,,
CSCCC([NH3+])C(=O)[O-],2.06,,
COC1OC(C)C(O)C(O)C1O,2.06,,
CC(=O)NC1C(O)CC(C(=O)[O-])OC1C(O)C(O)CO,2.06,,
Cn1nc(-c2ccc3c(c2)OCO3)cc1N,2.07,,
CCCCCSc1nnc[nH]1,2.07,,
Cc1cc(C[NH3+])nn1C,2.08,,
C[NH2+]C1C(O)C(OC2C([NH3+])CC([NH3+])C(OC3OC(C(C)O)C(O)C(O)C3[NH3+])C2O)OCC1(C)O,2.1,,
CC(=O)NC1C(O)CC(O)(C(=O)[O-])OC1C(O)C(O)CO,2.1,,
CCCNC(=O)OC1OC(CO)C(O)C(O)C1NC(C)=O,2.1,,
CCOP(=S)(OCC)Oc1ccc([S+](C)O)cc1,2.11,,
OCC1OCC(F)C(O)C1O,2.12,,
CC(=O)Nc1ccsc1C(=O)[O-],2.12,,
OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC8C(CO)OC(OC9C(CO)OC(OC1C(O)C2O)C(O)C9O)C(O)C8O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O,2.13,,
CC(=O)NC1C(O)CC(OC2C(O)C(O)OC(CO)C2O)(C(=O)[O-])OC1C(O)C(O)CO,2.15,,
[NH3+]C1CCC(O)CC1,2.15,,
OCc1cc(-c2cccs2)on1,2.15,This molecule is a member of isoxazoles.,CHEMBL1230155
O=C([O-])CCCCc1ccccc1,2.16,,
CC(=O)c1ccc(N2CC(C(=O)[O-])CC2=O)cc1,2.17,,
O=C(Nc1ccn(C2CC(F)C(O)C(CO)O2)c(=O)n1)c1ccccc1,2.18,,
O=C([O-])CCc1ccc2c(c1)OCO2,2.19,,
O=C([O-])c1cccc2ccoc12,2.19,,
OCC1(F)OCC(O)C(O)C1O,2.19,,
NC=CCC[NH2+]CCC[NH3+],2.19,,
Cc1cccc(N)c1N,2.19,,CHEMBL3183504
NC(=[NH2+])NCCCC1NC(=O)C2CCCN2C1=O,2.2,,
OCc1cccc(OCc2ccccc2)c1,2.2,,
CC1OC(=O)C(O)C(O)C1O,2.21,,
OCCOCCOCCOCCOCCOCCOCCOCCOCCO,2.22,,
CC1OC(O)C(O)C(O)C1O,2.22,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL273741
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],2.22,,
O=C([O-])Cc1cc(O)ccc1O,2.23,,
[NH3+]C(CO)C(=O)N1CCCC1C(=O)[O-],2.23,,
Cn1nc(N)cc1-c1cc(Br)c2c(c1)OCO2,2.23,,
OCC1OC(O)C(O)C(O)C1O,2.24,,
O=C([O-])CCCc1cccs1,2.24,,
OC1C(O)C(O)C(O)C(O)C1O,2.24,,
CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,2.25,,
Oc1ccc2c(c1)OCO2,2.26,This molecule is a member of benzodioxoles. This molecule is a natural product found in Sesamum indicum with data available.,CHEMBL1517998
O=C(c1ccc(C(F)(F)F)cc1)N1CC2CC(C1)c1cccc(=O)n1C2,2.26,,
Cc1[nH]cnc1C[NH+]1CCc2ccccc2C1,2.26,,
COC1(C(=O)[O-])CC(O)C(NC(C)=O)C(C(O)C(O)CO)O1,2.27,,
[NH3+]CCc1ccccc1,2.27,,
O=C([O-])c1c[nH]c2ccccc12,2.27,,
O=C([O-])C(=O)CO,2.27,,
O=C1NC2C(O)C(O)C(O)C(CO)N2C1=O,2.28,,
COc1ccc(C([NH3+])C(F)(F)C(=O)[O-])cc1,2.28,,
O=C(c1ccncc1)c1ccc(F)cc1,2.28,,CHEMBL563196
Nc1ccc(CCC(=O)[O-])cc1,2.29,,
O=C([O-])c1ccc2c(c1)OCO2,2.29,,
O=C(c1ccc(Cl)cc1)N1CC2CC(C1)c1cccc(=O)n1C2,2.29,,
c1ccc([As+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1,2.3,,
CC(=O)Nc1ccc(C(=O)[O-])cc1NC(=O)C[NH3+],2.3,,
Fc1nc(Cl)c2nc[nH]c2n1,2.3,,
Clc1nc(Br)nc2[nH]cnc12,2.3,,
CC(=O)NC1C(O)CC(OC2C(O)C(O)OC(CO)C2O)(C(=O)[O-])OC1C(O)C(O)CO,2.3,,
O=C1NCC(=O)N2CCCC12,2.3,"This molecule is an organonitrogen compound and an organooxygen compound. It is functionally related to an alpha-amino acid. This molecule is a natural product found in Streptomyces nigra, Streptomyces antioxidans, and Streptomyces xanthophaeus with data available. This molecule is a natural product found in Streptomyces nigra, Streptomyces antioxidans, and Streptomyces xanthophaeus with data available.",CHEMBL4564062
O=C([O-])CCCc1ccccc1,2.3,,
CC(=O)Nc1sccc1C(=O)[O-],2.3,,
Nc1nnc(N)[nH]1,2.3,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],2.3,,
Nc1nc2ccccc2s1,2.3,"This molecule is an odorless gray to white powder. (NTP, 1992) This molecule is a member of benzothiazoles.",CHEMBL329785
O=C([O-])Cc1ccc(O)cc1,2.3,,
Nc1cccc2cn[nH]c12,2.3,,CHEMBL463676
O=C([O-])c1cc(O)ccc1O,2.3,,
NS(=O)(=O)c1ccccc1,2.3,This molecule is a sulfonamide.,CHEMBL27601
CC1OC(O)C(O)C(O)C1O,2.3,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL273741
N#Cc1ccc(O)cc1F,2.3,,
[NH3+]C(c1ccc(O)cc1)C(F)(F)C(=O)[O-],2.32,,
OC1C2CCC(O)([NH2+]2)C(O)C1O,2.34,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,2.35,,
O=C([O-])C1CCCCC1c1n[nH]c(S)n1,2.35,,
CC(C)CCC(=O)NC(Cc1ccccc1)C(=O)[O-],2.35,,
O=C1C=C(Nc2nnn[nH]2)CCC1,2.36,,CHEMBL1213369
OCC1OC(SC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O,2.37,,
Clc1ccccc1-c1nnn[nH]1,2.38,,CHEMBL486329
CC(=O)NC(C(O)CC(O)C(=O)[O-])C(O)C(O)C(O)CO,2.39,,
CC(=O)NCCSSCCNC(=O)C1CCC(NC(=O)c2nccnc2C(=O)[O-])CC1,2.39,,
COCCOc1cc(C)nc(N)n1,2.4,,CHEMBL538937
N=c1ccn(C2OC(CO)C(O)C(F)C2O)c(=O)[nH]1,2.4,,
O=C([O-])c1cccc(O)c1,2.4,,
COC1OC(CO)C(O)C(OC(=O)c2ccc(C)cc2)C1OC(C)=O,2.4,,
C[N+](C)(C)CCCC(=O)[O-],2.41,"These molecules is an amino-acid betaine gamma-aminobutyric acid zwitterion in which all of the hydrogens attached to the nitrogen are replaced by methyl groups. It has a role as a human metabolite and an Escherichia coli metabolite. It is functionally related to a gamma-aminobutyrate and a gamma-aminobutyric acid zwitterion. It is a conjugate base of a 4-(trimethylammonio)butanoic acid. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a natural product found in Drosophila melanogaster, Homo sapiens, and other organisms with data available.",CHEMBL2074645
C[N+](C)(C)CCO,2.44,"This molecule is a choline that is the parent compound of the cholines class, consisting of ethanolamine having three methyl substituents attached to the amino function. It has a role as a neurotransmitter, a nutrient, a human metabolite, a plant metabolite, a Daphnia magna metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a mouse metabolite and an allergen. This molecule is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Amaranthus hybridus, Leonurus japonicus, and other organisms with data available.",CHEMBL920
CC(C)C([NH3+])C(=O)[O-],2.44,,
Nc1ncnc2c1ncn2C1OCC(O)C1O,2.44,,CHEMBL2361213
OCc1nc2ccccc2[nH]1,2.44,,CHEMBL71443
[NH3+]CCC([NH3+])C(=O)[O-],2.44,,
O=c1[nH]c(=O)n(C2OC(CO)C(O)C(F)C2O)cc1F,2.44,,CHEMBL2006351
Nc1ncc[nH]1,2.44,,CHEMBL291627
CC(=O)NC(C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)C(C)C)C(C)C,2.46,,
OCC1OC(OC2(COC3(CO)OC(CO)C(O)C3O)OC(CO)C(O)C2O)C(O)C(O)C1O,2.46,,
O=c1ccn(C2OC(CO)C(O)C(F)C2O)c(=O)[nH]1,2.46,,
c1ccc(-c2nsc(N3CCC[NH2+]CC3)n2)cc1,2.46,,
O=C([O-])c1ccc2nsnc2c1,2.46,,
O=C(Nc1ccccc1)c1cccnc1,2.46,,CHEMBL454533
O=C([O-])C=CC(=O)[O-],2.47,,
[NH3+]CCCc1ccccc1,2.47,,
OCC[NH+]1CC(O)C(O)C(O)C(O)C1,2.47,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)[O-])C(C)O)C(C)O,2.47,,
O=C([O-])c1ccccc1,2.48,,
O=C([O-])C(c1ccccc1)S(=O)(=O)[O-],2.49,,
CN(C)S(=O)(=O)c1ccsc1,2.49,,
CCCCCC#Cc1cn(C2OC(CO)C(O)C(O)C2O)c(=O)[nH]c1=O,2.49,,
CC12CCC(C(=O)[O-])(OC1=O)C2(C)C,2.49,,
O=C([O-])Cc1ccc(O)c(O)c1,2.5,,
O=C([O-])C1CC1C(=O)Nc1cc(F)ccc1F,2.51,,
O=C([O-])c1ccc2occc2c1,2.51,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],2.52,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,2.52,,
CSCC(=O)[O-],2.52,,
CCC1C(=O)N(c2nnn[nH]2)N=C1C,2.52,,
Nc1ncc(CCC([NH3+])C(=O)[O-])[nH]1,2.52,,
O=C([O-])c1c(O)cccc1O,2.52,,
[NH3+]C(CCC(=O)NC(CSCCN(CCCl)c1ccc(CCCC(=O)[O-])cc1)C(=O)NCC(=O)[O-])C(=O)[O-],2.53,,
CC(C)C(=O)[O-],2.54,,
Nc1nc2[nH]ccc2c(=O)[nH]1,2.55,,
CC(C)CC([NH3+])C(=O)[O-],2.55,,
Cn1nc(-c2cccs2)cc1N,2.55,,CHEMBL1615094
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,2.57,,
OCC(O)C1OC(O)C(O)C(O)C1O,2.57,,
C[Se]C1OC(C)C(O)C(O)C1O,2.57,,
[NH3+]Cc1ccc(C(=O)[O-])cc1,2.57,,
O=C([O-])CCc1c[nH]c2ccccc12,2.59,,
FC(F)(F)C(Cl)Br,2.59,"This molecule is a clear colorless highly volatile liquid with a sweet chloroform-like odor. Density 1.875 g / cm3. Boiling point 122.4 °F (50.2 °C). Noncombustible. These molecules is a potent volatile halogenated anesthetic gas that has been linked to many cases of idiosyncratic acute liver injury that are frequently severe. The potential of halothane to cause hepatotoxicity and the greater safety of newer anesthetics has led to a decrease in its use, currently limited to special situations, particularly in children. Because halothane is relatively inexpensive it continues to be used in developing countries. This molecule is a haloalkane comprising ethane having three flouro substituents at the 1-position as well as bromo- and chloro substituents at the 2-position. It has a role as an inhalation anaesthetic. It is a haloalkane, an organofluorine compound, an organochlorine compound and an organobromine compound. A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. nitrous oxide is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) This molecule is a nonflammable, halogenated, hydrocarbon and general inhalation anesthetic. Although the exact mechanism of action is unknown, halothane provides relatively rapid induction of anesthesia by depressing the central nervous system, thereby producing a reversible loss of consciousness and sensation. (NCI05) A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. nitrous oxide is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178)",CHEMBL931
O=C([O-])C1CC(=O)N(c2ccccc2O)C1,2.59,,
[NH3+]C(CC(=O)[O-])C(=O)[O-],2.59,,
[NH3+]C(CC(=O)[O-])C(=O)[O-],2.59,,
O=C([O-])C(C(=O)[O-])c1ccccc1,2.6,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],2.6,,
C[NH2+]CCCCC([NH3+])C(=O)[O-],2.6,,
C[NH2+]CCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,2.6,,
Nc1ccncc1,2.6,"This molecule is a white crystalline material with no odor. Used as an avicide, an intermediate and as a fixer for some textile dyes. (EPA, 1998)  It has been approved by the FDA for use as a treatment for multiple sclerosis. This molecule is a pyrimidine analogue used in the treatment of relapsing multiple sclerosis. This molecule has had limited clinical use, but has not been linked to serum enzyme elevations during treatment nor to instances of clinically apparent liver injury with jaundice. This molecule is an aromatic amine that is pyridine bearing a single amino substituent at position 4. An orphan drug in the US, it is used to improve walking in adults with multiple sclerosis. It has a role as an avicide, a potassium channel blocker and an orphan drug. It is an aromatic amine and an aminopyridine. This molecule is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients. FDA approved on January 22, 2010. This molecule is a Potassium Channel Blocker. The mechanism of action of dalfampridine is as a Potassium Channel Antagonist. This molecule is a natural product found in Houttuynia cordata with data available. This molecule is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients. FDA approved on January 22, 2010. 4-Aminopyridine is an organic compound with the formula H2NC5H4N. The molecule is one of the three isomeric amines of pyridine. 4-Aminopyridine (4-AP) is prepared by the decarbonylation of pyridine-4-carboxyamide using sodium hypochlorite via the Hofmann rearrangement (L1082).",CHEMBL284348
COc1ccc2nc(N)sc2c1,2.6,"This molecule is a fine off-white to light tan powder. (NTP, 1992)",CHEMBL97797
O=C([O-])CCC(=O)[O-],2.62,,
O=C1NC(Cc2ccc(O)cc2)C(=O)N2CCCC12,2.62,This molecule is an organonitrogen compound and an organooxygen compound. It is functionally related to an alpha-amino acid. This molecule is a natural product found in Microdochium nivale and Alternaria alternata with data available.,CHEMBL1980823
CC(NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(N)=O)NC(=O)C([NH3+])Cc1ccccc1)C(C)O)C(C)O)C(=O)NC(CCCC[NH3+])C(=O)[O-],2.62,,
Cc1cc(C[NH3+])c(C)o1,2.62,,
NC(=O)CCC([NH3+])C(=O)[O-],2.62,,
NC(=O)CCC([NH3+])C(=O)[O-],2.62,,
O=C([O-])Cc1ccc([N+](=O)[O-])cc1,2.63,,
ClCCCl,2.64,"This molecule is a manufactured chemical that is not found naturally in the environment. It is a clear liquid and has a pleasant smell and sweet taste. The most common use of 1,2-dichloroethane is in the production of vinyl chloride which is used to make a variety of plastic and vinyl products including polyvinyl chloride (PVC) pipes, furniture and automobile upholstery, wall coverings, housewares, and automobile parts. It is also used to as a solvent and is added to leaded gasoline to remove lead. This molecule appears as a clear colorless liquid with a chloroform-like odor. Flash point 56 °F. Denser than water and insoluble in water. Vapors are heavier than air. Density 10.4 lb / gal. This molecule is a member of the class of chloroethanes substituted by two chloro groups at positions 1 and 2. It has a role as a non-polar solvent, a hepatotoxic agent and a mutagen. Exposure to low levels of ethylene dichloride can occur from breathing ambient or workplace air. Inhalation of concentrated ethylene dichloride vapor can induce effects on the human nervous system, liver, and kidneys, as well as respiratory distress, cardiac arrhythmia, nausea, and vomiting. Chronic (long-term) inhalation exposure to ethylene dichloride produced effects on the liver and kidneys in animals. No information is available on the reproductive or developmental effects of ethylene dichloride in humans. Decreased fertility and increased embryo mortality have been observed in inhalation studies of rats. Epidemiological studies are not conclusive regarding the carcinogenic effects of ethylene dichloride, due to concomitant exposure to other chemicals. Following treatment by gavage (experimentally placing the chemical in the stomach), several tumor types were induced in rats and mice. EPA has classified ethylene dichloride as a Group B2, probable human carcinogen. This molecule is a clear, colorless, oily, synthetic, flammable liquid chlorinated hydrocarbon with a pleasant chloroform-like smell that emits toxic fumes of hydrochloric acid when heated to decomposition. Ethylene dichloride is primarily used to produce vinyl chloride. Inhalation exposure to this substance induces respiratory distress, nausea and vomiting and affects the central nervous system, liver and kidneys. It is mutagenic in animals and is reasonably anticipated to be a human carcinogen. (NCI05) This molecule is a solvent used in food processing.The chemical compound 1,2-dichloroethane, commonly known by its old name of ethylene dichloride (EDC), is a chlorinated hydrocarbon, mainly used to produce vinyl chloride monomer (VCM, chloroethene), the major precursor for PVC production. It is a colourless liquid with a chloroform-like odour. This molecule is also used generally as an intermediate for other organic chemical compounds, and as a solvent.

This molecule belongs to the family of Organochlorides. These are organic compounds containing a chlorine atom.",CHEMBL16370
CN1CCCC1=O,2.64,"This molecule appears as a clear colorless liquid with a &quot;fishlike&quot; odor. Denser than water. Flash point 199 °F. Contact may irritate skin, eyes and mucous membranes. May be toxic by ingestion. This molecule is a member of the class of pyrrolidine-2-ones that is pyrrolidin-2-one in which the hydrogen attached to the nitrogen is replaced by a methyl group. It has a role as a polar aprotic solvent. It is a N-alkylpyrrolidine, a lactam and a member of pyrrolidin-2-ones. This molecule is under investigation for the treatment of Multiple Myeloma. This molecule is a natural product found in Microtropis japonica, Melicope hayesii, and other organisms with data available. This molecule is a chemical compound with 5-membered lactam structure. It is a colorless to slightly yellow liquid miscible with water. It is used in petrochemical processing, and as a solvent for surface treatment of textiles, resins and metal coated plastics or as a paint stripper. In the pharmaceutical industry, N-methyl-2-pyrrolidone is used in the formulation for drugs by both oral and transdermal delivery routes. NMP has been identified as a reproductive toxicant, first by California in 2001[3] and then by the European Commission in 2003. In the face of increasing regulation, some manufacturers are considering alternative solvents for some applications, especially where worker exposure is difficult to control, such as in paint stripping, graffiti removal, and agriculture. (Wikipedia)",CHEMBL12543
O=C([O-])c1ccc(-c2ccccc2)nc1,2.64,,
Nc1nc(O)c(N)c(O)n1,2.66,,CHEMBL175083
NC(=[NH2+])NCCCC(=O)[O-],2.66,,
[NH3+]C(CCC(=O)NC(CS)C(=O)NCC(=O)[O-])C(=O)[O-],2.67,,
COC1(C(=O)[O-])CC(OC(C)=O)C(NC(C)=O)C(C(O)C(O)CO)O1,2.68,,
C[NH+](C)CCCN1c2ccccc2CCc2ccccc21,2.68,,
COC(=O)C1CC([NH3+])C[NH+]1C,2.68,,
Oc1ccc2[nH]ccc2c1,2.68,"This molecule is a member of the class of hydroxyindoles that is 1H-indole in which the hydrogen at position 5 has been replaced by a hydroxy group. It has a role as a human metabolite. This molecule is a natural product found in Ligusticum striatum, Solanum lycopersicum, and Ligusticum chuanxiong with data available.",CHEMBL404923
Cc1ccc2[nH]ccc2c1,2.68,,CHEMBL112462
N=c1[nH]c(=O)n(C2OC(CO)C(O)C2O)cc1F,2.69,,
Nc1nc2ncc(C(O)C(O)CO)nc2c(=O)[nH]1,2.7,,
[NH3+]C1C(OC2C(O)C(O)C(O)C(O)C2O)OC(CO)C(O)C1O,2.7,,
OCC1OC(SC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O,2.7,,
O=c1[nH]cnc2cn[nH]c12,2.7,,
CCCCC(=O)[O-],2.7,,
CC(=O)OCC[N+](C)(C)C,2.7,"This molecule is actylcholine is an ester of acetic acid and choline, which acts as a neurotransmitter. It has a role as a vasodilator agent, a muscarinic agonist, a hormone, a human metabolite, a mouse metabolite and a neurotransmitter. It is an acetate ester and an acylcholine. A neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. It is generally not used as an administered drug because it is broken down very rapidly by cholinesterases, but it is useful in some ophthalmological applications. This molecule is a Cholinergic Receptor Agonist. The mechanism of action of acetylcholine is as a Cholinergic Agonist. This molecule is a natural product found in Monascus pilosus, Poa huecu, and other organisms with data available.",CHEMBL667
CCC(C)C(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(C)C(=O)NC(CCSC)C(=O)NC(CCSC)C(=O)NC(CCC(N)=O)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)[O-],2.7,,
Nc1nccc2ccccc12,2.7,,CHEMBL62083
OC1C[S+]2CCCC(O)C2C1O,2.7,,
CCC(=O)C(=O)[O-],2.7,,
[NH3+]CCc1ccc(O)cc1,2.7,,
Nc1ccccc1OCc1cccnc1,2.7,,CHEMBL566838
C[NH2+]Cc1ccccc1-c1cccs1,2.7,,
Fc1ccc2[nH]ccc2c1,2.7,This molecule is an organofluorine compound that is the 5-fluoro derivative of indole.,CHEMBL555457
Oc1ccc2[nH]ccc2c1,2.7,"This molecule is a member of the class of hydroxyindoles that is 1H-indole in which the hydrogen at position 5 has been replaced by a hydroxy group. It has a role as a human metabolite. This molecule is a natural product found in Ligusticum striatum, Solanum lycopersicum, and Ligusticum chuanxiong with data available.",CHEMBL404923
C[NH+]1CCN(c2ccccc2C=NNC(N)=S)CC1,2.7,,
CC(C(=O)[O-])N1C(=O)C2C3CCC(C3)C2C1=O,2.7,,
CCCc1cc(=O)[nH]c(=[NH2+])[nH]1,2.7,,
CC(=O)OCC[N+](C)(C)C,2.7,"This molecule is actylcholine is an ester of acetic acid and choline, which acts as a neurotransmitter. It has a role as a vasodilator agent, a muscarinic agonist, a hormone, a human metabolite, a mouse metabolite and a neurotransmitter. It is an acetate ester and an acylcholine. A neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. It is generally not used as an administered drug because it is broken down very rapidly by cholinesterases, but it is useful in some ophthalmological applications. This molecule is a Cholinergic Receptor Agonist. The mechanism of action of acetylcholine is as a Cholinergic Agonist. This molecule is a natural product found in Monascus pilosus, Poa huecu, and other organisms with data available.",CHEMBL667
[NH3+]C(CCCCB(O)O)(C(=O)[O-])C(F)F,2.7,,
C=CC[NH+](Cc1ccccc1C(=O)NC(C)CC)Cc1ccc2c(c1C(=O)[O-])OCC(CCC(=O)[O-])O2,2.7,,
CCC(C)NC(=O)c1ccccc1C[NH+](C)Cc1ccc2c(c1C(=O)[O-])OCO2,2.7,,
COc1ccc(CNC(=O)c2ccccc2C[NH2+]Cc2ccc3c(c2C(=O)[O-])OCO3)cc1,2.7,,
O=C1c2ccc(S(=O)(=O)[O-])cc2C(=O)c2ccc(S(=O)(=O)[O-])cc21,2.7,,
C=C1CSC(C([NH3+])C(=O)[O-])N=C1C(=O)[O-],2.7,,
[NH3+]C(C(=O)[O-])C1N=C(C(=O)[O-])CCS1,2.7,,
CC[B+]O,2.7,,
O=C1CCN(c2cccc([N+](=O)[O-])c2)C(=O)N1,2.71,,
O=C([O-])CCCC(=O)[O-],2.72,,
O=S(=O)(O)CC[NH+]1CC[NH+](CCO)CC1,2.74,,
CC(=O)NC1C(O)CC(O)(C(=O)[O-])OC1C(O)C(O)CO,2.74,,
C[NH2+]CCCCC([NH3+])C(=O)[O-],2.74,,
O=C([O-])C(O)C(=O)[O-],2.74,,
COC1OC(CO)C(O)C(O)C1O,2.74,,
C=CS(=O)(=O)[O-],2.75,,
NC(=[NH2+])NCCCC([NH3+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NCC(=O)[O-],2.76,,
CC(O)C(C)(O)C(=O)[O-],2.76,,
CC(=O)Oc1c(C)cccc1C(=O)[O-],2.77,,
CN(C)C(=[NH2+])NCCCC([NH3+])C(=O)[O-],2.77,,
CN(C)S(=O)(=O)c1ccsc1,2.77,,
NS(=O)(=O)c1cc(Cl)sc1C(=O)[O-],2.77,,
C=NCCCC,2.78,,
c1ccc(NCc2cccnc2)cc1,2.78,,CHEMBL264669
O=C1CN(c2ccccc2)S(=O)(=O)N1,2.8,,CHEMBL190801
[NH3+]Cc1ccccc1,2.8,,
O=C1Cc2ccccc2C1=Cc1ccc2c(c1C(=O)[O-])OCO2,2.8,,
CCn1c(O)cc(=O)n(CC)c1=S,2.8,,
O=C(c1ccccc1)N1CCCCC1,2.81,This molecule is a N-acylpiperidine and a member of benzamides.,CHEMBL1897277
[NH2+]=C1N=C2NCC(CNc3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc3)N(C=O)C2C(=O)N1,2.81,,
O=C([O-])CCCC(=O)[O-],2.82,,
Cn1c(=O)c2[nH]cnc2n(C)c1=O,2.82,,
OCC(O)C1OC(O)C(O)C(O)C1O,2.82,,
CC(C)=CC[n+]1cnc(N)c2nc[nH]c21,2.82,,
Nc1ncc(C=CC(=O)[O-])cn1,2.82,,
O=C([O-])CCC(O)C(=O)[O-],2.82,,
Clc1ccc2[nH]ccc2c1,2.82,,CHEMBL555013
COc1ccc(S(N)(=O)=O)cc1,2.82,,CHEMBL176402
CC1[NH2+]CCC(C(=O)[O-])[NH2+]1,2.82,,
c1ccc2[nH]cnc2c1,2.82,"This molecule appears as white tabular crystals. (NTP, 1992) This molecule is the 1H-tautomer of benzimidazole. It is a benzimidazole and a polycyclic heteroarene. It is a conjugate acid of a benzimidazolide. It is a tautomer of a 4H-benzimidazole, a 2H-benzimidazole and a 3aH-benzimidazole.",CHEMBL306226
Oc1ccccc1O,2.82,"Solid; white; odorless. Sinks and mixes with water. (USCG, 1999) This molecule is a benzenediol comprising of a benzene core carrying two hydroxy substituents ortho to each other. It has a role as a genotoxin, an allelochemical and a plant metabolite. It is a conjugate acid of a catecholate(1-). Exposure to catechol may occur during its manufacture and use. Skin contact with catechol causes eczematous dermatitis in humans. In humans, absorption through the skin results in an illness resembling that induced by phenol, except convulsions are more pronounced. Large doses of catechol can cause depression of the central nervous system (CNS) and a prolonged rise of blood pressure in animals. Due to the lack of information regarding the duration of exposure in the above studies, it is not clear whether these health effects were observed following acute (short-term) or chronic (long-term) exposure. Tumors in the glandular stomach were observed in orally exposed rats. The International Agency for Research on Cancer (IARC) has classified catechol as a Group 2B, possible human carcinogen. EPA has not classified catechol with respect to potential carcinogenicity. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a natural product found in Pinus densiflora, Illicium simonsii, and other organisms with data available. This molecule is a benzenediol, with formula C6H4(OH)2. It was first prepared in 1839 by H. Reinsch by distilling catechin (the juice of Mimosa catechu). This colourless compound occurs naturally, but about 20000 tons are manufactured each year, mainly as precursors to pesticides, flavors, and fragrances. Its sulfonic acid is often present in the urine of many mammals. Small amounts of catechol occur naturally in fruits and vegetables, along with the enzyme polyphenol oxidase. Upon mixing the enzyme with the substrate and exposure to oxygen (as when a potato or apple is cut), the colorless catechol oxidizes to reddish-brown benzoquinone derivatives. The enzyme is inactivated by adding an acid, such as lemon juice, or by refrigeration. Excluding oxygen also prevents the browning reaction. Catechol melts at 28 oC and boils at 250 oC. It is employed in medicine as an expectorant. The dimethyl ether or veratrol is also used in medicine. Many other pyrocatechin derivatives have been suggested for therapeutic application.",CHEMBL280998
NC(=O)c1ncn(C2OC(CO)C(O)C2O)n1,2.82,This molecule is a nucleobase-containing molecular entity.,CHEMBL34
Nc1nc(-c2ccc(O)cc2)cs1,2.84,This molecule is a member of phenols.,CHEMBL483790
O=C1Cc2ccccc2C1=Cc1ccc2c(c1C(=O)[O-])OCO2,2.84,,
[NH3+]CCCCCC(=O)NC1Cc2ccccc2C1Cc1ccc2c(c1C(=O)[O-])OCO2,2.84,,
Nc1nc2cc[nH]c2c(=O)[nH]1,2.85,,CHEMBL367746
[NH3+]C1CCCCCC1,2.85,,
CNC(=O)NC,2.85,"This molecule appears as colorless crystals. (NTP, 1992) This molecule is a member of the class of ureas that is urea substituted by methyl groups at positions 1 and 3.",CHEMBL1234380
[NH3+]C1CCCCCC1,2.85,,
O=C1Nc2ccccc2C12CC[NH2+]C2,2.85,,
O=C([O-])c1ccc(-c2ccc(F)c(Cl)c2)o1,2.85,,
O=C([O-])c1c(C=C2c3ccccc3CC2O)ccc2c1OCO2,2.86,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,2.86,,
N=c1ccn(C2OC(CO)C(O)C2(F)F)c(=O)[nH]1,2.86,,
CC[NH+](CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,2.87,,
CCC(C=O)C(CNS(=O)(=O)c1ccc(C)cc1)C(=O)[O-],2.88,,
CC(=O)NC(C)CCCC(=O)[O-],2.88,,
CNC(NC)=[NH+]CCCC([NH3+])C(=O)[O-],2.88,,
CC[NH+](CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,2.89,,
CCCC(=O)[O-],2.89,,
CC(C)CC(NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)[O-],2.89,,
CCCN(CCC)C(=O)C(O)C(O)CO,2.89,,
CC(C(=O)[O-])N1C(=O)C2C3CCC(C3)C2C1=O,2.89,,
COC(=O)c1cccc2[nH]ccc12,2.89,,CHEMBL3416133
OCC1OC(OC2C(O)C(O)c3nccn3C2CO)C(O)C(O)C1O,2.89,,
CCOC(=O)C=Cc1ccc(O)c(O)c1,2.89,,
CC(C(=O)[O-])N(c1ccccc1)S(C)(=O)=O,2.89,,
Cc1cc(C)nc(N)n1,2.89,This molecule is an aminopyrimidine.,CHEMBL4546836
OCC(CO)(CO)[NH2+]CCC[NH2+]C(CO)(CO)CO,2.9,,
CC(=O)NC1C(O)CC(C(=O)[O-])OC1C(O)C(O)CO,2.91,,
Cc1ccc(CCC(=O)[O-])cc1,2.91,,
O=c1[nH]n(CCc2ccccc2)c(=O)c2cc(OC3OC(CO)C(O)C(O)C3O)ccc12,2.92,,
O=C([O-])CNC(=O)C(=O)[O-],2.92,,
CCCCC(=O)OCC(COP(=S)(S)OCC[N+](C)(C)C)OC(=O)CCCC,2.92,,
CN(CCOc1ccc(-c2ccc(C#N)cc2)cc1)C(=O)NO,2.92,,CHEMBL200435
O=C([O-])C1=CC(O)C(O)C(O)C1,2.92,,
O=C([O-])C1=CC(O)C(O)C(O)C1,2.92,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],2.92,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],2.92,,
CC(NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(N)=O)NC(=O)C([NH3+])Cc1ccccc1)C(C)O)C(C)O)C(=O)NC(CCCC[NH3+])C(=O)[O-],2.92,,
OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1O,2.92,,
Cn1cnc(N)c2ncnc1-2,2.92,,CHEMBL292268
O=C([O-])CCc1ccc2c(c1)OCO2,2.92,,
CC(=O)c1ccc2c(c1)OCCO2,2.92,This molecule is a benzodioxine.,CHEMBL4557075
CCN1CNS(=O)(=O)c2cnccc21,2.92,,CHEMBL99732
[NH3+]CC1CCCCC1,2.93,,
c1ccc(NCc2cccnc2)cc1,2.93,,CHEMBL264669
CC(=O)NC1C(O)OC(CO)C(O)C1O,2.94,"This molecule is a N-acyl-hexosamine. This molecule is under investigation for the other of GNE Myopathy. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655).",CHEMBL83479
Cc1ccc(S(=O)(=O)N2CCCC2C(=O)[O-])cc1,2.96,,
O=C1NC(Cc2c[nH]cn2)C(=O)N2CCCC12,2.96,,
O=C([O-])c1ccc(O)c(O)c1,2.96,,
[NH3+]C1CCOC1=O,2.96,,
O=C(OC1Cc2c(O)cc(O)cc2OC1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,2.96,"This molecule is a catechin. This molecule is a natural product found in Camellia sinensis, Cistus salviifolius, and other organisms with data available.",CHEMBL311663
O=c1c2c3c(sc2ncn1Cc1nn[nH]n1)CCCC3,2.96,,
COc1ccc2[nH]ccc2c1,2.96,This molecule is a member of indoles.,CHEMBL280311
COc1ccc2[nH]ccc2c1,2.96,This molecule is a member of indoles.,CHEMBL280311
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(OC3(C(=O)[O-])CC(O)C(NC(C)=O)C(C(O)C(O)CO)O3)C2O)C1O,2.96,,
Cc1[nH]c2cc(Cl)cc(Cl)c2c1CC[NH3+],2.96,,
CC(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)[O-],2.96,,
Nc1cccc2c1CC[NH2+]C2,2.96,,
Nc1c(F)cccc1C(=O)[O-],2.96,,
COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(c(C=NN5CC[NH+](C)CC5)c(O)c4c3C2=O)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C,2.97,,
C=CC[NH+](Cc1ccccc1C(=O)NCc1ccc(OC)cc1)Cc1ccc2c(c1C(=O)[O-])OCC(CCC(=O)[O-])O2,2.97,,
CC(=O)NCCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)O)C(C)O)C(=O)NC(CO)C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)[O-])C(C)O,2.98,,
OCC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1O,2.98,,
O=C([O-])Cc1ccc(N2C(=O)C(O)=C(C(=O)c3ccccc3Cl)C2c2ccccc2Cl)cc1,2.98,,
CN(C)C(=[NH2+])NCCCC([NH3+])C(=O)[O-],2.99,,
O=C([O-])CCc1cccc(C(=O)[O-])c1,2.99,,
O=C([O-])C(O)CC(O)C(O)C(=O)[O-],3.0,,
[NH3+]CCCC([NH3+])C(=O)[O-],3.0,,
O=C([O-])C(O)c1ccccc1,3.0,,
COC1OCC(OC2OCC(O)C(O)C2O)C(O)C1O,3.0,,
Nc1ncccc1OCc1ccccc1,3.0,,CHEMBL194009
CSc1nnc(-c2ccc(Cl)cc2)[nH]1,3.0,,CHEMBL225664
Oc1ccccc1Cl,3.0,"This molecule appears as a colorless to amber liquid with an unpleasant, penetrating odor. Density 1.265 g / cm3. Sinks in water and slowly dissolves. Freezing point 7 °C (46 °F). Boiling point 175 °C (347 °F). This molecule is a monochlorophenol and a 2-halophenol. This molecule is a monochlorophenol isomer that has a chlorine atom in the ortho position. It has a medicinal taste and smell, and is a slightly acidic liquid. 2-Chlorophenol is used as a disinfectant agent (L722).",CHEMBL108877
COC1OC(CO)C(O)C(O)C1O,3.0,,
NC(=O)c1cccnc1,3.0,"This molecule is a white powder. (NTP, 1992) This molecule is a pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group. It has a role as an EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor, a metabolite, a cofactor, an antioxidant, a neuroprotective agent, an EC 3.5.1.98 (histone deacetylase) inhibitor, an anti-inflammatory agent, a Sir2 inhibitor, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a mouse metabolite, a human urinary metabolite and a geroprotector. It is a vitamin B3, a pyridinecarboxamide and a pyridine alkaloid. It is functionally related to a nicotinic acid. An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and pellagra. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. This molecule is the active form of vitamin B3 and a component of the coenzyme nicotinamide adenine dinucleotide (NAD). This molecule acts as a chemo- and radio-sensitizing agent by enhancing tumor blood flow, thereby reducing tumor hypoxia.  This agent also inhibits poly(ADP-ribose) polymerases, enzymes involved in the rejoining of DNA strand breaks induced by radiation or chemotherapy. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Lactarius subplinthogalus, Taraxacum formosanum, and other organisms with data available. This molecule is a uremic toxin.  Uremic toxins can be subdivided into three major groups based upon their chemical and physical characteristics: 1) small, water-soluble, non-protein-bound compounds, such as urea; 2) small, lipid-soluble and/or protein-bound compounds, such as the phenols and 3) larger so-called middle-molecules, such as beta2-microglobulin. Chronic exposure of uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease. 
Niacinamide or vitamin B3 is an important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and pellagra. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Niacinamide is used to increase the effect of radiation therapy on tumor cells. Niacin (nicotinic acid) and niacinamide, while both labeled as vitamin B3 also have different applications. Niacinamide is useful in arthritis and early-onset type I diabetes while niacin is an effective reducer of high cholesterol levels.",CHEMBL1140
COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1,3.0,,
CC1[NH2+]C(C[NH2+]C(CO)c2ccccc2)C(O)C1O,3.0,,
C[NH+](CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,3.0,,
O=C([O-])C(Cl)Cl,3.0,,
CC(=O)NCCCCC([NH3+])C(=O)[O-],3.0,,
[NH3+]C(CO)C(=O)[O-],3.0,,
Cc1cccc(C)c1OCC(C)[NH3+],3.0,,
N#Cc1cnn2cccnc12,3.0,,CHEMBL503917
O=C([O-])C(=O)c1cccc(O)c1,3.0,,
O=C1NC(=O)C(=O)C(=O)N1,3.0,"This molecule is a member of the class of pyrimidones, the structure of which is that of perhydropyrimidine substituted at C-2, -4, -5 and -6 by oxo groups. It has a role as a hyperglycemic agent and a metabolite. It is functionally related to a barbituric acid. This molecule is a natural product found in Euglena gracilis with data available.",CHEMBL1096009
COc1ccccc1-c1ccc(C(=O)[O-])o1,3.0,,
CC(=O)NC1C(O)CC(OC2C(O)C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C2O)(C(=O)[O-])OC1C(O)C(O)CO,3.0,,
CC(O)C(NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C1CCC[NH2+]1)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(C=O)CO,3.0,,
O=C1OC(C(O)CO)C(O)=C1O,3.0,This molecule is a natural product found in Pisum sativum and Hippophae with data available.,CHEMBL1161421
O=C([O-])c1cnc(-c2ccccc2)[nH]1,3.0,,
O=C([O-])c1cc2ccccc2o1,3.0,,
O=C([O-])c1c(CN2C(=O)Cc3cc(Cl)ccc32)ccc2c1OCCO2,3.0,,
O=c1cc(C(F)(F)F)c2c([nH]1)CCC2,3.0,,CHEMBL1233750
CC(O)C1OC(OC2C(OC3C(OC4C(O)C(O)OC(CO)C4O)OC(CO)C(O)C3O)OC(CO)C(O)C2O)C(O)C(O)C1O,3.0,,
c1ccc2[nH]ncc2c1,3.0,This molecule is an indazole. It is a tautomer of a 2H-indazole.,CHEMBL86795
OCC1OC(OC2C(CO)OC(OC3C(CO)OC(OC4C(CO)OC(O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1O,3.0,,
COC1OC(CO)C(O)C(OC2OC(CO)C(O)C(O)C2NC(C)=O)C1O,3.0,,
O=C1NCc2ccc(Cl)cc21,3.0,,CHEMBL2381486
CC(=O)NC1C(O)CC(OCC2OC(O)C(O)C(O)C2O)(C(=O)[O-])OC1C(O)C(O)CO,3.0,,
CCC(C)C(NC(=O)C(NC(=O)C(CO)NC(=O)C([NH3+])CC(=O)[O-])C(C)CC)C(=O)[O-],3.0,,
CC(=O)NC1C(O)CC(O)(C(=O)[O-])OC1C(O)C(O)CO,3.0,,
Cc1nc(=O)c2ccccc2[nH]1,3.0,,
Oc1ccc(-n2ccnc2)cc1,3.0,,CHEMBL275339
O=C([O-])c1cc2ccccc2o1,3.0,,
Cc1[nH]ncc1-c1ccc(F)cc1,3.0,,
N#Cc1c(F)cc(O)cc1SCCS(=O)(=O)[O-],3.0,,
[Cl+]1C2C13[Cl+]C3C21C23[Cl+2]4[Cl+2]2C413,3.01,,
[NH3+]CCc1ccccc1,3.01,,
COC1OC(CO)C(O)C(O)C1O,3.02,,
O=C([O-])C(O)C(O)C(=O)[O-],3.02,,
O=C([O-])C1CC[NH+](CCOc2ccc3[nH]ccc3c2)CC1,3.02,,
OC1COC(O)C(O)C1O,3.03,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL14343
COC1OC(CO)C(O)C(O)C1O,3.03,,
OCC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1O,3.03,,
C[N+](C)(C)CCO,3.03,"This molecule is a choline that is the parent compound of the cholines class, consisting of ethanolamine having three methyl substituents attached to the amino function. It has a role as a neurotransmitter, a nutrient, a human metabolite, a plant metabolite, a Daphnia magna metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a mouse metabolite and an allergen. This molecule is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Amaranthus hybridus, Leonurus japonicus, and other organisms with data available.",CHEMBL920
[NH3+]CCc1c[nH]c2ccc(O)cc12,3.03,,
OCc1ccc2c(c1)OCCO2,3.03,,CHEMBL4582404
NC(=[NH2+])c1ccccc1,3.04,,
CC(C)C(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(N)=O)NC(=O)C([NH3+])Cc1ccccc1)C(=O)[O-],3.04,,
Nc1ncnc2c1ncn2C1OC(CO)C(O)C1O,3.04,"This molecule is a purine nucleoside. This molecule is a natural product found in Acanthus ilicifolius, Acanthus ebracteatus, and other organisms with data available.",CHEMBL11909
COC1OC(CO)C(O)C(NC(=O)c2ccc(C)cc2)C1OC(=O)c1ccc(C)cc1,3.04,,
Cc1cc(C)n2nc(N)cc2n1,3.04,,CHEMBL1916048
Cc1ccccc1,3.04,"This molecule is a clear, colorless liquid with a distinctive smell. This molecule occurs naturally in crude oil and in the tolu tree. It is also produced in the process of making gasoline and other fuels from crude oil and making coke from coal. This molecule is used in making paints, paint thinners, fingernail polish, lacquers, adhesives, and rubber and in some printing and leather tanning processes. This molecule appears as a clear colorless liquid with a characteristic aromatic odor. Flash point 40 °F. Less dense than water (7.2 lb / gal) and insoluble in water. Hence floats on water. Vapors heavier than air. May be toxic by inhalation, ingestion or skin contact. Used in aviation and automotive fuels, as a solvent, and to make other chemicals. This molecule is the simplest member of the class toluenes consisting of a benzene core which bears a single methyl substituent. It has a role as a non-polar solvent, a cholinergic antagonist, a neurotoxin and a fuel additive. It is a methylbenzene, a volatile organic compound and a member of toluenes. This molecule is a colorless, liquid that is immiscible in water. It is a mono-substituted benzene derivative used in veterinary medicine as a treatment for various parasites in dogs and cats. This molecule is added to gasoline, used to produce benzene, and used as a solvent. Exposure to toluene may occur from breathing ambient or indoor air affected by such sources. The central nervous system (CNS) is the primary target organ for toluene toxicity in both humans and animals for acute (short-term) and chronic (long-term) exposures. CNS dysfunction and narcosis have been frequently observed in humans acutely exposed to elevated airborne levels of toluene; symptoms include fatigue, sleepiness, headaches, and nausea. CNS depression has been reported to occur in chronic abusers exposed to high levels of toluene. Chronic inhalation exposure of humans to toluene also causes irritation of the upper respiratory tract and eyes, sore throat, dizziness, and headache. Human studies have reported developmental effects, such as CNS dysfunction, attention deficits, and minor craniofacial and limb anomalies, in the children of pregnant women exposed to high levels of toluene or mixed solvents by inhalation. EPA has concluded that that there is inadequate information to assess the carcinogenic potential of toluene. This molecule is an aromatic hydrocarbon composed of a benzene ring linked to one methyl group. This molecule is used a solvent or as a chemical intermediate in various industrial applications. Rapid inhalation of high concentrations of toluene can cause severe neurological complications. This molecule is a natural product found in Basella alba, Zingiber mioga, and other organisms with data available. This molecule is found in allspice. This molecule is isolated from distilled tolu balsam (Myroxylon balsamum). Minor constituent of lime oil (Citrus aurantifolia).This molecule, formerly known as toluol, is a clear, water-insoluble liquid with the typical smell of paint thinners. It is an aromatic hydrocarbon that is widely used as an industrial feedstock and as a solvent. (Wikipedia) 

This molecule has been shown to exhibit beta-oxidant, depressant, hepatoprotective, anesthetic and neurotransmitter functions (A7693, A7694, A7695, A7696, A7697).",CHEMBL9113
O=c1[nH]cnc2ccccc12,3.04,"This molecule is a member of quinazolines. This molecule is a natural product found in Streptomyces, Strobilanthes, and other organisms with data available.",CHEMBL266540
CC(=O)NC(CCC(=O)C(=O)[O-])C(O)C(O)C(O)CO,3.05,,
CCC(C)C(C=O)NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(C)=O,3.05,,
O=C([O-])CCC(=O)CF,3.05,,
OCC1OC(O)C(O)C(O)C1O,3.05,,
Nc1ccc2ccccc2n1,3.05,This molecule is an aminoquinoline. This molecule is a natural product found in Leucopaxillus albissimus with data available.,CHEMBL61236
O=C([O-])c1cnn(-c2ccccc2)c1,3.05,,
O=C([O-])C1COc2ccccc2O1,3.05,,
O=C([O-])C1=CC(O)C(O)C(O)C1,3.05,,
CCCCOc1ccc2cc(S(=O)(=O)NC(CCC(=O)[O-])C(=O)[O-])ccc2c1,3.06,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCC[NH3+])NC(=O)C1CCCN1C(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)[O-],3.06,,
[NH3+]CCc1c[nH]c2ccccc12,3.06,,
Nc1nc2ccccc2nc1N1CCCC1,3.06,,CHEMBL1232596
[NH3+]CCc1c[nH]c2ccccc12,3.06,,
NC(=[NH2+])Nc1ccc(C(=O)[O-])cc1,3.06,,
Cc1ccc2[nH]cc(C[NH+]3CCC(NC(=O)C([NH3+])Cc4c[nH]c5ccccc45)CC3)c2c1,3.06,,
O=C([O-])C(=O)[O-],3.07,,
[NH3+]C1(C(=O)[O-])CCC1,3.08,,
O=C([O-])C(O)c1ccccc1,3.09,,
OCC1OC(O)C(O)C(O)C1O,3.09,,
O=C(OCc1ccccc1)c1cccnc1,3.09,This molecule is a benzyl ester resulting from the formal condensation of the carboxy group of nicotinic acid with benzyl alcohol. It has been used as a rubefacient. It has a role as a vasodilator agent. It is functionally related to a nicotinic acid.,CHEMBL209744
CC(=O)Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(O)c12,3.1,,CHEMBL144613
O=c1ccn(C2OC(CO)C(O)C2O)c(=O)[nH]1,3.1,"This molecule is a pyrimidine nucleoside. This molecule is a natural product found in Homo sapiens, Apium graveolens, and other organisms with data available.",CHEMBL68846
O=C([O-])C(O)C(O)C(O)C(=O)NO,3.1,,
Cn1cnc2c(N)nc[n+](C)c21,3.1,,
c1nc2nc[n+]3cc[nH]c3c2[nH]1,3.1,,
c1ccccc1,3.1,"This molecule is a colorless liquid with a sweet odor. It evaporates into the air very quickly and dissolves slightly in water. It is highly flammable and is formed from both natural processes and human activities. This molecule is widely used in the United States; it ranks in the top 20 chemicals for production volume. Some industries use benzene to make other chemicals which are used to make plastics, resins, and nylon and synthetic fibers. This molecule is also used to make some types of rubbers, lubricants, dyes, detergents, drugs, and pesticides. Natural sources of benzene include volcanoes and forest fires. This molecule is also a natural part of crude oil, gasoline, and cigarette smoke. This molecule appears as a clear colorless liquid with a petroleum-like odor. Flash point less than 0 °F. Less dense than water and slightly soluble in water. Hence floats on water. Vapors are heavier than air. This molecule is a six-carbon aromatic annulene in which each carbon atom donates one of its two 2p electrons into a delocalised pi system. A toxic, flammable liquid byproduct of coal distillation, it is used as an industrial solvent. This molecule is a carcinogen that also damages bone marrow and the central nervous system. It has a role as a non-polar solvent, a carcinogenic agent and an environmental contaminant. It is an aromatic annulene, a volatile organic compound and a member of benzenes. This molecule is found in the air from emissions from burning coal and oil, gasoline service stations, and motor vehicle exhaust. Acute (short-term) inhalation exposure of humans to benzene may cause drowsiness, dizziness, headaches, as well as eye, skin, and respiratory tract irritation, and, at high levels, unconsciousness. Chronic (long-term) inhalation exposure has caused various disorders in the blood, including reduced numbers of red blood cells and aplastic anemia, in occupational settings. Reproductive effects have been reported for women exposed by inhalation to high levels, and adverse effects on the developing fetus have been observed in animal tests. Increased incidence of leukemia (cancer of the tissues that form white blood cells) have been observed in humans occupationally exposed to benzene. EPA has classified benzene as known human carcinogen for all routes of exposure. This molecule is a clear, colorless, highly flammable and volatile, liquid aromatic hydrocarbon with a gasoline-like odor. This molecule is found in crude oils and as a by-product of oil-refining processes. In industry benzene is used as a solvent, as a chemical intermediate, and is used in the synthesis of numerous chemicals. Exposure to this substance causes neurological symptoms and affects the bone marrow causing aplastic anemia, excessive bleeding and damage to the immune system. This molecule is a known human carcinogen and is linked to an increased risk of developing lymphatic and hematopoietic cancers, acute myelogenous leukemia, as well as chronic lymphocytic leukemia. (NCI05) This molecule is a natural product found in Swertia japonica, Basella alba, and other organisms with data available. This molecule is a toxic, volatile, flammable liquid hydrocarbon biproduct of coal distillation. Chronic benzene exposure produces hematotoxicity, bone marrow dysplasia (Displasia is a pre-neoplastic or pre-cancerous change). (A7669). It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. This molecule causes central nervous system damage acutely and is carcinogenic. It was formerly used as parasiticide.",CHEMBL277500
CCN(CC)C(=O)c1ccc(O)c(OC)c1,3.1,"This molecule is phenol substituted at C-2 and C-4 by a methoxy group and an N,N-diethylaminocarbonyl group respectively. A respiratory stimulant drug related to nikethamide, it has now fallen largely into disuse. It is a member of phenols and a member of methoxybenzenes. This molecule is marketed under the name Analepticon. Etamvin is a respiratory stimulant drug similar to nikethamide. It is no longer used in the United States.",CHEMBL1229908
CC([NH3+])Cc1ccc(O)cc1,3.1,,
FC(F)OC(Cl)C(F)(F)F,3.1,"This molecule is a commonly used inhalational anesthetic and has an excellent safety record. This molecule has been linked to rare instances of severe acute liver injury resembling halothane induced liver injury in small case series and individual case reports. This molecule is an organofluorine compound. It has a role as an inhalation anaesthetic. It is functionally related to a methoxyethane. A stable, non-explosive inhalation anesthetic, relatively free from significant side effects. This molecule is a General Anesthetic. The physiologic effect of isoflurane is by means of General Anesthesia. This molecule is a fluorinated ether with general anesthetic and muscle relaxant activities. Although the exact mechanism of action has not been established, inhaled isoflurane, appears to act on the lipid matrix of the neuronal cell membrane, which results in disruption of neuronal transmission. This agent enhances the release of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), thereby increasing the activity of the inhibitory neurotransmitter on synaptic transmission. This molecule may also both inhibit glutamatergic excitatory transmission by increasing glutamate re-uptake, and potentiate glycine receptor activity, which decreases motor function. In addition, isoflurane may alter certain pro- and anti-inflammatory cytokines, including interleukin-6 and -10 (IL-6, IL-10), possibly through the activation of the nuclear factor kappa B (NF-KB) pathway, which may affect immune responses during surgery. This molecule is only found in individuals that have used or taken this drug. It is a stable, non-explosive inhalation anesthetic, relatively free from significant side effects. [PubChem]This molecule induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. This molecule also activates calcium dependent ATPase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. Also appears to bind the D subunit of ATP synthase and NADH dehydogenase. This molecule also binds to the GABA receptor, the large conductance Ca<sup>2+</sup> activated potassium channel, the glutamate receptor and the glycine receptor.",CHEMBL1256
CC(NC(=O)C1CCC[NH2+]1)C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-])C(C)C)C(C)O,3.1,,
COc1ccc(CNC(=O)c2cc3c(cc2C[NH+](C)Cc2cccc(OC)c2C(=O)[O-])OCO3)cc1,3.1,,
CC(C)C(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])CCC(=O)[O-])C(C)C)C(=O)NC(CCC(N)=O)C(=O)[O-],3.1,,
CC1CCCC(C(=O)[O-])N1C(=O)CCS,3.1,,
CCC(C)C(NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(CCSC)C(=O)NCC(=O)NC(CC(C)C)C(=O)[O-])C(C)C,3.1,,
O=CC=Cc1ccc(O)cc1O,3.11,,
O=C([O-])CCCc1c[nH]c2ccccc12,3.11,,
CC(O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(=[NH2+])N(C)C)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C([NH3+])Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(CCC(N)=O)C(=O)NC(CO)C(=O)N1CCCC1C(=O)[O-],3.11,,
O=[N+]([O-])c1ccc(NN=C(S)Nc2ccc(F)cc2)c([N+](=O)[O-])c1,3.11,,
O=C([O-])c1ccccc1C(=O)[O-],3.11,,
Nc1nc2cc(Cl)ccc2n1CCCO,3.11,,CHEMBL1221922
CNc1nc2ccc(NC(C)=O)cc2s1,3.11,,CHEMBL2058997
Cc1nc2ccc(NC(=O)CCNC(N)=O)cc2s1,3.11,,CHEMBL2059004
CCCCCCCCCOC1OC(CO)C(O)C(O)C1O,3.11,,
CCC(C)C(C=O)NC(=O)C1CCCN1C(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])C(C)C,3.12,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCC[NH3+])NC(=O)C1CCCN1C(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)[O-],3.12,,
CC(O)C(C)(O)C(=O)[O-],3.12,,
[NH3+]CCCCCC(=O)NC1Cc2ccccc2C1Cc1ccc2c(c1C(=O)[O-])OCO2,3.12,,
CC(=O)NC1C(O)OC(CO)C(O)C1O,3.13,"This molecule is a N-acyl-hexosamine. This molecule is under investigation for the other of GNE Myopathy. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655).",CHEMBL83479
O=C([O-])CCc1nc2ccccc2[nH]1,3.13,,
OCC([NH2+]CC1[NH2+]CC(O)C1O)c1ccccc1,3.14,,
CC(=O)NC1C(NC(N)=[NH2+])C=C(C(=O)[O-])OC1C(O)C(O)CO,3.14,,
O=C([O-])c1cc(-c2ccccn2)n[nH]1,3.14,,
Nc1nc2ccccc2s1,3.14,"This molecule is an odorless gray to white powder. (NTP, 1992) This molecule is a member of benzothiazoles.",CHEMBL329785
OCC1C(O)C(O)C(O)c2nn[nH][n+]21,3.15,,
O=[N+]([O-])c1cccc(OC2OC(CO)C(O)C(O)C2O)c1,3.15,,
CCCCCCCC[NH2+]CC(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(N)=O,3.15,,
OCC1C(O)C(O)C(O)c2nnnn21,3.15,,
OCC1C(O)C(O)C(O)c2nnnn21,3.15,,
OCC1C(O)C(O)C(O)c2nnnn21,3.15,,
OCC1OC(O)C(O)C(O)C1O,3.15,,
Nc1ncnc2[nH]cnc12,3.15,"This molecule is the parent compound of the 6-aminopurines, composed of a purine having an amino group at C-6. It has a role as a human metabolite, a Daphnia magna metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a purine nucleobase and a member of 6-aminopurines. It derives from a hydride of a 9H-purine. A purine base and a fundamental unit of adenine nucleotides. This molecule is a purine nucleobase with an amine group attached to the carbon at position 6. This molecule is the precursor for adenosine and deoxyadenosine nucleosides. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Streptomyces piomogenus, Bridelia balansae, and other organisms with data available. This molecule is a purine base. This molecule is found in both DNA and RNA. This molecule is a fundamental component of adenine nucleotides. This molecule forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose; it forms adenosine triphosphate (ATP), a nucleotide, when three phosphate groups are added to adenosine. Adenosine triphosphate is used in cellular metabolism as one of the basic methods of transferring chemical energy between chemical reactions. Purine inborn errors of metabolism (IEM) are serious hereditary disorders, which should be suspected in any case of neonatal fitting, failure to thrive, recurrent infections, neurological deficit, renal disease, self-mutilation and other manifestations. Investigation usually starts with uric acid (UA) determination in urine and plasma. (OMIM 300322, 229600, 603027, 232400, 232600, 232800, 201450, 220150, 232200, 162000, 164050, 278300).  (A3372, A3373).",CHEMBL226345
CC1CC2OC2C=CC=CC(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1,3.15,This molecule is a macrocyclic antifungal antibiotic that inhibits signal-dependent transcriptional activation and induces differentiation in leukemia. (NCI),CHEMBL3972342
[NH3+]C(CCC(O)[NH2+]C(CS)C(O)[NH2+]CC(=O)[O-])C(=O)[O-],3.15,,
O=C([O-])C1COc2ccccc2O1,3.15,,
Cc1nn(C)c2sc(C(=O)[O-])cc12,3.15,,
O=C([O-])c1ccc(-c2ccc(F)c(Cl)c2)o1,3.15,,
[NH3+]CCc1c[nH]c2ccc(O)cc12,3.16,,
O=C([O-])c1ccc[nH]1,3.16,,
CC(C)Cn1c(=O)n(C)c(=O)c2[nH]cnc21,3.16,,
Oc1ccnc2ccccc12,3.16,"This molecule is a quinolone that is 1,4-dihydroquinoline substituted by an oxo group at position 4. It is a tautomer of a quinolin-4-ol. This molecule is a natural product found in Glycosmis parviflora and Glycosmis citrifolia with data available.",CHEMBL1232567
C[N+](C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,3.16,,
O=c1c2ccccc2ncn1-c1ccccc1,3.16,,
O=C([O-])C(O)(c1ccccc1)c1ccccc1,3.17,,
CCC(CC)C(=O)Nc1cc(C(=O)[O-])ccc1NC(C)=O,3.18,,
[NH3+]C(CCC(=O)NC(CS)C(=O)NCC(=O)[O-])C(=O)[O-],3.18,,
CCc1cc(CC[NH3+])ccc1O,3.18,,
CCOC(=O)c1ccc2nc(N)sc2c1,3.18,,CHEMBL95874
O=CC1CCC[NH2+]1,3.19,,
COc1ccc(-c2c(-c3ccc(O)cc3O)n[nH]c2C)cc1,3.19,,CHEMBL192894
CC(=O)NC1C(O)CC(OCC2OC(O)C(O)C(O)C2O)(C(=O)[O-])OC1C(O)C(O)CO,3.19,,
OCC1OC(O)C(O)C(O)C1O,3.2,,
O=C([O-])c1ccnc(C(=O)[O-])c1,3.2,,
Cc1ccc2cc(C(=O)[O-])[nH]c2c1,3.2,,
O=C([O-])CC(O)C(=O)[O-],3.2,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],3.2,,
Nc1ncccc1OCc1ccccc1,3.21,,CHEMBL194009
Nc1nc2ncc(CNc3ccc(C(=O)[O-])cc3)nc2c(=O)[nH]1,3.22,,
OCC1NC(=NO)C(O)C(O)C1O,3.22,,
OCC1[NH+]=C(NO)C(O)C(O)C1O,3.22,,
CC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)[O-],3.22,,
CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,3.22,,
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NCC(=O)[O-])C(C)O,3.22,,
OCC1(F)OCC(O)C(O)C1O,3.22,,
O=C([O-])CCc1ccccc1,3.22,,
COC1OC(CO)C(O)C(O)C1O,3.22,,
OC1COCC(O)C1O,3.22,,
Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,3.22,,
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,3.22,"This molecule is a xanthine derivative that decreases the viscosity of blood and is used to treat symptoms of intermittent claudication due to peripheral vascular disease. This molecule has not been associated with serum enzyme elevations during therapy, but in several isolated case reports has been linked to clinically apparent liver injury. This molecule is an oxopurine. This molecule is a synthetic dimethylxanthine derivative that modulates the rheological properties of blood and also has both anti-oxidant and anti-inflammatory properties. Although originally developed to treat intermittent claudication, a form of exertion-induced leg pain common in patients with peripheral arterial disease, PTX has been investigated for its possible use in diverse conditions, including osteoradionecrosis, diabetic kidney disease, and generally any condition associated with fibrosis. More recently, PTX has been suggested as a possible treatment for COVID-19-induced pulmonary complications due to its ability to regulate the production of inflammatory cytokines.  Pentoxifylline has been marketed in Europe since 1972; PTX extended-release tablets sold under the trade name TRENTAL by US Pharm Holdings were first approved by the FDA on Aug 30, 1984, but have since been discontinued. A branded product, PENTOXIL, marketed by Upsher-Smith Laboratories, and generic forms marketed by Valeant Pharmaceuticals and APOTEX have been available since the late 1990s. This molecule is developed to treat neurodegenerative disorders by ExonHit Therapeutics. This molecule is a Blood Viscosity Reducer. The physiologic effect of pentoxifylline is by means of Hematologic Activity Alteration. This molecule is a methylxanthine derivative with hemorrheologic and immunomodulating properties. This molecule inhibits phosphodiesterase, resulting in increased levels of cyclic adenosine monophosphate (cAMP) in erythrocytes, endothelium, and the surrounding tissues. This leads to vasodilation, improves erythrocyte flexibility, and enhances blood flow. In addition, the increased level of cAMP in platelets inhibits platelet aggregation, which may contribute to a reduction in blood viscosity. This agent also inhibits production of tumor necrosis factor-alpha and interferon-gamma, while it induces Th2-like (T-helper 2) cytokine production, thereby inhibiting Th1-mediated (T-helper 1) inflammatory and autoimmune responses.",CHEMBL628
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,3.22,,
Cc1ncc2c(n1)N(C)C(=O)C(=N)C2,3.22,,
Cc1cc2c(cc1N)n(C)c(=O)n2C,3.22,,CHEMBL2335381
C[NH+](Cc1ccccc1C(=O)NCC1CCCCC1)Cc1ccc2c(c1C(=O)[O-])OCO2,3.23,,
O=[N+]([O-])c1cccc2ncccc12,3.23,,CHEMBL164449
CC(C)Cn1c(=O)n(C)c(=O)c2[nH]cnc21,3.24,,
OCC1[NH2+]CC(O)C(O)C1O,3.24,,
COC(=O)C([NH3+])Cc1c[nH]c2ccccc12,3.24,,
O=C1Cc2ccc(Br)cc2N1,3.24,,CHEMBL2381492
Cc1cccc(-n2nc(C(=O)[O-])cc2-c2ccccc2)c1,3.24,,
NC(=[NH2+])c1ccccc1,3.25,,
O=[N+]([O-])c1ccc2n[nH]cc2c1,3.25,,
O=c1[nH]c(=O)c2[nH]c(=O)[nH]c2[nH]1,3.26,,
COC1OC(CO)C(O)C(OC(=O)c2ccc(C)cc2)C1OC(C)=O,3.26,,
O=C(c1ccc(O)cc1)N1CCOCC1,3.26,,
CC(=O)NC1C(O)CC(OC2C(O)C(O)OC(CO)C2O)(C(=O)[O-])OC1C(O)C(O)CO,3.26,,
OC(O)(C(F)(F)F)C(F)(F)F,3.26,This molecule appears as a colorless liquid with a acetone-like odor. Toxic by inhalation. Nonflammable. Emits toxic fumes when heated to high temperatures. Heavier than air. Used as an intermediate in organic synthesis.,CHEMBL84242
OCC1C(O)C(O)C(O)c2cnnn21,3.27,,
Nc1ncnc2c1ncn2C1OC(CSCCC(O)CO)C(O)C1O,3.27,,
CSCCC([NH3+])C(=O)[O-],3.27,,
Nc1ccc2cc3ccc(N)cc3nc2c1,3.28,"This molecule is an aminoacridine that is acridine that is substituted by amino groups at positions 3 and 6. A slow-acting bacteriostat that is effective against many Gram-positive bacteria (but ineffective against spores), its salts were formerly used for treatment of burns and infected wounds. It has a role as an antiseptic drug, a carcinogenic agent, an antibacterial agent, a chromophore and an intercalator. It is a conjugate base of a This molecule(1+). 3,6-Diaminoacridine. Topical antiseptic used mainly in wound dressings.",CHEMBL55400
O=C(Nc1ccc(Cl)cc1)ON=C1NC(CO)C(O)C(O)C1O,3.28,,
OCC1OC(NC(=S)N=NCc2ccc(C(F)(F)F)cc2)C(O)C(O)C1O,3.28,,
C=CC[NH+](Cc1ccccc1C(=O)NCc1ccccc1)Cc1ccc2c(c1C(=O)[O-])OCO2,3.28,,
OCc1cccc(Oc2ccccc2)c1,3.28,This molecule is a member of the class of benzyl alcohols that is benzyl alcohol bearing a phenoxy substituent at C-3. It is a metbaolite of the insecticide permethrin. It has a role as a marine xenobiotic metabolite. It is a member of benzyl alcohols and an aromatic ether.,CHEMBL1869836
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,3.29,,
NC(=O)CC(NC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)C(CO)NC(=O)C[NH3+])C(=O)NCC(=O)NC(CC(=O)[O-])C(=O)[O-],3.29,,
CC(=O)CCO,3.3,,
CC(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],3.3,,
O=[N+]([O-])c1cccc(OC2OC(CO)C(O)C(O)C2O)c1,3.3,,
O=C([O-])CNC(=O)NC1CCCCC1,3.3,,
O=C([O-])CCCNC(=O)NC1CCCCC1,3.3,,
CC=CC(C)=CC1(C)SC(=O)C(C)=C1O,3.3,,
C=CC=CC1(C)SC(=O)C(C)=C1O,3.3,,
CC(C)Cn1c(=O)n(C)c(=O)c2[nH]cnc21,3.3,,
O=S(=O)([O-])CC[NH2+]C1CCCCC1,3.3,,
O=C([O-])CNC(=O)C(=O)[O-],3.3,,
CCC(C)C1NC(=O)C(CCCC[NH3+])NC(=O)C(CC(=O)[O-])NC(=O)C(C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC1=O,3.3,,
CCC(C)C1NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC1=O,3.3,,
CCC(C)C1NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(CCSC)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC1=O,3.3,,
CCC(C)C1NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC(=O)[O-])NC(=O)C(CCSC)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC1=O,3.3,,
CCC(C)C1NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC1=O,3.3,,
CCC(C)C1NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC1=O,3.3,,
CCC(C)C1NC(=O)C(CCCC[NH3+])NC(=O)C(Cc2c[nH]cn2)NC(=O)C(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC1=O,3.3,,
CNC(=[NH2+])NC(=O)NC,3.3,,
CC(NC(=O)C(NC(=O)C([NH3+])CCC(N)=O)C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)[O-],3.3,,
Nc1nnc(N)c2[nH]cnc12,3.3,,CHEMBL566922
Clc1ccc(-c2noc(C3CCC[NH2+]C3)n2)cc1,3.3,,
CC(C)CC(NC(=O)C(C)[NH3+])C(=O)NC(C)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)[O-])C(C)O,3.3,,
CC(NC(=O)C(NC(=O)C([NH3+])CCC(N)=O)C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)NC(C(=O)NCC(=O)[O-])C(C)O,3.3,,
Cc1c(CC(=O)[O-])sc2ccc(Cl)cc12,3.3,,
O=C([O-])Cc1csc2ccc(Cl)cc12,3.3,,
COc1ccc2c(CC(=O)[O-])coc2c1,3.3,,
O=C([O-])C1Cc2ccccc2N1C(=O)OCc1ccccc1,3.3,,
[NH3+]Cc1ccc(Oc2ccccc2)cc1,3.3,,
COc1ccc2c(CC(=O)[O-])coc2c1,3.3,,
OC(CC1c2ccccc2Sc2ccccc21)C[NH+]1CCCC1,3.3,,
CC(O)C[NH+]1CC2=C(C1)c1ccccc1Nc1ccccc12,3.3,,
ON1CC=CCC1=S,3.3,,
Oc1ccnc2cc(Cl)ccc12,3.3,,CHEMBL1409793
O=[N+]([O-])c1ccc2nc[nH]c2c1,3.3,,
Cc1nc[nH]c1C[NH+]1CCc2cccc(N)c2C1,3.3,,
O=C([O-])Cc1c[nH]c2ccc(Br)cc12,3.3,,
CC(C)SC1OC(CO)C(O)C(O)C1O,3.3,,
CC1(C)CNC(=O)c2sc(N)nc2C1,3.3,,CHEMBL3356579
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],3.31,,
N#CC(CNc1ccc(Nc2ccccc2)cc1)c1nn[nH]n1,3.31,,
O=[N+]([O-])c1ccccc1CN=NC(=S)NC1OC(CO)C(O)C(O)C1O,3.31,,
Clc1ccc(CN(Cc2ccc(Cl)cc2)c2nnn[nH]2)cc1,3.32,,
O=C1N=CC(I)C(=O)N1,3.32,,
CNC(NC)=[NH+]CCCC([NH3+])C(=O)[O-],3.32,,
CC(C)CC(CNC(=O)c1cccnc1)Cc1ccc2c(c1C(=O)[O-])OCO2,3.32,,
c1ccccc1,3.32,"This molecule is a colorless liquid with a sweet odor. It evaporates into the air very quickly and dissolves slightly in water. It is highly flammable and is formed from both natural processes and human activities. This molecule is widely used in the United States; it ranks in the top 20 chemicals for production volume. Some industries use benzene to make other chemicals which are used to make plastics, resins, and nylon and synthetic fibers. This molecule is also used to make some types of rubbers, lubricants, dyes, detergents, drugs, and pesticides. Natural sources of benzene include volcanoes and forest fires. This molecule is also a natural part of crude oil, gasoline, and cigarette smoke. This molecule appears as a clear colorless liquid with a petroleum-like odor. Flash point less than 0 °F. Less dense than water and slightly soluble in water. Hence floats on water. Vapors are heavier than air. This molecule is a six-carbon aromatic annulene in which each carbon atom donates one of its two 2p electrons into a delocalised pi system. A toxic, flammable liquid byproduct of coal distillation, it is used as an industrial solvent. This molecule is a carcinogen that also damages bone marrow and the central nervous system. It has a role as a non-polar solvent, a carcinogenic agent and an environmental contaminant. It is an aromatic annulene, a volatile organic compound and a member of benzenes. This molecule is found in the air from emissions from burning coal and oil, gasoline service stations, and motor vehicle exhaust. Acute (short-term) inhalation exposure of humans to benzene may cause drowsiness, dizziness, headaches, as well as eye, skin, and respiratory tract irritation, and, at high levels, unconsciousness. Chronic (long-term) inhalation exposure has caused various disorders in the blood, including reduced numbers of red blood cells and aplastic anemia, in occupational settings. Reproductive effects have been reported for women exposed by inhalation to high levels, and adverse effects on the developing fetus have been observed in animal tests. Increased incidence of leukemia (cancer of the tissues that form white blood cells) have been observed in humans occupationally exposed to benzene. EPA has classified benzene as known human carcinogen for all routes of exposure. This molecule is a clear, colorless, highly flammable and volatile, liquid aromatic hydrocarbon with a gasoline-like odor. This molecule is found in crude oils and as a by-product of oil-refining processes. In industry benzene is used as a solvent, as a chemical intermediate, and is used in the synthesis of numerous chemicals. Exposure to this substance causes neurological symptoms and affects the bone marrow causing aplastic anemia, excessive bleeding and damage to the immune system. This molecule is a known human carcinogen and is linked to an increased risk of developing lymphatic and hematopoietic cancers, acute myelogenous leukemia, as well as chronic lymphocytic leukemia. (NCI05) This molecule is a natural product found in Swertia japonica, Basella alba, and other organisms with data available. This molecule is a toxic, volatile, flammable liquid hydrocarbon biproduct of coal distillation. Chronic benzene exposure produces hematotoxicity, bone marrow dysplasia (Displasia is a pre-neoplastic or pre-cancerous change). (A7669). It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. This molecule causes central nervous system damage acutely and is carcinogenic. It was formerly used as parasiticide.",CHEMBL277500
Cc1ccccc1C,3.33,"This molecule appears as a colorless watery liquid with a sweet odor. Less dense than water. Insoluble in water. Irritating vapor. (USCG, 1999) This molecule is a xylene substituted by methyl groups at positions 1 and 2. This molecule is a natural product found in Basella alba, Zea mays, and other organisms with data available. This molecule is an aromatic hydrocarbon based on benzene with two methyl substituents. It is a isomer of xylene. Xylene occurs naturally in petroleum and coal tar, and is major component of gasoline and fuel oil. Xylene is used mainly as a solvent and in the printing, rubber, and leather industries. This molecule is largely used in the production of phthalic anhydride, and is generally extracted by distillation from a mixed xylene stream in a plant primarily designed for p-xylene production. Contrary to popular belief, a series of switch condensers is required, and not a complicated setup of distillation columns that never work (L938, T10, L165). It can cause irritation eyes, skin, nose, throat; dizziness, excitement, drowsiness, incoordination, staggering gait; corneal vacuolization; anorexia, nausea, vomiting, abdominal pain; dermatitis. The targets of this compound are eyes, skin, respiratory system, central nervous system, gastrointestinal tract, blood, liver, kidneys.",CHEMBL45005
Cn1c(=O)c2c(ncn2C)n(C)c1=O,3.33,"This molecule appears as odorless white powder or white glistening needles, usually melted together. Bitter taste. Solutions in water are neutral to litmus. Odorless. (NTP, 1992) These molecules is a trimethylxanthine in which the three methyl groups are located at positions 1, 3, and 7. A purine alkaloid that occurs naturally in tea and coffee. It has a role as a central nervous system stimulant, an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor, an adenosine receptor antagonist, an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor, a ryanodine receptor agonist, a fungal metabolite, an adenosine A2A receptor antagonist, a psychotropic drug, a diuretic, a food additive, an adjuvant, a plant metabolite, an environmental contaminant, a xenobiotic, a human blood serum metabolite, a mouse metabolite, a geroprotector and a mutagen. It is a purine alkaloid and a trimethylxanthine. This molecule is a drug of the methylxanthine class used for a variety of purposes, including certain respiratory conditions of the premature newborn, pain relief, and to combat drowsiness. This molecule is similar in chemical structure to [Theophylline] and [Theobromine]. It can be sourced from coffee beans, but also occurs naturally in various teas and cacao beans, which are different than coffee beans. This molecule is also used in a variety of cosmetic products and can be administered topically, orally, by inhalation, or by injection.  The caffeine citrate injection, used for apnea of the premature newborn, was initially approved by the FDA in 1999. According to an article from 2017, more than 15 million babies are born prematurely worldwide. This correlates to about 1 in 10 births. Premature birth can lead to apnea and bronchopulmonary dysplasia, a condition that interferes with lung development and may eventually cause asthma or early onset emphysema in those born prematurely. This molecule is beneficial in preventing and treating apnea and bronchopulmonary dysplasia in newborns, improving the quality of life of premature infants. This molecule is a Central Nervous System Stimulant and Methylxanthine. The physiologic effect of caffeine is by means of Central Nervous System Stimulation. This molecule is xanthine alkaloid that occurs naturally in seeds, leaves and fruit of several plants and trees that acts as a natural pesticide. This molecule is a major component of coffee, tea and chocolate and in humans acts as a central nervous system (CNS) stimulant. Consumption of caffeine, even in high doses, has not been associated with elevations in serum enzyme elevations or instances of clinically apparent liver injury. This molecule is a methylxanthine alkaloid found in the seeds, nuts, or leaves of a number of plants native to South America and East Asia that is structurally related to adenosine and acts primarily as an adenosine receptor antagonist with psychotropic and anti-inflammatory activities. Upon ingestion, caffeine binds to adenosine receptors in the central nervous system (CNS), which inhibits adenosine binding. This inhibits the adenosine-mediated downregulation of CNS activity; thus, stimulating the activity of the medullary, vagal, vasomotor, and respiratory centers in the brain. This agent also promotes neurotransmitter release that further stimulates the CNS. The anti-inflammatory effects of caffeine are due the nonselective competitive inhibition of phosphodiesterases (PDEs). Inhibition of PDEs raises the intracellular concentration of cyclic AMP (cAMP), activates protein kinase A, and inhibits leukotriene synthesis, which leads to reduced inflammation and innate immunity. This molecule is a natural product found in Camellia sinensis, Claviceps sorghicola, and other organisms with data available. This molecule is the most widely consumed psychostimulant drug in the world that mostly is consumed in the form of coffee. Whether caffeine and/or coffee consumption contribute to the development of cardiovascular disease (CVD), the single leading cause of death in the US, is unclear. The literature indicates a strong relationship between boiled, unfiltered coffee consumption and elevated cholesterol levels; however, there is a critical gap in the literature regarding the effects of coffee or caffeine consumption on fibrinogen or CRP, which is an independent predictor of CVD risk. Available studies are limited by small samples sizes, inclusion of only men (or few women) and unrepresented age or ethnic groups. There is a critical need for controlled laboratory and epidemiological studies that include fibrinogen and CRP markers of CVD risk before conclusions can be drawn regarding the health effects of caffeine and/or coffee in a normal, healthy population of men and women. (A11723). The relationship between caffeine consumption and various illnesses such as cardiovascular disease and cancer remains equivocal. Prudence might dictate that pregnant women and chronically ill individuals exercise restraint in their use of caffeine, although research suggests relatively low or nonexistent levels of risk associated with moderate caffeine consumption. (A7827). There is extensive evidence that caffeine at dietary doses increases blood pressure (BP). However, concern that the drug may contribute to cardiovascular disease appears to have been dampened by (1) the belief that habitual use leads to the development of tolerance, and (2) confusion regarding relevant epidemiologic findings. When considered comprehensively, findings from experimental and epidemiologic studies converge to show that BP remains reactive to the pressor effects of caffeine in the diet. Overall, the impact of dietary caffeine on population BP levels is likely to be modest, probably in the region of 4/2 mm Hg. At these levels, however, population studies of BP indicate that caffeine use could account for premature deaths in the region of 14% for coronary heart disease and 20% for stroke. (A7828). This molecule is a purine alkaloid that occurs naturally in coffee beans. At intake levels associated with coffee consumption, caffeine appears to exert most of its biological effects through the antagonism of the A1 and A2A subtypes of the adenosine receptor. Adenosine is an endogenous neuromodulator with mostly inhibitory effects, and adenosine antagonism by caffeine results in effects that are generally stimulatory. Some physiological effects associated with caffeine administration include central nervous system stimulation, acute elevation of blood pressure, increased metabolic rate, and diuresis. This molecule concentrations in coffee beverages can be quite variable. A standard cup of coffee is often assumed to provide 100 mg of caffeine, but a recent analysis of 14 different specialty coffees purchased at coffee shops in the US found that the amount of caffeine in 8 oz (=240 ml) of brewed coffee ranged from 72 to 130 mg.This molecule in espresso coffees ranged from 58 to 76 mg in a single shot. (A7829). This molecule is a member of the methylxanthine family of drugs, and is the most widely consumed behaviourally active substance in the western world. A number of in vitro and in vivo studies have demonstrated that caffeine modulates both innate and adaptive immune responses. For instance studies indicate that caffeine and its major metabolite paraxanthine suppress neutrophil and monocyte chemotaxis, and also suppress production of the pro-inflammatory cytokine tumor necrosis factor (TNF) alpha from human blood. This molecule has also been reported to suppress human lymphocyte function as indicated by reduced T-cell proliferation and impaired production of Th1 (interleukin [IL]-2 and interferon [IFN]-gamma), Th2 (IL-4, IL-5) and Th3 (IL-10) cytokines. Studies also indicate that caffeine suppresses antibody production. The evidence suggests that at least some of the immunomodulatory actions of caffeine are mediated via inhibition of cyclic adenosine monophosphate (cAMP)-phosphodiesterase (PDE), and consequential increase in intracellular cAMP concentrations. Overall, these studies indicate that caffeine, like other members of the methylxanthine family, is largely anti-inflammatory in nature, and based on the pharmacokinetics of caffeine, many of its immunomodulatory effects occur at concentrations that are relevant to normal human consumption. (A7830).",CHEMBL113
Clc1cccc(Cl)c1[NH+]=C1NCCN1,3.33,,
[NH3+]Cc1ccc2occc2c1,3.33,,
Nc1cccc(Oc2ccccn2)c1,3.33,,
CCC(=O)C(=O)[O-],3.33,,
CC(O)C(=O)[O-],3.33,,
O=C1Cc2ccc(Cl)cc2N1,3.33,This molecule is a member of indoles.,CHEMBL1232568
Nc1ncnc2c1ncn2C1OC(CO)C(O)C1O,3.33,"This molecule is a purine nucleoside. This molecule is a natural product found in Acanthus ilicifolius, Acanthus ebracteatus, and other organisms with data available.",CHEMBL11909
Nc1ncnc2c1ncn2C1OC(C(O)NS(=O)(=O)CC2CC(n3ccc(=O)[nH]c3=O)OC2CO)C(O)C1O,3.34,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],3.34,,
Oc1ccc2ccccc2c1,3.34,"This molecule is a naphthol carrying a hydroxy group at position 2. It has a role as an antinematodal drug, a genotoxin, a human xenobiotic metabolite, a mouse metabolite, a human urinary metabolite and a radical scavenger. This molecule is a colorless crystalline solid and an isomer of 1-naphthol, differing by the location of the hydroxyl group on naphthalene. The naphthols are naphthalene homologues of phenol, with the hydroxyl group being more reactive than in the phenols. This molecule has several different uses including dyes, pigments, fats, oils, insecticides, pharmaceuticals, perfumes, antiseptics, synthesis of fungicides, and antioxidants for rubber. Detection of This molecule in urine usually results from long-term persistent exposure to pesticides such as chlorpyrifos, but also due to exposure to naphthalene in older types of mothballs, fires that produce polyaromatic hydrocarbons (PAHs), and tobacco smoke.",CHEMBL14126
CC(O)C(C)(O)C(=O)[O-],3.34,,
O=C([O-])c1cccnc1C(=O)[O-],3.35,,
O=C([O-])C1CCC(C(=O)[O-])CC1,3.35,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)O)C(C)O,3.35,,
CCC(C)C(NC(=O)C(NC(=O)C(CO)NC(=O)C(NC(=O)C1CCC[NH2+]1)C(C)O)C(C)CC)C(=O)[O-],3.35,,
Nc1nc(S)nc2[nH]ncc12,3.35,,
O=C([O-])C=CC(=O)[O-],3.36,,
CCCC(=O)SCC[N+](C)(C)C,3.36,This molecule is a quaternary ammonium ion obtained by the formal condensation of the carboxy group of butyric acid with the thiol group of thiocholine. It is used as a reagent for determination of butyrylcholinesterase activity.,CHEMBL139908
N=C(COS(=O)(=O)[O-])C(=O)[O-],3.36,,
CCCCCCCCCC(=O)NC1CCSC1=O,3.36,,
CCC(C)C1NC(=O)C(CCCC[NH3+])NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC1=O,3.36,,
NC(=[NH2+])NCCCC([NH3+])C(=O)[O-],3.36,,
CC(C)CC(CNC(=O)c1ccncc1)Cc1ccc2c(c1C(=O)[O-])OCO2,3.36,,
Cc1ccc(C)cc1,3.37,"This molecule appears as a colorless watery liquid with a sweet odor. Less dense than water. Insoluble in water. Irritating vapor. Freezing point is 56 °F. (USCG, 1999) This molecule is a xylene with methyl groups at positions 1 and 4. This molecule is a natural product found in Basella alba, Helianthus tuberosus, and other organisms with data available. This molecule is an aromatic hydrocarbon based on benzene with two methyl substituents with the chemical formula C8H10 or C6H4(CH3)2. The p stands for para, identifying the location of the methyl groups as across from one another. Overexposure of p-xylene in humans can cause headache, fatigue, dizziness, listlessness, confusion, irritability, gastrointestinal disturbances including nausea and loss of appetite, flushing of the face, and a feeling of increased body heat. This molecule vapor exposure over the recommended exposure limit of 100 parts per million (ppm) can cause irritation to eye, nose, and throat and possible chest tightening and an abnormal gait.",CHEMBL31561
[NH3+]Cc1ccc(F)cc1,3.37,,
NC(=[NH2+])c1ccccc1,3.37,,
NC(=[NH2+])c1ccccc1,3.37,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],3.37,,
Cc1cn(C2CC(O)C(C[NH+]3CCCC3)O2)c(=O)[nH]c1=O,3.37,,
CC(=O)NC1C(O)OC(CO)C(O)C1O,3.37,"This molecule is a N-acyl-hexosamine. This molecule is under investigation for the other of GNE Myopathy. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655).",CHEMBL83479
Oc1cccc2ccccc12,3.37,"This molecule is a naphthol carrying a hydroxy group at position 1. It has a role as a genotoxin and a human xenobiotic metabolite. This molecule is a natural product found in Selaginella sinensis, Juglans nigra, and Magnolia liliiflora with data available. This molecule is a metabolite of carbaryl and naphthalene that is an intermediate in Metabolism of xenobiotics by cytochrome P450. It is generated by spontaneous reaction from (1R,2S)-Naphthalene epoxide then is it converted to 1,4-Dihydroxynaphthalene. Although 1-Naphthol is not persistent in the body, a single urine sample may adequately predict exposure over several months to chlorpyrifos, which is a broad-spectrum organophosphate insecticide. In adult men, TCPY and 1N were associated with reduced testosterone levels  (A3198, A3199).",CHEMBL122617
CC(=O)NC1COC(CO)C(O)C1OC1OC(C(=O)[O-])C(OC2OC(CO)C(O)C(OC3OC(C(=O)[O-])C(O)C(O)C3O)C2NC(C)=O)C(O)C1O,3.37,,
Nc1nc(F)nc2c1ncn2C1CC(O)C(CO)O1,3.38,,
CCCCCC(O)C=CC1C(=O)C=CC1CC=CCCCC(=O)[O-],3.38,,
COC1(C(=O)[O-])CC(O)C(NC(=O)CO)C(C(O)C(O)CO)O1,3.38,,
O=C([O-])CCc1ccccc1,3.39,,
CCCCCCSCC(NC(=O)CCC([NH3+])C(=O)[O-])C(=O)NCC(=O)[O-],3.39,,
COc1ccc(CN=NC(=S)NC2OC(CO)C(O)C(O)C2O)cc1,3.39,,
Cc1cn(C2CC(N=[N+2]#N)C(CO)O2)c(=O)[nH]c1=O,3.39,,
Nc1cc(Cl)nc(N)n1,3.39,This molecule is a member of pyrimidines and an organohalogen compound.,CHEMBL4517551
CC(=O)NC1C(O)C=C(C(=O)[O-])OC1C(O)C(O)C[NH3+],3.4,,
OCC1[NH2+]CC(O)C(O)C1O,3.4,,
COCCOCCOCCOc1ccc(C(C)(C)CC(C)(C)C)cc1,3.4,,
Cc1nc2c(=O)[nH]c(N)nc2o1,3.4,,CHEMBL175367
CC(CS)C(=O)N1CCCC1C(=O)[O-],3.4,,
c1ccccc1,3.4,"This molecule is a colorless liquid with a sweet odor. It evaporates into the air very quickly and dissolves slightly in water. It is highly flammable and is formed from both natural processes and human activities. This molecule is widely used in the United States; it ranks in the top 20 chemicals for production volume. Some industries use benzene to make other chemicals which are used to make plastics, resins, and nylon and synthetic fibers. This molecule is also used to make some types of rubbers, lubricants, dyes, detergents, drugs, and pesticides. Natural sources of benzene include volcanoes and forest fires. This molecule is also a natural part of crude oil, gasoline, and cigarette smoke. This molecule appears as a clear colorless liquid with a petroleum-like odor. Flash point less than 0 °F. Less dense than water and slightly soluble in water. Hence floats on water. Vapors are heavier than air. This molecule is a six-carbon aromatic annulene in which each carbon atom donates one of its two 2p electrons into a delocalised pi system. A toxic, flammable liquid byproduct of coal distillation, it is used as an industrial solvent. This molecule is a carcinogen that also damages bone marrow and the central nervous system. It has a role as a non-polar solvent, a carcinogenic agent and an environmental contaminant. It is an aromatic annulene, a volatile organic compound and a member of benzenes. This molecule is found in the air from emissions from burning coal and oil, gasoline service stations, and motor vehicle exhaust. Acute (short-term) inhalation exposure of humans to benzene may cause drowsiness, dizziness, headaches, as well as eye, skin, and respiratory tract irritation, and, at high levels, unconsciousness. Chronic (long-term) inhalation exposure has caused various disorders in the blood, including reduced numbers of red blood cells and aplastic anemia, in occupational settings. Reproductive effects have been reported for women exposed by inhalation to high levels, and adverse effects on the developing fetus have been observed in animal tests. Increased incidence of leukemia (cancer of the tissues that form white blood cells) have been observed in humans occupationally exposed to benzene. EPA has classified benzene as known human carcinogen for all routes of exposure. This molecule is a clear, colorless, highly flammable and volatile, liquid aromatic hydrocarbon with a gasoline-like odor. This molecule is found in crude oils and as a by-product of oil-refining processes. In industry benzene is used as a solvent, as a chemical intermediate, and is used in the synthesis of numerous chemicals. Exposure to this substance causes neurological symptoms and affects the bone marrow causing aplastic anemia, excessive bleeding and damage to the immune system. This molecule is a known human carcinogen and is linked to an increased risk of developing lymphatic and hematopoietic cancers, acute myelogenous leukemia, as well as chronic lymphocytic leukemia. (NCI05) This molecule is a natural product found in Swertia japonica, Basella alba, and other organisms with data available. This molecule is a toxic, volatile, flammable liquid hydrocarbon biproduct of coal distillation. Chronic benzene exposure produces hematotoxicity, bone marrow dysplasia (Displasia is a pre-neoplastic or pre-cancerous change). (A7669). It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. This molecule causes central nervous system damage acutely and is carcinogenic. It was formerly used as parasiticide.",CHEMBL277500
O=C1NCC(CO)C(O)C1O,3.4,,
Clc1ccc(-c2cc(C3CC[NH2+]CC3)[nH]n2)cc1,3.4,,
c1ccccc1,3.4,"This molecule is a colorless liquid with a sweet odor. It evaporates into the air very quickly and dissolves slightly in water. It is highly flammable and is formed from both natural processes and human activities. This molecule is widely used in the United States; it ranks in the top 20 chemicals for production volume. Some industries use benzene to make other chemicals which are used to make plastics, resins, and nylon and synthetic fibers. This molecule is also used to make some types of rubbers, lubricants, dyes, detergents, drugs, and pesticides. Natural sources of benzene include volcanoes and forest fires. This molecule is also a natural part of crude oil, gasoline, and cigarette smoke. This molecule appears as a clear colorless liquid with a petroleum-like odor. Flash point less than 0 °F. Less dense than water and slightly soluble in water. Hence floats on water. Vapors are heavier than air. This molecule is a six-carbon aromatic annulene in which each carbon atom donates one of its two 2p electrons into a delocalised pi system. A toxic, flammable liquid byproduct of coal distillation, it is used as an industrial solvent. This molecule is a carcinogen that also damages bone marrow and the central nervous system. It has a role as a non-polar solvent, a carcinogenic agent and an environmental contaminant. It is an aromatic annulene, a volatile organic compound and a member of benzenes. This molecule is found in the air from emissions from burning coal and oil, gasoline service stations, and motor vehicle exhaust. Acute (short-term) inhalation exposure of humans to benzene may cause drowsiness, dizziness, headaches, as well as eye, skin, and respiratory tract irritation, and, at high levels, unconsciousness. Chronic (long-term) inhalation exposure has caused various disorders in the blood, including reduced numbers of red blood cells and aplastic anemia, in occupational settings. Reproductive effects have been reported for women exposed by inhalation to high levels, and adverse effects on the developing fetus have been observed in animal tests. Increased incidence of leukemia (cancer of the tissues that form white blood cells) have been observed in humans occupationally exposed to benzene. EPA has classified benzene as known human carcinogen for all routes of exposure. This molecule is a clear, colorless, highly flammable and volatile, liquid aromatic hydrocarbon with a gasoline-like odor. This molecule is found in crude oils and as a by-product of oil-refining processes. In industry benzene is used as a solvent, as a chemical intermediate, and is used in the synthesis of numerous chemicals. Exposure to this substance causes neurological symptoms and affects the bone marrow causing aplastic anemia, excessive bleeding and damage to the immune system. This molecule is a known human carcinogen and is linked to an increased risk of developing lymphatic and hematopoietic cancers, acute myelogenous leukemia, as well as chronic lymphocytic leukemia. (NCI05) This molecule is a natural product found in Swertia japonica, Basella alba, and other organisms with data available. This molecule is a toxic, volatile, flammable liquid hydrocarbon biproduct of coal distillation. Chronic benzene exposure produces hematotoxicity, bone marrow dysplasia (Displasia is a pre-neoplastic or pre-cancerous change). (A7669). It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. This molecule causes central nervous system damage acutely and is carcinogenic. It was formerly used as parasiticide.",CHEMBL277500
c1ccccc1,3.4,"This molecule is a colorless liquid with a sweet odor. It evaporates into the air very quickly and dissolves slightly in water. It is highly flammable and is formed from both natural processes and human activities. This molecule is widely used in the United States; it ranks in the top 20 chemicals for production volume. Some industries use benzene to make other chemicals which are used to make plastics, resins, and nylon and synthetic fibers. This molecule is also used to make some types of rubbers, lubricants, dyes, detergents, drugs, and pesticides. Natural sources of benzene include volcanoes and forest fires. This molecule is also a natural part of crude oil, gasoline, and cigarette smoke. This molecule appears as a clear colorless liquid with a petroleum-like odor. Flash point less than 0 °F. Less dense than water and slightly soluble in water. Hence floats on water. Vapors are heavier than air. This molecule is a six-carbon aromatic annulene in which each carbon atom donates one of its two 2p electrons into a delocalised pi system. A toxic, flammable liquid byproduct of coal distillation, it is used as an industrial solvent. This molecule is a carcinogen that also damages bone marrow and the central nervous system. It has a role as a non-polar solvent, a carcinogenic agent and an environmental contaminant. It is an aromatic annulene, a volatile organic compound and a member of benzenes. This molecule is found in the air from emissions from burning coal and oil, gasoline service stations, and motor vehicle exhaust. Acute (short-term) inhalation exposure of humans to benzene may cause drowsiness, dizziness, headaches, as well as eye, skin, and respiratory tract irritation, and, at high levels, unconsciousness. Chronic (long-term) inhalation exposure has caused various disorders in the blood, including reduced numbers of red blood cells and aplastic anemia, in occupational settings. Reproductive effects have been reported for women exposed by inhalation to high levels, and adverse effects on the developing fetus have been observed in animal tests. Increased incidence of leukemia (cancer of the tissues that form white blood cells) have been observed in humans occupationally exposed to benzene. EPA has classified benzene as known human carcinogen for all routes of exposure. This molecule is a clear, colorless, highly flammable and volatile, liquid aromatic hydrocarbon with a gasoline-like odor. This molecule is found in crude oils and as a by-product of oil-refining processes. In industry benzene is used as a solvent, as a chemical intermediate, and is used in the synthesis of numerous chemicals. Exposure to this substance causes neurological symptoms and affects the bone marrow causing aplastic anemia, excessive bleeding and damage to the immune system. This molecule is a known human carcinogen and is linked to an increased risk of developing lymphatic and hematopoietic cancers, acute myelogenous leukemia, as well as chronic lymphocytic leukemia. (NCI05) This molecule is a natural product found in Swertia japonica, Basella alba, and other organisms with data available. This molecule is a toxic, volatile, flammable liquid hydrocarbon biproduct of coal distillation. Chronic benzene exposure produces hematotoxicity, bone marrow dysplasia (Displasia is a pre-neoplastic or pre-cancerous change). (A7669). It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. This molecule causes central nervous system damage acutely and is carcinogenic. It was formerly used as parasiticide.",CHEMBL277500
CC([NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)O,3.4,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C,3.4,,
CC1CC2OC2C=CC=CC(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1,3.4,This molecule is a macrocyclic antifungal antibiotic that inhibits signal-dependent transcriptional activation and induces differentiation in leukemia. (NCI),CHEMBL3972342
CC(=O)NCCCCC(NC(=O)C(NC(=O)CNC(=O)CNC(=O)C(NC(=O)C([NH3+])CO)C(C)O)C(C)C)C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCC[NH3+])C(=O)NC(CS)C(=O)[O-],3.4,,
Cc1cn(C2CC(O)C(C[NH+]3CCCCC3)O2)c(=O)[nH]c1=O,3.4,,
CC(O)C(NC(=O)C(CCCC[N+](C)(C)C)NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)[O-],3.4,,
C[N+](C)(C)CCCCC([NH3+])C(=O)NC(CCC(N)=O)C(=O)[O-],3.4,,
[NH3+]Cc1cccc(-n2cccn2)c1,3.4,,
OCC(Cl)(Cl)Cl,3.41,This molecule is a chloroethanol. It has a role as a mouse metabolite. This molecule is a natural product found in Bos taurus and Euglena gracilis with data available.,CHEMBL1171
CC(=O)NC1C(O)C=C(C(=O)[O-])OC1C(O)C(O)CO,3.42,,
Nc1ncnc2c1ncn2C1OC(CS)C(O)C1O,3.42,,
Nc1ccc2ncccc2c1,3.42,,CHEMBL99408
CCC(=O)NCCCCC(NC(=O)C(NC(=O)C(C)[NH3+])C(C)O)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)[O-],3.42,,
[NH2+]=c1[nH]c(=O)c2ncc(C(=O)NCc3ccco3)nc2[nH]1,3.42,,
C=CC(C)=CC1(C)SC(=O)C(CCCCN=[N+2]#N)=C1O,3.42,,
COC(=O)CC(C)c1nnc2nc(N)[nH]c(=O)c2c1O,3.42,,
Nc1[nH]c(N)c2ccccc12,3.42,,CHEMBL4466464
CCc1ccc(C(C)CC(=O)NC2OC(CO)C(O)C(O)C2O)cc1,3.42,,
Nc1cc(F)ccc1C(=O)[O-],3.42,,
CC(=O)NC(=O)NC1OC(CO)C(O)C(O)C1O,3.43,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)[O-],3.43,,
O=C([O-])C1(O)C=CC(O)C(O)C1,3.43,,
Nc1ncnc2c1ncn2C1OC(C(O)NS(=O)(=O)CC2C(CO)OC(n3ccc(=O)[nH]c3=O)C2O)C(O)C1O,3.43,,
Nc1ncnc2c1ncn2C1OC(CO)C(O)C1O,3.43,"This molecule is a purine nucleoside. This molecule is a natural product found in Acanthus ilicifolius, Acanthus ebracteatus, and other organisms with data available.",CHEMBL11909
OCC1OC(NC(=S)N=NCc2ccccc2Cl)C(O)C(O)C1O,3.43,,
CC(=O)NC1C(O)CC(OCC2OC(O)C(O)C(O)C2O)(C(=O)[O-])OC1C(O)C(O)CO,3.43,,
Cc1[nH]c(-c2ccccc2)nc1C(=O)[O-],3.44,,
CCCn1cnc2c1c(=O)n(CCCCC(C)=O)c(=O)n2C,3.44,This molecule is an oxopurine.,CHEMBL1079905
CC(C)CC(NC(=O)C(NC(=O)C1CCC[NH2+]1)C(C)C)C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)NCC(=O)[O-],3.44,,
CC(NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)[O-],3.45,,
C=CC(C)=CC1(C)SC(=O)C(CC)=C1O,3.45,,
CCc1oc2cc(S(=O)(=O)N(C)C)ccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,3.46,,
Nc1cncc(Cl)n1,3.46,,CHEMBL191632
CSc1nc(C)nc(N)n1,3.46,,CHEMBL541949
CSc1nc(C)nc(N)n1,3.46,,CHEMBL541949
CCS(=O)(=O)c1ccccc1,3.46,This molecule is a sulfonic acid derivative.,CHEMBL162438
CC(NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)[O-],3.46,,
O=c1[nH]cnc2ccccc12,3.46,"This molecule is a member of quinazolines. This molecule is a natural product found in Streptomyces, Strobilanthes, and other organisms with data available.",CHEMBL266540
CC(CCC(=O)[O-])[N+](C)(C)C,3.46,This molecule is a methyl-branched fatty acid.,CHEMBL3234367
CCCCCCCCCOC1OC(CO)C(O)C(O)C1O,3.46,,
O=C([O-])c1ccnc(C(=O)[O-])c1,3.46,,
Nc1cccc(-c2nc(-c3ccccc3)n[nH]2)c1,3.46,,
OCC1OC(NC(=S)N=NCc2ccc(O)cc2)C(O)C(O)C1O,3.47,,
O=C([O-])c1c(CN2C(=O)Cc3cc(Cl)ccc32)ccc2c1OCO2,3.47,,
CC([NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)[O-],3.47,,
O=C(NC1=CCc2[nH]c(Cc3c[nH]c4ccccc34)nc2C1)C1CCC[NH2+]1,3.47,,
Nc1nc2ccc(C(=O)NCC(=O)[O-])cc2s1,3.47,,
CCC1C(O)C2C3CCC(C(C)CCC(=O)[O-])C3(C)CCC2C2(C)CCC(O)CC12,3.48,,
Clc1ccc(-n2cnnn2)cc1,3.48,,CHEMBL440394
CCC(CC)C(NC(C)=O)C1C(NC(N)=[NH2+])CC(C(=O)[O-])C1O,3.48,,
COC1(C(=O)[O-])CC(O)C(NC(C)=O)C(C(O)C(O)CO)O1,3.48,,
[NH3+]C(CCC(=O)NC(CSSCC(NC(=O)CCC([NH3+])C(=O)[O-])C(=O)NCC(=O)[O-])C(=O)NCC(=O)[O-])C(=O)[O-],3.48,,
O=[N+]([O-])c1ccc2nn[nH]c2c1,3.48,,
Cc1ccc(O)c(O)c1,3.48,"This molecule is a methylcatechol having a single methyl substituent at the 4-position. It has been isolated from Picea abies. It has a role as a hapten, a carcinogenic agent, an antioxidant, a human metabolite and a plant metabolite. This molecule is a natural product found in Camellia sinensis, Geosmithia langdonii, and Bistorta manshuriensis with data available.",CHEMBL158766
NC(=[NH2+])c1ccccc1,3.49,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,3.49,,
[NH3+]CCC[NH+]1CC[NH+](CCCNC(=O)c2cc(OC3OC(CO)C(O)C(O)C3O)cc([N+](=O)[O-])c2)CC1,3.49,,
[NH3+]Cc1ccccc1,3.49,,
O=[N+]([O-])c1ccc(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)cc1,3.49,,
O=c1[nH]c(=S)[nH]c2ccccc12,3.49,,
CC(=O)N1CCCC1C(=O)[O-],3.49,,
CC(=O)C(=O)[O-],3.49,,
[NH3+]CC(=O)NC1CC[NH+](Cc2c[nH]c3ccccc23)CC1,3.49,,
O=C1CC(C[NH2+]CCCC[NH2+]Cc2cccc(C(=O)[O-])c2)=NC(=O)N1,3.5,,
Brc1cnc[nH]1,3.5,,
CC(=O)NCCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(C(=O)[O-])C(C)C,3.5,,
CC1OC(OC2C(OC3C(CO)OC(O)C(O)C3O)OC(CO)C(O)C2O)C(O)C(O)C1O,3.51,,
Nc1ncccc1NCc1ccccc1,3.51,,CHEMBL435747
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3NC(C)=O)C(O)C2NC(C)=O)C1O,3.51,,
Nc1[nH]nc2ccccc12,3.51,This molecule is a member of indazoles.,CHEMBL1331627
Nc1ncn[nH]1,3.51,,
CC(CCC(=O)N(CCCNC(=O)C(O)C(O)C(O)C(O)CO)CCCNC(=O)C(O)C(O)C(O)C(O)CO)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C,3.52,,
Nc1ncnc2[nH]cnc12,3.52,"This molecule is the parent compound of the 6-aminopurines, composed of a purine having an amino group at C-6. It has a role as a human metabolite, a Daphnia magna metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a purine nucleobase and a member of 6-aminopurines. It derives from a hydride of a 9H-purine. A purine base and a fundamental unit of adenine nucleotides. This molecule is a purine nucleobase with an amine group attached to the carbon at position 6. This molecule is the precursor for adenosine and deoxyadenosine nucleosides. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Streptomyces piomogenus, Bridelia balansae, and other organisms with data available. This molecule is a purine base. This molecule is found in both DNA and RNA. This molecule is a fundamental component of adenine nucleotides. This molecule forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose; it forms adenosine triphosphate (ATP), a nucleotide, when three phosphate groups are added to adenosine. Adenosine triphosphate is used in cellular metabolism as one of the basic methods of transferring chemical energy between chemical reactions. Purine inborn errors of metabolism (IEM) are serious hereditary disorders, which should be suspected in any case of neonatal fitting, failure to thrive, recurrent infections, neurological deficit, renal disease, self-mutilation and other manifestations. Investigation usually starts with uric acid (UA) determination in urine and plasma. (OMIM 300322, 229600, 603027, 232400, 232600, 232800, 201450, 220150, 232200, 162000, 164050, 278300).  (A3372, A3373).",CHEMBL226345
O=C([O-])c1ccc(-c2ccc(F)cc2)cc1,3.52,,
O=C([O-])C(O)C(O)C(O)C(O)C[NH+]1CC(O)C(O)C1CO,3.52,,
CC(=O)NC1C(O)C=C(C(=O)[O-])OC1C(O)C(O)CO,3.52,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,3.52,,
Nc1ncc(CC([NH3+])C(=O)[O-])[nH]1,3.52,,
NC(=[NH2+])NCCCC([NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(CS)C(N)=O,3.52,,
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(N)=O)C(=O)[O-],3.52,,
COC[n+]1ccc(C(N)=O)cc1,3.52,,
N#Cc1cccc2n[nH]c(N)c12,3.52,,
C=CC(C)=CC1(C)SC(=O)C(CCC)=C1O,3.52,,
CC=CC=C=C1CN(C2OC(CO)C(O)C(O)C2O)C(=O)NC1=O,3.52,,
COc1ccccc1C(Br)C(NC(=O)c1ccc([N+](=O)[O-])cc1)C(=O)N1CCCCC1,3.52,,
[NH2+]=c1[nH]c(=O)c2ncc(C(=O)NCC(=O)NCC(=O)[O-])nc2[nH]1,3.52,,
Cc1ccnc(N)c1[N+](=O)[O-],3.52,,CHEMBL3981727
Cc1[nH]ncc1-c1ccccc1Cl,3.52,,
C[N+]1(C)CCCC1C(=O)[O-],3.53,"This molecule is a proline derivative. This molecule is a natural product found in Achillea virescens, Leonurus turkestanicus, and other organisms with data available.",CHEMBL1986864
O=C([O-])CCC(NS(=O)(=O)c1ccc(COc2ccc(C=C3SC(=O)NC3=O)cc2)cc1)C(=O)[O-],3.53,,
CCC(C)C1NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC1=O,3.53,,
[NH3+]C(C[NH+]1CCC(O)[NH+](CC2CCC(C(=O)[O-])CC2)C1O)C(O)O,3.53,,
O=C([O-])c1c(CN2C(=O)Cc3ccccc32)ccc2c1OCO2,3.53,,
O=C1CC(c2ccc(O)cc2)Oc2cc(O)cc(O)c21,3.53,"This molecule is a trihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 6 and 4'. It is a trihydroxyflavanone and a member of 4'-hydroxyflavanones. This molecule is a natural product found in Trichoderma virens, Cadophora gregata, and other organisms with data available.",CHEMBL32571
CCC(C)C(NC(=O)C(NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C(CCCCNC(C)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(C)[NH3+])C(C)O)C(C)CC)C(=O)[O-],3.53,,
OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,3.53,,
OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,3.53,,
c1ccc2[nH]ccc2c1,3.54,"This molecule is an indole and a polycyclic heteroarene. It has a role as an Escherichia coli metabolite. It is a tautomer of a 3H-indole. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a natural product found in Tetrastigma hemsleyanum, Daphne odora, and other organisms with data available.",CHEMBL15844
CC(C)C([NH3+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CO)C(=O)O)C(C)C,3.54,,
CCS(=O)(=O)Oc1ccccc1,3.54,,
CCS(=O)(=O)Oc1ccccc1,3.54,,
O=C([O-])c1c(CN2C(=O)Cc3ccc(Cl)cc32)ccc2c1OCO2,3.54,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C(NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(NC(=O)C1CCC[NH2+]1)C(C)O)C(C)C)C(=O)[O-],3.54,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)[O-])C(C)O)C(C)O,3.54,,
COC(=O)C(Cc1cccc(C(N)=[NH2+])c1)NC(=O)CNS(=O)(=O)c1ccc(C)cc1,3.55,,
COc1ccc(CCC(=O)[O-])cc1OC,3.55,,
O=C([O-])C(=O)[O-],3.55,,
CC(=O)NC1C(O)C=C(C(=O)[O-])OC1C(O)C(O)CO,3.55,,
O=[N+]([O-])c1ccc(O)cc1,3.55,"This molecule appears as a white to light yellow crystalline solid. Contact may severely irritate skin and eyes. Poisonous by ingestion and moderately toxic by skin contact. This molecule is a member of the class of This molecules that is phenol in which the hydrogen that is para to the hydroxy group has been replaced by a nitro group. It has a role as a human xenobiotic metabolite and a mouse metabolite. It is a conjugate acid of a This moleculeate. This molecule is used to manufacture drugs, fungicides, insecticides, and dyes and to darken leather. Acute (short-term) inhalation or ingestion of 4-nitrophenol in humans causes headaches, drowsiness, nausea, and cyanosis (blue color in lips, ears, and fingernails). Contact with eyes causes irritation in humans. No information is available on the chronic (long-term) effects of 4-nitrophenol in humans or animals from inhalation or oral exposure. No information is available on the reproductive, developmental, or carcinogenic effects of 4-nitrophenol in humans. EPA has not classified 4-nitrophenol for potential carcinogenicity. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Arabidopsis thaliana, Homo sapiens, and other organisms with data available. This molecule is a phenolic compound that is used mainly to make fungicides and dyes, and to darken leather. It is also used in the synthesis of drugs such as paracetamol, phenetidine, and acetophenetidine. This molecule measurement in urine is used in biological monitoring for establishing the presence and magnitude of exposures to pesticides. (A7736) (Methods in Biotechnology, 2006,61-78) (L1661, L1662)",CHEMBL14130
COc1ccc(CC(C(=O)[O-])C(=O)[O-])cc1OC,3.55,,
CC(C)CC(NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)[O-],3.55,,
CC(C(=O)[O-])c1ccc2c(c1)[nH]c1ccc(Cl)cc12,3.55,,
O=C([O-])c1ccc(-c2ccc(F)cc2)cc1,3.55,,
[NH3+]C(Cc1c[nH]c2ccccc12)C(=O)NC1CC[NH+](Cc2c[nH]c3ccccc23)CC1,3.55,,
CCC(C)C(NC(=O)C(CO)NC(=O)C(CCCCNC(C)=O)NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(C)O)C(=O)NC(CCSC)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)[O-],3.56,,
O=C([O-])c1c[nH][n+]2c(O)c(Cc3ccccc3)c(Cl)nc12,3.56,,
CCC(C)C(NC(=O)C(NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(C)[NH3+])C(C)O)C(C)CC)C(=O)[O-],3.56,,
CC(C)N=CC(O)COc1cccc2ccccc12,3.57,,
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCC[NH3+])NC(=O)C1CCC[NH2+]1)C(C)C)C(C)O)C(=O)NC(C)C(=O)NC(C(=O)[O-])C(C)O,3.57,,
CC1=NC2C(OC(CO)C(O)C2O)S1,3.57,,
O=C([O-])COc1ccc(-c2ccc(F)cc2F)cc1,3.57,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(NC(=O)C1CCC[NH2+]1)C(C)O)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)[O-],3.57,,
[NH2+]=c1[nH]c(O)c(CCCc2ccc(C(=O)[O-])cc2)c(=O)[nH]1,3.57,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],3.57,,
C[NH+]1CCN(c2cccc(C[NH3+])c2)CC1,3.57,,
CC(C)CC(CNC(=O)CCC[NH3+])Cc1ccc2c(c1C(=O)[O-])OCO2,3.57,,
Cc1cc(C)c(C2C(C(=O)c3cccs3)=C(O)C(=O)N2c2ccc(CC(=O)[O-])cc2)cc1C,3.57,,
[NH3+]C1CC(O)C(O)C1O,3.58,,
[NH3+]C(CCC(=O)NC(CS)C(=O)NCC(=O)[O-])C(=O)[O-],3.58,,
Nc1ncnc2nc[nH]c12,3.59,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,3.59,,
CC([NH3+])(CCCCB(O)O)C(=O)[O-],3.59,,
OCC1C[NH2+]CC(O)C1OC1OC(CO)C(O)C(O)C1O,3.59,,
CC(C)CC(CNC(=O)Cc1c[nH]c2ccccc12)Cc1ccc2c(c1C(=O)[O-])OCO2,3.59,,
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CCC(N)=O)[NH2+]C(C)O)C(=O)NC(C)C(=O)[O-],3.59,,
O=S(=O)(O)CC[NH+]1CC[NH+](CCO)CC1,3.6,,
CSCS(C)=O,3.6,,
CCOP(=O)(Cc1ccc(C)cc1)OCC,3.6,,
CC(Oc1ccc(Oc2ncc(C(F)(F)F)cc2Cl)cc1)C(=O)[O-],3.6,,
O=C([O-])CCCCO,3.6,,
O=C([O-])CCCCCNC(=O)NC1CCCCC1,3.6,,
CSCCC([NH3+])C(=O)NC(CC(=O)[O-])C(=O)N1CCCC1C=O,3.6,,
O=C([O-])CNC(=O)C(=O)[O-],3.6,,
C[NH+](C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,3.6,,
CC1OC(OC2C(CO)OCC(O)C2O)C(O)C(O)C1[NH2+]C1C(O)C(C)C(O)C(O)C1O,3.6,,
CC(=O)NCCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C(C)[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(C)C(N)=O,3.6,,
Nc1nccc(-c2cccnc2)n1,3.6,,CHEMBL1236798
O=C([O-])C=CC(=NC(=O)c1cc(CNc2ccc(C=C3SC(=S)NC3=O)cc2)ccc1F)C(=O)[O-],3.6,,
CC(=O)NC1C(OC(C)C([NH3+])C(=O)[O-])OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O,3.6,,
[NH3+]C(CC(=O)[O-])(CC(=O)[O-])C(=O)[O-],3.6,,
CCCC(CCC)C(N)=O,3.6,"This molecule is a fatty amide derived from valproic acid. It has a role as a metabolite, a teratogenic agent and a geroprotector. It is functionally related to a valproic acid.",CHEMBL93836
[NH3+]CCCC([NH3+])C(=O)[O-],3.6,,
C[N+](Cc1cccc(CCc2cccnc2N)c1)Cc1ccco1,3.6,,
CC(=O)NC1C(Oc2ccc([N+](=O)[O-])cc2)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O,3.6,,
COC(C(=O)NC1Cc2ccccc2C1)C(O)C(O)C(O)C=CC(C)(C)C,3.6,,
CC(=O)NC(Cc1ccccc1)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(C(=O)NC(C)C(N)=O)C(C)O,3.6,,
CC(=O)Nc1cccc(C2=CC(C)N(O)c3ccccc32)c1,3.6,,
Cc1cc(-c2ccccc2)n2nc(N)nc2n1,3.6,,CHEMBL1421650
CC(NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(N)=O)NC(=O)C([NH3+])Cc1ccccc1)C(C)O)C(C)O)C(=O)NC(CCCC[NH3+])C(=O)[O-],3.61,,
Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,3.61,"This molecule is a natural product found in Maclura pomifera, Caragana sinica, and other organisms with data available.",CHEMBL2019155
Oc1ccc(CCc2cc(O)cc(O)c2)cc1,3.61,"This molecule is a stilbenol that is 1,1'-ethane-1,2-diyldibenzene with hydroxy groups at positions 1, 3 and 4'. It has a role as a xenobiotic metabolite and a plant metabolite. This molecule is a natural product found in Hydrangea serrata, Maackia amurensis, and other organisms with data available.",CHEMBL111234
CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,3.61,,
COc1ccc(CO)c2nc3cccc(C(=O)[O-])c3nc12,3.61,,
CC(C)CC([NH3+])C(=O)NC(C)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)[O-],3.61,,
[NH3+]C1CONC1=O,3.62,,
O=C([O-])c1ccc(O)cc1,3.62,,
C=C(OC1C=CC=C(C(=O)[O-])C1=O)C(=O)[O-],3.62,,
COC(=O)C1CC2(C[NH2+]1)C(=O)Nc1ccccc12,3.62,,
CNC(=O)C1CC(O)CN1C(=O)Cc1cc(C)no1,3.62,,
[NH3+]C(Cc1ccccc1)C(=O)[O-],3.62,,
CNC(=O)c1scc2c1OCCO2,3.62,,CHEMBL3110245
c1ccn(CCOc2ccc3[nH]ccc3c2)c1,3.63,,
CC(C)CC(NC(=O)C(NC(=O)C(CCCC[N+](C)(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])Cc1c[nH]cn1)C(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],3.63,,
[NH3+]Cc1csc(-c2cccs2)n1,3.63,,
CCc1c(C(=O)Nc2cc(S(=O)(=O)N(CC)CC)ccc2O)[nH]c(C)c1C(C)=O,3.63,,CHEMBL3787231
C[NH+](C)CC(c1ccc(O)cc1)C1(O)CCCCC1,3.63,,
O=C([O-])C(F)=Cc1ccc(O)cc1,3.64,,
COc1cc(C)c2ccc(O)c(C(=O)OC3C(O)C=CC3O)c2c1,3.64,,
O=C([O-])COc1c(C(=O)[O-])sc2ncccc12,3.64,,
CCC(C)C(NC(=O)C(C)[NH3+])C(=O)NC(C)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(C)C(=O)[O-],3.64,,
CCN(CC)C(=O)C1OC(C(=O)[O-])=CC([NH3+])C1NC(C)=O,3.64,,
[NH2+]=c1[nH]c(=O)c2ncc(C(=O)[O-])nc2[nH]1,3.64,,
CC(=O)N1CCC(C(=O)Nc2ccc(C)cn2)CC1,3.64,,
O=C([O-])C1(O)CC(O)C(O)C(O)C1,3.64,,
O=C([O-])C1(O)CC(O)C(O)C(O)C1,3.64,,
CCC(CC)Nc1cc(C(=O)[O-])ccc1N1C(=O)CCC1(CO)CO,3.65,,
Cc1oc2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2c1C(=O)[O-],3.65,,
C[NH+](C)Cc1cc(I)cc(I)c1O,3.65,,
O=C([O-])CCCCCCCCC(=O)[O-],3.66,,
CCC(C)C(NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCCCNC(C)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C(C)NC(=O)CNC(=O)C[NH3+])C(C)C)C(=O)NC(CCC(N)=O)C(=O)[O-],3.66,,
Nc1nc(CCc2ccccc2)cc(=O)[nH]1,3.66,,CHEMBL235821
[NH3+]CCc1ccc(O)c(C2CCCCC2)c1,3.66,,
[NH2+]=c1[nH]c(=O)c2cc[nH]c2[nH]1,3.66,,
O=C([O-])C(O)C(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)CO,3.66,,
O=C([O-])Cc1ccc(O)c(O)c1,3.66,,
Cn1cnc(N)c2ncnc1-2,3.66,,CHEMBL292268
CCC(=O)NC1C(O)CC(OCc2ccccc2)(C(=O)[O-])OC1C(O)C(O)CO,3.67,,
Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,3.67,"This molecule is a natural product found in Maclura pomifera, Caragana sinica, and other organisms with data available.",CHEMBL2019155
CN1CC(CC(C)(C)O)N=C2C(=O)NC(=[NH2+])N=C21,3.67,,
CC1CNC2=NC(=N)NC(=O)C2=N1,3.67,,
COc1ccc(CNC(=O)c2cc3ccccc3cc2C[NH+](C)Cc2cccc(OC)c2C(=O)[O-])cc1,3.67,,
Cc1ccc(N2C(=O)C(O)=C(C(=O)c3ccccc3)C2c2cc(Br)cs2)cc1C(=O)[O-],3.67,,
CC([NH3+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)[O-],3.67,,
CCC(CC)OC1CC(C(=O)[O-])CC([NH3+])C1NC(C)=O,3.67,,
O=C([O-])c1cc2[nH]c3ccccc3c2cc1Cl,3.67,,
Nc1nc2[nH]c(I)nc2c(=O)[nH]1,3.68,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(C)=O)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)[O-])C(C)O,3.68,,
CC(=O)NC1C(OC2C(O)C(O)OC(CO)C2OC2OC(COC3OC(C)C(O)C(O)C3O)C(O)C(O)C2O)OC(CO)C(O)C1O,3.68,,
Nc1ncnc2c1ncn2C1OC(CSSCc2ccccc2)C(O)C1O,3.68,,
COc1ccc2[nH]c(C(=O)NS(C)(=O)=O)cc2c1,3.68,,
Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1)CN2,3.68,,
O=C([O-])C(Oc1ccc(Br)cc1)C(=O)[O-],3.68,,
[NH3+]C(Cc1ccccc1)C(=O)[O-],3.68,,
O=C([O-])CC12OC3C=CC[NH2+]C3C1C(=O)NC2C(=O)[O-],3.68,,
[NH2+]=c1[nH]c(=O)c2ncc(C(=O)NCCNC(=O)Nc3ccccc3)nc2[nH]1,3.68,,
OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,3.68,,
CC(C)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1c[nH]cn1)NC(=O)CNC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C([NH3+])CO)C(=O)[O-],3.69,,
Nc1nc2c(ncn2C2CC(O)C(CO)O2)c(=O)[nH]1,3.69,,
O=c1ccn(C2OC(C[NH+]3CCCC3)C(O)C2O)c(=O)[nH]1,3.69,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(O)C2OC2OC(C)C(O)C(O)C2O)C1OC1OC(C)C(O)C(O)C1O,3.69,,
COC(=O)c1cc(N)cc(-c2c(C)noc2C)c1,3.69,,CHEMBL3753410
CC(=O)NC1C(O)OC(CO)C(O)C1O,3.7,"This molecule is a N-acyl-hexosamine. This molecule is under investigation for the other of GNE Myopathy. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655).",CHEMBL83479
CCC(C=O)C(CNS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)[O-],3.7,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(OS(=O)(=O)[O-])C2O)C1OC1OC(C)C(O)C(O)C1O,3.7,,
O=C([O-])C1(O)C=CC(O)C(O)C1,3.7,,
CCCCn1c(Cc2cc(OC)c(OC)c(OC)c2)nc2c(N)ncnc21,3.7,,CHEMBL113690
CCCCn1c(Cc2ccc(OC)cc2)nc2c(N)ncnc21,3.7,,CHEMBL112834
CCCCn1c(Cc2cc(OC)c(OC)c(OC)c2Cl)nc2c(N)ncnc21,3.7,,CHEMBL112896
C#CCCCn1c(Cc2cc(OC)c(OC)c(OC)c2Cl)nc2c(N)ncnc21,3.7,,CHEMBL326523
O=C([O-])C(F)(F)F,3.7,,
O=C([O-])CC(Cc1ccccc1)C(=O)[O-],3.7,,
Oc1c2ccccc2cc2ccccc12,3.7,,
COC1OC(CO)C(O)C(OC2OCC(O)C(O)C2O)C1O,3.7,,
NC(=[NH2+])Nc1ccc(CC(NC(=O)CSc2ccc(Cl)cc2)C(N)=O)cc1,3.7,,
Nc1nc2ccccc2[nH]1,3.7,"Plates (in water); white powder. (NTP, 1992) This molecule is a member of the class of benzimidazoles that is benzimidazole in which the hydrogen at position 2 is replaced by an amino group. It has a role as a marine xenobiotic metabolite. This molecule is a natural product found in Euglena gracilis with data available.",CHEMBL305513
O=C(c1ccncc1)c1ccc(OCC[NH+]2CCCC2)cc1,3.7,,
CSCCC(NC(C)=O)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C,3.7,,
CC1(C)NC(=[NH2+])N(Cc2cccc(Cl)c2)C1=O,3.7,,
OCC1OC(NC(=S)N=NCc2ccncc2)C(O)C(O)C1O,3.7,,
O=C([O-])C1(O)C=CC(O)C(O)C1,3.7,,
CC1(O)CCN2C(=O)CCc3cccc1c32,3.7,,CHEMBL1702690
[NH3+]C(CO)C(=O)[O-],3.7,,
O=C([O-])c1sccc1S(=O)(=O)NC1CC1,3.7,,
N#Cc1cccnc1N1CCC2(c3ccc(F)cc3F)NC(=[NH2+])OC2C1,3.7,,
N#Cc1cccnc1N1CCC2OC(=[NH2+])NC2(c2ccc(F)cc2F)C1,3.7,,
[NH2+]=C1NC(=O)C(=Cc2ccc(O)cc2)S1,3.7,,
O=C1c2ccccc2C(=O)N1CCc1nn[nH]n1,3.71,,
Cc1cc(-c2csc(N)n2)c(C)n1CC1CCCO1,3.71,,CHEMBL3233608
Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1,3.71,,
O=C([O-])Cc1cccc([N+](=O)[O-])c1,3.72,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(C)C(O)C(O)C2O)C1OC1OC(CO)C(O)C(OS(=O)(=O)[O-])C1O,3.72,,
O=C([O-])CC(C(=O)[O-])C(O)C(=O)[O-],3.72,,
OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1O,3.72,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(C)C(=O)O)C(C)O,3.72,,
C=CCOC1(C(=O)[O-])CC(OC2(C(=O)[O-])OC(C(O)CO)C(O)C(O)C2O)C(O)C(C(O)CO)O1,3.72,,
O=C([O-])CCC(O)C(=O)[O-],3.72,,
OCC1OC(OC2C(O)C(O)OC(CO)C2O)C(O)C(O)C1O,3.72,,
Cc1ccc(CN=NC(=S)NC2OC(CO)C(O)C(O)C2O)cc1,3.72,,
CCC(C)C(NC(=O)C(NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CO)C(C)C)C(C)O)C(C)CC)C(=O)[O-],3.72,,
CCC(C)C(NC(=O)C(CC(N)=O)NC(=O)C([NH3+])Cc1ccccc1)C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(C(=O)NC(CC(N)=O)C(=O)[O-])C(C)CC)C(C)O)C(C)O)C(C)C,3.72,,
CCC(C)C(NC(=O)C(CC(N)=O)NC(=O)C([NH3+])Cc1ccccc1)C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)[O-])C(C)O)C(C)O)C(C)C,3.72,,
CC(C)CC([NH3+])C(=O)NO,3.72,,
c1ccc2n[nH]cc2c1,3.73,,
COc1cccc(C[NH3+])c1,3.73,,
CC(C)CC([NH3+])C(=O)NC(C)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)[O-])C(C)O,3.73,,
COc1cccc(C[NH3+])c1,3.73,,
CC(=O)NCCCCC(NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCNC(N)=[NH2+])NC(C)=O)C(=O)Nc1ccc2c(C)cc(=O)oc2c1,3.73,,
NC(=[NH2+])c1ccccc1,3.74,,
OCC1OC(OCC2OC(OC3C(COC4OC(CO)C(O)C(O)C4O)OC(OC4C(CO)OC(OC5C(CO)OC(O)C(O)C5O)C(O)C4O)C(O)C3O)C(O)C(O)C2OC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O,3.74,,
NC(=O)CCC(NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C[NH3+])C(=O)NC(CO)C(=O)NC(CO)C(=O)[O-],3.74,,
CN(C)c1ccc(O)c2c1CC1CC3C([NH+](C)C)C(O)C(C(N)=O)C(=O)C3(O)C(O)=C1C2=O,3.74,,
O=C([O-])c1cnc(-c2ccccc2)[nH]1,3.74,,
Nc1ncnc2[nH]cnc12,3.74,"This molecule is the parent compound of the 6-aminopurines, composed of a purine having an amino group at C-6. It has a role as a human metabolite, a Daphnia magna metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a purine nucleobase and a member of 6-aminopurines. It derives from a hydride of a 9H-purine. A purine base and a fundamental unit of adenine nucleotides. This molecule is a purine nucleobase with an amine group attached to the carbon at position 6. This molecule is the precursor for adenosine and deoxyadenosine nucleosides. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Streptomyces piomogenus, Bridelia balansae, and other organisms with data available. This molecule is a purine base. This molecule is found in both DNA and RNA. This molecule is a fundamental component of adenine nucleotides. This molecule forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose; it forms adenosine triphosphate (ATP), a nucleotide, when three phosphate groups are added to adenosine. Adenosine triphosphate is used in cellular metabolism as one of the basic methods of transferring chemical energy between chemical reactions. Purine inborn errors of metabolism (IEM) are serious hereditary disorders, which should be suspected in any case of neonatal fitting, failure to thrive, recurrent infections, neurological deficit, renal disease, self-mutilation and other manifestations. Investigation usually starts with uric acid (UA) determination in urine and plasma. (OMIM 300322, 229600, 603027, 232400, 232600, 232800, 201450, 220150, 232200, 162000, 164050, 278300).  (A3372, A3373).",CHEMBL226345
OCC1OC(NC(=S)N=NCc2cccc(O)c2)C(O)C(O)C1O,3.74,,
CSCCC(NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C([NH3+])C(C)O)C(C)C)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NCC(=O)NC(CO)C(=O)[O-],3.74,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])Cc1c[nH]cn1)C(=O)[O-],3.74,,
CC(NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])Cc1c[nH]cn1)C(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],3.74,,
CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC([NH+](C)C)C2O)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O,3.75,,
O=C(Cn1cc(-c2ccccc2)nn1)NC1OC(CO)C(O)C(O)C1O,3.75,,
O=c1ccn(C2OC(C[NH+]3CCOCC3)C(O)C2O)c(=O)[nH]1,3.75,,
CON=C(C(=O)NC1C(=O)N2C(C(=O)[O-])=C(COC(N)=O)CSC12)c1ccco1,3.75,,
[NH3+]CC1C(O)C(O)C2C(O)CC[NH+]12,3.76,,
O=c1ccn(C2OC(C[NH+]3CCCCC3)C(O)C2O)c(=O)[nH]1,3.76,,
C=CC(C)=CC1(C)SC(=O)C(C)=C1O,3.76,,
Cc1noc(C)c1-c1cc(NS(=O)(=O)c2ccccc2)cc(C(=O)[O-])c1,3.76,,
NC(=O)CCC(NC(=O)C1CCC(=O)N1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],3.77,,
CCCCCOc1ccc2cc(S(=O)(=O)NC(CCC(=O)[O-])C(=O)[O-])ccc2c1,3.77,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,3.77,,
Cn1nc(-c2cc(Br)c3c(c2)OCO3)cc1N,3.77,,CHEMBL1614842
OC(c1ccncc1)c1ccc(OCC[NH+]2CCCC2)cc1,3.77,,
C[NH2+]C1C(OC2C(OC3C(O)C(O)C(NC(N)=[NH2+])C(O)C3NC(N)=[NH2+])OC(C)C2(O)C=O)OC(CO)C(O)C1O,3.77,,
Brc1cnc[nH]1,3.77,,
O=C1NCCc2ccccc21,3.77,,CHEMBL1688212
OCC1OC(c2cc(O)c(Cl)cc2O)C(O)C(O)C1O,3.77,,
COc1ccc(C(=O)CCC(=O)[O-])c(O)c1,3.77,,
O=C(Nc1ccccc1N1CCOCC1)c1ccsc1,3.77,,CHEMBL3233609
CC(O)C([NH3+])C(=O)NC(Cc1ccccc1)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)NC(CC(N)=O)C(=O)[O-])C(C)O,3.77,,
CCCCCCCCCC(=O)[O-],3.78,,
Cc1ccccc1-n1ncc2c(=O)[nH]c(CC(C)C(F)(F)F)nc21,3.78,,
O=C(Nc1ccc2[nH]ccc2c1)c1cc(F)cc(N2CCOCC2)c1,3.79,This molecule is a solid. This compound belongs to the phenylmorpholines. These are aromatic compounds containing a morpholine ring and a benzene ring linked to each other through a CC or a CN bond. This drug targets mitogen-activated protein kinase 14.,CHEMBL195450
CC(=O)Nc1nnc(S(N)(=O)=O)s1,3.79,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
NC(=O)CC(NC(=O)C1CCC(=O)N1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],3.8,,
Cc1cc[nH]c1,3.8,,CHEMBL426643
CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(N)=O)NC(=O)C([NH3+])C(C)O)C(=O)[O-],3.8,,
O=C([O-])COc1c(Br)csc1C(=O)[O-],3.8,,
S=CNc1ccc2oc(C3=NCCN3)cc2c1,3.8,,
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)CNC(=O)CNC(=O)C(CO)NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1cnc[nH]1)NC(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CO)C(C)O)C(=O)[O-],3.8,,
[NH3+]CCNS(=O)(=O)c1ccc(Cl)c2ccncc12,3.8,,
Cn1c(=O)cc(C2CC2c2ccccc2)[nH]c1=[NH2+],3.8,,
OC1NC=CC2=CC(OCC3CC[NH2+]C3)C(Cl)C=C21,3.8,,
CCNC(=O)NCCC(=O)Nc1ccc2nc(C)sc2c1,3.8,,CHEMBL2059006
O=C(Nc1ccc2c(c1)C[NH2+]CC2)c1ccc(F)cc1,3.8,,
CCC(C)C(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(C)C(=O)NC(CCSC)C(=O)NC(CCSC)C(=O)NC(CCC(N)=O)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)[O-],3.81,,
O=C(NCc1ccc(-c2ccccc2)cc1)C1OC2CN(C(=O)NO)CC1O2,3.81,,
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C[NH3+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)[O-],3.81,,
CC(O)C(=O)[O-],3.81,,
O=[N+]([O-])c1ccc(O)c2ncccc12,3.81,"This molecule is a monohydroxyquinoline in which the hydroxy group is positioned at C-8 with a nitro group trans to it at C-5. It has a role as an antimicrobial agent, an antifungal agent, a renal agent and an antiinfective agent. It is a C-nitro compound and a monohydroxyquinoline. This molecule is a urinary antibacterial agent active against susceptible gram-positive and gram-negative organisms commonly found in urinary tract infections. It is a hydroxyquinoline derivative unrelated to other classes of drugs. This molecule is active against bacterial gyrases. This molecule is a natural product found in Bos taurus with data available.",CHEMBL1454910
COC1SC2C(C1C(=O)[O-])C(O)C2(Cl)Cl,3.81,,
O=C1CN2C(=NN1)COc1ccccc12,3.81,,CHEMBL1968515
O=C([O-])c1c(-c2ccccc2)nn(-c2ccccc2)c1C(=O)[O-],3.82,,
OCC1OC(n2cc(-c3ccccc3)nn2)C(O)C(O)C1O,3.82,,
Cc1ccc(Oc2ccc(NC(=O)c3ccccc3C(=O)[O-])cc2)cc1C,3.82,,
Oc1ccc(NCc2c(O)ccc3ccccc23)cc1,3.82,,
Nc1ncnc2c1ncn2C1OC(CSC2CC[NH+](CC[NH2+]Cc3cnc4[nH]c(=[NH2+])[nH]c(=O)c4n3)CC2)C(O)C1O,3.82,,
[NH3+]Cc1csc(-c2cccs2)n1,3.82,,
CC(=O)N1CC(O)CC1C(=O)NCc1ccc(-c2cnco2)cc1,3.82,,
Cc1nc(=N)[nH]c(=S)[nH]1,3.82,,
Cc1ncc2c(c1O)COC2=O,3.82,,
Oc1ccc(-c2ccccc2)cc1O,3.82,,CHEMBL475398
Oc1ccc(S)c(O)c1,3.83,,
O=[N+]([O-])c1ccccc1SC1OC(CO)C(O)C(O)C1O,3.83,,
Cn1ccc(N)nc1=O,3.84,"This molecule is a pyrimidone that is cytosine in which the hydrogen attached to the nitrogen at position 1 is substituted by a methyl group. It has a role as a metabolite. It is a pyrimidone, an aminopyrimidine and a methylcytosine. It is functionally related to a cytosine.",CHEMBL500883
NC(=[NH2+])c1ccccc1,3.84,,
NC(=[NH2+])c1ccccc1,3.84,,
[NH3+]Cc1ccccc1,3.84,,
OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC8C(CO)OC(OC1C(O)C2O)C(O)C8O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O,3.84,,
OC1C[NH2+]CC(O)C(O)C1O,3.84,,
O=C([O-])CNC(=O)C1CCCN1C(=O)C1CCCN1C(=O)CNC(=O)C1CCCN1C(=O)C1CCCN1C(=O)CNC(=O)C1CCCN1C(=O)C1CCC[NH2+]1,3.84,,
CN1CCC=CCCCCCC(=O)Cc2c(Cl)c(O)cc(O)c2C1=O,3.84,,
CC(CC(=O)[O-])c1n[n+](C)c2nc(N)[nH]c(=O)c2c1O,3.84,,
CC(=O)NC1C(O)C=C(C(=O)[O-])OC1C(O)C(O)CO,3.85,,
CC(=O)NC1C(O)C=C(C(=O)[O-])OC1C(O)C(O)CO,3.85,,
O=C([O-])c1ccccc1N=Nc1ccc(O)cc1,3.85,,
CC(=O)NC1C(O)CC(C(=O)[O-])OC1C(O)C(O)CO,3.85,,
OCC1C(O)C(O)C(O)c2nccn21,3.85,,
O=c1ccn(C2CC(O)C(CO)O2)c(=O)[nH]1,3.85,,
Clc1ncnc2[nH]cnc12,3.85,This molecule is a member of purines.,CHEMBL140037
CC1=C(C(=O)[O-])NC(C(C=O)NC(=O)Cc2cccs2)SC1,3.85,,
O=C([O-])c1cc(OCc2cccc([N+](=O)[O-])c2)cc(C(=O)[O-])c1,3.85,,
O=C([O-])CC(C(=O)[O-])N1C(=O)C(=C2C(=O)Nc3ccc(Br)cc32)SC1=S,3.86,,
C[NH+]1CC[NH+](CCCNC(=O)c2c(-c3ccccc3)c(-c3ccc(Cl)cc3)cn2CCC(O)CO)CC1,3.86,,
FC(F)(F)c1nc2ccccc2[nH]1,3.86,This molecule is a member of benzimidazoles.,CHEMBL55641
COc1ccc(Cl)cc1NC(=O)CSc1ccc(C(=O)[O-])cn1,3.86,,
CNC(=O)C1Cc2ccc(NS(=O)(=O)[O-])cc2CN1C(=O)OC(C)(C)C,3.87,,
[B+2]CNC(=O)Cc1ccccc1,3.87,,
OCC1OC(n2cc(-c3cccc4ccccc34)nn2)C(O)C(O)C1O,3.87,,
[NH3+]C(Cn1ccc(=O)n(CCC(=O)[O-])c1=O)C(=O)[O-],3.87,,
OCC1OC(c2cc(O)c(Br)cc2O)C(O)C(O)C1O,3.87,,
CC1OC(O)C(O)C(O)C1O,3.87,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL273741
[NH3+]Cc1cccc2c1OCCCO2,3.87,,
O=C([O-])CSc1nnc(-c2sc3ccccc3c2Cl)n1-c1ccccc1,3.87,,
Cc1cccnc1NCc1ccccc1O,3.87,,
CSCCC(NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCC(N)=O)C(C)O)C(N)=O,3.88,,
C[n+]1ccccc1CNC(=O)C1CCCN1C(=O)C([NH3+])Cc1ccccc1,3.88,,
CC(C(=O)[O-])c1ccc(C2CCCCC2)c2ccccc12,3.88,,
CC(NC(=O)C(CCC(=O)[O-])NC(=O)C(C)NC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])Cc1c[nH]cn1)C(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],3.88,,
O=C([O-])C(O)Cc1ccccc1,3.89,,
CC(=O)NC1C(OC2C(O)C(OC3C(O)C(COC4OC(CO)C(O)C(O)C4O)OC(O)C3NC(C)=O)OC(CO)C2OC2OC(COC3OC(C)C(O)C(O)C3O)C(O)C(O)C2O)OC(CO)C(O)C1O,3.89,,
O=C([O-])C=Cc1ccncc1,3.89,,
CC(NC(=O)C(CCC(=O)[O-])NC(=O)C1CCC[NH2+]1)C(=O)NC(C(=O)NC(C)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)[O-])C(C)O,3.89,,
O=c1o[nH]c2[n+]1-c1cc(Br)ccc1OC2,3.89,,
CC[NH+](CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C,3.89,,
C=CCSc1nc2ccc(NC(=O)CCC(=O)[O-])cc2s1,3.89,,
CC(C)CC(NC(=O)C1CCCN1C(=O)CNC(=O)C1CCC[NH2+]1)C(=O)N1CCCC1C(=O)NC(C)C(=O)[O-],3.89,,
C[NH2+]Cc1ccc(C(F)(F)F)cc1,3.89,,
[NH3+]CCc1cnc[nH]1,3.9,,
CCCCCCCCCCCCCCCC[SH+](=O)[O-],3.9,,
CC(O)C(NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(Cc1c[nH]cn1)NC(=O)C(CO)NC(=O)C([NH3+])Cc1ccccc1)C(=O)[O-],3.9,,
NP(=O)(OC1CCCC1)OC1CCCC1,3.9,,
COC1C(O)C(O)OC(CO)C1O,3.9,,
[NH3+]CCCCC([NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],3.9,,
CCn1c2ccccc2c2cc(C[NH2+]C)ccc21,3.9,,
O=S(=O)([O-])c1cccc2cccc(Nc3ccccc3)c12,3.9,,
O=S(=O)([O-])c1ccc2cc(Nc3ccccc3)ccc2c1,3.9,,
Oc1c(Cl)cc(Cl)cc1-c1[nH]c(Cl)c(Cl)c1Cl,3.9,,CHEMBL1738815
N#Cc1ccc(COc2ccc3cc(S(=O)(=O)NC4CCC(C(=O)[O-])CC4C(=O)[O-])ccc3c2)c(F)c1,3.9,,
Cn1cc(-c2nc3ccccc3[nH]2)cn1,3.9,,CHEMBL3233605
OCC1C(O)C(O)C(O)C1[NH2+]Cc1ccc(Br)cc1,3.9,,
[B+2]CNC(=O)Cc1ccccc1,3.9,,
CCN1CCN(C(=O)NC(C(=O)NC(C(=O)[O-])C2[NH2+]C(C(=O)[O-])C(C)(C)S2)c2ccccc2)C(=O)C1=O,3.9,,
CCN1CCN(C(=O)NC(C(=O)NC(C(=O)[O-])C2[NH2+]C(C(=O)[O-])C(C)(C)S2)c2ccccc2)C(=O)C1=O,3.9,,
Cc1ccc(CN(C)c2cc(C)nc3ncnn23)cc1,3.9,,CHEMBL2436015
O=[N+]([O-])c1ccc2[nH]cnc2c1,3.9,"This molecule is an off-white to pale yellow fluffy powder. (NTP, 1992)",CHEMBL164921
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(CC1C=CCCC1)NC(=O)C(CC(N)=O)NC(=O)C1=CCc2ccccc2N1,3.9,,
[NH3+]CCCCC(NC(=O)C1CCC(=O)N1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],3.91,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1C=CCN1C(=O)C1CCCN1C(=O)C1CC=CN1C(=O)C1CCC[NH2+]1)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)[O-],3.91,,
N#Cc1ccc(COc2ccc3ccc(S(=O)(=O)NC(CCC(=O)[O-])C(=O)[O-])cc3c2)cc1,3.91,,
CC(C)CC1(C)NC(=[NH2+])N(Cc2cccc(Cl)c2)C1=O,3.91,,
O=C([O-])CCc1ccccc1,3.92,,
Nc1ncnc2c1ccn2C1OC(CO)C(O)C1O,3.92,,
NS(=O)(=O)c1cccc2c(O)cccc12,3.92,,CHEMBL457047
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,3.92,,
CCOC(=O)c1nnn2c1nc(SC(C(C)=O)C(=O)OCC)c1ccccc12,3.92,,
O=C([O-])c1ccccc1O,3.92,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(C)[NH3+])C(C)C)C(=O)[O-],3.92,,
NC(=O)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(=O)[O-])NC(=O)C1CCC[NH2+]1)C(N)=O,3.92,,
CCC(C)C(NC(=O)C(NC(=O)C1CCCN1C(=O)CNC(=O)CNC(=O)C(C)[NH3+])C(C)O)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C,3.92,,
O=c1ncccn1C1OC(CO)C(O)C1O,3.92,,CHEMBL286977
COC1OC(CO)C(SC2OC(CO)C(SC3OC(CO)C(SC4OC(CO)C(SC5OC(CO)C(O)C(O)C5O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C1O,3.93,,
Nc1nc2c([nH]c(=O)n2C2CC(O)C(CO)O2)c(=O)[nH]1,3.93,,
CC(=O)NCCCCC(NC(=O)CNC(=O)C[NH3+])C(=O)NC(C)C(=O)[O-],3.93,,
CC(C)Cn1c(=O)n(C)c(=O)c2[nH]cnc21,3.93,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,3.94,,
CCC(NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)O)C(=O)NC(CCC(N)=O)C(=O)O,3.94,,
CCCC[NH+]1CC(O)C(O)C(O)C1CO,3.94,,
CC(C)CC(NC(=O)N1CCOCC1)C(=O)NC(CCc1ccccc1)CCS(=O)(=O)c1ccccc1,3.94,,
Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)cc1NC(=O)c1ccccc1,3.94,,
[NH3+]C(CO)C(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)[O-],3.94,,
[NH2+]=c1[nH]c(=O)c2ncc(C(=O)NC(CO)C(=O)NC(Cc3c[nH]c4ccccc34)C(=O)[O-])nc2[nH]1,3.94,,
CC(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(C)C(=O)NC(Cc1ccccc1)C(=O)[O-],3.94,,
CNC(=O)NC(=[NH2+])Nc1ccccc1,3.95,,
CCCCC(=O)NO,3.95,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C)C(=O)[O-],3.95,,
COC1OC(CO)C(O)C(O)C1SC1OC(CO)C(O)C(O)C1O,3.96,,
Nc1nc2ccccc2[nH]1,3.96,"Plates (in water); white powder. (NTP, 1992) This molecule is a member of the class of benzimidazoles that is benzimidazole in which the hydrogen at position 2 is replaced by an amino group. It has a role as a marine xenobiotic metabolite. This molecule is a natural product found in Euglena gracilis with data available.",CHEMBL305513
CC(C)CC(NC(=O)C(CCC(N)=O)NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C(C)[NH3+])C(=O)NC(C)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH+](C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)N1CCCC1C(=O)[O-])C(C)O,3.96,,
CC(C)CC(NC(=O)C([NH3+])CCC(N)=O)C(=O)NC(C)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(C(=O)NCC(=O)[O-])C(C)O)C(C)O,3.96,,
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C([NH3+])C(C)O)C(C)CC)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)O,3.96,,
CCC(=O)NC1C(=O)NC(=O)N=C1NCC(O)C(O)C(O)CO,3.96,,
C[NH2+]C(C)C(=O)NC(C(=O)N1CCCC1c1nc(-c2cccc3ccccc23)cs1)C1CCCCC1,3.96,,
N=C1NC(=[NH2+])C([N+](=O)[O-])C(=O)N1,3.96,,
CCC(C)C(NC(=O)C(CC(N)=O)NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(C)C)NC(=O)C1CCC[NH2+]1)C(C)O)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)[O-])C(C)O,3.96,,
COc1cc(OC)c(S(=O)(=O)NCc2ccccc2N2CCCCC2)cc1NC(C)=O,3.96,,CHEMBL1951180
CN1CCCC=CCCCC(=O)Cc2c(Cl)c(O)cc(O)c2C1=O,3.96,,
O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,3.96,"This molecule is a hexahydroxyflavone that is flavone substituted by hydroxy groups at positions 3, 3', 4', 5, 5' and 7. It has been isolated from the leaves of Myrica rubra and other plants. It has a role as a cyclooxygenase 1 inhibitor, an antineoplastic agent, an antioxidant, a plant metabolite, a food component, a hypoglycemic agent and a geroprotector. It is a hexahydroxyflavone and a 7-hydroxyflavonol. It is a conjugate acid of a myricetin(1-). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Caragana frutex, Camellia sinensis, and other organisms with data available.",CHEMBL164
CCC(C)C(NC(=O)C(NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CO)C(C)O)C(C)CC)C(=O)[O-],3.96,,
O=C([O-])Cc1ccc(O)cc1,3.97,,
Cn1c(=O)c2c(ncn2C)n(C)c1=O,3.97,"This molecule appears as odorless white powder or white glistening needles, usually melted together. Bitter taste. Solutions in water are neutral to litmus. Odorless. (NTP, 1992) These molecules is a trimethylxanthine in which the three methyl groups are located at positions 1, 3, and 7. A purine alkaloid that occurs naturally in tea and coffee. It has a role as a central nervous system stimulant, an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor, an adenosine receptor antagonist, an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor, a ryanodine receptor agonist, a fungal metabolite, an adenosine A2A receptor antagonist, a psychotropic drug, a diuretic, a food additive, an adjuvant, a plant metabolite, an environmental contaminant, a xenobiotic, a human blood serum metabolite, a mouse metabolite, a geroprotector and a mutagen. It is a purine alkaloid and a trimethylxanthine. This molecule is a drug of the methylxanthine class used for a variety of purposes, including certain respiratory conditions of the premature newborn, pain relief, and to combat drowsiness. This molecule is similar in chemical structure to [Theophylline] and [Theobromine]. It can be sourced from coffee beans, but also occurs naturally in various teas and cacao beans, which are different than coffee beans. This molecule is also used in a variety of cosmetic products and can be administered topically, orally, by inhalation, or by injection.  The caffeine citrate injection, used for apnea of the premature newborn, was initially approved by the FDA in 1999. According to an article from 2017, more than 15 million babies are born prematurely worldwide. This correlates to about 1 in 10 births. Premature birth can lead to apnea and bronchopulmonary dysplasia, a condition that interferes with lung development and may eventually cause asthma or early onset emphysema in those born prematurely. This molecule is beneficial in preventing and treating apnea and bronchopulmonary dysplasia in newborns, improving the quality of life of premature infants. This molecule is a Central Nervous System Stimulant and Methylxanthine. The physiologic effect of caffeine is by means of Central Nervous System Stimulation. This molecule is xanthine alkaloid that occurs naturally in seeds, leaves and fruit of several plants and trees that acts as a natural pesticide. This molecule is a major component of coffee, tea and chocolate and in humans acts as a central nervous system (CNS) stimulant. Consumption of caffeine, even in high doses, has not been associated with elevations in serum enzyme elevations or instances of clinically apparent liver injury. This molecule is a methylxanthine alkaloid found in the seeds, nuts, or leaves of a number of plants native to South America and East Asia that is structurally related to adenosine and acts primarily as an adenosine receptor antagonist with psychotropic and anti-inflammatory activities. Upon ingestion, caffeine binds to adenosine receptors in the central nervous system (CNS), which inhibits adenosine binding. This inhibits the adenosine-mediated downregulation of CNS activity; thus, stimulating the activity of the medullary, vagal, vasomotor, and respiratory centers in the brain. This agent also promotes neurotransmitter release that further stimulates the CNS. The anti-inflammatory effects of caffeine are due the nonselective competitive inhibition of phosphodiesterases (PDEs). Inhibition of PDEs raises the intracellular concentration of cyclic AMP (cAMP), activates protein kinase A, and inhibits leukotriene synthesis, which leads to reduced inflammation and innate immunity. This molecule is a natural product found in Camellia sinensis, Claviceps sorghicola, and other organisms with data available. This molecule is the most widely consumed psychostimulant drug in the world that mostly is consumed in the form of coffee. Whether caffeine and/or coffee consumption contribute to the development of cardiovascular disease (CVD), the single leading cause of death in the US, is unclear. The literature indicates a strong relationship between boiled, unfiltered coffee consumption and elevated cholesterol levels; however, there is a critical gap in the literature regarding the effects of coffee or caffeine consumption on fibrinogen or CRP, which is an independent predictor of CVD risk. Available studies are limited by small samples sizes, inclusion of only men (or few women) and unrepresented age or ethnic groups. There is a critical need for controlled laboratory and epidemiological studies that include fibrinogen and CRP markers of CVD risk before conclusions can be drawn regarding the health effects of caffeine and/or coffee in a normal, healthy population of men and women. (A11723). The relationship between caffeine consumption and various illnesses such as cardiovascular disease and cancer remains equivocal. Prudence might dictate that pregnant women and chronically ill individuals exercise restraint in their use of caffeine, although research suggests relatively low or nonexistent levels of risk associated with moderate caffeine consumption. (A7827). There is extensive evidence that caffeine at dietary doses increases blood pressure (BP). However, concern that the drug may contribute to cardiovascular disease appears to have been dampened by (1) the belief that habitual use leads to the development of tolerance, and (2) confusion regarding relevant epidemiologic findings. When considered comprehensively, findings from experimental and epidemiologic studies converge to show that BP remains reactive to the pressor effects of caffeine in the diet. Overall, the impact of dietary caffeine on population BP levels is likely to be modest, probably in the region of 4/2 mm Hg. At these levels, however, population studies of BP indicate that caffeine use could account for premature deaths in the region of 14% for coronary heart disease and 20% for stroke. (A7828). This molecule is a purine alkaloid that occurs naturally in coffee beans. At intake levels associated with coffee consumption, caffeine appears to exert most of its biological effects through the antagonism of the A1 and A2A subtypes of the adenosine receptor. Adenosine is an endogenous neuromodulator with mostly inhibitory effects, and adenosine antagonism by caffeine results in effects that are generally stimulatory. Some physiological effects associated with caffeine administration include central nervous system stimulation, acute elevation of blood pressure, increased metabolic rate, and diuresis. This molecule concentrations in coffee beverages can be quite variable. A standard cup of coffee is often assumed to provide 100 mg of caffeine, but a recent analysis of 14 different specialty coffees purchased at coffee shops in the US found that the amount of caffeine in 8 oz (=240 ml) of brewed coffee ranged from 72 to 130 mg.This molecule in espresso coffees ranged from 58 to 76 mg in a single shot. (A7829). This molecule is a member of the methylxanthine family of drugs, and is the most widely consumed behaviourally active substance in the western world. A number of in vitro and in vivo studies have demonstrated that caffeine modulates both innate and adaptive immune responses. For instance studies indicate that caffeine and its major metabolite paraxanthine suppress neutrophil and monocyte chemotaxis, and also suppress production of the pro-inflammatory cytokine tumor necrosis factor (TNF) alpha from human blood. This molecule has also been reported to suppress human lymphocyte function as indicated by reduced T-cell proliferation and impaired production of Th1 (interleukin [IL]-2 and interferon [IFN]-gamma), Th2 (IL-4, IL-5) and Th3 (IL-10) cytokines. Studies also indicate that caffeine suppresses antibody production. The evidence suggests that at least some of the immunomodulatory actions of caffeine are mediated via inhibition of cyclic adenosine monophosphate (cAMP)-phosphodiesterase (PDE), and consequential increase in intracellular cAMP concentrations. Overall, these studies indicate that caffeine, like other members of the methylxanthine family, is largely anti-inflammatory in nature, and based on the pharmacokinetics of caffeine, many of its immunomodulatory effects occur at concentrations that are relevant to normal human consumption. (A7830).",CHEMBL113
CC(=CCNc1ncnc2nc[nH]c12)CO,3.97,,
[NH3+]Cc1ccc(-c2cccs2)cc1,3.97,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C1CCCN1C(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)[O-],3.97,,
CC[NH+](CC)C1CC[NH+](Cc2cc(C#CCO)cc(I)c2O)CC1,3.97,,
Cc1cccc(C(=O)C2=C(O)C(=O)N(c3ccc(CC(=O)[O-])cc3)C2c2cc(Cl)c3c(c2)OCO3)c1,3.97,,
CC(NC(=O)C(CCCC[NH2+]C(C)C(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)[O-],3.98,,
N#Cc1ccc(COc2ccc3cc(S(=O)(=O)NC(CCC(=O)[O-])C(=O)[O-])ccc3c2)cc1,3.98,,
CC[NH+](CC)C1CC[NH+](Cc2cc(I)cc(I)c2O)CC1,3.98,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C1O,3.99,,
O=C([O-])C1CC[NH+](C2C(CO)OC(n3ccc(=O)[nH]c3=O)C2O)CC1,3.99,,
C[S+](C)CC(=O)[O-],3.99,,
CCCC(NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(C)[NH3+])C(=O)NC(CCCC[NH2+]C)C(=O)NCC(=O)[O-],3.99,,
Oc1ccccc1,3.99,"This molecule is both a manufactured chemical and a natural substance. It is a colorless-to-white solid when pure. The commercial product is a liquid. This molecule has a distinct odor that is sickeningly sweet and tarry. You can taste and smell phenol at levels lower than those that are associated with harmful effects. This molecule evaporates more slowly than water, and a moderate amount can form a solution with water. This molecule can catch fire. This molecule is used primarily in the production of phenolic resins and in the manufacture of nylon and other synthetic fibers. It is also used in slimicides (chemicals that kill bacteria and fungi in slimes), as a disinfectant and antiseptic, and in medicinal preparations such as mouthwash and sore throat lozenges. This molecule is a white crystalline mass dissolved in an aqueous solution. Solution may be colorless to slightly pink in color with a distinctive phenol odor; sharp burning taste. Aqueous solution will be acidic and act as such. Toxic by ingestion, inhalation and skin absorption; strong irritant to tissues. This molecule appears as a colorless liquid when pure, otherwise pink or red. Combustible. Flash point 175 °F. Must be heated before ignition may occur easily. Vapors are heavier than air. Corrosive to skin but because of anesthetic qualities will numb rather than burn. Upon contact skin may turn white. May be lethal by skin absorption. Does not react with water. Stable in normal transportation. Reactive with various chemicals and may be corrosive to lead, aluminum and its alloys, certain plastics, and rubber. Freezing point about 105 °F. Density 8.9 lb / gal. Used to make plastics, adhesives and other chemicals. This molecule is the white crystalline solid shipped at an elevated temperature to form a semi-solid. It is very hot and may cause burns from contact and also may cause the ignition of combustible materials. It is toxic by ingestion, and inhalation of its fumes, and skin absorption. It may also be very irritating to skin and eyes. It is used to make other chemicals. This molecule appears as a solid melting at 110 °F. Colorless if pure, otherwise pink or red. Flash point 175 °F. Density 9.9 lb / gal. Vapors are heavier than air Corrosive to the skin (turning skin white) but because of its anesthetic quality numbs rather than burn. Lethal amounts can be absorbed through the skin. Used to make plastics and adhesives. This molecule is an organic hydroxy compound that consists of benzene bearing a single hydroxy substituent. The parent of the class of phenols. It has a role as a disinfectant, an antiseptic drug, a human xenobiotic metabolite and a mouse metabolite. It is a conjugate acid of a phenolate. This molecule is an antiseptic and disinfectant. It is active against a wide range of micro-organisms including some fungi and viruses, but is only slowly effective against spores. This molecule has been used to disinfect skin and to relieve itching. This molecule is also used as an oral analgesic or anesthetic in products such as Chloraseptic to treat pharyngitis. Additionally, phenol and its related compounds are used in surgical ingrown toenail treatment, a process termed phenolization. Research indicates that parental exposure to phenol and its related compounds are positively associated with spontaneous abortion. During the second world war, phenol injections were used as a means of execution by the Nazis. This molecule is a toxic compound whose vapours are corrosive to the skin, eyes, and respiratory tract. Exposure to phenol may occur from the use of some medicinal products (including throat lozenges and ointments). Phenol is highly irritating to the skin, eyes, and mucous membranes in humans after acute (short-term) inhalation or dermal exposures. Phenol is considered to be quite toxic to humans via oral exposure. Anorexia, progressive weight loss, diarrhea, vertigo, salivation, a dark coloration of the urine, and blood and liver effects have been reported in chronically (long-term) exposed humans. Animal studies have reported reduced fetal body weights, growth retardation, and abnormal development in the offspring of animals exposed to phenol by the oral route. EPA has classified phenol as a Group D, not classifiable as to human carcinogenicity. This molecule is hydroxybenzene; Carbolic Acid. Used as a germicidal agent and as an intermediate in chemical synthesis.  Highly toxic; corrosive to the skin. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a natural product found in Aspergillus violaceofuscus, Scrophularia buergeriana, and other organisms with data available. This molecule is a toxic, colourless crystalline solid with a sweet tarry odor that resembles a hospital smell. It is commonly used as an antiseptic and disinfectant. It is active against a wide range of micro-organisms including some fungi and viruses, but is only slowly effective against spores. It has been used to disinfect skin and to relieve itching. Phenol is also used in the preparation of cosmetics including sunscreens, hair dyes, and skin lightening preparations. It is also used in the production of drugs (it is the starting material in the industrial production of aspirin), weedkillers, and synthetic resins. Phenol can be found in areas with high levels of motor traffic, therefore, people living in crowded urban areas are frequently exposed to traffic-derived phenol vapor. The average (mean +/- SD) phenol concentration in urine among normal individuals living in urban areas is 7.4 +/- 2.2 mg/g of creatinine. Exposure of the skin to concentrated phenol solutions causes chemical burns which may be severe; in laboratories where it is used, it is usually recommended that polyethylene glycol solution is kept available for washing off splashes. Notwithstanding the effects of concentrated solutions, it is also used in cosmetic surgery as an exfoliant, to remove layers of dead skin (Wikipedia). In some bacteria phenol can be directly synthesized from tyrosine via the enzyme tyrosine phenol-lyase [EC:4.1.99.2].",CHEMBL14060
CC(=O)NC(C(=O)NC(C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CO)C(N)=O)C(C)C)C(C)O,4.0,,
CC(C)CC(C(=O)NO)C(=O)NC(CC(=O)[O-])C(=O)NCc1ccccc1,4.0,,
COC1OC(CO)C(OC2OC(CO)C(SC3OC(CO)C(SC4OC(CO)C(O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C1O,4.0,,
Cn1c(=O)c2c(ncn2C)n(C)c1=O,4.0,"This molecule appears as odorless white powder or white glistening needles, usually melted together. Bitter taste. Solutions in water are neutral to litmus. Odorless. (NTP, 1992) These molecules is a trimethylxanthine in which the three methyl groups are located at positions 1, 3, and 7. A purine alkaloid that occurs naturally in tea and coffee. It has a role as a central nervous system stimulant, an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor, an adenosine receptor antagonist, an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor, a ryanodine receptor agonist, a fungal metabolite, an adenosine A2A receptor antagonist, a psychotropic drug, a diuretic, a food additive, an adjuvant, a plant metabolite, an environmental contaminant, a xenobiotic, a human blood serum metabolite, a mouse metabolite, a geroprotector and a mutagen. It is a purine alkaloid and a trimethylxanthine. This molecule is a drug of the methylxanthine class used for a variety of purposes, including certain respiratory conditions of the premature newborn, pain relief, and to combat drowsiness. This molecule is similar in chemical structure to [Theophylline] and [Theobromine]. It can be sourced from coffee beans, but also occurs naturally in various teas and cacao beans, which are different than coffee beans. This molecule is also used in a variety of cosmetic products and can be administered topically, orally, by inhalation, or by injection.  The caffeine citrate injection, used for apnea of the premature newborn, was initially approved by the FDA in 1999. According to an article from 2017, more than 15 million babies are born prematurely worldwide. This correlates to about 1 in 10 births. Premature birth can lead to apnea and bronchopulmonary dysplasia, a condition that interferes with lung development and may eventually cause asthma or early onset emphysema in those born prematurely. This molecule is beneficial in preventing and treating apnea and bronchopulmonary dysplasia in newborns, improving the quality of life of premature infants. This molecule is a Central Nervous System Stimulant and Methylxanthine. The physiologic effect of caffeine is by means of Central Nervous System Stimulation. This molecule is xanthine alkaloid that occurs naturally in seeds, leaves and fruit of several plants and trees that acts as a natural pesticide. This molecule is a major component of coffee, tea and chocolate and in humans acts as a central nervous system (CNS) stimulant. Consumption of caffeine, even in high doses, has not been associated with elevations in serum enzyme elevations or instances of clinically apparent liver injury. This molecule is a methylxanthine alkaloid found in the seeds, nuts, or leaves of a number of plants native to South America and East Asia that is structurally related to adenosine and acts primarily as an adenosine receptor antagonist with psychotropic and anti-inflammatory activities. Upon ingestion, caffeine binds to adenosine receptors in the central nervous system (CNS), which inhibits adenosine binding. This inhibits the adenosine-mediated downregulation of CNS activity; thus, stimulating the activity of the medullary, vagal, vasomotor, and respiratory centers in the brain. This agent also promotes neurotransmitter release that further stimulates the CNS. The anti-inflammatory effects of caffeine are due the nonselective competitive inhibition of phosphodiesterases (PDEs). Inhibition of PDEs raises the intracellular concentration of cyclic AMP (cAMP), activates protein kinase A, and inhibits leukotriene synthesis, which leads to reduced inflammation and innate immunity. This molecule is a natural product found in Camellia sinensis, Claviceps sorghicola, and other organisms with data available. This molecule is the most widely consumed psychostimulant drug in the world that mostly is consumed in the form of coffee. Whether caffeine and/or coffee consumption contribute to the development of cardiovascular disease (CVD), the single leading cause of death in the US, is unclear. The literature indicates a strong relationship between boiled, unfiltered coffee consumption and elevated cholesterol levels; however, there is a critical gap in the literature regarding the effects of coffee or caffeine consumption on fibrinogen or CRP, which is an independent predictor of CVD risk. Available studies are limited by small samples sizes, inclusion of only men (or few women) and unrepresented age or ethnic groups. There is a critical need for controlled laboratory and epidemiological studies that include fibrinogen and CRP markers of CVD risk before conclusions can be drawn regarding the health effects of caffeine and/or coffee in a normal, healthy population of men and women. (A11723). The relationship between caffeine consumption and various illnesses such as cardiovascular disease and cancer remains equivocal. Prudence might dictate that pregnant women and chronically ill individuals exercise restraint in their use of caffeine, although research suggests relatively low or nonexistent levels of risk associated with moderate caffeine consumption. (A7827). There is extensive evidence that caffeine at dietary doses increases blood pressure (BP). However, concern that the drug may contribute to cardiovascular disease appears to have been dampened by (1) the belief that habitual use leads to the development of tolerance, and (2) confusion regarding relevant epidemiologic findings. When considered comprehensively, findings from experimental and epidemiologic studies converge to show that BP remains reactive to the pressor effects of caffeine in the diet. Overall, the impact of dietary caffeine on population BP levels is likely to be modest, probably in the region of 4/2 mm Hg. At these levels, however, population studies of BP indicate that caffeine use could account for premature deaths in the region of 14% for coronary heart disease and 20% for stroke. (A7828). This molecule is a purine alkaloid that occurs naturally in coffee beans. At intake levels associated with coffee consumption, caffeine appears to exert most of its biological effects through the antagonism of the A1 and A2A subtypes of the adenosine receptor. Adenosine is an endogenous neuromodulator with mostly inhibitory effects, and adenosine antagonism by caffeine results in effects that are generally stimulatory. Some physiological effects associated with caffeine administration include central nervous system stimulation, acute elevation of blood pressure, increased metabolic rate, and diuresis. This molecule concentrations in coffee beverages can be quite variable. A standard cup of coffee is often assumed to provide 100 mg of caffeine, but a recent analysis of 14 different specialty coffees purchased at coffee shops in the US found that the amount of caffeine in 8 oz (=240 ml) of brewed coffee ranged from 72 to 130 mg.This molecule in espresso coffees ranged from 58 to 76 mg in a single shot. (A7829). This molecule is a member of the methylxanthine family of drugs, and is the most widely consumed behaviourally active substance in the western world. A number of in vitro and in vivo studies have demonstrated that caffeine modulates both innate and adaptive immune responses. For instance studies indicate that caffeine and its major metabolite paraxanthine suppress neutrophil and monocyte chemotaxis, and also suppress production of the pro-inflammatory cytokine tumor necrosis factor (TNF) alpha from human blood. This molecule has also been reported to suppress human lymphocyte function as indicated by reduced T-cell proliferation and impaired production of Th1 (interleukin [IL]-2 and interferon [IFN]-gamma), Th2 (IL-4, IL-5) and Th3 (IL-10) cytokines. Studies also indicate that caffeine suppresses antibody production. The evidence suggests that at least some of the immunomodulatory actions of caffeine are mediated via inhibition of cyclic adenosine monophosphate (cAMP)-phosphodiesterase (PDE), and consequential increase in intracellular cAMP concentrations. Overall, these studies indicate that caffeine, like other members of the methylxanthine family, is largely anti-inflammatory in nature, and based on the pharmacokinetics of caffeine, many of its immunomodulatory effects occur at concentrations that are relevant to normal human consumption. (A7830).",CHEMBL113
CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C([NH3+])CC(=O)[O-])C(C)C)C(=O)NC(CO)C(=O)NCC(=O)NC(CO)C(=O)[O-],4.0,,
O=C([O-])c1ccccc1,4.0,,
CCCCCCCCCCCCCC=O,4.0,"These molecules is a long-chain fatty aldehyde that is tetradecane in which two hydrogens attached to a terminal carbon are replaced by an oxo group. It is found in coriander. It has a role as a bacterial metabolite and a plant metabolite. It is a long-chain fatty aldehyde and a 2,3-saturated fatty aldehyde. It derives from a hydride of a tetradecane. This molecule is a natural product found in Euschistus heros, Eryngium foetidum, and other organisms with data available.",CHEMBL2228569
Nc1ccccc1F,4.0,"This molecule is a clear liquid with a mild sweet odor. Sinks in and mixes slowly with water. (USCG, 1999) This molecule is a derivative of aniline in which the hydrogen at position 2 has been substituted by fluorine. It is used as a pharmaceutical intermediate It is a primary arylamine and a fluoroaniline.",CHEMBL195328
Nc1c2c(nc3ccccc13)CCCC2,4.0,"This molecule is an oral acetylcholinesterase inhibitor previously used for therapy of Alzheimer disease. This molecule therapy is associated with a very high rate of serum aminotransferase elevations during therapy and has been linked to several instances of clinically apparent, acute liver injury. This molecule is a member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease. It has a role as an EC 3.1.1.7 (acetylcholinesterase) inhibitor. It is a member of acridines and an aromatic amine. It is a conjugate base of a tacrine(1+). A centerally active cholinesterase inhibitor that has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. Tacrine has been discontinued for the United States market. This molecule is a Cholinesterase Inhibitor. The mechanism of action of tacrine is as a Cholinesterase Inhibitor. This molecule is only found in individuals that have used or taken this drug. It is a centerally active cholinesterase inhibitor that has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. The mechanism of tacrine is not fully known, but it is suggested that the drug is an anticholinesterase agent which reversibly binds with and inactivates cholinesterases. This inhibits the hydrolysis of acetylcholine released from functioning cholinergic neurons, thus leading to an accumulation of acetylcholine at cholinergic synapses. The result is a prolonged effect of acetylcholine.",CHEMBL95
CCCC(CCC)C(N)=O,4.0,"This molecule is a fatty amide derived from valproic acid. It has a role as a metabolite, a teratogenic agent and a geroprotector. It is functionally related to a valproic acid.",CHEMBL93836
CC(C)CC(NC(=O)C(CCC(=O)[O-])NC(=O)C1CCCN1C(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)CNC(=O)C[NH3+])C(=O)N1CCCC1C(=O)NCC(=O)[O-],4.0,,
CC(C)CC(NC(=O)C(O)CC(=O)[O-])C(=O)NCCCCNC(N)=[NH2+],4.0,,
[NH3+]CCCCc1ccccc1,4.0,,
CN1c2ccc(C3CN(Cc4ccccc4)C(=O)CO3)cc2CS1(=O)=O,4.0,,
C[NH+](CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,4.0,,
c1ccc([P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1,4.0,"This molecule is a polyatomic cation consisting of four phenyl groups attached to a central phosphonium. It is a polyatomic cation, a phosphorus molecular entity and a heteroorganic entity. It derives from a hydride of a phosphonium.",CHEMBL1182234
CCCCCCCCCCn1c(-c2ccc(OS(N)(=O)=O)cc2)cc2ccc(OS(N)(=O)=O)cc21,4.0,,CHEMBL1235943
O=C([O-])c1ccc(O)c(O)c1,4.0,,
[NH3+]C(Cc1ccccc1)C(O)CNS(=O)(=O)c1ccc2ccccc2c1,4.0,,
[NH3+]CCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12,4.0,,
COc1ccc(-c2ccc(CN(C(=O)c3cc(C(=O)[O-])c(C(=O)[O-])cc3C(=O)[O-])C3CCCc4ccccc43)cc2)cc1,4.0,,
Nc1ncccc1NCc1cccc(-c2cccnc2)c1,4.0,,CHEMBL220346
O=C([O-])CNC(=O)C(=O)[O-],4.0,,
CC(=O)OCC[N+](C)(C)C,4.0,"This molecule is actylcholine is an ester of acetic acid and choline, which acts as a neurotransmitter. It has a role as a vasodilator agent, a muscarinic agonist, a hormone, a human metabolite, a mouse metabolite and a neurotransmitter. It is an acetate ester and an acylcholine. A neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. It is generally not used as an administered drug because it is broken down very rapidly by cholinesterases, but it is useful in some ophthalmological applications. This molecule is a Cholinergic Receptor Agonist. The mechanism of action of acetylcholine is as a Cholinergic Agonist. This molecule is a natural product found in Monascus pilosus, Poa huecu, and other organisms with data available.",CHEMBL667
NC(=O)c1cc[n+](COC[n+]2ccccc2)cc1,4.0,,
c1ccc(Nc2c[nH]c3ncccc23)cc1,4.0,,CHEMBL1231605
O=C1CC(C=NOCCC[NH2+]Cc2cccc(C(=O)[O-])c2)=NC(=O)N1,4.0,,
CCCOC1(C(=O)[O-])OC(C(O)CO)C(O)C(O)C1O,4.0,,
NS(=O)(=O)c1ccc([N+](=O)[O-])cc1,4.0,,CHEMBL282157
CC(=O)NCCCCC(NC(=O)C(C)NC(=O)C[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],4.0,,
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)Nc1c(F)cccc1F,4.0,,
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)Nc1cc(F)cc(F)c1,4.0,,
Nc1nc(Nc2ccccc2)sc1C(O)c1cccc(C(F)(F)F)c1,4.0,,
NC(=O)c1sc(Nc2ccccc2)nc1N,4.0,,CHEMBL2377833
C[NH+](C)NC(=O)CCC(=O)[O-],4.0,,
O=S(=O)([O-])C=Cc1cc(Br)ccc1O,4.0,,
Cc1c(C(=O)[O-])cccc1-c1nc2nc(N)nc(OCC3CCCCC3)c2[nH]1,4.0,,
O=C(NCC1c2ccccc2Oc2ccccc21)C1CCC[NH2+]C1,4.0,,
[NH3+]C(C(=O)[O-])C(O)C1(C(=O)[O-])CCC(CC(NC(=O)c2cc(Cl)c(O)c(Cl)c2)C(=O)[O-])[NH2+]1,4.0,,
Cc1cc(NS(=O)(=O)c2cc(Cl)c(Cl)cc2Cl)no1,4.0,,CHEMBL2376565
[NH2+]=C1NC2(c3cccc(-c4cncnc4)c3)CCOCC2O1,4.0,,
O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)[O-])c(CCCOc3ccc(-n4ncc5cncnc54)cc3)s1)CC2,4.0,,
NC(=[NH2+])NCCCC([NH3+])C(=O)[O-],4.0,,
CC(C)CC(NC(=O)C(NC(=O)C1CCC[NH2+]1)C(C)C)C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)[O-],4.0,,
C[n+]1cnc2[nH]cnc2c1N,4.01,,
NC(=[NH2+])c1ccccc1,4.01,,
COC(=O)C(Cc1cccc(C(N)=[NH2+])c1)NC(=O)CNS(=O)(=O)c1ccc(C)cc1,4.01,,
CC(C)CC([NH2+]CC(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)CNC(=O)C1CCCN1C(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CCC(N)=O)C(=O)NC(CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(N)=O,4.01,,
O=C(Nc1ccccc1)c1ccn[nH]1,4.01,,
CC(=O)OCC[N+](C)(C)C,4.01,"This molecule is actylcholine is an ester of acetic acid and choline, which acts as a neurotransmitter. It has a role as a vasodilator agent, a muscarinic agonist, a hormone, a human metabolite, a mouse metabolite and a neurotransmitter. It is an acetate ester and an acylcholine. A neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. It is generally not used as an administered drug because it is broken down very rapidly by cholinesterases, but it is useful in some ophthalmological applications. This molecule is a Cholinergic Receptor Agonist. The mechanism of action of acetylcholine is as a Cholinergic Agonist. This molecule is a natural product found in Monascus pilosus, Poa huecu, and other organisms with data available.",CHEMBL667
Clc1ccc2nc[nH]c2c1,4.01,,
O=[N+]([O-])c1ccc(O)c(OS(=O)(=O)[O-])c1,4.01,,
O=C(Nc1ccc(Oc2ccncc2)cc1)c1ccnc(N2CCOCC2)c1,4.01,,CHEMBL3930928
O=C1NC2C(O)C(O)C(O)C(CO)N2C1=O,4.02,,
COc1ccc2c(c1OC)CN(C)c1c-2ccc2cc3c(cc12)OCO3,4.02,"This molecule is a benzophenanthridine alkaloid. This molecule is a natural product found in Zanthoxylum simulans, Zanthoxylum ailanthoides, and other organisms with data available.",CHEMBL400359
CSCCC(NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(N)=O,4.02,,
OCC1OC(c2cc(O)c(Cl)cc2O)C(O)C(O)C1O,4.02,,
CCOC(=O)C[n+]1c(NC(N)=[NH2+])sc2cc(O)ccc21,4.02,,
COC(=O)c1ccc(CNC(=O)C2CC(O)CN2C(=O)Cc2cc(C)no2)cc1,4.02,,
Brc1cncc(-c2nnn[nH]2)c1,4.02,,CHEMBL2425111
CC(C)CC([NH3+])C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NCC(=O)O)C(C)O,4.03,,
N=c1cccc(CCc2ccc3cc[nH]c3c2)[nH]1,4.03,,
O=[N+]([O-])c1ccc(C2=NOC3(C2)OC(CO)C(O)C(O)C3O)cc1,4.03,,
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)[O-],4.03,,
CC([NH3+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C=O,4.03,,
OCC1OC(NC(=S)N=NCc2ccc(Br)cc2)C(O)C(O)C1O,4.03,,
CCCCCCCC(=O)[O-],4.03,,
c1cc2c(cn1)cnc1sccc12,4.03,,
Cc1n[nH]c2cn[nH]c12,4.03,,
O=[N+]([O-])c1cccc2cccnc12,4.03,,CHEMBL167727
CC(NC(=O)C(CCC(=O)[O-])NC(=O)CNC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])Cc1cnc[nH]1)C(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],4.03,,
Cn1c(=O)c2c(ncn2C)n(C)c1=O,4.04,"This molecule appears as odorless white powder or white glistening needles, usually melted together. Bitter taste. Solutions in water are neutral to litmus. Odorless. (NTP, 1992) These molecules is a trimethylxanthine in which the three methyl groups are located at positions 1, 3, and 7. A purine alkaloid that occurs naturally in tea and coffee. It has a role as a central nervous system stimulant, an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor, an adenosine receptor antagonist, an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor, a ryanodine receptor agonist, a fungal metabolite, an adenosine A2A receptor antagonist, a psychotropic drug, a diuretic, a food additive, an adjuvant, a plant metabolite, an environmental contaminant, a xenobiotic, a human blood serum metabolite, a mouse metabolite, a geroprotector and a mutagen. It is a purine alkaloid and a trimethylxanthine. This molecule is a drug of the methylxanthine class used for a variety of purposes, including certain respiratory conditions of the premature newborn, pain relief, and to combat drowsiness. This molecule is similar in chemical structure to [Theophylline] and [Theobromine]. It can be sourced from coffee beans, but also occurs naturally in various teas and cacao beans, which are different than coffee beans. This molecule is also used in a variety of cosmetic products and can be administered topically, orally, by inhalation, or by injection.  The caffeine citrate injection, used for apnea of the premature newborn, was initially approved by the FDA in 1999. According to an article from 2017, more than 15 million babies are born prematurely worldwide. This correlates to about 1 in 10 births. Premature birth can lead to apnea and bronchopulmonary dysplasia, a condition that interferes with lung development and may eventually cause asthma or early onset emphysema in those born prematurely. This molecule is beneficial in preventing and treating apnea and bronchopulmonary dysplasia in newborns, improving the quality of life of premature infants. This molecule is a Central Nervous System Stimulant and Methylxanthine. The physiologic effect of caffeine is by means of Central Nervous System Stimulation. This molecule is xanthine alkaloid that occurs naturally in seeds, leaves and fruit of several plants and trees that acts as a natural pesticide. This molecule is a major component of coffee, tea and chocolate and in humans acts as a central nervous system (CNS) stimulant. Consumption of caffeine, even in high doses, has not been associated with elevations in serum enzyme elevations or instances of clinically apparent liver injury. This molecule is a methylxanthine alkaloid found in the seeds, nuts, or leaves of a number of plants native to South America and East Asia that is structurally related to adenosine and acts primarily as an adenosine receptor antagonist with psychotropic and anti-inflammatory activities. Upon ingestion, caffeine binds to adenosine receptors in the central nervous system (CNS), which inhibits adenosine binding. This inhibits the adenosine-mediated downregulation of CNS activity; thus, stimulating the activity of the medullary, vagal, vasomotor, and respiratory centers in the brain. This agent also promotes neurotransmitter release that further stimulates the CNS. The anti-inflammatory effects of caffeine are due the nonselective competitive inhibition of phosphodiesterases (PDEs). Inhibition of PDEs raises the intracellular concentration of cyclic AMP (cAMP), activates protein kinase A, and inhibits leukotriene synthesis, which leads to reduced inflammation and innate immunity. This molecule is a natural product found in Camellia sinensis, Claviceps sorghicola, and other organisms with data available. This molecule is the most widely consumed psychostimulant drug in the world that mostly is consumed in the form of coffee. Whether caffeine and/or coffee consumption contribute to the development of cardiovascular disease (CVD), the single leading cause of death in the US, is unclear. The literature indicates a strong relationship between boiled, unfiltered coffee consumption and elevated cholesterol levels; however, there is a critical gap in the literature regarding the effects of coffee or caffeine consumption on fibrinogen or CRP, which is an independent predictor of CVD risk. Available studies are limited by small samples sizes, inclusion of only men (or few women) and unrepresented age or ethnic groups. There is a critical need for controlled laboratory and epidemiological studies that include fibrinogen and CRP markers of CVD risk before conclusions can be drawn regarding the health effects of caffeine and/or coffee in a normal, healthy population of men and women. (A11723). The relationship between caffeine consumption and various illnesses such as cardiovascular disease and cancer remains equivocal. Prudence might dictate that pregnant women and chronically ill individuals exercise restraint in their use of caffeine, although research suggests relatively low or nonexistent levels of risk associated with moderate caffeine consumption. (A7827). There is extensive evidence that caffeine at dietary doses increases blood pressure (BP). However, concern that the drug may contribute to cardiovascular disease appears to have been dampened by (1) the belief that habitual use leads to the development of tolerance, and (2) confusion regarding relevant epidemiologic findings. When considered comprehensively, findings from experimental and epidemiologic studies converge to show that BP remains reactive to the pressor effects of caffeine in the diet. Overall, the impact of dietary caffeine on population BP levels is likely to be modest, probably in the region of 4/2 mm Hg. At these levels, however, population studies of BP indicate that caffeine use could account for premature deaths in the region of 14% for coronary heart disease and 20% for stroke. (A7828). This molecule is a purine alkaloid that occurs naturally in coffee beans. At intake levels associated with coffee consumption, caffeine appears to exert most of its biological effects through the antagonism of the A1 and A2A subtypes of the adenosine receptor. Adenosine is an endogenous neuromodulator with mostly inhibitory effects, and adenosine antagonism by caffeine results in effects that are generally stimulatory. Some physiological effects associated with caffeine administration include central nervous system stimulation, acute elevation of blood pressure, increased metabolic rate, and diuresis. This molecule concentrations in coffee beverages can be quite variable. A standard cup of coffee is often assumed to provide 100 mg of caffeine, but a recent analysis of 14 different specialty coffees purchased at coffee shops in the US found that the amount of caffeine in 8 oz (=240 ml) of brewed coffee ranged from 72 to 130 mg.This molecule in espresso coffees ranged from 58 to 76 mg in a single shot. (A7829). This molecule is a member of the methylxanthine family of drugs, and is the most widely consumed behaviourally active substance in the western world. A number of in vitro and in vivo studies have demonstrated that caffeine modulates both innate and adaptive immune responses. For instance studies indicate that caffeine and its major metabolite paraxanthine suppress neutrophil and monocyte chemotaxis, and also suppress production of the pro-inflammatory cytokine tumor necrosis factor (TNF) alpha from human blood. This molecule has also been reported to suppress human lymphocyte function as indicated by reduced T-cell proliferation and impaired production of Th1 (interleukin [IL]-2 and interferon [IFN]-gamma), Th2 (IL-4, IL-5) and Th3 (IL-10) cytokines. Studies also indicate that caffeine suppresses antibody production. The evidence suggests that at least some of the immunomodulatory actions of caffeine are mediated via inhibition of cyclic adenosine monophosphate (cAMP)-phosphodiesterase (PDE), and consequential increase in intracellular cAMP concentrations. Overall, these studies indicate that caffeine, like other members of the methylxanthine family, is largely anti-inflammatory in nature, and based on the pharmacokinetics of caffeine, many of its immunomodulatory effects occur at concentrations that are relevant to normal human consumption. (A7830).",CHEMBL113
Oc1ccccc1,4.04,"This molecule is both a manufactured chemical and a natural substance. It is a colorless-to-white solid when pure. The commercial product is a liquid. This molecule has a distinct odor that is sickeningly sweet and tarry. You can taste and smell phenol at levels lower than those that are associated with harmful effects. This molecule evaporates more slowly than water, and a moderate amount can form a solution with water. This molecule can catch fire. This molecule is used primarily in the production of phenolic resins and in the manufacture of nylon and other synthetic fibers. It is also used in slimicides (chemicals that kill bacteria and fungi in slimes), as a disinfectant and antiseptic, and in medicinal preparations such as mouthwash and sore throat lozenges. This molecule is a white crystalline mass dissolved in an aqueous solution. Solution may be colorless to slightly pink in color with a distinctive phenol odor; sharp burning taste. Aqueous solution will be acidic and act as such. Toxic by ingestion, inhalation and skin absorption; strong irritant to tissues. This molecule appears as a colorless liquid when pure, otherwise pink or red. Combustible. Flash point 175 °F. Must be heated before ignition may occur easily. Vapors are heavier than air. Corrosive to skin but because of anesthetic qualities will numb rather than burn. Upon contact skin may turn white. May be lethal by skin absorption. Does not react with water. Stable in normal transportation. Reactive with various chemicals and may be corrosive to lead, aluminum and its alloys, certain plastics, and rubber. Freezing point about 105 °F. Density 8.9 lb / gal. Used to make plastics, adhesives and other chemicals. This molecule is the white crystalline solid shipped at an elevated temperature to form a semi-solid. It is very hot and may cause burns from contact and also may cause the ignition of combustible materials. It is toxic by ingestion, and inhalation of its fumes, and skin absorption. It may also be very irritating to skin and eyes. It is used to make other chemicals. This molecule appears as a solid melting at 110 °F. Colorless if pure, otherwise pink or red. Flash point 175 °F. Density 9.9 lb / gal. Vapors are heavier than air Corrosive to the skin (turning skin white) but because of its anesthetic quality numbs rather than burn. Lethal amounts can be absorbed through the skin. Used to make plastics and adhesives. This molecule is an organic hydroxy compound that consists of benzene bearing a single hydroxy substituent. The parent of the class of phenols. It has a role as a disinfectant, an antiseptic drug, a human xenobiotic metabolite and a mouse metabolite. It is a conjugate acid of a phenolate. This molecule is an antiseptic and disinfectant. It is active against a wide range of micro-organisms including some fungi and viruses, but is only slowly effective against spores. This molecule has been used to disinfect skin and to relieve itching. This molecule is also used as an oral analgesic or anesthetic in products such as Chloraseptic to treat pharyngitis. Additionally, phenol and its related compounds are used in surgical ingrown toenail treatment, a process termed phenolization. Research indicates that parental exposure to phenol and its related compounds are positively associated with spontaneous abortion. During the second world war, phenol injections were used as a means of execution by the Nazis. This molecule is a toxic compound whose vapours are corrosive to the skin, eyes, and respiratory tract. Exposure to phenol may occur from the use of some medicinal products (including throat lozenges and ointments). Phenol is highly irritating to the skin, eyes, and mucous membranes in humans after acute (short-term) inhalation or dermal exposures. Phenol is considered to be quite toxic to humans via oral exposure. Anorexia, progressive weight loss, diarrhea, vertigo, salivation, a dark coloration of the urine, and blood and liver effects have been reported in chronically (long-term) exposed humans. Animal studies have reported reduced fetal body weights, growth retardation, and abnormal development in the offspring of animals exposed to phenol by the oral route. EPA has classified phenol as a Group D, not classifiable as to human carcinogenicity. This molecule is hydroxybenzene; Carbolic Acid. Used as a germicidal agent and as an intermediate in chemical synthesis.  Highly toxic; corrosive to the skin. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a natural product found in Aspergillus violaceofuscus, Scrophularia buergeriana, and other organisms with data available. This molecule is a toxic, colourless crystalline solid with a sweet tarry odor that resembles a hospital smell. It is commonly used as an antiseptic and disinfectant. It is active against a wide range of micro-organisms including some fungi and viruses, but is only slowly effective against spores. It has been used to disinfect skin and to relieve itching. Phenol is also used in the preparation of cosmetics including sunscreens, hair dyes, and skin lightening preparations. It is also used in the production of drugs (it is the starting material in the industrial production of aspirin), weedkillers, and synthetic resins. Phenol can be found in areas with high levels of motor traffic, therefore, people living in crowded urban areas are frequently exposed to traffic-derived phenol vapor. The average (mean +/- SD) phenol concentration in urine among normal individuals living in urban areas is 7.4 +/- 2.2 mg/g of creatinine. Exposure of the skin to concentrated phenol solutions causes chemical burns which may be severe; in laboratories where it is used, it is usually recommended that polyethylene glycol solution is kept available for washing off splashes. Notwithstanding the effects of concentrated solutions, it is also used in cosmetic surgery as an exfoliant, to remove layers of dead skin (Wikipedia). In some bacteria phenol can be directly synthesized from tyrosine via the enzyme tyrosine phenol-lyase [EC:4.1.99.2].",CHEMBL14060
CCC(C)C(NC(=O)C(NC(=O)C(CO)NC(=O)C(CCCCNC(C)=O)NC(=O)C1CCCN1C(=O)C([NH3+])Cc1c[nH]c2ccccc12)C(C)CC)C(=O)[O-],4.04,,
O=C([O-])C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCC[NH2+]1,4.05,,
Nc1nc2c(ncn2COCCO)c(=O)[nH]1,4.05,,
[NH3+]C(CCC(=O)NC(CS)C(=O)NCC(=O)[O-])C(=O)[O-],4.05,,
O=C([O-])CCc1ccccc1,4.05,,
O=C([O-])CCCCCCCC(=O)[O-],4.05,,
O=C([O-])C(=O)[O-],4.05,,
CC(=O)NC1C(O)C[NH2+]C(CO)C(O)C1O,4.05,,
OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC1C(O)C2O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O,4.05,,
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(=O)C(NC(=O)C(NC(=O)C(CO)NC(=O)C(C)NC(=O)C(CCCC[NH3+])NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C1CCC[NH2+]1)C(C)C)C(C)C)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(=O)NC(C)C(=O)N1CCCC1C(=O)[O-])C(C)O,4.05,,
O=C([O-])c1cc(O)[nH]c(=O)c1,4.05,,
OCC1[NH2+]CC(O)C(O)C1O,4.05,,
CC(C)CC(NC(=O)C(C)NC(=O)C(CCCC[NH3+])NC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)CNC(=O)C1CCCN1C(=O)C(CCCC[NH3+])NC(=O)C(Cc1cnc[nH]1)NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CCC(=O)[O-])C(C)O)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)[O-])C(C)O,4.06,,
CN1CC=Nc2c1[nH]c(=[NH2+])[nH]c2=O,4.06,,
CC(=O)NC1C(Oc2ccc([N+](=O)[O-])cc2)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O,4.06,,
CC[NH+](CC)CCNS(=O)(=O)c1ccc(Cl)cc1,4.06,,
OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC1C(O)C2O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O,4.06,,
OCC1OC(OC2C(O)C(O)c3[nH]cc[n+]3C2CO)C(O)C(O)C1O,4.06,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3NC(C)=O)C(O)C2NC(C)=O)C1O,4.07,,
NC(=[NH2+])c1cc2cc(-c3cccc(-c4ccccc4)c3O)[nH]c2cc1Cl,4.07,,
[NH3+]Cc1ccc(NC(=O)C(=O)[O-])cc1,4.07,,
N=c1ccn(C2OC(CNC(=O)Cc3nc4ccccc4[nH]3)C(O)C2O)c(=O)[nH]1,4.07,,
Nc1nc(CCc2ccc3cc[nH]c3c2)cc(=O)[nH]1,4.07,,CHEMBL236777
N#Cc1ccc(COc2ccc3cc(S(=O)(=O)NC(CCC(=O)[O-])C(=O)[O-])ccc3c2)c(F)c1,4.07,,
CC1(C)SC(C(CO)NC(=O)Cc2ccccc2)[NH2+]C1C(=O)[O-],4.07,,
O=C([O-])CCC(NC(=O)c1cccc(CNc2ccc(C=C3SC(=O)NC3=O)cc2)c1)C(=O)[O-],4.07,,
CCC(C)C1NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC1=O,4.07,,
C[n+]1cnc(N)c2nc[nH]c21,4.07,,
Cn1c(N)ccnc1=O,4.07,,
CC(=NO)c1ccc(O)cc1O,4.07,,
N#CC(CC1CCCCC1)c1n[nH]c2cc(O)ccc12,4.07,,CHEMBL2042886
CCC(C)C(NC(=O)C(NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C([NH3+])CC(N)=O)C(C)O)C(C)CC)C(=O)[O-],4.07,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)[O-],4.08,,
CCCCc1nc2c(=O)[nH][nH]c(=O)c2[nH]1,4.08,,CHEMBL280051
CC(=O)N(C)c1cccc(-c2nnc3ccc(-c4ccccc4)nn23)c1,4.08,,CHEMBL369180
O=C([O-])C(=O)NC(Cc1ccccc1)C(=O)[O-],4.08,,
CCC(C)C(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(C)=O)C(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCSC)C(N)=O,4.08,,
CC12CCC3c4ccc(O)cc4CCC3C1CCC2O,4.08,This molecule is a steroid. It has a role as an estrogen. This molecule is a natural product found in Punica granatum with data available.,CHEMBL412
O=C([O-])CS(=O)(=O)[O-],4.08,,
CCCCc1nc2c(=O)[nH][nH]c(=O)c2[nH]1,4.08,,CHEMBL280051
[NH3+]C1NC=Nc2c1ncn2C1OC(CO)C(O)C1O,4.08,,
[NH3+]CCC[NH2+]CCCC[NH2+]CCC[NH3+],4.08,,
CC(C)C(NC(=O)C([NH3+])CCC(N)=O)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(N)=O)C(=O)[O-],4.08,,
[NH3+]Cc1cccc(-n2cccc2)c1,4.08,,
Oc1ccccc1,4.09,"This molecule is both a manufactured chemical and a natural substance. It is a colorless-to-white solid when pure. The commercial product is a liquid. This molecule has a distinct odor that is sickeningly sweet and tarry. You can taste and smell phenol at levels lower than those that are associated with harmful effects. This molecule evaporates more slowly than water, and a moderate amount can form a solution with water. This molecule can catch fire. This molecule is used primarily in the production of phenolic resins and in the manufacture of nylon and other synthetic fibers. It is also used in slimicides (chemicals that kill bacteria and fungi in slimes), as a disinfectant and antiseptic, and in medicinal preparations such as mouthwash and sore throat lozenges. This molecule is a white crystalline mass dissolved in an aqueous solution. Solution may be colorless to slightly pink in color with a distinctive phenol odor; sharp burning taste. Aqueous solution will be acidic and act as such. Toxic by ingestion, inhalation and skin absorption; strong irritant to tissues. This molecule appears as a colorless liquid when pure, otherwise pink or red. Combustible. Flash point 175 °F. Must be heated before ignition may occur easily. Vapors are heavier than air. Corrosive to skin but because of anesthetic qualities will numb rather than burn. Upon contact skin may turn white. May be lethal by skin absorption. Does not react with water. Stable in normal transportation. Reactive with various chemicals and may be corrosive to lead, aluminum and its alloys, certain plastics, and rubber. Freezing point about 105 °F. Density 8.9 lb / gal. Used to make plastics, adhesives and other chemicals. This molecule is the white crystalline solid shipped at an elevated temperature to form a semi-solid. It is very hot and may cause burns from contact and also may cause the ignition of combustible materials. It is toxic by ingestion, and inhalation of its fumes, and skin absorption. It may also be very irritating to skin and eyes. It is used to make other chemicals. This molecule appears as a solid melting at 110 °F. Colorless if pure, otherwise pink or red. Flash point 175 °F. Density 9.9 lb / gal. Vapors are heavier than air Corrosive to the skin (turning skin white) but because of its anesthetic quality numbs rather than burn. Lethal amounts can be absorbed through the skin. Used to make plastics and adhesives. This molecule is an organic hydroxy compound that consists of benzene bearing a single hydroxy substituent. The parent of the class of phenols. It has a role as a disinfectant, an antiseptic drug, a human xenobiotic metabolite and a mouse metabolite. It is a conjugate acid of a phenolate. This molecule is an antiseptic and disinfectant. It is active against a wide range of micro-organisms including some fungi and viruses, but is only slowly effective against spores. This molecule has been used to disinfect skin and to relieve itching. This molecule is also used as an oral analgesic or anesthetic in products such as Chloraseptic to treat pharyngitis. Additionally, phenol and its related compounds are used in surgical ingrown toenail treatment, a process termed phenolization. Research indicates that parental exposure to phenol and its related compounds are positively associated with spontaneous abortion. During the second world war, phenol injections were used as a means of execution by the Nazis. This molecule is a toxic compound whose vapours are corrosive to the skin, eyes, and respiratory tract. Exposure to phenol may occur from the use of some medicinal products (including throat lozenges and ointments). Phenol is highly irritating to the skin, eyes, and mucous membranes in humans after acute (short-term) inhalation or dermal exposures. Phenol is considered to be quite toxic to humans via oral exposure. Anorexia, progressive weight loss, diarrhea, vertigo, salivation, a dark coloration of the urine, and blood and liver effects have been reported in chronically (long-term) exposed humans. Animal studies have reported reduced fetal body weights, growth retardation, and abnormal development in the offspring of animals exposed to phenol by the oral route. EPA has classified phenol as a Group D, not classifiable as to human carcinogenicity. This molecule is hydroxybenzene; Carbolic Acid. Used as a germicidal agent and as an intermediate in chemical synthesis.  Highly toxic; corrosive to the skin. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a natural product found in Aspergillus violaceofuscus, Scrophularia buergeriana, and other organisms with data available. This molecule is a toxic, colourless crystalline solid with a sweet tarry odor that resembles a hospital smell. It is commonly used as an antiseptic and disinfectant. It is active against a wide range of micro-organisms including some fungi and viruses, but is only slowly effective against spores. It has been used to disinfect skin and to relieve itching. Phenol is also used in the preparation of cosmetics including sunscreens, hair dyes, and skin lightening preparations. It is also used in the production of drugs (it is the starting material in the industrial production of aspirin), weedkillers, and synthetic resins. Phenol can be found in areas with high levels of motor traffic, therefore, people living in crowded urban areas are frequently exposed to traffic-derived phenol vapor. The average (mean +/- SD) phenol concentration in urine among normal individuals living in urban areas is 7.4 +/- 2.2 mg/g of creatinine. Exposure of the skin to concentrated phenol solutions causes chemical burns which may be severe; in laboratories where it is used, it is usually recommended that polyethylene glycol solution is kept available for washing off splashes. Notwithstanding the effects of concentrated solutions, it is also used in cosmetic surgery as an exfoliant, to remove layers of dead skin (Wikipedia). In some bacteria phenol can be directly synthesized from tyrosine via the enzyme tyrosine phenol-lyase [EC:4.1.99.2].",CHEMBL14060
CC(N)=C(c1ccc(S(=O)(=O)[O-])cc1)c1ccc(C(=C(C)N)c2ccc(S(=O)(=O)[O-])cc2)[nH]1,4.09,,
CCOC(=O)c1c(C)n[nH]c1C,4.09,,CHEMBL506972
O=C1c2ccccc2C(=O)c2cc(S(=O)(=O)[O-])ccc21,4.09,,
CNC(NC)=[NH+]CCCC(NC(=O)C(C)[NH3+])C(=O)NC(C(=O)NC(CCCC[NH+](C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O,4.09,,
CNC(=O)NC(=[NH2+])NCCCC(NC(C)=O)C(=O)NC,4.09,,
O=C(NC1OC(CO)C(O)C(O)C1O)c1ccccc1,4.09,,
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1ccc2ccccc2c1,4.09,,CHEMBL2377685
CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,4.09,,
Cc1cc(-c2ccccc2)[nH]n1,4.09,,CHEMBL1411986
CCC(C)C(NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(C)NC(=O)C([NH3+])C(C)O)C(C)O)C(C)CC)C(=O)[O-],4.09,,
CNC(=O)COc1cccc(Nc2cc(Cl)ccn2)c1,4.09,,
O=C([O-])CCC(=O)C(=O)[O-],4.09,,
NC(=[NH2+])c1cc2cccnc2s1,4.1,,
OCC1OC(OC2C(CO)OC(OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1O,4.1,,
CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)[NH+]1CCCC1,4.1,,
Nc1nc2c(ncn2C2OC(CO)C(O)C2O)c(=O)[nH]1,4.1,,
CCOC(=O)c1cnc(N)[nH]c1=O,4.1,,
CC(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(C(=O)[O-])C(C)C)C(C)C,4.1,,
NC(=[NH2+])Nc1ccc(CC(NC(=O)CSc2ccc(Cl)cc2)C(=O)NCCOCCOCC(N)=O)cc1,4.1,,
OCC([NH2+]CC1[NH2+]CC(O)C1O)c1ccccc1,4.1,,
CCOC(=O)CCC(CC1CCNC1=O)NC(=O)C(CC=C(C)C)CC(=O)C(NC(=O)C(CO)NC(=O)OC(C)(C)C)C(C)C,4.1,,
C[NH2+]CCCN1c2ccccc2CCc2ccccc21,4.1,,
Cc1n[nH]cc1-c1ccccc1,4.1,,CHEMBL228114
CNC(=[NH2+])NC(=O)NC,4.1,,
CCCCC#Cc1ccc(C(=O)NNC(=S)NC)o1,4.1,,
Nc1ncnc2c1ncn2C1OC(CSSCc2cccc([N+](=O)[O-])c2)C(O)C1O,4.1,,
CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl,4.1,"This molecule is an organic molecular entity. This molecule is a thienodiazepine which is chemically related to benzodiazepine (BDZ) drug class; it differs from BDZs in having a benzene ring replaced with a thiophene ring. It is an agonist at GABA-A receptors and possesses amnesic, anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. Initially introduced in 1983 in Japan as treatment for neurological conditions such as anxiety and sleep disorders, etizolam is marketed in Japan, Italy and India. It is not approved for use by FDA in the US; however it remains unscheduled in several states and is legal for research purposes. This molecule belongs to a new class of diazepines, thienotriazolodiazepines. This new class is easily oxidized, rapidly metabolized, and has a lower risk of accumulation, even after prolonged treatment. Etizolam has an anxiolytic action about 6 times greater than that of diazepam. Etizolam produces, especially at higher dosages, a reduction in time taken to fall asleep, an increase in total sleep time and a reduction in the number of awakenings. During tests there were not substantial changes in deep sleep. There is a reduction of REM sleep. In EEG tests of healthy volunteers Etizolam showed some characteristics of tricyclic antidepressants. Etizolam (marketed under the brand name Etilaam, Etizola, Sedekopan, Pasaden or Depas) is a thienodiazepine drug which is a benzodiazepine analog. The etizolam molecule differs from a benzodiazepine in that the benzene ring has been replaced by a thiophene ring. It possesses amnesic, anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. This molecule is a DEA Schedule I controlled substance. Substances in the DEA Schedule I have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. It is a Temporary listing of substances subject to emergency scheduling substance.",CHEMBL1289779
CC(C(=O)[O-])c1ccc2c(c1)[nH]c1ccc(Cl)cc12,4.1,,
COc1cccc(-c2cc(C(F)(F)F)[nH]n2)c1,4.1,,
Cn1c(=O)n(C)c2cc(C(N)=O)ccc21,4.1,,CHEMBL1487662
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,4.11,,
CC(C)=CCNc1ncnc2[nH]cnc12,4.11,"This molecule is a 6-isopentenylaminopurine in which has the isopentenyl double bond is located between the 2 and 3 positions of the isopentenyl group. It has a role as a cytokinin. This molecule is a natural product found in Mercurialis ambigua, Bridelia balansae, and other organisms with data available.",CHEMBL476189
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH+](C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)O)C(C)O)C(C)O,4.11,,
[NH3+]CC(c1ccccc1)c1ccc(Cl)cc1,4.11,,
O=c1ccn(C2OC(C[NH+]3CCCCC3)C(O)C2O)c(=O)[nH]1,4.11,,
CCCCNC(=O)NCc1ccc(CN2C(=[NH2+])NC(C)(CC(C)C)C2=O)cc1,4.11,,
OCC1OC(SC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O,4.11,,
Cc1n[nH]c(N)c1-c1cccs1,4.11,,
c1ccc(NNc2ncnc3n[nH]cc23)cc1,4.11,,
NC(=O)c1cnc(N)c2cc(Br)sc12,4.11,,CHEMBL3098807
N#CC(OC1OC(CO)C(O)C(O)C1O)c1ccc(O)cc1,4.12,,
COc1cc(OC)cc(C(=O)NC2C(O)C(CO)OC2n2cnc3c(NC4CCCc5ccccc54)ncnc32)c1,4.12,,
CCCCn1c(Cc2cccc(OC)c2)nc2c(N)ncnc21,4.12,,CHEMBL109612
[NH3+]Cc1ccc(-c2cccs2)s1,4.12,,
COc1ccc2c(c1)cc(C(=O)OCc1cc3ccccc3o1)n2CC(=O)[O-],4.12,,
CC(NC(=O)C(NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C1CCC[NH2+]1)C(C)C)C(C)O)C(=O)[O-],4.12,,
C[N+](C)(C)CC(=O)[O-],4.12,"This molecule is a modified amino acid consisting of glycine with three methyl groups that serves as a methyl donor in several metabolic pathways and is used to treat the rare genetic causes of homocystinuria. This molecule has had only limited clinical use, but has not been linked to instances of serum enzyme elevations during therapy or to clinically apparent liver injury. This molecule is the amino acid betaine derived from glycine. It has a role as a fundamental metabolite. It is an amino-acid betaine and a glycine derivative. It is a conjugate base of a N,N,N-trimethylglycinium. This molecule is a methyl group donor that functions in the normal metabolic cycle of methionine. It is a naturally occurring choline derivative commonly ingested through diet, with a role in regulating cellular hydration and maintaining cell function. Homocystinuria is an inherited disorder that leads to the accumulation of homocysteine in plasma and urine. Currently, no treatments are available to correct the genetic causes of homocystinuria. However, in order to normalize homocysteine levels, patients can be treated with vitamin B6 ([pyridoxine]), vitamin B12 ([cobalamin]), [folate] and specific diets. This molecule reduces plasma homocysteine levels in patients with homocystinuria. Although it is present in many food products, the levels found there are insufficient to treat this condition. The FDA and EMA have approved the product Cystadane (betaine anhydrous, oral solution) for the treatment of homocystinuria, and the EMA has approved the use of Amversio (betaine anhydrous, oral powder). This molecule is a Methylating Agent. The mechanism of action of betaine is as a Methylating Activity. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Amaranthus hybridus, Cornulaca leucacantha, and other organisms with data available.",CHEMBL1182
Nc1ccc(C2[NH2+]C(CO)C(O)C2O)cc1N,4.12,,
CC1OC(OC2C(O)C(CO)OC(OC3C(C)OC(OC4C(O)C(CO)OC(OC5C(OC6C(C)OC(O)C(O)C6O)OC(CO)C(O)C5OC5OC(C)C(O)CC5O)C4O)C(O)C3O)C2OC2OC(CO)C(O)C(O)C2O)C(O)CC1O,4.12,,
CCC(C)C(NC(=O)C([NH3+])Cc1ccc(O)cc1)C(=O)NC(Cc1c[nH]cn1)C(=O)N1CCCC1C(N)=O,4.12,,
Nc1cc(-c2cccnc2)n[nH]1,4.12,,
C[NH+](C)Cc1cccc(C(=O)Nc2cccc(-c3nn[nH]n3)c2)c1,4.12,,
CC(C)CC(NC(=O)C(O)C([NH3+])Cc1ccccc1)C(=O)[O-],4.12,,
CC(Cc1ccc(C(C)C)cc1)C(=O)NC1OC(CO)C(O)C(O)C1O,4.12,,
Oc1ccc(F)cc1O,4.12,,
Oc1ccc(F)cc1O,4.12,,
Oc1ccc(F)cc1O,4.12,,
COC(=O)C(Cc1cccc(C(N)=[NH2+])c1)NC(=O)CNS(=O)(=O)c1ccc(C)cc1,4.13,,
O=C(NCC=CC1OC(n2ccc(=O)cc2)C(O)C1O)c1cc([N+](=O)[O-])cc(O)c1O,4.13,,
C[n+]1cccc(CNC(=O)C2CCCN2C(=O)C([NH3+])Cc2ccccc2)c1,4.13,,
CC(O)C(NC(=O)CNC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)[O-],4.13,,
OC1COC(OC2COC(OC3COC(OC4COC(OC5COC(O)C(O)C5O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C1O,4.14,,
CC(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(CO)CCC(N)=O,4.14,,
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,4.14,"This molecule is a xanthine derivative that decreases the viscosity of blood and is used to treat symptoms of intermittent claudication due to peripheral vascular disease. This molecule has not been associated with serum enzyme elevations during therapy, but in several isolated case reports has been linked to clinically apparent liver injury. This molecule is an oxopurine. This molecule is a synthetic dimethylxanthine derivative that modulates the rheological properties of blood and also has both anti-oxidant and anti-inflammatory properties. Although originally developed to treat intermittent claudication, a form of exertion-induced leg pain common in patients with peripheral arterial disease, PTX has been investigated for its possible use in diverse conditions, including osteoradionecrosis, diabetic kidney disease, and generally any condition associated with fibrosis. More recently, PTX has been suggested as a possible treatment for COVID-19-induced pulmonary complications due to its ability to regulate the production of inflammatory cytokines.  Pentoxifylline has been marketed in Europe since 1972; PTX extended-release tablets sold under the trade name TRENTAL by US Pharm Holdings were first approved by the FDA on Aug 30, 1984, but have since been discontinued. A branded product, PENTOXIL, marketed by Upsher-Smith Laboratories, and generic forms marketed by Valeant Pharmaceuticals and APOTEX have been available since the late 1990s. This molecule is developed to treat neurodegenerative disorders by ExonHit Therapeutics. This molecule is a Blood Viscosity Reducer. The physiologic effect of pentoxifylline is by means of Hematologic Activity Alteration. This molecule is a methylxanthine derivative with hemorrheologic and immunomodulating properties. This molecule inhibits phosphodiesterase, resulting in increased levels of cyclic adenosine monophosphate (cAMP) in erythrocytes, endothelium, and the surrounding tissues. This leads to vasodilation, improves erythrocyte flexibility, and enhances blood flow. In addition, the increased level of cAMP in platelets inhibits platelet aggregation, which may contribute to a reduction in blood viscosity. This agent also inhibits production of tumor necrosis factor-alpha and interferon-gamma, while it induces Th2-like (T-helper 2) cytokine production, thereby inhibiting Th1-mediated (T-helper 1) inflammatory and autoimmune responses.",CHEMBL628
CC(C)CC(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NCC(=O)N1CCCC1C(=O)NC(C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C)C(=O)[O-],4.14,,
CCCc1ccccc1O,4.14,This molecule is a member of the class of phenols that is phenol which is substituted by a propyl group at position 2. It has a role as a flavouring agent and a plant metabolite.,CHEMBL225569
O=C([O-])c1cccc(N2C(=O)C(O)=C(C(=O)c3cccc(C(F)(F)F)c3)C2c2cc(Cl)c3c(c2)OCO3)c1,4.14,,
CC(CS)C(=O)N1CCCC1C(=O)[O-],4.15,,
CC(NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)O)C(C)O,4.15,,
CCOC(=O)C=CC(CC1CCNC1=O)NC(=O)C(CC=C(C)C)CC(=O)C(NC(=O)c1cc(C)on1)C(C)C,4.15,,
CC(O)C(O)C1=Nc2c(nc(N)[nH]c2=O)NC1,4.15,,
N=c1ccn(C2OC(CNC(=O)CCc3nc4ccccc4[nH]3)C(O)C2O)c(=O)[nH]1,4.15,,
OCC1[NH2+]CC(O)C(O)C1OC1OC(CO)C(O)C(O)C1O,4.15,,
[NH3+]CCCCC([NH3+])C(=O)[O-],4.15,,
[NH3+]C(CCC(=O)NC(CS)C(=O)NCC(=O)[O-])C(=O)[O-],4.15,,
OCC1NC(=NO)C(O)C(O)C1O,4.15,,
Cc1nc2c(N)ncnc2n1C1OC(C[NH+](C)CCC[NH3+])C(O)C1O,4.15,,
CC(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CCCC[N+](C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],4.15,,
[NH2+]=c1ccn(C2OC(CNC(=O)c3c[nH]c4scc[n+]34)C(O)C2O)c(=O)[nH]1,4.15,,
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)Nc1cccc(F)c1,4.15,,
CC1=NC2C(OC(CO)C(O)C2O)S1,4.15,,
CC1[NH2+]C2C(OC(CO)C(O)C2O)S1,4.15,,
Nc1ncc(Cc2ccc(Br)cc2)s1,4.15,,CHEMBL3233606
[NH3+]Cc1cccc(N2CCCC2)c1,4.15,,
[NH2+]=c1[nH]c(=O)c2ncc(C(=O)NCc3cn[nH]n3)nc2[nH]1,4.15,,
O=C(C1=C(O)C(=O)N(c2ccc(Cl)c(C(=O)[O-])c2)C1c1cc(Br)cs1)c1ccccc1,4.15,,
CCCS(=O)(=O)Nc1ccccc1C(=O)[O-],4.15,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(C)C(=O)NC(C)C(=O)[O-])C(C)O,4.15,,
O=C([O-])Cc1cn(Cc2cccc(Cl)c2)c2ccccc12,4.15,,
CCC(C)C(NC(=O)C(C)[NH3+])C(=O)NC(CCSC)C(=O)[O-],4.16,,
CC(=O)NCCCCC(NC(=O)CNC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CCCC[NH3+])NC(=O)C[NH3+])C(=O)[O-],4.16,,
[NH3+]C(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCc1ccccn1,4.16,,
c1cc2cnc3ccsc3c2cn1,4.16,,
NC(=O)c1ccsc1NC(=O)CSc1nc[nH]n1,4.16,,
CC(O)(C(=O)[O-])c1ccccc1,4.17,,
NC(=[NH2+])c1ccccc1,4.17,,
CC(C)CC(NC(=O)C(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C(C)NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(C)[NH3+])C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)NC(Cc1ccccc1)C(=O)[O-],4.17,,
OCC1OC(OC2C(O)C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C2O)C(O)C(O)C1O,4.17,,
CCC(C)C(NC(=O)CNC(=O)C(C)NC(=O)C(C)[NH3+])C(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(C(=O)[O-])C(C)C)C(C)O)C(C)CC,4.17,,
O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,4.17,"This molecule is a chromone substituted with a phenyl group at position 8 and a morpholine group at position 2. It has a role as an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor, an autophagy inhibitor and a geroprotector. It is a member of chromones, a member of morpholines and an organochlorine compound. Specific inhibitor of phosphatidylinositol 3-kinase. This molecule is a morpholine-based inhibitor of phosphatidylinositol 3-kinase (PI3K) and the bromodomain and extra-terminal (BET) family of proteins, with potential antineoplastic activity. Upon administration, the PI3K/BET inhibitor LY294002 specifically targets and binds to both PI3K and the acetylated lysine recognition motifs in the bromodomains of BET proteins. Inhibition of PI3K activity inhibits the PI3K/AKT kinase signaling pathway. This may result in inhibition of growth and survival for tumor cells in which the PI3K-mediated signaling pathway is overactivated. Inhibition of BET proteins prevents their interaction with acetylated histones, disrupts chromatin remodeling and inhibits the expression of oncogenic drivers that are important for cell proliferation and survival, which together may lead to an inhibition of proliferation in BET-overexpressing tumor cells. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis. BET proteins, comprised of BRD2, BRD3, BRD4 and BRDT, are transcriptional regulators and play an important role during development and cellular growth. In tumor cells, BET proteins play a key role in the regulation of oncogene transcription and tumor cell proliferation. This molecule is a natural product found in Hexagonia apiaria and Dietes bicolor with data available.",CHEMBL98350
CNC(NC)=[NH+]CCCC(NC(=O)CNC(=O)C(C)[NH3+])C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)C,4.17,,
CCC(C)C(NC(=O)C(NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(C)CC)C(=O)[O-],4.17,,
N#Cc1cccc(-c2nc(-c3cccnc3)no2)c1,4.17,,CHEMBL3103988
C=CC(C)(C)OCC1OC(OC2C3=C(C(C)COC(C)=O)CC(O)C3(C)C=C3C(COC)CCC3C(C)C2O)C(O)C(OC(C)=O)C1O,4.18,,
Cc1ncc(C[N+]2CSC(CCO)C2C)c(N)n1,4.18,,
CCC(C)C1NC(=O)C(CCCC[NH3+])NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC1=O,4.18,,
[NH3+]CCNS(=O)(=O)c1ccc(Cl)c2ccncc12,4.18,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3NC(C)=O)C(O)C2NC(C)=O)C1O,4.19,,
C=CC(C)(C)C1=Cc2cc3c(cc2OC1O)OC(C(C)(C)O)C3,4.19,,
CC(C)CC(NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(Cc1ccccc1)C(=O)[O-],4.19,,
CC(=O)NC1C(Oc2ccc([N+](=O)[O-])cc2)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O,4.19,,
CC(C)CC([NH3+])C(=O)[O-],4.19,,
Nc1cccc2c(S(=O)(=O)[O-])cccc12,4.19,,
NC(=[NH2+])c1ccc(OCCCCCOc2ccc(C(N)=[NH2+])cc2)cc1,4.19,,
CCC(C)C([NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)N1CCCC1C(=O)[O-])C(C)O,4.19,,
COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1,4.19,,
[NH3+]C(Cc1c[nH]c2ccccc12)C(=O)[O-],4.19,,
OCC1OC(n2cnc3cc(Cl)c(Cl)cc32)C(O)C1O,4.19,,CHEMBL267071
CCCCCCCCCC[N+2](C)(C)=O,4.19,,
C=CCNc1ncnc2ccc(Br)cc12,4.19,"This molecule is a member of the class of quinazolines that is quinazoline which is substituted by a prop-2-en-1-ylnitrilo group and a bromo group at positions 4 and 6, respectively. It is a modulator of mammalian autophagy. It has a role as an autophagy inducer. It is a member of quinazolines, a secondary amino compound and an organobromine compound.",CHEMBL494325
[NH3+]C(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCc1ccncc1,4.19,,
CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(C)NC(=O)C(C)[NH3+])C(=O)NC(CC(=O)[O-])C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCSC)C(=O)N1CCCC1C(=O)[O-],4.19,,
O=C([O-])C1CCCc2c1[nH]c1ccc(Cl)cc21,4.19,,
CC(=O)n1ccc2nc3ccc(Cl)cc3c-2c1,4.19,,
NC(=[NH2+])c1cc2cccnc2s1,4.2,,
O=C([O-])C(=O)Nc1sc2c(c1C(=O)[O-])CCOC2,4.2,,
NC(=[NH2+])c1ccc2[nH]c(-c3ccccc3O)nc2c1,4.2,,
CC=COC1(C(=O)[O-])CC(OC2(C(=O)[O-])CC(OC3(C(=O)[O-])CC(O)C(O)C(C(O)CO)O3)C(O)C(C(O)CO)O2)C(O)C(C(O)CO)O1,4.2,,
CSCCC(NC(=O)C(C)[NH3+])C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(C)C)C(=O)[O-])C(C)O,4.2,,
CC([NH3+])C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)[O-])C(=O)NCC=O)C(C)O)C(C)O,4.2,,
C[n+]1ccc(Cl)cc1CNC(=O)C1CCCN1C(=O)C([NH3+])Cc1ccccc1,4.2,,
CC(C)c1ccc2oc3nc(N)c(C(=O)[O-])cc3c(=O)c2c1,4.2,,
Nc1ncnc2c1ncn2C1OC(CO)C(O)C1O,4.21,"This molecule is a purine nucleoside. This molecule is a natural product found in Acanthus ilicifolius, Acanthus ebracteatus, and other organisms with data available.",CHEMBL11909
CC(=O)NC1C(O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O,4.21,,
CNC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)C(CSc1cccs1)C(=O)NO,4.21,,CHEMBL3827321
CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,4.21,,
CCC(C)C(NC(=O)C(C)NC(=O)C(CC(N)=O)NC(=O)C1CCCN1C(=O)C([NH3+])CC(C)C)C(=O)NCC(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],4.21,,
O=C1CN(Cc2ccccc2)c2ccccc2N1,4.21,,CHEMBL2094355
O=C([O-])C1=CC2OCC=CC(O)(C1)C2O,4.21,,
[NH2+]=c1ccn(C2OC(CO)C(O)C2O)c(=O)[nH]1,4.21,,
C=CCC(C(=O)N1CCCCC1C(=O)OC(CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)[O-])c1)c1cc(OC)c(OC)c(OC)c1,4.21,,
CC(C)C([NH3+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)C,4.22,,
CSCCC(NC(C)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(N)=O,4.22,,
O=[N+]([O-])c1cc(CO)cc(OC2OC(CO)C(O)C(O)C2O)c1,4.22,,
[NH3+]C(CCCCC(O)O)C(=O)[O-],4.22,,
NC(=[NH2+])NCCCC([NH3+])C(=O)NO,4.22,,
CC(C)CC(NC(=O)C(CCC(=O)[O-])NC(=O)C(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-])C(C)O,4.22,,
CC[NH2+]C1COC(OC2C(OC3C#CC=CC#CC4(O)CC(=O)C(NC(=O)OC)C3C4CCSSSC)OC(C)C([NH2+]OC3CC(O)C(SC(=O)c4c(C)c(I)c(OC5OC(C)C(O)C(OC)C5O)c(OC)c4OC)C(C)O3)C2O)CC1OC,4.22,,
CSCCC(NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C[NH3+])C(=O)NC(CC(=O)[O-])C(=O)[O-],4.22,,
CC1(C)CC(=O)c2c(N)ncnc2C1,4.22,,
[NH3+]C(CCCC[N+](=O)[O-])C(=O)[O-],4.22,,
CN(C(=O)c1ccccc1)C1C(=N)N(Cc2ccccc2)C(=O)NC1=O,4.22,,
CCCCCCCCCCCCOS(=O)(=O)[O-],4.22,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(OC3(C(=O)[O-])CC(O)C(NC(C)=O)C(C(O)C(O)CO)O3)C2O)C1O,4.22,,
CC([NH3+])C(=O)NC(C)C(=O)[O-],4.22,,
Nc1ccc(F)cc1C(=O)[O-],4.22,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(C)NC(=O)C(Cc1ccccc1)NC(=O)C(C)[NH3+])C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],4.23,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(C)NC(=O)C(Cc1ccccc1)NC(=O)C(C)[NH3+])C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],4.23,,
OCC1[NH2+]CC(O)C(O)C1O,4.23,,
OC1C[NH+]2CCC(O)C2C(O)C1O,4.23,,
CCC(C)C(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(C)C(=O)[O-],4.23,,
CC(CCC(=O)[O-])C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C,4.23,,
c1ccc2c(c1)[nH]c1cncnc12,4.23,,
CC(C)CC([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)[O-],4.24,,
CC(=O)NC1C(OC(=O)NCCCOCCOCCOCCCNC(=O)OC2OC(CO)C(O)C(O)C2NC(C)=O)OC(CO)C(O)C1O,4.24,,
CC(=O)NC1C(O)CC(OC2C(O)C(OC3C(CO)OC(O)C(O)C3O)OC(CO)C2OC2OC(CO)C(O)C(OC3OC(CO)C(O)C(O)C3O)C2NC(C)=O)(C(=O)[O-])OC1C(O)C(O)CO,4.24,,
Nc1ccc(Br)cc1C(=O)N1CCCC1Cc1ccccc1Cl,4.24,,CHEMBL255661
Nc1ccccc1C(=O)[O-],4.24,,
Cn1c(=O)[nH]c2ncc(-c3ccccc3)cc21,4.24,,CHEMBL1956634
C[NH2+]C1(c2ccccc2Cl)CCCCC1=O,4.24,,
Cc1cccc(C[NH2+]CCS(=O)(=O)[O-])c1,4.24,,
CC(C)CC(C=O)NC(=O)C(CC(C)C)NC(=O)C(Cc1cnc[nH]1)NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CC(=O)[O-],4.25,,
Oc1cccc(Cl)c1,4.25,"This molecule appears as white crystals with an odor of phenol. Sinks in and slowly dissolves in water. (NTP, 1992) This molecule is a monochlorophenol carrying the chloro substituent at position 3.",CHEMBL41172
O=C(c1ccccc1)c1ccc2n1CCC2C(=O)[O-],4.25,,
CCc1ccsc1-c1ccc(O)c(O)c1,4.25,,CHEMBL445245
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(=O)[O-],4.25,,
CCC(C)C(NC(=O)C([NH3+])CO)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)[O-])C(C)CC,4.26,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O)C(C)O,4.26,,
O=C([O-])c1ccccc1S,4.26,,
C[n+]1ccc(Cl)c(CNC(=O)C2CCCN2C(=O)C([NH3+])Cc2ccccc2)c1,4.26,,
CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C1CCC[NH2+]1)C(=O)NC(C(=O)[O-])C(C)C,4.26,,
Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl,4.26,"This molecule is an aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items such as plastic chopping boards, sports equipment and shoes. It has a role as an antibacterial agent, a fungicide, an EC 1.5.1.3 (dihydrofolate reductase) inhibitor, an antimalarial, an EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor, a xenobiotic, a persistent organic pollutant and a drug allergen. It is a member of phenols, an aromatic ether, a dichlorobenzene and a member of monochlorobenzenes. This molecule is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items such as plastic chopping boards, sports equipment and shoes. This molecule is a polychloro phenoxy phenol with antibacterial and antifungal activity. This molecule is added to toothpastes to prevent gingivitis and has been added to many household products for its topical antibiotic activity. This molecule is an antibacterial and antifungal agent. It is a polychloro phenoxy phenol. Though many consumer products contain triclosan, according to the Food and Drug Administration (FDA) at the present time there is no evidence that triclosan in personal care products provides an extra benefit to health beyond its anti-gingivitis effect in toothpaste. The FDA does not recommend changing consumer use of triclosan containing products one way or the other due to currently insufficient safety evidence. Studies by the Environmental Protection Agency (EPA) found triclosan to be an effective antibacterial. This molecule safety is currently under review by the FDA and Health Canada.",CHEMBL849
CCC(C)C(NC(=O)C([NH3+])CO)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(CC(C)C)C(=O)[O-],4.27,,
COc1ccc(OC)c(Cc2nc3c(N)nc(F)nc3[nH]2)c1,4.27,,
CC([NH3+])C(=O)c1c(C(C)C)nn2ccccc12,4.27,,
COC1OC(C(O)CO)C(O)C(O)C1O,4.27,,
c1cc2cnc3sccc3c2cn1,4.27,,
CSCCC(NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1c[nH]cn1)NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(Cc1ccccc1)C(=O)[O-])C(C)O,4.27,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CO)NC(=O)C[NH3+])C(C)O)C(=O)N1CCCC1C(=O)NCC(=O)NC(C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)[O-])C(C)O,4.28,,
[NH3+]C(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)[O-],4.28,,
O=C([O-])C1OC(O)C(O)C(O)C1O,4.28,,
O=c1[nH]cnc2sc3c(c12)CCCC3,4.28,,CHEMBL539906
NC(=[NH2+])c1ccc(OCCCCCOc2ccc(C(N)=[NH2+])cc2)cc1,4.28,,
OCC1OC(OC2C(CO)OC(OC3C(CO)OC(OC4C(CO)OC(O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1O,4.28,,
C[NH2+]C(C)C(=O)NC(C(=O)N1CCCC1c1nc2c(-c3ccccc3)cccc2s1)C1CCCCC1,4.28,,
CCC([NH3+])[NH2+]CCCC([NH3+])C(=O)[O-],4.28,,
CC1=CC(O)=CC(C)(C)C1(O)C=CC(C)CC(=O)[O-],4.28,,
CC(NC(=O)C(CO)NC(=O)C(CCCC[NH+](C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])Cc1ccc(O)cc1)C(C)C)C(=O)NCC(=O)[O-],4.28,,
O=C(NCc1ccc(Cl)cc1)C1CC(O)CN1C(=O)c1ccccc1Cl,4.28,,
C[S+](CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,4.28,,
Cc1cn(C2CC(O)C3(CO)CC23)c(=O)[nH]c1=O,4.29,,
NC(=[NH2+])c1ccccc1,4.29,,
NC(=[NH2+])c1ccccc1,4.29,,
CC(C=CC(=O)C(=O)[O-])C(=O)CCC1C(=O)CCC2(C)C(=O)CCC12,4.29,,
CCSC1OC(CO)C(O)C(O)C1O,4.29,,
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CCC(=O)[O-])C(=O)[O-],4.3,,
CC(C)CC(NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)N1CCCC1C(=O)NC(C(=O)[O-])C(C)C)C(C)C,4.3,,
COC=CC([NH3+])C(=O)[O-],4.3,,
Cn1c(=O)c2[nH]c(=[NH2+])[nH]c2n(C)c1=O,4.3,,
OCC1OC(OC2C(O)C[NH2+]OC2CO)C(O)C(O)C1O,4.3,,
[NH3+]C(Cc1ccc(O)cc1)C(=O)[O-],4.3,,
O=C1N=C(S)SC1Cc1ccc(C(F)(F)F)cc1,4.3,,
O=C([O-])c1ccccc1Nc1cccc(C(F)(F)F)c1,4.3,,
CCCCCCCCCCCCCCCC(O)C(COC1OC(CO)C(O)C(O)C1O)NC(=O)CCCCCCC,4.3,,
CC(Oc1cc(-n2cnc3ccccc32)sc1C(N)=O)c1ccccc1C(F)(F)F,4.3,,CHEMBL1689163
O=C([O-])c1cccc(CSCc2ccc(Cl)cc2Cl)c1,4.3,,
Cc1ccc(OCCn2c(SCCC(=O)[O-])nc3ccccc32)cc1,4.3,,
COc1ccc2c(c1)cc(CNS(=O)(=O)c1cc3ccccc3o1)n2CC(=O)[O-],4.3,,
O=C([O-])C(=O)CS(=O)(=O)[O-],4.3,,
OCC1OC(NC(S)=NN=Cc2cccc(Br)c2)C(O)C(O)C1O,4.3,,
O=C([O-])C1Cc2ccccc2N1C(=O)OCc1ccccc1,4.3,,
CC(NC(=O)C(NC(=O)C1CCCN1C(=O)C(CCC(=O)[O-])NC(=O)C1CCC[NH2+]1)C(C)O)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)[O-],4.3,,
CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(CCCC[NH3+])NC(=O)C1CCC[NH2+]1)C(=O)NC(C(=O)[O-])C(C)C,4.3,,
O=C(CS)NCCCCCC(=O)Nc1ccccc1,4.3,,CHEMBL178727
Cn1c(=O)c2[nH]cnc2n(C)c1=O,4.3,,
CC(O)C([NH3+])C(=O)NS(=O)(=O)c1cccc(-c2ccc3[nH]ncc3c2)c1,4.3,,
O=C([O-])c1cccc(N2C(=O)C(O)=C(C(=O)c3ccc(Cl)s3)C2c2cc(Cl)c3c(c2)OCO3)c1,4.3,,
[NH2+]=C(N=O)NCCC([NH3+])C(=O)[O-],4.3,,
OCC1OC(SC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O,4.3,,
CC(C)(C)c1ccc(O)c(O)c1,4.3,This molecule is a natural product found in Mangifera indica with data available.,CHEMBL220845
O=C([O-])c1cc(O)c(O)c(Oc2cccc([N+](=O)[O-])c2)c1,4.3,,
CC(C)CN1C(=O)C(=Cc2ccc(O)cc2)SC1=S,4.3,,
CCC(C)N1C(=O)C(=Cc2ccc(O)cc2)SC1=S,4.3,,
N=C1NC(=O)C(=Cc2ccc(N)cc2)S1,4.3,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],4.3,,
CC(C)CC(NC(=O)C(NC(=O)C1CCC[NH2+]1)C(C)C)C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C)C(=O)[O-],4.3,,
CC(C)CC(NC(=O)C(NC(=O)C1CCC[NH2+]1)C(C)C)C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NC(C)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C)C(=O)[O-],4.3,,
O=C([O-])Cc1cccs1,4.31,,
CCC(C)C([NH3+])C(=O)NC(C(=O)[O-])C(C)C,4.31,,
CCC(C)C(NC(=O)C(CO)NC(=O)C[NH3+])C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(N)=O)C(=O)[O-])C(C)CC,4.31,,
CCCNc1nc(N)c(C(O)c2ccncc2)s1,4.31,,
CC(C)CC(NC(=O)C(NC(=O)C(C)NC(=O)OC(C)(C)C)C(C)C)C(=O)NC(C=N)CCC(N)=O,4.31,,
CC(C)CC(NC(=O)C(NC(=O)C(C)[NH3+])C(C)C)C(=O)NC(C=N)CCC(N)=O,4.31,,
Nc1nc2ccc(C(F)(F)F)cc2s1,4.31,,CHEMBL442384
CC[NH+](CC)CCNS(=O)(=O)Cc1ccc(C)cc1,4.31,,
COC1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)[O-])=C(COC(N)=O)CSC21,4.31,,
O=C(CCCc1ccc2c(c1)CCCC2)NC1OC(CO)C(O)C(O)C1O,4.31,,
CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(=O)[O-])NC(=O)C1CCC[NH2+]1)C(=O)[O-],4.31,,
CC(C)C(NC(=O)CNC(=O)C(CO)NC(=O)C1CCCN1C(=O)C([NH3+])CO)C(=O)NC(Cc1ccccc1)C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)[O-])C(C)O,4.31,,
CC(C)C(NC(=O)CNC(=O)C(CO)NC(=O)C1CCCN1C(=O)C([NH3+])CO)C(=O)NC(Cc1ccccc1)C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)[O-])C(C)O,4.31,,
OCC1OC(OC2C(CO)OC(OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(O)C(O)C5O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1O,4.32,,
COC1OC(C)C(O)C(O)C1O,4.32,,
C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,4.32,"This molecule is a quaternary ammonium ion that is the bis-choline ester of succinic acid. It has a role as a neuromuscular agent, a muscle relaxant and a drug allergen. It is a quaternary ammonium ion and a succinate ester. This molecule is a depolarizing skeletal muscle relaxant consisting of two molecules of the endogenous neurotransmitter [acetylcholine] (ACh) linked by their acetyl groups. It has been widely used for over 50 years, most commonly in its chloride salt form, as a means of neuromuscular blockade during intubation and surgical procedures. Its rapid onset and offset, with effects beginning within 60 seconds of intravenous administration and lasting between four to six minutes, make succinylcholine particularly useful in the setting of short medical procedures requiring brief periods of muscle relaxation. This molecule is a Depolarizing Neuromuscular Blocker. The physiologic effect of succinylcholine is by means of Neuromuscular Depolarizing Blockade. This molecule is a quaternary ammonium compound and depolarizing agent with short-term muscle relaxant properties. This molecule binds to nicotinic receptors at the neuromuscular junction and opening the ligand-gated channels in the same way as acetylcholine, resulting in depolarization and inhibition of neuromuscular transmission. Depolarization may be prolonged due to succinylcholine's resistance to acetylcholinesterases thereby leading to disorganized muscle contraction followed by skeletal muscle relaxation and flaccid paralysis.",CHEMBL703
Nc1ncnc2c(C3OC(CO)C(O)C3O)n[nH]c12,4.32,,CHEMBL273712
CCC(C)C([NH3+])C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(C(=O)NC(Cc1c[nH]cn1)C(=O)NCC(=O)NC(C(=O)[O-])C(C)C)C(C)C,4.32,,
CSCCC(NC(=O)C(CO)NC(=O)CNC(=O)C(C)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(N)=O)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCC[NH3+])NC(=O)C(CCSC)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CCCC[NH3+])C(=O)[O-],4.32,,
CNC(NC)=[NH+]CCCC(NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(=O)NCC(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],4.32,,
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C([NH3+])Cc1ccccc1)C(=O)[O-],4.32,,
CC1=CC(=O)C(C(C)C)=CC1=O,4.32,"These molecules is a member of the class of 1,4-benzoquinones that is 1,4-bezoquinone in which the hydrogens at positions 2 and 5 are replaced by methyl and isopropyl groups, respectively. It is a natural compound isolated from Nigella sativa which has demonstrated promising chemotherapeutic activity. It has a role as an anti-inflammatory agent, an antioxidant, an adjuvant, an antineoplastic agent, a cardioprotective agent, an antidepressant and a plant metabolite. This molecule is a natural compound with widespread protective effects, including anti-oxidative, anti-inflammatory, immunomodulatory, anti-cancer, and anti-microbial. This molecule is a natural product found in Origanum dictamnus, Ranunculaceae, and other organisms with data available.",CHEMBL1672002
c1cncc(Nc2ncnn3cccc23)c1,4.32,,CHEMBL3326654
N=C1NC(=O)C(=Cc2ccc(-c3ccc(C(=O)[O-])cc3)o2)S1,4.33,,
Oc1c(Cl)cc(Cl)cc1-c1[nH]c(Br)c(Br)c1Br,4.33,,CHEMBL1738810
CC(=O)NC1C(OC(C)C([NH3+])C(=O)[O-])OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O,4.33,,
O=C(Nc1ccn(C2OC(CO)C(O)C(F)C2O)c(=O)n1)c1ccccc1,4.33,,
CC(C)CC(NC(=O)C(C)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NCC(=O)[O-],4.33,,
CC(C)CC(NC(=O)C(C)NC(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CO)C(N)=O,4.33,,
O=C([O-])c1cccc(N2C(=O)C(O)=C(C(=O)c3cccc(C(F)(F)F)c3)C2c2cccc(C(F)(F)F)c2)c1,4.33,,
O=C([O-])c1sc2cc(-n3c(S)nnc3-c3ccc(F)cc3)ccc2c1Cl,4.33,,
CC(CCC(=O)[O-])C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C,4.34,,
CC(C)CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)C)C(=O)NC(C(=O)NC(C)C(=O)NC(CO)C(=O)NCC(=O)NC(CO)C(=O)[O-])C(C)O,4.34,,
CC(=O)SCC[N+](C)(C)C,4.34,,CHEMBL1231076
CC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)C(CC(=O)[O-])NC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CO)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)O,4.34,,
C=CCc1ccc(O)c(-c2cc(C=CC)ccc2O)c1,4.34,,
CCC(NC(=O)C(CCCCNC(C)=O)NC(=O)C(C)NC(=O)CNC(=O)C[NH2+]C(O)C(CCCCNC(C)=O)NC(=O)C[NH3+])C(=O)[O-],4.34,,
COc1cc2c(c(OC)c1OC)C1=CCC(=O)C(=O)C=C1C(NC(C)=O)CC2,4.34,,
NC(=[NH2+])c1ccc2[nH]c(-c3ccc[nH]c3=O)nc2c1,4.35,,
COc1ccc(C(=O)[O-])cc1,4.35,,
CCC(C)C(NC(=O)C(C)NC(=O)C([NH3+])CC(C)C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CO)CO,4.35,,
CCC(C)C(NC(=O)C(C)NC(=O)C([NH3+])CC(C)C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CO)C(=O)[O-],4.35,,
CCC(C)C(NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(NC(=O)C([NH3+])CC(=O)[O-])C(C)CC)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)[O-],4.35,,
Oc1ccc(-c2n[nH]c3cc(O)ccc23)cc1,4.35,,CHEMBL2042885
NS(=O)(=O)c1ccc(N=Nc2ccc(=O)[nH]c2O)cc1,4.35,,
NC(=O)CCC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CO)NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)[O-],4.35,,
Nc1ccccc1C(=O)[O-],4.35,,
OC(C[NH2+]C1CC1)COc1cccc2ccccc12,4.36,,
CSCCC([NH3+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O)C(C)O,4.36,,
Nc1ncccc1OCc1cccc2ccccc12,4.36,,CHEMBL195393
O=C([O-])C1=CC(O)C(O)C(O)C1,4.36,,
[NH3+]C(Cc1c[nH]cn1)C(=O)[O-],4.36,,
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CCC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)NCC(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)O)C(C)C,4.36,,
CC(C)CC(NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(=O)NC(CO)C(=O)[O-])C(C)C,4.36,,
O=C([O-])CNC(=O)C(=O)[O-],4.36,,
Oc1ccccc1CNc1cc(NCc2ccccc2O)ncn1,4.36,,
NC(=S)Nc1ccccc1,4.37,"Needle-like crystals. Used in the manufacture of rodenticides and in medical genetics. (EPA, 1998) This molecule is a member of the class of thioureas that is thiourea in which one of the hydrogens is replaced by a phenyl group. Depending on their genetic makeup, humans find it either very bitter-tasting or tasteless. This unusual property resulted in This molecule being used in paternity testing prior to the advent of DNA testing. It has a role as an EC 1.14.18.1 (tyrosinase) inhibitor. It is functionally related to a thiourea.",CHEMBL263376
O=C([O-])c1cccnc1Nc1cccc(C(F)(F)F)c1,4.37,,
COC1OC(CO)C(O)C(O)C1O,4.37,,
C[S+](CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,4.37,,
O=S(=O)([O-])c1cc(N=C=S)ccc1C=Cc1ccc(N=C=S)cc1S(=O)(=O)[O-],4.37,,
CC1(C)Cc2cccc(CO)c2O1,4.37,,CHEMBL4226715
Fc1ccccc1Nc1ncnc2[nH]ncc12,4.37,,CHEMBL2315560
CCC(C)C([NH3+])C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCSC)C(=O)[O-])C(C)C,4.37,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(CC(=O)[O-])cc1)NC(C)=O)C(=O)[O-],4.38,,
C[n+]1cnc(N)c2[nH]cnc21,4.38,,
Nc1ccc2cc3ccc(N)cc3nc2c1,4.38,"This molecule is an aminoacridine that is acridine that is substituted by amino groups at positions 3 and 6. A slow-acting bacteriostat that is effective against many Gram-positive bacteria (but ineffective against spores), its salts were formerly used for treatment of burns and infected wounds. It has a role as an antiseptic drug, a carcinogenic agent, an antibacterial agent, a chromophore and an intercalator. It is a conjugate base of a This molecule(1+). 3,6-Diaminoacridine. Topical antiseptic used mainly in wound dressings.",CHEMBL55400
c1nc(N2CCOCC2)c2[nH]cnc2n1,4.38,,
O=C(NCB(O)O)c1ccccc1Cl,4.38,,CHEMBL2035289
CCSc1nc(C)nc(N)n1,4.38,,CHEMBL1834390
CC(C)(CO)C(O)C(=O)[O-],4.38,,
CCC(C)C([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CO)C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)[O-])C(C)C,4.38,,
O=c1[nH]ccc2cc(-c3ccccc3CO)ccc12,4.38,,
CC(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(=O)[O-])C(=O)NC(C=O)CCC(N)=O,4.38,,
CCCCCCCCCC(=O)[O-],4.38,,
CN1CCC=CCCCCCCC(=O)Cc2c(Cl)c(O)cc(O)c2C1=O,4.38,,
C=CCN=C1NN=C(c2ccc(Cl)cc2)CS1,4.39,,
CCCCn1c(Cc2cc(OC)ccc2OC)nc2c(N)ncnc21,4.39,,CHEMBL113194
CCCCC(C[NH2+]C(CCCC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)CC,4.39,,
COc1ccc(C[NH3+])cc1,4.39,,
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C)C(=O)NC(C(=O)[O-])C(C)O,4.39,,
Nc1[nH]nc2ccc(Br)cc12,4.39,,
CC(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)NC(C(=O)NC(CO)C(=O)NC(CO)CCC(N)=O)C(C)O,4.39,,
CCNc1[nH]c2cc3[nH]c(NC)nc3cc2c(=O)[nH+]1,4.39,,
COc1ccc(C2(C)CCSC(=[NH2+])N2)cc1,4.39,,
CC(O)C([NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(N)=O)C(=O)[O-],4.39,,
CC(C)C(NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(NC(=O)C[NH3+])C(C)O)C(C)O)C(=O)NCC(=O)[O-],4.4,,
NC(=[NH2+])c1ccc2[nH]c(-c3ccccc3O)nc2c1,4.4,,
COc1cncc(-c2cccc(CNc3ccc[nH]c3=N)c2)c1,4.4,,
OCC1[NH2+]CC(O)C(O)C1O,4.4,,
[NH3+]CCOc1c(Cl)cc(C(=O)[O-])cc1Cl,4.4,,
CCC(C)C1NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC1=O,4.4,,
O=C1CC(C=NOCCON=Cc2cccc(C(=O)[O-])c2)=NC(=O)N1,4.4,,
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(N)=O)NC(=O)C([NH3+])Cc1c[nH]c2ccccc12)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(C)C=O)C(C)O,4.4,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(CO)C(=O)[O-],4.4,,
CC(C)Cn1c(=O)n(C)c(=O)c2nc[nH]c21,4.4,This molecule is a 3-isobutyl-1-methylxanthine. It is functionally related to a 9H-xanthine. It is a tautomer of a 3-isobutyl-1-methyl-7H-xanthine.,CHEMBL275084
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)[O-],4.4,,
CC(C)CC(NC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)CNC(=O)CNC(=O)CNC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(Cc1c[nH]cn1)C(=O)[O-],4.4,,
COc1cc(Cl)c(O)c(C2OC(CO)C(O)C(O)C2O)c1,4.4,,
COC(=O)c1c[nH]c2ncccc12,4.4,,CHEMBL2391621
[NH3+]Cc1cccc(-n2cccc2)c1,4.4,,
CC[NH+](CC)CCNS(=O)(=O)Cc1ccc(F)cc1,4.4,,
NC(=[NH2+])NCCCC(C(=O)[O-])[NH+]1C(O)CCC1C(=O)[O-],4.4,,
OB(O)CCc1ccccc1,4.4,,CHEMBL20461
O=c1[c][c]n([C]2O[C]([C][O-])[C]3O[V+9](=O)(=O)(=O)O[C]32)c(=O)[n-]1,4.4,,
CC(=O)NC(Cc1ccc(C(N)=[NH2+])cc1)C(=O)NC(C(=O)NC(CO)Cc1ccc[n+](C)c1)C1CCCCC1,4.4,,
O=C([O-])CCCCCCCCC(=O)[O-],4.41,,
O=C([O-])CCCCCCCCC(=O)[O-],4.41,,
O=C([O-])C(=O)N(c1ccccc1C(=O)[O-])c1cccc2ccccc12,4.41,,
[NH3+]CCNS(=O)(=O)c1ccc(Cl)c2ccncc12,4.41,,
[NH3+]C(Cc1ccc(O)cc1)C(=O)[O-],4.41,,
CCC(C)C(NC(=O)C(CC(N)=O)NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CC(N)=O)C(=O)[O-],4.41,,
CC(C)CC(NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CO)C(=O)NC(CC(N)=O)C(=O)[O-],4.41,,
Nc1ccc2cc(-c3ccsc3)ccc2n1,4.41,,CHEMBL1821801
Clc1cc(Cl)c2nn[nH]c2c1,4.41,,
CC(C)CC(NC(=O)C(NC(=O)C(C)[NH3+])C(C)C)C(=O)NC(C=N)CCC(N)=O,4.41,,
CC(Cc1ccc(O)c(O)c1)C(C)Cc1ccc(O)c(O)c1,4.41,"This molecule is a tetrol that is butane which is substituted at positions 2 and 3 by 3,4-dihydroxybenzyl groups. Masoprocol, the meso-form found in the leaves of the creosote bush (Larrea divaricata), is a potent lipoxygenase inhibitor. It has a role as an antioxidant, a plant metabolite, a ferroptosis inhibitor and a geroprotector. It is a member of catechols, a tetrol and a lignan. This molecule is a natural product found in Arabidopsis thaliana, Magnolia sinica, and other organisms with data available.",CHEMBL52
CC(CS)C(=O)N1CCCC1C(=O)[O-],4.41,,
O=S(=O)([O-])CC[NH2+]Cc1cccc(Cl)c1,4.41,,
NC(=[NH2+])NCCCC1NC(=O)CNC(=O)C(CC(N)=O)NC(=O)C([NH3+])CSSCC(C(=O)NCC(=O)[O-])NC1=O,4.41,,
O=C([O-])CCC(=O)C(=O)[O-],4.41,,
C[NH+](C)CC(O)COc1ccc(Nc2cc(Nc3c(F)cccc3F)ncn2)cc1,4.42,,
Nc1nc(-c2ccccc2)c(Br)c(=O)[nH]1,4.42,,
O=C1OC(C(O)CO)C(O)C1O,4.42,,
CC([NH3+])C(=O)NC(C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(C)C(=O)[O-],4.42,,
[NH2+]=C1NC(c2ccccc2)(c2ccccc2)C2=NCCCN12,4.42,,
N#Cc1cc2ccc(O)cc2oc1=O,4.42,,CHEMBL150302
CN(C(=O)CCc1cc2ccccc2nc1N)C1CCCCC1,4.42,,CHEMBL1821809
Clc1cncc(-c2nnc[nH]2)n1,4.42,,
C[NH+](C)CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,4.42,,
CNC(=O)c1ccccc1OC1CCOCC1,4.42,,CHEMBL3110243
CC([NH3+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]cn1)C(=O)N1CCCC1C(=O)NC(CCC(N)=O)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NCC(=O)[O-],4.43,,
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,4.43,"This molecule is a xanthine derivative that decreases the viscosity of blood and is used to treat symptoms of intermittent claudication due to peripheral vascular disease. This molecule has not been associated with serum enzyme elevations during therapy, but in several isolated case reports has been linked to clinically apparent liver injury. This molecule is an oxopurine. This molecule is a synthetic dimethylxanthine derivative that modulates the rheological properties of blood and also has both anti-oxidant and anti-inflammatory properties. Although originally developed to treat intermittent claudication, a form of exertion-induced leg pain common in patients with peripheral arterial disease, PTX has been investigated for its possible use in diverse conditions, including osteoradionecrosis, diabetic kidney disease, and generally any condition associated with fibrosis. More recently, PTX has been suggested as a possible treatment for COVID-19-induced pulmonary complications due to its ability to regulate the production of inflammatory cytokines.  Pentoxifylline has been marketed in Europe since 1972; PTX extended-release tablets sold under the trade name TRENTAL by US Pharm Holdings were first approved by the FDA on Aug 30, 1984, but have since been discontinued. A branded product, PENTOXIL, marketed by Upsher-Smith Laboratories, and generic forms marketed by Valeant Pharmaceuticals and APOTEX have been available since the late 1990s. This molecule is developed to treat neurodegenerative disorders by ExonHit Therapeutics. This molecule is a Blood Viscosity Reducer. The physiologic effect of pentoxifylline is by means of Hematologic Activity Alteration. This molecule is a methylxanthine derivative with hemorrheologic and immunomodulating properties. This molecule inhibits phosphodiesterase, resulting in increased levels of cyclic adenosine monophosphate (cAMP) in erythrocytes, endothelium, and the surrounding tissues. This leads to vasodilation, improves erythrocyte flexibility, and enhances blood flow. In addition, the increased level of cAMP in platelets inhibits platelet aggregation, which may contribute to a reduction in blood viscosity. This agent also inhibits production of tumor necrosis factor-alpha and interferon-gamma, while it induces Th2-like (T-helper 2) cytokine production, thereby inhibiting Th1-mediated (T-helper 1) inflammatory and autoimmune responses.",CHEMBL628
CNC(=O)C1Cc2ccc(NS(=O)(=O)[O-])cc2CN1C(=O)OCc1ccccc1,4.43,,
CC(O)CCC[N+](C)(C)C,4.43,,
O=C([O-])c1ccc2c(c1)C(=O)N(C(Cc1ccc(O)cc1)C(=O)[O-])C2=O,4.43,,
COC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O,4.43,,
Cc1cc(=N)c2ccccc2n1CCCCCCCCCCN1c2ccccc2C(N)=CC1C,4.43,,
CC(=O)NC1C(Oc2ccc([N+](=O)[O-])cc2)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O,4.43,,
O=S(=O)([O-])c1cccc2cccc(Nc3ccccc3)c12,4.43,,
O=S(=O)([O-])c1cccc2cccc(Nc3ccccc3)c12,4.43,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],4.43,,
O=C(c1cccc(-c2ccn[nH]2)c1)N1CC[N+](CC2=Cc3ccccc3OC2)CC1,4.43,,
Oc1ccc(Cl)cc1-c1cc[nH]n1,4.43,,CHEMBL2032374
CC(C)(C)NC(=O)Nc1ccc2nccnc2c1,4.43,,CHEMBL1490765
O=C([O-])c1cncc(-c2ccccc2)c1,4.43,,
O=C([O-])Cc1ccc(N2C(=O)C(O)=C(C(=O)c3ccc(Cl)s3)C2c2cc(Br)cs2)cc1,4.43,,
CN1C(=[NH2+])NC2(CC(C)(C)Oc3ccc(Br)cc32)C1=O,4.43,,
[NH3+]C(Cc1ccccc1)C(=O)[O-],4.43,,
CCC(C)C([NH3+])C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccccc1)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)[O-],4.43,,
CC1=[O+][Fe+7]2345[O+]=C(CCC(=O)NCCCCCN([OH+]2)C(=[O+]3)CCC(=O)NCCCCCN1[OH+]4)N(C)[OH+]5,4.44,,
CC[N+](CC)(CC)Cc1ccccc1,4.44,,
Nc1c(C(=O)Nc2cccc(F)c2)sc2nc(-c3cccs3)ccc12,4.44,,CHEMBL1084955
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)[O-],4.44,,
CC(NC(=O)C([NH3+])C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)NC(C(=O)NCC(=O)[O-])C(C)O,4.44,,
CC(O)C([NH3+])C(=O)NC1C(CO)OC(n2cnc3c(N)ncnc32)C1O,4.44,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,4.44,,
CN1C(=[NH2+])NC(C)(CCc2ccccc2)CC1=O,4.44,,
O=C1NC(=O)C(Cc2ccccc2)N1,4.44,,CHEMBL1914996
CC(C)C(NC(=O)CNC(=O)CNC(=O)C(NC(=O)C([NH3+])CO)C(C)O)C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],4.44,,
CCC(C)C(NC(=O)CNC(=O)C(NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(=O)[O-])C(C)CC)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(C(=O)[O-])C(C)C)C(C)O,4.44,,
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C(C)NC(=O)C(CCC(N)=O)[NH2+]C(C)O)C(=O)NC(Cc1ccccc1)C(=O)[O-],4.44,,
O=c1ccn(C2OC(CO)C(O)C2O)c(=O)[nH]1,4.44,"This molecule is a pyrimidine nucleoside. This molecule is a natural product found in Homo sapiens, Apium graveolens, and other organisms with data available.",CHEMBL68846
CC(C)CC([NH3+])C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CCC(N)=O)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(C)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-])C(C)O,4.45,,
CCCCCCCCN=C1OCC2C(O)C(O)C(O)C(O)N12,4.45,,
[NH3+]C(CO)C(=O)[O-],4.45,,
CC(Oc1ccc(Oc2ncc(C(F)(F)F)cc2Cl)cc1)C(=O)[O-],4.45,,
CC1=CC(=O)C(C(C)C)=CC1=NO,4.45,,
Nc1ccc2cc3ccc(N)cc3nc2c1,4.46,"This molecule is an aminoacridine that is acridine that is substituted by amino groups at positions 3 and 6. A slow-acting bacteriostat that is effective against many Gram-positive bacteria (but ineffective against spores), its salts were formerly used for treatment of burns and infected wounds. It has a role as an antiseptic drug, a carcinogenic agent, an antibacterial agent, a chromophore and an intercalator. It is a conjugate base of a This molecule(1+). 3,6-Diaminoacridine. Topical antiseptic used mainly in wound dressings.",CHEMBL55400
C[NH+](C)CC(O)COc1ccc(Nc2cc(Nc3cc(C(F)(F)F)ccc3F)ncn2)cc1,4.46,,
c1ccc2c(CCc3ccncc3)c[nH]c2c1,4.46,"This molecule is a solid. This compound belongs to the indoles. These are compounds containing an indole moiety, which consists of a pyrrole ring fused to benzene to form 2,3-benzopyrrole. This drug is known to target mitogen-activated protein kinase 14.",CHEMBL193156
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NCC(=O)O)C(C)O,4.46,,
C[S+](CCC[NH3+])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,4.46,,
CNC(=[NH2+])NCCCC(NC(=O)C(C)[NH3+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NCC(=O)[O-])C(C)O)C(C)O,4.46,,
CC([NH3+])C(=O)NC(CCCNC(=[NH2+])N(C)C)C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)C(C)O)C(C)O,4.46,,
CC(C)CC(NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(Cc1c[nH]cn1)C(=O)N1CCCC1C(=O)N1CCCC1C=O,4.46,,
Nc1nc(N)nc(NC2CC2)n1,4.46,"This molecule is a triamino-1,3,5-triazine. It has a role as a triazine insecticide and a mouse metabolite. Ectoparasiticide. Insect growth regulator. Specific activity against dipterous larvae. Cyromazine is a fda approved for use in livestock. Cyromazine belongs to the family of Aminotriazines. These are organic compounds containing an amino group attached to a triazine ring.",CHEMBL1231107
CC1=Nc2c(N)nc(N)nc2NC1(C)C,4.46,,CHEMBL566271
Nc1nc(S)c2nc[nH]c2n1,4.46,,
Nc1nc(N)nc(N)n1,4.46,"This molecule appears as colorless to white monoclinic crystals or prisms or white powder. Sublimes when gently heated. (NTP, 1992) This molecule is a trimer of cyanamide, with a 1,3,5-triazine skeleton. It has a role as a xenobiotic metabolite. It is functionally related to a cyanamide. It is a conjugate base of a melamine(1+). This molecule is a natural product found in Apis cerana, Euglena gracilis, and Aeromonas veronii with data available. This molecule is an organic base and a trimer of cyanamide, with a 1,3,5-triazine skeleton. Like cyanamide, it contains 66% nitrogen by mass and, if mixed with resins, has fire retardant properties due to its release of nitrogen gas when burned or charred, and has several other industrial uses. This molecule is also a metabolite of cyromazine, a pesticide. It is formed in the body of mammals who have ingested cyromazine. It has been reported that cyromazine can also be converted to melamine in plants. This molecule is described as Harmful if swallowed, inhaled or absorbed through the skin. Chronic exposure may cause cancer or reproductive damage. Eye, skin and respiratory irritant. However, the short-term lethal dose is on a par with common table salt with an LD50 of more than 3 grams per kilogram of bodyweight.[15] U.S. Food and Drug Administration (FDA) scientists explained that when melamine and cyanuric acid are absorbed into the bloodstream, they concentrate and interact in the urine-filled renal tubules, then crystallize and form large numbers of round, yellow crystals, which in turn block and damage the renal cells that line the tubes, causing the kidneys to malfunction.",CHEMBL1231106
CC(O)C1NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(CCC(=O)[O-])NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2c[nH]c3ccccc23)[NH2+]C(O)CSCC(C(=O)[O-])NC(=O)C2CCCN2C(=O)C(Cc2ccccc2)NC1=O,4.46,,
Cc1ccc(Oc2cccc(NC(=O)c3cc([N+](=O)[O-])ccc3C(=O)[O-])c2)cc1C,4.46,,
CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(C)NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CCC(=O)[O-])C(C)O)C(=O)NC(C(=O)[O-])C(C)C,4.46,,
CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,4.46,This molecule is a pyrazolopyrimidine. It has a role as a tyrosine kinase inhibitor.,CHEMBL573578
O=C([O-])C(=O)Nc1ccc(CC(c2nc3ccccc3o2)S(=O)(=O)Nc2ccc(F)cc2)cc1,4.46,,
COC1C(OC(N)=O)C(O)C(Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C,4.46,This molecule is a natural product found in Actinoalloteichus cyanogriseus and Streptomyces niveus with data available.,CHEMBL35025
CCC(=C(c1ccc(O)cc1)c1ccc(OCC[NH+](C)C)cc1)c1ccccc1,4.47,,
O=C(CCc1cccc(NS(=O)(=O)[O-])c1)NCc1cccc(NS(=O)(=O)[O-])c1,4.47,,
NC(=[NH2+])Nc1ccc(CC(=O)c2ccccc2)cc1,4.47,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)O)C(C)O,4.47,,
Cc1ccc(NC(=O)c2ccc(C[N+]3CC[N+](C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,4.47,,
C[NH2+]C(C)C(=O)NC(C(=O)N1CCC(C)C1C(=O)Nc1ccccc1-c1ncccn1)C1CCCCC1,4.47,,
[NH3+]C(CCC[CH2]~B(O)(O)O)(C(=O)[O-])C(F)F,4.47,,
O=C([O-])C1(O)C=C(C(O)Cc2ccccc2)C(O)C(O)C1,4.47,,
OCC1[NH2+]CC(O)C(O)C1O,4.47,,
NC(=O)c1cc2c(N)ncc(C(N)=O)c2s1,4.47,,CHEMBL3098810
O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,4.47,"This molecule appears as yellow needles or yellow powder. Converts to anhydrous form at 203-207 °F. Alcoholic solutions taste very bitter. (NTP, 1992) This molecule is a pentahydroxyflavone having the five hydroxy groups placed at the 3-, 3'-, 4'-, 5- and 7-positions. It is one of the most abundant flavonoids in edible vegetables, fruit and wine. It has a role as an antibacterial agent, an antioxidant, a protein kinase inhibitor, an antineoplastic agent, an EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor, a plant metabolite, a phytoestrogen, a radical scavenger, a chelator, an Aurora kinase inhibitor and a geroprotector. It is a pentahydroxyflavone and a 7-hydroxyflavonol. It is a conjugate acid of a quercetin-7-olate. This molecule is a flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin. This molecule is a flavonoid found in many foods and herbs and is a regular component of a normal diet. Extracts of quercetin have been used to treat or prevent diverse conditions including cardiovascular disease, hypercholesterolemia, rheumatic diseases, infections and cancer but have not been shown to be effective in clinical trials for any medical condition. This molecule as a nutritional supplement is well tolerated and has not been linked to serum enzyme elevations or to episodes of clinically apparent liver injury. This molecule is a polyphenolic flavonoid with potential chemopreventive activity. This molecule, ubiquitous in plant food sources and a major bioflavonoid in the human diet, may produce antiproliferative effects resulting from the modulation of either EGFR or estrogen-receptor mediated signal transduction pathways. Although the mechanism of action of action is not fully known, the following effects have been described with this agent in vitro: decreased expression of mutant p53 protein and p21-ras oncogene, induction of cell cycle arrest at the G1 phase and inhibition of heat shock protein synthesis. This compound also demonstrates synergy and reversal of the multidrug resistance phenotype, when combined with chemotherapeutic drugs, in vitro. This molecule also produces anti-inflammatory and anti-allergy effects mediated through the inhibition of the lipoxygenase and cyclooxygenase pathways, thereby preventing the production of pro-inflammatory mediators. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Salvia miltiorrhiza, Hydrangea serrata, and other organisms with data available. This molecule is a flavonoid widely distributed in many plants and fruits including red grapes, citrus fruit, tomato, broccoli and other leafy green vegetables, and a number of berries, including raspberries and cranberries. This molecule itself (aglycone quercetin), as opposed to quercetin glycosides, is not a normal dietary component. Quercitin glycosides are converted to phenolic acids as they pass through the gastrointestinal tract. This molecule has neither been confirmed scientifically as a specific therapeutic for any condition nor been approved by any regulatory agency. The U.S. Food and Drug Administration has not approved any health claims for quercetin. Nevertheless, the interest in dietary flavonoids has grown after the publication of several epidemiological studies showing an inverse correlation between dietary consumption of flavonols and flavones and reduced incidence and mortality from cardiovascular disease and cancer. In recent years, a large amount of experimental and some clinical data have accumulated regarding the effects of flavonoids on the endothelium under physiological and pathological conditions. The meta-analysis of seven prospective cohort studies concluded that the individuals in the top third of dietary flavonol intake are associated with a reduced risk of mortality from coronary heart disease as compared with those in the bottom third, after adjustment for known risk factors and other dietary components. A limited number of intervention studies with flavonoids and flavonoid containing foods and extracts has been performed in several pathological conditions. (A7896)",CHEMBL50
Nc1cccc(F)c1C(=O)[O-],4.47,,
CC(C)CC(C(=O)NO)C(=O)NC(C)C(=O)NCC(N)=O,4.48,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,4.48,,
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(C)[NH3+])C(=O)NC(C)C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccccc1)C(=O)[O-])C(C)O,4.48,,
CC(C)CC(NC(=O)C(NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],4.48,,
CC(C)CC(NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCC(N)=O)NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(N)=O)C(=O)[O-],4.48,,
CN1c2c(nc(N)[nH]c2=O)NCC1CNc1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,4.48,,
O=C([O-])C(=O)NC(Cc1ccc(OCc2ccccc2)cc1)C(=O)[O-],4.48,,
COc1cccc(OC)c1C(=O)NC(C)B(O)O,4.48,,
COc1ccc2c(c1)S(=O)(=O)NC(c1c(O)c(-c3ccccc3)nn(CCC(C)C)c1=O)=N2,4.48,,CHEMBL255134
[NH3+]C(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCc1cccnc1,4.48,,
Nc1ncnc2c1ncn2C1OC(CO)C(NC(=O)C[NH3+])C1O,4.48,,
CCCNc1nc(N)c(C(O)c2ccccn2)s1,4.48,,
O=C(OCc1ccccc1)C1CC2(C[NH2+]1)C(=O)Nc1ccccc12,4.48,,
NC(=O)C1CCCc2c1[nH]c1ccc(Cl)cc21,4.48,"This molecule is a member of the class of carbazoles that is 2,3,4,9-tetrahydro-1H-carbazole which is substituted at position 1 by an aminocarbohyl group and at position 6 by a chlorine. It is a member of carbazoles, a monocarboxylic acid amide and an organochlorine compound. These molecules are 98, 19600, 48700, > 100000 and > 100000 nM for SIRT1, SIRT2, SIRT3, HDAC and NADase respectively). Enhances p53 acetylation in response to DNA damaging agents.",CHEMBL420311
Cc1ccc(-c2nc(C(=O)[O-])cs2)cc1,4.48,,
CCCCCc1cc2c(o1)NC(=O)N(C1OC(CO)C(O)C(O)C1O)C2,4.48,,
COc1ccc([N+](=O)[O-])cc1Cn1cc(CC(=O)[O-])c2ccc(-c3cc(N)cc(N)c3)cc21,4.48,,
NC(=[NH2+])c1ccccc1,4.49,,
CC(=O)NC1OC(CO)C(O)C(O)C1O,4.49,,
C[NH2+]CCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(C(=O)NC(CC(C)C)C(=O)[O-])C(C)C,4.49,,
C[n+]1cc(C(=O)[O-])nc2c(=O)[nH]c(=[NH2+])[nH]c21,4.49,,
CC(C)(C)C1=NN(c2nc3ccc(Cl)cc3s2)C(=O)C1,4.49,,
Nc1ncccc1CCc1cccc(Cl)c1,4.49,,CHEMBL575232
O=C(OC1CCOCC1)C1CC2(C[NH2+]1)C(=O)Nc1ccccc12,4.49,,
OCC1OCCC(O)C1O,4.49,,
CCCc1nc2ccccc2c2[nH]c(N)n[n+]12,4.49,,
CCCC1=CC2=CN(C3OC(CO)C(O)C(O)C3O)C(=O)NC2O1,4.49,,
CCC(C)C(NC(=O)C(NC(=O)C(CO)NC(=O)C(NC(=O)C(CCCCNC(C)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(C)[NH3+])C(C)O)C(C)CC)C(=O)[O-],4.49,,
O=c1[nH]cnc2c1N=NC2,4.5,,
O=C([O-])c1[nH]c(=O)[nH]c(=O)c1F,4.5,,
CCN(CC)C(=O)c1cccc(C)c1,4.5,"This molecule is a chemical (N,N-diethyl-meta-toluamide) used as the active ingredient in many insect repellent products. This molecule was developed by the U.S. Army in 1946 and was registered for use by the general public in 1957. It is now widely used, with approximately 30% of the U.S. population using This molecule repellents each year. This molecule products are currently available in a variety of forms: liquids, lotions, sprays, and even impregnated materials, such as wristbands. Formulations registered for direct application to human skin contain from 4% to 100% This molecule. Approximately 230 products containing This molecule are currently registered with the U.S. Environmental Protection Agency (EPA). This molecule appears as clear colorless or faintly yellow slightly viscous liquid. Faint pleasant odor. (NTP, 1992) This molecule is a monocarboxylic acid amide resulting from the formal condensation of the carboxy group of m-toluic acid with the nitrogen of diethylamine. First developed by the U.S. Army in 1946 for use by military personnel in insect-infested areas, it is the most widely used insect repellent worldwide. It has a role as an insect repellent, an environmental contaminant and a xenobiotic. It is a monocarboxylic acid amide and a member of benzamides. It is functionally related to a m-toluic acid. This molecule is the common active ingredient in many insect repellent products. It is widely used to repel biting pests such as mosquitoes and ticks. Every year, DEET formulations are used to protect populations from mosquito-borne illnesses like West Nile Virus, the Zika virus, malaria, and/or tick-borne illnesses like Lyme disease and Rocky Mountain spotted fever. And, despite concerns over excessive exposure to the chemical, appropriate usage of the chemical at the recommended dosages and routes of administration have generally proven to be safe - even when most DEET products are largely designed to be applied directly to human skin, where the exact mechanisms of actions in which DEET is capable of repelling insects and causing toxicity to humans is still not fully elucidated. This molecule is a natural product found in Penicillium with data available. This molecule is a slightly yellow oil. It is the most common active ingredient in insect repellents. It is intended to be applied to the skin or to clothing, and provides protection against mosquitos, ticks, fleas, chiggers, and many other biting insects.",CHEMBL1453317
c1cc[n+]2c(c1)-c1cccc3[n+]1[Pt+4]2[n+]1ccccc1-3,4.5,,
O=CN(O)CCNC(=O)c1cccc(Cl)c1Cl,4.5,,
O=C1C[N+]23Cc4cccc[n+]4[Fe+7]245(O1)OC(=O)C[N+]4(Cc1cccc[n+]15)C1CCCCC13,4.5,,
[NH3+]CCCCC([NH3+])C(=O)N1CCCC1C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CO)C(=O)NC(CC(=O)[O-])C(=O)[O-],4.5,,
NC(=[NH2+])c1ccc2[nH]c(-c3ccc[nH]c3=O)nc2c1,4.51,,
CC(C)Cn1c(=O)n(C)c(=O)c2[nH]cnc21,4.51,,
O=C([O-])C1CC(O)C(O)C(C(O)CO)O1,4.51,,
O=C([O-])c1c[n+](C2CC2)c2cc(N3CC[NH2+]CC3)c(F)cc2c1O,4.51,,
Cc1cn(C2CC(O)C(CNC(=S)Nc3ccc(Cl)c(C(F)(F)F)c3)O2)c(=O)[nH]c1=O,4.51,,
CC(C)CC(NC(=O)C(NC(=O)C([NH3+])Cc1ccccc1)C(C)O)C(=O)NC(CC(=O)[O-])C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)[O-],4.51,,
CC(N=Cc1cc(NC(N)=[NH2+])ccc1O)C(=O)[O-],4.51,,
CC(C)CC(NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCC(N)=O)C(=O)[O-],4.51,,
O=C([O-])C1OC(O)C(O)C(O)C1O,4.51,,
[NH3+]Cc1csc2ccccc12,4.51,,
O=C(Nc1ccc2c(c1)CC[NH2+]CC2)c1ccc(Br)cc1,4.51,,
O=C1NC(O)=C(F)CN1Cc1cn(C2OC(CO)C(O)C2O)nn1,4.51,,
CCC(C)C(NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NCC(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(C(=O)[O-])C(C)C)C(C)O,4.51,,
O=C([O-])c1ccc(CCNS(=O)(=O)c2ccsc2C(=O)[O-])cc1,4.51,,
C#Cc1cccc(Cn2cc(CC(=O)[O-])c3ccccc32)c1,4.51,,
CC(C)CC(C(=O)NO)C(=O)NC(CC(N)=O)C(=O)NCc1cccc(N)c1,4.52,,CHEMBL325924
O=C1NCC=CN1C1OC(CO)C(O)C1O,4.52,,
O=C([O-])C1(O)C=CC(O)C(O)C1,4.52,,
C#CCCCn1c(Cc2cc(OC)c(OC)c(OC)c2Cl)nc2c(N)nc(F)nc21,4.52,"This molecule is a member of the class of 6-aminopurines that is 2-fluoroadenine carrying additional 2-chloro-3,4,5-trimethoxybenzyl and pent-4-yn-1-yl substituents at positions 8 and 9 respectively. It has a role as a Hsp90 inhibitor and an antineoplastic agent. It is a member of 6-aminopurines, an organofluorine compound, an acetylenic compound, a member of methoxybenzenes and a member of monochlorobenzenes. It is functionally related to an adenine.",CHEMBL112953
[NH3+]C(Cc1c[nH]c2ccccc12)C(=O)[O-],4.52,,
[NH3+]CC1(c2ccccc2)CCCC1,4.52,,
O=C([O-])c1c(-c2ccccc2)oc(-c2ccccc2)c1C(=O)[O-],4.52,,
CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C(CCCC[NH3+])NC(=O)C(CC(N)=O)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(C)C)NC(=O)C1CCC(=O)N1)C(=O)NC(CC(C)C)C(=O)[O-],4.52,,
CC([NH3+])c1nc(C(=O)N2CCCC2C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)[O-])co1,4.52,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)[O-])C(C)O)C(C)O,4.52,,
CCc1ccc(O)cc1,4.52,"This molecule is a member of the class of phenols carrying an ethyl substituent at position 4. It has a role as a fungal xenobiotic metabolite. This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Brettanomyces anomalus, Gossypium hirsutum, and other organisms with data available. This molecule is found in arabica coffee. This molecule (4-EP) is a phenolic compound produced in wine and beer by the spoilage yeast Brettanomyces. (Wikipedia) 

This molecule belongs to the family of Phenols and Derivatives. These are compounds containing a phenol moiety, which is a benzene bearing an hydroxyl group.",CHEMBL108475
CN([NH2+]O)C(=O)NC1C(O)OC(CO)C(O)C1O,4.52,,
CC(=O)NC1C(OC2C(CO)OC(OC3C(CO)OC4SC(C)=NC4C3O)C(NC(C)=O)C2O)OC(CO)C(O)C1O,4.52,,
c1ccc(-c2cnc3cnc(-c4cn[nH]c4)cn23)cc1,4.52,,CHEMBL1172464
CSCCC(NC(=O)C([NH3+])C(C)C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)[O-],4.52,,
[NH3+]Cc1ccccc1-c1ccccc1,4.52,,
NC(=[NH2+])NC(=[NH2+])Nc1cc(C(F)(F)F)ccc1Cl,4.52,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)[O-])C(C)O)C(C)O,4.52,,
NC(=[NH2+])c1ccccc1,4.52,,
CCCC(=O)Nc1[nH]nc2cc(-c3ccc(O)cc3)ccc12,4.52,,
[NH3+]C(Cc1ccccc1)C(=O)NC(CCCCNC(=O)OCc1ccccc1)C(=O)N=O,4.52,,
CC(C)CC(NC(=O)C(CCl)NC(=O)CC(O)C(Cc1ccccc1)NC(=O)C(NC(=O)c1ccccn1)C(C)C)C(N)=O,4.52,,
C[N+](C)(C)CCO,4.52,"This molecule is a choline that is the parent compound of the cholines class, consisting of ethanolamine having three methyl substituents attached to the amino function. It has a role as a neurotransmitter, a nutrient, a human metabolite, a plant metabolite, a Daphnia magna metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a mouse metabolite and an allergen. This molecule is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Amaranthus hybridus, Leonurus japonicus, and other organisms with data available.",CHEMBL920
CCC(=O)OC1CCC2(C)C(CCC3C2CCC2(C)C(C(C)CCC(=O)[O-])CCC32)C1,4.52,,
C[N+]12Cc3cccc[n+]3[Fe+6]134OC(=O)C[N+]3(Cc1cccc[n+]14)C1CCCCC12,4.52,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(OC3(C(=O)[O-])CC(O)C(NC(C)=O)C(C(O)C(O)CO)O3)C2O)C1O,4.52,,
CC(O)C([NH3+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)[O-],4.52,,
CC(C)CC(NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)[O-],4.52,,
Cc1cc(S(=O)(=O)N(Cc2cccc(N)c2)C(C)C(=O)NO)ccc1F,4.52,,
NC(=O)c1cccc(N)c1,4.52,This molecule is a substituted aniline that is benzamide in which one of the meta- hydrogens is replaced by an amino group. It has a role as an EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor. It is a member of benzamides and a substituted aniline.,CHEMBL81977
O=c1[nH]cnc2ccccc12,4.52,"This molecule is a member of quinazolines. This molecule is a natural product found in Streptomyces, Strobilanthes, and other organisms with data available.",CHEMBL266540
Nc1ccc2oc(=O)ccc2c1I,4.52,,CHEMBL4570898
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,4.52,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,4.52,,
OCC1OC(n2cnc3cc(Cl)c(Cl)cc32)C(O)C1O,4.53,,CHEMBL267071
CC(O)C([NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(N)=O)C(=O)[O-],4.53,,
[NH3+]CCCCC([NH3+])C(=O)NC(CCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],4.54,,
CC(=O)NCC(=O)NC(C)C(=O)NC1CSSCC(C(=O)NC(C)C(=O)NC(C)C(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(C)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc2cnc[nH]2)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC1=O,4.54,,
OCC1OC(O)C(O)C(O)C1O,4.54,,
NC(=[NH2+])c1ccccc1,4.54,,
C[As+](C)(C)CCOC(c1ccccc1[N+](=O)[O-])C(F)(F)F,4.54,,
COc1ccc2[nH]c(C(=O)NS(=O)(=O)c3ccc(C)cn3)cc2c1,4.54,,CHEMBL1232723
Cn1c(N)c(N2CCCCC2)c(=O)[nH]c1=O,4.54,,CHEMBL3233607
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCC[NH2+]1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)NC(C(=O)[O-])C(C)C,4.54,,
[NH3+]Cc1ccc(F)c(Oc2ccccc2)c1F,4.54,,
CC([NH3+])C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-])C(C)C)C(C)O,4.54,,
N#Cc1ccc(CSc2nc3[nH]c(=[NH2+])[nH]c(=O)c3[nH]2)cc1,4.54,,
CC(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(C(=O)[O-])C(C)C.CCC(NC(=O)C(C)NC(=O)C1CCC[NH2+]1)C(=O)NC(C)C(=O)NC(C=O)CCCNC(N)=[NH2+],4.54,,
C[NH+](C)CC(O)COc1ccc(Nc2ncc(Br)c(Nc3ccccc3)n2)cc1,4.55,,
Cn1cnc2c(=O)[nH]c(N)nc21,4.55,,
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C([NH3+])C(C)O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],4.55,,
CC(C)CC([NH2+]CC(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)CNC(=O)C1CCCN1C(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CCC(N)=O)C(=O)NC(CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(N)=O,4.55,,
CC1(C)CCC2(C(=O)[O-])CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C)C5CCC43C)C2C1,4.55,,
CC1=NC2C(OC(CO)C(O)C2O)S1,4.55,,
O=C([O-])Cc1c[nH]c2ccc(O)cc12,4.55,,
C[n+]1c(S)n(CCSc2nc3ccccc3[nH]2)c2ccccc21,4.55,,
CN1Cc2c(ccc3c2OCO3)-c2ccc3cc4c(cc3c21)OCO4,4.55,"This molecule is a benzophenanthridine alkaloid obtained by selective hydrogenation of the 13,14-position of sanguinarine. It has a role as a metabolite and an antifungal agent. It derives from a hydride of a sanguinarine. This molecule is a natural product found in Pteridophyllum racemosum, Corydalis balansae, and other organisms with data available.",CHEMBL465678
OCC1OC(NC(S)=NN=Cc2ccc(Cl)cc2)C(O)C(O)C1O,4.55,,
C[NH2+]CCCCC([NH3+])C(=O)[O-],4.55,,
CCCCC(=[NH2+])NCCCC([NH3+])C(=O)[O-],4.55,,
C[N+](C)(C)CCO,4.55,"This molecule is a choline that is the parent compound of the cholines class, consisting of ethanolamine having three methyl substituents attached to the amino function. It has a role as a neurotransmitter, a nutrient, a human metabolite, a plant metabolite, a Daphnia magna metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a mouse metabolite and an allergen. This molecule is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Amaranthus hybridus, Leonurus japonicus, and other organisms with data available.",CHEMBL920
CNc1nc2cc3[nH]c(NC)nc3cc2c(=O)[nH]1,4.55,,
CC(=O)NC1C[NH2+]C(CO)C(O)C1O,4.55,,
O=C(c1ccco1)c1c[nH]c2ccccc12,4.55,,CHEMBL2032373
CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCC[NH2+]1)C(=O)NC(C(=O)[O-])C(C)C,4.55,,
NC(=O)SCC(=O)Nc1ccccc1C(=O)[O-],4.55,,
[NH2+]=c1[nH]c(=O)c2ncc(C(=O)NCCNC(=O)[O-])nc2[nH]1,4.55,,
O=C([O-])CCC(=O)C1=CC=CC(O)C1C(=O)[O-],4.55,,
FC(F)(F)c1n[nH]cc1-c1ccccc1,4.55,,
[NH3+]CC(O)CNc1ccc([N+](=O)[O-])c2cccnc12,4.56,,
CC(=O)NCCCCC([NH3+])C(=O)NCC(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCNC(C)=O)C(=O)[O-],4.56,,
Cc1cc(CC(=O)N2CC(O)CC2C(=O)NCc2ccc(-c3ccccc3)cc2)on1,4.56,,
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C(C)NC(=O)C(C)[NH3+])C(=O)NC(C(=O)[O-])C(C)C,4.56,,
CSCCC(NC(=O)C1CCCN1C(=O)C([NH3+])C(C)O)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)O)C(C)C,4.57,,
Cc1cn(C2CC(O)C(CO)O2)c(=O)[nH]c1=O,4.57,"This molecule is a pyrimidine 2'-deoxyribonucleoside. This molecule is a natural product found in Penicillium commune, Fritillaria thunbergii, and other organisms with data available.",CHEMBL6497
CC(C)CC(NC(=O)C(O)CC(=O)[O-])C(=O)NCCCCNC(N)=[NH2+],4.57,,
NS(=O)(=O)c1ccc(-c2ccc(C=C3SC(=O)NC3=O)o2)cc1,4.57,,
O=C(NCB(O)O)c1ccccc1Cl,4.57,,CHEMBL2035289
CC(NC(=O)c1ccccc1Cc1ccccc1)B(O)O,4.57,,
CC(C)(C)NC(=O)C1CC(O)(C(=O)[O-])CC(O)C1O,4.57,,
FC(F)OC(F)C(F)(F)F,4.57,"This molecule is one of the most commonly used volatile anesthetic agents and has an excellent safety record. Rare single case reports of severe acute liver injury resembling halothane hepatitis due to desflurane have been published. This molecule is an organofluorine compound. It has a role as an inhalation anaesthetic. It is functionally related to a methoxyethane. This molecule is more rapidly cleared and less metabolized than previous inhaled anesthetics such as [methoxyflurane], [sevoflurane], [enflurane], or [isoflurane].. It was developed in the late 1980s out of a need for a more rapidly acting and rapidly cleared inhaled anesthetic.  Desflurane was granted FDA approval on 18 September 1992. This molecule is a General Anesthetic. The physiologic effect of desflurane is by means of General Anesthesia. This molecule is a fluorinated ether with general anesthetic and muscle relaxant activities. Although the exact mechanism of action has not been established, desflurane, administered by inhalation, appears to act on the lipid matrix of the neuronal membrane, resulting in disruption of neuronal transmission in the brain. This agent may also enhance the synaptic activity of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). This molecule is a highly fluorinated methyl ethyl ether used for maintenance of general anaesthesia. Volatile agents such as desflurane may activate GABA channels and hyperpolarize cell membranes. In addition, they may inhibit certain calcium channels and therefore prevent release of neurotransmitters and inhibit glutamate channels. Volatile anesthetics easily partition into cellular membranes and could expand the volume of the cell membrane and subsequently distort channels necessary for sodium ion flux and the development of action potentials necessary for synaptic transmission. This molecule preconditions human myocardium against ischemia through activation of mitochondrial K(ATP) channels, adenosine A1 receptor, and alpha and beta adrenoceptors.",CHEMBL1200733
CCC(C)C(NC(=O)C(C)NC(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(C)=O)C(=O)NC(CCCC[NH3+])C(=O)NC(CC(N)=O)C(N)=O,4.57,,
O=c1[nH]c(=O)n(C2OC(CO)C(O)C(O)(CO)C2O)cc1F,4.57,,
CN1C(=[NH2+])NC(C)(C2CC2c2ccccc2)CC1=O,4.57,,
O=C([O-])C1(O)C=C(C(O)Cc2ccccc2)C(O)C(O)C1,4.57,,
Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21,4.57,"This molecule is a 9H-purine that is substituted by a (2-hydroxyethyl)nitrilo, benzylnitrilo and a methyl group at positions 2,6 and 9, respectively. It is a cyclin-dependent kinase inhibitor. It has a role as an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor. It is a member of 2,6-diaminopurines and a member of ethanolamines.",CHEMBL280074
O=C([O-])C(O)(C(F)(F)F)C(F)(F)F,4.57,,
CC1(C)Cc2ccccc2C(NC(Cc2ccccc2)C(=O)[O-])=N1,4.57,,
OCC1OC(OC2C(CO)OCC(F)C2O)C(O)C(O)C1O,4.57,,
OCC1OC(OC2C(O)C(O)OC(CO)C2O)C(O)C(O)C1O,4.58,,
OCC1OC(NC(=S)N=NCc2ccccc2O)C(O)C(O)C1O,4.58,,
CCNc1cc2c(cc1C)C(c1ccccc1C(=O)OCC)c1cc(C)c(NCC)cc1O2,4.58,,
CC(C)CC(NC(=O)C(F)(F)F)C(=O)N[N+](C)(CC(=O)Nc1ccc(C(C)C)cc1)Cc1ccccc1,4.59,,
C=CC(C)=CC1(C)SC(=O)C(C)=C1O,4.59,,
OCC1OCC(F)C(O)C1O,4.59,,
O=C([O-])c1sccc1S(=O)(=O)Nc1ccc(Cl)cc1,4.59,,
CCC(CC)Nc1cc(C(=O)[O-])ccc1N1C(=O)CCC1(C[NH3+])CO,4.59,,
Brc1cccc(-c2cc(NCc3ccncc3)[n+]3[nH]cnc3n2)c1,4.59,,
CC(=O)NC1C([NH3+])C=C(CO)C(O)C1O,4.59,,
C[n+]1cnc(N)c2nc[nH]c21,4.59,,
CC(=O)NC1C(OC2C(O)C(OC3C(O)C(COC4OC(CO)C(O)C(O)C4O)OC(O)C3NC(C)=O)OC(CO)C2OC2OC(COC3OC(C)C(O)C(O)C3O)C(O)C(O)C2O)OC(CO)C(O)C1O,4.59,,
O=C(NCB(O)O)c1ccccc1[N+](=O)[O-],4.59,,CHEMBL2035292
O=C([O-])CCC(O)C(=O)[O-],4.59,,
CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1,4.59,,CHEMBL522387
[NH2+]=c1[nH]c(=O)c2nc(CCNc3ccc(C(=O)[O-])cc3)cnc2[nH]1,4.59,,
COc1ccc(Nc2cc(C(F)(F)F)ccc2Cl)c(C(=O)[O-])c1,4.59,,
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])Cc1ccc(O)cc1)C(=O)[O-],4.59,,
CN(C(=O)CCCn1c(N)nc2cc(Cl)ccc21)C1CCCCC1,4.59,,CHEMBL1221977
O=[N+]([O-])c1ccc(CN=NC(=S)NC2OC(CO)C(O)C(O)C2O)cc1,4.59,,
C=CC(C)=CC1(C)SC(=O)C(C(C)=O)=C1O,4.59,,
C=CC(C)=CC1(C)SC(=O)C(C(C)=O)=C1O,4.59,,
CC1=C(O)NC(=O)N(Cc2cn(C3OC(CO)C(O)C3O)nn2)C1,4.59,,
CC1=NC(c2ccc(Cl)cc2)C(c2ccc(Cl)cc2)N1,4.59,,
O=C([O-])CNC(=O)C(=O)[O-],4.59,,
CC(=O)NC(C(=O)CCC(=O)[O-])C(O)C(O)C(O)CO,4.6,,
O=[N+]([O-])c1ccc(O)c(OS(=O)(=O)[O-])c1,4.6,,
CCCC(C(=O)NCCc1ccc(O)cc1)N1C(=O)C2Cc3ccccc3CN2C(=O)C1Cc1ccc(O)cc1,4.6,,
COC1C(CO)OC(OC2C(CO)OC(OC3C(CO)NC(=NO)C(O)C3O)C(O)C2O)C(O)C1O,4.6,,
O=c1[nH]cc(F)c(=O)[nH]1,4.6,"This molecule is a white to nearly white crystalline powder; practically odorless. Used as an anti neoplastic drug, chemosterilant for insects. (EPA, 1998) This molecule is a pyrimidine analogue used as an antineoplastic agent to treat multiple solid tumors including colon, rectal, breast, gastric, pancreatic, ovarian, bladder and liver cancer. Fluorouracil is associated with a low rate of transient serum aminotransferase elevations during therapy and has been implicated in rare cases of clinically apparent acute liver injury. This molecule is a nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth. It has a role as a xenobiotic, an environmental contaminant, a radiosensitizing agent, an antineoplastic agent, an immunosuppressive agent and an antimetabolite. It is a nucleobase analogue and an organofluorine compound. It is functionally related to a uracil. This molecule is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the thymidylate synthetase conversion of deoxyuridylic acid to thymidylic acid. This molecule is a Nucleoside Metabolic Inhibitor. The mechanism of action of fluorouracil is as a Nucleic Acid Synthesis Inhibitor. This molecule is an antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity. This molecule and its metabolites possess a number of different mechanisms of action. In vivo, fluoruracil is converted to the active metabolite 5-fluoroxyuridine monophosphate (F-UMP); replacing uracil, F-UMP incorporates into RNA and inhibits RNA processing, thereby inhibiting cell growth. Another active metabolite, 5-5-fluoro-2'-deoxyuridine-5'-O-monophosphate (F-dUMP), inhibits thymidylate synthase, resulting in the depletion of thymidine triphosphate (TTP), one of the four nucleotide triphosphates used in the in vivo synthesis of DNA. Other fluorouracil metabolites incorporate into both RNA and DNA; incorporation into RNA results in major effects on both RNA processing and functions. This molecule is a natural product found in Paramyrothecium roridum, Antrodia cinnamomea, and other organisms with data available. This molecule is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the thymidylate synthetase conversion of deoxyuridylic acid to thymidylic acid.",CHEMBL185
COC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(O)C([NH3+])c1ccc(C)cc1,4.6,,
CCCNC(=O)C(O)C(O)C(=O)[O-],4.6,,
COCCNC(=[NH2+])NCCCC([NH3+])C(=O)[O-],4.6,,
CCC(C)C(NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CCC(N)=O)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)CC,4.6,,
COc1cccc(-c2cccc(CCc3cccc(=N)[nH]3)c2)c1,4.6,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],4.6,,
O=C([O-])C1(O)C=CCC(C(O)CO)O1,4.6,,
CNC(NC)=[NH+]CCCC(NC(=O)C(C)[NH3+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(N)=O)C(C)O)C(C)O,4.6,,
C=CC(C)=CC1(C)SC(=O)C(C)=C1O,4.6,,
CC(=O)c1sc(Nc2ccccc2)nc1C,4.6,,CHEMBL1235108
Nc1nc(N)nc(OCCOc2ccccc2)n1,4.6,,
CC(=O)NC1C(OC2C(CO)OC3SC(C)=NC3C2O)OC(CO)C(O)C1O,4.6,,
Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O,4.6,"This molecule is an oxopurine that is theophylline bearing a 2,3-dihydroxypropyl group at the 7 position. It has broncho- and vasodilator properties, and is used in the treatment of asthma, cardiac dyspnea, and bronchitis. It is also an ingredient in preparations that have been promoted for coughs. It has a role as a bronchodilator agent, a vasodilator agent, an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor and a muscle relaxant. It is an oxopurine and a member of propane-1,2-diols. This molecule is a theophylline derivative with broncho- and vasodilator properties. It is typically used in the management of asthma, cardiac dyspnea, and bronchitis. This molecule is a xanthine derivative. Dyphilline exerts bronchodilator effects and to a lesser extent vasodilator and diuretic properties. Dyphilline probably acts as a competitive inhibitor of phosphodiesterase which leads to an increase in intracellular cAMP. This results in relaxation of bronchial smooth muscle and other smooth muscles. This molecule may also antagonize adenosine receptors. This molecule is used in the treatment of acute bronchial asthma, chronic bronchitis and emphysema. This molecule is a natural product found in Haplophyllum patavinum and Haplophyllum tuberculatum with data available.",CHEMBL1752
Cc1cn(C2CC(O)C(CNC(=S)Nc3ccc(Cl)c(C(F)(F)F)c3)O2)c(=O)[nH]c1=O,4.6,,
Cc1ccc(C(=O)NCCC2CCCC2)cc1C(=O)Nc1ccc(N)nc1,4.6,,CHEMBL487431
CCC(C)C(NC(=O)C(CC(N)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CC(N)=O)C(=O)[O-],4.6,,
O=C(NCc1cccc(-c2ccccc2)c1)c1cc(-c2cc(C(=O)NC(C(=O)[O-])C3CCCCC3)nc(C(=O)N3CCCC3Cn3cccc3)c2)cc(C(=O)N2CCCC2C[NH+]2CCCC2)n1,4.6,,
Cc1oc(-c2ccccc2)nc1COc1cccc(CO)c1,4.6,,CHEMBL2069625
O=C(CO)C(O)C(O)CF,4.6,,
[NH3+]CC1OC(OC2C([NH3+])CC([NH3+])C(OC3OC(CO)C(O)C([NH3+])C3O)C2O)C(O)C(O)C1O,4.6,,
O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,4.6,"This molecule appears as yellow needles or yellow powder. Converts to anhydrous form at 203-207 °F. Alcoholic solutions taste very bitter. (NTP, 1992) This molecule is a pentahydroxyflavone having the five hydroxy groups placed at the 3-, 3'-, 4'-, 5- and 7-positions. It is one of the most abundant flavonoids in edible vegetables, fruit and wine. It has a role as an antibacterial agent, an antioxidant, a protein kinase inhibitor, an antineoplastic agent, an EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor, a plant metabolite, a phytoestrogen, a radical scavenger, a chelator, an Aurora kinase inhibitor and a geroprotector. It is a pentahydroxyflavone and a 7-hydroxyflavonol. It is a conjugate acid of a quercetin-7-olate. This molecule is a flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin. This molecule is a flavonoid found in many foods and herbs and is a regular component of a normal diet. Extracts of quercetin have been used to treat or prevent diverse conditions including cardiovascular disease, hypercholesterolemia, rheumatic diseases, infections and cancer but have not been shown to be effective in clinical trials for any medical condition. This molecule as a nutritional supplement is well tolerated and has not been linked to serum enzyme elevations or to episodes of clinically apparent liver injury. This molecule is a polyphenolic flavonoid with potential chemopreventive activity. This molecule, ubiquitous in plant food sources and a major bioflavonoid in the human diet, may produce antiproliferative effects resulting from the modulation of either EGFR or estrogen-receptor mediated signal transduction pathways. Although the mechanism of action of action is not fully known, the following effects have been described with this agent in vitro: decreased expression of mutant p53 protein and p21-ras oncogene, induction of cell cycle arrest at the G1 phase and inhibition of heat shock protein synthesis. This compound also demonstrates synergy and reversal of the multidrug resistance phenotype, when combined with chemotherapeutic drugs, in vitro. This molecule also produces anti-inflammatory and anti-allergy effects mediated through the inhibition of the lipoxygenase and cyclooxygenase pathways, thereby preventing the production of pro-inflammatory mediators. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Salvia miltiorrhiza, Hydrangea serrata, and other organisms with data available. This molecule is a flavonoid widely distributed in many plants and fruits including red grapes, citrus fruit, tomato, broccoli and other leafy green vegetables, and a number of berries, including raspberries and cranberries. This molecule itself (aglycone quercetin), as opposed to quercetin glycosides, is not a normal dietary component. Quercitin glycosides are converted to phenolic acids as they pass through the gastrointestinal tract. This molecule has neither been confirmed scientifically as a specific therapeutic for any condition nor been approved by any regulatory agency. The U.S. Food and Drug Administration has not approved any health claims for quercetin. Nevertheless, the interest in dietary flavonoids has grown after the publication of several epidemiological studies showing an inverse correlation between dietary consumption of flavonols and flavones and reduced incidence and mortality from cardiovascular disease and cancer. In recent years, a large amount of experimental and some clinical data have accumulated regarding the effects of flavonoids on the endothelium under physiological and pathological conditions. The meta-analysis of seven prospective cohort studies concluded that the individuals in the top third of dietary flavonol intake are associated with a reduced risk of mortality from coronary heart disease as compared with those in the bottom third, after adjustment for known risk factors and other dietary components. A limited number of intervention studies with flavonoids and flavonoid containing foods and extracts has been performed in several pathological conditions. (A7896)",CHEMBL50
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,4.6,,
Cc1nn(C)cc1-c1ccn[nH]1,4.6,,
CC(NC(=O)C(CC(=O)[O-])NC(=O)CNC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])Cc1c[nH]cn1)C(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],4.6,,
CC(NC(=O)C(CC(=O)[O-])NC(=O)CNC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])Cc1cnc[nH]1)C(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],4.6,,
CCCC(=O)NCCCCC(NC(=O)C1(C(C)O)[NH2+]C(O)(C([NH3+])CCCNC(N)=[NH2+])O1)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)O,4.6,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],4.61,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(C)[NH3+])C(=O)[O-],4.61,,
COC1CCCC(C)C(=O)NC2=CC(=O)C(OC)C(CC(C)CC(OC)C(O)C(C)C=C(C)C1OC(N)=O)C2=O,4.61,,
Nc1ncnc2c1ncn2C1OCC(O)C1O,4.61,,CHEMBL2361213
[NH3+]C(CO)C(=O)[O-],4.61,,
CC(=O)NC1C(O)OC(CO)C(O)C1O,4.61,"This molecule is a N-acyl-hexosamine. This molecule is under investigation for the other of GNE Myopathy. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655).",CHEMBL83479
O=C([O-])c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,4.62,,
O=C([O-])CCC(NC(=O)c1ccc(S(=O)(=O)N2CCCC2C(=O)[O-])cc1)C(=O)[O-],4.62,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C([NH3+])CO)C(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CS)C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(CCC(=O)[O-])C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)O)C(C)O,4.62,,
CC1OC(O)C(O)C(O)C1O,4.62,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL273741
CC([NH3+])C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NC(C)C(=O)N1CCCC1C=O)C(C)O,4.62,,
O=C([O-])C(=O)[O-],4.62,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(NC(=O)C(NC(=O)C(C)NC(=O)C(C)NC(=O)C1CCCN1C(=O)C([NH3+])CCCC[NH3+])C(C)C)C(C)C)C(=O)O,4.62,,
Nc1ncnc2c1[nH]c(=O)n2C1CC(O)C(CO)O1,4.62,,
CNC(=O)C1Cc2ccc(NS(=O)(=O)[O-])cc2CN1C(=O)OC(C)(C)C,4.62,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(N)=O)NC(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C[NH3+])C(C)C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],4.62,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(=O)[O-])NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C1CCCN1C(=O)C(NC(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(C)C)C(=O)NC(C=O)CCCNC(N)=[NH2+],4.62,,
CC(=O)NC1C(=NO)OC(CO)C(O)C1O,4.62,,
O=C([O-])CCC(O)C(=O)[O-],4.62,,
O=C([O-])CCC(O)C(=O)[O-],4.62,,
Cc1ccc(Nc2cc(-c3ccccc3)ncn2)cc1NS(C)(=O)=O,4.62,,CHEMBL469117
OCC1OC(OC2C(CO)OC(OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(O)C(O)C5O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1O,4.62,,
CC(C)c1cccc(C(C)C)c1O,4.62,"This molecule is the mostly commonly used parenteral anesthetic agent in the United States, extensively used for minor and outpatient surgical procedures because of its rapid onset and reversal of action, and in intensive care units (ICUs) for maintenance of coma. This molecule has been associated with rare instances of idiosyncratic acute liver injury; in addition, prolonged high dose propofol therapy can cause the “This molecule infusion syndrome” which is marked by bradyarrhythmias, metabolic acidosis, rhabdomyolysis, hyperlipidemia and an enlarged or fatty liver. This molecule is a phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group. It has a role as an intravenous anaesthetic, a sedative, a radical scavenger, an antiemetic and an anticonvulsant. This molecule is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. This molecule may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries. This molecule is a General Anesthetic. The physiologic effect of propofol is by means of General Anesthesia. This molecule is a hypnotic alkylphenol derivative. Formulated for intravenous induction of sedation and hypnosis during anesthesia, propofol facilitates inhibitory neurotransmission mediated by gamma-aminobutyric acid (GABA). This agent is associated with minimal respiratory depression and has a short half-life with a duration of action of 2 to 10 minutes. This molecule is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. This molecule may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.",CHEMBL526
[NH3+]C(Cc1ccccc1)C(=O)[O-],4.62,,
[NH3+]C(Cc1ccccc1)C(=O)[O-],4.62,,
CCCCCCCCCCCCOS(=O)(=O)[O-],4.62,,
CCCC(=O)[O-],4.62,,
[NH3+]Cc1csc2ccc(Br)cc12,4.62,,
OCC1[NH2+]CC(O)C(OC2OC(CO)C(O)C(O)C2O)C1O,4.62,,
CCC(C)C(NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(=O)NC(CC(C)C)C(=O)[O-],4.62,,
Cc1cn(C2CCC[NH+](Cc3cccc(Oc4cccc(C(F)(F)F)c4)c3)C2)c(=O)[nH]c1=O,4.62,,
CC(C)CC(NC(=O)C1CSSCCCN2CCCSSCC(NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(NC(=O)C[NH3+])CC2=O)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(Cc2c[nH]cn2)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1)C(N)=O,4.62,,
N=Cc1ncc(C(=O)NCc2ccccc2)cn1,4.62,,
CCC(C)C(NC(=O)C([NH3+])CS)C(=O)NC(C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCSC)C(=O)N1CCCC1C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)[O-])C(C)O)C(C)CC,4.63,,
OCC1OC(NC(=S)N=NCc2cccc(Cl)c2)C(O)C(O)C1O,4.63,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O,4.63,,
Cc1c(O)cccc1-c1nc2nc(N)nc(OCC3CCCCC3)c2[nH]1,4.63,,
CCCC(=O)NC1C[NH2+]C(CO)C(O)C1O,4.63,,
CC(C)CC(NC(=O)C1CSSCC2CC(NC(=O)C[NH3+])C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(CSS2)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(Cc2c[nH]cn2)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1)C(N)=O,4.63,,
O=C([O-])C(=O)Nc1ccccc1C(=O)[O-],4.64,,
O=C([O-])CNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12,4.64,,
Oc1ccc(C2Nc3cccc4cccc(c34)N2)cc1O,4.64,,CHEMBL1822156
CN(CCC([NH3+])CC(=O)NC1C=CC(n2ccc(=O)[nH]c2=O)OC1C(=O)[O-])C(N)=[NH2+],4.64,,
CN(C(=O)C(Cc1c[nH]cn1)NC(=O)OCc1ccccc1)C(Cc1ccccc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],4.64,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(C)[NH3+])C(C)O)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)[O-],4.64,,
CCOc1ccc(Nc2c(C)c(NC3CCC[NH2+]C3)nc3ccnn23)cc1,4.64,,
CN1Cc2cc(Br)ccc2NC1=O,4.64,,CHEMBL2179381
[NH3+]C(CCC(=O)NC(CS)C(=O)NCC(=O)[O-])C(=O)[O-],4.64,,
C=C1CC23CC1(O)CCC2C12C=CC(O)C(C)(C(=O)O1)C2C3C(=O)[O-],4.64,,
CNC(=O)C(NC(=O)C(CC(C)C)C(CNC(=O)c1nccs1)C(=O)NO)C(C)(C)C,4.65,,
O=C([O-])C1OC(O)C(O)C(O)C1O,4.65,,
C[n+]1ccc(CNC(=O)C2CCCN2C(=O)C([NH3+])Cc2ccccc2)cc1,4.65,,
CSc1ccc2c(c1)N(CCC1CCCC[NH+]1C)c1ccccc1S2,4.65,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C([NH3+])CCCC[NH3+])C(C)O)C(=O)[O-],4.65,,
CNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(=O)NO)CC(C)C,4.65,,
Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,4.65,"This molecule is a natural product found in Maclura pomifera, Caragana sinica, and other organisms with data available.",CHEMBL2019155
CC(C)(C)CC(=O)N1CC(O)CC1C(=O)NCc1ccc(-c2cnco2)cc1,4.65,,
C[NH+](C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1,4.66,,
NC(=[NH2+])c1ccccc1,4.66,,
O=C([O-])C(=O)CS(=O)(=O)[O-],4.66,,
CCc1oc2cc(S(=O)(=O)Nc3ccc(S(N)(=O)=O)cc3)ccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,4.66,,
CCC(C)C(NC(=O)C(CCC(N)=O)NC(=O)C1CCC[NH+]1CC(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C([NH3+])C(C)C)C(=O)NC(C(=O)NC(C)C(=O)NC(C)C(N)=O)C(C)O,4.66,,
[NH3+]C(CCC(=O)NC(CS)C(=O)NCC(=O)[O-])C(=O)[O-],4.66,,
C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,4.66,"This molecule is a quaternary ammonium ion that is the bis-choline ester of succinic acid. It has a role as a neuromuscular agent, a muscle relaxant and a drug allergen. It is a quaternary ammonium ion and a succinate ester. This molecule is a depolarizing skeletal muscle relaxant consisting of two molecules of the endogenous neurotransmitter [acetylcholine] (ACh) linked by their acetyl groups. It has been widely used for over 50 years, most commonly in its chloride salt form, as a means of neuromuscular blockade during intubation and surgical procedures. Its rapid onset and offset, with effects beginning within 60 seconds of intravenous administration and lasting between four to six minutes, make succinylcholine particularly useful in the setting of short medical procedures requiring brief periods of muscle relaxation. This molecule is a Depolarizing Neuromuscular Blocker. The physiologic effect of succinylcholine is by means of Neuromuscular Depolarizing Blockade. This molecule is a quaternary ammonium compound and depolarizing agent with short-term muscle relaxant properties. This molecule binds to nicotinic receptors at the neuromuscular junction and opening the ligand-gated channels in the same way as acetylcholine, resulting in depolarization and inhibition of neuromuscular transmission. Depolarization may be prolonged due to succinylcholine's resistance to acetylcholinesterases thereby leading to disorganized muscle contraction followed by skeletal muscle relaxation and flaccid paralysis.",CHEMBL703
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)NC(C(=O)[O-])C(C)O)C(C)O)C(C)O,4.66,,
Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)[O-])c5cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c45)ccc3C)c2)c1,4.66,,
O=C([O-])C1C(c2ccccc2)Sc2c(C3CC3)c(Cc3cccc4ccccc34)cc(=O)n21,4.66,,
O=C1NC(C[NH2+]C(CO)c2ccccc2)C(O)C1O,4.66,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C1C=CCN1C(=O)C(Cc1ccccc1)NC(=O)C([NH3+])Cc1ccc(O)cc1)C(C)O)C(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)[O-],4.66,,
CNC(=O)C([NH3+])Cc1ccc(OCc2ccccc2)cc1,4.66,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(NC(=O)C(CCCC[NH3+])NC(=O)C(C)NC(=O)C(CC(N)=O)NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C([NH3+])CC(C)C)C(C)C)C(=O)[O-],4.66,,
CCNC(=O)c1cccnc1N1CC[NH+](C)CC1,4.66,,
CCCCCCCCC(=O)[O-],4.66,,
CC[NH+](CC)CCNS(=O)(=O)c1cccc(C(F)(F)F)c1,4.66,,
[NH3+]C(Cc1ccc(O)cc1)C(=O)[O-],4.66,,
CC(NC(=O)C(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(CCCC[NH+](C)C)C(=O)NC(C(=O)[O-])C(C)C,4.66,,
CC(=O)NCCCCC(NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C([NH3+])CO)C(=O)NCC(=O)[O-],4.66,,
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(=O)[O-])NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(C)[NH3+])C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)[O-],4.67,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,4.67,,
Nc1ncc(C(=O)c2cccc(Br)c2)o1,4.67,,CHEMBL1234904
O=C(OC1Cc2c(O)cc(O)cc2OC1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,4.67,"This molecule is a catechin. This molecule is a natural product found in Camellia sinensis, Cistus salviifolius, and other organisms with data available.",CHEMBL311663
COC1OC(C(=O)[O-])C(OC2OC(COS(=O)(=O)[O-])C(O)C(O)C2NS(=O)(=O)[O-])C(O)C1OS(=O)(=O)[O-],4.67,,
CC1=CC([NH3+])c2ccccc2N1CCCCCCCCCCN1c2ccccc2C(N)=CC1C,4.67,,
CN(C)c1ccc(C(c2ccc(N(C)C)cc2)c2ccc(N(C)C)cc2)cc1,4.67,This molecule is a benzenoid aromatic compound.,CHEMBL81595
O=C([O-])C(O)=CC(=O)c1ccccc1,4.67,,
CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21,4.67,This molecule is a pyrazolopyrimidine. It has a role as a tyrosine kinase inhibitor.,CHEMBL264406
NC(=[NH2+])c1ccccc1,4.68,,
Cc1onc(-c2ccccc2Cl)c1C(=O)NCB(O)O,4.68,,CHEMBL324688
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=O)NC(=O)C([NH3+])CCCNC(N)=O)C(=O)NC(Cc1ccc(F)cc1)C(=O)[O-],4.68,,
CN(CCC([NH3+])CC(=O)NC1C=CC(N2C=CC([NH3+])(O)NC2=O)OC1C(=O)[O-])C(N)=[NH2+],4.68,,
O=C1CC(C(=O)[O-])NC(=O)N1,4.68,,
CC(=O)Nc1nnc(S(N)(=O)=O)s1,4.68,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
[NH3+]C(Cc1ccccc1)C(=O)[O-],4.68,,
O=C(Nc1cccc(-c2nn[nH]n2)c1)c1cccc(F)c1,4.68,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(C=O)CCCNC(N)=[NH2+])C(C)O)C(C)O,4.68,,
[NH3+]C(Cc1c[nH]c2ccccc12)C(=O)[O-],4.68,,
O=C([O-])C(=Cc1ccccc1)Oc1cccc(C(=O)[O-])c1O,4.68,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)[O-])C(C)O,4.68,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O,4.68,,
CC([NH3+])Cc1ccccc1,4.68,,
CC[NH+](CC)C1CC[NH+](Cc2cc(C#CCOc3ccccc3)cc(I)c2O)CC1,4.69,,
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(=O)NC(CC(=O)[O-])C(=O)[O-],4.69,,
Oc1ccc(C(c2ccc(O)cc2)C(Cl)(Cl)Cl)cc1,4.69,"This molecule is a bisphenol. It is functionally related to a 1,1,1-trichloro-2,2-diphenylethane. This molecule is a biologically active liver metabolite of methoxychlor. Methoxychlor is a commonly used pesticide.",CHEMBL196585
O=C([O-])C(Cc1ccccc1[N+](=O)[O-])=NNc1nc(-c2ccc(Cl)c(Cl)c2)cs1,4.69,,
O=CN1CCN(c2ccc(C=C3C(=O)Nc4ccccc43)cc2)CC1,4.7,,
NC(=[NH2+])c1cc2c(I)cccc2s1,4.7,,
O=C([O-])C(=O)Nc1sc2c(c1C(=O)[O-])CCOC2,4.7,,
OCC1[NH2+]CC(O)C(O)C1O,4.7,,
CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,4.7,This molecule is a corticosteroid hormone.,CHEMBL125608
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C[NH3+])C(=O)NC(CO)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C)C(=O)[O-],4.7,,
[NH2+]=c1[nH]c(=O)c2[nH]nnc2[nH]1,4.7,,
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CC[NH+](C)CC4)ccc3OCC)nc12,4.7,,
O=c1c2ccccc2oc2ccc(S(=O)(=O)Nc3nnn[nH]3)cc12,4.7,,
CC(=O)NC1C(O)C=C(C(=O)[O-])OC1C(O)C(O)CO,4.7,,
O=C([O-])C(O)C(O)C(=O)[O-],4.7,,
CC(CS)C(=O)N1CCCC1C(=O)[O-],4.7,,
Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)[O-])c5cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c45)ccc3C)c2)c1,4.7,,
Nc1ncnc2c1ncn2C1OC(CSSCC2OC(n3cnc4c(N)ncnc43)C(O)C2O)C(O)C1O,4.7,,
NC(=[NH2+])c1ccccc1,4.7,,
CC(C)CC1(C(=O)[O-])CC(C(=O)[O-])C(c2cccs2)N1C(=O)c1ccc(C(F)(F)F)cc1,4.7,,
CC(CCC(=O)[O-])C1CCC2C3CCC4CC(NC(=O)CCC(C(=O)[O-])[NH+](CC[NH+](CC(=O)[O-])CC(=O)[O-])CC[NH+](CC(=O)[O-])CC(=O)[O-])CCC4(C)C3CCC12C,4.7,,
CC(C)CC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(C)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH+](C)C)C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(CO)C(=O)NC(C(=O)[O-])C(C)O,4.7,,
Cc1cc(C(F)(F)F)nc(N)n1,4.7,,CHEMBL504181
Cc1cnc2c(NCc3ccncc3)nccn12,4.7,,
Cc1nc(-c2cccc(Cl)c2)[nH]c1C(=O)[O-],4.7,,
CC(NC(=O)c1c(F)cccc1-c1ccccc1)B(O)O,4.7,,
O=C(OC1CC2CCC(C1)[NH2+]2)c1ccccc1,4.7,,
Cn1cnc2c1c(=O)n(CCCn1c(=O)c3c(ncn3C)n(C)c1=O)c(=O)n2C,4.7,,CHEMBL1738791
COc1cc(NC(=[NH2+])NC(N)=[NH2+])cc(OC)c1,4.7,,
CC(C(=O)[O-])C1=NN(C)C2=NC(=[NH2+])NC(=O)C2C1=O,4.7,,
CC(C)CC(NC(=O)C(NC(=O)C(CCCC[N+](C)(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)C)C(=O)NC(C=O)CCCNC(N)=[NH2+],4.7,,
[NH3+]CCCCCC(=O)[O-],4.7,,
Nc1nc2ccc(O)cc2[nH]1,4.7,,
CC(=O)NC1C(Oc2ccc([N+](=O)[O-])cc2)OC(CO)C(O)C1O,4.7,,
Cc1ccc(C(N)=[NH2+])cc1F,4.7,,
C[S+](CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,4.7,,
CCC(C)C(NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)[O-])C(C)CC,4.7,,
CC(=O)NC1C[NH+]2CCC(O)C2C(O)C1O,4.7,,
CC(C)CC(NC(=O)C([NH3+])Cc1c[nH]cn1)C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NCC(=O)NC(CCC(N)=O)C(=O)[O-],4.7,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(C)[NH3+])C(C)C)C(=O)[O-],4.7,,
CCOc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1,4.7,,CHEMBL1785021
Cc1cn(C2CC(O)C(CF)O2)c(=O)[nH]c1=O,4.7,,
Nc1nc2cnc(-c3ccccc3)cn2n1,4.7,,
[NH2+]=c1[nH]c(=O)c2ncc(C(=O)NCC(=O)NC(Cc3ccccc3)C(=O)[O-])nc2[nH]1,4.7,,
CCOc1cc(C(C)(C)C)ccc1C1=NC(C)(c2ccc(Cl)cc2)C(C)(c2ccc(Cl)cc2)N1,4.7,,
O=C1NC(c2cccnc2)c2c1n[nH]c2-c1ccccc1,4.7,,
Cc1cccc(-n2nc(C(=O)[O-])cc2-c2ccc(OCc3ccc(-c4ccc(C(=O)[O-])o4)cc3)cc2)c1,4.7,,
COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,4.7,"This molecule is an alkaloid that is a carbotricyclic compound comprising 5,6,7,9-tetrahydrobenzo[a]heptalene having four methoxy substituents at the 1-, 2-, 3- and 10-positions as well as an oxo group at the 9-position and an acetamido group at the 7-position. It has been isolated from the plants belonging to genus Colchicum. It has a role as a microtubule-destabilising agent and a plant metabolite. It is a carbotricyclic compound, an alkaloid, an aromatic ether and a member of acetamides. This molecule is a natural product found in Colchicum crocifolium, Colchicum doerfleri, and other organisms with data available. This molecule is only found in individuals that have used or taken this drug. It is a major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (periodic disease). The precise mechanism of action has not been completely established. In patients with gout, colchicine apparently interrupts the cycle of monosodium urate crystal deposition in joint tissues and the resultant inflammatory response that initiates and sustains an acute attack. This molecule decreases leukocyte chemotaxis and phagocytosis and inhibits the formation and release of a chemotactic glycoprotein that is produced during phagocytosis of urate crystals. This molecule also inhibits urate crystal deposition, which is enhanced by a low pH in the tissues, probably by inhibiting oxidation of glucose and subsequent lactic acid production in leukocytes. This molecule has no analgesic or antihyperuricemic activity. This molecule inhibits microtubule assembly in various cells, including leukocytes, probably by binding to and interfering with polymerization of the microtubule subunit tubulin. Although some studies have found that this action probably does not contribute significantly to colchicine's antigout action, a recent in vitro study has shown that it may be at least partially involved.",CHEMBL87
Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CC[NH2+]CC3)n2)c1C,4.7,,
Cc1cc(-c2cc(C(N)=O)n[nH]2)c(C)s1,4.7,,CHEMBL3337972
CC(=O)NC(Cc1ccccc1)C(O)C(F)(F)F,4.7,,
COC(=O)C(Cc1cccc(C(N)=[NH2+])c1)NC(=O)CNS(=O)(=O)c1ccc(C)cc1,4.71,,
CC(CCCC[NH+](C)C)NC(=O)C([NH3+])CCCNC(N)=[NH2+],4.71,,
OCC1OC2(CC(c3ccccc3)=NO2)C(O)C(O)C1O,4.71,,
[NH3+]C(C(=O)[O-])C1CC=NO1,4.71,,
C[NH2+]C1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21,4.71,,
N=C1N=C(NCCCOc2ccc(C(=O)[O-])cc2)C(N=O)C(=O)N1,4.71,,
CCC(C)C(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)[O-],4.71,,
[NH3+]C(Cc1c[nH]c2ccccc12)C(=O)[O-],4.71,,
Cc1cc(N)nc(C=Cc2cncc(C(C[NH3+])Cc3cc(C)cc(N)n3)c2)c1,4.71,,
Cn1cc(OC2OC(CO)C(O)C(O)C2O)c2ccccc21,4.71,,
CC(C)Cc1ccccc1,4.72,"This molecule is a clear colorless liquids with an aromatic odor. Less dense than water and insoluble in water. Vapors heavier than air. This molecule is an alkylbenzene that is benzene carrying an isobutyl substituent. This molecule is a natural product found in Vaccinium virgatum, Vaccinium ashei, and other organisms with data available.",CHEMBL195882
CSCCC([NH3+])C(O)(O)c1nccs1,4.72,,
CC(=O)NC(CCCNC(N)=[NH2+])C(=O)NC1CCCCNC(=O)CNC(=O)C(Cc2ccccc2)NC(=O)C(CC(C)C)NC1=O,4.72,,
O=c1[nH]cnc2c(C3[NH2+]C(CO)C(O)C3O)c[nH]c12,4.72,,
O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12,4.72,"These molecules is a dihydroxyflavone in which the two hydroxy groups are located at positions 5 and 7. It has a role as an anti-inflammatory agent, an antineoplastic agent, an antioxidant, a hepatoprotective agent, an EC 2.7.11.18 (myosin-light-chain kinase) inhibitor and a plant metabolite. It is a dihydroxyflavone and a 7-hydroxyflavonol. This molecule is a natural product found in Apis, Populus yunnanensis, and other organisms with data available. This molecule is found in carrot. Chrysin is a naturally occurring flavone chemically extracted from the blue passion flower (Passiflora caerulea). Honeycomb also contains small amounts. It is also reported in Oroxylum indicum or Indian trumpetflower. (Wikipedia).",CHEMBL117
CCC(C)C([NH3+])C(=O)[O-],4.72,,
CCC(C)C([NH3+])C(=O)[O-],4.72,,
CC(C)CC(NC(=O)C(NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)C)C(=O)NC(C=O)CCCNC(N)=[NH2+],4.72,,
CNC(NC)=[NH+]CCCC(NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C[NH3+])C(=O)NCC(=O)NC(CCC(N)=O)C(=O)[O-],4.72,,
COc1cccc2c1cc(C(=O)[O-])c1c(C(=O)[O-])cc3c(c12)OCO3,4.72,,
O=C1NC(=O)C(Cc2c[nH]c3ccccc23)N1,4.72,,CHEMBL198830
O=C([O-])c1ccc(CCCNS(=O)(=O)c2ccsc2C(=O)[O-])cc1,4.72,,
Cc1ccccc1C(=O)CSc1nc2nc(N)[nH]c(=O)c2[nH]1,4.72,,CHEMBL3233209
Oc1c(Br)cccc1-c1[nH]c(Br)c(Br)c1Br,4.72,,
CCc1cnn2c(NCC3=CC=CN(O)C3)cc(N3CCCCC3CCO)nc12,4.72,,
O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1,4.72,,CHEMBL160333
Nc1nonc1C(=O)c1ccccc1,4.72,,
C=CCn1c(=O)c2[nH]c(Cc3ccc(NC(C)=O)cc3)nc2n(CCCC)c1=O,4.73,,CHEMBL120293
COC(=O)C(Cc1cccc(C(N)=[NH2+])c1)NC(=O)CNS(=O)(=O)c1ccc(C)cc1,4.73,,
COC(=O)C(Cc1cccc(C(N)=[NH2+])c1)NC(=O)CNS(=O)(=O)c1ccc(C)cc1,4.73,,
CCc1nnc(N)s1,4.73,"This molecule is a member of the class of thiadiazoles that is 1,3,4-thiadiazole substituted by an amino group at position 2 and an ethyl group at position 5 respectively. It is an aromatic amine and a member of thiadiazoles. It derives from a hydride of a 1,3,4-thiadiazole.",CHEMBL568688
CC(=O)N1CCCC1C(=O)[O-],4.73,,
CC(=O)Nc1cccc(-c2nc(=O)c(O)c(C(=O)[O-])[nH]2)c1,4.73,,
CCC(C)C(NC(=O)C(NC(=O)C(NC(=O)C(C)NC(=O)C(NC(=O)C(CO)NC(=O)C(C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CO)C(C)O)C(C)C)C(C)C)C(=O)NC(C)C(=O)[O-],4.74,,
NC(=[NH2+])c1ccccc1,4.74,,
NC(=[NH2+])c1ccccc1,4.74,,
Nc1ncnc2c1ncn2C1OC(CC([NH3+])CCC([NH3+])C(=O)[O-])C(O)C1O,4.74,,
O=C1CC(c2ccc(O)cc2)Oc2cc(O)cc(O)c21,4.74,"This molecule is a trihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 6 and 4'. It is a trihydroxyflavanone and a member of 4'-hydroxyflavanones. This molecule is a natural product found in Trichoderma virens, Cadophora gregata, and other organisms with data available.",CHEMBL32571
COCCCN(C(=O)c1ccc(Cl)cc1)C1CCC[NH+](CCc2ccccc2)C1,4.74,,
CC(=O)NC1C(O)CC(OC2C(O)C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C2O)(C(=O)[O-])OC1C(O)C(O)CO,4.74,,
O=C(NO)c1cccc(O)c1,4.74,,CHEMBL232053
OC1C[N+]2CCCC(O)C2C1O,4.74,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(NC(=O)c3ccccc3)C2O)C1O,4.74,,
Nc1ccc(CN2C(=O)c3cccc4cc(S(=O)(=O)[O-])cc(c34)C2=O)cc1,4.74,,
Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CC[NH2+]CC2)n1,4.74,,
CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(N)c2)n1,4.74,,CHEMBL87580
OCC1[NH2+]CC(O)C(O)C1O,4.74,,
COc1ccc(CSc2cc(N)nc(N)n2)cc1,4.74,,CHEMBL577502
CC(=NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)C(O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(C)=NC(=O)OCc1ccccc1)C(C)C)C(C)C,4.74,,
C[S+](CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,4.74,,
CC(C)CC(NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],4.74,,
O=C([O-])c1ccccc1Cc1ccccc1,4.74,,
CC(C)CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C([NH3+])CO)C(=O)NC(C(=O)NC(C(=O)NC(CO)C(=O)NC(C(=O)[O-])C(C)C)C(C)O)C(C)C,4.74,,
COC1OC(C(=O)[O-])C(OC2OC(CO)C(O)C(O)C2NS(=O)(=O)[O-])C(O)C1OS(=O)(=O)[O-],4.74,,
CC(NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCC[NH2+]1)C(=O)NC(C(=O)[O-])C(C)C,4.74,,
Cc1ccccc1-c1nc2c(OCC3CCCCC3)nc(N)nc2[nH]1,4.74,,CHEMBL3110221
CC(C)C1NC(=O)N(Cc2ccc(C(C)(C)C)cc2)C1=O,4.74,,CHEMBL2324309
COc1cc2c(c(OC)c1)C1C3CCCC(C(=O)N1CC2)N3C(=O)C(=O)c1cc(OC)c(OC)c(OC)c1,4.74,,CHEMBL202012
O=C([O-])c1ccc(CNS(=O)(=O)c2ccsc2C(=O)[O-])cc1,4.74,,
COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1,4.74,,
[NH2+]=c1[nH]c(=S)c2[nH]cnc2[nH]1,4.74,,
C[NH+]1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1,4.74,,
O=C(CO)NC1OC(CO)C(O)C(O)C1O,4.75,,
CC(NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)[O-],4.75,,
COC1=CC=C2Cc3c4cc5c(cc4cc[n+]3CC2C1OC)OCO5,4.75,,
CCC(C)C(NC(=O)CNC(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(C)NC(=O)C([NH3+])Cc1ccc(O)cc1)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)[O-])C(C)O,4.75,,
CC(C)CC([NH3+])C(=O)NC(CS)C(=O)NC(CO)C(=O)NC(CC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(CS)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CS)C(=O)NC(CCCC[NH3+])C(N)=O,4.75,,
CC([NH3+])C1CCC(C(=O)Nc2ccncc2)CC1,4.76,,
CCCn1nc(-c2nonc2N)nc1-c1nonc1N,4.76,,
OC1(c2ccc(-c3ccccc3)cc2)C[NH+]2CCC1CC2,4.76,,
NC(=[NH2+])c1ccccc1,4.76,,
CCCCC(C[NH2+]C(CCCC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)CC,4.76,,
O=C([O-])c1ccc([N+](=O)[O-])c2c1NC(C(=O)[O-])C1CCCC21,4.76,,
NC(=[NH2+])c1ccccc1,4.76,,
CC(O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCC(N)=O)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(N)=O,4.76,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,4.76,,
COC1OC(C(=O)[O-])C(OC2OC(COS(=O)(=O)[O-])C(O)C(O)C2NS(=O)(=O)[O-])C(O)C1OS(=O)(=O)[O-],4.76,,
O=C(Nc1n[n+]2c(-c3ccc(C[NH+]4CCS(=O)(=O)CC4)cc3)cccc2[nH]1)C1CC1,4.76,,
CC(C)CC(NC(=O)C(NC(=O)CNC(=O)c1ccccc1)C(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(C(=O)[O-])C(C)C,4.76,,
CC12C=CC(=O)C=C1CCC1C2CCC2(C)C(=O)CCC12,4.77,,
Cc1cc2nc3c(=O)[nH]c(=O)[nH]c3[n+](CC(O)C(O)C(O)CO)c2cc1C,4.77,,
Nc1nccc(-c2cc(Cl)sc2Cl)n1,4.77,,
Cc1c(Sc2ccccc2)n(COCCO)c(=O)[nH]c1=O,4.77,"This molecule is a pyrimidone that is thymine which is substituted at positions 1 and 6 by a (2-hydroxyethoxy)methyl group and a phenylsulfanyl group, respectively. It has a role as a HIV-1 reverse transcriptase inhibitor and an antiviral drug. It is a pyrimidone, an aryl sulfide and a primary alcohol. It is functionally related to a thymine.",CHEMBL31871
CC(=O)NC(CS)C(=O)NC(Cc1cnc[nH]1)C(=O)N1CCCC1C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(C(N)=O)C(C)O,4.77,,
CCCCn1c(Cc2ccc3c(c2)OCO3)nc2c(N)nc(F)nc21,4.77,,CHEMBL109822
CC(=O)NCCc1c[nH]cn1,4.77,"This molecule is a member of the class of acetamides that is acetamide comprising histamine having an acetyl group attached to the side-chain amino function. It has a role as a human metabolite. It is a member of acetamides and a member of imidazoles. It is functionally related to a histamine. This molecule is a natural product found in Drosophila melanogaster, Euglena gracilis, and other organisms with data available.",CHEMBL1230893
C[NH2+]CCCCC(NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)O)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)O)C(C)O,4.77,,
C[N+](C)(C)CC(=O)[O-],4.77,"This molecule is a modified amino acid consisting of glycine with three methyl groups that serves as a methyl donor in several metabolic pathways and is used to treat the rare genetic causes of homocystinuria. This molecule has had only limited clinical use, but has not been linked to instances of serum enzyme elevations during therapy or to clinically apparent liver injury. This molecule is the amino acid betaine derived from glycine. It has a role as a fundamental metabolite. It is an amino-acid betaine and a glycine derivative. It is a conjugate base of a N,N,N-trimethylglycinium. This molecule is a methyl group donor that functions in the normal metabolic cycle of methionine. It is a naturally occurring choline derivative commonly ingested through diet, with a role in regulating cellular hydration and maintaining cell function. Homocystinuria is an inherited disorder that leads to the accumulation of homocysteine in plasma and urine. Currently, no treatments are available to correct the genetic causes of homocystinuria. However, in order to normalize homocysteine levels, patients can be treated with vitamin B6 ([pyridoxine]), vitamin B12 ([cobalamin]), [folate] and specific diets. This molecule reduces plasma homocysteine levels in patients with homocystinuria. Although it is present in many food products, the levels found there are insufficient to treat this condition. The FDA and EMA have approved the product Cystadane (betaine anhydrous, oral solution) for the treatment of homocystinuria, and the EMA has approved the use of Amversio (betaine anhydrous, oral powder). This molecule is a Methylating Agent. The mechanism of action of betaine is as a Methylating Activity. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Amaranthus hybridus, Cornulaca leucacantha, and other organisms with data available.",CHEMBL1182
COc1ccccc1-n1c(CSc2ncnc3nc[nH]c23)nc2cccc(Cl)c2c1=O,4.77,,
O=C([O-])C(=O)[O-],4.77,,
CC(=O)NC1C(NC(N)=[NH2+])CC(C(=O)[O-])OC1C(O)C(O)CO,4.77,,
CC1CCC2(C(=O)[O-])CCC3(C)C(C=CC4C5(C)CC(O)C(O)C(C)(CO)C5CCC43C)C2C1C,4.77,,
CC(C)CC(NC(=O)C(NC(=O)C(NC(=O)C(CS)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCCC[NH3+])C(C)O)C(C)C)C(C)O)C(=O)[O-],4.77,,
CSCCC(NC(=O)C1CCCN1C(=O)C(NC(=O)C(CC(C)C)NC(=O)C([NH3+])CC(N)=O)C(C)C)C(=O)NC(C(=O)NC(C)C(=O)NC(C(=O)NC(C(=O)[O-])C(C)C)C(C)O)C(C)C,4.77,,
CCOc1cc(-c2nc(-c3cc(OC)c(OC)c(OC)c3)cnc2N)ccc1C(=O)[O-],4.77,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)[O-],4.77,,
CCCCCCCC[NH2+]C1C=C(CO)C(O)C(O)C1O,4.77,,
CCn1ccn(C(=O)NC(C(=O)NCB(O)O)c2ccc(O)cc2)c(=O)c1=O,4.77,,
NC(=[NH2+])N1CCN(c2ccc(Cl)cc2)CC1,4.77,,
CC(C)CC(NC(=O)C(C)NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(CO)C(=O)NC(C(=O)[O-])C(C)O,4.77,,
COc1ccc(C(O)c2sc(Nc3ccc(S(N)(=O)=O)cc3)nc2N)cc1,4.77,,
O=c1[nH]c(=O)n(C2OC(CO)C(O)C(O)C2O)cc1C(F)(F)F,4.77,,
O=c1c(O)cccc2cc(O)c(O)c(O)c12,4.77,"This molecule is a cyclic ketone that is 5H-benzocycloheptene bearing an oxo group at position 5 and hydroxy groups at positions 2, 3, 4 and 6. It has a role as an antibacterial agent, an antioxidant, an EC 1.17.3.2 (xanthine oxidase) inhibitor and a protective agent. It is a tetrol, a cyclic ketone and a member of phenols. It derives from a hydride of a 5H-benzocycloheptene. This molecule is a natural product found in Quercus with data available.",CHEMBL66953
O=C1CC(=O)c2cc(Br)ccc2O1,4.77,,
Cc1cccc(-c2ccc(C3CC3C3=NC(=N)N(C)C(=O)C3)cc2)c1,4.77,,
CSCCC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C([NH3+])C(C)O)C(=O)NC(CC(C)C)C(=O)[O-],4.77,,
CC(=O)OCC1=C(C(=O)[O-])N2C(=O)C(NC(=O)Cc3cccs3)C2SC1,4.77,,
CCNc1nc(Cl)nc(NC(C)(C#N)CC)n1,4.77,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)[O-])C(C)O)C(C)O,4.78,,
[NH2+]=c1[nH]c(=O)c2c(nc(S)n2CCO)[nH]1,4.78,,
CC(C)CC(NC(=O)CC(O)C(CC1CCCCC1)NC(=O)CCC(O)C(Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)[O-],4.79,,
NC(=[NH2+])c1ccccc1,4.79,,
O=C([O-])C(=O)CC(O)c1cccc(N(Cc2ccccc2)Cc2ccccc2)c1,4.79,,
OCC1OC(n2cc(-c3ccc4ccccc4c3)nn2)C(O)C(O)C1O,4.79,,
C=C1CC=CC(OC)C(OC(N)=O)C(=C)CC(C)C(O)C(OC)CC(C)CC2=C(OC)C(=O)C(C)=C(NC1=O)C2=O,4.79,,
CC(C)CC([NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)[O-])C(C)O,4.79,,
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(C)[NH3+])C(C)O)C(=O)[O-],4.79,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(=O)N1CCCC1C(=O)NC(C(=O)NC(C)C(=O)N1CCCC1C(=O)NCC(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)[O-])C(C)O)C(C)C,4.8,,
NC(=[NH2+])c1ccc(NC(=O)Nc2ccc(Cl)cc2)cc1,4.8,,
NC(=[NH2+])c1ccc2[nH]c(-c3ccc[nH]c3=O)nc2c1,4.8,,
CSCCC([NH3+])C(O)(O)c1ccccn1,4.8,,
CN(C(=O)c1cc(OS(=O)(=O)c2ccc3ccccc3c2)ccc1NS(=O)(=O)c1ccc2ccccc2c1)C(CC(=O)[O-])C(=O)[O-],4.8,,
c1csc(-c2cc(C[NH2+]C34CC5CC(CC(C5)C3)C4)no2)c1,4.8,,
O=C1CN(c2csc(-c3ccccc3)c2Cl)S(=O)(=O)N1,4.8,,CHEMBL394484
C=CCOC1(C(=O)[O-])CC(O)C(O)C(C(O)COC2C=C(C(=O)[O-])OC(C(O)CO)C2)O1,4.8,,
COc1ccc(Nc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)n2)cc1Cl,4.8,,CHEMBL403673
O=C(NCB(O)O)c1ccccc1F,4.8,,CHEMBL2035291
CC=COC1(C(=O)[O-])CC(O)C(O)C(C(O)COC2(C(=O)[O-])C=CCC(C(O)CO)O2)O1,4.8,,
Nc1ncc(Cc2ccccc2)s1,4.8,,CHEMBL1234033
CC(C=O)NC(=O)C(C)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCC[N+](C)(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+],4.8,,
O=C([O-])c1ccc(-c2ccccc2Cl)o1,4.8,,
Cc1ccc2[nH]c(C(=O)[O-])cc2c1,4.8,,
O=C(CCC(=O)Nc1ccccc1Cl)NN=Cc1ccc(C=NNC(=O)CCC(=O)Nc2ccccc2Cl)cc1,4.8,,
CCCCN(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)c1nc(C)cc(C)n1,4.8,,CHEMBL90825
CC([NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)[O-],4.8,,
O=C([O-])Cc1cc(O)ccc1O,4.8,,
Cc1ccc2ncnc(N)c2c1,4.8,,
CC1OC(n2ccc(=O)[nH]c2=O)C(O)C1O,4.8,,
CC(=N)NCCCC(NC(=O)C([NH3+])CC(=O)[O-])C(N)=O,4.8,,
Cc1cc(N)ccc1O,4.8,,CHEMBL3092391
CCc1c(C(=O)NC)[nH]c(C)c1C(C)=O,4.8,,CHEMBL3785648
Oc1cc(Br)cnc1O,4.8,,
O=c1[nH]c(=O)n(C2OC(CO)C(O)C2O)cc1F,4.8,,
COC(=O)NC1(C(N)=O)OC(CO)C(O)C(O)C1O,4.81,,
Brc1c(Br)c(Br)c2[nH]nnc2c1Br,4.81,,CHEMBL177820
NC(=O)CSc1nc2ncnc(N)c2[nH]1,4.81,,CHEMBL468815
CC[NH+](CC)C1CC[NH+](Cc2cc(C#CCNC(=O)OC(C)(C)C)cc(I)c2O)CC1,4.81,,
OC1(c2ccc(Cl)cc2)CC[NH+](CCCC2(c3ccc(F)cc3)SCCS2)CC1,4.82,,
CC(=O)NC1C([NH3+])C=C(C(=O)[O-])OC1C(O)C(O)C[NH3+],4.82,,
CC(=O)NC(C(=O)NC(C(=O)NC(CC(=O)N(C)C)C(=O)NC(C)CO)C(C)(C)C(=O)[O-])C(C)C,4.82,,
CCCCn1c(Cc2ccc3c(c2)OCO3)nc2c(N)ncnc21,4.82,,CHEMBL326564
O=C([O-])C1(O)C=C(F)C(O)C(O)C1,4.82,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],4.82,,
O=C([O-])C1=CC(O)C(O)C(OC2C(C(=O)[O-])OC(OC3C(C(=O)[O-])OC(OC4C(C(=O)[O-])OC(O)C(O)C4O)C(O)C3O)C(O)C2O)O1,4.82,,
CCC(=C(c1ccccc1)c1ccc(OCC[NH+](C)C)cc1)c1ccccc1,4.82,,
Nc1ncnc2c1ncn2C1OC(CO)C(O)C1O,4.82,"This molecule is a purine nucleoside. This molecule is a natural product found in Acanthus ilicifolius, Acanthus ebracteatus, and other organisms with data available.",CHEMBL11909
Cc1ccccc1-c1nnc(S)n1N,4.82,,
O=C(C=Cc1ccc(Cl)cc1)NO,4.82,,
OCC1C(O)CC(O)C(O)C1O,4.82,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O)C(C)O,4.82,,
OC1C[NH+]2CCC(O)C2C(O)C1O,4.82,,
O=C([O-])c1[nH]c(-c2ccccc2)nc1C(=O)N1CCOCC1,4.82,,
CC(=O)NC(CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(CCC(=O)[O-])C(=O)[O-])C(C)O)C(C)O,4.82,,
CC(C=O)NC(=O)CNC(=O)C(C)NC(=O)C(C)NC(=O)C(C)NC(=O)CNC(=O)CNC(=O)C(C)NC(=O)C(C)[NH3+],4.82,,
Cc1nc(N)nc2c1CSCC2,4.82,,
C[S+](C)CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,4.82,,CHEMBL2008367
CCCCOc1ccc(CSC(N)=[NH2+])cc1Cl,4.82,,
Nc1nc2c(O)cccc2[nH]1,4.82,,
O=C([O-])c1ccc([Hg-2])cc1,4.82,,
C=CCNc1nc(N)c(C(=O)c2ccccc2)s1,4.82,,CHEMBL2377862
COc1cc(N)c(C(=O)[O-])cc1OC,4.82,,
O=C([O-])c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1,4.82,,
O=C(CC1CCCC1)Nc1nccs1,4.82,,CHEMBL3233604
O=C([O-])C1(O)C=C(CCO)C(O)C(O)C1,4.82,,
O=C1Cc2ccccc2C(=O)[N+]1=O,4.82,,
CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C([NH3+])C(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)[O-],4.82,,
[NH2+]=c1[nH]c(=O)c2ncc(C(=O)NCC(=O)NC(Cc3ccccc3)C(=O)NC(Cc3ccccc3)C(=O)[O-])nc2[nH]1,4.82,,
O=C([O-])CNC(=O)c1ncccc1O,4.82,,
O=C([O-])c1cccc(C(=O)[O-])n1,4.82,,
CSCCC([NH3+])C(=O)[O-],4.82,,
O=C1C(=O)N(Cc2ccccc2)c2ccccc21,4.82,,CHEMBL115581
Cc1cc(S(=O)(=O)N(Cc2ccccc2)C(C)C(=O)NO)ccc1F,4.82,,
Cc1cc(S(=O)(=O)N(Cc2cccnc2)C(C)C(=O)NO)ccc1F,4.82,,
O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,4.83,"This molecule is a trihydroxyflavone that is flavone substituted by hydroxy groups at positions 4', 5 and 7. It induces autophagy in leukaemia cells. It has a role as a metabolite and an antineoplastic agent. It is a conjugate acid of an apigenin-7-olate. This molecule is a natural product found in Camellia sinensis, Apis, and other organisms with data available. This molecule is a plant-derived flavonoid that has significant promise as a skin cancer chemopreventive agent. This molecule inhibits the expression of involucrin (hINV), a marker of keratinocyte differentiation, is increased by differentiating agents via a protein kinase Cdelta (PKCdelta), Ras, MEKK1, MEK3 cascade that increases AP1 factor level and AP1 factor binding to DNA elements in the hINV promoter. This molecule suppresses the 12-O-tetradeconylphorbol-13-acetate-dependent increase in AP1 factor expression and binding to the hINV promoter and the increase in hINV promoter activity. This molecule also inhibits the increase in promoter activity observed following overexpression of PKCdelta, constitutively active Ras, or MEKK1. The suppression of PKCdelta activity is associated with reduced phosphorylation of PKCdelta-Y311. Activation of hINV promoter activity by the green tea polyphenol, (-)-epigellocathecin-3-gallate, is also inhibited by apigenin, suggesting that the two chemopreventive agents can produce opposing actions in keratinocytes. (A7924). This molecule, a flavone abundantly found in fruits and vegetables, exhibits antiproliferative, anti-inflammatory, and antimetastatic activities through poorly defined mechanisms. This flavonoid provides selective activity to promote caspase-dependent-apoptosis of leukemia cells and uncover an essential role of PKCdelta during the induction of apoptosis by apigenin. (A7925). This molecule markedly induces the expression of death receptor 5 (DR5) and synergistically acts with exogenous soluble recombinant human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in malignant tumor cells. On the other hand, apigenin-mediated induction of DR5 expression is not observed in normal human peripheral blood mononuclear cells. Moreover, apigenin does not sensitize normal human peripheral blood mononuclear cells to TRAIL-induced apoptosis. (A7926).",CHEMBL28
CCC(C)C([NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)N1CCCC1C(=O)[O-])C(C)O,4.83,,
CCC(C)C(NC(=O)C(NC(=O)C(CO)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CO)C(C)O)C(C)CC)C(=O)[O-],4.83,,
CCC(C)C(NC(=O)C(CCCCNC(C)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(=O)[O-],4.83,,
Cc1cc(S(=O)(=O)N(Cc2ccc([N+](=O)[O-])cc2)C(C)C(=O)NO)ccc1F,4.83,,
CC(C)C1C[NH2+]C(C(=O)[O-])C1CC(=O)[O-],4.84,,
Oc1ccccc1Nc1ccc(Cl)cc1Cl,4.84,,
CCCCn1c(Cc2cc(OC)ccc2OC)nc2c(N)nc(F)nc21,4.84,,CHEMBL326651
CCCNC(=O)C(Cc1ccccc1)NC(=O)CC(O)C(Cc1ccccc1)NC(=O)C(NC(=O)c1ccccn1)C(C)C,4.84,,
CCN1c2cc(N)ccc2-c2ccc(N)cc2C1c1ccccc1,4.84,,
CCCC(NC(=O)C([NH3+])CO)C(=O)NC(CCSC)C(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C,4.84,,
Nc1ncnc2c1ncn2C1OC(CO)C(O)C1O,4.84,"This molecule is a purine nucleoside. This molecule is a natural product found in Acanthus ilicifolius, Acanthus ebracteatus, and other organisms with data available.",CHEMBL11909
O=C([O-])C(=O)Cc1ccccc1,4.84,,
CC(NC(=O)CCc1nc2ccccc2c(=O)[nH]1)c1ccc(S(N)(=O)=O)cc1,4.84,,CHEMBL3092517
COc1ccc(C(=O)CSc2nc3nc(N)[nH]c(=O)c3[nH]2)cc1,4.84,,CHEMBL3233207
COc1nc(NCCc2c[nH]c3ccccc23)nc(Nc2ccc3n[nH]cc3c2)n1,4.84,,
CCCCc1ccccc1,4.85,This molecule appears as a colorless liquid. Less dense than water and insoluble in water. Used to make plastics and as a solvent. This molecule is an alkylbenzene that is benzene substituted by a butyl group at position 1. This molecule is a natural product found in Solanum lycopersicum and Carica papaya with data available. This molecule belongs to the family of Substituted Benzenes. These are aromatic compounds containing a benzene substituted at one or more positions.,CHEMBL195441
O=C([O-])C(=O)Nc1cc2[nH]ccc2cc1C(=O)[O-],4.85,,
O=C([O-])C(=O)Nc1ccc(I)cc1C(=O)[O-],4.85,,
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCC[NH3+])NC(=O)C1CCC[NH2+]1)C(C)C)C(C)O)C(=O)NC(C)C(=O)NC(C(=O)[O-])C(C)O,4.85,,
CC(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(O)C([NH3+])Cc1ccccc1)C(N)=O,4.85,,
CC(C)COc1cccc(-c2nc3cc(C(N)=[NH2+])c(Cl)cc3[nH]2)c1O,4.85,,
C[NH+]1CCCC1CCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,4.85,,
O=C([O-])c1sccc1S(=O)(=O)Nc1cccc([N+](=O)[O-])c1,4.85,,
COC(C=O)(NC(=O)Cc1cccs1)C1NC(C(=O)[O-])=C(C)CS1,4.85,,
OC1C[S+]2CCCCC2C1O,4.85,,
O=[V+9]1(=O)(=O)ONC(c2ccccc2)=[O+]1,4.85,,
CC(=O)NC1C([NH3+])C=C(C(=O)[O-])OC1C(O)C(O)CO,4.85,,
O=C([O-])CC(Cc1cccc2ccccc12)N1C(=O)c2ccc(C(=O)[O-])cc2C1=O,4.85,,
CN(N=O)C(=O)NC1C(O)OC(CO)C(O)C1O,4.85,"This molecule is an off-white powder. Melting point 115 °C. Used as an anti-cancer drug. Carcinogenic. This molecule is a unique antineoplastic agent used to treat metastatic pancreatic islet cell carcinoma. This molecule has been associated with a high rate of serum enzyme elevation during therapy and to rare instances of severe, clinically apparent acute liver injury. This molecule is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals. This molecule is a methylnitrosourea antineoplastic antibiotic isolated from the bacterium Streptomyces achromogenes.  This molecule alkylates DNA, forming inter-strand DNA cross-links and inhibiting DNA synthesis.  Due to its glucose moiety, this agent is readily taken up by pancreatic beta cells, inducing diabetes mellitus at high concentrations.  Unlike other nitrosoureas, streptozocin causes little myelosuppression. (NCI04)",CHEMBL163484
OC1C[NH+]2CCCC(O)C2C1O,4.85,,
CC1CC(C)CN(C(=O)c2cc(Br)ccc2N)C1,4.85,,
C[NH2+]CCCCC([NH3+])C(=O)[O-],4.85,,
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(C)NC(=O)C(C)[NH3+])C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NCC(=O)NC(C=O)CO)C(C)CC,4.85,,
Cc1cccc2c1C(=O)N(c1ccc(C(=O)[O-])c(O)c1)C2=O,4.85,,
Nc1nccc2ccccc12,4.85,,CHEMBL62083
C=C1C(O)=C(O)CC(O)C1O,4.85,,
CC(=O)NC1C(O)CC(O)(C(=O)[O-])OC1C(O)C(O)CO,4.85,,
Nc1nc2ccccc2cc1CCC(=O)NCC1CCCCC1,4.85,,CHEMBL1821813
CC(C)C=C(Oc1cccc(C(=O)[O-])c1O)C(=O)[O-],4.85,,
O=[N+]([O-])c1ccc(OC2OC(CO)C(O)C(O)C2O)cc1,4.85,,
CC(=O)NC1C(OC2C(CO)OC(OC3C(CO)[NH2+]CC(O)C3O)C(NC(C)=O)C2O)OC(CO)C(O)C1O,4.85,,
OCC1C[NH2+]CC(O)C1O,4.85,,
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCC(N)=O)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C([NH3+])CC(=O)[O-])C(=O)[O-],4.85,,
CC1=NC(C)(c2ccc(Cl)cc2)C(C)(c2ccc(Cl)cc2)N1C(=O)N1CC[NH+](CCCS(C)(=O)=O)CC1,4.85,,
O=S(=O)([O-])c1cccc2c(S(=O)(=O)[O-])cccc12,4.85,,
CCC(C)C(NC(=O)C(CCCCNC(=O)C(F)(F)F)NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(=O)[O-],4.85,,
COc1ccc([N+](=O)[O-])cc1Cn1cc(CC(=O)[O-])c2ccccc21,4.85,,
OCCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12,4.86,,CHEMBL189434
OCc1cn(C2OC(CO)C(O)C(O)C2O)nn1,4.86,,
O=C([O-])CCCCCCNC(=O)NC1CCCCC1,4.87,,
O=C([O-])COc1ccc2c(c1)C(=NO)c1cc(OCC(=O)[O-])ccc1-2,4.87,,
[NH3+]C(Cc1cccc(O)c1)C(=O)[O-],4.87,,
[NH3+]C(COCc1ccccc1)c1csc(NC(=O)Nc2ccc(F)c(Cl)c2)n1,4.87,,
CC(=O)C(CC(=O)[O-])NC(=O)C1C=C2CCCCC2n2c(=O)n(CC(CCC(=O)[O-])NC(=O)Cc3ccccc3)c(=O)n21,4.87,,
CC(C)CC(NC(=O)C(C)NC(=O)C([NH3+])CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)[O-],4.87,,
CSCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(C)[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C,4.87,,
O=C([O-])CC(O)C(=O)[O-],4.87,,
CC(C)CC(NC(=O)C1CSSC2CSSCC(NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(NC(=O)C[NH3+])C2)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(Cc2c[nH]cn2)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1)C(N)=O,4.87,,
C=C1CC23CC1(O)CCC2C12C=CC(O)C(C)(C(=O)O1)C2C3C(=O)[O-],4.87,,
Nc1n[nH]c(N)c1N=Nc1ccc(O)cc1,4.88,,
Cc1ccc(OCCn2c(SCCOc3ccccc3)nc3ccccc32)cc1,4.88,,CHEMBL1738936
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)NC(C(=O)[O-])C(C)O,4.88,,
[NH3+]CCCCC([NH3+])C(=O)[O-],4.88,,
CC(NC(=O)CCc1nc2ccccc2c(=O)[nH]1)c1ccc(-n2ccnc2)cc1,4.88,,CHEMBL3092518
Nc1cc2[nH]cnc2c(OCC2CC=CCC2)n1,4.89,,
CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(O)C=O,4.89,,
CSCCC(NC(C)=O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NCCCCCC(=O)NC(CCSC)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CO)C(=O)N1CCCC1C(N)=O,4.89,,
Cc1o[nH]c(=O)c1CC([NH3+])C(=O)[O-],4.89,,
Cc1nc(C)c(-c2ccnc(N)n2)s1,4.89,,CHEMBL47302
CC(NC(=O)C(CCCCNC(=O)OCc1ccccc1)NC(=O)CCC(NC(=O)OC(C)(C)C)C(=O)[O-])B(O)O,4.89,,
CCCCC(C[NH2+]C(CCCC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)OC)C(C)CC,4.89,,
OCC1[NH2+]CC(O)C(O)C1O,4.89,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CCCC[NH3+])NC(=O)C(CCC(N)=O)NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C([NH3+])CCC(N)=O)C(C)O)C(C)O)C(=O)[O-],4.89,,
OCC1CC2C(O)C(O)C1(O)C[NH+]2Cc1ccccc1,4.89,,
OCC1C(O)C(O)C(O)c2nccn21,4.89,,
[NH3+]C(Cc1cccc(O)c1)C(=O)[O-],4.89,,
[NH3+]C(CCC(=O)NC(CSSCC(NC(=O)CCC([NH3+])C(=O)[O-])C(=O)NCC(=O)[O-])C(=O)NCC(=O)[O-])C(=O)[O-],4.89,,
CCC(C)C(NC(=O)C([NH3+])Cc1c[nH]cn1)C(=O)NC(C)C(=O)[O-],4.89,,
O=C([O-])c1ccc(NC(=O)c2cccc(CC3CCCCC3)n2)c(Cc2ccccc2)c1,4.89,,
[NH3+]C(Cc1c[nH]c2ccccc12)C(=O)[O-],4.89,,
Cc1cccc(Nc2cc(S(=O)(=O)[O-])c(N)c3c2C(=O)c2ccccc2C3=O)c1,4.89,,
CC(C)CC(NC(=O)C(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(C)O)C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)[O-],4.89,,
Fc1ccc(C2CC[NH2+]CC2COc2ccc3c(c2)OCO3)cc1,4.89,,
Cc1ccc(-c2nc(C)c(C(OC(C)(C)C)C(=O)[O-])c(-c3ccc(Cl)cc3)c2C)cc1C,4.89,,
COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CC[NH2+]CC2)n1,4.89,,
C[S+](CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,4.89,,
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C(CS)NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C)[NH3+])C(C)O)C(C)O)C(C)O)C(N)=O,4.89,,
CCC(C)C(NC(=O)C(NC(=O)C(NC(=O)C(CCCC[NH3+])NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])C(C)C)C(C)C)C(C)C)C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)[O-],4.89,,
CCNc1nc(Cl)nc(NC(C)C)n1,4.89,"This molecule is an herbicide that does not occur naturally. Pure atrazine is an odorless, white powder that is not very volatile, reactive, or flammable and that will dissolve in water. This molecule is used to kill weeds, primarily on farms, but has also been used on highway and railroad rights-of-way. The EPA now restricts how atrazine can be used and applied; only trained people are allowed to spray it. This molecule is a white crystalline solid. Melting point 173-175 °C. Sinks in water. A selective herbicide used for season-long weed control in a variety of crops. This molecule is a diamino-1,3,5-triazine that is 1,3,5-triazine-2,4-diamine substituted by a chloro group at position 6 while one of hydrogens of each amino group is replaced respectively by an ethyl and a propan-2-yl group. It has a role as a herbicide, an environmental contaminant and a xenobiotic. It is a chloro-1,3,5-triazine and a diamino-1,3,5-triazine. It is functionally related to a 6-chloro-1,3,5-triazine-2,4-diamine. This molecule is a selective triazine herbicide. Inhalation hazard is low and there are no apparent skin manifestations or other toxicity in humans. Acutely poisoned sheep and cattle may show muscular spasms, fasciculations, stiff gait, increased respiratory rates, adrenal degeneration, and congestion of the lungs, liver, and kidneys. (From The Merck Index, 11th ed) This molecule is a natural product found in Apis cerana with data available. This molecule is an organic compound consisting of an s-triazine-ring is a widely used herbicide. Its use is controversial due to widespread contamination in drinking water and its associations with birth defects and menstrual problems when consumed by humans at concentrations below government standards. Although it has been banned in the European Union, it is still one of the most widely used herbicides in the world . This molecule is a suspected teratogen, causing demasculinization in male northern leopard frog even at low concentrations, and an estrogen disruptor. A 2010 study found that atrazine rendered 75 percent of male frogs sterile and turned one in 10 into females. A 2002 study found that exposure to atrazine caused male tadpoles to turn into hermaphrodites - frogs with both male and female sexual characteristics. But another study, requested by EPA and funded by Syngenta, was unable to reproduce these results. This molecule was banned in the European Union (EU) in 2004 because of its persistent groundwater contamination. In the United States, however, atrazine is one of the most widely used herbicides, with 76 million pounds of it applied each year, in spite of the restriction that used to be imposed. Its endocrine disruptor effects, possible carcinogenic effect, and epidemiological connection to low sperm levels in men has led several researchers to call for banning it in the US.Rates of biodegradation are affected by atrazine's low solubility, thus surfactants may increase the degradation rate. Though the two alkyl moieties readily support growth of certain microorganisms, the atrazine ring is a poor energy source due to the oxidized state of ring carbon. In fact, the most common pathway for atrazine degradation involves the intermediate, cyanuric acid, in which carbon is fully oxidized, thus the ring is primarily a nitrogen source for aerobic microorganisms. This molecule may be catabolized as a carbon and nitrogen source in reducing environments, and some aerobic atrazine degraders have been shown to use the compound for growth under anoxia in the presence of nitrate as an electron acceptor, a process referred to as a denitrification. When atrazine is used as a nitrogen source for bacterial growth, degradation may be regulated by the presence of alternative sources of nitrogen. In pure cultures of atrazine-degrading bacteria, as well as active soil communitites, atrazine ring nitrogen, but not carbon are assimilated into microbial biomass. Low concentrations of glucose can decrease the bioavailability, whereas higher concentrations promote the catabolism of atrazine. Tyrone Hayes, Department of Integrative Biology, University of California, notes that all of the studies that failed to conclude that atrazine caused hermaphroditism were plagued by poor experimental controls and were funded by Syngenta, one of the companies that produce the chemical. The U.S. Environmental Protection Agency (EPA) and its independent Scientific Advisory Panel (SAP) examined all available studies on this topic including Hayes' work and concluded that there are 'currently insufficient data' to determine if atrazine affects amphibian development. Hayes, formerly part of the SAP panel, resigned in 2000 to continue studies independently. The EPA and its SAP made recommendations concerning proper study design needed for further investigation into this issue. As required by the EPA, Syngenta conducted two experiments under Good Laboratory Practices (GLP) and inspection by the EPA and German regulatory authorities. The paper concluded 'These studies demonstrate that long-term exposure of larval X. laevis to atrazine at concentrations ranging from 0.01 to 100 microg/l does not affect growth, larval development, or sexual differentiation.' Another independent study in 2008 determined that 'the failure of recent studies to find that atrazine feminizes X. laevis calls into question the herbicide's role in that decline.' A report written in Environmental Science and Technology (May 15, 2008) cites the independent work of researchers in Japan, who were unable to replicate Hayes' work. 'The scientists found no hermaphrodite frogs; no increase in aromatase as measured by aromatase mRNA induction; and no increase in vitellogenin, another marker of feminization.'",CHEMBL15063
O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,4.9,"This molecule appears as yellow needles or yellow powder. Converts to anhydrous form at 203-207 °F. Alcoholic solutions taste very bitter. (NTP, 1992) This molecule is a pentahydroxyflavone having the five hydroxy groups placed at the 3-, 3'-, 4'-, 5- and 7-positions. It is one of the most abundant flavonoids in edible vegetables, fruit and wine. It has a role as an antibacterial agent, an antioxidant, a protein kinase inhibitor, an antineoplastic agent, an EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor, a plant metabolite, a phytoestrogen, a radical scavenger, a chelator, an Aurora kinase inhibitor and a geroprotector. It is a pentahydroxyflavone and a 7-hydroxyflavonol. It is a conjugate acid of a quercetin-7-olate. This molecule is a flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin. This molecule is a flavonoid found in many foods and herbs and is a regular component of a normal diet. Extracts of quercetin have been used to treat or prevent diverse conditions including cardiovascular disease, hypercholesterolemia, rheumatic diseases, infections and cancer but have not been shown to be effective in clinical trials for any medical condition. This molecule as a nutritional supplement is well tolerated and has not been linked to serum enzyme elevations or to episodes of clinically apparent liver injury. This molecule is a polyphenolic flavonoid with potential chemopreventive activity. This molecule, ubiquitous in plant food sources and a major bioflavonoid in the human diet, may produce antiproliferative effects resulting from the modulation of either EGFR or estrogen-receptor mediated signal transduction pathways. Although the mechanism of action of action is not fully known, the following effects have been described with this agent in vitro: decreased expression of mutant p53 protein and p21-ras oncogene, induction of cell cycle arrest at the G1 phase and inhibition of heat shock protein synthesis. This compound also demonstrates synergy and reversal of the multidrug resistance phenotype, when combined with chemotherapeutic drugs, in vitro. This molecule also produces anti-inflammatory and anti-allergy effects mediated through the inhibition of the lipoxygenase and cyclooxygenase pathways, thereby preventing the production of pro-inflammatory mediators. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Salvia miltiorrhiza, Hydrangea serrata, and other organisms with data available. This molecule is a flavonoid widely distributed in many plants and fruits including red grapes, citrus fruit, tomato, broccoli and other leafy green vegetables, and a number of berries, including raspberries and cranberries. This molecule itself (aglycone quercetin), as opposed to quercetin glycosides, is not a normal dietary component. Quercitin glycosides are converted to phenolic acids as they pass through the gastrointestinal tract. This molecule has neither been confirmed scientifically as a specific therapeutic for any condition nor been approved by any regulatory agency. The U.S. Food and Drug Administration has not approved any health claims for quercetin. Nevertheless, the interest in dietary flavonoids has grown after the publication of several epidemiological studies showing an inverse correlation between dietary consumption of flavonols and flavones and reduced incidence and mortality from cardiovascular disease and cancer. In recent years, a large amount of experimental and some clinical data have accumulated regarding the effects of flavonoids on the endothelium under physiological and pathological conditions. The meta-analysis of seven prospective cohort studies concluded that the individuals in the top third of dietary flavonol intake are associated with a reduced risk of mortality from coronary heart disease as compared with those in the bottom third, after adjustment for known risk factors and other dietary components. A limited number of intervention studies with flavonoids and flavonoid containing foods and extracts has been performed in several pathological conditions. (A7896)",CHEMBL50
O=C(NCc1ccccc1C(F)(F)F)c1cc(-c2ccncc2)nn(-c2ccc(F)cc2)c1=O,4.9,,CHEMBL1232634
O=C([O-])CNC(=O)c1nc2cc(Cl)c(Cl)cc2[nH]1,4.9,,
CC(=O)c1cc(-c2ccccn2)c2ccccn12,4.9,,CHEMBL1950956
CC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(C)C(=O)NC(CO)CC(=O)[O-])C(C)C,4.91,,
O=C([O-])c1cc(Br)ccc1NC1CCC[NH2+]C1,4.91,,
O=C([O-])Cc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O,4.91,,
CC(C)CC(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(CCC(=O)[O-])C(=O)[O-],4.91,,
[NH3+]CCCCC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CO)NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NCC(=O)NC(CS)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],4.91,,
O=c1ccn(C2OC(CO)C(O)C(O)C2O)c(=O)[nH]1,4.91,,
CC([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(CCC(=O)[O-])C(=O)[O-])C(C)C,4.91,,
C[NH2+]C(CSSCC(NC(=O)CCC([NH3+])C(=O)[O-])C(=O)NCC(=O)[O-])C(=O)NCC(=O)[O-],4.91,,
Nc1nc(OCC2CCCCC2)c2nc[nH]c2n1,4.92,,CHEMBL269881
CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C(NC(=O)C([NH3+])CO)C(C)O)C(=O)[O-],4.92,,
Nc1nc(OCC2CCCCC2)c2nc[nH]c2n1,4.92,,CHEMBL269881
[NH3+]C(CO)(CO)CO,4.92,,
O=C(NCCC[NH+]1CCOCC1)c1cc(OC2OC(CO)C(O)C(O)C2O)cc([N+](=O)[O-])c1,4.92,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(C)C)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C[NH3+])C(=O)NC(C=O)CO,4.92,,
Cc1ccc(Nc2nccc(-c3ccnc(N4CC[NH+](CC[NH3+])CC4)c3)n2)cc1Cl,4.92,,
Cc1cc2nc3c(=O)[nH]c(=O)[nH]c3[n+](CC(O)C(O)C(O)CO)c2cc1C,4.92,,
COc1cc(C)c(S(=O)(=O)NCC(O)C([NH3+])Cc2ccccc2)c(C)c1C,4.92,,
CC#CCC([NH3+])C(O)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)OC,4.92,,
Nc1nccc(-c2csc(N)n2)n1,4.92,,
Clc1cccc(COc2ccc(Cl)c3cccnc23)c1,4.92,,
CNC(=O)NC(=[NH2+])NCCCC(NC(C)=O)C(=O)N(C)C(Cc1ccccc1)C(=O)[O-],4.92,,
C=C(CC)C(=O)c1ccc(OCC(=O)[O-])c(Cl)c1Cl,4.92,,
O=C(CC(=O)c1cccc(OCC2=CCCC=C2)c1)C(=O)N1CCN(C(=O)C(=O)CC(=O)c2cccc(OCC3C=CC=CC3)c2)CC1,4.92,,
O=C(NC(Cc1cccc(F)c1)C(=O)[O-])c1ccc2ccccc2c1,4.92,,
O=C([O-])C(=CC1C=C1)OC1C=CC=C(C(=O)[O-])C1=O,4.92,,
CCC=C(OC1C=CC=C(C(=O)[O-])C1=O)C(=O)[O-],4.92,,
CCCNc1nc(N)c(C(=O)c2ccc(Cl)s2)s1,4.92,,
CCC(=O)c1ccccc1,4.92,These molecules is an aromatic ketone in which the two substituents on the carbonyl C atom are phenyl and ethyl. It has a role as a fragrance. This molecule is a natural product found in Artemisia judaica and Manilkara zapota with data available.,CHEMBL193446
Cc1[nH]c2ccccc2c1CCNC(=O)c1ccccc1F,4.92,,
CC[NH+](CC)CCNS(=O)(=O)Cc1ccc(Cl)cc1,4.92,,
C=CC(C)=CC1(C)SC(=O)C(C(=O)C(F)(F)F)=C1O,4.92,,
O=C1NC(=NS(=O)(=O)c2cccc3ccccc23)SC1=Cc1ccc(Br)cc1,4.92,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C([NH3+])CO)C(C)C)C(=O)[O-],4.92,,
[NH3+]CC1(c2ccccc2)CCC(OCC=Cc2ccccc2)CC1,4.92,,
O=C([O-])c1ccccc1O,4.93,,
O=C(NO)c1ccccc1,4.93,"Rhombic crystals or light beige solid. (NTP, 1992)",CHEMBL16300
CC(C)COC(=O)NC(CC=O)c1ccccc1,4.93,,
O=C(NCc1ccco1)c1ccc2nccnc2c1,4.93,,CHEMBL1408855
O=C([O-])CCC(=O)NNC(=O)c1cccnc1,4.93,,
[NH2+]=C1NC2(c3cccc(-c4cncc(Cl)c4)c3)CCCCC2O1,4.93,,
Cc1cn(C2CC(O)C3(CO)CC23)c(=O)[nH]c1=O,4.94,,
CCC(C)C(NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(NC(=O)C(C)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C[NH3+])C(C)C)C(C)O)C(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)CC,4.94,,
C=C(CC)C(=O)c1ccc(OCC(=O)[O-])c(Cl)c1Cl,4.94,,
COc1ccc(C=CC(=O)Nc2ccccc2C(=O)[O-])cc1OC,4.94,,
O=[N+]([O-])c1ccc(CS)cc1,4.94,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH+](C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O,4.94,,
CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CC(=O)[O-])C(=O)N1CCCC1C(=O)N1CCCC1C(N)=O,4.94,,
O=C1C=C(O)C(=O)C=C1O,4.94,,
CC(O)C([NH3+])C(=O)NC(CS)C(=O)N1CCCC1C(N)=O.CSCCC(NC(=O)C(CO)NC(=O)C(CCC(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CS)NC(=O)C([NH3+])C(C)O)C(=O)NC(CS)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)O,4.94,,
CCC(C)C(NC(=O)C(CCCCNC(=O)c1ccc(F)cc1)NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])Cc1c[nH]c2ccccc12)C(C)O)C(=O)[O-],4.94,,
[NH3+]C(Cc1ccc(O)cc1)C(=O)[O-],4.94,,
O=C(CCCCCCC(=O)C(F)(F)F)Nc1ccccc1,4.95,,CHEMBL113537
[NH3+]CCCCC([NH2+]C(CCc1ccccc1)C(=O)[O-])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],4.95,,
CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(NCCO)nc21,4.95,,
CCN1CCN(C(=O)NC(CCc2ccc(O)cc2)C(=O)NCB(O)O)C(=O)C1=O,4.95,,
CCCc1nnc(N)s1,4.95,,
C[S+](CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,4.95,,
Nc1ccc2ccc(CC[NH2+]CCc3cccc(F)c3)cc2n1,4.95,,
O=C([O-])C1(O)C=C(CO)C(O)C(O)C1,4.95,,
NC(=O)c1cccc(NC(=O)CCC(=O)[O-])c1,4.95,,
CCC(C)C(NC(=O)C(CCCCNC(=O)c1ccc(Br)cc1)NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])Cc1c[nH]c2ccccc12)C(C)O)C(=O)[O-],4.95,,
[NH3+]CCCCCC(=O)[O-],4.96,,
CSCCC(NC(C)=O)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C,4.96,,
NC(=[NH2+])c1ccc2nc(-c3cccc(-c4ccccc4)c3O)[nH]c2c1,4.96,,
CC(=O)N1Cc2ccccc2CC1c1nc(C(=O)N2CCC(C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)N3CCCC3C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)N3CCCC3C(N)=O)CC2)c(C(C)C)s1,4.96,,
CC1CCCCC1Oc1cccc(-c2nc3cc(C(N)=[NH2+])c(F)cc3[nH]2)c1O,4.96,,
CSCCC([NH3+])C(=O)[O-],4.96,,
CSCCC(NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)CS)C(N)=O,4.96,,
COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(OC2OC(C)C(O)C(O)C2O)C1NC(C)=O,4.96,,
NS(=O)(=O)c1ccc(Nc2cc(OCC3CCCCC3)nc3ncnn23)cc1,4.96,,CHEMBL206109
Cc1cccc(C(=O)c2ccnc(NCc3ccc(C(N)=[NH2+])cc3)c2)c1,4.96,,
O=C1NCC(CO)C(O)C1O,4.96,,
CC(=O)NC1C[NH2+]CC(O)C(O)C1O,4.96,,
CC(=O)NC1C(=O)OC(CO)C(O)C1O,4.96,,
Cc1cn(C2CC(O)C(CNC(=O)Nc3ccc([N+](=O)[O-])cc3)O2)c(=O)[nH]c1=O,4.96,,
NC(=[NH2+])NCCSC(CC(=O)[O-])C(=O)[O-],4.96,,
CCCCCCCCCCC(=O)NC(Cc1cnc[nH]1)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1ccc(O)cc1)C(=O)N(C)CCc1ccccn1,4.96,,
C[NH+](C)CCC[NH+](C)C1CCN(C(=O)c2[nH]c3cc(Cl)ccc3c2-c2c(-c3ccccc3)ncn2Cc2ccc(Cl)cc2)C1,4.96,,
CC(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],4.96,,
[NH3+]C(CCCC[B-2](=O)(O)O)C(=O)[O-],4.96,,
Nc1ccc2c(O)c(N=Nc3ccc4c(O)cc(S(=O)(=O)[O-])cc4c3)c(S(=O)(=O)[O-])cc2c1,4.96,,
O=C(c1ccccc1)c1cccc(C2=CC(O)(C(=O)[O-])CC(O)C2O)c1,4.96,,
N#CC1(OC(=O)C2CC3(C[NH2+]2)C(=O)Nc2ccccc23)CCCCC1,4.96,,
O=C([O-])c1ccc(Nc2nccc(Nc3ccccc3)n2)cc1,4.96,,
CC=C(OC1=CCCC(C(=O)[O-])C1O)C(=O)[O-],4.96,,
C=CC[NH+](Cc1ccccc1C(=O)NC(CCC)c1ccc(OC)cc1)Cc1ccc2c(c1C(=O)[O-])OCO2,4.96,,
O=C([O-])c1ccc(Cl)cc1NS(=O)(=O)c1cc(Cl)c(Cl)cc1Cl,4.96,,
NS(=O)(=O)c1ccccc1,4.96,This molecule is a sulfonamide.,CHEMBL27601
CC(=O)NC1C(O)CC(OC2C(O)C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C2O)(C(=O)[O-])OC1C(O)C(O)CO,4.96,,
COc1cccc(C(=O)c2nonc2N)c1,4.96,,
COc1cc(-c2ccc(N3CCOCC3)cc2)cc(C)c1O,4.96,,
O=C(C=Cc1ccc(O)c(O)c1)NCCc1ccc(O)cc1,4.97,,
CC1=C(CC(=O)[O-])c2cc(F)ccc2C1Cc1ccc(S(C)=O)cc1,4.97,,
Nc1nc2ccc(Cl)cc2[nH]1,4.97,,CHEMBL269158
CN1Cc2c(ccc3c2OCO3)-c2ccc3cc4c(cc3c21)OCO4,4.97,"This molecule is a benzophenanthridine alkaloid obtained by selective hydrogenation of the 13,14-position of sanguinarine. It has a role as a metabolite and an antifungal agent. It derives from a hydride of a sanguinarine. This molecule is a natural product found in Pteridophyllum racemosum, Corydalis balansae, and other organisms with data available.",CHEMBL465678
[NH2+]=c1[nH]c(=O)c2[nH]c(S)nc2[nH]1,4.97,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)O,4.97,,
CC(NC(=O)C(C)NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCC[NH2+]1)C(=O)[O-],4.97,,
O=C([O-])c1ccc(O)cc1,4.97,,
[NH3+]C(CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)[O-],4.97,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)O)C(C)O)C(C)O,4.98,,
CC(=O)NCCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C(C)[NH3+])C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)C(C)O)C(C)C)C(C)O,4.98,,
[NH3+]C(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-],4.98,,
CC(C)CC(NC(=O)C(C)NC(=O)C[NH3+])C(=O)NCC(=O)NCC(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C)C(=O)NCC(=O)NC(C)C(=O)NC(C(=O)[O-])C(C)C,4.98,,
O=C([O-])C1=CC(O)C(O)C(OC2C(C(=O)[O-])OC(O)C(O)C2O)O1,4.98,,
O=C([O-])c1ccccc1O,4.98,,
COc1ccc(OCCN2CC3CCCC(C2=O)N3S(=O)(=O)c2ccc3[nH]c(=O)sc3c2)cc1OC,4.98,,CHEMBL2348593
CC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(C)C(=O)NC(CO)CC(=O)[O-])C(C)C,4.99,,
O=C([O-])C=C(CCc1ccc(Cl)cc1)c1ccccc1,4.99,,
Cc1c(C(=O)CCc2ccccc2)oc2cccc(OC3CC[NH2+]CC3)c12,4.99,,
O=C([O-])c1ccc(O)c2ncccc12,4.99,,
Cc1nc2ccccc2c(-c2ccc3c(c2)CCCO3)c1C(OC(C)(C)C)C(=O)[O-],4.99,,
Cc1ncoc1-c1ccc(CNC(=O)C2CC(O)CN2C(=O)CC(C)(C)C)cc1,4.99,,
O=C([O-])C(=O)Nc1cc2ccccc2cc1C(=O)[O-],5.0,,
CCCB(O)O,5.0,,
Cc1c[nH]c(C=C2C(=O)Nc3ccccc32)c1CCC(=O)[O-],5.0,,
Nc1nc2ccc(O)cc2[nH]1,5.0,,
C=C(CC)C(=O)c1ccc(OCC(=O)[O-])c(Cl)c1Cl,5.0,,
COC1OC(C)Cc2oc3cc(O)c(O)c(C(=O)[O-])c3c(=O)c21,5.0,,
[NH2+]=C(NO)NCCCC([NH3+])C(=O)[O-],5.0,,
COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(c(C=NN5CC[NH+](C)CC5)c(O)c4c3C2=O)NC(=O)C(C)=CCCC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C,5.0,,
COc1ccc(C(=O)N2CCCc3cc(C4[NH2+]NC(=O)SC4C)ccc32)cc1OC,5.0,,
CC(=O)Nc1ccc(C(=O)[O-])cc1NC(N)=[NH2+],5.0,,
CC(=O)NCCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C([NH3+])CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CS)C(=O)[O-],5.0,,
CCC(C)C(NC(=O)C(Cc1cnc[nH]1)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CO)C(=O)[O-],5.0,,
COC1OC(C)Cc2oc3cc(O)c(O)c(C(=O)[O-])c3c(=O)c21,5.0,,
Nc1ncnc2c(C3OC(CO)C(O)C3O)n[nH]c12,5.0,,CHEMBL273712
CC(=O)NC1C(O)C=C(C(=O)[O-])OC1C(O)C(O)CO,5.0,,
NC(=[NH2+])c1ccc2[nH]c(-c3cc(F)ccc3O)nc2c1,5.0,,
[NH3+]CCCCC(NC(=O)C(CO)NC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)C(CO)NC(=O)C([NH3+])CC(=O)[O-])C(=O)[O-],5.0,,
CC(NC(=O)C(C)NC(=O)C(NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)CCC(=O)[O-])C(C)C)C(C)C)C(=O)Nc1ccc([N+](=O)[O-])cc1,5.0,,
O=C(C1CCN(c2ccncc2)CC1)N1CCN(S(=O)(=O)c2ccc3cc(Cl)ccc3c2)CC1,5.0,,CHEMBL270527
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,5.0,,
Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1,5.0,"This molecule is a primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively. It has a role as a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a primary alcohol and a vitamin B1. It is a conjugate base of a thiamine(2+). This molecule is a colorless compound with the chemical formula C12H17N4OS. It is soluble in water and insoluble in alcohol. Thiamine decomposes if heated. Thiamine was first discovered by Umetaro Suzuki in Japan when researching how rice bran cured patients of Beriberi. Thiamine plays a key role in intracellular glucose metabolism and it is thought that thiamine inhibits the effect of glucose and insulin on arterial smooth muscle cell proliferation. Thiamine plays an important role in helping the body convert carbohydrates and fat into energy. It is essential for normal growth and development and helps to maintain proper functioning of the heart and the nervous and digestive systems. Thiamine cannot be stored in the body; however, once absorbed, the vitamin is concentrated in muscle tissue. This molecule is a heat-labile and water-soluble essential vitamin, belonging to the vitamin B family, with antioxidant, erythropoietic, mood modulating, and glucose-regulating activities. This molecule reacts with adenosine triphosphate (ATP) to form an active coenzyme, thiamine pyrophosphate. This molecule pyrophosphate is necessary for the actions of pyruvate dehydrogenase and alpha-ketoglutarate in carbohydrate metabolism and for the actions of transketolase, an enzyme that plays an important role in the pentose phosphate pathway. This molecule plays a key role in intracellular glucose metabolism and may inhibit the action of glucose and insulin on arterial smooth muscle cell proliferation. This molecule may also protect against lead toxicity by inhibiting lead-induced lipid peroxidation. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Alhagi persarum, Solanum tuberosum, and other organisms with data available. This molecule is a colorless compound with the chemical formula C12H17N4OS. It is soluble in water and insoluble in alcohol. Thiamine decomposes if heated. Thiamine was first discovered by Umetaro Suzuki in Japan when researching how rice bran cured patients of Beriberi. Thiamine plays a key role in intracellular glucose metabolism and it is thought that thiamine inhibits the effect of glucose and insulin on arterial smooth muscle cell proliferation. Thiamine plays an important role in helping the body convert carbohydrates and fat into energy. It is essential for normal growth and development and helps to maintain proper functioning of the heart and the nervous and digestive systems. Thiamine cannot be stored in the body; however, once absorbed, the vitamin is concentrated in muscle tissue.",CHEMBL1547
CC(O)C(NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(Cc1c[nH]cn1)NC(=O)C(CS)NC(=O)C([NH3+])Cc1ccccc1)C(N)=O,5.0,,
CCOC(=O)CCc1ccc2ccc(C(N)=[NH2+])cc2c1,5.0,,
CC(C)CC([NH3+])C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CCC(N)=O)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(C)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-])C(C)O,5.0,,
CC(C)CC(NC(=O)c1ccco1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],5.0,,
COc1ccc(-c2ccccc2)cc1N1CC(=O)NS1(=O)=O,5.0,,CHEMBL193233
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C([NH3+])C(C)O)C(=O)NC(C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(C)C)C(=O)[O-])C(C)O,5.0,,
Cc1ccc(NC(=O)c2ccc(C[NH+]3CC[NH+](C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,5.0,,
CN(C)c1ccc(C(=O)NCC2[NH2+]C(CO)C(O)C2O)cc1,5.0,,
CC(=O)[N+](=O)CCCC(NC(=O)C(C)NC(=O)C([NH3+])CO)C(=O)NC1CCCNC(=O)C(CO)NC(=O)C(CCC[N+](=O)C(C)=O)NC(=O)C(CC(=O)[O-])NC1=O,5.0,,
NC(=O)CCC(NC(=O)C(CCC(N)=O)NC(=O)C(CCC[N+](=O)C=O)NC(=O)C1CCN=C(C([NH3+])CO)N1)C(=O)NC(CCC[N+](=O)C=O)C(=O)NCC(=O)[O-],5.0,,
O=C([O-])C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(Cl)c(C(F)(F)F)c1,5.0,,
O=S(=O)([O-])c1cccc2cccc(Nc3ccccc3)c12,5.0,,
CCOc1cc(CC2SC(=S)N(CC(=O)[O-])C2=O)c(Br)c(Br)c1O,5.0,,
Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,5.0,"This molecule is a member of the class of triazolopyridazines that is 6-(1-methylpyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazine-3-thiol in which the thiol hydrogen is replaced by a quinolin-6-yl group. It has a role as a c-Met tyrosine kinase inhibitor and a nephrotoxic agent. It is a member of quinolines, a triazolopyridazine, a member of pyrazoles, a biaryl and an aryl sulfide. A MET receptor tyrosine kinase inhibitor. This molecule is an orally bioavailable small molecule, c-Met inhibitor with potential antineoplastic activity. MET receptor tyrosine kinase inhibitor SGX523 specifically binds to c-Met protein, or hepatocyte growth factor receptor (HGFR), preventing binding of hepatocyte growth factor (HGF) and disrupting the MET signaling pathway; this agent may induce cell death in tumor cells expressing c-Met. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays an important role in tumor cell proliferation, survival, invasion, and metastasis, and in tumor angiogenesis.",CHEMBL1236107
COc1ccc(C(=O)N=NCc2cc(Br)c(O)c(Br)c2O)cc1,5.0,,
CC([NH3+])C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(C)C(=O)NC(C(=O)NC(CO)C(=O)N1CCCC1C(=O)[O-])C(C)O)C(C)C)C(C)O,5.0,,
COc1cc(N)ccc1-c1ccc2c(-c3nc4cccc(N5CC[NH+](C)CC5)c4[nH]3)[nH]nc2c1,5.0,,
OCC1[NH2+]CC(O)C(O)C1O,5.0,,
CC1OC(OC2C(CO)OC(OC3C(CO)OC(OC4C(CO)OC(O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,5.0,,
O=c1cc(C(F)(F)F)c2c(-c3cccc(C(F)(F)F)c3)[nH]nc2[nH]1,5.0,,
CNC(NC)=[NH+]CCCC(NC(=O)C[NH3+])C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)[O-],5.0,,
CCC(C)C(NC(=O)C([NH3+])CO)C(=O)NC(C(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)[O-])C(C)CC,5.0,,
COc1cccc(C(N)=O)c1,5.0,,CHEMBL123978
CCCC(NC(=O)C1C2CCCC2CN1C(=O)C(NC(=O)C(NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(O)C(=O)NC1CC1,5.0,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)O,5.0,,
Nc1ncnc2c1cnn2CC1CC[NH2+]CC1,5.0,,
NC(=O)c1ccc2cccc(O)c2n1,5.0,This molecule is a member of quinolines.,CHEMBL2032371
COc1ccc(C2(c3cccc(-c4cccnc4)c3)CC(OC)C(=[NH2+])N2)cc1,5.0,,
O=C([O-])CC(=O)C(=O)[O-],5.0,,
O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccccc1,5.0,,CHEMBL2064419
O=C([O-])c1ccc2cccc(O)c2n1,5.0,,
CCOc1c(I)cc(Cl)cc1C[NH2+]CCCNC(=O)Nc1ccsc1,5.0,,
CC1=C(CCc2nn[nH]n2)c2cc(F)ccc2C1=Cc1ccc(C(C)C)cc1,5.0,,
CC1=C(CCc2nn[nH]n2)c2ccccc2C1=Cc1ccc(C(C)C)cc1,5.0,,
O=NC1CCc2cc(-c3nc(C4CC[NH2+]CC4)[nH]c3-c3ccncc3)ccc21,5.0,,
Cc1ccc(OCc2nc(C(=O)NC3CCS(=O)(=O)C3)cs2)cc1,5.0,,
Nc1cccc2c(=O)[nH]ccc12,5.0,This molecule is a member of isoquinolines.,CHEMBL446240
CC1Cn2ncc(-c3ccc(S(=O)(=O)N(C)C)cc3)c2CN1c1ccnc2[nH]ccc12,5.0,,
CC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O,5.01,,
O=C(NN=Cc1cc(Br)c(O)c(Br)c1O)c1cccnc1,5.01,,
CCc1ccc(C=C2SC(=NC(c3ccc(F)cc3)c3nnn[nH]3)NC2=O)o1,5.01,,
COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1,5.01,,
CCN1CCN(C(=O)NC(Cc2ccc(O)cc2)C(=O)NCB(O)O)C(=O)C1=O,5.01,,
CSCCC(NC(=O)C1CCCN1C(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(N)=O)C(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)[O-],5.01,,
COC1OC(C(=O)[O-])C(OC2OC(COS(=O)(=O)[O-])C(O)C(OS(=O)(=O)[O-])C2NS(=O)(=O)[O-])C(O)C1OS(=O)(=O)[O-],5.01,,
CC[NH+](CC)C1CC[NH+](Cc2cc(C#CCNc3ccccc3)cc(I)c2O)CC1,5.01,,
O=C([O-])C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCC[NH2+]1,5.01,,
O=C(Nc1cccc(-c2nn[nH]n2)c1)c1cccc(-c2ncccn2)c1,5.01,,
Nc1nc2nc(SCC(=O)c3ccccc3)[nH]c2c(=O)[nH]1,5.01,,CHEMBL3233201
CCN1CNS(=O)(=O)c2ncccc21,5.01,,CHEMBL103741
O=C1C[NH2+]CC2=C1C(c1ccccc1F)c1c[nH]nc1N2,5.01,,
Nc1nc2cc[nH]c2c(=O)[nH]1,5.02,,CHEMBL367746
CCC(C)C(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)[O-],5.02,,
CCNC(=O)c1[nH]nc(C2=CC(Cl)=C(O)CC2=O)c1N1CC[NH2+]CC1,5.02,,
Nc1nc2ncc(CNc3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc3)nc2c(=O)[nH]1,5.02,,
CC(C)C(NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCC(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCC(O)[NH2+]1)C(C)O)C(C)O)C(=O)[O-],5.02,,
[NH3+]C(Cn1oc(=O)[nH]c1=O)C(=O)[O-],5.02,,
Nc1ccc(S(=O)(=O)N(CC[NH2+]CCN(Cc2ccccc2)S(=O)(=O)c2ccc(N)cc2)Cc2ccccc2)cc1,5.02,,
O=C(NCCC1C=CCCC1)Nc1ccc2nnsc2c1,5.02,,
CCCCCCCCCCCCCC(=O)[O-],5.02,,
CC(C)CC(NC(=O)C(NC(=O)C(CCCC[N+](C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C(C)NC(=O)C[NH3+])C(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)[O-],5.02,,
CC(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(C)C)C(O)C(F)(F)C(=O)NCCc1ccccc1,5.02,,
CCC(CO)NC(=O)CCc1nc2ccccc2c(=O)[nH]1,5.02,,
CC(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])CO)C(=O)[O-],5.02,,
O=C([O-])CCC(=O)C(=O)[O-],5.02,,
O=C([O-])c1ccc(C=NN=C2c3ccccc3-c3ccccc32)cc1,5.02,,
O=C([O-])c1ccc(C=NN=C2c3ccccc3-c3ccccc32)cc1,5.02,,
CC(=O)NC(C(=O)NC(C(=O)N1CC(O)CC1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C)C(C)(C)C,5.02,,
COc1cccc2c(O)c3c(O)c4c(c(O)c3c(O)c12)C(OC1CC([NH3+])C(O)C(C)O1)CC(O)(C(=O)CO)C4,5.03,,
CC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)C[NH3+])C(C)O)C(=O)[O-],5.03,,
CC(O)C([NH3+])C(=O)[O-],5.03,,
CC([NH3+])C(=O)[O-],5.03,,
CC([NH3+])C(=O)NC(CO)C(=O)NC(C(=O)NC(C=O)CO)C(C)O,5.03,,
[NH3+]C(Cc1o[nH]c(=O)c1Br)C(=O)[O-],5.04,,
COC1OC(CO)C(O)C(OC2OC(C)C(O)CC2O)C1OC1OC(CO)C(O)C(O)C1O,5.04,,
CC(=O)NCCCCC(NC(=O)C(C)NC(=O)C([NH3+])Cc1cnc[nH]1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)O)C(C)C,5.04,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)O)C(C)O,5.04,,
Nc1ncccc1NCc1cccc(-c2ccc3cc[nH]c3c2)c1,5.04,,CHEMBL220896
CC(C)CC(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)C(CCCC[NH3+])NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(=O)[O-],5.04,,
[NH3+]CC1CN(c2ncnc3[nH]cnc23)CCO1,5.04,,
CC(C)CC(Cl)C(=O)[O-],5.04,,
C[N+](=NO)C1=CC(=O)C(=O)C=C1,5.04,,
CCC[NH+](CCC)Cc1cc(C(=O)[O-])ccc1N1C(=O)CCC1(CO)CO,5.04,,
Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,5.04,"This molecule is a natural product found in Maclura pomifera, Caragana sinica, and other organisms with data available.",CHEMBL2019155
CC1C(=O)OC2=C1C=COC2,5.04,,
OCC1OC(Oc2ccc3c(c2)Oc2cc(O)ccc2N3)C(O)C(O)C1O,5.04,,
Nc1ncnc2c1ncn2C1OC(CO)C(O)C1O,5.05,"This molecule is a purine nucleoside. This molecule is a natural product found in Acanthus ilicifolius, Acanthus ebracteatus, and other organisms with data available.",CHEMBL11909
OCC1OC(n2cnc3cncnc32)C(O)C1O,5.05,,
NC(=[NH2+])c1ccc2nc(-c3ccccc3O)[nH]c2c1,5.05,,
COC(=O)c1c(O)cccc1OCCCCNC(=O)C(Cc1ccc(OCC(=O)[O-])c(O)c1)NC(C)=O,5.05,,
C[NH+](C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,5.05,,
CCc1cc(-c2[nH]nc(C)c2-c2ccc3c(c2)OCCO3)c(O)cc1O,5.05,"This molecule is a member of the class of pyrazoles that is 1H-pyrazole carrying 1,4-benzodioxane-6-yl and 5-ethyl-2,4-dihydroxyphenyl substituents at positions 4 and 5 respectively. It has a role as a Hsp90 inhibitor, an antineoplastic agent and an apoptosis inducer. It is a benzodioxine, a member of pyrazoles and a member of resorcinols.",CHEMBL399530
NC(=[NH2+])Nc1ccc(O)c(C=NCC=NCc2cc(NC(N)=[NH2+])ccc2O)c1,5.05,,
CC(N=C1C(=O)C(=O)C1=Nc1ccncc1)c1ccccc1,5.05,,
CN(C(=O)C(Cc1c[nH]cn1)NC(=O)OCc1ccccc1)C(Cc1ccccc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NO,5.05,,
CCC(CC(=O)NC1C2CC3CC(C2)CC1C3)n1c(N)nc2cc(Cl)ccc21,5.05,,
NS(=O)(=O)c1ncc[nH]1,5.05,,CHEMBL4574085
CCC(C)C(NC(=O)C([NH3+])CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)[O-],5.05,,
Oc1cc(O)c2c(c1)OC(c1ccc(O)c(O)c1)C(O)C2,5.05,"This molecule is members of the class of hydroxyflavan that have a flavan-3-ol skeleton and its substituted derivatives. This molecule is a natural product found in Salvia miltiorrhiza, Camellia sinensis, and other organisms with data available.",CHEMBL206452
[NH3+]CCCC(=O)[O-],5.05,,
CC(C)CC([NH3+])C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(=O)[O-],5.05,,
O=C([O-])c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O,5.05,,
O=C([O-])CCC(=O)C(=O)[O-],5.05,,
COC1OC(C(=O)[O-])C(OC2OC(COS(=O)(=O)[O-])C(O)C(OS(=O)(=O)[O-])C2NS(=O)(=O)[O-])C(O)C1OS(=O)(=O)[O-],5.05,,
O=S(=O)(Nc1nc2ccc(Cl)cc2s1)c1cc2ccccc2s1,5.05,,
C[NH2+]CCCCC(NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)O)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)O,5.06,,
CC(CC(CC(CCC(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-],5.06,,
CCC(C)C([NH3+])C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)NC(C=O)CCCNC(N)=[NH2+])C(C)C,5.06,,
COC1=C2CC(C)CC(OC)C(O)C(C)C=C(C)C(OC(N)=O)C(OC)C=CC=C(C)C(=O)NC(=CC1=O)C2=O,5.06,,
CC(=O)NC(CC1CCCCC1)C(=O)N1CCCC1C(=O)NCc1cccc(Cl)c1,5.06,,
COc1ccc(C=NOC2CC(C(=O)NC(C(=O)NC(C)C(=O)N3CCCC3C(=O)N3CCCC3C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(N)=O)C(C)O)N(C(=O)C(CCC(=O)[O-])NC(=O)C3CCCN3C(C)=O)C2)cc1OC,5.06,,
Nc1nc(OCC2CCCCC2)c2[nH]c(-c3cccc(S(N)(=O)=O)c3)nc2n1,5.06,,
CCc1ccc(-c2ccc3c(c2)-c2c(cnn2CC)S(=O)(=O)N3C)cc1,5.06,,CHEMBL2333436
CC(C)CC(=O)C(=O)[O-],5.06,,
CC(NC(=O)C(CC(=O)[O-])NC(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(=O)C(C)NC(=O)C([NH3+])CO)C(=O)[O-],5.06,,
c1ccc2[nH]c(-c3n[nH]c4ccccc34)nc2c1,5.07,,CHEMBL383990
Nc1ncnc2c1ncn2C1OC(CSC(=CC[NH3+])CCCCC[NH3+])C(O)C1O,5.07,,
CC(=O)NC1C(=O)NC(CO)C(O)C1O,5.07,,
O=C([O-])CC(O)C(=O)[O-],5.07,,
O=C([O-])c1cc(Br)ccc1NC1CCC[NH2+]C1,5.07,,
O=C([O-])c1cc2cc(Br)ccc2o1,5.07,,
NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,5.07,,CHEMBL319467
O=C([O-])C=Cc1ccc(O)cc1,5.07,,
Nc1ccc2c(=O)[nH][nH]c(=O)c2c1,5.08,,CHEMBL14882
O=C([O-])C(=O)Nc1sc2c(c1C(=O)[O-])CCSC2,5.08,,
CSCC1OC(n2ccc3c(N)ncnc32)C(O)C1O,5.08,,
O=C([O-])CCCCC1SCC2NC(=O)NC21,5.08,,
O=C(c1ccc(F)nc1)N1CCCC1c1nc(Nc2cc(C3C=C3)[nH]n2)c2cccn2n1,5.08,,
CCCC(=NOCc1ccc(-c2ccc(F)cc2)cc1)C1C(=O)CC(C)(C)C(C#N)C1=O,5.08,,
CC(C)CC([NH3+])C(=O)NC(CO)CCC(N)=O,5.08,,
OC1COC(O)C(O)C1O,5.08,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL14343
CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,5.08,"This molecule is an orally bioavailable, small molecule and dual kinase inhibitor of human epidermal growth factor receptors 1 (EGFR/ErbB1) and 2 (HER2/ErbB2), with potential antineoplastic activity. EGFR/HER2 kinase inhibitor TAK-285 binds to and inhibits EGFR and HER2, which may result in the inhibition of tumor growth and angiogenesis, and tumor regression in EGFR/HER2-expressing tumors. This agent may be active against EGFR/HER2-expressing tumor cells that are resistant to trastuzumab. EGFR and HER2, receptor tyrosine kinases overexpressed in a variety of tumor cell types, play major roles in tumor cell proliferation and tumor vascularization. In addition, TAK-285 appears to pass the blood brain barrier (BBB) and does not appear to be a substrate for efflux pumps.",CHEMBL1614725
CCC(C)(C)C(=O)C(=O)N1CCCCC1C(=O)OC(CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)[O-])c1,5.08,,
O=C([O-])c1ccnc(C(=O)[O-])c1,5.08,,
O=C(COc1ccc(-c2ccccc2)cc1)NC1OC(CO)C(O)C(O)C1O,5.08,,
CC(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C)C(=O)NC(C(=O)NC(CS)C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(N)=O)C(C)O,5.08,,
CC12CC3CC(C)(C1)CC([NH3+])(C3)C2,5.08,,
COC(=O)C(Cc1ccc(C#Cc2ccccc2)cc1)NC(=O)CC1CCCN(C(N)=[NH2+])C1,5.09,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,5.09,,
NC(=[NH2+])N1CCCC(CC(CO)NC(=O)CN2CCCC(N[SH+](=O)[O-])C2=O)C1,5.09,,
CC(C)Cn1c(=O)n(C)c(=O)c2[nH]cnc21,5.09,,
O=C([O-])CCC(NC(=O)c1cccc(NCc2ccc(C=C3SC(=S)NC3=O)cc2)c1)C(=O)[O-],5.09,,
COC1CCCC(C)C(=O)NC2=CC(=O)C(OC)C(CC(C)CC(OC)C(O)C(C)C=C(C)C1OC(N)=O)C2=O,5.09,,
O=C1c2ccccc2-c2c1cccc2-c1nc2ccncc2[nH]1,5.09,,
CCCCC(C[NH2+]C(CCCC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)CC,5.09,,
CSCCC(NC(=O)C(C)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CS)NC(=O)C(CC(C)C)NC(=O)C[NH3+])C(C)O)C(C)C)C(=O)NC(CC(C)C)C(=O)[O-],5.09,,
C[NH+](C)CCCC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,5.09,,
C=CC(C)=CC1(C)SC(=O)C(C(C)=O)=C1O,5.09,,
Nc1ccc2c(c1)S(=O)(=O)NC2=O,5.09,,CHEMBL2016952
CCCCCCOc1cccc(Cn2ccc(O)c(C(=O)[O-])c2=O)c1,5.09,,
CC(=O)N(Cc1ccc(-c2ccc(C(=O)[O-])o2)cc1)Cc1ccc(-c2cc(C(=O)[O-])nn2-c2ccc(Cl)c(Cl)c2)cc1,5.09,,
CC(C)CC(NC(=O)C(NC(=O)CNC(=O)c1ccccc1)C(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(C(=O)[O-])C(C)C,5.09,,
NC(=[NH2+])Nc1cc(C(=O)[O-])ccc1N1C(=O)CCC1(CO)CO,5.1,,
OCC(O)C(O)C(OC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)CO,5.1,,
Oc1cccc(-c2ccccc2)c1O,5.1,,
O=C1NCCC(OC2OCC(O)C(O)C2O)C1O,5.1,,
O=C([O-])C(=O)N(c1ccccc1C(=O)[O-])c1cccc2ccc(O)cc12,5.1,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.1,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.1,,
CCc1oc2cc(S(=O)(=O)Nc3ccc(S(=O)(=O)Nc4nccs4)cc3)ccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,5.1,,CHEMBL1232829
OC1C[NH2+]CC(OC2OCC(O)C(O)C2O)C1O,5.1,,
OC1C[NH2+]CC(OC2OCC(O)C(O)C2O)C1O,5.1,,
CC(C)CC(NC(=O)C([NH3+])Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(C(=O)NC(CO)C(=O)NC(C(=O)[O-])C(C)C)C(C)O)C(C)C,5.1,,
NC(=[NH2+])NCCCC(NS(=O)(=O)c1cccc(C(F)(F)F)c1)C(=O)N1CC[NH+](CCC[NH3+])CC1,5.1,,
CSCCC(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])Cc1c[nH]cn1)C(=O)NC(C)C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(CS)C(=O)N1CCCC1C(=O)[O-])C(C)C,5.1,,
Cc1ccc(C(=O)N(c2cc(-c3ccccc3)sc2C(=O)[O-])C(C)C)cc1,5.1,,
CCN(CC)S(=O)(=O)c1ccc(Cl)c(C(=O)Nc2sc3c(c2C#N)CCC3)c1,5.1,,CHEMBL329363
NC(=[NH2+])NCCCC(NC(=O)C([NH3+])CCCC[NH3+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NCC(=O)O,5.1,,
CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)C([NH3+])C(C)C)C(C)C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)[O-],5.1,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(C=O)C(C)O)C(C)O)C(C)O,5.1,,
Cc1ccc(C2=NOC3(C2)OC(CO)C(O)C(O)C3O)cc1,5.1,,
CC(C)CC(NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(=O)[O-])C(C)O)C(=O)O,5.1,,
O=C([O-])c1ccc2c(c1)C(=O)N(C(Cc1cccc3ccccc13)C(=O)[O-])C2=O,5.1,,
CC(C)C1NC(=O)CCCCOc2ccc(cc2)CC(C(=O)[O-])NC1=O,5.1,,
NC(=[NH2+])c1ccc(N)cc1,5.1,,
N=C1NC(=[NH2+])NC(=O)C1N=O,5.1,,
CCc1nn2c(=O)cc(N3CC[NH2+]CC3)nc2s1,5.1,,
COC(=O)C=CC(=O)NC(Cc1ccc(O)c(Cl)c1)C(=O)[O-],5.1,,
NC(=[NH2+])NCCCC(NC(=O)C([NH3+])CS)C(=O)NCC(=O)NC(CS)C(N)=O,5.1,,
O=c1[nH]c(=O)n(C2OC(CO)C(O)C(O)C2O)cc1F,5.1,,CHEMBL1977258
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(NC(=O)C(C)NC(=O)C(C)[NH3+])C(C)O)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)[O-],5.1,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,5.1,,
Nc1nnc(CC=S)s1,5.1,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)[O-])C(C)O,5.1,,
COc1ccc(C2(c3cccc(-c4cncnc4)c3)CCC(=[NH2+])N2)cc1,5.1,,
CCCOCC(NC(=O)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(NC(C)=O)C(C)C)C(C)O)C(C)C)C(=O)NC(C(=O)NC(C)C(N)=O)C(C)O,5.1,,
CCC(C)C(NC(=O)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)C(CS)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)C)C(C)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C)C(=O)[O-],5.1,,
CCC(C)C(NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(NC(=O)C1CCCN1C(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)C)C(C)O)C(=O)NC(C)C(=O)[O-],5.1,,
CC(C)CC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)CNC(=O)C([NH3+])CCC(=O)[O-])C(=O)[O-],5.1,,
CC1CNc2c(cccc2S(=O)(=O)NC(CCCNC(N)=[NH2+])C(=O)N2CCC(C)CC2C(=O)[O-])C1,5.1,,
CCC(C)C(NC(=O)C(CO)NC(=O)C([NH3+])Cc1ccccc1)C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)[O-])C(C)O)C(C)C,5.1,,
CCC(C)C(NC(=O)C(CO)NC(=O)C([NH3+])Cc1ccccc1)C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)[O-])C(C)O)C(C)C,5.1,,
CCCSCc1cc(N)cc2c(=O)[nH]c(N)nc12,5.11,,
NC(=[NH2+])c1ccc(C2C3C(=O)N(Cc4ccc5c(c4)OCO5)CC3C3CCC[NH+]32)cc1,5.11,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O,5.11,,
CC(C)C1CCC(=O)NCCCCC(NC(=O)C(NC(=O)NC(C(=O)[O-])C(C)C)C(C)C)C(=O)N1,5.11,,
Nc1n(CC[N+]2CCCCC2)c2ccccc2[n+]1CC(O)COc1ccc(Cl)cc1Cl,5.11,,
O=C1NC(C(=O)[O-])C(O)C(O)C1O,5.11,,
C=C1C(=O)OC2CC(C)C3C=CC(=O)C3(C)C(OC(C)=O)C12,5.11,,
Oc1cccc(O)c1,5.11,"This molecule is a very white crystalline solid that becomes pink on exposure to light if not completely pure. Burns although ignition is difficult. Density approximately 1.28 g / cm3. Irritating to skin and eyes. Toxic by skin absorption. Used to make plastics and pharmaceuticals. This molecule is a benzenediol that is benzene dihydroxylated at positions 1 and 3. It has a role as an erythropoietin inhibitor and a sensitiser. It is a benzenediol, a member of resorcinols and a phenolic donor. This molecule is a 1,3-isomer (or meta-isomer) of benzenediol with the formula C6H4(OH)2. It is used as an antiseptic and disinfectant in topical pharmaceutical products in the treatment of skin disorders and infections such as acne, seborrheic dermatitis, eczema, psoriasis, corns, calluses, and warts. It exerts a keratolytic activity. This molecule works by helping to remove hard, scaly, or roughened skin.  Although it is primarily indicated for use as a topical application, resorcinol also possesses a well-documented anti-thyroidal activity that is generally not relied upon for any kind of formal therapeutic indication. This molecule is a natural product found in Dothiorella vidmadera, Maclura pomifera, and other organisms with data available. This molecule is found in alcoholic beverages. This molecule is present in roasted barley, cane molasses, coffee, beer and wine. This molecule is a flavouring ingredientThis molecule belongs to the family of Resorcinols. These are compounds containing a resorcinol moiety, which is a benzene ring bearing two hydrocyl groups at positions 1 and 3.",CHEMBL24147
O=C([O-])C=Cc1cccc(-c2cnc3[nH]ccc3c2)c1,5.11,,
CC(C)CC(NC(=O)C1CSSCC([NH3+])C(=O)NC2CSSCC(NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(CC(C)C)NC2=O)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(Cc2c[nH]cn2)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1)C(N)=O,5.11,,
[NH3+]C(Cc1c[nH]c2ccccc12)C(=O)[O-],5.12,,
C[N+](C)(C)CCOC(N)=O,5.12,"This molecule is a muscarinic agonist discovered in 1932. Carbamoylcholine was initially used as a treatment for migraines, induction of diuresis, and other parasympathetic effects.  Carbamoylcholine was granted FDA approval on 28 September 1972. This molecule is a Cholinergic Receptor Agonist. The mechanism of action of carbamoylcholine is as a Cholinergic Agonist.",CHEMBL965
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)CNC(=O)C1CCCN1C(=O)C([NH3+])CC(N)=O)C(=O)N1CCCC1C(=O)NC(C)C(=O)[O-],5.12,,
Cc1onc(-c2ccc(O)cc2O)c1-c1ccccc1,5.12,,CHEMBL1917723
O=C1c2ccccc2C2=C(c3nc4cnccc4[nH]3)CCCN12,5.12,,CHEMBL1917724
O=c1[nH]c2cc3no[n+](O)c3cc2[nH]c1=O,5.12,,
O=C(CCc1ccccc1)NC(Cc1nc2ccccc2[nH]1)C(=O)[O-],5.12,,
C=CC[NH+](Cc1ccccc1C(=O)NC(c1ccc(OC)cc1)c1ccc(OC)cc1)Cc1ccc2c(c1C(=O)[O-])OCO2,5.12,,
O=C([O-])c1ccc(O)c2ncccc12,5.12,,
NC(=O)c1cccc(NC(=O)C=CC(=O)[O-])c1,5.12,,
Clc1ccc(N(CC2C[NH2+]CC2Cc2ccccc2)c2ccccc2)cc1,5.12,,
O=C([O-])C(Cl)Cc1ccccc1,5.12,,
O=C([O-])c1cc(NCc2cccc([N+](=O)[O-])c2)cc(C(=O)[O-])c1,5.12,,
[NH2+]=c1[nH]c(=S)[nH]c2[nH]cnc12,5.12,,
CN1C(=O)CC(c2ccccc2)Nc2ccccc21,5.12,,CHEMBL1620811
CCOC(=O)c1cc2ccc(O)cc2oc1=O,5.13,,CHEMBL155103
CC(=O)NCCCCC(NC(=O)C(C)NC(=O)CNC(=O)CNC(=O)C(CCCC[NH3+])NC(=O)CNC(=O)C(CC(C)C)NC(=O)C[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)C,5.13,,
CSCCC(NC(=O)C(O)C(O)CNC(=O)C(NC(=O)C(CC(C)C)NC(=O)C([NH3+])CC(N)=O)C(C)C)C(=O)NC(C(=O)NC(C)C(=O)NC(C(=O)NC(C(=O)[O-])C(C)C)C(C)O)C(C)C,5.13,,
Clc1ccc(OCc2ccccc2)c2ncccc12,5.13,,
N#[N+2]=NCC(=O)N1CCC(c2nc(-c3cccs3)no2)CC1,5.13,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],5.13,,
CC(NC(=O)Nc1ccccc1)C1CC1,5.13,,CHEMBL3233603
CCC(C)C(NC(=O)C(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCC[NH2+]1)C(C)C)C(=O)NC(CCSC)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O,5.13,,
COC(C(=O)NCC1CCCN(C(=O)C2CC2)C1)C(O)C(O)C(O)C=CC(C)(C)C,5.13,,
O=C1c2ccccc2C(=O)N1CC1c2ccccc2CCN1C(=O)C1CCCCC1c1nn[nH]n1,5.13,,
CSCCC(NC(=O)C1CSSCC(NC(=O)C(CC(N)=O)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(=O)[O-])C(=O)NC(CO)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)[O-],5.14,,
O=C(c1c2ccccc2cc2ccccc12)N1CCC([NH+]2CCCC(C(=O)N3CCOCC3)C2)CC1,5.14,,
CCC1C2C(C(=O)N1Cc1ccc3c(c1)OCO3)C(c1ccc(C(N)=[NH2+])cc1)[NH+](C)C2(C)C,5.14,,
NC(=[NH2+])N1CCCC(CC(CO)NC(=O)CN2CCCC([NH3+])C2=O)C1,5.14,,
COc1ccc(-c2oc3ncnc(NCCO)c3c2-c2ccc(OC)cc2)cc1,5.14,,CHEMBL190201
O=C([O-])C(O)=CC(=O)c1ccccc1,5.14,,
CNC(N[N+](=O)[O-])=[NH+]Cc1cnc(Cl)s1,5.14,,
Nc1cccc(B(O)O)c1,5.14,,CHEMBL20852
Nc1nc2cc(F)ccc2[nH]1,5.14,,
CC[NH+](CC)CCOc1ccc(Nc2ncc3cc(Oc4ccc(F)cc4)c(=O)n(C)c3n2)cc1,5.14,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)[O-])C(C)O)C(C)O,5.14,,
O=C(c1ccc[nH]1)c1nc2ccccc2[nH]1,5.14,,CHEMBL2089060
C1=CC1c1[nH]nc2nccc(-c3ccco3)c12,5.14,,
O=C([O-])CCc1c[nH]c2ccccc12,5.14,,
Cc1nc(-c2ccccn2)nc(NCCNc2cccc(C(F)(F)F)n2)c1Cl,5.14,,CHEMBL2392771
CC(NC(=O)C(NC(=O)C([NH3+])CCC(N)=O)C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH+](C)C)C(=O)NC(C=O)CO,5.15,,
COC(=O)CC1CC(c2ccc(O)cc2)=NO1,5.15,,CHEMBL210858
O=C([O-])CCCCCn1c(C(=O)[O-])cc2cc(OCc3c(Cl)cccc3Cl)ccc21,5.15,,
[NH3+]C(CO)C(=O)[O-],5.15,,
CCCCC([NH3+])C(O)(O)C[NH2+]C1CC1,5.15,,
Cc1cccc2c(=O)[nH]c(N)nc12,5.15,,
Cc1cc(S(=O)(=O)[O-])ccc1-n1[nH]c(C)c(N=Nc2cc(S(=O)(=O)[O-])ccc2C(=O)[O-])c1=O,5.15,,
c1ccc(Cn2ccnc2)cc1,5.15,"This molecule, an N-imidazole derivative, has been shown to have strong cardiotonic activity.",CHEMBL14192
CCCCCCCCCCCCCC(=O)OC1C(CC(=O)NO)COC(CO)C1O,5.15,,
O=C([O-])C1CC2(C(=O)[O-])C=CC(O)C(C2)O1,5.15,,
CCC(C)C([NH3+])C(=O)NCC(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCSC)C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)[O-])C(C)O,5.15,,
CCc1ccc(C=C2SC(NC(C(=O)NS(=O)(=O)c3ccc([N+](=O)[O-])cc3)c3ccc(F)cc3)=NC2=O)o1,5.15,,
ON=Cc1ccc(O)cc1,5.15,,
CC(C)CC(NC(=O)C([NH3+])CC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)[O-])C(=O)O,5.15,,
CC(C)CC(CO)NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(=O)[O-],5.15,,
CC(C)CC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(C)[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)[O-],5.15,,
CC(C)CC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)[O-],5.15,,
CC([NH3+])C(=O)NC(C)C(=O)NC(CCCC[NH+](C)C)C(=O)NC(CO)C(=O)NC(C(=O)NCC(=O)NCC(=O)[O-])C(C)O,5.15,,
CC(C)CC1(C)NC(=[NH2+])N(Cc2ccc(CNC(=O)Nc3ccc(C#N)cc3)cc2)C1=O,5.15,,
CCC(CC(=O)NCC1CCCCC1)n1c(N)nc2cc(Cl)ccc21,5.15,,
O=C([O-])Cc1csc2ccc3ccccc3c12,5.15,,
O=C(NCC=CC1OCC(O)C1O)c1cc([N+](=O)[O-])cc(O)c1O,5.15,,
CCCCC([NH3+])[NH2+]CCCC([NH3+])C(=O)[O-],5.15,,
N#Cc1ccc(COC(=O)C2CC3(C[NH2+]2)C(=O)Nc2ccccc23)cc1,5.15,,
CC[NH+](CC)CCNS(=O)(=O)c1cccc(OC)c1,5.15,,
CC(C)CC(Cl)C(=O)[O-],5.15,,
[NH3+]C(Cc1ccccc1)C(=O)[O-],5.15,,
CCc1cc2c(n1Cc1ccccc1)CCCC2=O,5.15,,CHEMBL3262777
CC(C)(C)CC(=O)N1CC(O)CC1C(=O)NCc1ccc(-c2cncs2)cc1,5.15,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,5.16,,
COC(=O)c1c(O)cccc1OCC=Cc1ccc(F)c(-c2cc(C(=O)[O-])no2)c1,5.16,,
CSCCC(NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C([NH3+])CO)C(=O)NC(CC(=O)[O-])C(=O)[O-],5.16,,
O=C(NCB(O)O)c1c(F)cccc1F,5.16,,CHEMBL2035285
CSc1nc(N)nc(-c2ccccc2Cl)n1,5.16,,CHEMBL1834095
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH+](C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)O)C(C)O,5.16,,
NC(=[NH2+])c1ccc(OCCCCCCCOc2ccc(C(N)=[NH2+])cc2)cc1,5.16,,
CCOC(=O)C1=C(C)NC(=S)NC1c1cccc(O)c1,5.17,"This molecule is a racemate comprising equimolar amounts of R- and S-monastrol. It has a role as an antineoplastic agent, an EC 3.5.1.5 (urease) inhibitor, an antileishmanial agent and an antimitotic. It contains a (R)-monastrol and a (S)-monastrol.",CHEMBL236789
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,5.17,,
CC(O)C(NC(=O)C([NH3+])CS)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)NC(CC(N)=O)C(=O)[O-])C(C)O)C(C)O,5.17,,
CCC([NH3+])C(=O)N1CCCC1C(=O)NCc1cccc(Cl)c1,5.17,,
O=C1C=CC(=O)c2c(O)cccc21,5.17,"This molecule is a hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone in which the hydrogen at position 5 has been replaced by a hydroxy group. A plant-derived 1,4-naphthoquinone with confirmed antibacterial and antitumor activities. It has a role as a herbicide, a reactive oxygen species generator and a geroprotector. This molecule is a natural product found in Talaromyces diversus, Pterocarya fraxinifolia, and other organisms with data available.",CHEMBL43612
CCC(C)C(NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(C)[NH3+])C(C)CC)C(N)=O,5.17,,
CC(NC(=O)C(Cc1ccc(OCc2ccccc2)cc1)NC(=O)OC(C)(C)C)C(=O)NC(CC1(O)C(=O)Nc2ccccc21)C(=O)NCc1ccccc1,5.17,,
Nc1nc(Nc2cccc(S(N)(=O)=O)c2)sc1C(=O)c1ccccc1,5.17,,
CC(=O)NCCCCC(NC(=O)CNC(=O)CNC(=O)C(CCCCNC(C)=O)NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C([NH3+])CO)C(=O)NCC(=O)NC(CC(C)C)C(=O)NCC(=O)NC(C)C(=O)[O-],5.17,,
Cc1ccc(Nc2ccccc2C(=O)[O-])c(C(=O)[O-])c1,5.17,,
CC(C)CC(NC(=O)C(CO)NC(=O)CNC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C([NH3+])C(C)C)C(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)[O-],5.17,,
Cc1ccc(C(=O)CSc2nc3nc(N)[nH]c(=O)c3[nH]2)cc1,5.17,,CHEMBL3233203
O=C(NCc1cccnc1)c1cc(C(=O)NCc2cccnc2)ncn1,5.18,This molecule is a pyrimidinecarboxamide having the amido groups at the 4- and 6-positions and pyridin-3-ylmethyl as the amide N-substituents. It is a member of pyridines and a pyrimidinecarboxamide.,CHEMBL468900
N=NC(=O)c1ccc(-c2ccccc2Cl)o1,5.18,,
COc1ccc(C2=NOC3(C2)OC(CO)C(O)C(O)C3O)cc1,5.18,,
Cc1occc1C(=O)NC(Cc1nc2ccccc2[nH]1)C(=O)[O-],5.18,,
CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,5.18,,
CCC(=O)Nc1nc(C)c(-c2csc(Nc3ccc(C(=O)[O-])cc3)n2)s1,5.18,,
OC1C[NH+]2CCC(O)C2C(O)C1O,5.18,,
[NH3+]C(CC(=O)[O-])C(=O)[O-],5.18,,
OCC1C[NH2+]CC(O)C1OC1OC(CO)C(O)C(O)C1O,5.19,,
CC(=O)NC1C(OC2C(CO)OC(OC3C(O)C4[NH+]=C(N(C)C)OC4C3CO)C(NC(C)=O)C2O)OC(CO)C(O)C1O,5.19,,
CC(=O)Oc1ccccc1C(=O)[O-],5.19,,
Cc1nc(C)c(-c2ccnc(N)n2)s1,5.19,,CHEMBL47302
CCOC(=O)CN1C(=O)CC(CC(O)C2CC(C)CC(C)C2=O)CC1=O,5.19,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)[O-])C(C)O)C(C)O,5.19,,
CC([NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NCC(=O)O)C(C)C)C(C)O,5.19,,
CC(NC(=O)CCS)C(=O)[O-],5.19,,
c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1,5.19,,CHEMBL1170126
CC(=O)C(CC(=O)[O-])NC(=O)C1C=C(CC2CCCCC2)Cn2c(=O)n(CCNC(=O)c3ccc4nc[nH]c4c3)c(=O)n21,5.19,,
CNc1nc2cc3c(=O)[nH]cnc3cc2[nH]1,5.19,,CHEMBL3298016
CCC(C)C(NC(=O)C(CO)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CC(=O)[O-])C(=O)[O-],5.19,,
CC(C)CC([NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(N)=O,5.19,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(=O)[O-])C(C)C)C(=O)[O-],5.19,,
[NH3+]C(CCC(=O)NC(CS)C(=O)NCC(=O)[O-])C(=O)[O-],5.19,,
COc1ccc2cccc(-n3cc(NC(N)=O)c(C(N)=O)n3)c2c1,5.19,,
CCC(C)C(NC(=O)CNC(=O)C(C)NC(=O)C(C)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(C(=O)[O-])C(C)C)C(C)O)C(C)CC,5.19,,
Cc1c(N)c(O)c2c(c1O)[N+]1=CC([NH3+])C(O)C1=C2COC(N)=O,5.2,,
CC(C)C(CO)Nc1ccc2ncc(-c3ccc(C#N)cc3)n2n1,5.2,,
[NH2+]=c1[nH]c2ccccc2[nH]1,5.2,,
O=NC(=O)C1CC(Oc2ccc(Cl)cc2)CN1S(=O)(=O)c1ccc(Cl)cc1,5.2,,
CCC(C)C(NC(=O)C(C)[NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(CCSC)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(C)C(=O)[O-])C(C)CC)C(C)CC,5.2,,
Cc1cc(C)c(N)c(C(=O)[O-])c1,5.2,,
CC1CN=C(NCCc2ccccc2)S1,5.2,,CHEMBL1873898
OCC1OC(Sc2ccc3ccccc3c2)C(O)C(O)C1O,5.2,,
CC1(c2cccc(-c3cccc(Cl)c3)c2)NC(=[NH2+])CCO1,5.2,,
Cc1noc(C)c1-c1ccc2c(Nc3ccccc3C(C)(C)C)c(C(=O)[O-])cnc2n1,5.2,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(N)=O)C(=O)[O-],5.2,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C(Cc1c[nH]cn1)NC(=O)C([NH3+])CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)[O-])C(C)C,5.2,,
O=S(=O)([O-])c1ccccc1C(c1ccc(O)c(Cl)c1)c1ccc(OC2OC(CO)C(O)C(O)C2O)c(Cl)c1,5.2,,
O=C1NCc2cc(OCC3C[NH2+]CCC3c3ccc(F)cc3)ccc21,5.2,,
C[S+](CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,5.21,,
CC1CCCCC1Oc1cccc(-c2nc3cc(C(N)=[NH2+])c(F)cc3[nH]2)c1O,5.21,,
CC([NH3+])C(=O)NC(C)C(=O)NC(CC(N)=O)C(=O)NC(CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C)C(=O)[O-],5.21,,
O=C([O-])CC(CO)NC(=O)c1cncc(Br)c1,5.21,,
CN(CCO)c1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12,5.21,,CHEMBL364811
O=c1ccn(C2OC(CO)C(O)C(O)C2O)c(=O)[nH]1,5.21,,
CCCCCCCCC=CCCCCCCCC(=O)OCC(COC1OC(CO)C(O)C(O)C1O)OC(=O)CCCCCCCCCCCCCCC,5.21,,
O=C1c2cccc(O)c2C(=O)c2c(O)cccc21,5.21,"This molecule is an orange crystalline powder. Almost odorless and tasteless. (NTP, 1992) This molecule is a dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 8. It has a role as an apoptosis inducer and a plant metabolite. Withdrawn from the Canadian, US, and UK markets in 1998 due to genotoxicity. This molecule is a reddish, synthetic anthraquinone derivative. This molecule has been widely used as a laxative, but is no longer used to treat constipation and is currently used as an antioxidant in synthetic lubricants, in the synthesis of experimental antitumor agents, as a fungicide and as an intermediate for making dyes. This substance is a suspected mutagen and is reasonably anticipated to be a human carcinogen based on evidence of carcinogenicity in experimental animals. (NCI05) This molecule is a natural product found in Senna obtusifolia, Asphodelus fistulosus, and other organisms with data available.",CHEMBL53418
COC(CC(CC[N+](C)CCCc1ccc(F)c(C)c1)C(=O)N=O)c1ccc(F)cc1,5.21,,
CC(C)(C)C#Cc1ccccc1-c1ccc2nc(N)ccc2c1,5.21,,CHEMBL1821808
[NH3+]C1C(OC2C(CO)OC(OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(O)C([NH3+])C5O)C([NH3+])C4O)C([NH3+])C3O)C([NH3+])C2O)OC(CO)C(O)C1O,5.21,,
Nc1n[n+]2c(Cc3cc(O)cc(O)c3)nc3ccccc3c2[nH]1,5.21,,
CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21,5.21,"This molecule is a member of the class of pyrazolopyrimidine that is pyrazolo[3,4-d]pyrimidin-4-amine bearing additional tert-butyl and 4-chlorophenyl substituents at positions 1 and 3 respectively. It is a potent ATP-competitive inhibitor of the Src family of protein tyrosine kinases. It has a role as an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, a beta-adrenergic antagonist and a geroprotector. It is a pyrazolopyrimidine, an aromatic amine and a member of monochlorobenzenes.",CHEMBL406845
[NH3+]CCc1cc(Br)cc(C#Cc2cccc(C=Cc3cc(Br)cc(CC[NH3+])c3)c2)c1,5.21,,
CSCCC([NH3+])C(=O)NC(C)C(=O)NC(CO)C(=O)[O-],5.21,,
O=C([O-])c1ccccc1Nc1cccc(Nc2ccccc2C(=O)[O-])c1C(=O)[O-],5.21,,
CCC(C)(C)NC(=O)C(c1cccn1C)N(C(=O)Cn1nnc2ccccc21)c1ccc(NC(C)=O)cc1,5.21,This molecule is a member of acetamides and an anilide. It has a role as an anticoronaviral agent.,CHEMBL1604997
CCNc1nc(Cl)nc(NC(C)(C#N)CC)n1,5.21,,
O=C([O-])c1c(C(=O)[O-])c(C(=O)[O-])c(C(=O)[O-])c(C(=O)[O-])c1C(=O)[O-],5.22,,
CSCCC(NC(=O)C(C)[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]cn1)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CO)C(=O)[O-],5.22,,
COc1ccc(O)c(-c2nc3ccc(C(N)=[NH2+])cc3[nH]2)c1,5.22,,
Cc1cc(I)c(O)c(C(=O)Nc2ccc(C(N)=[NH2+])c(Cl)c2)c1,5.22,,
O=C(C1CCN(c2ccncc2)CC1)N1CCN(S(=O)(=O)c2ccc3cc(Cl)ccc3c2)CC1,5.22,,CHEMBL270527
CC1CCCCC1Oc1cccc(-c2nc3cc(C(N)=[NH2+])c(F)cc3[nH]2)c1O,5.22,,
NC(=[NH2+])NC(C(=O)NCC(=O)N1CCC(c2cc(-c3cccc(Cl)c3Cl)n[nH]2)CC1)C1CCCCC1,5.22,,
CC(C)C([NH3+])C(=O)N1CCCC1C(=O)NCC(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(=O)[O-],5.22,,
O=S(=O)(Nc1cccc(Oc2ccc(F)cc2)c1)N1CCC([NH2+]Cc2ccccc2O)CC1,5.22,,
CC([NH3+])C1CCC(C(=O)Nc2ccncc2)CC1,5.22,,
CC([NH3+])C1CCC(C(=O)Nc2ccncc2)CC1,5.22,,
O=C([O-])c1ccc(C=NOCCON=Cc2cc(=O)[nH]c(=O)[nH]2)cc1,5.22,,
CCC(C)C(NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CC(=O)[O-])NC(=O)C(CO)NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCSC)C(C)CC)C(=O)[O-],5.22,,
CCC(C)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(N)=O)NC(=O)C([NH3+])CO)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C=O)CCC(N)=O,5.22,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,5.22,,
COC(=O)Cc1ccc(N)cc1C=O,5.22,,
C[N+](C)CC[N+](C)C1COc2ccccc2-c2c(C3CCCCC3)c3ccc(C(=O)[O-])cc3n2C1,5.22,,
CC(C)C1[NH2+]CC(O)C(O)C1O,5.22,,
c1ccc2c(-c3ccncc3)n[nH]c2c1,5.22,,CHEMBL1234032
CCC(C)C([NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)N1CCCC1C(=O)[O-])C(C)O,5.22,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CO)C(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)[O-],5.22,,
CC(=O)c1ccc(N2C(=O)c3cccc(C)c3C2=O)cc1,5.22,,CHEMBL1229661
CC(C)OP(=O)(OC(C)C)c1ccccc1CS,5.22,,CHEMBL1173337
COC(=O)c1ccc(Cl)cc1N,5.22,,CHEMBL1234477
O=C([O-])Cc1c(C(=O)[O-])[nH]c2c(Cl)cc(Cl)cc12,5.22,,
CNC(NC)=[NH+]CCCC(NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(C)C(=O)[O-],5.22,,
O=C1C=CC(O)(c2nc3ccccc3s2)CC1,5.22,,
CC(C)(c1cc(Cl)c(O)c(Cl)c1)c1cc(Cl)c(O)c(Cl)c1,5.22,"This molecule is a bisphenol. This molecule is estrogen receptor(ER) alpha agonists, antagonists for androgen receptor(AR), progesterone receptor(PR) antagonists. It exhibits the ability to reverse the ERR inhibition induced by 4-hydroxytamoxifen.",CHEMBL1738928
C[N+](C)(C)CC(=O)[O-],5.22,"This molecule is a modified amino acid consisting of glycine with three methyl groups that serves as a methyl donor in several metabolic pathways and is used to treat the rare genetic causes of homocystinuria. This molecule has had only limited clinical use, but has not been linked to instances of serum enzyme elevations during therapy or to clinically apparent liver injury. This molecule is the amino acid betaine derived from glycine. It has a role as a fundamental metabolite. It is an amino-acid betaine and a glycine derivative. It is a conjugate base of a N,N,N-trimethylglycinium. This molecule is a methyl group donor that functions in the normal metabolic cycle of methionine. It is a naturally occurring choline derivative commonly ingested through diet, with a role in regulating cellular hydration and maintaining cell function. Homocystinuria is an inherited disorder that leads to the accumulation of homocysteine in plasma and urine. Currently, no treatments are available to correct the genetic causes of homocystinuria. However, in order to normalize homocysteine levels, patients can be treated with vitamin B6 ([pyridoxine]), vitamin B12 ([cobalamin]), [folate] and specific diets. This molecule reduces plasma homocysteine levels in patients with homocystinuria. Although it is present in many food products, the levels found there are insufficient to treat this condition. The FDA and EMA have approved the product Cystadane (betaine anhydrous, oral solution) for the treatment of homocystinuria, and the EMA has approved the use of Amversio (betaine anhydrous, oral powder). This molecule is a Methylating Agent. The mechanism of action of betaine is as a Methylating Activity. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Amaranthus hybridus, Cornulaca leucacantha, and other organisms with data available.",CHEMBL1182
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,5.22,,
O=C(OC1CCSc2ccc(Br)cc21)C1CC2(C[NH2+]1)C(=O)Nc1ccccc12,5.22,,
N#CC1C(=O)c2ccccc2C1=O,5.22,,CHEMBL2032370
Cc1cc(C)c(C=NNC(=O)C([NH3+])Cc2c[nH]c3ccccc23)c(C)c1,5.22,,
O=C(Oc1ccc2c3c(cccc13)C(=O)O2)c1ccc([N+](=O)[O-])cc1,5.22,,CHEMBL3088232
C(#C[P+](c1ccccc1)(c1ccccc1)c1ccccc1)c1ccccc1,5.22,,
[NH3+]CCCCC([NH3+])C(=O)NC(CC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)[O-],5.23,,
NC(=O)c1cn(C(CO)CCc2ccccc2)cn1,5.23,,CHEMBL13696
O=C1NS(=O)(=O)c2ccccc21,5.23,"This molecule appears as odorless white crystals or crystalline powder. Aqueous solution is neutral or alkaline to litmus, but not alkaline to phenolphthalein. Effloresces in dry air. Intensely sweet taste. (NTP, 1992) This molecule is a 1,2-benzisothiazole having a keto-group at the 3-position and two oxo substituents at the 1-position. It is used as an artificial sweetening agent. It has a role as a sweetening agent, a xenobiotic and an environmental contaminant. It is a 1,2-benzisothiazole and a N-sulfonylcarboxamide. This molecule has been investigated for the treatment of Hypertension and Hyperglycemia.",CHEMBL310671
CCC(NC(=O)CC1OC(C)C(O)C(O)C1O)C(=O)N1CCCC1C(=O)NC(CC(C)C)C(N)=O,5.23,,
COc1ccc(-c2ccc3sc(C(N)=[NH2+])cc3c2)cc1OC,5.23,,
COc1ccc(O)c(-c2nc(N)nc(N)n2)c1,5.23,,CHEMBL1327043
COc1ccc(O)c(-c2nc(N)nc(N)n2)c1,5.23,,CHEMBL1327043
[NH3+]C1C(=O)OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(OC4OC(CO)C(OC5OC(CO)C(O)C(O)C5[NH3+])C(O)C4[NH3+])C(O)C3[NH3+])C(O)C2[NH3+])C1O,5.23,,
Cc1cccc(C(=O)CSc2nc3nc(N)[nH]c(=O)c3[nH]2)c1,5.23,,CHEMBL3233208
CCCCNc1ncc(C(=O)N(C)CCCC)c(NC2CCC(O)CC2)n1,5.23,,
OC1C[NH2+]CC(OC2OCC(O)C(O)C2O)C1O,5.24,,
[NH3+]C(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-],5.24,,
O=S(=O)(c1cccc2cnccc12)N1CCC[NH2+]CC1,5.24,,
C[NH+](C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,5.24,,
CC(C)Cn1c(=O)n(C)c(=O)c2c(-c3ccncc3)n(Cc3cccc4ccccc34)nc21,5.24,"This molecule is a pyrazolopyrimidine that is alloxanthine which is substituted at positions 2, 3, 5, and 7 by 1-naphthylmethyl, 4-pyridyl, methyl, and isobutyl groups, respectively. It is functionally related to an alloxanthine.",CHEMBL401874
CCC(C)C([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)O)C(C)C,5.24,,
CC(C)CC(NC(=O)C(CO)NC(=O)C[NH3+])C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)C,5.24,,
C[NH+](C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,5.24,,
CC(=O)NC(BO)Cc1ccc(Cl)cc1,5.24,,
CCCCOc1nc(NCC[NH+]2CCOCC2)c2ncn(Cc3c(F)cccc3F)c2n1,5.24,,
CC(=O)NC(CO)C(=O)NC(C)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)[O-])C(C)C,5.24,,
[NH3+]CCCCC(NC(=O)OCc1ccccc1)C(=O)NC(CCc1ccccc1)C(=O)NC(CCCC[NH3+])C(O)c1nc2ccccc2o1,5.24,,
CC(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CCCC[N+](C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.24,,
OCC1OC(NC(=S)N=NCc2ccc(F)cc2)C(O)C(O)C1O,5.24,,
O=C([O-])c1ccc2nc(-c3ccc(Cl)cc3)n(C(C(=O)NC3CCCCC3)C3CCCCC3)c2c1,5.24,,
CC(=O)NCCc1c[nH]cn1,5.24,"This molecule is a member of the class of acetamides that is acetamide comprising histamine having an acetyl group attached to the side-chain amino function. It has a role as a human metabolite. It is a member of acetamides and a member of imidazoles. It is functionally related to a histamine. This molecule is a natural product found in Drosophila melanogaster, Euglena gracilis, and other organisms with data available.",CHEMBL1230893
O=C([O-])c1ccccc1SCc1ccc(Cl)c(Cl)c1,5.24,,
COc1cc(Br)cc2cc(C(=O)[O-])oc12,5.24,,
Nc1nc(Nc2cccc(F)c2)sc1C(=O)c1ccccc1,5.24,,CHEMBL2377846
O=C([O-])CCCc1ccccc1,5.24,,
CCCCCCCCCCCC(=O)[O-],5.24,,
CCC1CCCCC1(O)C(=O)C(=O)N1CCCCC1C(=O)OC(CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)[O-])c1,5.24,,
CCC1CCCCC1(O)C(=O)C(=O)N1CCCCC1C(=O)OC(CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)[O-])c1,5.24,,
CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)C)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(N)=O,5.24,,
Nc1ccc2[nH]c(=O)c3ccccc3c2c1,5.24,,CHEMBL225725
CC1OC(Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)C(O)C(O)C1O,5.24,,
CC(C)(C)c1cccc(C2C=CC=NC2=O)c1,5.24,,
CCC(C)C(CO)C(O)C(=O)NC1CC1CC(CCc1ccccc1)NC(=O)C(C)NC(=O)OCc1ccccc1,5.24,,
Oc1cccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)c1,5.24,,
CC(C)CC(NC(=O)C(NC(=O)CNC(=O)c1ccccc1)C(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(C(=O)[O-])C(C)C,5.24,,
CC(C)CC(NC(=O)C(NC(=O)CNC(=O)c1ccccc1)C(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(C(=O)[O-])C(C)C,5.24,,
CC(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)NC(Cc1cccc(Cl)c1)C(N)=O,5.25,,
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1ccccc1)NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CC(N)=O)C(C)O)C(=O)NC(Cc1ccccc1)C(=O)O,5.25,,
CC(NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(C(=O)NC(CO)C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C)C(C)O)C(C)C)C(C)C,5.25,,
CC(C)C(NC(=O)C(CO)NC(=O)C(NC(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CC(=O)[O-])C(C)C)C(C)C)C(C)O)C(=O)NC(CC(=O)[O-])C(=O)[O-],5.25,,
Cc1ccc(NC(=O)C=Cc2ccccc2)cc1C(=O)Nc1cnc2nc(-c3ccccc3)[nH]c2c1,5.25,,
C[S+](CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,5.25,,
CCN1CNS(=O)(=O)c2cc(F)ccc21,5.25,,CHEMBL411612
CCCCC(NC(=O)c1ccccc1)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C=O)CCCNC(N)=[NH2+],5.25,,
COC(C(=O)NC1Cc2ccccc2C1)C(O)C(O)C(O)CCC(C)(C)C,5.25,,
CSCCC(NC(=O)CNC(=O)C(Cc1c[nH]cn1)NC(=O)C(C)[NH3+])C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)[O-],5.25,,
Cc1cc(S(=O)(=O)N(Cc2ccc(C[NH3+])cc2)C(C)C(=O)NO)ccc1F,5.25,,
O=C1Nc2ccc(S(=O)(=O)[O-])cc2C1=C1Nc2ccccc2C1=O,5.26,,
CC(O)CNc1ncnc2[nH]c(-c3ccccc3)c(-c3ccccc3)c12,5.26,,
CC(=O)NC1C(=NOC(=O)Nc2ccccc2)OC(CO)C(O)C1O,5.26,,
Cc1ccc(F)c(C(=O)C=C(O)C(=O)[O-])c1Cl,5.26,,
NC(=[NH2+])NCCCC(NC(=O)C([NH3+])CCC(N)=O)C(=O)NC(CCC(=O)[O-])C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(N)=O,5.26,,
O=c1[nH]c2ncccc2c2ccccc12,5.26,,
Nc1cccc(C(=O)NC(C(=O)NO)c2ccc(-n3cccn3)cc2)c1,5.26,,CHEMBL3359699
Cc1cc(CNC(=O)C2CC(O)CN2C(=O)CC(C)(C)C)ccc1-c1cncs1,5.26,,
CC(=O)OC1CC2(C)C(CC(O)C3C4(C)CCC(O)C(C)C4CCC32C)C1=C(CCC=C(C)C)C(=O)[O-],5.27,,
Cc1cc2occ(C[NH+](C)CC[NH+](C)Cc3cn(-c4cccc(C(F)(F)F)c4)c4ccccc34)c(=O)c2cc1C,5.27,,
CSCCC(NC(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C(C)[NH3+])C(C)O)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C,5.27,,
COc1cc2c(cc1OS(N)(=O)=O)CCC1C2CCC2(C)C(O)CCC12,5.27,,
Cc1ccc(Sc2cc(N)nc(N)n2)cc1,5.27,,CHEMBL578789
[NH3+]C(CC(=O)[O-])C(=O)Nc1ccc(OCc2ccccc2)cc1,5.27,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CO)C(=O)NC(CCC(=O)[O-])C(=O)[O-],5.27,,
CCC(=O)c1ccc(CC)cc1,5.27,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,5.27,,
Cc1cc(CC(=O)N2CC(O)CC2C(=O)NCc2ccc(-c3cnco3)cc2)on1,5.27,,
COc1ccc(C2C(O)C(O)C(C)[NH+]2C)cc1,5.27,,
COc1cc(-c2ccc3c(c2)OCCN3C)cc(C)c1O,5.27,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,5.27,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,5.27,,
[NH3+]CCCCC([NH3+])C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)[O-],5.28,,
CC(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(C)C,5.28,,
NC(=[NH2+])NC(=O)c1nc(Cl)c(N)nc1N,5.28,,
CC(c1ccc(Cl)cc1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O,5.28,,
CCC(C)C(NC(=O)C(CC(N)=O)NC(=O)C(CCSC)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CCC(N)=O)C(=O)NC(CCSC)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C)C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],5.28,,
Cc1n[nH]cc1-c1ccc(CC[NH3+])cc1,5.28,,
CC(C)Oc1cccc(NC(=O)c2cc(Cl)c(OCC[NH3+])c(Cl)c2)c1,5.28,,
COc1ccc(C=C2C(=O)Nc3ccc(N)cc32)cc1,5.28,,
OCC1OC(OC2C(CO)OC(OC3C(O)C[NH2+]OC3CO)C(O)C2O)C(O)C(O)C1O,5.28,,
CN(C(=O)C(Cc1c[nH]cn1)NC(=O)OCc1ccccc1)C(Cc1ccccc1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NO,5.28,,
Cn1c(-c2ccccc2)c(-c2cn(CCC(=O)Nc3ccc(-c4ccccc4)cc3)nn2)c2cc(C(=O)[O-])c(O)cc21,5.28,,
O=C([O-])C(=O)NC(CSCc1cccc([N+](=O)[O-])c1)C(=O)[O-],5.28,,
O=CCC(NC(=O)OC1CCCC1)c1ccccc1,5.28,,
COc1cc(C=CCO)ccc1O,5.28,,
CC(C)CC(NC(=O)CNC(=O)C1CCCN1C(=O)C([NH3+])CC(N)=O)C(=O)NC(C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CO)C(=O)[O-],5.28,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(C)[NH3+])C(C)C)C(=O)[O-],5.28,,
Cn1nccc1C(=O)Nc1cccnc1,5.28,,CHEMBL1494030
O=C([O-])C(=O)Nc1sc2c(c1C(=O)[O-])CC[NH2+]C2,5.29,,
[NH3+]CCCNc1ccccc1[N+](=O)[O-],5.29,,
CCCCCCCCN=C1SCC2C(O)C(O)C(O)C(O)N12,5.29,,
O=C([O-])CCC(=O)C(=O)[O-],5.29,,
CNC(=O)NC(=[NH2+])NCCCC(NC(C)=O)C(=O)N(C)C(Cc1ccccc1)C(=O)NC(CC(=O)[O-])C(=O)[O-],5.29,,
C=CC(C)(C)c1cc2cc3c(cc2oc1=O)OC(C(C)(C)OC(C)=O)C3,5.29,"This molecule is a natural product found in Boenninghausenia albiflora, Ruta graveolens, and other organisms with data available. This molecule is a member of psoralens.",CHEMBL1917738
COC(C(=O)NCCC(c1ccccc1)c1ccco1)C(O)C(O)C(O)C=CC(C)(C)C,5.29,,
O=C(CCc1ccc(-c2ccccc2)cc1)NC1OC(CO)C(O)C(O)C1O,5.29,,
CCC(C)CC=CC(=O)NC(Cc1cc(F)cc(F)c1)C(=O)NC1C(=O)N2CCCC2C(=O)N2CCC(C)CC2C(=O)NC(C)C(=O)N2CCCC2C(=O)OC1C,5.29,,
O=c1[nH]cnc2c(C3OC(CO)C(O)C3O)n[nH]c12,5.3,,
COc1cc2ncnc(Nc3cccc(SC)c3)c2cc1OC,5.3,,CHEMBL29641
NC(=[NH2+])c1ccc2[nH]c(Cc3nc4ccc(C(N)=[NH2+])cc4[nH]3)nc2c1,5.3,,
NC(=[NH2+])c1ccc2[nH]c(Cc3nc4ccc(C(N)=[NH2+])cc4[nH]3)nc2c1,5.3,,
NC(=[NH2+])c1ccc2[nH]c(Cc3nc4ccc(C(N)=[NH2+])cc4[nH]3)nc2c1,5.3,,
NC(=[NH2+])c1ccc2[nH]c(Cc3nc4ccc(C(N)=[NH2+])cc4[nH]3)nc2c1.NC(=[NH2+])c1ccc2[nH]c(Cc3nc4ccc(C(N)=[NH2+])cc4[nH]3)nc2c1,5.3,,
CN(C)c1cccc2c(S(=O)(=O)NC(Cc3ccc(OS(=O)(=O)c4cccc5c(N(C)C)cccc45)cc3)C(=O)[O-])cccc12,5.3,,
CC(C)CC(NC(=O)C1CCCN1C(=O)CNC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(C(=O)NCC(=O)NC(C)C(=O)O)C(C)C,5.3,,
CC(C)CC([NH3+])C(=O)NC(C)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)O)C(C)O,5.3,,
O=c1[nH]cnc2c(C3OC(CO)C(O)C3O)n[nH]c12,5.3,,
Cc1cc(N=Nc2ccccc2C(=O)[O-])ccc1O,5.3,,
[NH2+]=c1[nH]c(=O)c2[nH]cnc2[nH]1,5.3,,
O=c1ccn(C2CC(F)C(COC(c3ccccc3)(c3ccccc3)c3ccccc3)O2)c(=O)[nH]1,5.3,,CHEMBL197951
Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21,5.3,"This molecule is a 9H-purine that is substituted by a (2-hydroxyethyl)nitrilo, benzylnitrilo and a methyl group at positions 2,6 and 9, respectively. It is a cyclin-dependent kinase inhibitor. It has a role as an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor. It is a member of 2,6-diaminopurines and a member of ethanolamines.",CHEMBL280074
Cc1ccc(NC(=O)c2ccc(C[NH+]3CC[NH+](C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,5.3,,
[NH3+]CCCCC([NH3+])C(=O)[O-],5.3,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH+](C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)O)C(C)O)C(C)O,5.3,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(NC(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CS)C(=O)[O-],5.3,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)[O-])C(C)O)C(C)O,5.3,,
CC(C)CC(NC(=O)C(NC(=O)C(C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(C)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(C)NC(=O)C([NH3+])C(C)O)C(C)O)C(=O)NCC(=O)[O-],5.3,,
OCC1C[NH2+]CC(O)C1OC1OC(CO)C(O)C(O)C1O,5.3,,
[NH3+]Cc1ccc(Cl)cc1,5.3,,
O=Cc1ccccc1,5.3,"This molecule appears as a clear colorless to yellow liquid with a bitter almond odor. Flash point near 145 °F. More denser than water and insoluble in water. Hence sinks in water. Vapors are heavier than air. The primary hazard is to the environment. Immediate steps should be taken to limit spread to the environment. Easily penetrates the soil to contaminate groundwater and nearby waterways. Used in flavoring and perfume making. This molecule is an arenecarbaldehyde that consists of benzene bearing a single formyl substituent; the simplest aromatic aldehyde and parent of the class of benzaldehydes. It has a role as a flavouring agent, a fragrance, an odorant receptor agonist, a plant metabolite, an EC 3.5.5.1 (nitrilase) inhibitor and an EC 3.1.1.3 (triacylglycerol lipase) inhibitor. This molecule is an aromatic aldehyde bearing a single formyl group with an almond odor. This molecule can be derived from natural sources and is widely used by the chemical industry in the preparation of various aniline dyes, perfumes, flavorings, and pharmaceuticals. This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Camellia sinensis, Humulus lupulus, and other organisms with data available.",CHEMBL15972
CC(=O)NC1C(O)C=C(C(=O)[O-])OC1C(O)C(O)CO,5.3,,
OC1C[NH+]2CCCC(O)C2C1O,5.3,,
OC1C[NH2+]C(Cc2ccccc2)C(O)C1O,5.3,,
c1ccc(-c2ccncn2)cc1,5.3,This molecule is a biaryl that is pyrimidine substituted at position 4 by a phenyl group. It is a member of pyrimidines and a biaryl.,CHEMBL1235765
CSCCC(NC(=O)CNC(=O)C(C)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NCC(=O)O)C(C)O,5.3,,
CN(C)c1cccc(C[NH2+]CC(O)C(Cc2ccccc2)NC(=O)C2(Cc3ccccc3)CN(Cc3ccccc3)C(=O)N2)c1,5.3,,
Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1,5.3,,CHEMBL504805
CC(C)CC(NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)[O-],5.3,,
COc1cc(CS(C)(=O)=O)ccc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1,5.3,,
CC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C1CCC[NH2+]1)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)N1CCCC1C(=O)[O-])C(C)O,5.3,,
NC(=O)c1ccc2c(c1)nc(NCc1ccccc1Cl)n2CC1CCCCC1,5.3,,CHEMBL1086880
NC(=O)c1cc(N)c2c(c1)nc(NCc1ccccc1Cl)n2CC1CCCCCC1O,5.3,,
O=C(c1cncc(Br)c1)N1CCC([N+]2CCCC2)CC1,5.3,,
CCC(C)C(NC(=O)C([NH3+])CO)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)[O-])C(C)CC,5.3,,
COCCCOc1ccnc(C[S+](O)c2nc3ccccc3[nH]2)c1C,5.3,,
C[N+](C)(C)CC(=O)CC(=O)[O-],5.3,,
Nc1ccc(C(=O)[O-])cc1,5.3,,
CCCNc1nc(N)c(C(O)c2ccc3ccccc3c2)s1,5.3,,
Nc1ncc2c(n1)-c1ccccc1C(c1ccccc1)C2,5.3,,
CC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)C(NC(=O)C1CCC[NH2+]1)C(C)O)C(C)C)C(=O)NC(CC(=O)[O-])C(=O)[O-],5.3,,
CC(NC(=O)C(CO)NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)[O-])C(C)C)C(C)C)C(C)O)C(C)O)C(C)C,5.3,,
Cn1cnc(-c2nc(=O)c(O)c(C(=O)[O-])[nH]2)c1,5.3,,
CCCCCCCCCc1nc2cc(Cl)ccc2c(=O)n1[NH3+],5.3,,
CC(C)c1ccc(CCC(=O)NC2OC(CO)C(O)C(O)C2O)cc1,5.3,,
CSCCC([NH3+])C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CO)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C)C(=O)NC(CC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(CC(C)C)C(=O)[O-])C(C)C)C(C)C,5.3,,
Cc1nc(-c2nc3ccc(Cl)cc3[nH]2)c(C)c(-c2ccccc2)c1C(OC(C)(C)C)C(=O)[O-],5.3,,
[NH3+]C(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-],5.31,,
COC1OC(CO)C(O)C(OC2OC(C)C(O)CC2O)C1OC1OC(CO)C(O)C(O)C1O,5.31,,
O=C([O-])CCNC(=O)c1cc(-c2ccc(F)cc2F)cc(I)c1O,5.31,,
CC(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.31,,
CC(C)CC(NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(NC(=O)C1CCCN1C(=O)C(C)[NH3+])C(C)O)C(=O)NC(CO)C(=O)[O-],5.31,,
Cc1nc(-c2ccc(S(=O)(=O)NCCC(C)C)cc2)cs1,5.31,,CHEMBL3286496
CCC(NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCC=CCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C2CCCN2C(=O)C(NC(=O)C(CC(N)=O)NC(=O)C(CCCC[NH3+])NC(C)=O)C(C)CC)C(=O)NC(CCC(N)=O)C(=O)NC(C)C(=O)NC(Cc2c[nH]cn2)C(=O)N1)C(=O)NC(CCSC)C(=O)NC(C(=O)[O-])C(C)C,5.31,,
CCCCCCCCCCC1=C(O)C(=O)NC1=O,5.32,,
[NH3+]C(Cn1ccc(=O)[nH]c1=O)C(=O)[O-],5.32,,
OCC1[NH2+]CC(O)C(O)C1O,5.32,,
[NH3+]C1(C(=O)[O-])CC1,5.32,,
CNC(=O)C1Cc2ccc(NS(=O)(=O)[O-])cc2CN1C(=O)CCc1cccc(NS(=O)(=O)[O-])c1,5.32,,
CC(C)CC([NH3+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C=O)Cc1ccc(O)cc1)C(C)O)C(C)C,5.32,,
NC(=O)c1sc(Nc2ccc(S(N)(=O)=O)cc2)nc1N,5.32,,CHEMBL2377813
Cc1ccccc1C(=O)c1sc(Nc2ccc(S(N)(=O)=O)cc2)nc1N,5.32,,CHEMBL2377814
O=C(c1c2ccccc2cc2ccccc12)N1CCC([N+]2CCCC(C(=O)N3CCOCC3)C2)CC1,5.32,,
CC(C)(C)NC(=O)C(c1cccnc1)N(C(=O)c1ccco1)c1ccc(C(C)(C)C)cc1,5.32,,CHEMBL2311694
O=C(Nc1ccc(C2=NCCN2)cc1)c1ccc(C(=O)Nc2ccc(C3=NCCN3)cc2)c(-n2oo2)c1,5.32,,
CCNS(=O)(=O)c1ccc2c(c1)CN(C)C(=O)N2,5.32,,CHEMBL2179383
O=C([O-])CC(O)C(=O)[O-],5.32,,
O=C([O-])Cc1cc(=O)oc2c(O)c(O)ccc12,5.32,,
[NH3+]C(Cc1c[nH]c2ccccc12)C(=O)[O-],5.32,,
[NH3+]C(Cc1c[nH]c2ccccc12)C(=O)[O-],5.32,,
CCCCCCSCC(NC(=O)CCC([NH3+])C(=O)[O-])C(=O)NCC(=O)[O-],5.33,,
CCCn1cnc2c1c(=O)n(CCCCC(C)=O)c(=O)n2C,5.33,This molecule is an oxopurine.,CHEMBL1079905
CC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CO)CC(=O)[O-],5.33,,
CCCCCCCCCCC(=O)NC(Cc1cnc[nH]1)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)N(C)CCc1ccccn1,5.33,,
O=C(NCC=CC1OC(n2cnc(C(F)(F)F)c2)C(O)C1O)c1cc([N+](=O)[O-])cc(O)c1O,5.33,,
[NH3+]C(CO)C(=O)[O-],5.33,,
[NH3+]C(Cc1c[nH]c2ccccc12)C(=O)[O-],5.33,,
CC[NH2+]C1C(=N)N(Cc2ccccc2)C(=O)NC1=O,5.33,,
Cc1ccc(C(=O)[O-])c(Nc2c(C)cccc2C(=O)[O-])c1,5.33,,
O=c1[nH]cnc2scc(-c3ccccc3)c12,5.33,,
Cc1cccnc1-n1nc(-c2ccccc2)nc1C1C=NC(=O)C(Cl)=C1,5.33,,
CC(O)C(NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)[O-],5.34,,
O=C(NO)NC(Cc1ccccc1)C(=O)[O-],5.34,,
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCC[NH3+])NC(=O)C1CCC[NH2+]1)C(C)C)C(C)O)C(=O)NC(C)C(=O)NC(C(=O)[O-])C(C)O,5.34,,
O=C(NC(=O)c1ccccc1)NC1OC(CO)C(O)C(O)C1O,5.34,,
O=C(NC(=O)c1ccccc1)NC1OC(CO)C(O)C(O)C1O,5.34,,
FC(F)(CNc1nccc2oc(Cc3ccccc3-n3cncn3)nc12)C1CCCC[NH2+]1,5.34,,
O=C(NC(=O)c1ccccc1)NC1OC(CO)C(O)C(O)C1O,5.34,,
NS(=O)(=O)C1OC(CO)C(O)C(O)C1O,5.34,,
O=S(=O)([O-])OC1C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C1OS(=O)(=O)[O-],5.34,,
Cn1c(N)nc2ccccc21,5.34,This molecule is a member of benzimidazoles.,CHEMBL1232570
Cc1cc(OCC(=O)[O-])cc(C)c1Cc1ccc(O)c(C(C)C)c1,5.34,,
O=c1nc[nH]c2nc[nH]c12,5.34,,
O=C(CCC[N+](Cc1ccc(Cl)cc1)Cc1ccc(Cl)cc1)NO,5.34,,
O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)c(O)c(O)c12,5.34,"This molecule is a hexahydroxyflavone that is flavone substituted by hydroxy groups at positions 3, 5, 6, 7, 3' and 4' respectively. It has a role as an antioxidant, an antiviral agent and a plant metabolite. It is a member of flavonols and a hexahydroxyflavone. It is functionally related to a quercetin. This molecule is a natural product found in Citrus reticulata, Cupressus sempervirens, and other organisms with data available.",CHEMBL413552
CC(C)CC(NC(=O)C(NC(=O)C(C)NC(=O)OCc1ccccc1)C(C)C)C(=O)NC(C=N)CCC(N)=O,5.34,,
COc1cccc(-c2cccc(C3CC3C3=NC(=N)N(C)C(=O)C3)c2)c1,5.34,,
CC(=O)NC1C(NC(=O)CC([NH3+])C(=O)[O-])OC(CO)C(OC2OC(CO)C(OC3OC(COC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4NC(C)=O)C(O)C(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4NC(C)=O)C3O)C(O)C2NC(C)=O)C1O,5.34,,
O=C([O-])c1ccc(Cl)cc1NS(=O)(=O)c1ccc(Br)s1,5.34,,
O=C1C2(Cl)C3C4(Cl)C(Cl)(Cl)C5(Cl)C3(Cl)C1(Cl)C5(Cl)C24Cl,5.34,,
COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,5.34,,CHEMBL479079
O=C(C1CCN(c2ccncc2)CC1)N1CCN(S(=O)(=O)c2ccc3cc(Cl)ccc3c2)CC1,5.35,,CHEMBL270527
CNC(=O)NC(=[NH2+])NCCCC1NC(=O)C(C)NC(=O)CC(C(=O)[O-])NC(=O)CC(C(=O)[O-])NC(=O)C(Cc2ccccc2)N(C)C1=O,5.35,,
O=C([O-])c1ccnc(C(=O)[O-])c1,5.35,,
CCC(NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)O)C(=O)NC(CCC(N)=O)C(=O)O,5.35,,
CSCCC(NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)[O-],5.35,,
Cc1ccc(F)cc1-c1nc2n[nH]c(N)c2c2ccccc12,5.35,,
[NH3+]CCOC(=O)Cc1cccc2ccccc12,5.35,,
O=C(C=CC1=CN(C2OC(CO)C(O)C2O)CC=C1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,5.35,,
CC(=O)OCC1OC(OC2C(COC(C)=O)OC(S(N)(=O)=O)C(OC(C)=O)C2OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O,5.35,,
CCCCCCCN(CCc1ccc(OC(C)(C)C(=O)[O-])cc1)c1nc2ccccc2o1,5.35,,
CC(C)CC([NH3+])C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)[O-])C(C)O,5.35,,
Nc1c(I)c(C(=O)[O-])c(I)c(C(=O)[O-])c1I,5.35,,
CCC(C)C(NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(Cc1c[nH]cn1)NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C([NH3+])CO)C(=O)NCC(=O)[O-],5.35,,
CC([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C)C(C)O,5.35,,
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(NC(=O)C1CCCN1C(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CO)C(C)O)C(C)O)C(=O)[O-],5.35,,
NC(=[NH2+])NCCCC(NC(=O)C(CCC(N)=O)NC(=O)c1ccc(OC2OC(CO)C(O)C(O)C2O)cc1)C(=O)NC(CO)C(N)=O,5.35,,
CC1CN(C(C)C(=O)[O-])C(=O)c2cccc(NS(=O)(=O)c3ccc(F)cc3)c2OC1CN(C)C(=O)Nc1ccc(C(F)(F)F)cc1,5.35,,
CCCCCC=CCC=CCC=CCC=CCCCC(=O)[O-],5.36,,
CC([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(C(=O)[O-])C(C)C)C(C)C,5.36,,
CC12CCc3c(ccc4cc(O)ccc34)C1CCC2=O,5.36,,
CC(C)N(C(=O)c1ccc(Cl)cc1Cl)c1cc(-c2ccccc2)sc1C(=O)[O-],5.36,,
NS(=O)(=O)c1ccc(CC[NH3+])cc1,5.36,,
[NH3+]C(Cc1c[nH]c2ccccc12)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1c[nH]cn1)C(=O)NC(C=O)CC(=O)[O-],5.36,,
O=C(NC(=O)c1ccc(Cl)cc1)NC1OC(CO)C(O)C(O)C1O,5.36,,
CC1C=CC(CC(NC(=O)C(C)NC(=O)C2CCCN2C(=O)C2CC3CCCCC3N2C(=O)C([NH3+])CC=CNC(N)=[NH2+])C(=O)O)CC1,5.36,,
Nc1ncnc2c1nc(NCc1ccc3ccccc3n1)n2C1OC(CO)C(O)C1O,5.36,,
CC1CCC(c2ccccc2-c2cc(-c3ccccc3)sc2C(=O)[O-])CC1,5.36,,
CC1OC(OC2=C(O)c3c(O)cc(O)cc3OC2c2ccc(O)cc2)C(O)C(O)C1O,5.36,,
CN1Cc2cc(S(=O)(=O)Nc3ccccc3)ccc2NC1=O,5.36,,CHEMBL2179384
NC(=[NH2+])c1ccc(NC(=O)Nc2cccc(C[NH3+])c2)cc1,5.36,,
CC=C1C2C=C(C)CC1([NH3+])c1ccc(=O)[nH]c1C2,5.37,,
CC(C)(C)NC(=O)C1C[NH+](Cc2cccnc2)CC[NH+]1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O,5.37,,
COCCN1C(=O)C(=Cc2ccc(-c3ccc(Cl)c(C(=O)[O-])c3)o2)SC1=Nc1ccccc1,5.37,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(CCCCNC(C)=O)NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1cnc[nH]1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(NC(=O)C(CO)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C([NH3+])CCCC[NH3+])C(C)O)C(=O)NC(C=O)Cc1ccccc1,5.37,,
[NH3+]Cc1ccc([N+](=O)[O-])cc1,5.37,,
CCCC(NC(=O)C(CC(C)C)NC(=O)C(CC=CCC(C)C)C(C)C)C(O)C(=O)NCC(=O)NC(C(=O)[O-])c1ccccc1,5.37,,
CNC(=O)NC(=[NH2+])NCCCC(NC(=O)C(C)NC(C)=O)C(=O)N(C)C(Cc1ccccc1)C(=O)NC(CC(=O)[O-])C(=O)[O-],5.37,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)[O-])C(C)O)C(C)O,5.37,,
Cc1nnc(C[NH2+]CC[NH+]2C(O)c3cccc4cccc(c34)C2O)s1,5.37,,
C#Cc1cn(C2OC(CO)C(O)C(O)C2O)c(=O)[nH]c1=O,5.37,,
CC1=C(SCC(NC(=O)CCC([NH3+])C(=O)[O-])C(O)[NH2+]CC(=O)[O-])C(=O)c2ccccc2C1=O,5.37,,
NC(=O)CNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(OC2OC(CO)C(O)C(O)C2O)cc1,5.37,,
NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(OC2OC(CO)C(O)C(O)C2O)cc1,5.37,,
Oc1ccccc1O,5.37,"Solid; white; odorless. Sinks and mixes with water. (USCG, 1999) This molecule is a benzenediol comprising of a benzene core carrying two hydroxy substituents ortho to each other. It has a role as a genotoxin, an allelochemical and a plant metabolite. It is a conjugate acid of a catecholate(1-). Exposure to catechol may occur during its manufacture and use. Skin contact with catechol causes eczematous dermatitis in humans. In humans, absorption through the skin results in an illness resembling that induced by phenol, except convulsions are more pronounced. Large doses of catechol can cause depression of the central nervous system (CNS) and a prolonged rise of blood pressure in animals. Due to the lack of information regarding the duration of exposure in the above studies, it is not clear whether these health effects were observed following acute (short-term) or chronic (long-term) exposure. Tumors in the glandular stomach were observed in orally exposed rats. The International Agency for Research on Cancer (IARC) has classified catechol as a Group 2B, possible human carcinogen. EPA has not classified catechol with respect to potential carcinogenicity. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a natural product found in Pinus densiflora, Illicium simonsii, and other organisms with data available. This molecule is a benzenediol, with formula C6H4(OH)2. It was first prepared in 1839 by H. Reinsch by distilling catechin (the juice of Mimosa catechu). This colourless compound occurs naturally, but about 20000 tons are manufactured each year, mainly as precursors to pesticides, flavors, and fragrances. Its sulfonic acid is often present in the urine of many mammals. Small amounts of catechol occur naturally in fruits and vegetables, along with the enzyme polyphenol oxidase. Upon mixing the enzyme with the substrate and exposure to oxygen (as when a potato or apple is cut), the colorless catechol oxidizes to reddish-brown benzoquinone derivatives. The enzyme is inactivated by adding an acid, such as lemon juice, or by refrigeration. Excluding oxygen also prevents the browning reaction. Catechol melts at 28 oC and boils at 250 oC. It is employed in medicine as an expectorant. The dimethyl ether or veratrol is also used in medicine. Many other pyrocatechin derivatives have been suggested for therapeutic application.",CHEMBL280998
CC(N=Cc1ccc(C(N)=[NH2+])cc1O)C(=O)[O-],5.38,,
CC(C)CC(NC(=O)C(O)C([NH3+])Cc1ccccc1)C(=O)[O-],5.38,,
O=C([O-])C=Cc1ccc(B(O)O)cc1,5.38,,
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CO)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(N)=O)C(=O)[O-],5.38,,
Nc1ncnc2c1ncn2C1OC(CC([NH3+])CCC([NH3+])C(=O)[O-])C(O)C1O,5.38,,
CSCCC(NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)[O-],5.38,,
CC(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C1CCCN1C(=O)C(CCCC[NH3+])NC(=O)C(CCCC[N+](C)(C)C)NC(=O)C(NC(=O)CNC(=O)CNC(=O)C(NC(=O)C(C)[NH3+])C(C)O)C(C)C,5.38,,
Nc1ncccc1NCc1cc(-c2ccc3cc[nH]c3c2)ccc1OCc1ccccn1,5.38,,CHEMBL220428
CCCCCCCCCCCC(=O)[O-],5.38,,
O=C([O-])c1ccnc(C(=O)[O-])c1,5.38,,
COc1cccc(-c2cnc(N)c(N3CCC(C(=O)[O-])CC3)n2)c1,5.38,,
O=C(Nc1ccccc1)Nc1ccccc1,5.38,"This molecule is an off-white powder. (NTP, 1992) This molecule is a member of the class of phenylureas that is urea in which one of the hydrogens of each amino group is replaced by a phenyl group. It is present in coconut milk (Cocos nucifera). It has a role as a plant metabolite and a cytokinin.",CHEMBL354676
CC(NC(=O)C([NH3+])C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)[O-])C(C)C,5.38,,
NC(=[NH2+])NCCCC(NC(=O)C([NH3+])CCC(N)=O)C(=O)NC(CCC(N)=O)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(N)=O,5.38,,
COC1OC(C(=O)[O-])C(OC2OC(CO)C(O)C(OS(=O)(=O)[O-])C2NS(=O)(=O)[O-])C(O)C1OS(=O)(=O)[O-],5.38,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C([NH3+])CCCC[NH3+])C(N)=O,5.38,,
CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1,5.38,,CHEMBL2333445
CC1(C)N=C2NC(=[NH2+])NC(=O)C2N=C1C(=O)NCC(=O)NCCS(=O)(=O)CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,5.38,,
c1ccc(OCCSc2nc3ccccc3[nH]2)cc1,5.38,,CHEMBL1563710
COC(=O)c1ccc2nc(NC(C)=O)sc2c1,5.38,,CHEMBL2418960
COc1cc(O)cc(Nc2ccc(C(=O)Nc3ccccc3)c(OCCC[NH3+])c2)c1,5.38,,
COCC#CCC(NS(=O)(=O)c1ccc(-c2ccc(OC)cc2)cc1)C(=O)[O-],5.39,,
[NH3+]C(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCCNc1ccncc1,5.39,,
C#CCCCn1c(Cc2cc(OC)ccc2OC)nc2c(N)nc(F)nc21,5.39,,CHEMBL326082
O=C([O-])Cc1ccc(O)c(Cl)c1,5.39,,
CSCCC(NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)[O-],5.39,,
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)c1nc(C)n(-c2ccc(Cl)cc2)n1)C(=O)NC(Cc1ccc(F)cc1)C(N)=O,5.39,,
CN(CC(N)=O)C(=O)c1nc(-c2ccccc2)[nH]c1C(=O)[O-],5.39,,
Cc1ccccc1S(=O)(=O)N(CCN(Cc1cncn1C)c1ccc(C#N)cc1)CC1CCN(C(=O)OC(C)(C)C)CC1,5.39,,
COC(=O)CCNC(=O)C1C=C(c2ccc(F)cc2F)C=C(I)C1=O,5.39,,
CC(COC(=O)NCC[NH3+])(C(Nc1c(CO)cc2ccccn12)C(=O)[O-])[SH+](=O)[O-],5.39,,
NS(=O)(=O)C1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O,5.39,,
O=C(NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-])OCc1ccccc1,5.39,,
ON1CC=CC=C1S,5.39,,
C=C(C)C(NC(=O)C1C=CCN1C(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C([NH3+])CO)C(C)CC)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)NC(C(=O)[O-])C(C)O)C(C)O,5.39,,
CC1(C)CC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC(C)(C)[NH2+]1,5.39,,
COC(=O)c1cc(Nc2ncnc3[nH]ccc23)ccc1Br,5.39,,CHEMBL4517951
O=C([O-])c1ccc2cc[nH]c2c1,5.39,,
O=c1[nH]c(-c2cccc(NS(=O)(=O)c3cccs3)c2)cs1,5.39,,CHEMBL2349349
O=c1[nH]c(-c2cccc(NS(=O)(=O)Cc3ccccc3)c2)cs1,5.39,,CHEMBL2349347
CC(=O)NC1C(O)C=C(C(=O)[O-])OC1C(O)C(O)CO,5.4,,
COC1OC(C)C(O)C(O)C1OC1OC(CO)C(O)C(OC2OC(C)C(O)C(OC3OC(C)C(O)C(O)C3OC3OC(C)C(O)C(O)C3O)C2O)C1NC(C)=O,5.4,,
CC(C)CC(CS(C)(=N)=N)C(=O)NC1Cc2cn(c3ccccc23)CCCCCCNC1=O,5.4,,
[NH3+]C(Cn1cc(Br)c(=O)[nH]c1=O)C(=O)[O-],5.4,,
[NH3+]C(Cn1cc(Br)c(=O)[nH]c1=O)C(=O)[O-],5.4,,
CON=C(C(=O)NCB(O)O)c1csc(N)n1,5.4,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])C(C)O)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)[O-],5.4,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])C(C)O)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)[O-],5.4,,
CC(C)CC([NH3+])C(=O)NC(CO)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)[O-],5.4,,
CSCCC([NH3+])C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(N)=O)C(=O)NC(CCSC)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(C)C(=O)NC(C)C(=O)[O-],5.4,,
C[N+](C)(C)CC(=O)[O-],5.4,"This molecule is a modified amino acid consisting of glycine with three methyl groups that serves as a methyl donor in several metabolic pathways and is used to treat the rare genetic causes of homocystinuria. This molecule has had only limited clinical use, but has not been linked to instances of serum enzyme elevations during therapy or to clinically apparent liver injury. This molecule is the amino acid betaine derived from glycine. It has a role as a fundamental metabolite. It is an amino-acid betaine and a glycine derivative. It is a conjugate base of a N,N,N-trimethylglycinium. This molecule is a methyl group donor that functions in the normal metabolic cycle of methionine. It is a naturally occurring choline derivative commonly ingested through diet, with a role in regulating cellular hydration and maintaining cell function. Homocystinuria is an inherited disorder that leads to the accumulation of homocysteine in plasma and urine. Currently, no treatments are available to correct the genetic causes of homocystinuria. However, in order to normalize homocysteine levels, patients can be treated with vitamin B6 ([pyridoxine]), vitamin B12 ([cobalamin]), [folate] and specific diets. This molecule reduces plasma homocysteine levels in patients with homocystinuria. Although it is present in many food products, the levels found there are insufficient to treat this condition. The FDA and EMA have approved the product Cystadane (betaine anhydrous, oral solution) for the treatment of homocystinuria, and the EMA has approved the use of Amversio (betaine anhydrous, oral powder). This molecule is a Methylating Agent. The mechanism of action of betaine is as a Methylating Activity. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Amaranthus hybridus, Cornulaca leucacantha, and other organisms with data available.",CHEMBL1182
Cc1nc2cnccc2n1-c1ccc(Cn2c(=O)sc3ccccc32)cc1,5.4,,
[NH3+]CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,5.4,,
O=C(CNS(=O)(=O)C1CCCCC1)NC(CCNc1ccncc1)C(=O)N1CCCCC1,5.4,,CHEMBL24817
O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,5.4,"This molecule is a chromone substituted with a phenyl group at position 8 and a morpholine group at position 2. It has a role as an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor, an autophagy inhibitor and a geroprotector. It is a member of chromones, a member of morpholines and an organochlorine compound. Specific inhibitor of phosphatidylinositol 3-kinase. This molecule is a morpholine-based inhibitor of phosphatidylinositol 3-kinase (PI3K) and the bromodomain and extra-terminal (BET) family of proteins, with potential antineoplastic activity. Upon administration, the PI3K/BET inhibitor LY294002 specifically targets and binds to both PI3K and the acetylated lysine recognition motifs in the bromodomains of BET proteins. Inhibition of PI3K activity inhibits the PI3K/AKT kinase signaling pathway. This may result in inhibition of growth and survival for tumor cells in which the PI3K-mediated signaling pathway is overactivated. Inhibition of BET proteins prevents their interaction with acetylated histones, disrupts chromatin remodeling and inhibits the expression of oncogenic drivers that are important for cell proliferation and survival, which together may lead to an inhibition of proliferation in BET-overexpressing tumor cells. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis. BET proteins, comprised of BRD2, BRD3, BRD4 and BRDT, are transcriptional regulators and play an important role during development and cellular growth. In tumor cells, BET proteins play a key role in the regulation of oncogene transcription and tumor cell proliferation. This molecule is a natural product found in Hexagonia apiaria and Dietes bicolor with data available.",CHEMBL98350
N#Cc1ccc(C(C(O)Cc2ccc(F)cc2)n2cncn2)cc1,5.4,,CHEMBL2218882
[NH3+]C(Cn1ccc(=O)n(Cc2ccccc2C(=O)[O-])c1=O)C(=O)[O-],5.4,,
CCc1nc(N)nc(N)c1-c1ccc(NCc2cc(F)cc(F)c2)cc1,5.4,,CHEMBL230153
CC(C)(CCl)C(=O)Nc1ccc(C(F)(F)F)cc1,5.4,,CHEMBL463588
COC1OC(C)C(O)C(O)C1O,5.4,,
Cc1cc(C#Cc2ccccc2C=NN2CCOC2=O)nc(N)n1,5.4,,
O=CC1C(NS(=O)(=O)[O-])CCN1C(=O)NC1CCC[NH2+]CC1,5.4,,
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,5.4,"This molecule is a xanthine derivative that decreases the viscosity of blood and is used to treat symptoms of intermittent claudication due to peripheral vascular disease. This molecule has not been associated with serum enzyme elevations during therapy, but in several isolated case reports has been linked to clinically apparent liver injury. This molecule is an oxopurine. This molecule is a synthetic dimethylxanthine derivative that modulates the rheological properties of blood and also has both anti-oxidant and anti-inflammatory properties. Although originally developed to treat intermittent claudication, a form of exertion-induced leg pain common in patients with peripheral arterial disease, PTX has been investigated for its possible use in diverse conditions, including osteoradionecrosis, diabetic kidney disease, and generally any condition associated with fibrosis. More recently, PTX has been suggested as a possible treatment for COVID-19-induced pulmonary complications due to its ability to regulate the production of inflammatory cytokines.  Pentoxifylline has been marketed in Europe since 1972; PTX extended-release tablets sold under the trade name TRENTAL by US Pharm Holdings were first approved by the FDA on Aug 30, 1984, but have since been discontinued. A branded product, PENTOXIL, marketed by Upsher-Smith Laboratories, and generic forms marketed by Valeant Pharmaceuticals and APOTEX have been available since the late 1990s. This molecule is developed to treat neurodegenerative disorders by ExonHit Therapeutics. This molecule is a Blood Viscosity Reducer. The physiologic effect of pentoxifylline is by means of Hematologic Activity Alteration. This molecule is a methylxanthine derivative with hemorrheologic and immunomodulating properties. This molecule inhibits phosphodiesterase, resulting in increased levels of cyclic adenosine monophosphate (cAMP) in erythrocytes, endothelium, and the surrounding tissues. This leads to vasodilation, improves erythrocyte flexibility, and enhances blood flow. In addition, the increased level of cAMP in platelets inhibits platelet aggregation, which may contribute to a reduction in blood viscosity. This agent also inhibits production of tumor necrosis factor-alpha and interferon-gamma, while it induces Th2-like (T-helper 2) cytokine production, thereby inhibiting Th1-mediated (T-helper 1) inflammatory and autoimmune responses.",CHEMBL628
O=C([O-])c1ccccc1NC1CCCCC1,5.4,,
CCC=CCC=CCC=CCC=CCC=CCCCC(=O)[O-],5.4,,
[NH3+]C(CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)[O-],5.4,,
C[N+](C)(C)CC(=O)[O-],5.4,"This molecule is a modified amino acid consisting of glycine with three methyl groups that serves as a methyl donor in several metabolic pathways and is used to treat the rare genetic causes of homocystinuria. This molecule has had only limited clinical use, but has not been linked to instances of serum enzyme elevations during therapy or to clinically apparent liver injury. This molecule is the amino acid betaine derived from glycine. It has a role as a fundamental metabolite. It is an amino-acid betaine and a glycine derivative. It is a conjugate base of a N,N,N-trimethylglycinium. This molecule is a methyl group donor that functions in the normal metabolic cycle of methionine. It is a naturally occurring choline derivative commonly ingested through diet, with a role in regulating cellular hydration and maintaining cell function. Homocystinuria is an inherited disorder that leads to the accumulation of homocysteine in plasma and urine. Currently, no treatments are available to correct the genetic causes of homocystinuria. However, in order to normalize homocysteine levels, patients can be treated with vitamin B6 ([pyridoxine]), vitamin B12 ([cobalamin]), [folate] and specific diets. This molecule reduces plasma homocysteine levels in patients with homocystinuria. Although it is present in many food products, the levels found there are insufficient to treat this condition. The FDA and EMA have approved the product Cystadane (betaine anhydrous, oral solution) for the treatment of homocystinuria, and the EMA has approved the use of Amversio (betaine anhydrous, oral powder). This molecule is a Methylating Agent. The mechanism of action of betaine is as a Methylating Activity. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Amaranthus hybridus, Cornulaca leucacantha, and other organisms with data available.",CHEMBL1182
CC(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.4,,
O=C([O-])c1ccc(O)c(Cl)c1,5.4,,
O=S(=O)([O-])OCC1OC(OC2(COS(=O)(=O)[O-])OC(COS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C2OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C1OS(=O)(=O)[O-],5.4,,
O=C([O-])c1ccc(C#CCCO)cc1SCc1ccc(Cl)c(Cl)c1,5.4,,
Nc1nc(Nc2ccc(C(=O)[O-])cc2)sc1C(O)c1cccnc1,5.4,,
CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)C)C(=O)NC(Cc1c[nH]cn1)C(N)=O,5.4,,
CCCN(C(=O)NC(CSCc1ccc(Br)cc1)C(=O)[O-])C(=O)c1cccc(C#Cc2ccc(F)cc2F)c1,5.4,,
O=C([O-])c1ccccc1Nc1ccccc1C(=O)[O-],5.4,,
COC(C(=O)[O-])c1c(C)nc2ccc(Br)cc2c1-c1ccc(Cl)cc1,5.4,,
[NH3+]C(CCS)C(=O)[O-],5.4,,
CNC(=O)CCC(CC([NH3+])C(=O)[O-])C(=O)[O-],5.4,,
C[NH+](C)C(Cc1c[nH]cn1)C(=O)[O-],5.4,,
O=C(OCc1ccccc1)c1ccccc1,5.41,"This molecule is a benzoate ester obtained by the formal condensation of benzoic acid with benzyl alcohol. It has been isolated from the plant species of the genus Polyalthia. It has a role as a scabicide, an acaricide and a plant metabolite. It is a benzyl ester and a benzoate ester. It is functionally related to a benzoic acid. This molecule is one of the older preparations used to treat scabies. Scabies is a skin infection caused by the mite sarcoptes scabiei. It is characterised by severe itching (particularly at night), red spots, and may lead to a secondary infection. This molecule is lethal to this mite and so is useful in the treatment of scabies. It is also used to treat lice infestation of the head and body. This molecule is not the treatment of choice for scabies due to its irritant properties. This molecule is a natural product found in Camellia sinensis, Desmos chinensis, and other organisms with data available.",CHEMBL1239
CCCCCCCCCCCCCC(=O)OC1C(CC(=O)NO)COC(CO)C1O,5.41,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CO)C(C)C)C(C)O)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)[O-],5.41,,
O=C(c1ccccc1)c1cccc(OCC[NH+](O)CO)c1,5.41,,
CC(=O)NC1c2nc(C(=O)Nc3ccccc3)cn2C(CO)C(O)C1O,5.41,,
CC(C)(CCCOCn1ccc(=O)[nH]c1=O)NS(=O)(=O)c1ccccc1,5.41,,CHEMBL1234485
Cn1nc(-c2ccccc2)cc1C(=O)NC(Cc1ccc2ccccc2c1)C(=O)[O-],5.41,,
CCC(C)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C([NH3+])CO)C(=O)[O-],5.41,,
CCC1CCCCC1(O)C(=O)C(=O)N1CCCCC1C(=O)OC(CCc1ccc(OC)c(OC)c1)c1ccccc1,5.41,,
CCC1CCCCC1(O)C(=O)C(=O)N1CCCCC1C(=O)OC(CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)[O-])c1,5.41,,
CCC(C)C(NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(Cc1c[nH]cn1)NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C[NH3+])C(=O)NCC(=O)NC(C(=O)[O-])C(C)O,5.41,,
CC(=O)N1CCCC(C2(Cc3cccc(Cl)c3)C(=O)Nc3cc(Cl)ccc32)C1,5.41,,
O=C(NCCC(F)(F)F)c1ccc(C#CCNS(=O)(=O)c2ccccc2)cc1,5.41,,CHEMBL3286509
CC1OC(O)C(O)C(O)C1O,5.42,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL273741
NC(=[NH2+])c1ccc(NC(=O)c2ccccc2O)cc1,5.42,,
CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,5.42,"This molecule is an odorless and colorless solid. Used as a rodenticide for Norway rats and for house mice. (EPA, 1998) This molecule is a commonly used oral anticoagulant with anti-vitamin K activity. This molecule therapy is associated with rare instances of idiosyncratic, clinically apparent liver injury that are usually mild and rapidly reversible on stopping. This molecule is a member of the class of coumarins that is 4-hydroxycoumarin which is substituted at position 3 by a 1-phenyl-3-oxo-1-butyl group. It is a methyl ketone, a hydroxycoumarin and a member of benzenes. This molecule is an anticoagulant drug normally used to prevent blood clot formation as well as migration. Although originally marketed as a pesticide (d-Con, Rodex, among others), This molecule has since become the most frequently prescribed oral anticoagulant in North America. This molecule has several properties that should be noted when used medicinally, including its ability to cross the placental barrier during pregnancy which can result in fetal bleeding, spontaneous abortion, preterm birth, stillbirth, and neonatal death. Additional adverse effects such as necrosis, purple toe syndrome, osteoporosis, valve and artery calcification, and drug interactions have also been documented with warfarin use. This molecule does not actually affect blood viscosity, rather, it inhibits vitamin-k dependent synthesis of biologically active forms of various clotting factors in addition to several regulatory factors. This molecule is a Vitamin K Antagonist. The mechanism of action of warfarin is as a Vitamin K Inhibitor. This molecule is a synthetic anticoagulant. This molecule inhibits the regeneration of vitamin K1 epoxide and so the synthesis of vitamin K dependent clotting factors, which include Factors II, VII, IX and X, and the anticoagulant proteins C and S. This inhibition results in a sequential depression of Factors VII, IX, X and II activities. Vitamin K is an essential cofactor for the post ribosomal synthesis of the vitamin K dependent clotting factors. The vitamin promotes the biosynthesis of gamma-carboxyglutamic acid residues in these proteins which are essential for biological activity. This molecule is an anticoagulant drug normally used to prevent blood clot formation as well as migration. Although originally marketed as a pesticide (d-Con, Rodex, among others), This molecule has since become the most frequently prescribed oral anticoagulant in North America. This molecule has several properties that should be noted when used medicinally, including its ability to cross the placental barrier during pregnancy which can result in fetal bleeding, spontaneous abortion, preterm birth, stillbirth, and neonatal death. Additional adverse effects such as necrosis, purple toe syndrome, osteoporosis, valve and artery calcification, and drug interactions have also been documented with warfarin use. This molecule does not actually affect blood viscosity, rather, it inhibits vitamin-k dependent synthesis of biologically active forms of various clotting factors in addition to several regulatory factors.",CHEMBL1464
CCC(C)C([NH3+])C(=O)N1CCCC1C(O)[NH2+]C(C(=O)[O-])C(C)CC,5.42,,
CC(=O)C(C)O,5.42,"This molecule appears as a light-yellow colored liquid that can form a crystalline solid when it dimerizes. Slightly denser than water. Hence sinks in water. Used to make other chemicals. This molecule is a methyl ketone that is butan-2-one substituted by a hydroxy group at position 3. It has a role as a metabolite. It is a methyl ketone and a secondary alpha-hydroxy ketone. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a natural product found in Francisella tularensis, Camellia sinensis, and other organisms with data available.",CHEMBL3561873
CCCc1[nH]c(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CC[NH+](CC)CC4)ccc3OCC)n[n+]12,5.42,,
CC1(C(=O)[O-])OCC(OC(=O)NCCNC(=O)OC2COC(C)(C(=O)[O-])OC2)CO1,5.42,,
CCCCCCCCCCOC=O,5.42,,
CC1=NC(C(=O)[O-])C(O)CN1,5.42,,
CC(C)CC(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)CNC(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(C=O)C(C)O,5.42,,
O=S(=O)([O-])OC(C(O)CO)C(O)C[S+]1CC(O)C(O)C1CO,5.42,,
Nc1cccc(S(=O)(=O)NC(=O)c2sccc2SCc2ccc(Cl)c(Cl)c2)c1,5.42,,CHEMBL1910888
Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1,5.42,,CHEMBL306380
CNC(=O)C(CC(C)C)CC(O)C(CC1CCCCC1)NC(=O)C(Cc1cnc[nH]1)NC(=O)C(Cc1ccccc1)NC(=O)OC(C)(C)C,5.43,,
C=C(C)C1C[NH2+]C(C(=O)[O-])C1CC(=O)[O-],5.43,,
O=C(NC(=O)c1ccc(-c2ccccc2)cc1)NC1OC(CO)C(O)C(O)C1O,5.43,,
NC(=[NH2+])NC(=O)Cn1c(-c2ccccc2)ccc1-c1ccccc1,5.43,,
C=O.CC([NH3+])C(=O)NC(C)C(=O)NC(C(=O)NC(C(=O)NC(CO)C(=O)NC(C(=O)NC(C(=O)NC(CO)C(=O)NC(C)C(N)=O)C(C)O)C(C)O)C(C)O)C(C)C,5.43,,
CCCCNC(=O)C(C)CC(O)C(Cc1ccccc1)NC(=O)C1CCCC(C(C)(C)NC(C)=O)C1,5.43,,
O=C([O-])C(O)C(O)C(=O)[O-],5.43,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O,5.43,,
CC(C)CC([NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NCC(=O)[O-],5.43,,
CC(C)CC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])CCC(N)=O)C(=O)NCC(=O)NCC(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C)C(=O)NCC(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)[O-])C(C)C,5.43,,
CS(=O)(=O)NC(=O)c1ccc(NC(=O)c2cccc(CC3CCCCC3)n2)c(Cc2ccccc2)c1,5.43,,
NC(=[NH2+])NC=CCC([NH2+]C(CCC(=O)[O-])C(=O)[O-])C(=O)[O-],5.43,,
CC(=O)NCCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])C(C)O)C(C)O)C(=O)NC(CO)C(N)=O,5.43,,
CCCN(CCc1ccccc1)C(=O)C1OC(C(=O)[O-])=CC([NH3+])C1NC(C)=O,5.44,,
O=C(c1ccccc1)c1ccccc1,5.44,"This molecule appears as white solid with a flowery odor. May float or sink in water. (USCG, 1999) These molecules is the simplest member of the class of benzophenones, being formaldehyde in which both hydrogens are replaced by phenyl groups. It has a role as a photosensitizing agent and a plant metabolite. This molecule is the organic compound. Substituted benzophenones such as oxybenzone and dioxybenzone are used in sunscreen. This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Glycine max, Streptomyces, and other organisms with data available. This molecule is found in fruits. This molecule is present in grapes. This molecule is a flavouring agent This molecule is a common photosensitizer in photochemistry. It crosses from the S1 state into the triplet state with nearly 100% yield. The resulting diradical will abstract a hydrogen atom from a suitable hydrogen donor to form a ketyl radical. This molecule is the organic compound with the formula (C6H5)2CO, generally abbreviated Ph2CO. This molecule is a widely used building block in organic chemistry, being the parent diarylketone.

This molecule has been shown to exhibit anti-inflammatory function 

This molecule belongs to the family of This molecules. These are organic compounds containing a ketone attached to two phenyl groups. (A3203).",CHEMBL90039
[NH3+]C(Cn1c2c(c(=O)[nH]c1=O)CCC2)C(=O)[O-],5.44,,
Cc1cc(C(=O)NC(C)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)OCc2ccccc2)CC2CCNC2=O)C(C)C)no1,5.44,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,5.44,,
COc1ccccc1C=NOCCC(=O)[O-],5.44,,
[NH2+]=C(NO)NCCCC([NH3+])C(=O)[O-],5.44,,
CCCCCCCC(=O)NC1=CC(=O)CCC1,5.44,,
CCCCCCCCOC1OC(CO)C(O)C1O,5.44,,
C[NH2+]C(CC(C)C)C(=O)NC1C(=O)NC(CC(N)=O)C(=O)NC2C(=O)NC3C(=O)NC(C(=O)NC(C(=O)[O-])c4cc(O)cc(O)c4-c4cc3ccc4O)C(O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O)Oc2ccc(cc2Cl)C1O,5.44,,
COc1ccc(CNC(=O)c2ccc3nccnc3c2)cc1,5.44,,CHEMBL1456597
CN1C(=[NH2+])NC(c2ccccc2)(c2ccccc2)C1=O,5.44,,
COC(C(=O)NCC(N)=O)C(O)C(O)C(O)CCC(C)(C)C,5.44,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C([NH3+])Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1c[nH]cn1)C(=O)N1CCCC1C(=O)NC(CO)C(=O)[O-],5.44,,
CC(C)(c1cc(Cl)c(O)c(Cl)c1)c1cc(Cl)c(O)c(Cl)c1,5.44,"This molecule is a bisphenol. This molecule is estrogen receptor(ER) alpha agonists, antagonists for androgen receptor(AR), progesterone receptor(PR) antagonists. It exhibits the ability to reverse the ERR inhibition induced by 4-hydroxytamoxifen.",CHEMBL1738928
NC(=O)c1cccc2ncc(-c3ccc(Cl)cc3)nc12,5.44,,
CCc1nc(N)nc(N)c1-c1ccc(NCc2cc(F)cc(F)c2)cc1,5.45,,CHEMBL230153
[NH3+]CCCCC([NH3+])C(=O)[O-],5.45,,
OCC1OC(n2cnc3cc(Cl)c(Cl)cc32)C(O)C1O,5.45,,CHEMBL267071
O=C(c1cc(Br)c(O)cc1O)N1Cc2ccccc2C1,5.45,,CHEMBL4168598
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,5.46,,
[NH3+]CCCCC([NH3+])C(=O)NC(CC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],5.46,,
CC(C)(C)c1o[nH]c(=O)c1CC([NH3+])C(=O)[O-],5.46,,
C[NH+](C)CCSCc1cc(N)cc2c(=O)[nH]c(N)nc12,5.46,,
[NH2+]=C1NC(=O)C(=C2CCNC(=O)c3[nH]ccc32)N1,5.46,,
COc1cc(-c2ccc(OC)nc2)c2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc2c1,5.46,,CHEMBL1230742
COC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(O)C([NH3+])c1ccc(C(C)C)cc1,5.46,,
CC(=O)NC(C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)C(C)C)C(C)C,5.46,,
Cc1ccccc1-n1ncc(C(=O)c2cccc(C3CCN(S(C)(=O)=O)CC3)c2)c1N,5.46,,
C[NH2+]CCCCNC(=O)N1CCC(NS(=O)(=O)[O-])C1CO,5.46,,
CC(C)CC1NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])CSSCC(C(=O)[O-])NC(=O)C(CCCC[NH3+])NC1=O,5.46,,
COc1ccc(C2[NH2+]C(C)C(O)C2O)cc1,5.46,,
CON=C(C(=O)NC1C(=O)N2C(C(=O)[O-])=C(COC(C)=O)CSC12)c1csc(N)n1,5.46,,
CCCCCNC(=O)C(Cc1ccc(OC(C(=O)[O-])C(=O)[O-])cc1)NC(=O)NC(Cc1ccccc1)C(=O)[O-],5.47,,
NC(=[NH2+])c1ccc2[nH]c(-c3ccccc3O)nc2c1,5.47,,
CC(=O)N(Cc1ccc(C(=O)N(CCC(=O)N2CCC(C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)N3CCCC3C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)N3CCCC3C(N)=O)CC2)Cc2ccc(C[NH3+])cc2)cc1)CC(C)C,5.47,,
NC(=[NH2+])c1ccc2[nH]c(-c3ccccc3O)nc2c1,5.47,,
CC1(C)CCC[NH2+]C1c1ccc(O)c(C(=O)c2ccc(C(=O)NC3CCC[NH2+]CC3NC(=O)c3ccncc3)cc2)c1F,5.47,,
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6c(n2c5c31)CCCC6)C(=O)NC4,5.47,,
CC([NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CC(=O)[O-])C(=O)[O-],5.47,,
Cc1[nH]c2ccccc2c1CC(=O)NC(Cc1ccccc1)C(=O)N(C)c1ccccc1,5.47,,
O=C([O-])c1ccccc1O,5.47,,
Nc1ncnc2c1ncn2C1OC(CO)C(NC(=O)C([NH3+])CO)C1O,5.47,,
O=C([O-])C=NC(=O)c1ncccc1O,5.47,,
[NH3+]CCCCC([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CC(=O)[O-])C(=O)[O-],5.47,,
COc1ccc(C(=O)Nc2ccc(Oc3ccc(N(C(=O)C4CCC(C)CC4)C(C)C)c(C(=O)[O-])c3)cc2)cc1,5.47,,
N=C1Cc2ccccc2C(=O)N1,5.47,,
CN(C)C1=NC(=O)c2ccccc2C1,5.47,,
O=C1NC(=[N+]2CCCC2)Cc2ccccc21,5.47,,
CCCCCC(O)CC,5.48,"This molecule is a secondary alcohol that is octane substituted by a hydroxy group at position 3. It has a role as a human metabolite, a plant metabolite, a pheromone and a flavouring agent. It is an octanol and a secondary alcohol. This molecule is a natural product found in Camellia sinensis, Perilla frutescens, and other organisms with data available.",CHEMBL487998
COC1OC(CO)C(O)C(OC2OC(CO)C(O)C(O)C2NC(C)=O)C1O,5.48,,
OC1C2CCC(O)([NH2+]2)C(O)C1O,5.48,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(N)=O)C(C)O,5.48,,
[NH3+]C(C(=O)[O-])C(OCc1ccccc1)C(=O)[O-],5.48,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)O)C(C)O)C(C)O,5.48,,
O=C([O-])c1ccc(-c2cc3cccnc3c(-c3cccc([N+](=O)[O-])c3)n2)cc1,5.48,,
C[NH+](C)CCSC(Cc1ccccc1)=NOS(=O)(=O)[O-],5.48,,
CCOC(=O)c1c(C)c(C(=O)N2CC[NH+](Cc3ccccc3)CC2)c(C)n1CC,5.48,,
C[NH2+]CCCCC(NC(=O)C(CO)NC(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(C)=O)C(=O)NC(CC(=O)[O-])C(=O)NC(CCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.48,,
CS(=O)(=O)NC(=O)c1sccc1SCc1ccc(Cl)c(Cl)c1,5.48,,CHEMBL1910886
O=C(Cc1ccccc1)Nc1nnc(CC=S)s1,5.48,,
COC1OC(CNS(=O)(=O)c2c(C)cc(C)cc2C)C(O)C(O)C1O,5.48,,
C[N+](C)(C)CCCC(=O)[O-],5.48,"These molecules is an amino-acid betaine gamma-aminobutyric acid zwitterion in which all of the hydrogens attached to the nitrogen are replaced by methyl groups. It has a role as a human metabolite and an Escherichia coli metabolite. It is functionally related to a gamma-aminobutyrate and a gamma-aminobutyric acid zwitterion. It is a conjugate base of a 4-(trimethylammonio)butanoic acid. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a natural product found in Drosophila melanogaster, Homo sapiens, and other organisms with data available.",CHEMBL2074645
O=C([O-])c1ccc(O)c2ncccc12,5.48,,
COc1ccc(OCCOC(=O)C2CCCCN2S(=O)(=O)c2ccc3[nH]c(=O)sc3c2)cc1OC,5.48,,CHEMBL2348592
NS(=O)(=O)c1cccc(C(=O)CSc2ncccn2)c1,5.48,,CHEMBL2443189
CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(C)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)[O-])C(C)C,5.48,,
CCCc1ccc(-c2ccc(O)c(C(=O)[O-])c2)cc1,5.48,,
OCc1cn(C2OC(CO)C(O)C(O)C2O)nn1,5.48,,
[NH3+]CCCC[NH2+]CCC[NH3+],5.49,,
COC(=O)c1c(O)cccc1OCCCCNC(=O)C(Cc1ccc(OC(C(=O)[O-])C(=O)[O-])cc1)NC(=O)OC(C)(C)C,5.49,,
CCC(C)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])C(C)O)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(CCSC)C(=O)O,5.49,,
O=C([O-])COc1c(C(=O)[O-])sc(-c2ccccc2)c1Br,5.49,,
N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCN(C(=O)CC[NH+]1CCCCC1)C2,5.49,,
CC(C)C([NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1ccccc1)C(=O)[O-],5.49,,
c1coc(CNc2ncnc3[nH]cnc23)c1,5.49,"This molecule is a member of the class of 6-aminopurines that is adenine carrying a (furan-2-ylmethyl) substituent at the exocyclic amino group. It has a role as a geroprotector and a cytokinin. It is a member of furans and a member of 6-aminopurines. These molecules is a cytokinin which are plant hormones promotes cell division and plant growth. It was shown to naturally exist in DNA of organisms including humans and various plants. While kinetin is used in tissue cultures to produce new plants, it is also found in cosmetic products as an anti-aging agents. This molecule is a natural product found in Humulus lupulus, Cocos nucifera, and other organisms with data available.",CHEMBL228792
Nc1cc(SCc2ccccc2)nc(N)n1,5.49,,CHEMBL566948
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,5.49,,
OCC(O)COC1OC(CO)C(O)C(O)C1O,5.49,,
COc1ccc(C(Cc2cc([N+](=O)[O-])ccc2OC)c2c[nH]c(N)n2)cc1F,5.49,,CHEMBL522520
Clc1ccc2c(NCC3CC3)ncnc2c1,5.49,,
Cc1c[nH]c2ncnc(N3CCC([NH3+])C3)c12,5.49,,
O=C(Nc1cccc(Oc2ccc(C(=O)[O-])c(C(=O)[O-])c2)c1)c1ccc(-c2ccccc2)cc1,5.49,,
O=c1[nH]c(=O)n(C2OC(CO)C(O)C(O)C2O)cc1Br,5.49,,
CC(C)CC(Cl)C(=O)[O-],5.49,,
COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCC(=O)[O-],5.49,,
Cc1ncsc1-c1ccc(CNC(=O)C2CC(O)CN2C(=O)CC(C)(C)C)cc1,5.49,,
CCC(C)C([NH2+]C(O)C1CCCN1C(=O)C([NH3+])C(C)(C)C)C(=O)[O-],5.5,,
C[N+]1(CC(O)c2ccccc2)C2CCC1CC(OC(=O)c1ccccc1)C2,5.5,,
CC(O)C([NH3+])C(=O)[O-],5.5,,
CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)c(-c3ccccc3)cc12,5.5,,CHEMBL1093745
[NH3+]C(Cc1cc(Cl)c([N+](=O)[O-])cc1CCC(=O)[O-])C(=O)[O-],5.5,,
[NH3+]CC1CCC(C(=O)[O-])CC1,5.51,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C(C)NC(=O)C([NH3+])CC(=O)[O-])C(C)O)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1ccccc1)C(=O)NC(C)C(=O)NC(C(=O)NC(CCC(=O)[O-])C(=O)NC(CO)C(=O)NC(C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)O)C(C)O,5.51,,
CC(C)CC([NH3+])C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NCC(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(N)=O)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-])C(C)C)C(C)C,5.51,,
Cc1cc(S(=O)(=O)N2CCCC2C(=O)[O-])c(N)cc1Cl,5.51,,
CCN(CC)C(=O)c1c(NC(=O)c2cccs2)sc2c1CC(C)(C)CC2,5.51,,CHEMBL390721
Cc1cc(C=Cc2ccccc2)cc(C)c1O,5.51,,
CCCNC(=O)C1CCCN1C(=O)C([NH3+])C(c1ccccc1)c1ccccc1,5.51,,
O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,5.51,"This molecule is a 7-hydroxyisoflavone with additional hydroxy groups at positions 5 and 4'. It is a phytoestrogenic isoflavone with antioxidant properties. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a phytoestrogen, a plant metabolite, a geroprotector and a human urinary metabolite. It is a conjugate acid of a genistein(1-). An isoflavonoid derived from soy products. It inhibits protein-tyrosine kinase and topoisomerase-II (DNA topoisomerases, type II) activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines.  Additionally, genistein has antihelmintic activity. It has been determined to be the active ingredient in Felmingia vestita, which is a plant traditionally used against worms. It has shown to be effective in the treatment of common liver fluke, pork trematode and poultry cestode.  Further, genistein is a phytoestrogen which has selective estrogen receptor modulator properties. It has been investigated in clinical trials as an alternative to classical hormone therapy to help prevent cardiovascular disease in postmenopausal women.    Natural sources of genistein include tofu, fava beans, soybeans, kudzu, and lupin. This molecule is a soy-derived isoflavone and phytoestrogen with antineoplastic activity. This molecule binds to and inhibits protein-tyrosine kinase, thereby disrupting signal transduction and inducing cell differentiation.  This agent also inhibits topoisomerase-II, leading to DNA fragmentation and apoptosis, and induces G2/M cell cycle arrest.  This molecule exhibits antioxidant, antiangiogenic, and immunosuppressive activities. (NCI04) This molecule is a natural product found in Salvia hispanica, Glycine soja, and other organisms with data available. This molecule is one of several known isoflavones. Isoflavones compounds, such as genistein and daidzein, are found in a number of plants, but soybeans and soy products like tofu and textured vegetable protein are the primary food source. This molecule is a natural bioactive compound derived from legumes and has drawn because of its potentially beneficial effects on some human degenerative diseases. It has a weak estrogenic effect and is a well-known non-specific tyrosine kinase inhibitor at pharmacological doses. Epidemiological studies show that genistein intake is inversely associated with the risk of cardiovascular diseases. Data suggests a protective role of genistein in cardiovascular events. However, the mechanisms of the genistein action on vascular protective effects are unclear. Past extensive studies exploring its hypolipidemic effect resulted in contradictory data. This molecule also is a relatively poor antioxidant. However, genistein protects against pro-inflammatory factor-induced vascular endothelial barrier dysfunction and inhibits leukocyte-endothelium interaction, thereby modulating vascular inflammation, a major event in the pathogenesis of atherosclerosis. This molecule exerts a non-genomic action by targeting on important signaling molecules in vascular endothelial cells (ECs). This molecule rapidly activates endothelial nitric oxide synthase and production of nitric oxide in ECs. This genistein effect is novel since it is independent of its known effects, but mediated by the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) cascade. This molecule directly stimulates the plasma membrane-associated adenylate cyclases, leading to activation of the cAMP signaling pathway. In addition, genistein activates peroxisome proliferator-activated receptors, ligand-activated nuclear receptors important to normal vascular function. Furthermore, genistein reduces reactive oxygen species (ROS) by attenuating the expression of ROS-producing enzymes. These findings reveal the roles for genistein in the regulation of vascular function and provide a basis for further investigating its therapeutic potential for inflammatory-related vascular disease.  (A3190).",CHEMBL44
CCCNc1nc(N)c(C(O)c2cccnc2)s1,5.51,,
COc1cccc(C(O)c2sc(Nc3ccccc3)nc2N)c1,5.51,,
NC(=O)C1CCNC(=O)C(CCCNC(=O)c2cnccn2)NC(=O)C(CC2CCCCC2)NC(=O)C(CCCc2ccccc2)NC(=O)C=CC(=O)N1,5.51,,
CC(=O)NC(Cc1cccc2ccccc12)B(O)O,5.51,,
CCC(C)C(NC(=O)C(CCSC)NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCC(N)=O)C(=O)[O-],5.51,,
Cc1ccc2c(=O)c3cccc(CC(=O)[O-])c3oc2c1C,5.51,,
O=C1NC(=O)C2(N1)OC(CO)C(O)C(O)C2O,5.52,,
CCCCCCC#Cc1ccccc1C=CC(=O)[O-],5.52,,
[NH3+]C(CCC(=O)NC(CS)C(=O)NCC(=O)[O-])C(=O)[O-],5.52,,
[NH3+]C(CCC(=O)NC(CS)C(=O)NCC(=O)[O-])C(=O)[O-],5.52,,
CC(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CO)CCCNC(N)=[NH2+],5.52,,
CC1C[NH2+]CCN1S(=O)(=O)c1cccc2cnccc12,5.52,,
O=C([O-])C1CC2(C(=O)[O-])C=CC(O)C(C2)O1,5.52,,
CC(C)CC(NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)CNC(=O)C([NH3+])C(C)O)C(=O)NC(Cc1c[nH]cn1)C(=O)O,5.52,,
O=C([O-])c1cc(Br)ccc1NS(=O)(=O)c1ccc(Cl)cc1,5.52,,
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.52,,
O=C(Sc1nnc(C(F)(F)F)[nH]1)c1ccc(C#Cc2ccccc2)o1,5.52,"This molecule is a member of furans, a member of triazoles, an organofluorine compound, a thioester and an acetylenic compound.",CHEMBL379642
CCc1ccc(C=C2SC(NC(C(=O)[O-])c3ccc(F)cc3)=NC2=O)o1,5.52,,
CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C)NC(=O)C(CO)NC(=O)CNC(=O)C(CCSC)NC(=O)C(C)NC(=O)C[NH3+])C(=O)NC(C(=O)NC(C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)NC(CO)C(=O)[O-])C(C)CC)C(C)CC,5.52,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)O)C(C)O,5.52,,
OCC1OC(OCC2[NH2+]CC(O)C2O)C(O)C1O,5.52,,
CNC(=O)C[NH+]1CCC(Nc2nccc(-c3cnc4ccccn34)n2)CC1,5.52,,
NC(=[NH2+])NCCCC(NC(=O)C(Cc1ccccc1)NC(=O)C1CCC(=O)N1)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CC(=O)[O-])C(=O)[O-],5.52,,
O=C([O-])CNC(=O)C(=O)[O-],5.52,,
O=C([O-])C1(O)CC(O)C(O)C(C(O)CO)O1,5.52,,
NC(=[NH2+])NCCCC(NC(=O)c1sccc1NS(=O)(=O)c1cccc2nsnc12)C(=O)[O-],5.52,,
Cn1ccnc1C([NH2+]CC1OC(n2ccc(=O)[nH]c2=O)CC1O)c1ccccc1,5.52,,
CC(C)CC(NC(=O)C([NH3+])Cc1c[nH]cn1)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(CS)C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(N)=O,5.52,,
O=C(Nc1cccc(-c2nn[nH]n2)c1)c1cccc(Br)c1,5.52,,
COCc1c(CO)cnc(C)c1O,5.52,This molecule is a member of pyridines. This molecule is a natural product found in Ginkgo biloba with data available.,CHEMBL1076875
CCCCCCCCCCOc1cccc(C(=O)Nc2ccc([N+](=O)[O-])cc2C(=O)[O-])c1,5.52,,
Cc1nc2c(c(=O)[nH]1)CSCC2,5.52,,CHEMBL483348
C[NH+]1CCCC1CCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,5.53,,
CC(O)C([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(N)=O)C(=O)[O-],5.53,,
[NH3+]CCC(C1CC=CC1)n1cc(-c2ncnc3[nH]ccc23)cn1,5.53,,
Nc1ccccc1CO,5.54,This molecule is a natural product found in Justicia gendarussa with data available.,CHEMBL1235999
NC(=[NH2+])c1ccc(NC(=O)Nc2ccc(Oc3ccccc3)cc2)cc1,5.54,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCC[NH3+])C(=O)[O-],5.54,,
CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,5.54,"This molecule is an odorless and colorless solid. Used as a rodenticide for Norway rats and for house mice. (EPA, 1998) This molecule is a commonly used oral anticoagulant with anti-vitamin K activity. This molecule therapy is associated with rare instances of idiosyncratic, clinically apparent liver injury that are usually mild and rapidly reversible on stopping. This molecule is a member of the class of coumarins that is 4-hydroxycoumarin which is substituted at position 3 by a 1-phenyl-3-oxo-1-butyl group. It is a methyl ketone, a hydroxycoumarin and a member of benzenes. This molecule is an anticoagulant drug normally used to prevent blood clot formation as well as migration. Although originally marketed as a pesticide (d-Con, Rodex, among others), This molecule has since become the most frequently prescribed oral anticoagulant in North America. This molecule has several properties that should be noted when used medicinally, including its ability to cross the placental barrier during pregnancy which can result in fetal bleeding, spontaneous abortion, preterm birth, stillbirth, and neonatal death. Additional adverse effects such as necrosis, purple toe syndrome, osteoporosis, valve and artery calcification, and drug interactions have also been documented with warfarin use. This molecule does not actually affect blood viscosity, rather, it inhibits vitamin-k dependent synthesis of biologically active forms of various clotting factors in addition to several regulatory factors. This molecule is a Vitamin K Antagonist. The mechanism of action of warfarin is as a Vitamin K Inhibitor. This molecule is a synthetic anticoagulant. This molecule inhibits the regeneration of vitamin K1 epoxide and so the synthesis of vitamin K dependent clotting factors, which include Factors II, VII, IX and X, and the anticoagulant proteins C and S. This inhibition results in a sequential depression of Factors VII, IX, X and II activities. Vitamin K is an essential cofactor for the post ribosomal synthesis of the vitamin K dependent clotting factors. The vitamin promotes the biosynthesis of gamma-carboxyglutamic acid residues in these proteins which are essential for biological activity. This molecule is an anticoagulant drug normally used to prevent blood clot formation as well as migration. Although originally marketed as a pesticide (d-Con, Rodex, among others), This molecule has since become the most frequently prescribed oral anticoagulant in North America. This molecule has several properties that should be noted when used medicinally, including its ability to cross the placental barrier during pregnancy which can result in fetal bleeding, spontaneous abortion, preterm birth, stillbirth, and neonatal death. Additional adverse effects such as necrosis, purple toe syndrome, osteoporosis, valve and artery calcification, and drug interactions have also been documented with warfarin use. This molecule does not actually affect blood viscosity, rather, it inhibits vitamin-k dependent synthesis of biologically active forms of various clotting factors in addition to several regulatory factors.",CHEMBL1464
O=C([O-])c1ccc(B(O)O)cc1,5.54,,
CC(=O)Nc1nccc(-c2c(C)[nH]c3cccc[n+]23)n1,5.54,,
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(C)[NH3+])C(=O)NC(C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccccc1)C(=O)[O-])C(C)O,5.54,,
O=c1[nH]c(=O)c2[nH]c(=O)n(CC(O)C(O)C(O)CO)c2[nH]1,5.54,,
CN1c2c([nH]c(=[NH2+])[nH]c2=O)NCC1CNc1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,5.54,,
CC(C)(C)C(=O)Nc1cccnc1C(=O)Nc1nccs1,5.54,,CHEMBL316308
[NH3+]CCCCC([NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],5.54,,
NC(=[NH2+])NCCCC([NH3+])C(=O)[O-],5.54,,
C=CC=C=NC(=O)c1cccc(NC(=O)CCCCCNc2ncnc3[nH]cnc23)c1,5.54,,
Cn1cc(C(=O)Cc2ccccc2)cc1C=CC(=O)NO,5.54,,
CCC(C)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C([NH3+])Cc1ccc(O)cc1)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(C=O)CCC(N)=O,5.54,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(CC(N)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])C(C)O)C(C)CC)C(=O)NC(C)C(=O)[O-],5.54,,
CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,5.54,,
CCCNc1nc(N)c(C(O)c2cccc([N+](=O)[O-])c2)s1,5.54,,
CC(=O)OC1C(C)OC(Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)C(O)C1OC(C)=O,5.54,"This molecule is a member of flavonoids and a glycoside. This molecule is a natural product found in Forsteronia refracta, Zingiber spectabile, and Zingiber zerumbet with data available.",CHEMBL3187298
CCN1c2cc(N)ccc2-c2ccc(N)cc2C1c1ccccc1,5.54,,
CC(C)CC([NH3+])C(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.54,,
COC(=O)C(Cc1c[nH]cn1)NC(=O)C[NH+](CC(=O)[O-])Cc1ccccc1,5.54,,
O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,5.54,"This molecule is a trihydroxyflavone that is flavone substituted by hydroxy groups at positions 4', 5 and 7. It induces autophagy in leukaemia cells. It has a role as a metabolite and an antineoplastic agent. It is a conjugate acid of an apigenin-7-olate. This molecule is a natural product found in Camellia sinensis, Apis, and other organisms with data available. This molecule is a plant-derived flavonoid that has significant promise as a skin cancer chemopreventive agent. This molecule inhibits the expression of involucrin (hINV), a marker of keratinocyte differentiation, is increased by differentiating agents via a protein kinase Cdelta (PKCdelta), Ras, MEKK1, MEK3 cascade that increases AP1 factor level and AP1 factor binding to DNA elements in the hINV promoter. This molecule suppresses the 12-O-tetradeconylphorbol-13-acetate-dependent increase in AP1 factor expression and binding to the hINV promoter and the increase in hINV promoter activity. This molecule also inhibits the increase in promoter activity observed following overexpression of PKCdelta, constitutively active Ras, or MEKK1. The suppression of PKCdelta activity is associated with reduced phosphorylation of PKCdelta-Y311. Activation of hINV promoter activity by the green tea polyphenol, (-)-epigellocathecin-3-gallate, is also inhibited by apigenin, suggesting that the two chemopreventive agents can produce opposing actions in keratinocytes. (A7924). This molecule, a flavone abundantly found in fruits and vegetables, exhibits antiproliferative, anti-inflammatory, and antimetastatic activities through poorly defined mechanisms. This flavonoid provides selective activity to promote caspase-dependent-apoptosis of leukemia cells and uncover an essential role of PKCdelta during the induction of apoptosis by apigenin. (A7925). This molecule markedly induces the expression of death receptor 5 (DR5) and synergistically acts with exogenous soluble recombinant human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in malignant tumor cells. On the other hand, apigenin-mediated induction of DR5 expression is not observed in normal human peripheral blood mononuclear cells. Moreover, apigenin does not sensitize normal human peripheral blood mononuclear cells to TRAIL-induced apoptosis. (A7926).",CHEMBL28
COCCNc1nc2ccc(C#CC3(O)CCCCC3)cc2n1-c1ccnc(N)n1,5.54,,CHEMBL3128042
O=C([O-])c1cc(-c2ccc(CNC(=O)c3ccc(-c4ccc(C(=O)[O-])o4)cc3Cl)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,5.54,,
CC(N=Cc1cc(C(N)=[NH2+])ccc1O)C(=O)[O-],5.55,,
O=C([O-])C1=CC(O)C(O)C(OC2C(C(=O)[O-])OC(O)C(O)C2O)O1,5.55,,
CSCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(NC(=O)C([NH3+])CC(=O)[O-])C(C)O)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C,5.55,,
Cn1cnc2c1c(=O)n(CCn1c(=O)c3c(ncn3C)n(C)c1=O)c(=O)n2C,5.55,,CHEMBL1232048
OCC1OC(OC2C[N+]3C(CO)C(O)C(O)C3C2CO)C(O)C(O)C1O,5.55,,
CC(=O)Nc1ccc(C[NH+]2CCC3(CC2)C(NC2CCCCC2)=NC(=O)N3c2cccc(F)c2)cc1,5.55,,
O=C(CCC(F)(F)F)N1CCC(c2nc(-c3nccs3)no2)CC1,5.55,,CHEMBL1945701
c1ccc2[nH]nnc2c1,5.55,"This molecule appears as white to light tan crystals or white powder. No odor. (NTP, 1992) This molecule is the simplest member of the class of benzotriazoles that consists of a benzene nucleus fused to a 1H-1,2,3-triazole ring. It has a role as an environmental contaminant and a xenobiotic.",CHEMBL84963
COc1ccc(C2(c3cccc(-c4cccnc4F)c3)COC(=[NH2+])N2)cc1,5.55,,
O=C([O-])CNC(=O)c1nc(Cl)c2ccccc2c1O,5.55,,
O=C([O-])c1ccccc1C(=O)[O-],5.55,,
O=C1NCCc2c(OCCCC[NH+]3CCCCC3)cccc21,5.55,,
COC1OC(CO)C(O)C(O)C1O,5.56,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)NC(Cc1c[nH]cn1)C(=O)NCC(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(Cc1c[nH]cn1)C(=O)NC(C)C(=O)[O-])C(C)C,5.56,,
COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,5.56,"This molecule is a nonselective alpha-1 adrenergic antagonist used in the therapy of hypertension and benign prostatic hypertrophy. This molecule therapy is associated with a low rate of transient serum aminotransferase elevations and to rare instances of clinically apparent acute liver injury. This molecule is a member of quinazolines, a member of piperazines, a member of furans and a primary amino compound. It has a role as an antineoplastic agent, an antihypertensive agent and an alpha-adrenergic antagonist. This molecule is a quinazoline derivative alpha-1-selective adrenergic blocking agent indicated for benign prostatic hyperplasia and hypertension. This molecule blocks adrenaline's action on alpha-1 adrenergic receptors, causing relaxation of smooth muscle in blood vessels and the prostate. This molecule is an alpha-Adrenergic Blocker. The mechanism of action of terazosin is as an Adrenergic alpha-Antagonist. This molecule is a selective alpha 1 antagonist used for treatment of symptoms of prostate enlargement (BPH). It also acts to lower blood pressure, so it is a drug of choice for men with hypertension and prostate enlargement. It works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls.",CHEMBL611
CC(=O)NC1[NH2+]CC(CO)C(O)C1O,5.57,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)O)C(C)O)C(C)O,5.57,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O)C(C)O,5.57,,
CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(C)[NH3+])C(=O)NC(C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)CC,5.57,,
CC(=O)NCCc1ccc(S(N)(=O)=O)cc1,5.57,,
O=C([O-])CCCCCCCCCCOC(=O)S,5.57,,
CC(C)(CO)C(O)C(=O)NCCC(=O)[O-],5.57,,
CC(C)C([NH3+])C(=O)NS(=O)(=O)OCC1OC(n2cnc3c(N)ncnc32)C(O)C1O,5.57,,
O=N[N+](=O)c1ccccc1,5.57,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(OC4OC(CO)C(O)C(O)C4[N+](C)(C)C)C(O)C3NC(C)=O)C(O)C2NC(C)=O)C1O,5.57,,
O=C([O-])C(=O)CC(=O)c1ccccc1,5.57,,
c1ccc2c(c1)nc1[nH]cnn12,5.57,,
O=C([O-])c1cc(Br)ccc1NC1CCC[NH2+]C1,5.58,,
CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3cn(cc13)C(=O)O2)C(=O)NS(=O)(=O)C1CC1,5.58,,
CC(NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])C(C)O)C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)[O-],5.58,,
COc1ccc(CCC(OC(=O)C2CCCCN2C(=O)C(c2cc(OC)c(OC)c(OC)c2)C2CC=CCC2)c2cccc(OCC(=O)NCc3c(O)ccc4cc5ccc(=O)cc-5oc34)c2)cc1OC,5.58,,
COC1OC(C)C(NC(=O)C(O)CCO)C(O)C1OC,5.59,,
CCC(C)C([NH3+])C(=O)NC(CC(N)=O)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(C(=O)[O-])C(C)CC)C(C)O,5.59,,
O=C([O-])C(F)=Cc1ccc(O)cc1,5.59,,
CC(C)C(NC(=O)NC1CCCC1)C(=O)N1CCC(NC(=O)C2CC2)C1C1(C=O)CCC1,5.59,,
CCCCCCCCCCCCCCCC(=O)[O-],5.59,,
COc1cc(-c2cnc(N)c(-c3ccc(C(=O)[O-])c(C)c3)n2)cc(OC)c1OC,5.59,,
CC(C)CC([NH2+]CC(=O)C(c1ccccc1)N(C)C(=O)OCC1c2ccccc2-c2ccccc21)C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)[O-])C1CCCCC1,5.59,,
CCCCCOC1OC(CO)C(O)C(OC2OC(CO)C(O)C(O)C2OC2OC(CO)C(O)C(O)C2O)C1O,5.59,,
CSCCC([NH3+])C(=O)NC(Cc1ccccc1)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(B(O)O)C(C)C,5.59,,
[NH3+]C(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCc1cnccc1Cl,5.59,,
CC1(C)N=C2NC(=[NH2+])NC(=O)C2N=C1C(=O)NCC[N+]1CCC(SCC2OC(n3cnc4c(N)ncnc43)C(O)C2O)CC1,5.59,,
Cc1ccc2c(c1Br)C(O)(CC(=O)c1ccc3c(c1)OCO3)C(=O)N2,5.59,,
COc1cc(Cc2nc3ccccc3c3[nH]c(N)n[n+]23)cc(OC)c1,5.59,,
CC(C)CC(NC(=O)C(Cc1ccccc1)N=[N+2]#N)C(=O)NC(CC(C)C)C(=O)NC(CCS(C)(=O)=O)Cc1ccc(C[NH3+])cc1,5.59,,
COc1ccccc1-c1noc2nc(C)[nH]c(=O)c12,5.59,,
Cc1ccc(C(C)C)c(O)c1,5.6,"This molecule is a phenol that is a natural monoterpene derivative of cymene. It has a role as a volatile oil component. It is a member of phenols and a monoterpenoid. It derives from a hydride of a p-cymene. A phenol obtained from thyme oil or other volatile oils. It is used as a stabilizer in pharmaceutic preparations. It has been used for its antiseptic, antibacterial, and antifungal actions, and was formerly used as a vermifuge. (Dorland, 28th ed) This molecule is a natural product found in Acanthospermum australe, Humulus lupulus, and other organisms with data available.",CHEMBL29411
C[NH+]1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1,5.6,,
CC(=O)NO,5.6,"This molecule is a member of the class of acetohydroxamic acids that is acetamide in which one of the amino hydrogens has been replaced by a hydroxy group. It has a role as an EC 3.5.1.5 (urease) inhibitor and an algal metabolite. It is functionally related to an acetamide. It is a tautomer of a N-hydroxyacetimidic acid. This molecule is similar in structure to urea. In the urine, it acts as an antagonist of the bacterial enzyme urease. Acetohydroxamic Acid has no direct antimicrobial action and does not acidify urine directly. It is used, in addition to antibiotics or medical procedures, to treat chronic urea-splitting urinary infections. This molecule is an Urease Inhibitor. The mechanism of action of acetohydroxamic acid is as an Urease Inhibitor. This molecule is a natural product found in Arabidopsis thaliana and Chlamydomonas reinhardtii with data available.",CHEMBL734
CC(C)CC(NC(=O)C(CC(N)=O)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)N1CCCC1C(=O)[O-],5.6,,
CC(NC(=O)C(NC(=O)C([NH3+])CCC(N)=O)C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(C=O)CO,5.6,,
O=C([O-])CCc1c(C(=O)[O-])[nH]c2cc(Cl)cc(Cl)c12,5.6,,
O=c1[nH]cnc2nc[nH]c12,5.6,"This molecule is a natural product found in Glycine max, Eleutherococcus giraldii, and other organisms with data available. This molecule is a uremic toxin.  Uremic toxins can be subdivided into three major groups based upon their chemical and physical characteristics: 1) small, water-soluble, non-protein-bound compounds, such as urea; 2) small, lipid-soluble and/or protein-bound compounds, such as the phenols and 3) larger so-called middle-molecules, such as beta2-microglobulin. Chronic exposure of uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease. 
This molecule is a naturally occurring purine derivative and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway. This molecule is also a spontaneous deamination product of adenine. Lesch-Nyhan disease is caused by deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase. This molecule is a purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway. This molecule is a purine nucleobase that consists of purine bearing an oxo substituent at position 6. It has a role as a fundamental metabolite. It is an oxopurine, a purine nucleobase and a nucleobase analogue. It is functionally related to an adenine. This molecule is a purine-based organic compound in human muscle tissues, This molecule is formed during purine catabolism as a product of xanthine oxidase action on xanthine, and occasionally is found as a constituent of nucleic acids. The potent anti-inflammatory and cytoprotective effects of purines may be mediated by cell surface adenosine receptors. This molecule protects against oxidant-induced cell injury by inhibiting activation of nuclear poly(ADP-ribose) polymerase (PARP). (NCI04) This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae.",CHEMBL1427
CC(NC(=O)C1CCC[NH2+]1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],5.6,,
CNC(=O)C1Cc2ccc(NS(=O)(=O)[O-])cc2CN1C(=O)CCc1cccc(C(=O)[O-])c1,5.6,,
Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(CC(O)C(O)C(O)CO)c2cc1C,5.6,"This molecule is a natural product found in Aspergillus unilateralis, Syzygium, and Eremothecium gossypii with data available.",CHEMBL511565
CCCC(=O)NC1C(=NOC(=O)Nc2ccccc2)OC(CO)C(O)C1O,5.6,,
Cn1c(N2CCOCC2)nc2c1c(=O)n(Cc1ccc(Cl)c(Cl)c1)c(=O)n2C,5.6,,CHEMBL1229712
CC(=O)NC1C(O)OC(CO)C(O)C1O,5.6,"This molecule is a N-acyl-hexosamine. This molecule is under investigation for the other of GNE Myopathy. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655).",CHEMBL83479
CC(=O)NC1C(O)OC(CO)C(O)C1O,5.6,"This molecule is a N-acyl-hexosamine. This molecule is under investigation for the other of GNE Myopathy. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655).",CHEMBL83479
CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,5.6,"This molecule is a sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine. It has a role as an antihypertensive agent and a diuretic. It is a member of indoles, an organochlorine compound and a sulfonamide. It is functionally related to a benzamide. This molecule is hypertension. Characterized by an office blood pressure of ≥140/90, hypertension is pervasive and impacts an estimated 25% of adults globally. Treatment for hypertension should include a number of lifestyle changes (ie. reduced sodium intake) along with pharmacotherapy - it should be noted that treatment with several antihypertensive agents may be required in order to achieve blood pressure targets.  Thiazide-like diuretics such as indapamide are a valuable tool for the treatment of hypertension and continue to grow in popularity, falling behind only ACE inhibitors in terms of prescription frequency. When compared to [hydrochlorothiazide] (another commonly prescribed diuretic), indapamide has been shown to be superior at lowering systolic blood pressure, reducing left ventricular mass index, lowering oxidative stress, inhibiting platelet aggregation, and reducing microalbuminuria associated with diabetes. Interestingly, unlike thiazide diuretics, several sources suggest that indapamide is not associated with glucose or lipid disturbances.   Indapamide is characterized by both a methylindoline and a sulfamoyl chlorobenzamide functional group, with the former being largely responsible for the molecule’s lipid solubility. This molecule is a Thiazide-like Diuretic. The physiologic effect of indapamide is by means of Increased Diuresis. This molecule is an indole derivative of chlorosulphonamide and a sulfamyl diuretic with antihypertensive activity. This molecule may interact directly with the subunits of delayed rectifier potassium channels, thereby blocking both slow and rapid K+ (IKs and IKr) currents through the channels. Through the homeostasis mechanism in balancing total ion concentration (Ca++, Na+), it reduces vascular hyperreactivity and peripheral and arterial vascular resistance, possibly by inhibiting transmembrane ionic influx, probably calcium ions, and stimulating prostaglandin E2 synthesis, thereby causing vasodilatation. This molecule exerts its diuretic effect by inhibiting reabsorption of sodium and chloride, primarily as a result of action on the cortical diluting segment of the renal distal tubule, thereby promoting urinary excretion of water and electrolytes.",CHEMBL406
Nc1ncnc2c1ncn2C1OC(CC([NH3+])CCC([NH3+])C(=O)[O-])C(O)C1O,5.6,,
COCC1OC(OC2C3=C(C(C)C)CCC3(C)C=C3C(CCC3(O)COC)C(C)C2O)C(O)C2OC3OC12OC3(C)CCOC=O,5.6,,
O=C([O-])C(O)(O)C(F)(F)C(=O)[O-],5.6,,
CCCC(=O)Nc1[nH]nc2cc(Cl)c(-c3ccccc3)cc12,5.6,,
O=C([O-])c1sccc1SCc1ccc(Cl)c(Cl)c1,5.6,,
O=C([O-])c1sccc1SCc1ccc(Cl)c(Cl)c1,5.6,,
CC(CCC(=O)[O-])C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,5.6,,
COc1cc2c(N)nc(NCCC[N+](C)C)nc2cc1OCCCCC[NH3+],5.6,,
Nc1ncnc2c1cnn2CC1CC[NH2+]CC1,5.6,,
CC[NH+](CC)CCNS(=O)(=O)c1ccc(Oc2c(Cl)cccc2[N+](=O)[O-])cc1,5.6,,
CC([NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(C)C(=O)[O-])C(C)C)C(C)O,5.6,,
Oc1ccc(-c2nc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1,5.6,,
CC(C)CC(NC(=O)C1CSSC2CSSCC(NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(NC(=O)C[NH3+])C2)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(Cc2c[nH]cn2)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1)C(N)=O,5.6,,
Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,5.61,"This molecule is an orally available benzodiazepine used predominantly for therapy of anxiety. As with most benzodiazepines, alprazolam t has not been associated with serum aminotransferase or alkaline phosphatase elevations during therapy, and clinically apparent liver injury from alprazolam has been reported but is very rare. This molecule is a member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. This molecule is only found in individuals that have taken this drug. It has a role as an anxiolytic drug, an anticonvulsant, a muscle relaxant, a sedative, a GABA agonist and a xenobiotic. It is a triazolobenzodiazepine and an organochlorine compound. This molecule is a triazolobenzodiazepine indicated for the treatment of anxiety and panic disorders. It is mainly metabolized by CYP3As and so is contraindicated with CYP3A inhibitors like ketoconazole and itraconazole. Benzodiazepine treatment should be stopped gradually by tapering down a patient's dose to avoid withdrawal symptoms. This molecule's adverse effects are generally related to the sedation it can cause. This molecule has been mixed with alcohol as a drug of abuse to potentiate the sedative effects of the drug which may lead to coma and death. This molecule was given FDA approval on October 16, 1981. This molecule is a Benzodiazepine. This molecule is a triazolobenzodiazepine agent with anxiolytic, sedative-hypnotic and anticonvulsant activities. This molecule binds to a specific site distinct from the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) binding site on the benzodiazepine-GABA-A-chloride ionophore receptor complex located in the limbic, thalamic and hypothalamic regions of the central nervous system (CNS). This binding causes an allosteric modification of the receptor and enhances the affinity of GABA to the receptor leading to an increase in the frequency of chloride-channel opening events. This leads to an increase in chloride ion conductance, neuronal hyperpolarization, inhibition of the action potential and leads to a decrease in neuronal excitability. This molecule is only found in individuals that have used or taken this drug. It is a triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of panic disorders, with or without agoraphobia, and in generalized anxiety disorders. (From AMA Drug Evaluations Annual, 1994, p238) Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABA<sub>A</sub>) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. This molecule is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance.",CHEMBL661
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,5.62,,
CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,5.62,,
NC(=[NH2+])Nc1ccc(CNC(=O)NC23CC4CC(CC(C4)C2)C3)cc1,5.62,,
CSCCC(NC(=O)C(CCCC[NH3+])NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CCC(N)=O)NC(=O)C[NH3+])C(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(CCCC[NH3+])C(=O)O,5.62,,
CCCCCCCCCCOC(=O)S,5.62,,
COc1cc(-c2nc(-c3cc(OC)c(OC)c(OC)c3)cnc2N)ccc1C(=O)[O-],5.62,,
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C([NH3+])CCC(=O)[O-])C(C)O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)O,5.62,,
CC1=CC([NH3+])c2ccccc2N1CCCCCCCCCCN1c2ccccc2C(N)=CC1C,5.62,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)O)C(C)O)C(C)O,5.62,,
[NH3+]CCCC(=O)[O-],5.62,,
Nc1ncnc2c1nc(NCc1ccc3ccccc3n1)n2C1OC(CO)C(O)C1O,5.62,,
Cc1cc(OCC(=O)[O-])cc(C)c1Cc1ccc(O)c(C(C)C)c1,5.62,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C([NH3+])C(C)C)C(=O)NCC(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(N)=O)C(C)C,5.62,,
O=C(Nc1cccc(-c2nn[nH]n2)c1)c1cccc(C(F)(F)F)c1,5.62,,
Nc1ccc2c(NC3CC3)nc(-c3ccccc3)nc2c1,5.62,,
O=C([O-])C(Cl)Cc1ccccc1,5.62,,
CC([NH3+])C(=O)NC(C(=O)N1CCCC1C(=O)NC(CCC(N)=O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(C)C(=O)[O-])C(C)C)C(C)C,5.62,,
OCC1[NH2+]CC(O)C(O)C1O,5.62,,
CSCCC(NC(=O)C(C)[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)[O-])C(C)C,5.62,,
Cn1c2c(c(-c3cccc(Cl)c3)cc1=O)C=C(C([NH3+])(c1ccc(Cl)cc1)C1CNC=[N+]1C)CC2,5.62,,
CCCCOC(=O)c1ccccc1C(=O)OCc1ccccc1,5.62,"This molecule appears as a clear colorless liquid with a mild odor. Primary hazard is to the environment. Immediate steps should be taken to limit spread to the environment. Easily penetrates the soil to contaminate groundwater and nearby waterways. This molecule is a benzyl ester. This molecule is a natural product found in Festuca rubra and Mangifera indica with data available. This molecule is a phthalate ester mostly used as a plasticizer for PVC. Phthalate esters can cause reproductive and developmental toxicity. (A2883, L1902)",CHEMBL1450327
CCCC(NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(Cc1cnc[nH]1)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)CN1CC=CCCC(=O)NC(CC(N)=O)C(=O)NC(C(C)CC)C1=O)C(C)C)C(C)CC)C(=O)NC(CCSC)C(=O)NC(C(=O)[O-])C(C)C,5.62,,
CC([NH3+])C(=O)NC(CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)N1CCCC1C(=O)[O-])C(C)O,5.62,,
Cc1ccc(OCC(O)C[NH2+]C2Cc3ccccc3C2)cc1C,5.62,,
NC(=O)CCC1NC(=O)C2CCCN2C(=O)C(Cc2c[nH]cn2)NC(=O)CCCCSCC(C(=O)NC(CCCC[NH3+])C(N)=O)NC(=O)C2CCCN2C(=O)C2CCCN2C(=O)CNC1=O,5.63,,
NC(=[NH2+])c1ccc(OCCCCCOc2ccc(C(N)=[NH2+])cc2)cc1,5.63,,
CCCCCCCCCCCCCCCC(=O)[O-],5.63,,
O=C([O-])c1ccccc1NCc1ccco1,5.63,,
[NH3+]C(CS)C(=O)[O-],5.64,,
Clc1cccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)c1,5.64,,
[NH3+]C(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-],5.64,,
O=C1NC(=S)NC12OC(CO)C(O)C(O)C2O,5.64,,
CC1(C)SC(C(NC(=O)Cc2ccccc2)C(=O)NCc2ccccc2)[NH2+]C1C(=O)[O-],5.64,,
O=C(CC(=O)c1c[nH]c2ccc(Cl)cc12)c1nn[nH]n1,5.64,,
NC(=[NH2+])c1ccc(C2C3C(=O)N(Cc4ccc5c(c4)OCO5)C(C4CC4)C3C3CCC[NH+]32)cc1,5.64,,
CN1CC2C(C1=O)C(c1ccc(C(N)=[NH2+])cc1)[NH+]1CCCC21,5.64,,
O=C([O-])CC(=O)NC(CS)Cc1ccccc1,5.64,,
O=S(=O)(c1cccc2cnccc12)N1CCC[NH2+]CC1,5.64,,
CN(C)C(=O)c1cc(-c2[nH]ncc2-c2ccccc2)c[nH]1,5.64,,
Cc1ccc(C(=O)NC(=O)NC2OC(CO)C(O)C(O)C2O)cc1,5.64,,
C[N+](C)(C)CCO,5.64,"This molecule is a choline that is the parent compound of the cholines class, consisting of ethanolamine having three methyl substituents attached to the amino function. It has a role as a neurotransmitter, a nutrient, a human metabolite, a plant metabolite, a Daphnia magna metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a mouse metabolite and an allergen. This molecule is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Amaranthus hybridus, Leonurus japonicus, and other organisms with data available.",CHEMBL920
Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,5.64,"This molecule is an organic heterotricyclic compound that is pyrido[3',2':4,5]furo[3,2-d]pyrimidine substituted at positions 2 and 4 by 3-hydroxyphenyl and morpholin-4-yl groups respectively. A dual-kinase inhibitor with anti-cancer properties. It has a role as an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor, a mTOR inhibitor and an antineoplastic agent. It is a member of morpholines, a member of phenols, an organic heterotricyclic compound, a tertiary amino compound and an aromatic amine. This molecule is an inhibitor of p110α of class I PI3K.",CHEMBL573339
COc1cc(-c2cnc(N)c(-c3ccc(C(=O)[O-])cc3)n2)cc(OC)c1OC,5.64,,
CN1Cc2c(ccc3c2OCO3)-c2ccc3cc4c(cc3c21)OCO4,5.64,"This molecule is a benzophenanthridine alkaloid obtained by selective hydrogenation of the 13,14-position of sanguinarine. It has a role as a metabolite and an antifungal agent. It derives from a hydride of a sanguinarine. This molecule is a natural product found in Pteridophyllum racemosum, Corydalis balansae, and other organisms with data available.",CHEMBL465678
COC(=O)N=c1ccn2c(c1)C=C(CO)C2[NH2+]C(C(=O)[O-])C(C)(C)[SH+](=O)[O-],5.64,,
CSCCC(NC(C)=O)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)[O-])C(C)C,5.64,,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCC[N+]3CCOCC3)cc2)cc1,5.64,,
O=C(c1ccc(CS)cc1)N1CCC(Cc2ccccc2)CC1,5.64,,
O=C(CCC1=CC(O)(C(=O)[O-])CC(O)C1O)Nc1ccccc1,5.64,,
CC(C)(C)c1cc(NC(=O)Nc2ccc3ccccc3c2)n(CC(=O)N2CCS(=O)(=O)CC2)n1,5.64,,CHEMBL1929210
CCOC(=O)CCC(CC1CCNC1=O)NC(=O)C(CC(=O)C(NC(=O)c1cc(C)on1)C(C)C)Cc1ccc(F)cc1,5.64,,
Cc1c(C(=O)NCc2cccc3ccccc23)oc2cccc(OC3CC[NH2+]CC3)c12,5.64,,
O=C1CC(c2ccc(O)cc2)Oc2cc(O)cc(O)c21,5.64,"This molecule is a trihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 6 and 4'. It is a trihydroxyflavanone and a member of 4'-hydroxyflavanones. This molecule is a natural product found in Trichoderma virens, Cadophora gregata, and other organisms with data available.",CHEMBL32571
COC(C(=O)[O-])c1c(C)nc2ccc(Br)cc2c1-c1ccc(Cl)cc1,5.64,,
CC(NC(=O)C(NC(=O)C([NH3+])CCC(N)=O)C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)C)C(=O)NC(CO)C(=O)NC(C(=O)[O-])C(C)O,5.64,,
N#CC(=Cc1ccncc1)C(=O)NCc1ccccc1,5.64,,
O=C([O-])C1CCCCC1C(=O)N1CCc2ccccc2C1CN1C(=O)c2ccccc2C1=O,5.64,,
OCC1OC(OC2C(CO)OC(OC3C(CO)OC(OC4C(CO)OC(O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1O,5.64,,
[NH3+]C(CSCC[B-](O)(O)O)C(=O)[O-],5.65,,
O=CC(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)CCc1ccccc1,5.65,,
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CC(N)=O)C(=O)NC(CC(C)C)C(=O)[O-],5.65,,
C[NH2+]CCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])C(C)O)C(C)O)C(=O)NC(CO)C(=O)[O-],5.65,,
CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21,5.66,This molecule is a quaternary ammonium ion and a member of phenanthridines. It has a role as an intercalator and a fluorochrome.,CHEMBL332935
O=C([O-])C(Cc1ccccc1)N(Cc1cccc(C(F)(F)F)c1)C(=O)c1ccc(Cl)cc1Cl,5.66,,
O=C([O-])C(Cc1ccccc1)N(Cc1ccc(-c2cc3ccccc3o2)s1)C(=O)c1ccc(Cl)cc1Cl,5.66,,
CC(=O)NC(=Cc1ccc(CC(=O)[O-])c(CO)c1)C(=O)NC1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O,5.66,,
Cc1nc(C)c(-c2ccnc(NC=NO)n2)s1,5.66,,
Cc1cccc(CCC[NH+](O)CO)n1,5.66,,
CCCCC(C[NH2+]C(CCCC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)OC)C(C)CC,5.66,,
O=c1[nH]ccc2c(S(=O)(=O)N3CCC[NH2+]CC3)cccc12,5.66,,
Cc1cc(Nc2cc(N3CC[NH+](C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,5.66,,
CCC(C)C(NC(=O)C(C)NC(=O)C(C)[NH3+])C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NCC(=O)O,5.66,,
CC(NC(=O)C(Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)CCO,5.66,,
CC(C)CC1NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCC(N)=O)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCC(=O)[O-])NC(=O)C2CCCN2C(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)C(C)NC(=O)CNC(=O)C([NH3+])CCCC[NH3+])CSSCC(C(=O)NC(C)C(=O)NC(C)C(=O)O)NC1=O,5.66,,
CCC([NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)O)C(C)O,5.66,,
CC(=N)NCCCC(NC(=O)c1ccccc1C(=O)[O-])C(N)=O,5.66,,
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(C)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(N)=O)C(=O)[O-],5.66,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C([NH3+])CC(C)C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)[O-],5.66,,
CC(C)(ON=C(C(=O)NCB(O)O)c1csc(N)n1)C(=O)[O-],5.66,,
COC(=O)c1sccc1NC(=O)Cc1cccs1,5.66,"This molecule is a carboxamide resulting from the formal condensation of the carboxy group of 2-thienylacetic acid with the amino group of methyl 3-aminothiophene-2-carboxylate. It is a selective inhibitor of c-Jun N-terminal kinases (JNKs). It has a role as a c-Jun N-terminal kinase inhibitor. It is a methyl ester, a member of thiophenes and a secondary carboxamide. It is functionally related to a 2-thienylacetic acid.",CHEMBL1288895
CC(C)C(NC(=O)C(CO)NC(=O)C(NC(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CCC(=O)[O-])C(C)C)C(C)C)C(C)O)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.66,,
CCCCCCCCCCCCOc1cccc(O)c1C(=O)[O-],5.66,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)[O-])C(C)O,5.66,,
[NH3+]C(CCCC([NH3+])C(=O)[O-])C(=O)[O-],5.66,,
CC1OCC(O)C(O)C1O,5.66,,
OCCOCCOCCOCCOCCOCCOCCOCCO,5.66,,
O=C(CCC1CCCCC1)Nc1cc(NS(=O)(=O)c2cccs2)cc(-c2csc(=O)[nH]2)c1,5.66,,CHEMBL2349362
CCC(NC(=O)CCc1nc2ccccc2c(=O)[nH]1)c1ccccc1,5.66,,
COC(=O)C(Cc1ccccc1)NC(=O)CCc1nc2ccccc2c(=O)[nH]1,5.66,,
CC(C)CC(NC(=O)CNC(=O)C([NH3+])CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CO)C(=O)[O-],5.66,,
Oc1c(Cl)cc(Cl)cc1-c1[nH]c(Br)c(Br)c1Br,5.66,,CHEMBL1738810
CC(NC(=O)C(CC(=O)[O-])NC(=O)CNC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])Cc1c[nH]cn1)C(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.66,,
CC(NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])Cc1c[nH]cn1)C(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.66,,
CC(NC(=O)C(CCC(=O)[O-])NC(=O)C(C)NC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])Cc1c[nH]cn1)C(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.66,,
CC(NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])Cc1cnc[nH]1)C(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.66,,
CS(=O)(=O)Nc1cccc2cccnc12,5.67,,CHEMBL1235568
CC1(C)OC2COC3(CNS(N)(=O)=O)OC(C)(C)OC3C2O1,5.67,,
O=S(=O)(c1ccccc1)N(Cc1ccccc1)C1C[NH2+]CC1N(Cc1ccccc1)S(=O)(=O)c1ccccc1,5.67,,
CCCN(C)C(=O)C1OC(C(=O)[O-])=CC(NC(N)=[NH2+])C1NC(C)=O,5.67,,
CCC(C)C(NC(=O)C(CCSC)NC(C)=O)C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)[O-],5.67,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)[O-])C(C)O)C(C)O,5.67,,
CC(=O)NC(CC1CCCCC1)C(O)CC(C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)C(C)C,5.68,,
O=S(=O)([O-])c1cccc2cccc(Nc3ccccc3)c12,5.68,,
CC([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(C)C(=O)NC(C(=O)[O-])C(C)C,5.68,,
CNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(=O)NO)CC(C)C,5.68,,
CC(C)c1cc(Sc2ccc(O)c(C(C)C)c2)ccc1O,5.68,,
[NH3+]C1CCc2ccccc2C1O,5.68,,
OC1C[NH+]2CCC(O)C2C(O)C1O,5.68,,
Nc1ncnc2c1ncn2C1OCC(O)C1O,5.68,,CHEMBL2361213
CC([NH3+])C(=O)NC(CCCNC(=[NH2+])N(C)C)C(=O)NC(C(=O)NC(CCCC[NH+](C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O,5.68,,
[NH3+]CCCCNC1=NC(CO)C(O)C(O)C1O,5.68,,
CCC1C=CS[C]1c1cnc(N)c(C2CCC(C(=O)[O-])CC2)n1,5.68,,
COc1ccc(Nc2nc(NCCc3ccccc3F)nc(Nc3ccc4ncccc4c3)n2)cc1OC,5.68,,CHEMBL1213151
CCc1cc2c(cc1OS(N)(=O)=O)CCC1C2CCC2(C)C(O)CCC12,5.68,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)O)C(C)O,5.68,,
Nc1c(S(=O)(=O)[O-])cc(Nc2ccc(S(N)(=O)=O)cc2)c2c1C(=O)c1ccccc1C2=O,5.68,,
CCCN(C(=O)NC(CSCC(C)C)C(=O)[O-])C(=O)c1cccc(C#Cc2ccc(F)cc2F)c1,5.68,,
CC(C)(C)c1ccc(Cc2ccncc2C(=O)NNC(=O)CCC(=O)[O-])cc1,5.68,,
COc1cc(O)cc(Nc2ccc(C(=O)Nc3ccc4c(c3)C[NH2+]CC4)cc2)c1,5.68,,
O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,5.68,"These molecules is a tetrahydroxyflavone in which the four hydroxy groups are located at positions 3, 5, 7 and 4'. Acting as an antioxidant by reducing oxidative stress, it is currently under consideration as a possible cancer treatment. It has a role as an antibacterial agent, a plant metabolite, a human xenobiotic metabolite, a human urinary metabolite, a human blood serum metabolite and a geroprotector. It is a member of flavonols, a 7-hydroxyflavonol and a tetrahydroxyflavone. It is a conjugate acid of a kaempferol oxoanion. This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Hydrangea serrata, Caragana frutex, and other organisms with data available. This molecule is a natural flavonoid which has been isolated from Delphinium, Witch-hazel, grapefruit, and other plant sources. This molecule is a yellow crystalline solid with a melting point of 276-278 degree centigrade. It is slightly soluble in water, and well soluble in hot ethanol and diethyl ether.",CHEMBL150
COc1ccc(OCCN2CCC3CCCC(C2=O)N3S(=O)(=O)c2ccc3ncsc3c2)cc1OC,5.68,,CHEMBL2348591
CCCCOC(=O)c1ccc(O)cc1,5.68,"This molecule appears as odorless white crystals or crystalline powder. Tasteless, but numbs the tongue. Aqueous solutions slightly acidic to litmus. (NTP, 1992) This molecule is an organic molecular entity. This molecule is a Standardized Chemical Allergen. The physiologic effect of butylparaben is by means of Increased Histamine Release, and Cell-mediated Immunity. This molecule is a natural product found in Strychnos cathayensis and Carica papaya with data available. This molecule is a preservative and flavouring agent. This molecule has been shown to exhibit anti-microbial function  This molecule belongs to the family of Hydroxybenzoic Acid Derivatives. These are compounds containing an hydroxybenzoic acid (or a derivative), which is a benzene ring bearing a carboxylic acid. (A3205).",CHEMBL459008
COCCCCC([NH2+]OCC[NH3+])c1ccc(C(F)(F)F)cc1,5.68,,
CCOC(=O)CCC(CC1CC[NH2+]C1O)NC(=O)C(CC(=O)C(NC(=O)c1cc(C)on1)C(C)C)Cc1ccc(F)cc1,5.69,,
CC(NC(=O)C(CCCC[NH3+])NC(=O)C1CCCN1C(=O)C(CCC(=O)[O-])NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(CO)NC(=O)C[NH3+])C(=O)[O-],5.69,,
[NH3+]CCCCC(NC(=O)C1CC[NH+]2CCC([NH3+])(Cc3ccccc3)C(=O)N12)C(O)C(=O)NC1CCCCC1,5.7,,
[NH3+]CCCC[NH3+],5.7,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1cnc[nH]1)NC(=O)C(NC(=O)C(NC(=O)C(CO)NC(C)=O)C(C)O)C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)O,5.7,,
CSCCC(NC(=O)C([NH3+])Cc1c[nH]c2ccccc12)C(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(CC(C)C)C(=O)NC(Cc1cnc[nH]1)C(=O)N1CCCC1C(=O)[O-])C(C)O)C(C)O,5.7,,
CC1(c2ccc(Oc3ccccc3)cc2)C(=O)NC(=O)NC1=O,5.7,This molecule is a member of barbiturates.,CHEMBL176467
COc1cc(OC)cc(C(=O)NC2C(O)C(CO)OC2n2cnc3c(NCc4cccc5ccccc45)ncnc32)c1,5.7,,
O=C([O-])CSc1nc(-c2cccc(Cl)c2)no1,5.7,,
Nc1cc(Nc2ccc(S(N)(=O)=O)cc2)ncn1,5.7,,CHEMBL265964
CC(C)C([NH3+])C(=O)N1CCCC1,5.7,,
O=C([O-])C1=CC(O)C(OS(=O)(=O)[O-])C(OC2C(COS(=O)(=O)[O-])OC(OC3C(C(=O)[O-])OC(OC4C(COS(=O)(=O)[O-])OC(OC5C(C(=O)[O-])OC(OC6C(COS(=O)(=O)[O-])OC(O)C(NS(=O)(=O)[O-])C6O)C(OS(=O)(=O)[O-])C5O)C(NS(=O)(=O)[O-])C4O)C(OS(=O)(=O)[O-])C3O)C(NS(=O)(=O)[O-])C2O)O1,5.7,,
CCOC(=O)c1c(C)nn(-c2ccc(OC)cc2)c1C,5.7,,CHEMBL1230268
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,5.7,,
C[S+](CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,5.7,,
CCCCC(C[NH2+]C(CCCC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)CC,5.7,,
CSCCC([NH3+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)N1CCCC1C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)N1CCCC1C=O)C(C)C,5.7,,
CC12CCC3c4cc(O)c(O)cc4CCC3C1CCC2O,5.7,,
Oc1cc(O)c(-c2[nH]ncc2N2CC[NH2+]CC2)cc1Cl,5.7,,
CC(C)c1ccc(C=NNC(=O)c2ccc(O)cc2)cc1,5.7,,
Cc1ccc(S(=O)(=O)Nc2nc(O)c(Cc3ccc(C)o3)s2)cc1,5.7,,
CCCCCCCN(CCc1ccc(OC(C)(CC)C(=O)[O-])cc1)c1nc2ccccc2o1,5.7,,
CCCCCCCN(CCc1ccc(OC(C)(CC)C(=O)[O-])cc1)c1nc2ccccc2o1,5.7,,
CCCCCCCOc1cccc(C(=O)[O-])c1,5.7,,
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(N)=O)C(=O)O,5.7,,
O=C1CCCC2=C1C(c1cccc(O)c1)NC(=S)N2,5.7,,CHEMBL240690
OCC1OC(O)(CO)C(O)C1O,5.7,,
CN(Cc1ccccc1)C(=O)c1nc(-c2cccc(Cl)c2)[nH]c1C(=O)[O-],5.7,,
CC(=O)NC1C(O)C=C(C(=O)[O-])OC1C(O)C(O)CO,5.7,,
CC1CC2OC2C=CC=CC(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1,5.7,This molecule is a macrocyclic antifungal antibiotic that inhibits signal-dependent transcriptional activation and induces differentiation in leukemia. (NCI),CHEMBL3972342
C=CCc1cc(-c2ccccc2)ccc1OCCC[NH2+]C(C)C,5.7,,
CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O,5.7,This molecule is a natural product found in Streptomyces purpurascens and Streptomyces violaceus with data available.,CHEMBL20692
Cc1nc2c(c(=O)[nH]1)CSCC2,5.7,,CHEMBL483348
OCC1C(O)C(O)C(O)c2nccn21,5.7,,
O=C(N=NCc1cc(Br)c(O)c(Br)c1O)c1cccc(Br)c1,5.7,,
CCC(C)C([NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC=O)C(C)O,5.7,,
C=C1C(C)C2C(Cc3ccccc3)NC(=O)C23C(OC(C)=O)C=CC(C)(O)C(=O)C(C)CC=CC3C1O,5.7,,
Nc1cccc(C(=O)[O-])c1,5.7,,
Cn1c(=O)c2c(nc(N3CC[NH2+]CC3)n2Cc2ccccc2Cl)n(C)c1=O,5.7,,
O=C(COc1ccccc1Br)NCCc1nc2ccccc2[nH]1,5.7,This molecule is a member of benzimidazoles.,CHEMBL1173694
O=C([O-])Cc1c(C(=O)[O-])[nH]c2c(Cl)ccc(Cl)c12,5.7,,
O=C(CC(O)C(=O)[O-])c1ccccc1,5.7,,
O=c1ccc2ccccc2[nH]1,5.7,"This molecule is a monohydroxyquinoline carrying a hydroxy substituent at position 2. It is an intermediate metabolite produced duting the microbial degradation of quinoline. It has a role as a bacterial xenobiotic metabolite. It is a tautomer of a quinolin-2(1H)-one. This molecule is a natural product found in Glycosmis pentaphylla, Houttuynia cordata, and Aconitum ferox with data available.",CHEMBL186422
N#Cc1ccc(COC(=O)C2CC3(C[NH2+]2)C(=O)Nc2ccccc23)cc1Br,5.7,,
COc1cc(OC)c(S(=O)(=O)N2c3ccccc3CC2C)cc1NC(C)=O,5.7,,CHEMBL1951072
Cc1c(-c2nc(Cc3ccccc3)no2)oc2cccc(OC3CC[NH2+]CC3)c12,5.7,,
O=[N+]([O-])c1ccc2nn[nH]c2c1,5.7,,
O=C1N=C(Cc2cccc(Br)c2)C(=O)N1,5.7,,
C=C(C)C1C[NH2+]C(C(=O)[O-])C1CC(=O)[O-],5.7,,
[NH3+]CCCCC([NH3+])C(=O)[O-],5.7,,
CCC(NC(=O)C(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CC(C)C)C(C)C)C(=O)NC(CCSC)C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NC(C(=O)NC(C(=O)[O-])C(C)C)C(C)O)C(C)C,5.7,,
CC1[NH2+]C(c2nc3ccccc3[nH]2)C(O)C1O,5.7,,
CCC(C)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(N)=O)NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)CC)C(=O)NC(CO)C(=O)NC(C(=O)NC(CO)C(=O)[O-])C(C)C,5.7,,
Nc1nc(-c2ccc(Cc3ccccc3)cc2)cs1,5.7,,CHEMBL3883608
C[NH+](C)C(Cc1c[nH]cn1)C(=O)[O-],5.7,,
CC1(C)Nc2nc(N)[nH]c(=O)c2N=C1C(=O)NCC(=O)NCCS(=O)(=O)CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,5.7,,
Cc1ccc2c(=O)c3cccc(CC(=O)[O-])c3oc2c1C,5.7,,
CC(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(O)C(F)(F)F,5.7,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(C)[NH3+])B(O)O,5.7,,
C=CC1=C(C)C2CC3C(C=C)=C(C)C(CC4N=C(CC5NC(=CC1[NH2+]2)C(C)=C5CCC(O)O)C(CCC(O)O)=C4C)[NH+]3C,5.71,,
C[N+]1CCN(C(=O)NC(Cc2ccccc2)C(=O)NC(CCc2ccccc2)CCS(=O)(=O)c2ccccc2)CC1,5.71,,
O=c1[nH]c(=O)c2[nH]cnc2[nH]1,5.71,,
CC1=CC([NH3+])c2ccccc2N1CCCCCCCCCCN1c2ccccc2C(N)=CC1C,5.71,,
Cc1cc(C=Cc2cccc(C=O)c2)cc(C)c1O,5.71,,
O=c1[nH]c(=O)n(C2OC(CO)C(O)C(O)C2O)cc1I,5.71,,
CC(C)CC(NC(=O)C(CS)NC(=O)C1CCCN1C(=O)C(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CS)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CS)NC(=O)C[NH3+])C(C)C)C(C)C)C(N)=O,5.71,,
CC(C)CC(NC(=O)C(C)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)NC(C)CCCC[NH3+],5.72,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH+](C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH+](C)C)C(=O)NC(CO)C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)N1CCCC1C(=O)NCC(=O)NCC(=O)[O-])C(C)O)C(C)O)C(C)O,5.72,,
CC(C)C(NC(=O)C(CO)NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)[O-],5.72,,
CC1=CC(C(=O)NC(C)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)OCc2ccccc2)CC2CCNC2=O)C(C)C)[NH2+]O1,5.72,,
Cc1cc(CNS(=O)(=O)c2cccc(NC=C3CCOC3=O)c2)nc(N)n1,5.72,,
[NH3+]C(CC(=O)[O-])C(=O)[O-],5.72,,
NS(=O)(=O)c1ccc(Nc2cncc(Cl)n2)cc1,5.72,,CHEMBL487738
CC(=N)NCCCC(NC(=O)c1ccccc1C(=O)[O-])C(N)=O,5.72,,
COc1cccc(Cc2c[nH]c3ncccc23)c1,5.72,,CHEMBL1231606
CC(OC(=O)Nc1ccc(Cl)c(Cl)c1)c1nc2ccccc2[nH]1,5.72,,
Brc1ccc(-c2c[nH]c(C3Cc4ccccc4C[NH2+]3)n2)cc1,5.72,,
O=C([O-])c1ccc2ccccc2c1-c1c(C(=O)[O-])ccc2ccccc12,5.72,,
[NH3+]C(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCc1cc(Cl)ccn1,5.72,,
O=S(=O)(c1cccc2cnccc12)N1CCC[NH2+]CC1,5.72,,
CC(C)c1nc(CN(C)C(=O)NC(C(=O)NC(Cc2ccccc2)CC(O)C(Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,5.72,,
O=C(NO)c1coc(-c2ccccc2C(F)(F)F)n1,5.72,,
O=C(NO)c1ncc(-c2ccccc2Cl)o1,5.72,,
O=C(OC1Cc2c(O)cc(O)cc2OC1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,5.72,"This molecule is a catechin. This molecule is a natural product found in Camellia sinensis, Cistus salviifolius, and other organisms with data available.",CHEMBL311663
C[N+](C)=c1ccn(Cc2ccc(-c3ccc(Cn4cnc(N)c5ncnc4-5)cc3)cc2)cc1,5.72,,
[NH3+]C1Cc2ccccc2C1NC(=O)C(=O)Nc1ccc(Cl)c(F)c1,5.72,,
CCCCCCCCCCOc1cccc(C(=O)CC(O)C(=O)[O-])c1,5.72,,
CN1Cc2cc(S(=O)(=O)N3CCCC3)ccc2NC1=O,5.72,,CHEMBL2179382
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C([NH3+])CCC(=O)[O-])C(C)O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)[O-],5.72,,
O=C(CCS)N1CCC(O)(c2ccc(Cl)c(C(F)(F)F)c2)CC1,5.72,,
CC(NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])C(C)O)C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH+](C)C)C(=O)NC(CO)C(=O)[O-],5.72,,
C[NH2+]CCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCCC[NH2+]C)NC(=O)C([NH3+])C(C)O)C(C)O)C(=O)NC(CO)C(=O)NC(C(=O)[O-])C(C)O,5.72,,
COc1ccc(CC(=O)NC(=[NH2+])NCc2ccc(C)cc2)cc1OC,5.72,,
Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O,5.73,"This molecule appears as orange needles or powder. (NTP, 1992) This molecule is a trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by hydroxy groups at positions 1, 3, and 8 and by a methyl group at position 6. It is present in the roots and barks of numerous plants (particularly rhubarb and buckthorn), moulds, and lichens. It is an active ingredient of various Chinese herbs. It has a role as a tyrosine kinase inhibitor, an antineoplastic agent, a laxative and a plant metabolite. It is functionally related to an emodin anthrone. It is a conjugate acid of an emodin(1-). This molecule has been investigated for the treatment of Polycystic Kidney. This molecule is a natural product found in Hamigera avellanea, Setophoma terrestris, and other organisms with data available. This molecule is found in dock. This molecule is present in Cascara sagrada.This molecule is a purgative resin from rhubarb, Polygonum cuspidatum, the buckthorn and Japanese Knotweed (Fallopia japonica). The term may also refer to any one of a series of principles isomeric with the emodin of rhubarb. (Wikipedia) 

This molecule has been shown to exhibit anti-inflammatory, signalling, antibiotic, muscle building and anti-angiogenic functions (A3049, A7853, A7854, A7855, A7857).",CHEMBL289277
CNc1nc2c(N)ncnc2n1C1OC(COCC(N)=O)C(O)C1O,5.73,,
CCC(C)C(NC(=O)C(C)[NH3+])C(=O)NC(C)C(=O)NC(C(=O)[O-])C(C)C,5.73,,
OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC8C(CO)OC(OC1C(O)C2O)C(O)C8O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O,5.74,,
CC(N=Cc1cc(C(N)=[NH2+])ccc1O)C(=O)[O-],5.74,,
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(CCCC[NH3+])NC(=O)C1CCC[NH2+]1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccccc1)C(=O)NC(CC(=O)[O-])C(=O)[O-],5.74,,
NC(=[NH2+])c1ccc2[nH]c(-c3ncccc3O)nc2c1,5.74,,
NC(=[NH2+])c1ccc2[nH]c(-c3ncccc3O)nc2c1,5.74,,
NC(=[NH2+])c1ccc2[nH]c(-c3ncccc3O)nc2c1,5.74,,
NC(=[NH2+])c1cc2cc(-c3cccc(-c4ccccc4)c3O)[nH]c2cc1Cl,5.74,,
COc1nccnc1C(C)C,5.74,"This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Zingiber mioga, Panax notoginseng, and other organisms with data available.",CHEMBL96852
CC(C)CC(NC(=O)C[NH3+])C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(=O)[O-])C(C)O,5.74,,
O=C([O-])CNC(=O)C(CS)Cc1ccccc1,5.74,,
CC1=CCC2(CO)COC(c3ccc(O)cc3)C1C2,5.74,,
Brc1cccc(-c2cc(NCc3ccncc3)n3nccc3n2)c1,5.74,,CHEMBL204054
NC(=[NH2+])c1ccc2nc(-c3n[nH]c(-c4ccccc4)c3O)[nH]c2c1,5.74,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(N)=O)NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)C)C(C)CC)C(C)CC)C(C)C,5.74,,
COC(=O)C1C(OC(=O)c2ccccc2)CC2CCC1[NH+]2C,5.74,,
CC1CCc2cccc(c2)CC(C)([NH3+])C(=O)OCc2cc(nc(N(C)S(C)(=O)=O)c2)CC1,5.74,,
CCCCCS(=O)(=O)c1cccc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]C(C)C(=O)NC2CCCCC2)c1,5.74,,
CC(NC(=O)c1ccccc1Cc1ccccc1)B(O)O,5.74,,
O=c1cc(-c2ccccc2)c2ccc(O)c(O)c2o1,5.74,This molecule is a natural product found in Mesua ferrea with data available.,CHEMBL1233867
CC(C)CC(NC(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CO)C(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(CC(=O)[O-])C(=O)[O-],5.74,,
O=C1C(=NO)c2c(-c3ccccc3)cccc2N1Cc1cc(F)cc2c1OCOC2,5.74,,
NC(=[NH2+])c1ccc(N=NNc2ccc(C(N)=[NH2+])cc2)cc1,5.74,,
COc1ccc2c(c1)cc(C(=O)NS(=O)(=O)c1cc3ccccc3o1)n2CC(=O)[O-],5.74,,
O=C(NC(CC=Cc1ccccc1)C(=O)[O-])c1ccc2ccccc2c1,5.74,,
Nc1nc2ccc(Cl)cc2[nH]1,5.74,,CHEMBL269158
NC(=[NH2+])NCCCC(NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)C([NH3+])CO)C(=O)NCC(=O)NCC(=O)NC(CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)[O-],5.74,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(C)[NH3+])C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)[O-],5.74,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C[NH3+])C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)[O-],5.74,,
COc1ccc(NC(=S)NCCCn2ccnc2)cc1OC,5.74,,CHEMBL201747
NC(=[NH2+])NCCCC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccccc1)C(=O)NC(CS)C(N)=O,5.74,,
CCC1(C)OC2=CC(C=CC2=O)C(O)C([NH2+]C)C(=O)NC(C(C)C)C(=O)NC1C(=O)NCC(=O)[O-],5.74,,
CC1(C)OC2C(Cn3cc(CCCCCC4SCC5NC(=O)NC54)nn3)OC(n3cnc4c(N)ncnc43)C2O1,5.74,,
O=C1NC(=O)C(Cc2ccc3ccccc3c2)N1,5.74,,
[NH3+]Cc1ccc(NC(=O)C2C(O)=CC=CN2Cc2nccn2Cc2ccccc2)cc1,5.74,,
COCCn1cccc1C(O)(c1ccc(N(C)S(=O)(=O)c2ccccc2)cc1)C(F)(F)F,5.74,,CHEMBL2012764
CCC(C)C(NC(=O)C(CCSC)NC(C)=O)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)[O-],5.74,,
O=C1N=Nc2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc21,5.74,,
COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1,5.74,"This molecule has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.",CHEMBL2393130
CN1C(=O)C(Cc2ccccc2)OC(c2ccc(Cl)cc2)C1c1ccc(Cl)cc1,5.74,,
COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(Cc3ccccc3)nc2cc1O,5.74,,CHEMBL3343036
O=C(c1ccc(O)cc1O)n1cc2ccccc2c1,5.74,,
N#CCCNc1nonc1-c1nc2ccccc2n1CC(=O)c1ccc(N)cc1,5.74,,CHEMBL3422109
COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,5.74,"This molecule is an alkaloid that is a carbotricyclic compound comprising 5,6,7,9-tetrahydrobenzo[a]heptalene having four methoxy substituents at the 1-, 2-, 3- and 10-positions as well as an oxo group at the 9-position and an acetamido group at the 7-position. It has been isolated from the plants belonging to genus Colchicum. It has a role as a microtubule-destabilising agent and a plant metabolite. It is a carbotricyclic compound, an alkaloid, an aromatic ether and a member of acetamides. This molecule is a natural product found in Colchicum crocifolium, Colchicum doerfleri, and other organisms with data available. This molecule is only found in individuals that have used or taken this drug. It is a major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (periodic disease). The precise mechanism of action has not been completely established. In patients with gout, colchicine apparently interrupts the cycle of monosodium urate crystal deposition in joint tissues and the resultant inflammatory response that initiates and sustains an acute attack. This molecule decreases leukocyte chemotaxis and phagocytosis and inhibits the formation and release of a chemotactic glycoprotein that is produced during phagocytosis of urate crystals. This molecule also inhibits urate crystal deposition, which is enhanced by a low pH in the tissues, probably by inhibiting oxidation of glucose and subsequent lactic acid production in leukocytes. This molecule has no analgesic or antihyperuricemic activity. This molecule inhibits microtubule assembly in various cells, including leukocytes, probably by binding to and interfering with polymerization of the microtubule subunit tubulin. Although some studies have found that this action probably does not contribute significantly to colchicine's antigout action, a recent in vitro study has shown that it may be at least partially involved.",CHEMBL87
CCC(CC)OC1C=C(C(=O)[O-])CC([NH3+])C1NC(C)=O,5.75,,
CN(C)c1ccc(C(c2ccccc2)c2ccc(N(C)C)cc2)cc1,5.75,This molecule is a benzenoid aromatic compound.,CHEMBL1898627
CC(=O)NCC(=O)NC(CO)C(=O)NC(CC(C)C)C(C)=O,5.75,,
CC(=O)NC1C(OC2C(O)C(CO)OC(OC3C(O)C(CO)OC(OC4C(O)C(CO)OC(OC5C(CO)OC(O)C(O)C5O)C4O)C3NC(C)=O)C2OC2OC(C)C(O)C(O)C2O)OC(CO)C(O)C1O,5.75,,
CC(C)CC(NC(=O)OCc1ccccc1)C(=O)NC(CO)CC1CCNC1=O,5.75,,
Cc1nc(-c2ccccn2)nc(NC(Cc2ccccc2)C(N)=O)c1Cl,5.75,,
CC(=O)NC(Cc1ccccc1)C(=O)NC(C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(N)=O,5.75,,
[NH3+]C(Cn1oc(=O)[nH]c1=O)C(=O)[O-],5.76,,
O=C([O-])CC(CO)NC(=O)c1cncc(-c2ccc(C(=O)[O-])cc2)c1,5.76,,
Nc1n[nH]c(N)c1N=Nc1cccc(C(=O)[O-])c1,5.76,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)O)C(C)O,5.76,,
COCC(=O)NC(Cc1ccc(-c2cc(Cl)cc(Cl)c2)cc1)C(O)C(O)C(=O)[O-],5.76,,
CCCCc1c(C)nc2ccc(OC)cc2c1SCCC#N,5.76,,CHEMBL2079453
NC(=[NH2+])NCCCC(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CS)NC(=O)C([NH3+])CCC(N)=O)C(=O)NCC(=O)NC(CS)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CS)C(=O)NC(CC(N)=O)C(N)=O,5.76,,
COC(=O)CCC(CC([NH3+])C(=O)[O-])C(=O)[O-],5.76,,
COC1OC(C(=O)[O-])C(OC2OC(CO)C(O)C(OS(=O)(=O)[O-])C2NS(=O)(=O)[O-])C(O)C1OS(=O)(=O)[O-],5.76,,
CSCCC(NC(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)C[NH3+])C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)[O-],5.77,,
O=C1NC(=O)C(c2ccccc2)([NH+]2CCC(CCO)CC2)C(=O)N1,5.77,,
O=[N+]([O-])c1cccc(B(O)O)c1,5.77,,CHEMBL20945
NC(=[NH2+])c1cc2c(I)cccc2s1,5.77,,
Nc1nc2c(CSc3ccccc3)cc(C[NH3+])cc2c(=O)[nH]1,5.77,,
CC(=O)NC1C(=NOC(=O)Nc2ccccc2)OC(CO)C(OC2OC(CO)C(O)C(O)C2NC(C)=O)C1O,5.77,,
CC1(C)CCN(c2ccc(O)c(C(=O)c3ccc(C(=O)NC4CCC[NH2+]CC4NC(=O)c4ccncc4)cc3)c2)CC1,5.77,,
CCC1C2C(C(=O)N1Cc1ccc3c(c1)OCO3)C(c1ccc(C(N)=[NH2+])cc1)[NH+]1CCCC21,5.77,,
COC1OCC(O)C(O)C1O,5.77,,
COC(=O)CNC(=O)C(C)NC(=O)C(O)C([NH3+])c1ccc(C(F)(F)F)cc1,5.77,,
COc1ccc(-c2oc3c(CC=C(C)C)c(O)cc(O)c3c(=O)c2OC2OC(C)C(O)C(O)C2O)cc1,5.77,,
CCN(CC)C(=O)c1c(NC(=O)c2cccs2)sc2c1CCCC2,5.77,,CHEMBL228369
CC(C)CC([NH3+])C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCNC(N)=[NH2+],5.77,,
COC(=O)C(Cc1ccc(Br)cc1)NC(=O)CCCCCCC(=O)NO,5.77,,
O=C([O-])c1nc(-c2ccccc2)[nH]c1C(=O)[O-],5.77,,
CC(C)CC([NH3+])C(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1cnc[nH]1)C(=O)[O-],5.77,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C1CCC[NH2+]1)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C)C=O,5.77,,
CC(=O)N1c2ccccc2NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(OCc2ccccc2)c(Cl)c1,5.77,,CHEMBL1673155
CC(C)CC(NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CCC(N)=O)NC(=O)C[NH3+])C(=O)NC(Cc1ccccc1)C(=O)[O-],5.77,,
CC(=O)NCC(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CC(C)C)C(=O)[O-])C(C)C,5.77,,
OCC1OC(OC2C(CO)OC(OC3C(CO)OC(OC4C(CO)OC(O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1O,5.77,,
O=C([O-])C1CC(O)C(O)C(C(O)CO)O1,5.77,,
O=C([O-])c1ccc(O)c2ncccc12,5.77,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(CCSC)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)C(CO)NC(=O)C([NH3+])CC(C)C)C(C)CC)C(C)O)C(C)CC)C(=O)[O-],5.77,,
NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,5.77,This molecule is a member of thiophenes and an aromatic amide. This molecule is a selective inhibitor of human IκB kinase 2 (IKK-2).,CHEMBL257167
Nc1nc(N2CC[NH+](CCOc3ccc(Br)cc3)CC2)n[nH]1,5.77,,
COC(=O)C1NC(=O)C2NC(=O)C(NC(=O)C3NC(=O)C4NC(=O)C(NC(=O)C([NH3+])c5ccc(O)c(c5)Oc5cc4cc(O)c5C)C(O)c4ccc(cc4)Oc4cc3cc(c4O)Oc3ccc(cc3)C2O)c2ccc(O)c(c2)-c2c(O)cc(O)cc21,5.77,,
O=C(CC[NH+]1CCCCC1)N1CCc2nc(O)c3cc(F)ccc3c2C1,5.77,,
CC([NH3+])C(=O)NC(C(=O)NC(C)C(=O)NC(C)C(=O)[O-])C(C)O,5.77,,
CC(=O)NC1C(O)CC(OC2C(O)C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C2O)(C(=O)[O-])OC1C(O)C(O)CO,5.77,,
CC(COC(=O)CCCCC(=O)[O-])(C(NCCC=O)C(=O)[O-])[SH](=O)=O,5.77,,
Cc1onc(-c2ccccc2Cl)c1C(=O)Nc1ccc(C(C)C)cc1,5.77,,
C[NH+]1C(CNc2ccc(C(=O)NC(CCC(=O)NC(CCC(=O)[O-])C(=O)[O-])C(=O)[O-])cc2)CNC2=NC(=[NH2+])NC(O)C21,5.77,,
C[NH+]1C(CNc2ccc(C(=O)NC(CCC(=O)NC(CCC(=O)[O-])C(=O)[O-])C(=O)[O-])cc2)CNC2=NC(=[NH2+])NC(O)C21,5.77,,
CN1C2=C(NCC1CNc1ccc(C(=O)NC(CCC(=O)NC(CCC(=O)[O-])C(=O)[O-])C(=O)[O-])cc1)NC(=[NH2+])NC2O,5.77,,
COc1cc2c(cc1O)CCC1C2CCC2(C)C(OS(N)(=O)=O)CCC12,5.78,,
CC1(C)CC(=O)c2sc(N3CCOCC3)nc2C1,5.78,,CHEMBL469099
C=CCc1ccc(O)c(-c2cc(CC=C)ccc2O)c1,5.78,"This molecule is a member of biphenyls. This molecule is a natural product found in Magnolia henryi, Magnolia officinalis, and other organisms with data available.",CHEMBL180920
CCOC(=O)CCC(CC1CC[NH2+]C1O)NC(=O)C(CC(=O)C(NC(=O)c1cc(C)on1)C(C)C)Cc1ccc(F)cc1,5.78,,
CCOC(=O)CCC(CC1CCNC1=O)NC(=O)C(CC(=O)C(NC(=O)c1cc(C)on1)C(C)C)Cc1ccc(F)cc1,5.78,,
Cc1nc2c(=O)[nH]c(=O)nc-2n(CC(O)C(O)C(O)CO)c1O,5.78,,
C=CCc1cc(Cl)cc(C[NH2+]CCCNC(=O)Nc2ccsc2)c1OCc1ccccc1,5.78,,
CCCCCCCCCCCCCCCCCC(=O)[O-],5.79,,
C[NH+]1CC[NH+](Cc2ccc(C(=O)Nc3cccc(Nc4nccc(-c5cccnc5)n4)c3)cc2)CC1,5.79,,
O=C(COc1ccc(Cl)cc1)Nc1ccccc1C(=O)[O-],5.79,,
C[N+](C)(C)CCCN1C(=O)C2C(C1=O)C(c1coc(-c3ccc(Cl)s3)n1)[NH+]1CCCC21,5.79,,
O=c1cccc2n1CC1C[NH2+]CC2C1,5.79,,
O=c1[nH]cnc2cc3[nH]c(NCc4cccs4)nc3cc12,5.79,,
CCCCc1nc2ccc(O)cc2c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,5.8,,CHEMBL26514
COC(=O)C(NC(=O)CNC(=O)C(CS)[NH2+]Cc1ccc(-c2ccccc2)cc1)C(C)C,5.8,,
CC(N=Cc1ccc(C(N)=[NH2+])cc1O)C(=O)[O-],5.8,,
CC(=O)NC(CC(C)C)C(=O)NC(CO)Cc1ccccc1,5.8,,
CC(=O)NC1C(OCc2ccccc2)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O,5.8,,
c1ccc2c(c1)Cc1c-2n[nH]c1-c1ccncc1,5.8,,CHEMBL1234009
Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CC=CC(C)C=CCC(C)C)O2,5.8,,
Cc1ccc(NCCC[NH3+])c([N+](=O)[O-])c1,5.8,,
COc1cc2ncn(-c3cc(OC(C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,5.8,,CHEMBL1893257
CC1=NCCC(C(=O)[O-])N1,5.8,,
O=C([O-])c1ccc(-c2ccc([N+](=O)[O-])cc2Cl)o1,5.8,,
Nc1ncc(C2SCCC2C2CC2)nc1C1CCC(C(=O)[O-])CC1,5.8,,
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCSC)NC(=O)C([NH3+])C(C)O)C(C)C)C(C)O)C(=O)NC(CCSC)C(=O)[O-],5.8,,
Nc1[nH]nc2ccc(-c3ccccc3)cc12,5.8,,
CC(COC(N)=O)(C(Nc1c(CO)cc2cc(C(N)=O)ccn12)C(=O)[O-])[SH+](=O)[O-],5.8,,
CCCCC(C[NH2+]C(CCCC)C(O)[NH2+]C(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)CC,5.8,,
CCN(CC)S(=O)(=O)c1cc(C(=O)Nc2ccccc2C(=O)[O-])ccc1Br,5.8,,
CC(COC(N)=O)(C(Nc1c(CO)cc2cc(C(N)=O)ccn12)C(=O)[O-])[SH+](=O)[O-],5.8,,
CCC(C)C(NC(=O)C(CC(N)=O)NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(C)=O)C(C)O)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)[O-])C(C)O,5.8,,
CCCCNc1c(-c2ccc(OCC(=O)[O-])cc2)[nH]c2ccc(Br)c[n+]12,5.8,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NCC(=O)[O-])C(C)O,5.8,,
O=C(CC(=O)C(=O)[O-])NCCCc1cccc(Oc2ccccc2)c1,5.8,,
O=C1NC(O)=CCN1Cc1cn(C2OC(CO)C(O)C2O)nn1,5.8,,
Cc1c(O)cccc1C(=O)NC(C(=O)NC(CO)C(=O)NC(CCS(C)(=O)=O)Cc1ccc(C[NH3+])cc1)C(C)C,5.8,,
CC(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)[O-],5.8,,
CCC(C)C(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCC=CCCCC(NC(=O)C(CC(N)=O)NC(=O)C(CCCC[NH3+])NC(C)=O)C(=O)N2CCCC2C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)N1)C(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCSC)C(=O)NC(C(=O)[O-])C(C)C,5.8,,
CCOC(=O)COc1cccc(C(=O)c2nonc2N)c1,5.8,,
CC1(C)SC2C(NC(=O)C([NH3+])c3ccccc3)C(=O)N2C1C(=O)[O-],5.81,,
Nc1ncc(N=Nc2ccccc2)c(-c2ccc(Cl)cc2Cl)n1,5.81,,
O=[N+]([O-])NC1=[NH+]CCN1Cc1ccc(Cl)nc1,5.81,,
CCC(CSCC(NC(=O)CCC([NH3+])C(=O)[O-])C(=O)NCC(=O)[O-])C(=O)c1ccc(OCC(=O)[O-])c(Cl)c1Cl,5.82,,
CC1OC(O)C(O)C(O)C1O,5.82,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL273741
CC(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CO)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)[O-],5.82,,
O=C(NO)NC(Cc1ccccc1)C(=O)[O-],5.82,,
Cn1c(Cc2ccc(C(N)=[NH2+])cc2)nc2cc(NS(=O)(=O)c3ccccc3)ccc21,5.82,,
C[N+](C)(C)c1ccc(CNC(=O)c2cc3ccccc3n2Cc2cccc(C(N)=[NH2+])c2)cc1,5.82,,
CC(C)C(NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)[O-])C(C)O,5.82,,
OCC1OC(SC2C(CO)OC(OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(O)C(O)C5O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1O,5.82,,
Nc1nc2nn(-c3cccc(C(=O)[O-])c3)nc2c(=O)[nH]1,5.82,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,5.82,,
CC(=O)NC1CSSCC(C(=O)[O-])NC(=O)C(Cc2ccccc2)NC(=O)C(CCC(N)=O)NC(=O)C2CCCN2C(=O)C(Cc2cnc[nH]2)NC1=O,5.82,,
O=C(NCc1ccccn1)c1ccc(Oc2ccccc2)cc1,5.82,"This molecule is a member of the class of benzamides obtained by formal condensation of the carboxy group of 4-phenoxybenzoic acid with the amino group of (pyridin-2-yl)methylamine. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of benzamides, an aromatic ether and a member of pyridines.",CHEMBL199237
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)O)C(C)O)C(C)O,5.82,,
CCC(C)C(NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C1CCCN1C(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(C)NC(=O)C(C)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)[O-],5.82,,
CCC(C)C(NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C1CCCN1C(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(C)NC(=O)C(C)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)[O-],5.82,,
NS(=O)(=O)c1ccc(CCC(=O)[O-])cc1,5.82,,
CC(C)(C)OC(=O)Nc1cccnc1C(=O)Nc1nccs1,5.82,,CHEMBL327579
CC(C)Nc1cc(Cl)nc2c(C#N)cnn12,5.82,,CHEMBL458926
c1cc(-c2cnc3cnc(-c4cn[nH]c4)cn23)[nH]n1,5.82,,
CCC1CN(c2nc(-c3cc(OC)c(OC)c(OC)c3)cnc2N)CCC1C(=O)[O-],5.82,,
CCOC(=O)c1cnc2[nH]nc(-c3cccc(C#N)c3)c2c1N1CCOC(C[NH3+])C1,5.82,,
COc1cc2c(cc1OS(N)(=O)=O)CCC1C2CCC2(C)C(CC#N)CCC12,5.82,,
O=C(N=NCc1cc(Br)c(O)c(Br)c1O)c1ccc(Cl)cc1,5.82,,
O=C(N=NCc1cc(Br)c(O)c(Br)c1O)c1ccc(Br)cc1,5.82,,
CC(C)(C)c1ccc(C(=O)N=NCc2cc(Br)c(O)c(Br)c2O)cc1,5.82,,
CC(NC(=O)C([NH3+])CCC(N)=O)C(=O)NC(CCC(N)=O)C(=O)NCC(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NCC(=O)NC(Cc1ccc(O)cc1)C(=O)[O-])C(C)O,5.82,,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCC[NH+]3CCOCC3)c3ccccc23)cc1,5.82,,
CCC(CSCC(NC(=O)CCC([NH3+])C(=O)[O-])C(=O)NCC(=O)[O-])C(=O)c1ccc(OCC(=O)[O-])c(Cl)c1Cl,5.82,,
C[NH2+]CCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])Cc1cnc[nH]1)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)C,5.82,,
CN1C(=[NH2+])NC(c2ccccc2)(C23CC4CC(CC(C4)C2)C3)C1=O,5.82,,
COc1ccc2c(c1)cc(C(=O)NS(=O)(=O)c1ccc(C)cn1)n2CC(=O)[O-],5.82,,
CC(NC(=O)C(Cc1ccc(OCc2ccccc2)cc1)NC(=O)OC(C)(C)C)C(=O)NC(CC1(O)C(=O)Nc2ccccc21)C(=O)NCc1ccccc1,5.82,,
Cc1cnc(Cl)c2c1[nH]c1c3ccc(O)cc3ccc12,5.82,,
CC(CCC(=O)NCCS(=O)(=O)[O-])C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,5.82,,
O=C([O-])c1ccccc1Nc1ccccc1C(=O)[O-],5.82,,
Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1C=C1,5.82,,
[NH3+]C(Cc1cc(Cl)c([N+](=O)[O-])cc1CCC(=O)[O-])C(=O)[O-],5.82,,
N#CSCCOc1ccc(Oc2ccccc2)cc1,5.82,,CHEMBL39581
CC(=O)NCC(C=O)NC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1,5.82,,
O=C(NCc1ccc(C[NH2+]Cc2ncc[nH]2)cc1)c1csc2nc[nH]c(=O)c12,5.82,,
O=c1[nH]ccc2c(O)cccc12,5.82,,
O=C([O-])c1cc(-c2ccc(C(=S)NCc3ccc(-c4ccc(C(=O)[O-])o4)cc3)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,5.82,,
O=S(=O)(Nc1nc2ccc(Cl)cc2s1)c1csc2ccccc12,5.82,,CHEMBL4592040
OCC1[NH2+]CC(O)C(O)C1O,5.83,,
O=C(NCC[N+]1CCOCC1)c1ccc(-c2c(CO)ccc3ccccc23)cc1,5.83,,
CC(C)CC(=O)NC(C(=O)NC(C(=O)NC(CC(C)C)C(O)CC(N)=O)C(C)C)C(C)C,5.84,,
CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21,5.84,,CHEMBL3298400
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,5.84,"This molecule is an odorless white powder. Bitter taste. (NTP, 1992) This molecule is an aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge. It has a role as an EC 1.5.1.3 (dihydrofolate reductase) inhibitor, a xenobiotic, an environmental contaminant, a drug allergen, an antibacterial drug and a diuretic. It is a member of methoxybenzenes and an aminopyrimidine. This molecule is an antifolate antibacterial agent that inhibits bacterial dihydrofolate reductase (DHFR), a critical enzyme that catalyzes the formation of tetrahydrofolic acid (THF) - in doing so, it prevents the synthesis of bacterial DNA and ultimately continued bacterial survival. This molecule is often used in combination with [sulfamethoxazole] due to their complementary and synergistic mechanisms but may be used as a monotherapy in the treatment and/or prophylaxis of urinary tract infections. It is structurally and chemically related to [pyrimethamine], another antifolate antimicrobial used in the treatment of plasmodial infections. This molecule is a Dihydrofolate Reductase Inhibitor Antibacterial. The mechanism of action of trimethoprim is as a Dihydrofolate Reductase Inhibitor, and Cytochrome P450 2C8 Inhibitor, and Organic Cation Transporter 2 Inhibitor. This molecule is a synthetic derivative of trimethoxybenzyl-pyrimidine with antibacterial and antiprotozoal properties.  As a pyrimidine inhibitor of bacterial dihydrofolate reductase, trimethoprim binds tightly to the bacterial enzyme, blocking the production of tetrahydrofolic acid from dihydrofolic acid.  The antibacterial activity of this agent is potentiated by sulfonamides. (NCI04)",CHEMBL22
CC(C)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]cn1)NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)O,5.85,,
CC(C)C(NC(=O)C(Cc1ccccc1)CC(O)C(Cc1ccccc1)NC(=O)OC(C)(C)C)c1ncc[nH]1,5.85,,
CCC(C)C(NC(=O)C(NC(=O)C(CO)NC(=O)C([NH3+])CO)C(C)C)C(=O)NCC(=O)NC(C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)[O-])C(C)C,5.85,,
Nc1cc(CSc2ncc[nH]2)c2nc(N)[nH]c(=O)c2c1,5.85,,
CCOc1ccc2ccccc2c1C(=O)NCB(O)O,5.85,,CHEMBL1234635
NC(=[NH2+])c1ccc2[nH]c(-c3cc(C(CC(=O)[O-])C(=O)[O-])cc(Br)c3O)nc2c1,5.85,,
NC(=[NH2+])c1ccc2[nH]c(-c3cc(C(CC(=O)[O-])C(=O)[O-])cc(Br)c3O)nc2c1,5.85,,
NC(=[NH2+])c1ccc2[nH]c(-c3cc(C(CC(=O)[O-])C(=O)[O-])cc(Br)c3O)nc2c1,5.85,,
NC(=[NH2+])c1ccc2[nH]c(-c3cc(C(CC(=O)[O-])C(=O)[O-])cc(Br)c3O)nc2c1,5.85,,
NC(=[NH2+])c1ccc2[nH]c(-c3cc(C(CC(=O)[O-])C(=O)[O-])cc(Br)c3O)nc2c1,5.85,,
CC12CCc3c(ccc4cc(O)ccc34)C1CCC2=O,5.85,,
Nc1cc(CSc2ncc[nH]2)c2nc(N)[nH]c(=O)c2c1,5.85,,
NC(=[NH2+])c1ccc(O)c(Oc2cc(C(=O)[O-])cc(Oc3cccc(-c4ncc[nH]4)c3)n2)c1,5.85,,
CC(NC(=O)c1cc(OCC(=O)NCCCCC[NH3+])cc(OS(=O)(=O)Cc2ccccc2)c1)c1ccc(F)cc1,5.85,,
Nc1c(O)cccc1C(=O)[O-],5.85,,
O=C([O-])CC(NC(=O)c1cc(-c2ccc(-c3ccncc3)cc2)cs1)c1ccccc1,5.85,,
Cc1ccc(NS(=O)(=O)c2ccccc2)c(C(=O)[O-])c1,5.85,,
OCC(O)CNc1ncnc2[nH]c(-c3ccccc3)c(-c3ccccc3)c12,5.85,,
O=C([O-])CNC(=O)c1ncc2c(I)cccc2c1O,5.85,,
COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2NC(C)=O)C(OC2OC(C)C(O)C(O)C2O)C1NC(C)=O,5.85,,
CC(C)(C)OC(=O)NC(C(=O)N1CC2OC(C)(C)C2C1C(=O)NC(CC1CCC1)C(O)C(N)=O)C1CCCCC1,5.85,,
NC(=O)c1ccc(S(=O)(=O)N(Cc2ccccc2)C2C[NH2+]CC2N(Cc2ccccc2)S(=O)(=O)c2ccc(C(N)=O)cc2)cc1,5.85,,
OCC1C(O)C(O)C(O)c2nccn21,5.85,,
Cc1ccc(S)c(S)c1,5.85,,
CC(C)CC1NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C[NH3+])CSSCC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(C)C(=O)[O-])NC1=O,5.85,,
CC(C)C1C(O)=C(C2=NS(=O)(=O)c3ccccc32)C(=O)N1Cc1ccccc1,5.85,,
O=C(N=NCc1cc(Br)c(O)c(Br)c1O)c1ccc2ccccc2c1,5.85,,
CCCCNC(=O)C(C)CC(O)C(CC(C)C)NC(=O)C(CCSC)NC(=O)CCC(C)C,5.85,,
O=C([O-])Cc1ccc(O)c(Cl)c1,5.85,,
COc1ccc(S(=O)(=O)NC(C)C(=O)[O-])cc1,5.85,,
CC1=NC(C(=O)[O-])CCN1,5.85,,
Nc1nc(NC2CCCCC2)sc1C(O)c1cccc([N+](=O)[O-])c1,5.85,,
COc1ccc(CC2C(=O)C(O)C(O)CC2(O)C(=O)[O-])cc1,5.85,,
O=C([O-])c1ccnc2c(O)cccc12,5.85,,
O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12,5.85,"These molecules is a dihydroxyflavone in which the two hydroxy groups are located at positions 5 and 7. It has a role as an anti-inflammatory agent, an antineoplastic agent, an antioxidant, a hepatoprotective agent, an EC 2.7.11.18 (myosin-light-chain kinase) inhibitor and a plant metabolite. It is a dihydroxyflavone and a 7-hydroxyflavonol. This molecule is a natural product found in Apis, Populus yunnanensis, and other organisms with data available. This molecule is found in carrot. Chrysin is a naturally occurring flavone chemically extracted from the blue passion flower (Passiflora caerulea). Honeycomb also contains small amounts. It is also reported in Oroxylum indicum or Indian trumpetflower. (Wikipedia).",CHEMBL117
COc1cc(C(=O)[O-])c2c(c1C)OC(=O)c1c(C)cc(O)c(C)c1O2,5.85,,
COC(=O)C(Cc1cnc[nH]1)NC(=O)C[NH+](CCc1ccccc1)CC(=O)[O-],5.85,,
c1ccc(C2Nc3ccccc3-c3nc4ccccc4n32)nc1,5.85,,CHEMBL1390049
O=S(=O)(c1cccs1)N1CCN(c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)CC1,5.85,,CHEMBL3113992
Oc1c(Br)cc(Br)cc1-c1[nH]c(Br)c(Br)c1Br,5.85,This molecule is a member of pyrroles. It has a role as a metabolite. This molecule is a natural product found in Pseudoalteromonas luteoviolacea with data available.,CHEMBL1235156
Cc1nc2c(O)cccc2c(=O)[nH]1,5.85,This molecule is a member of the class of quinazolines that is quinazolin-4(1H)-one substituted by a hydroxy group at position 8 and a methyl group at position 2. It has been shown to exhibit inhibitory activity against poly(ADP-ribose) polymerase. It has a role as an EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor. It is a member of quinazolines and a member of phenols. This molecule is a natural product found in Streptomyces with data available.,CHEMBL123904
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,5.85,,
CC([NH3+])C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(=O)NC1CSSCC(C(=O)[O-])NC(=O)C(CO)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CO)NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(C(C)C)NC1=O,5.85,,
NC(=O)CCC(NC(=O)C1CCCN1C(=O)C(Cc1cnc[nH]1)NC(=O)C([NH3+])CO)C(=O)NC(Cc1ccccc1)C(=O)NC(C=O)CCC(=O)[O-],5.86,,
CN(C)c1ccc(C=O)cc1,5.86,"This molecule is a member of the class of benzaldehydes that is benzaldehyde carrying a dimethylamino substituent at position 4. Used as an indicator for detection of indoles and hydrazine. It has a role as a chromogenic compound. It is a member of benzaldehydes, a substituted aniline and a tertiary amino compound.",CHEMBL3188333
CCCC(C(=O)[O-])c1c(C)nc2ccc(Cl)cc2c1-c1ccccc1,5.86,,
Cc1ncnc2c1ncn2C1OC(C=CCNC(=O)c2cc(-c3ccc(F)cc3)cc(O)c2O)CC1O,5.86,,
CC(F)(F)c1cccc(C[NH2+]C2CS(=O)(=O)CC(Cc3cc(F)c(N)c(Br)c3)C2O)c1,5.86,,
Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccccc21,5.86,,CHEMBL2064330
CC1[NH2+]C2C(OC(CO)C(O)C2O)S1,5.86,,
CC(C)(C)CC(C)(C)c1ccc(O)cc1,5.86,"This molecule is an alkylbenzene. This molecule is used as a food additive [EAFUS] (EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]).

This molecule belongs to the family of p-Menthane Monoterpenes. These are monoterpenes whose structure is based on the p-menthane backbone.",CHEMBL259327
O=C1C=C(c2cccc(O)c2)S(=O)(=O)N1,5.87,,
Cc1[nH]nc2ccc(-c3cncc(OCC([NH3+])Cc4cccc(OCC5CCCCC5)c4)c3)cc12,5.87,,
[NH3+]CCCCC([NH3+])C(=O)NCC(=O)NC(CCC(=O)[O-])C(=O)[O-],5.87,,
Cc1sc2ccccc2c1C[NH2+]CCCNC(=O)Nc1ccsc1,5.87,,
NC(=[NH2+])c1ccc2cc(C3CC3c3ccccc3)ccc2c1,5.88,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CO)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CO)C(=O)NC(C(=O)NC(C)C(=O)N1CC=CC1C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)N1CCCC1C(=O)[O-])C(C)C)C(C)C)C(C)O)C(C)CC,5.88,,
CC(=O)C(CC(=O)[O-])NC(=O)C1C=CC(C)n2c(=O)n(CCCC(=O)[O-])c(=O)n21,5.88,,
N=C1C(NS(=O)(=O)c2ccccc2)C(=O)NC(=O)N1Cc1ccccc1,5.88,,
O=c1cc(N2CC[NH2+]CC2)oc2c(-c3ccccc3)cccc12,5.88,,
[NH3+]CCCCC([NH3+])C(=O)NCC(=O)NC(CCCC[NH3+])C(=O)[O-],5.89,,
CCCCc1nc(N)sc1CCC,5.89,,
Nc1nc(N)c(N=O)c(OCC2CCCCC2)n1,5.89,,CHEMBL303958
Cc1ccc(S(=O)(=O)NC(Cc2ccc(C(N)=[NH2+])cc2)C(=O)N2CCCCC2)cc1,5.89,,
CCCCCCSCC(NC(=O)CCC([NH3+])C(=O)[O-])C(=O)NCC(=O)[O-],5.89,,
OCC1OC(OC2C(OC3C(OC4C(O)COC(COC5OC(C6OC67OC(CO)C(O)C(O)C7O)C(O)C(OC6OC(CO)C(O)C(O)C6O)C5O)C4O)OC(CO)C(O)C3O)OC(CO)C(O)C2O)C(O)C(O)C1O,5.89,,
OCCNc1ncnc2[nH]c(-c3ccccc3)c(-c3ccccc3)c12,5.89,,CHEMBL366312
O=C1NC(C(=O)[O-])=CC(C(=O)[O-])N1,5.89,,
CCCCCCCC([NH3+])C(O)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.89,,
CC=C(C)C=CC=CC(OC)C(C)C(OC)C(C)CCc1oc2c(O)c(OC)cc(OC)c2c(=O)c1C,5.89,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccc(OS(=O)(=O)[O-])cc1)NC(=O)C(Cc1ccc(OS(=O)(=O)[O-])cc1)NC(=O)C(CO)NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])C(C)C)C(C)O)C(C)O)C(C)O)C(C)C)C(=O)[O-],5.89,,
O=C(ON=Cc1ccc(O)cc1)C1CCCCC1,5.89,,
CC(C)C(NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(=O)[O-],5.89,,
COc1ccc2c3c1OC1CC(O)C=CC31CC[NH+](C)C2,5.89,,
CSCCC(NC(=O)C(CO)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(C=O)CC(=O)[O-],5.89,,
CCOc1ccc(OCC)c(NC(=O)c2cc(C)c(OCC[NH3+])c(C)c2)c1,5.89,,
CC(=O)OC1C(C)OC(c2ccc3c(c2O)C(O)C24OC2(C3=O)C2(O)C(=O)C=C(C)CC2(O)CC4O)CC1OC(=O)C=CC=CC=CC=CC(=O)Nc1c(O)c2ccc(O)c(Cl)c2oc1=O,5.89,,
NC(=[NH2+])NCCCCNC=O,5.89,,
[NH3+]C1[NH2+]C(O)NC(=O)C1Br,5.89,,
CCCCC(Sc1[nH]c2ccccc2c(=O)[n+]1-c1cccc(Cl)c1)C(=O)N1CCCC2(CCC[NH2+]C2)C1,5.89,,
O=C1CC(C[NH2+]CCCON=Cc2cccc(C(=O)[O-])c2)=NC(=O)N1,5.89,,
CCC(C)C(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)CC)C(=O)NCC(=O)N1CCCC1C(=O)NCC(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C)C(=O)NC(C=O)C(C)O,5.89,,
COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1,5.89,,
CC(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],5.89,,
NS(=O)(=O)c1cccc(Nc2ncc3c(n2)-c2cc(-c4ccccc4)sc2CC3)c1,5.89,,
Oc1ccc2c(c1)Oc1cc(O)ccc1N2,5.89,,
CCCCCCCCCCCCCC(=O)[O-],5.89,,
[NH3+]C(CO)Cc1cc(I)c(Oc2ccc(O)cc2)c(I)c1,5.89,,
CNC(=O)c1cc([N+](=O)[O-])c(N(C)C)cc1OC,5.89,,
CC[NH+]1CCCC1CNC(=O)c1cc([N+](=O)[O-])c(N(C)C)cc1OC,5.89,,
CCC([NH3+])c1ccc(Cl)c(Oc2ccccc2)c1F,5.89,,
O=C(Nc1cccc(-c2nn[nH]n2)c1)c1cccc2nc[nH]c12,5.89,,
O=C(CC1SC(N=NCc2ccccc2O)=NC1=O)Nc1cccc(C(F)(F)F)c1,5.89,,
COc1ccc(-c2cc(C(=O)NC(CO)Cc3cccc(C#N)c3)co2)cc1OC,5.89,,
C[NH+]1CCN(C(=O)Nc2ccc3c(c2)C(NC(=O)c2ccccc2)CCC3)CC1,5.89,,
CCC(C)C(NC(=O)C(CS)NC(=O)C([NH3+])C(C)O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NC(CO)C(=O)[O-],5.89,,
NC(=[NH2+])c1ccc(C=C2CCCCC(=Cc3ccc(C(N)=[NH2+])cc3)C2=O)cc1,5.9,,
CC(=O)Oc1ccc(C=CC(=O)NCCc2ccccc2)cc1OC(C)=O,5.9,,
COc1c(O)cc2c(O)c1CC(C)CC(OC)C(O)C(C)CC(C)C(OC(N)=O)C(OC)CCCC(C)C(O)N2,5.9,,
CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O,5.9,,
CCCCCCCCCCCCCCCCCCCC(=O)NCCO,5.9,This molecule is an N-(long-chain-acyl)ethanolamine that is the ethanolamide of eicosanoic acid. It is a N-(long-chain-acyl)ethanolamine and a N-(saturated fatty acyl)ethanolamine. It is functionally related to an icosanoic acid.,CHEMBL4237704
Cc1noc(C)c1-c1ccc2c(Nc3ccccc3C(C)(C)C)c(C(=O)[O-])cnc2c1,5.9,,
CC1(C)NC(=[NH2+])NC(=[NH2+])N1c1ccc(Cl)cc1,5.9,,
CCCCCC=CCCCCCCCCCCC(=O)[O-],5.9,,
COC1OC(CO)C(O)C(OC2OC(CO)C(O)C(O)C2O)C1NC(C)=O,5.91,,
COc1cc(-c2nn(C3CCC([NH+]4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C,5.91,,
Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2O,5.91,,CHEMBL207228
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1ccccc1)NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CC(N)=O)C(C)O)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)[O-],5.91,,
C[NH+]1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1,5.91,,
Brc1ccc(C2Oc3ccccc3C3=C2C(c2ccc(Br)cc2)n2ncnc2N3)cc1,5.91,,CHEMBL584303
COC1OC(C)C(O)C(O)C1O,5.91,,
C=CCOc1c(CC=C)cc(Cl)cc1C[NH2+]CCCNC(=O)Nc1ccsc1,5.91,,
COC1=C2CC(C)CC(OC)C(O)C(C)C=C(C)C(OC(N)=O)C(OC)C=CC=C(C)C(=O)NC(=CC1=O)C2=O,5.92,,
CN(C)c1cccc2c(S(=O)(=O)NC(CCCNC(N)=[NH2+])C(=O)N3CCCCC3CCC(=O)c3nccs3)cccc12,5.92,,
COC1C(OC(N)=O)C(O)C(Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C,5.92,This molecule is a natural product found in Actinoalloteichus cyanogriseus and Streptomyces niveus with data available.,CHEMBL35025
CC(NC(=O)C(CS)Cc1ccccc1)C(=O)NCC(N)=O,5.92,,
Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(CC(O)C(O)C(O)CO)c2cc1C,5.92,"This molecule is a natural product found in Aspergillus unilateralis, Syzygium, and Eremothecium gossypii with data available.",CHEMBL511565
NC(=[NH2+])Nc1nc(-c2ccc(CNc3nc4ccccc4[nH]3)s2)cs1,5.92,,
O=c1occn1N=Cc1ccc([N+](=O)[O-])o1,5.92,,
CC(C)CC(NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)C)C(=O)[O-],5.92,,
Cc1ccc(S(=O)(=O)NC(Cc2cccc(C(N)=[NH2+])c2)C(=O)N2CCCCC2)cc1,5.92,,
O=C(NCC(=O)N1C(C(=O)[O-])CCC1c1ccccc1)C(S)Cc1ccccc1,5.92,,
NC(=[NH2+])NCCCC(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],5.92,,
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(C)[NH3+])C(=O)[O-],5.92,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(OC3OC(CO)C(O)C(O)C3O)C2O)C1O,5.92,,
CC(=O)NC(Cc1ccc(Cl)cc1)B(O)O,5.92,,
C[NH2+]CCNS(=O)(=O)c1cccc2cnccc12,5.92,,
COC1=C2CC(C)CC(OC)C(O)C(C)C=C(C)C(OC(N)=O)C(OC)C=CC=C(C)C(=O)NC(=CC1=O)C2=O,5.92,,
CCOc1ccc2ccccc2c1C(=O)NCB(O)O,5.92,,CHEMBL1234635
O=S(=O)([O-])c1cccc2cccc(Nc3ccccc3)c12,5.92,,
OCC1C[NH2+]CC(O)C1O,5.92,,
O=C1CCCC=CCCOC(=O)c2c(O)cc(O)c(Cl)c2C1,5.92,,
O=C([O-])c1ccc(Cc2ccccc2Cl)o1,5.92,,
Cc1cccc(Nc2ccccc2C(=O)[O-])c1C,5.92,,
OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC8C(CO)OC(OC1C(O)C2O)C(O)C8O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O,5.92,,
O=C([O-])c1nc(Cc2ccc(Cl)c(Cl)c2)[nH]c(=O)c1O,5.92,,
Nc1nc(N)c2nc(C3C=CC=CC3)c(N)nc2n1,5.92,,
O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,5.92,"This molecule is a 7-hydroxyisoflavone with additional hydroxy groups at positions 5 and 4'. It is a phytoestrogenic isoflavone with antioxidant properties. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a phytoestrogen, a plant metabolite, a geroprotector and a human urinary metabolite. It is a conjugate acid of a genistein(1-). An isoflavonoid derived from soy products. It inhibits protein-tyrosine kinase and topoisomerase-II (DNA topoisomerases, type II) activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines.  Additionally, genistein has antihelmintic activity. It has been determined to be the active ingredient in Felmingia vestita, which is a plant traditionally used against worms. It has shown to be effective in the treatment of common liver fluke, pork trematode and poultry cestode.  Further, genistein is a phytoestrogen which has selective estrogen receptor modulator properties. It has been investigated in clinical trials as an alternative to classical hormone therapy to help prevent cardiovascular disease in postmenopausal women.    Natural sources of genistein include tofu, fava beans, soybeans, kudzu, and lupin. This molecule is a soy-derived isoflavone and phytoestrogen with antineoplastic activity. This molecule binds to and inhibits protein-tyrosine kinase, thereby disrupting signal transduction and inducing cell differentiation.  This agent also inhibits topoisomerase-II, leading to DNA fragmentation and apoptosis, and induces G2/M cell cycle arrest.  This molecule exhibits antioxidant, antiangiogenic, and immunosuppressive activities. (NCI04) This molecule is a natural product found in Salvia hispanica, Glycine soja, and other organisms with data available. This molecule is one of several known isoflavones. Isoflavones compounds, such as genistein and daidzein, are found in a number of plants, but soybeans and soy products like tofu and textured vegetable protein are the primary food source. This molecule is a natural bioactive compound derived from legumes and has drawn because of its potentially beneficial effects on some human degenerative diseases. It has a weak estrogenic effect and is a well-known non-specific tyrosine kinase inhibitor at pharmacological doses. Epidemiological studies show that genistein intake is inversely associated with the risk of cardiovascular diseases. Data suggests a protective role of genistein in cardiovascular events. However, the mechanisms of the genistein action on vascular protective effects are unclear. Past extensive studies exploring its hypolipidemic effect resulted in contradictory data. This molecule also is a relatively poor antioxidant. However, genistein protects against pro-inflammatory factor-induced vascular endothelial barrier dysfunction and inhibits leukocyte-endothelium interaction, thereby modulating vascular inflammation, a major event in the pathogenesis of atherosclerosis. This molecule exerts a non-genomic action by targeting on important signaling molecules in vascular endothelial cells (ECs). This molecule rapidly activates endothelial nitric oxide synthase and production of nitric oxide in ECs. This genistein effect is novel since it is independent of its known effects, but mediated by the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) cascade. This molecule directly stimulates the plasma membrane-associated adenylate cyclases, leading to activation of the cAMP signaling pathway. In addition, genistein activates peroxisome proliferator-activated receptors, ligand-activated nuclear receptors important to normal vascular function. Furthermore, genistein reduces reactive oxygen species (ROS) by attenuating the expression of ROS-producing enzymes. These findings reveal the roles for genistein in the regulation of vascular function and provide a basis for further investigating its therapeutic potential for inflammatory-related vascular disease.  (A3190).",CHEMBL44
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])CCCC[NH3+])C(=O)[O-],5.92,,
Cc1cc(OCC(=O)[O-])cc(C)c1Cc1ccc(O)c(Cc2ccccc2)c1,5.92,,
Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,5.92,,
CC(C)CC(NC(=O)C(C)[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(N)=O)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(=O)[O-])C(C)C,5.92,,
COc1ccccc1-c1cc(Cl)nc(N)n1,5.92,,CHEMBL1236713
O=S(=O)(NCC[NH2+]CC=Cc1ccc(Br)cc1)c1cccc2cnccc12,5.92,,
CN1C(=[NH2+])NC(C)(c2cccc(NC(=O)c3ccc(OCC(F)(F)F)cn3)c2)CC1=O,5.92,,
CC12CC[NH2+]C1Nc1ccc(O)cc12,5.92,,
[B+2]CNC(=O)c1c(OC)cccc1OC,5.92,,
O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,5.92,"This molecule is a trihydroxyflavone that is flavone substituted by hydroxy groups at positions 4', 5 and 7. It induces autophagy in leukaemia cells. It has a role as a metabolite and an antineoplastic agent. It is a conjugate acid of an apigenin-7-olate. This molecule is a natural product found in Camellia sinensis, Apis, and other organisms with data available. This molecule is a plant-derived flavonoid that has significant promise as a skin cancer chemopreventive agent. This molecule inhibits the expression of involucrin (hINV), a marker of keratinocyte differentiation, is increased by differentiating agents via a protein kinase Cdelta (PKCdelta), Ras, MEKK1, MEK3 cascade that increases AP1 factor level and AP1 factor binding to DNA elements in the hINV promoter. This molecule suppresses the 12-O-tetradeconylphorbol-13-acetate-dependent increase in AP1 factor expression and binding to the hINV promoter and the increase in hINV promoter activity. This molecule also inhibits the increase in promoter activity observed following overexpression of PKCdelta, constitutively active Ras, or MEKK1. The suppression of PKCdelta activity is associated with reduced phosphorylation of PKCdelta-Y311. Activation of hINV promoter activity by the green tea polyphenol, (-)-epigellocathecin-3-gallate, is also inhibited by apigenin, suggesting that the two chemopreventive agents can produce opposing actions in keratinocytes. (A7924). This molecule, a flavone abundantly found in fruits and vegetables, exhibits antiproliferative, anti-inflammatory, and antimetastatic activities through poorly defined mechanisms. This flavonoid provides selective activity to promote caspase-dependent-apoptosis of leukemia cells and uncover an essential role of PKCdelta during the induction of apoptosis by apigenin. (A7925). This molecule markedly induces the expression of death receptor 5 (DR5) and synergistically acts with exogenous soluble recombinant human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in malignant tumor cells. On the other hand, apigenin-mediated induction of DR5 expression is not observed in normal human peripheral blood mononuclear cells. Moreover, apigenin does not sensitize normal human peripheral blood mononuclear cells to TRAIL-induced apoptosis. (A7926).",CHEMBL28
Nc1ccc2c(NCCc3ccccc3)nc(-c3ccccc3)nc2c1,5.92,,
Cc1ccc(S(=O)(=O)NC2C[NH2+]CC(C(=O)NCC(c3ccccc3)c3ccccc3)C2)cc1,5.92,,
COc1ccc(-c2cc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)[nH]n2)c(C)c1,5.92,,
CCc1[nH]c2nc(Sc3cccnc3)nc(OC)c2c1C=O,5.92,,CHEMBL2331853
O=C([O-])Cc1nn(Cc2nc3cc(C(F)(F)F)ccc3s2)c(=O)c2ccccc12,5.92,,
Nc1ncc(-c2cnn(C3CC[NH2+]CC3)c2)c2cc(-c3cccc4ccsc34)oc12,5.92,,
CC(=O)NC1C(O)CC(OCC2OC(O)C(O)C(O)C2O)(C(=O)[O-])OC1C(O)C(O)CO,5.92,,
CC(C)CC([NH2+]C(C(=O)NCc1ccccc1)c1c(C(=O)NO)[nH]c2cc(Cl)ccc12)C(=O)NO,5.92,,
CS(=O)(=O)c1ccc(C(=O)Nc2cccc(-c3cn4ccnc4c(Nc4ccc(C(=O)N5CCOCC5)cc4)n3)c2)cc1,5.92,,
CC(C)C1=CC2=C(C(O)C1=O)C1(C)CCCC(C)(C)C1C(=O)C2,5.92,,
CC(C)C1=CC2=CC(=O)C3C(C)(C)CCCC3(C)C2=C(O)C1=O,5.92,,
CC([NH3+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)[O-],5.92,,
O=C([O-])c1ccc(-c2cncc(-c3cccc(O)c3)n2)cc1,5.92,,
CNc1ncnc2c1ncn2C1OC(CO)C(O)C1O,5.92,,
O=C1NC(c2ccc(O)cc2)c2c1n[nH]c2-c1ccccc1,5.92,,
Cc1ccc([N+](=O)[O-])c(Oc2ccc(CC([NH3+])C([NH3+])O)cc2)c1,5.92,,
COc1c(O)ccc2c1cc([N+](=O)[O-])c1c(C(=O)[O-])cc3c(c12)OCO3,5.93,,
Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,5.93,"This molecule is a nonnucleoside reverse transcriptase inhibitor used in combination with other agents in the therapy of human immunodeficiency virus (HIV) infection and the acquired immune deficiency syndrome (AIDS). This molecule is associated with a high rate of serum aminotransferase elevations during therapy and is a well established cause of acute, clinically apparent liver injury. This molecule is a dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection. It has a role as an antiviral drug and a HIV-1 reverse transcriptase inhibitor. It is a dipyridodiazepine and a member of cyclopropanes. A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. Structurally, nevirapine belongs to the dipyridodiazepinone chemical class. This molecule is a Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor. The mechanism of action of nevirapine is as a Non-Nucleoside Reverse Transcriptase Inhibitor, and Cytochrome P450 3A Inducer, and Cytochrome P450 2B6 Inducer. This molecule is a benzodiazepine non-nucleoside reverse transcriptase inhibitor. In combination with other antiretroviral drugs, nevirapine reduces HIV viral loads and increases CD4 counts, thereby retarding or preventing the damage to the immune system and reducing the risk of developing AIDS. This molecule is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults and children. This molecule comes in three different forms: immediate-release tablets, oral suspension (a liquid), and extended-release tablets. The immediate-release tablet and liquid forms of nevirapine are approved for use in adults and children. The extended-release tablets are approved for use in adults and in children 6 years of age and older who meet certain height and weight requirements. This molecule is always used in combination with other HIV medicines. This molecule is a natural product found in Stachybotrys chartarum with data available.",CHEMBL57
CC(SC(COCc1ccccc1C(F)(F)F)C(N)=O)n1cnc2ccc(OC3CC[N+](C)CC3)cc21,5.93,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C([NH3+])C(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C)C(=O)[O-],5.93,,
CCN1c2cc(N)ccc2-c2ccc(N)cc2C1c1ccccc1,5.93,,
CCC1C(=O)N(C)c2cncnc2N1C1CCCC1,5.93,,
CC(O)(c1ccc(-c2ccc(S(=O)(=O)c3ccc(N)nc3)cc2)cc1)C(F)(F)F,5.93,,CHEMBL3578071
Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1,5.94,"This molecule is a member of the class of phenylureas that is urea which is substituted at position 1 by a 3-tert-butyl-1-methylpyrazol-5-yl group and at position 3 by a p-chlorophenyl group. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of pyrazoles, a member of monochlorobenzenes and a member of phenylureas.",CHEMBL87277
CC(=O)N1Cc2[nH]nc(NC(=O)c3ccccc3)c2C1,5.94,,
N=NC(=O)c1ccc(-c2ccccc2Cl)o1,5.94,,
O=C([O-])CC(O)CCc1ccc2c(c1)Cc1ccccc1-2,5.94,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],5.94,,
CCCN(CCC)C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C2CN(C(=O)c3ccccc3)CC[NH2+]2)c1,5.94,,
O=S(=O)(NCc1ccccn1)c1ccc(Br)c2ccccc12,5.94,"This molecule is a sulfonamide obtained by formal condensation of the sulfo group of 4-bromonaphthalene-1-sulfonic acid with the exocyclic amino group of 2-pyridylmethylamine. Mimics the action of the abscisic acid, a phytohormone. It has a role as a hormone, a plant growth regulator and an abscisic acid receptor agonist. It is a sulfonamide, a member of pyridines, a member of naphthalenes and an organobromine compound.",CHEMBL1235543
O=S(=O)(NCc1ccccn1)c1ccc(Br)c2ccccc12,5.94,"This molecule is a sulfonamide obtained by formal condensation of the sulfo group of 4-bromonaphthalene-1-sulfonic acid with the exocyclic amino group of 2-pyridylmethylamine. Mimics the action of the abscisic acid, a phytohormone. It has a role as a hormone, a plant growth regulator and an abscisic acid receptor agonist. It is a sulfonamide, a member of pyridines, a member of naphthalenes and an organobromine compound.",CHEMBL1235543
COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(O)c(C)c3)nc2c1,5.94,,CHEMBL4073612
COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1,5.94,"This molecule has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.",CHEMBL2393130
CCC(C)C(NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(C)[NH3+])C(C)O)C(=O)NC(CS)C(=O)NC(C)C(=O)NCC(=O)NC(C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)N1CCCC1C(=O)[O-])C(C)O)C(C)O,5.94,,
NS(=O)(=O)c1ccccc1Cl,5.95,,CHEMBL367983
O=CCC(NC(=O)Oc1ccccc1)c1ccccc1,5.95,,
O=CCC(NC(=O)Oc1ccccc1)c1ccccc1,5.95,,
CC(C)CC(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],5.96,,
Nc1ncc(C2CCC(NC(=O)C3C=CCn4c(=O)n(CCS(=O)(=O)c5ccccc5)c(=O)n43)CC2)[nH]1,5.96,,
CCCCCNC(=O)C(Cc1ccc(N(C(=O)C(=O)[O-])c2ccccc2C(=O)[O-])c2ccccc12)NC(C)=O,5.96,,
NC(=[NH2+])c1ccc2[nH]c(-c3cc(C(CC(=O)[O-])C(=O)[O-])cc(-c4ccccc4[N+](=O)[O-])c3O)nc2c1,5.96,,
CCCCC(NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(C)[NH3+])B(O)O,5.96,,
Cc1cncc2cccc(S(=O)(=O)N3CCC[NH2+]CC3C)c12,5.96,,
CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,5.96,,
O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1cc(Cl)ccc1Cl,5.96,,CHEMBL207095
OCC1NC(=NO)C(O)C(O)C1O,5.96,,
CCC(C)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(=O)[O-])C(C)C,5.96,,
CC(C)CC(NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C(Cc1ccc(O)cc1)NC(=O)CNC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CC(=O)[O-])C(C)O)C(=O)[O-],5.96,,
O=C1C=C(O)Cc2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c21,5.96,,
CCO[PH](=O)OCC,5.96,,
CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)N1CCCC1C(=O)[O-])C(C)O,5.96,,
O=C([O-])c1ccc(-c2ccccc2[N+](=O)[O-])o1,5.96,,
CC(C)(C)c1cc(C(=O)N2CCOCC2)ccc1O,5.96,,CHEMBL1231552
NC(=O)CCC(=O)NC1c2ccccc2-c2c(-c3nc4cnccc4[nH]3)cccc21,5.96,,CHEMBL1917726
O=C(NC1c2ccccc2-c2c(-c3nc4ccncc4[nH]3)cccc21)c1cccc2ncccc12,5.96,,
CN(C)c1ccc(C(c2ccccc2)c2ccc(N(C)C)cc2)cc1,5.96,This molecule is a benzenoid aromatic compound.,CHEMBL1898627
CCC(C)C(NC(=O)CNC(=O)C([NH3+])CCC(N)=O)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)O)C(C)CC)C(C)O,5.96,,
O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21,5.96,,CHEMBL226471
CCCCC(NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(C)[NH3+])B(O)O,5.96,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH+](C)C)C(=O)[O-])C(C)O,5.96,,
N=CCCSCC1OC(n2cnc3c(N)ncnc32)C(O)C1O,5.96,,
Cc1ccccc1C(O)=CC(=O)C(=O)[O-],5.96,,
O=C1N=CCc2cc(OC3CC[NH2+]C3)c(Cl)cc21,5.96,,
O=C([O-])C(O)=CC(=O)C1(Cc2ccc(Cl)cc2)CCC[N+](Cc2ccccc2)C1,5.96,,
CC(NC(=O)c1nc(Cl)c2ccccc2c1O)C(=O)[O-],5.96,,
Nc1ncnc2c1ncn2C1OC(CO)C(O)C1O,5.96,"This molecule is a purine nucleoside. This molecule is a natural product found in Acanthus ilicifolius, Acanthus ebracteatus, and other organisms with data available.",CHEMBL11909
O=C(Nc1cccc(-c2nnn[nH]2)c1)c1ccc2n[nH]cc2c1,5.96,,
O=C(NCCCN1CCCC1=O)c1cnc(NCCc2ccncc2)nc1NC1CCCC1,5.96,,CHEMBL2312308
O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,5.96,"These molecules is a tetrahydroxyflavone in which the four hydroxy groups are located at positions 3', 4', 5 and 7. It is thought to play an important role in the human body as an antioxidant, a free radical scavenger, an anti-inflammatory agent and an immune system modulator as well as being active against several cancers. It has a role as an EC 2.3.1.85 (fatty acid synthase) inhibitor, an antineoplastic agent, a vascular endothelial growth factor receptor antagonist, a plant metabolite, a nephroprotective agent, an angiogenesis inhibitor, a c-Jun N-terminal kinase inhibitor, an anti-inflammatory agent, an apoptosis inducer, a radical scavenger and an immunomodulator. It is a 3'-hydroxyflavonoid and a tetrahydroxyflavone. It is a conjugate acid of a luteolin-7-olate. This molecule is a naturally-occurring flavonoid, with potential anti-oxidant, anti-inflammatory, apoptosis-inducing and chemopreventive activities. Upon administration, luteolin scavenges free radicals, protects cells from reactive oxygen species (ROS)-induced damage and induces direct cell cycle arrest and apoptosis in tumor cells. This inhibits tumor cell proliferation and suppresses metastasis. This molecule is a natural product found in Camellia sinensis, Codonopsis lanceolata, and other organisms with data available. This molecule is a mineral with formula of Bi3+2O3 or Bi2O3. The IMA symbol is Bis.",CHEMBL151
O=c1cc(-c2ccc(F)cc2)oc2ccccc12,5.96,,CHEMBL53738
Cc1ccc(-c2cc(=O)c3ccccc3o2)cc1,5.96,,CHEMBL16861
c1cnc2cc(OCc3ccc4ccccc4n3)ccc2c1,5.96,,CHEMBL4583461
O=C([O-])C1CCCCC1C(=O)N1CCc2ccccc2C1CN1Cc2ccccc2C1=O,5.96,,
CC1CCCC2C1(C)CCC(C)C2(C)CC1=CC(=O)C=CC1=O,5.96,,
Cc1cc(C(C)Nc2ccccc2C(=O)[O-])c2nc(N3CCOCC3)cc(=O)n2c1,5.96,,
CC(=O)N1CC(O)CC1C(=O)N1CC(O)CC1C(=O)NCc1ccc(-c2scnc2C)cc1,5.96,,
OCC1NC(=NO)C(O)C(O)C1O,5.97,,
N#CCc1cc(O)cc2cc(-c3ccc(O)cc3)oc12,5.97,,CHEMBL184151
CC([NH3+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NCC(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(=O)[O-])C(C)O,5.97,,
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CCC(N)=O)C(C)O)C(=O)[O-],5.97,,
CC(C)Oc1cccc(C[NH+]2CCC3(CC2C)CN(C)S(=O)(=O)N3c2cccc(F)c2)c1,5.97,,
O=C(Nc1ccc2n[nH]c(-c3ccncc3)c2c1)C1CC[NH+](CC(=O)N2CCN(c3ccc(-c4ncccn4)cc3)CC2)C1,5.97,,
O=NC1[NH2+]C(CO)C(O)C(O)C1O,5.98,,
CCC(C)C(NC(=O)C(CO)NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCC(=O)[O-])NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(NC(=O)C(NC(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(C)C)C(C)CC)C(C)O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)[O-])C(C)O,5.98,,
C[NH+]1CCN(c2cccc3[nH]c(-c4[nH]nc5cc(-c6ccc(N)cc6)ccc45)nc23)CC1,5.98,,
CC(C)CC(NC(=O)C([NH3+])Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(C(=O)NC(CO)C(=O)NC(C(=O)[O-])C(C)C)C(C)O)C(C)C,5.98,,
CC(C)CC(NC(=O)C([NH3+])Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(C(=O)NC(CO)C(=O)NC(C(=O)[O-])C(C)C)C(C)O)C(C)C,5.98,,
NC(=O)CCC(NC(=O)C1CCCN1C(=O)C(Cc1cnc[nH]1)NC(=O)C([NH3+])CO)C(=O)NC(C=O)Cc1ccccc1,5.99,,
O=C(NCc1cc(CNC(=O)c2cccc(O)c2O)cc(CNC(=O)c2cccc(O)c2O)c1)c1cccc(O)c1O,5.99,,CHEMBL1232471
C=CC(=O)Nc1ccc2c(Nc3ccn[nH]3)nc(-c3ccccc3)nc2c1,5.99,,
O=c1[nH]c(=O)n(C2OC(CO)C(O)C(O)C2O)cc1Cl,5.99,,
CC1[NH2+]C2C(OC(CO)C(O)C2O)S1,5.99,,
NC(=[NH2+])c1cc2ccccc2s1,6.0,,
C[NH+]1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1,6.0,,
[NH3+]CC1CCC(C(=O)[O-])CC1,6.0,,
CN1C=CN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)C=C1,6.0,,
COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC,6.0,,CHEMBL127907
CCC(C)C(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],6.0,,
[NH3+]CCCCC(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CC(=O)[O-],6.0,,
Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O,6.0,"This molecule appears as orange needles or powder. (NTP, 1992) This molecule is a trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by hydroxy groups at positions 1, 3, and 8 and by a methyl group at position 6. It is present in the roots and barks of numerous plants (particularly rhubarb and buckthorn), moulds, and lichens. It is an active ingredient of various Chinese herbs. It has a role as a tyrosine kinase inhibitor, an antineoplastic agent, a laxative and a plant metabolite. It is functionally related to an emodin anthrone. It is a conjugate acid of an emodin(1-). This molecule has been investigated for the treatment of Polycystic Kidney. This molecule is a natural product found in Hamigera avellanea, Setophoma terrestris, and other organisms with data available. This molecule is found in dock. This molecule is present in Cascara sagrada.This molecule is a purgative resin from rhubarb, Polygonum cuspidatum, the buckthorn and Japanese Knotweed (Fallopia japonica). The term may also refer to any one of a series of principles isomeric with the emodin of rhubarb. (Wikipedia) 

This molecule has been shown to exhibit anti-inflammatory, signalling, antibiotic, muscle building and anti-angiogenic functions (A3049, A7853, A7854, A7855, A7857).",CHEMBL289277
NC(=[NH2+])c1ccc(O)c(CN2CCC(NS(=O)(=O)c3cc4ncccc4s3)C2=O)c1,6.0,,
CCC(C)(C)C(=O)C(=O)N1CCCC1C(=O)OCCCc1cccnc1,6.0,,CHEMBL149192
O=c1[nH]c2cc([N+](=O)[O-])c([N+](=O)[O-])cc2[nH]c1=O,6.0,,
Nc1cccc2cc3ccccc3cc12,6.0,This molecule is an anthracenamine.,CHEMBL82321
c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,6.0,,
Nc1cccc2cc3ccccc3cc12,6.0,This molecule is an anthracenamine.,CHEMBL82321
CCOC(Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)[O-],6.0,,
CCC(C)C(NC(=O)C(C)NC(=O)C([NH3+])CC(C)C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CO)C(=O)[O-],6.0,,
O=Cc1ccc(O)cc1,6.0,"This molecule is a hydroxybenzaldehyde that is benzaldehyde substituted with a hydroxy group at position C-4. It has a role as a plant metabolite, a mouse metabolite and an EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor. This molecule is a natural product found in Spiranthes vernalis, Rhinacanthus nasutus, and other organisms with data available.",CHEMBL14193
CCC(C)C1NC(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(N)=O)NC(=O)CNC(=O)C[NH3+])CSSCC(C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCSC)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC1=O,6.0,,
O=C1Nc2ccccc2C1=CNc1ccc(S(=O)(=O)Nc2nccs2)cc1,6.0,,
O=C([O-])C(O)C(O)C(=O)[O-],6.0,,
[NH3+]C(CS)C(=O)[O-],6.0,,
O=C(CSc1nc(C(F)(F)F)cc(=O)[nH]1)N1CCCCC1,6.0,,
O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccc([N+](=O)[O-])c3cccc1c23,6.0,,CHEMBL303950
Cn1cc(C2=C(c3cn(CCC[NH3+])c4ccccc34)C(=O)NC2=O)c2ccccc21,6.0,,
CCCCn1c(Cc2cc(OC)c(OC)c(OC)c2)nc2c(N)ncnc21,6.0,,CHEMBL113690
O=C([O-])c1ccc(NS(=O)(=O)c2ccsc2C(=O)[O-])c(O)c1,6.0,,
CCCCNc1cc(C)nc2[nH]c(Nc3cc(Cl)ccc3C)n[n+]12,6.0,,
N#Cc1c(NC(=O)c2cc(S(=O)(=O)N3CCOCC3)c(Cl)cc2Cl)sc2c1CCCC2,6.0,,CHEMBL327236
OCC1C[NH2+]CC(OC2OC(CO)C(O)C(O)C2O)C1O,6.0,,
OCC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1O,6.0,,
[NH2+]=C1NC2CSC(CCCCC(=O)[O-])C2N1,6.0,,
CCC(C)C([NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC1(C)CCCC=CCCCC(C)(C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccc(O)cc2)C(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC1=O)C(C)O,6.0,,
O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,6.0,"This molecule is a 7-hydroxyisoflavone with additional hydroxy groups at positions 5 and 4'. It is a phytoestrogenic isoflavone with antioxidant properties. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a phytoestrogen, a plant metabolite, a geroprotector and a human urinary metabolite. It is a conjugate acid of a genistein(1-). An isoflavonoid derived from soy products. It inhibits protein-tyrosine kinase and topoisomerase-II (DNA topoisomerases, type II) activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines.  Additionally, genistein has antihelmintic activity. It has been determined to be the active ingredient in Felmingia vestita, which is a plant traditionally used against worms. It has shown to be effective in the treatment of common liver fluke, pork trematode and poultry cestode.  Further, genistein is a phytoestrogen which has selective estrogen receptor modulator properties. It has been investigated in clinical trials as an alternative to classical hormone therapy to help prevent cardiovascular disease in postmenopausal women.    Natural sources of genistein include tofu, fava beans, soybeans, kudzu, and lupin. This molecule is a soy-derived isoflavone and phytoestrogen with antineoplastic activity. This molecule binds to and inhibits protein-tyrosine kinase, thereby disrupting signal transduction and inducing cell differentiation.  This agent also inhibits topoisomerase-II, leading to DNA fragmentation and apoptosis, and induces G2/M cell cycle arrest.  This molecule exhibits antioxidant, antiangiogenic, and immunosuppressive activities. (NCI04) This molecule is a natural product found in Salvia hispanica, Glycine soja, and other organisms with data available. This molecule is one of several known isoflavones. Isoflavones compounds, such as genistein and daidzein, are found in a number of plants, but soybeans and soy products like tofu and textured vegetable protein are the primary food source. This molecule is a natural bioactive compound derived from legumes and has drawn because of its potentially beneficial effects on some human degenerative diseases. It has a weak estrogenic effect and is a well-known non-specific tyrosine kinase inhibitor at pharmacological doses. Epidemiological studies show that genistein intake is inversely associated with the risk of cardiovascular diseases. Data suggests a protective role of genistein in cardiovascular events. However, the mechanisms of the genistein action on vascular protective effects are unclear. Past extensive studies exploring its hypolipidemic effect resulted in contradictory data. This molecule also is a relatively poor antioxidant. However, genistein protects against pro-inflammatory factor-induced vascular endothelial barrier dysfunction and inhibits leukocyte-endothelium interaction, thereby modulating vascular inflammation, a major event in the pathogenesis of atherosclerosis. This molecule exerts a non-genomic action by targeting on important signaling molecules in vascular endothelial cells (ECs). This molecule rapidly activates endothelial nitric oxide synthase and production of nitric oxide in ECs. This genistein effect is novel since it is independent of its known effects, but mediated by the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) cascade. This molecule directly stimulates the plasma membrane-associated adenylate cyclases, leading to activation of the cAMP signaling pathway. In addition, genistein activates peroxisome proliferator-activated receptors, ligand-activated nuclear receptors important to normal vascular function. Furthermore, genistein reduces reactive oxygen species (ROS) by attenuating the expression of ROS-producing enzymes. These findings reveal the roles for genistein in the regulation of vascular function and provide a basis for further investigating its therapeutic potential for inflammatory-related vascular disease.  (A3190).",CHEMBL44
CCOC(=O)C1C2OC(C(c3ccc(O)cc3)=C2c2ccc(O)cc2)C1C(=O)OCC,6.0,,CHEMBL388318
Fc1ccccc1-c1cc(NCc2ccncc2)n2nccc2n1,6.0,,
Nc1ccc(S(=O)(=O)N(Cc2ccccc2)C2C[NH2+]CC2N(Cc2ccccc2)S(=O)(=O)c2ccc(N)cc2)cc1,6.0,,
[NH3+]CCN=C1NC(CO)C(O)C(O)C1O,6.0,,
c1ccc(C[NH+]2C3CCC2CC(OC2c4ccccc4CCc4ccccc42)C3)cc1,6.0,,
[NH3+]CCCCC(=O)c1cccnc1,6.0,,
O=CC1C(NS(=O)(=O)[O-])CCN1C(=O)NC1CCC[NH2+]CC1,6.0,,
CC(C)CC1NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])N=C(C(CC(C)C)NC(=O)C(NC(=O)C([NH3+])CO)C(C)O)OCC(C)CC(C(=O)NC(C(=O)NC(CC(N)=O)C(=O)[O-])C(C)O)NC1=O,6.0,,
CCOC(=O)c1cnc2[nH]ncc2c1N1CCOC(C[NH3+])C1,6.0,,
CC([NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)[O-],6.0,,
C=Cc1c(C)c2n3c1[CH]c1c(C)c(C=C)c4n1[FeH2+7]31n3c(c(C)c(C)c3[CH]c3c(CCC(=O)[O-])c(C)c(n31)[CH]4)[CH]2,6.0,,
CC(C)CC(NC(=O)c1ccco1)C(=O)N1Cc2[nH]c3ccccc3c2CC1C(=O)[O-],6.0,,
S=CNc1ccc2oc(C3=NCCN3)cc2c1,6.0,,
S=CNc1ccc2oc(C3=NCCN3)cc2c1,6.0,,
O=C(CC(=O)C(F)(F)F)c1ccc([N+](=O)[O-])cc1,6.0,,CHEMBL483287
Oc1ccc(Cl)cc1Oc1ccc(Cl)c2cccnc12,6.0,,CHEMBL222361
CSCCC(NC(=O)C([NH3+])C(C)C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(C)C)C(=O)[O-])C(C)O,6.0,,
CN1C(=O)C(O)C(O)C1C[NH2+]C(CO)c1ccccc1,6.0,,
O=C1CSC(c2cccc(Br)c2)N1c1cc(Cl)ccc1O,6.0,,CHEMBL3261537
COC(=O)C1(O)CC2OC1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,6.0,This molecule is a natural product found in Streptomyces longisporoflavus with data available.,CHEMBL1591330
CCCCC(C[NH2+]C(CCCC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)CC,6.0,,
OCC[NH+]1CC(O)C(O)C(O)C1CO,6.0,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)C)C(=O)NC(C)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)O)C(C)O,6.0,,
Cc1cc(OCC(=O)[O-])cc(C)c1Cc1ccc(O)c(Cc2ccccc2)c1,6.0,,
NC(=O)c1cn(C2OC(CO)C(O)C2O)c2ncnc(N)c12,6.0,,CHEMBL328834
CC(C)CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C([NH3+])CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)[O-],6.0,,
CC(=O)Nc1nnc(S(N)(=O)=O)s1,6.0,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
O=C(OC1CCS(=O)(=O)c2ccc(Br)cc21)C1CC2(C[NH2+]1)C(=O)Nc1ccccc12,6.0,,
C[N+](C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,6.0,,
CCCCCCCCCCCC(=O)[O-],6.0,,
CC(=O)N1CCCC1C(=O)N1CCCC1C(=O)NCC(=O)N1CCCC1C(=O)N1CCCC1C(=O)NCC(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)N1CCCC1C(=O)N1CCCC1C(=O)NCC(=O)N1CCCC1C(=O)N1CCCC1C(=O)[O-])C(C)O,6.0,,
c1nc(N2CCC3(CCCC[NH2+]3)CC2)c2[nH]cnc2n1,6.0,,
CC(C)c1cc2c(-c3ccc(S(=O)(=O)NC4CCS(=O)(=O)CC4)cc3)ccnc2[nH]1,6.0,,CHEMBL2164411
CCC(C)C(NC(=O)C(C)[NH3+])C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCC(N)=O)CC(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])CC(=O)NC(CCSC)C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(=O)[O-])CC(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)NC(C)CC(=O)NC(CCC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCC(=O)[O-])C(N)=O,6.0,,
[NH3+]CCCOc1cc(-c2cn[nH]c2)ccc1C(=O)Nc1ccccc1,6.0,,
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NCC(=O)[O-])C(C)O,6.0,,
CCCOc1ccc(S(=O)(=O)N2CC[NH+](C)CC2)cc1-c1nc2c(c(=O)[nH]1)CCC2,6.0,,
CC(=O)Nc1c(Cl)cc(CNC(=[NH2+])NC(=O)Cn2ccc3ccccc32)cc1Cl,6.0,,
COc1cc2cc(c1)NC(=O)C(C)=CCCC(OC(N)=O)C(OC(N)=O)C(C)=CC(C)C(OC)C(OC)COC2,6.0,,
CN1C(=O)C(Cc2ccccc2)OC(c2ccc(Br)cc2)C1c1ccc(Br)cc1,6.0,,
Cc1cc(Br)c2c(c1)C(=O)C(=O)N2,6.0,,CHEMBL3128208
CC(C)C1NC(=O)C(Cc2c[nH]cn2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(C(C)O)NC(=O)C(Cc2c[nH]cn2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CSCC(C(N)=O)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CC(N)=O)NC(=O)C(C(C)O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCCNC(=O)C(F)(F)F)NC1=O,6.0,,
O=C(CCc1nc2ccccc2c(=O)[nH]1)NC(CO)Cc1ccccc1,6.0,,
Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cccc(S(=O)(=O)[O-])c23)cc1N,6.0,,
O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12,6.0,This molecule is a member of dibenzothiophenes.,CHEMBL188678
O=C(Nc1ccc(-c2nnn[nH]2)cc1Cc1ccccc1)c1cccc(CC2CCCCC2)n1,6.0,,
c1cncc(CNc2ccc3ncnc(Nc4ccc(N5CCOCC5)cc4)c3n2)c1,6.0,,CHEMBL3298264
[NH2+]=C1NC2(CO1)c1cc(-c3cncc(Cl)c3)ccc1OC1COCCC12,6.0,,
Cc1ccc2c(=O)c3cccc(CC(=O)[O-])c3oc2c1C,6.0,,
CC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1[NH2+]C1C(O)C(O)C(OC2OC(CO)C(OC3OC(C)C([NH2+]C4C(O)C(O)C(O)C5(CO)OC45)C(O)C3O)C(O)C2O)C2(CO)OC12,6.0,,
CC(=O)OC1CCC2(C)C3CC(O)C4(C)C(C(C=O)CC(=O)C=C(C)C)C(O)CC4(CO)C3=CCC2C1(C)C(=O)OC1OC(CO)C(O)C(O)C1O,6.01,,
[NH3+]CCCCC([NH3+])C(=O)NC(C[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],6.01,,
NC(=[NH2+])c1cccc(C(=O)NC(C(=O)N2CCC(C(=O)c3ccccc3)CC2)c2ccccc2)c1,6.01,,
CC(=O)c1ccc(O)cc1,6.01,"This molecule is a monohydroxyacetophenone carrying a hydroxy substituent at position 4'. It has a role as a plant metabolite, a fungal metabolite and a mouse metabolite. This molecule is a natural product found in Cytospora ceratosperma, Haplopappus arbutoides, and other organisms with data available.",CHEMBL201083
CCn1c(=O)c2c(C)n[nH]c2c2ccccc21,6.01,,
OCC1C[NH2+]C(O)C(O)C1O,6.01,,
O=C(NO)c1ccc(C(=O)N2CCn3c(-c4ccccc4)cnc3C2)s1,6.01,,
O=C1C(O)C(O)CC(O)(C(=O)[O-])C1Cc1c(F)c(F)c(F)c(F)c1F,6.01,,
CCC(C)C(NC(=O)C(NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(C)[NH3+])C(C)O)C(C)CC)C(=O)[O-],6.01,,
CC(C)C(NC(=O)C(Cc1ccccc1)CC(O)C(Cc1ccccc1)NC(=O)OC(C)(C)C)c1ncc[nH]1,6.02,,
COc1ccc(C(C)[NH2+]OC(N)=O)cc1OC1CCCC1,6.02,,
O=C(CCCCCCC(=O)Nc1ccccc1)NO,6.02,"This molecule is an oral histone deacetylase inhibitor and antineoplastic agent that is approved for use in refractory or relapsed cutaneous T cell lymphoma. This molecule is associated with modest rate of minor serum enzyme elevations during therapy, but has not been linked to cases of clinically apparent liver injury. This molecule is a dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL). It has a role as an EC 3.5.1.98 (histone deacetylase) inhibitor, an apoptosis inducer and an antineoplastic agent. It is a hydroxamic acid and a dicarboxylic acid diamide. It is functionally related to a suberic acid, a hydroxylamine and an aniline. This molecule is a drug currently under investigation for the treatment of cutaneous T cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines. It is the first in a new class of agents known as histone deacetylase inhibitors.  A recent study suggested that vorinostat also possesses some activity against recurrent glioblastoma multiforme, resulting in a median overall survival of 5.7 months (compared to 4 - 4.4 months in earlier studies). Further brain tumor trials are planned using combinations of vorinostat with other drugs. This molecule is a Histone Deacetylase Inhibitor. The mechanism of action of vorinostat is as a Histone Deacetylase Inhibitor. This molecule is a synthetic hydroxamic acid derivative with antineoplastic activity. This molecule, a second generation polar-planar compound, binds to the catalytic domain of the histone deacetylases (HDACs). This allows the hydroxamic moiety to chelate zinc ion located in the catalytic pockets of HDAC, thereby inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors. Hyperacetylation of histone proteins results in the upregulation of the cyclin-dependant kinase p21, followed by G1 arrest. Hyperacetylation of non-histone proteins such as tumor suppressor p53, alpha tubulin, and heat-shock protein 90 produces additional anti-proliferative effects. This agent also induces apoptosis and sensitizes tumor cells to cell death processes. This molecule crosses the blood-brain barrier. This molecule is a natural product found in Humicola fuscoatra and Campanularia with data available. This molecule is a drug that has been approved by the U.S. Food and Drug Administration (FDA) under the brand name Zolinza for the treatment of a certain type of cancer.This molecule is also being studied as an investigational drug as part of a strategy to cure HIV infection.As an investigational HIV drug, vorinostat belongs to a group of drugs called latency-reversing agents.",CHEMBL98
CCCCCCCCN=C1SCC2C(O)C(O)C(O)C(O)N12,6.02,,
CC(C)(C)C([NH3+])C(=O)NS(=O)(=O)OCC1OC(n2cnc3c(N)ncnc32)C(O)C1O,6.02,,
[NH3+]C(Cc1ccc(F)cc1)C(=O)[O-],6.02,,
[NH2+]=c1[nH]c(=O)c2c(CCc3ccccc3)c[nH]c2[nH]1,6.02,,
O=S1(=O)CC(Cc2ccc(O)c(Br)c2)C(O)C([NH2+]Cc2cccc(C3CC3)c2)C1,6.02,,
COC(C(=O)NCC1CCCN(C(=O)C2CC2)C1)C(O)C(O)C(O)C=CC(C)(C)C,6.02,,
CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1,6.02,,
COC(C(O)COC=O)C1OC(C(=O)[O-])CC(NC(N)=[NH2+])C1NC(C)=O,6.02,,
CC(=O)Nc1cc(Oc2ccc3c(ccn3C(=O)Nc3ccc(C[NH+]4CC[NH+](C)CC4)c(C(F)(F)F)c3)c2)ncn1,6.02,,
OCC1C[NH2+]C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O,6.02,,
COC1CCC(OC)C(NC(=O)C[NH+]2CC[NH+](Cc3ccc4c(c3)OCO4)CC2)C1,6.02,,
N#Cc1ccc(OCCC[NH+]2CCC(C(O)(c3ccccc3)C3CCCC3)CC2)cc1,6.02,,
C[NH+](C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,6.02,,
CCC(C)C(NC(=O)C([NH2+]CC(O)C([NH3+])CC(C)C)C(C)C)C(=O)NC(Cc1ccccc1)C(=O)OC,6.02,,
CCCCC(NC(=O)C(Cc1ccccc1)NC(=O)N1CCOCC1)C(=O)NC(CC1CCCCC1)C(O)C(F)(F)C(=O)NC,6.03,,
OCCCCCCCCCCCCBr,6.03,,CHEMBL1231267
OCCCCCCCCCCCCBr,6.03,,CHEMBL1231267
CN(C)c1cccc2c(S(N)(=O)=O)cccc12,6.03,,CHEMBL119489
CC(C)c1nc(CN(C)C(=O)NC(C(=O)NC(Cc2ccccc2)CC(O)C(Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,6.03,,
CC(=O)N(C)C(CO)C(=O)NC(C)C(=O)NCC(=O)N(C)C1C(=O)NC(C)C(=O)NC(C(=O)[O-])Cc2ccc(O)c(c2)-c2cc1ccc2O,6.03,,
CSCCC([NH3+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],6.03,,
Nc1nc(Nc2ccccc2)sc1C(O)c1ccccc1,6.03,,
OCC1C[NH2+]CC(O)C1OC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O,6.03,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O,6.03,,
COc1ccc(NC(S)=NCCCn2ccnc2)cc1OC,6.03,,
COc1ccc(NC(=S)NCCCn2ccnc2)cc1OC,6.03,,CHEMBL201747
Cc1cc2c([nH]1)NC(=O)N(C1OC(CO)C(O)C1O)C2,6.03,,
CC(C)CC(NC(=O)C(C)NC(=O)C(C)NC(=O)C(Cc1ccccc1)NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(=O)[O-])C(=O)[O-],6.04,,
COC(=O)c1c(O)cccc1OCC=Cc1cccc(-c2onc(C(=O)[O-])c2CO)c1,6.04,,
CC(NC(=O)C[NH3+])C(=O)NC(CO)C(=O)NC(CC(=O)[O-])C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O,6.04,,
c1ccc(-c2cc(-c3cc[nH]n3)on2)cc1,6.04,,CHEMBL265720
c1ccc2[nH]c(-c3cc[nH]n3)nc2c1,6.04,,CHEMBL495758
O=C([O-])c1ccnc(C(=O)[O-])c1,6.04,,
Cc1ccc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)cc1,6.04,,
CC=COC1(C(=O)[O-])CC(O)C(O)C(C(O)COC2(C(=O)[O-])CC(O)C(O)C(C(O)CO)O2)O1,6.04,,
O=C([O-])c1[nH]c2cc(Cl)ccc2c1-c1c(-c2ccccc2)ncn1Cc1ccc(Cl)cc1,6.04,,
CCOc1ccc(C(=O)Nc2ccc(F)c(C3(C)NC(=[NH2+])OCC3(F)F)c2)nc1,6.04,,
CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,6.04,"This molecule is an odorless white crystalline powder. Tasteless. An antimalarial drug. This molecule is an aminopyrimidine that is pyrimidine-2,4-diamine which is substituted at position 5 by a p-chlorophenyl group and at position 6 by an ethyl group. It is a folic acid antagonist used as an antimalarial or with a sulfonamide to treat toxoplasmosis. It has a role as an antimalarial, an EC 1.5.1.3 (dihydrofolate reductase) inhibitor and an antiprotozoal drug. It is an aminopyrimidine and a member of monochlorobenzenes. This molecule is used as an antimalarial or with a sulfonamide to treat toxoplasmosis. This molecule is a Dihydrofolate Reductase Inhibitor Antimalarial. The mechanism of action of pyrimethamine is as a Dihydrofolate Reductase Inhibitor. This molecule is a synthetic derivative of ethyl-pyrimidine with potent antimalarial properties.  This molecule is a competitive inhibitor of dihydrofolate reductase (DHFR).  DHFR is a key enzyme in the redox cycle for production of tetrahydrofolate, a cofactor that is required for the synthesis of DNA and proteins.  This agent is often used in combination with other antimalarials for the treatment of uncomplicated falciparum malaria. (NCI04) This molecule is an antiparasitic prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of Toxoplasma gondiiinfection (toxoplasmosis). This molecule is usually used together with a sulfonamide (sulfa medicine) to treat toxoplasmosis. This molecule is a natural product found in Acronychia pubescens with data available. This molecule is used as an antimalarial or with a sulfonamide to treat toxoplasmosis.",CHEMBL36
C[NH+](C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,6.04,,
Cc1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)cc(C)c1O,6.04,,
CCC(C)C(NC(=O)C(O)Cc1ccc(O)cc1)C(=O)N1C(C(=O)NCCCCNC(N)=[NH2+])CC2CCC(OS(=O)(=O)O)CC21,6.05,,
O=[N+]([O-])c1ccc(O)c(O)c1,6.05,"This molecule is a member of the class of catechols that is benzene-1,2-diol substituted by a nitro group at position 4.It is the by-product of the hydroxylation of p-nitrophenol. It has a role as a lipoxygenase inhibitor and a human xenobiotic metabolite. It is a C-nitro compound and a member of catechols. It is a conjugate acid of a 2-hydroxy-4-nitrophenolate. This molecule is a natural product found in Homo sapiens with data available.",CHEMBL42423
CON=C(C(=O)NC(C=O)C1[NH2+]C(C(=O)[O-])C(C)(C)S1)c1csc(N)n1,6.05,,
Cc1nc(C)c(-c2ccnc(Nc3ccc(C(F)(F)F)cc3)n2)s1,6.05,,CHEMBL48109
O=C(Nc1ccccc1Oc1ccc(C(=O)[O-])c(C(=O)[O-])c1)c1cccc([N+](=O)[O-])c1,6.05,,
CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C(C(=O)CO)CCC12,6.05,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)NC(C(=O)[O-])C(C)O)C(C)O)C(C)O,6.05,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(CCCC[NH+](C)C)NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(NC(=O)C([NH3+])CO)C(C)O)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)[O-])C(C)O,6.05,,
CC(=O)NCCc1ccc(S(N)(=O)=O)cc1,6.05,,
CN(C(=O)CCN1Cc2cc(C(=O)c3ccccc3)ccc2N=C1N)C1CCCCC1,6.05,,CHEMBL244342
N#CSc1cnn2c(NCc3ccncc3)cc(-c3cccc(Cl)c3Cl)nc12,6.05,,
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1cnc[nH]1)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(C)O)C(=O)O,6.05,,
CCOc1ccc(-c2c(C#N)c(N)nc3sc(C(N)=O)c(N)c23)cc1,6.05,,CHEMBL554496
CC(=O)NC1C(OC(N)=O)OC(CO)C(O)C1O,6.05,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],6.05,,
Nc1ncnc2c1c(I)cn2C1OC(CO)C(O)C1O,6.05,This molecule is a nucleobase-containing molecular entity.,CHEMBL63388
CC(C)CN(CC[NH2+]CCN(CC(C)C)S(=O)(=O)c1ccc(N)cc1)S(=O)(=O)c1ccc(N)cc1,6.05,,
CCC(C)C(NC(=O)CNC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(CC(N)=O)NC(=O)C([NH3+])CC(=O)[O-])C(C)CC)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)O)C(C)CC)C(C)O,6.05,,
COc1cc(O)c2c(c1)OC(c1ccc(O)cc1)CC2=O,6.05,"This molecule is a natural product found in Daphne aurantiaca, Prunus cerasus, and other organisms with data available.",CHEMBL74852
C[NH+]1CCN(c2cnc3cc(C(F)(F)F)cc(-c4cccc(O)c4)c3n2)CC1,6.05,,
O=[N+]([O-])c1ccc(SCCCCCCO)c2nonc12,6.05,,CHEMBL1234570
C[NH+](C)CCCCC([NH3+])C(=O)[O-],6.05,,
Nc1ccc(-c2ccccc2)cc1NC(=O)c1ccccc1,6.05,,CHEMBL271741
O=C([O-])CCC(=O)C(=O)[O-],6.05,,
O=C([O-])c1ccc(O)c(F)c1,6.05,,
O=C([O-])c1c(-c2ccccc2F)c2cc(Cl)ccc2n1Cc1ccccc1,6.05,,
CC[NH+]1CCCC1CNC(=O)c1cc([N+](=O)[O-])c(N(C)C)cc1OC,6.05,,
CCC(C)C(NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CO)C(C)O)C(=O)NC(CC(C)C)C(=O)[O-],6.05,,
O=C1N=C(NCc2cccs2)SC1Cc1ccc2ncccc2c1,6.05,,
O=C1N=C(NCc2cccs2)SC1Cc1ccc2ncccc2c1,6.05,,
O=C1N=C(NCc2cccs2)SC1=Cc1ccc2ncccc2c1,6.05,,
O=C1N=C(NCc2cccs2)SC1=Cc1ccc2ncccc2c1,6.05,,
O=C1N=C(NCc2cccs2)SC1Cc1ccc2ncccc2c1,6.05,,
CCc1[nH]c2nc(Sc3cccnc3)nc(OC)c2c1C=O,6.05,,CHEMBL2331853
COCCNC=C1C(=O)N(C)c2ccc(C(F)(F)F)cc2N(c2ccccc2)C1=O,6.05,,
NC(=O)CCC([NH3+])C(=O)[O-],6.05,,
CCOc1ccc2cccc(-n3cc(NC(N)=O)c(C(N)=O)n3)c2c1,6.05,,
N#Cc1c(O)c2c(-c3ccc(Br)cc3)c(Br)sc2[nH]c1=O,6.05,,
Cc1nc(N)nc2c1C(=O)CC(c1ccccc1)C2,6.05,,CHEMBL3360303
CC(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C1CCCN1C(=O)C(C)NC(=O)C([NH3+])CO)C(C)O)C(=O)[O-],6.06,,
COc1c(F)c(F)c(C(=O)NC2C(O)C(CO)OC(OC3C(CO)OC(O)C(NC(C)=O)C3O)C2O)c(F)c1F,6.06,,
Cc1c(F)c(Oc2cccc(C(N)=[NH2+])c2)nc(Oc2cccc(C(N)=[NH2+])c2)c1F,6.06,,
C=C(CC(C)C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C(=O)C(CC)NC(=O)C(C(O)C(C)CC=CC)[NH+](C)OO)C(C)C,6.06,,
COC(=O)c1c(O)cc(O)c(Cl)c1CCC(=O)N=C1CC(=O)C(OC)=CC1=O,6.06,,
COc1nccnc1CC(C)C,6.06,"This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Zygaena lonicerae, Zingiber mioga, and other organisms with data available. This molecule is a member of pyrazines and an aromatic ether.",CHEMBL97355
COc1cc(-c2cnc(N)c(N3CCC(C(=O)[O-])CC3)n2)cc(OC)c1OC,6.06,,
[NH3+]CC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1,6.06,,
O=c1ccn(C2OC(CO)C(O)C2O)c(=S)[nH]1,6.06,,
CC([NH3+])(CCC[CH2]~B(O)(O)O)C(=O)[O-],6.06,,
O=C1N=C(Nc2ccccc2)N=C1Cc1ccc2c(c1)OCO2,6.06,,CHEMBL1738733
O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)ccc12,6.06,"This molecule is a natural product found in Spatholobus suberectus, Thermopsis villosa, and other organisms with data available. This molecule is a member of flavones.",CHEMBL301624
[NH3+]C(CC(=O)[O-])C(=O)[O-],6.06,,
CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,6.07,,
CC(C)CC(CC(=O)[O-])C(=O)NC1Cc2cn(c3ccccc23)CCCCCCNC1=O,6.07,,
CC1CCCCC1Oc1cccc(-c2nc3cc(C(N)=[NH2+])c(F)cc3[nH]2)c1O,6.07,,
O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12,6.07,"This molecule is a 7-hydroxyflavonol with additional hydroxy groups at positions 3, 3' and 4'. It has a role as an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, an antioxidant, an anti-inflammatory agent, a metabolite, a plant metabolite and a geroprotector. It is a 3'-hydroxyflavonoid, a 7-hydroxyflavonol and a tetrahydroxyflavone. It is a conjugate acid of a fisetin(1-). This molecule is an orally bioavailable naturally occurring polyphenol found in many fruits and vegetables, with potential antioxidant, neuroprotective, anti-inflammatory, antineoplastic, senolytic, and longevity promoting activities. Upon administration, fisetin, as an antioxidant, scavenges free radicals, protect cells from oxidative stress, and is able to upregulate glutathione. It inhibits pro-inflammatory mediators, such as tumor necrosis factor alpha (TNF-a), interleukin-6 (IL-6), and nuclear factor kappa B (NF-kB). This molecule promotes cellular metabolism, reduces senescence, regulates sirtuin function and may promote longevity. This molecule also exerts anti-cancer activity by inhibiting certain signaling pathways. It also inhibits certain anti-apoptotic proteins and induces apoptosis in susceptible cells. This molecule is a natural product found in Glycine max, Streptomyces, and other organisms with data available.",CHEMBL31574
CC(O)C(NC(=O)C(CO)NC(=O)C1CCCN1C(=O)CNC(=O)C(CCC(=O)[O-])NC(=O)CNC(=O)C1CCCN1C(=O)C([NH3+])CC(=O)[O-])C(=O)O,6.07,,
CC(C)CCC(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(O)c1nccs1)C(C)C,6.07,,
[NH3+]C(CCC(=O)NC(CSC1c2ccccc2-c2ccccc2C1O)C(=O)NCC(=O)[O-])C(=O)[O-],6.07,,
CCC(C)C(NC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C([NH3+])CCSC)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)O,6.07,,
CC#CCNc1ccc(S(=O)(=O)CC2(C(=O)NO)CCN(C(=O)OC(C)(C)C)CC2)cc1,6.07,,CHEMBL236573
CC(=O)Nc1cn[nH]c1C(=O)Nc1ccc(F)cc1,6.07,,
[NH3+]CC1CN(c2c(-c3ccccc3)cnc3[nH]ncc23)CCO1,6.07,,
Cc1ccc(S(=O)(=O)c2cc(C)nc(N)n2)cc1,6.07,,CHEMBL1834091
CSCCC(NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)O,6.07,,
O=C(CO)CC(Cc1ccccc1)C(=O)[O-],6.07,,
Cc1ccc2cc(CC3CCN(C(=O)c4cc(-c5ccccc5)nc5ccccc45)CC3)ccc2n1,6.07,,
COc1ccc2c(c1)cc(CNC(=O)c1cc3ccccc3o1)n2CC(=O)[O-],6.07,,
Cc1c2cc[nH]c(=O)c2c(C)c2c1[nH]c1ccc(O)cc12,6.07,,
Oc1cc(CCl)ccc1Oc1ccc(Cl)cc1Cl,6.07,,CHEMBL240805
[NH3+]Cc1ccc2ccccc2c1-c1ccc(C(=O)NCC[N+]2CCOCC2)cc1,6.07,,
O=C([O-])c1ccc(-c2cc(=O)c3ccccc3o2)cc1,6.07,,
CC(Nc1ncnc2nc[nH]c12)c1cc2ccc(F)cc2nc1-c1ccccn1,6.07,,CHEMBL4303302
CC(=O)OC1CCC2(C)C3CCC4(C)C(C(CO)CC(=O)C=C(C)C)C(O)CC4(C)C3=CCC2C1(C)C(=O)[O-],6.08,,
COC1OC(C)C(NC(=O)C(O)CCO)C(O)C1OC1OC(C)C(NC(=O)C(O)CCO)C(O)C1OC,6.08,,
CCOc1cc2ncnc(Nc3cccc(-c4csc(CO)n4)c3)c2cc1OCC,6.08,,CHEMBL123678
CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C,6.08,,
Cc1cc(N=Nc2ccccc2C(=O)[O-])cc(C)c1O,6.08,,
CCC(C)C(NC(=O)C(Cc1cnc[nH]1)NC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)CNC(=O)C1CCCN1C(=O)C([NH3+])C(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)NC(C=O)CCCC[NH3+],6.08,,
OCC1C[NH+](CCCc2ccccc2)CC(O)C1O,6.08,,
OCC1C[NH+](CCCc2ccccc2)CC(O)C1O,6.08,,
CC(=O)NC1C(OC2C(O)C(CO)OC(O)C2OC2OC(C)C(O)C(O)C2O)OC(CO)C(O)C1O,6.08,,
CCCCCCCCN=C1OCC2C(O)C(O)C(O)C(O)N12,6.08,,
NS(=O)(=O)c1ccccc1,6.08,This molecule is a sulfonamide.,CHEMBL27601
COc1ccc2c(c1OC)NC(=[NH+]C(=O)c1cccnc1)N1CC[NH2+]C21,6.08,,
O=C(CCC(O)(O)C(Cc1ccccc1)NC(=O)c1ccccc1)NC(Cc1ccccc1)C(=O)[O-],6.08,,
O=C(CSc1cn(CCNC(=O)c2cccc(C(F)(F)F)c2)c2ccccc12)Nc1ccc2c(c1)OCCO2,6.08,,CHEMBL1232179
O=C(NC(Cc1nc2ccccc2[nH]1)C(=O)[O-])c1cc2ccccc2s1,6.08,,
Nc1ncc2c(n1)-c1ccccc1C(c1ccccc1)C2,6.08,,
CCCC(NC(=O)C1C2CCCC2CN1C(=O)C(NC(=O)C(NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(O)C(=O)NC1CC1,6.08,,
NS(=O)(=O)c1ccc(C(=O)CSc2ncccn2)cc1Cl,6.08,,CHEMBL2443188
CC(C)CC(NC(=O)C(NC(=O)CNC(=O)c1ccccc1)C(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(C(=O)[O-])C(C)C,6.08,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.09,,
NC(=[NH2+])c1cc2nc(-c3cccc(-c4ccccc4)c3O)[nH]c2cc1Cl,6.09,,
CC12CCc3c(ccc4cc(O)ccc34)C1CCC2=O,6.09,,
CC(=O)NC(=[NH2+])NCCCC1NC(=O)C(CCCC(=O)[O-])NC(=O)C(Cc2c[nH]cn2)N2C(=O)C(CC2O)NC(=O)C2CCCN2C1=O,6.09,,
[NH3+]C(CCSCC1OC(n2cnc3c(NCc4cccc(Cl)c4)ncnc32)C(O)C1O)C(=O)[O-],6.09,,
COc1cc(-c2ccc(NNc3ccc4c(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c(N)c4c3O)c(OC)c2)ccc1N=Nc1ccc2c(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c(N)c2c1O,6.09,,
O=C([O-])CCC(=O)NNC(=O)c1cnccc1Cc1ccccc1,6.09,,
COc1cccc(OC)c1-c1cnnc(NCc2nc3cc(OCC(=O)[O-])ccc3s2)n1,6.09,,
COc1cccc(OC)c1-c1cnnc(NCc2nc3cc(OCC(=O)[O-])ccc3s2)n1,6.09,,
CC(C)CC(NC(=O)OCc1ccccc1)C(=O)NC(CO)CC1CCNC1=O,6.09,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.09,,
COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)C[NH+](C)C)CCC2(C)C,6.09,,
CC(=O)Nc1nnc(S(N)(=O)=O)s1,6.1,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
CCCCCCCCCCCCCCCC(=O)[O-],6.1,,
COc1nccnc1CC(C)C,6.1,"This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Zygaena lonicerae, Zingiber mioga, and other organisms with data available. This molecule is a member of pyrazines and an aromatic ether.",CHEMBL97355
CCC(C)CCCC(C)(C)O,6.1,,CHEMBL3188990
OC(c1ccccc1)c1ccccc1,6.1,"This molecule is a secondary alcohol that is diphenylmethane which carries a hydroxy group at position 1. It has a role as a rat metabolite, a bacterial xenobiotic metabolite, a human xenobiotic metabolite and a human urinary metabolite. It is a secondary alcohol and a member of benzyl alcohols. It derives from a hydride of a diphenylmethane.",CHEMBL2386190
Oc1cccc(-c2ccccc2Cl)c1O,6.1,,
O=c1c2c(O)cccc2oc2c([N+](=O)[O-])ccc(O)c12,6.1,"This molecule is a member of the class of xanthones that is xanthen-9-one substituted at position 4 by a nitro group and at positions 1 and 8 by hydroxy groups. It has a role as a protein kinase inhibitor. It is a member of xanthones, a polyphenol and a C-nitro compound.",CHEMBL270512
O=C1N(Cc2ccc(CO)cc2)C(Cc2ccccc2)C(O)C(O)C(Cc2ccccc2)N1Cc1ccc(CO)cc1,6.1,,
CCC(NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C([NH3+])CC(C)C)C(C)O)C(C)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)O,6.1,,
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)[O-],6.1,,
O=C([O-])CCN1C(=O)C(=Cc2ccc(-c3ccc(Cl)cc3)o2)SC1=S,6.1,,
c1ccc(C(OC2CC[NH+](CCCc3nnn[nH]3)CC2)c2ccccc2)cc1,6.1,,
CN1c2c(nc(N)[nH]c2=O)NCC1CNc1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,6.1,,
CC(CS)C(=O)N1CC(Sc2ccccc2)CC1C(=O)[O-],6.1,,
NC(=O)NCc1cccc(-c2cccc(-c3cc4cnccc4[nH]3)c2O)c1,6.1,,
O=C1c2c(O)ccc(O)c2C(=O)c2c(NCC[NH2+]CCO)ccc(NCC[NH2+]CCO)c21,6.1,,
Cc1cc(O)ccc1Cl,6.1,"This molecule appears as a pinkish to white crystalline solid with a phenolic odor. Melting point 64-66 °C. Shipped as a solid or in a liquid carrier. Soluble in aqueous base. Toxic by ingestion, inhalation or skin absorption. Used as an external germicide. Used as a preservative in paints and inks. This molecule is a hydroxytoluene that is 3-methylphenol which is substituted by a chlorine at position 4. A ryanodine receptor agonist. It has a role as a ryanodine receptor agonist, an antimicrobial agent and a disinfectant. It is a hydroxytoluene and a member of monochlorobenzenes.",CHEMBL1230222
NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2,6.1,,CHEMBL379367
Fc1ccccc1-c1c[n+]2cc[nH]c2c(NCc2cccnc2)n1,6.1,,
CS(=O)(=O)Nc1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1,6.1,,CHEMBL496574
Cc1cc2[nH][nH]c(=O)[n+]2c2ccccc12,6.1,,
CC(NC(=O)C1CCCN1C(=O)C([NH3+])CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(CO)C(=O)NC(Cc1c[nH]cn1)C(N)=O,6.1,,
CC(=O)CCC(CC1CCNC1=O)NC(=O)C(CC(C)C)NC(=O)C(CNC(=O)C(C)(C)C)NC(=O)OCc1ccccc1,6.1,,
CCC(C)C(NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)O,6.1,,
CSCCC(NC(=O)C([NH3+])C(C)C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(C)C)C(=O)[O-])C(C)O,6.1,,
CC(=O)CNC(=O)OCc1ccccc1,6.1,,
[NH2+]=c1[nH]c(=O)c2[nH]cc(Cc3cccnc3)c2[nH]1,6.1,,
C=C1CC23C=CC(=O)C(C)(CCC(=O)Nc4c(O)ccc(C(=O)[O-])c4O)C2CC1CC3O,6.1,,
CCCCN(C)C(=O)c1c(F)cccc1OCC(=O)NC(CO)Cc1ccccc1,6.1,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)[O-])C(C)O,6.1,,
O=C([O-])C1OC(OC2C(COS(=O)(=O)[O-])OC(OC3C(C(=O)[O-])OC(OC4C(COS(=O)(=O)[O-])OC(O)C(NS(=O)(=O)[O-])C4O)C(OS(=O)(=O)[O-])C3O)C(NS(=O)(=O)[O-])C2O)C(OS(=O)(=O)[O-])C(O)C1O,6.1,,
c1ccc(Cn2cc(-c3c[nH]c4ncccc34)nn2)cc1,6.1,,
O=C([O-])C(=O)C=C(O)c1cccc(Br)c1,6.1,,
CCCCCCCCCCCCCC(=O)[O-],6.1,,
Cc1noc(C)c1-c1ccc2c(Nc3ccccc3C(C)(C)C)c(C(=O)[O-])cnc2c1,6.1,,
O=C([O-])C1OC(O)C(OS(=O)(=O)[O-])C(O)C1OC1OC(COS(=O)(=O)[O-])C(OC2OC(C(=O)[O-])C(OC3OC(COS(=O)(=O)[O-])C(OC4OC(C(=O)[O-])C(OC5OC(COS(=O)(=O)[O-])C(O)C(O)C5NS(=O)(=O)[O-])C(O)C4OS(=O)(=O)[O-])C(O)C3NS(=O)(=O)[O-])C(O)C2OS(=O)(=O)[O-])C(O)C1NS(=O)(=O)[O-],6.1,,
CC(C)n1nc(-c2ccc3cc(OCc4cccc(Cl)c4)ccc3c2)c2c(N)ncnc21,6.1,,CHEMBL2078817
CC(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)C,6.1,,
COc1nc2nc(N)nc(N)c2nc1C,6.1,,CHEMBL2165173
CC(C)CC([NH3+])C(=O)[O-],6.1,,
CC(C)CC([NH3+])C(=O)[O-],6.1,,
CCCC(=O)Nc1cc(NS(=O)(=O)c2cccs2)cc(-c2csc(=O)[nH]2)c1,6.1,,CHEMBL2349462
O=c1cc(-c2ccc(O)cc2)oc2ccccc12,6.1,,CHEMBL327209
Cc1ccc(CSc2nc3c(c(=O)[nH]2)CCC3)cc1,6.1,,
CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C([NH3+])CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)[O-],6.1,,
CC(C)(C)OC(=O)NC(C(=O)NO)c1ccc(-n2cccn2)cc1,6.1,,CHEMBL3359688
Cc1nc2ccccc2n1Cc1ccc2c(c1)nc(CNc1ccc(C(N)=[NH2+])cc1)n2C,6.11,,
O=C1c2c(O)cccc2C(=O)c2c([N+](=O)[O-])ccc(O)c21,6.11,,CHEMBL574060
COc1ccccc1-c1cc(C(CC(=O)[O-])C(=O)[O-])cc(-c2nc3cc(C(N)=[NH2+])ccc3[nH]2)c1O,6.11,,
CCC(C)C(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NCC(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(C(=O)NC(CC(C)C)C(=O)O)C(C)CC)C(C)O)C(C)CC,6.11,,
C=CCC(NC(=O)C(O)CC(=O)OCC)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]c2ccccc12)C(N)=O,6.11,,
O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,6.11,"This molecule is a hexahydroxyflavone that is flavone substituted by hydroxy groups at positions 3, 3', 4', 5, 5' and 7. It has been isolated from the leaves of Myrica rubra and other plants. It has a role as a cyclooxygenase 1 inhibitor, an antineoplastic agent, an antioxidant, a plant metabolite, a food component, a hypoglycemic agent and a geroprotector. It is a hexahydroxyflavone and a 7-hydroxyflavonol. It is a conjugate acid of a myricetin(1-). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Caragana frutex, Camellia sinensis, and other organisms with data available.",CHEMBL164
O=S(=O)(c1ccccc1Cl)N(Cc1ccccc1)C1C[NH2+]CC1N(Cc1ccccc1)S(=O)(=O)c1ccccc1Cl,6.11,,
Nc1nc2c(c(=O)[nH]1)N=C(CO)CN2,6.11,"This molecule is a dihydropterin that is 7,8-dihydropteridin-4-ol substituted at positions 2 and 6 by amino and hydroxymethyl groups respectively. It has a role as a Saccharomyces cerevisiae metabolite. It is a tautomer of a 2-amino-6-(hydroxymethyl)-7,8-dihydropteridin-4-one. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Arabidopsis thaliana and Trypanosoma brucei with data available.",CHEMBL1233322
O=C(NC1c2ccccc2-c2c(-c3nc4ccncc4[nH]3)cccc21)c1ccncc1,6.11,,
COC(c1ccccc1)C1NC(=O)C(C)NC(=O)C(CC(C)CO)N(C)C(=O)C(C(O)c2cn(C(C)(C)C(C)O)c3ccccc23)NC(=O)C(C(C)C=C(C)C)NC(=O)C(CC(C)C)N(C)C(=O)C(C(C)C)NC1=O,6.11,,
CC(Oc1cc(-c2cnn(C)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,6.11,,CHEMBL1824894
Cc1nc2ccc(Br)cc2c(-c2ccc(Cl)cc2)c1C(OC(C)(C)C)C(=O)[O-],6.11,,
O=C(CCc1cc(C(=O)c2cccc(F)c2)c[nH]1)CC(O)C(=O)[O-],6.11,,
CC1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)CC(C(F)(F)F)OC(=[NH2+])N1,6.11,,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1,6.11,,CHEMBL2425156
COc1cc(Cl)c(C#N)cc1C(=O)NCC[NH+]1CCC(C(=O)c2ccc(F)cc2)CC1,6.11,,
C=CCOC1(C(=O)[O-])CC(OC2(C(=O)[O-])CC(O)C(O)C(C(O)COC3(C(=O)[O-])CC(O)C(O)C(C(O)CO)O3)O2)C(O)C(C(O)CO)O1,6.11,,
C[NH2+]CCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,6.11,,
CSCCC(NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)[O-])NC(=O)CNC(=O)C(NC(=O)C(C)NC(=O)C1CCC[NH2+]1)C(C)O)C(=O)NC(CC(N)=O)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(C(=O)NCC=O)C(C)C,6.12,,
CSCC1OC(n2ccc3c(N)ncnc32)C(O)C1O,6.12,,
NC(=[NH2+])c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3O)cc2c1,6.12,,
C[NH+](C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,6.12,,
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,6.12,,
CC(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCCC[N+](C)(C)C)NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)O)C(C)O,6.12,,
[NH3+]C(Cc1c(-c2nnn(Cc3ccccc3)n2)o[nH]c1=O)C(=O)[O-],6.12,,
Nc1ccn(C2OC(CO)C(O)C2(F)F)c(=O)n1,6.12,This molecule is a pyrimidine 2'-deoxyribonucleoside. This molecule is a natural product found in Beta vulgaris with data available.,CHEMBL264883
OCC1[NH2+]C(CO)C(O)C(O)C1O,6.12,,
COC(C(=O)NC1Cc2ccccc2C1)C(O)C(O)C(O)C=CC(C)(C)C,6.12,,
OCC1C[NH2+]CC(O)C1O,6.12,,
O=C([O-])c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O,6.12,,
CC[NH+]1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)CC1,6.12,,
COC1OC(CO)C(O)C(O)C1SC1OC(CO)C(O)C(O)C1O,6.12,,
CC(=O)NC1C(OC2C(CO)OC(OC3C(CO)OC(OC4C(CO)[NH2+]CC(O)C4O)C(NC(C)=O)C3O)C(NC(C)=O)C2O)OC(CO)C(O)C1O,6.12,,
CC1(C)Cc2cc(Cl)ccc2C(NC(Cc2ccccc2)c2nc(=O)o[nH]2)=N1,6.12,,
OC1C(O)C(O)C(O)C(O)C1O,6.12,,
CC(=CC=CC(C)=CC(=O)[O-])C=C1CCCc2ccccc21,6.12,,
Cc1cccc2c1CCN(C(=O)C1CCCCC1C(=O)[O-])C2CN1Cc2ccccc2C1=O,6.12,,
CC(C)CC(NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CO)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CO)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-])C(C)C,6.12,,
CS(=O)(=O)c1ccc(C[NH+]2CCN(c3cn[nH]c3-c3cc(Cl)c(O)cc3O)CC2)cc1,6.13,,
Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1,6.13,"This molecule is a novel anticancer compound with a unique target profile involving both cell cycle and angiogenesis inhibition mechanisms. In preclinical studies, This molecule has demonstrated antitumor activity in both solid tumors and hematological cancers.  Cyclacel's small molecule investigational drug, This molecule, is the third orally-available Cyclacel drug to enter development, which demonstrated anticancer activity with a mechanism consistent with inhibition of Aurora kinase.",CHEMBL482967
Nc1ncnc2c1ncn2C1OC(CC([NH3+])CCC([NH3+])C(=O)[O-])C(O)C1O,6.13,,
CCOC(Cc1ccc(OCc2csc(-c3ccc(Cl)cc3)n2)cc1C)C(=O)[O-],6.13,,
O=C1C(=NO)c2c(C=Cc3ccccc3)cccc2N1Cc1cc(F)cc2c1OCOC2,6.13,,
CC1SCc2ncnc(N3CCN(C(=O)C([NH3+])Cc4c[nH]c5ccccc45)CC3)c21,6.13,,
CNc1nc2cc3c(=O)[nH]cnc3c(CC[NH2+]CC3CCCC3)c2[nH]1,6.13,,
Nc1n[nH]c(N)c1N=Nc1ccc(O)cc1,6.13,,
Nc1ccc(CC(=O)OCCc2ccccc2)c(C=O)c1,6.13,,
COc1ccc(-c2nc(CSc3nc(N)cc(N)n3)cs2)cc1OCCF,6.13,,CHEMBL2426582
CCCc1sc(-c2ccc(OC)c(OCC(C)(C)O)c2)nc1CSc1cc(N)nc(N)n1,6.13,,CHEMBL3358092
NS(=O)(=O)c1ccc(Nc2cc(NC3CCCCC3)nc3ncnn23)cc1,6.14,,CHEMBL203569
[NH3+]C(CCSCC(O)C(O)C(=O)NO)C(=O)[O-],6.14,,
OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC1C(O)C2O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O,6.14,,
COc1ccc2c(c1OC)CN1CCc3cc4c(cc3C1=C2)OCO4,6.14,"This molecule is an alkaloid. This molecule is a natural product found in Thalictrum foliolosum, Chelidonium majus, and other organisms with data available.",CHEMBL11848
Cc1cc(NC(=O)Nc2ncc(CCNc3cc(Nc4ncn[nH]4)ncn3)s2)c(C(F)(F)F)o1,6.14,,
CC(C)C1=CC(=O)C(=O)C(O)C=C1,6.14,,
O=C(NCc1cccs1)C(O)C(O)C(=O)N1CCCC1c1ccccc1,6.14,,
COc1ccc(S(=O)(=O)N2Cc3cc(C#N)ccc3N(Cc3cncn3C)CC2Cc2ccccc2)cc1,6.14,,
COc1ccc(S(=O)(=O)N2Cc3cc(C#N)ccc3N(Cc3cncn3C)CC2Cc2ccccc2)cc1,6.14,,
CC(=O)NC(Cc1cccnc1)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(=O)NC(CCC(C)C)C(=O)NC(CC(=O)[O-])C(C)=O)CC(C)C,6.14,,
N#Cc1cccc(-c2c[nH]c(=O)c(O)c2)c1,6.14,,
COc1cc(OCC#Cc2ccc3ccncc3c2)ccc1C[NH+]1CC[NH2+]CC1,6.14,,
CCCCCCCCCCC=O,6.15,"This molecule is a saturated fatty aldehyde formally arising from reduction of the carboxylic acid group of undecanoic acid. It is a component of essential oils from citrus plants like Citrus reticulata. It has a role as an antimycobacterial drug, a volatile oil component and a plant metabolite. It is a saturated fatty aldehyde, a n-alkanal and a medium-chain fatty aldehyde. It is a tautomer of an undec-1-en-1-ol. This molecule is a natural product found in Gymnodinium nagasakiense, Daphne odora, and other organisms with data available.",CHEMBL1236576
CSCCC(NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C([NH3+])C(C)O)C(C)O)C(C)C)C(C)C)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)[O-],6.15,,
CCCc1c(OC2CCCCC2)c2cc(Cl)ccc2[nH]c1=O,6.15,,CHEMBL187718
O=C1OC(c2ccc(O)c(Cl)c2)(c2ccc(O)c(Cl)c2)c2cccc3cccc1c23,6.15,,CHEMBL67116
COc1ccc2c3c1OC1CC(O)C=CC31CC[N+](C)=C2,6.15,,
COc1ccc2c3c1OC1CC(O)C=CC31CC[N+](C)=C2,6.15,,
OCC1OC(OC2C(OC3C(OC4C(O)C(O)OC(CO)C4O)OC(CO)C(O)C3O)OC(CO)C(O)C2O)C(O)C(O)C1O,6.15,,
O=S(=O)(Nc1ccc(O)c(-c2c(O)ccc3ccccc23)c1)c1cc(Cl)ccc1Cl,6.15,,CHEMBL371915
Cc1cccc(C[NH2+]CC(O)C(Cc2ccccc2)NC(=O)C2=Cc3ccccc3Oc3ccccc32)c1,6.15,,
Nc1c(C(=O)c2cccc(OCC(O)CO)c2)cnn1-c1ccc(F)cc1,6.15,,
CN(C)c1ccc(C2Sc3cc(O)ccc3N2C)cc1,6.15,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(C)NC(=O)C(CC(N)=O)NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])C(C)O)C(C)C)C(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)[O-],6.15,,
C[NH+](C)CCNC(=O)c1cc([C]2SCC3OCCOC23)cnc1N,6.15,,
Cc1cc(CNC(=O)c2nn(C)c3c2ccc2cnc(Nc4ccc(N5CC[N+](C)CC5)cc4)nc23)ccn1,6.15,,
OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC8C(CO)OC(OC1C(O)C2O)C(O)C8O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O,6.15,,
CSCCC([NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)[O-],6.15,,
c1ccccc1,6.15,"This molecule is a colorless liquid with a sweet odor. It evaporates into the air very quickly and dissolves slightly in water. It is highly flammable and is formed from both natural processes and human activities. This molecule is widely used in the United States; it ranks in the top 20 chemicals for production volume. Some industries use benzene to make other chemicals which are used to make plastics, resins, and nylon and synthetic fibers. This molecule is also used to make some types of rubbers, lubricants, dyes, detergents, drugs, and pesticides. Natural sources of benzene include volcanoes and forest fires. This molecule is also a natural part of crude oil, gasoline, and cigarette smoke. This molecule appears as a clear colorless liquid with a petroleum-like odor. Flash point less than 0 °F. Less dense than water and slightly soluble in water. Hence floats on water. Vapors are heavier than air. This molecule is a six-carbon aromatic annulene in which each carbon atom donates one of its two 2p electrons into a delocalised pi system. A toxic, flammable liquid byproduct of coal distillation, it is used as an industrial solvent. This molecule is a carcinogen that also damages bone marrow and the central nervous system. It has a role as a non-polar solvent, a carcinogenic agent and an environmental contaminant. It is an aromatic annulene, a volatile organic compound and a member of benzenes. This molecule is found in the air from emissions from burning coal and oil, gasoline service stations, and motor vehicle exhaust. Acute (short-term) inhalation exposure of humans to benzene may cause drowsiness, dizziness, headaches, as well as eye, skin, and respiratory tract irritation, and, at high levels, unconsciousness. Chronic (long-term) inhalation exposure has caused various disorders in the blood, including reduced numbers of red blood cells and aplastic anemia, in occupational settings. Reproductive effects have been reported for women exposed by inhalation to high levels, and adverse effects on the developing fetus have been observed in animal tests. Increased incidence of leukemia (cancer of the tissues that form white blood cells) have been observed in humans occupationally exposed to benzene. EPA has classified benzene as known human carcinogen for all routes of exposure. This molecule is a clear, colorless, highly flammable and volatile, liquid aromatic hydrocarbon with a gasoline-like odor. This molecule is found in crude oils and as a by-product of oil-refining processes. In industry benzene is used as a solvent, as a chemical intermediate, and is used in the synthesis of numerous chemicals. Exposure to this substance causes neurological symptoms and affects the bone marrow causing aplastic anemia, excessive bleeding and damage to the immune system. This molecule is a known human carcinogen and is linked to an increased risk of developing lymphatic and hematopoietic cancers, acute myelogenous leukemia, as well as chronic lymphocytic leukemia. (NCI05) This molecule is a natural product found in Swertia japonica, Basella alba, and other organisms with data available. This molecule is a toxic, volatile, flammable liquid hydrocarbon biproduct of coal distillation. Chronic benzene exposure produces hematotoxicity, bone marrow dysplasia (Displasia is a pre-neoplastic or pre-cancerous change). (A7669). It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. This molecule causes central nervous system damage acutely and is carcinogenic. It was formerly used as parasiticide.",CHEMBL277500
CC(=O)c1ccc(Oc2ccc(-c3ccc(-c4ccccc4Cl)n3CC(=O)NC(N)=[NH2+])cc2)cc1,6.15,,
COc1ccc2c(c1OC)CN(C)c1c-2ccc2cc3c(cc12)OCO3,6.15,"This molecule is a benzophenanthridine alkaloid. This molecule is a natural product found in Zanthoxylum simulans, Zanthoxylum ailanthoides, and other organisms with data available.",CHEMBL400359
Fc1cccc(COc2ccc(Nc3ncnc4ccccc34)cc2Cl)c1,6.15,,CHEMBL3736478
CCCC(C)=O,6.15,"This molecule appears as a clear colorless liquid with the odor of fingernail polish. Flash point 45 °F. Less dense than water and soluble in water. Hence floats on water. Density 0.809 g / cm3. Vapors heavier than air. This molecule is a pentanone carrying an oxo substituent at position 2. It has a role as a plant metabolite. It is a methyl ketone and a pentanone. This molecule is a natural product found in Aloe africana, Malpighia emarginata, and other organisms with data available.",CHEMBL45345
C[NH+](C)CC(=O)NC1CCC2[NH2+]C(O)C3CCCCC3C2C1,6.15,,
COc1cc2nc(N3CCC[NH+](C)CC3)nc(NC3CC[NH+](Cc4ccccc4)CC3)c2cc1OC,6.15,,
CC(C)CC(NC(=O)C([NH3+])C(C)O)C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)NC(CC(N)=O)C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)[O-],6.15,,
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])Cc1c[nH]cn1)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(CS)C(=O)NC(CO)C(=O)NC(CO)C(=O)[O-])C(C)O,6.15,,
Nc1ncnc2c1ncn2C1OC(CC([NH3+])CCC([NH3+])C(=O)[O-])C(O)C1O,6.15,,
CC(C)(c1cc(Br)c(O)c(Br)c1)c1cc(Br)c(O)c(Br)c1,6.15,"This molecule is a white powder. A monomer for flame-retardant epoxy, polyester and polycarboante resins. These molecules is a bromobisphenol that is 4,4'-methanediyldiphenol in which the methylene hydrogens are replaced by two methyl groups and the phenyl rings are substituted by bromo groups at positions 2, 2', 6 and 6'. It is a brominated flame retardant. It is a brominated flame retardant and a bromobisphenol. It is functionally related to a bisphenol A. This molecule is an organobromide compound and a brominated flame retardant. In the reactive application, TBBPA is bound chemically to the polymers. The main use is epoxy resins of printed circuit boards. As an additive flame retardant it is used in acrylonitrile butadiene styrene, which is found in products such as TVs. Bromine is a halogen element with the symbol Br and atomic number 35. Diatomic bromine does not occur naturally, but bromine salts can be found in crustal rock. (L625, L705)",CHEMBL184450
CSCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCSC)NC(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(=O)C(NC(=O)C1CCC[NH2+]1)C(C)C)C(=O)NC(C)C(=O)NC(C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CCC(N)=O)C(=O)[O-])C(C)O,6.15,,
CC(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C,6.15,,
CC(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C,6.15,,
Cc1[nH]c2ccccc2c1C[NH+]1CCN(c2ccccn2)CC1,6.15,,
CNC(=O)C(Cc1ccccc1)NC(=O)Nc1nnc(S)s1,6.15,,
CC(CCCCC(O)C(C=O)CO)CC(C)CC(C)CC(=O)[O-],6.15,,
C[N+](C)CCCC(=O)Nc1ccc(C(=O)Nc2cccc(Nc3nccc(-c4cccnc4)n3)c2)cc1,6.15,,
CC(=O)NC(C(=O)NC(C(=O)NC(CC(C)C)C(O)CC(N)=O)C(C)C)C(C)C,6.15,,
Nc1ncnc2c1c(COc1cccc(Cl)c1)nn2C1CCOCC1,6.15,"This molecule is a pyrazolopyrimidine that is 1H-pyrazolo[3,4-d]pyrimidin-4-amine which is substituted at positions 1 and 3 by tetrahydro-2H-pyran-4-yl and (m-chlorophenoxy)methyl groups, respectively. It is a selective inhibitor of the epsilon isoform of casein kinase 1 (CK1epsilon). It has a role as an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor. It is a pyrazolopyrimidine, a member of monochlorobenzenes, an aromatic ether and a member of oxanes.",CHEMBL2069623
O=c1cc(-c2ccc(F)cc2)oc2ccccc12,6.15,,CHEMBL53738
O=S(=O)(c1ccc(O)cc1O)n1cc2ccccc2c1,6.15,,
Cc1cc(=O)oc2c(C[NH2+]C(CC(C)C)C(=O)[O-])c(O)ccc12,6.15,,
CC(C)(C)C(=O)NC(C(=O)NO)c1ccc(-n2cccn2)cc1,6.15,,CHEMBL3359693
CC(C)CC(NC(=O)C(NC(=O)CNC(=O)c1ccccc1)C(C)C)C(=O)NC(CCCCNC(=O)CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(C(=O)[O-])C(C)C,6.15,,
CC(C)CC(NC(=O)C(NC(=O)CNC(=O)c1ccccc1)C(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(C(=O)[O-])C(C)C,6.15,,
NC(=[NH2+])c1ccc(CC(NC(=O)CNS(=O)(=O)c2ccc3ccccc3c2)C(=O)N2CCCCC2)cc1,6.16,,
O=C([O-])c1ccc(-c2cc(Cl)ccc2Cl)o1,6.16,,
CCCCCCCN(CCc1ccc(OC(C)(CC)C(=O)[O-])cc1)c1nc2ccccc2o1,6.16,,
Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)C(=O)N1CSC(C)(C)C1C(=O)NC1c2ccccc2CC1O,6.16,,
Cc1ccc2[nH]c(=O)c(CN(CCO)C(=O)Nc3ccccc3F)cc2c1,6.16,,CHEMBL1236933
Cc1ccc(-c2cnc(Nc3ccc(OCCC[NH+]4CC[NH+](C)CC4)cc3)c(C(N)=O)n2)cc1C,6.16,,
CCC(C)C(NC(C)=O)C(=O)NC(CO)C(=O)NC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC2CCCCNC(=O)CCC(C(=O)[O-])NC(=O)C3CCC(=O)OCC(NC(=O)C4CCCN4C(=O)C(Cc4ccc(O)cc4)NC2=O)C(=O)NC(CC(=O)OC1C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)N3,6.16,,
Cc1nc2cc(OCc3ccc4ccccc4n3)ccc2s1,6.16,,CHEMBL4453729
C[NH+]1CCc2c3c(n(-c4ccc(C(N)=O)cc4)c2C1)CC(C)(C)CC3=O,6.16,,
CCCCC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(Cc1cccnc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1cccnc1)NC(=O)C(C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CCCC[NH3+])C(C)O)C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(=O)[O-],6.16,,
O=c1[nH]cnc2[nH]cnc12,6.17,,
O=C([O-])CCCNC(=O)c1ccc(C2CCC(c3ccccc3)CC2O)cc1,6.17,,
NC(=[NH2+])NCCCNC(=O)C1CCCCN1C(=O)C(CC1CCCCC1)[NH2+]CC(=O)[O-],6.17,,
NC(=O)c1cn(C(CO)CCc2cccc3ccccc23)cn1,6.17,,CHEMBL327830
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(Cc1ccccc1)C(N)=O,6.17,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)[O-])C(=O)[O-],6.17,,
CC(=O)NC1CSSCC(C(N)=O)NC(=O)C2CCCN2C(=O)C2CCCN2C(=O)CNC(=O)C(CCC(N)=O)NC(=O)C2CCCN2C(=O)C(Cc2cnc[nH]2)NC1=O,6.17,,
CCc1cc(-c2n[nH]c(C(=O)[O-])c2-c2ccc3c(c2)OCO3)c(O)cc1O,6.17,,
Cc1nc2ccc(CN(C)c3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])s3)cc2c(=O)[nH]1,6.17,,
COc1cccc(-c2cccc(C3(C)CC(=O)N(C)C(=[NH2+])N3)c2)c1,6.17,,
O=C(CCC(O)(O)C(Cc1ccccc1)NC(=O)c1ccccc1)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],6.17,,
COC(=O)c1sc(-c2cccs2)cc1NC(=O)CCC(=O)[O-],6.17,,
O=c1c(Br)c(OCc2ccccc2)ccn1Cc1ccccc1,6.17,,CHEMBL1095447
NC(=[NH2+])NCCSC(CC(=O)[O-])C(=O)[O-],6.17,,
CCc1cc2c(cc1OS(N)(=O)=O)CCC1C2CCC2(C)C(OS(N)(=O)=O)CCC12,6.17,,
Cc1cnc(Cl)c2c1[nH]c1ccc3cc(O)ccc3c12,6.17,,
Cc1ncsc1-c1ccc(CNC(=O)C2CC(O)CN2C(=O)c2cccc(N)c2C)cc1,6.17,,
CCC(C)C(NC(=O)CC(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(C)[NH3+])C(=O)NCC(=O)NC(C)C(=O)NC(CCC(N)=O)CC(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])CC(=O)NC(CCSC)C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(=O)[O-])CC(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)NC(C)CC(=O)NC(CCC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],6.17,,
[NH3+]CCCCCCCCCC(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NCCC1CCCCC1,6.17,,
CS(=O)(=O)Nc1cccc(-c2cnc(N)c(C(=O)NCC3CC[NH2+]CC3)n2)c1,6.17,,
O=C([O-])c1ccc(O)c(O)c1,6.17,,
Cc1nc(-c2ccccn2)nc(NCCNc2ccc(C(F)(F)F)cn2)c1Cl,6.17,,CHEMBL2375628
CC1CCC(C(=O)N(c2ccc(Oc3ccccc3)cc2C(=O)[O-])C(C)C)CC1,6.17,,
CC1CCC(C(=O)N(c2ccc(Oc3ccccc3)cc2C(=O)[O-])C(C)C)CC1,6.17,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,6.17,,
CC([NH3+])C(=O)NC(C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(N)=O)C(=O)[O-])C(C)O,6.17,,
NC(=[NH2+])NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccccc32)cc1,6.18,,
CC(C)C1C[NH2+]C(C(=O)[O-])C1CC(=O)[O-],6.18,,
NC1=NC(=C2CCNC(=O)c3[nH]ccc32)C(=O)N1,6.18,,
C[NH+]1C2CCC1CC(OC(=O)c1c[nH]c3ncccc13)C2,6.18,,
NS(=O)(=O)c1ccc(NC(=O)c2[nH]nc3ccccc23)cc1,6.18,,
Cc1cc(Nc2cc(N3CC[N+](C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,6.18,,
CC(C)CC(NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)O,6.18,,
CCC(C)C(NC(=O)C1CCCN1C(=O)CNC(=O)C(C)[NH3+])C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C=O,6.18,,
CC(C=CC1(O)C(C)=CC(=O)CC1(C)C)=CC(=O)[O-],6.18,,
O=C1COc2ccc(C3=C(c4ccc(F)cc4F)C(=O)OC3)cc2N1,6.18,,CHEMBL2419303
CC(C)CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C([NH2+]C(C)O)C(C)O)C(C)C)C(C)O)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(N)=O)C(C)C,6.18,,
Cc1cc(C)n(C(=O)CCNc2ccc(S(N)(=O)=O)cc2)n1,6.18,,
CCC(C)C(NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C([NH3+])CCCC[NH3+])C(C)O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(CCC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)C,6.19,,
COc1ccc2c3c1OC1CC(O)C=CC31CC[NH+](C)C2,6.19,,
CC(C)c1cc(C(C)C)c(S(=O)(=O)NC(Cc2cccc(C(N)=[NH2+])c2)C(=O)N2CCN(C(=O)CC[NH3+])CC2)c(C(C)C)c1,6.19,,
NS(=O)(=O)NC(Cc1ccccc1)C(=O)[O-],6.19,,
O=C(C1CCN(c2ccncc2)CC1)N1CCN(S(=O)(=O)c2ccc3cc(Cl)ccc3c2)CC1,6.19,,CHEMBL270527
COC1OC(C)C(O)C(O)C1O,6.19,,
O=c1cc(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,6.19,"This molecule is flavone hydroxylated at positions 3', 4', 5, 5' and 7. It has a role as an antineoplastic agent and a metabolite. It is a conjugate acid of a tricetin(1-). This molecule is a natural product found in Camellia sinensis, Rhodiola quadrifida, and other organisms with data available.",CHEMBL247484
[NH3+]NC(=O)c1cn2ccc3ccccc3c2n1,6.19,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,6.19,,
O=C([O-])c1ccc(-c2cc3cccnc3c(-c3cccc([N+](=O)[O-])c3)n2)cc1,6.19,,
O=C1CCCCC(CO)=CCCOC(=O)c2c(O)cc(O)c(Cl)c2C1,6.19,,
O=C([O-])c1cccc2c3c(n(Cc4ccccc4C(F)(F)F)c12)CCCC3,6.19,,
Nc1nc(Nc2ccccc2)sc1C(O)c1cccnc1,6.19,,
Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NN2C,6.19,,CHEMBL1958337
O=C(NCCc1ccccc1)Nc1ccc2n[nH]cc2c1,6.19,,
COc1ccc(Nc2nc3cc(C(=O)[O-])ccc3n2Cc2ccccc2C(F)(F)F)cc1F,6.19,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])Cc1c[nH]cn1)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(=O)[O-])C(=O)NCC(=O)[O-],6.19,,
CN1c2ccc(NCc3ccc(C(C)(C)C)cc3)cc2-c2c(cnn2C)S1(=O)=O,6.19,,CHEMBL2333444
CCN(CC)C(=S)S,6.19,"A chelating agent that has been used to mobilize toxic metals from the tissues of man and experimental animals. It is the main metabolite of DISULFIRAM. These molecules is a member of the class of dithiocarbamic acids that is diethylcarbamic acid in which both of the oxygens are replaced by sulfur. It has a role as a chelator and a copper chelator. It is a conjugate acid of a diethyldithiocarbamate. This molecule is a sulfhydryl-containing carbamate that is the primary in vivo metabolite of disulfiram. Diethyldithiocarbamate chelates zinc, thereby inhibiting metalloproteinases, thereby preventing the degradation of the extracellular matrix and inhibiting an initial step in cancer metastasis and angiogenesis. A known inhibitor of superoxide dismutase, this agent can either potentiate or protect against cell oxidative damage caused by ionizing radiation, depending on the time of administration. (NCI04)",CHEMBL961
CN1C(=[NH2+])NC(CCC2CCCCC2)(CC2CCN(C(=O)CC3CCCC3)C2)C1=O,6.19,,
CCOc1cc(OCC#Cc2ccc3ccncc3c2)ccc1C[NH3+],6.19,,
Cc1c(N)nc(C(CC(N)=O)[NH2+]CC([NH3+])C(N)=O)nc1C(=O)NC(C(=O)NC(C)C(O)C(C)C(=O)NC(C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)C(C)O)C(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)c1cnc[nH]1,6.2,,
NC(=[NH2+])c1ccc2cc(C(=O)Nc3ccccc3)ccc2c1,6.2,,
COc1ccc2ccc(C(N)=[NH2+])cc2c1C1C[NH2+]N(S(C)(=O)=O)C1,6.2,,
CC(C)c1c(OC2CCCCC2)c2cc(Cl)ccc2[nH]c1=O,6.2,,CHEMBL190170
O=C(Nc1ccc2[nH]cc(CCc3ccncc3)c2c1)c1cc(F)cc(N2CCOCC2)c1,6.2,,CHEMBL365776
Cn1c(=O)c2c(nc(N3CC[NH2+]CC3)n2Cc2ccccc2)n(C)c1=O,6.2,,
CCCCn1c(=O)n(Cc2ccccc2F)c(=O)c2nc(Cc3ccc(NS(=O)(=O)c4cn(C)cn4)cc3)[nH]c21,6.2,,
Oc1ccccc1S,6.2,,
OCC1OC2(CC(c3ccc4ccccc4c3)=NO2)C(O)C(O)C1O,6.2,,
CCc1nn(CCO)c(CC)c1Oc1cc(C#N)cc(C#N)c1,6.2,"This molecule has been used in trials studying the treatment of HIV-1. This molecule is an aromatic ether. This molecule is a next-generation, pyrazole non-nucleoside reverse transcriptase inhibitor. This molecule retains activity against HIV viruses with mutations at position Y181, which confers resistance to efavirenz, etravirine, and nevirapine.",CHEMBL571987
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(COc3cccnc3)[nH]n2)cc1,6.2,,
Cc1ccc2c(c1)C(=O)CC1(CCN(C(=O)c3cccc4cn[nH]c34)CC1)O2,6.2,,CHEMBL1090121
CSCCC(NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C(Cc1ccccc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(N)=O,6.2,,
Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl,6.2,"This molecule is an aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items such as plastic chopping boards, sports equipment and shoes. It has a role as an antibacterial agent, a fungicide, an EC 1.5.1.3 (dihydrofolate reductase) inhibitor, an antimalarial, an EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor, a xenobiotic, a persistent organic pollutant and a drug allergen. It is a member of phenols, an aromatic ether, a dichlorobenzene and a member of monochlorobenzenes. This molecule is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items such as plastic chopping boards, sports equipment and shoes. This molecule is a polychloro phenoxy phenol with antibacterial and antifungal activity. This molecule is added to toothpastes to prevent gingivitis and has been added to many household products for its topical antibiotic activity. This molecule is an antibacterial and antifungal agent. It is a polychloro phenoxy phenol. Though many consumer products contain triclosan, according to the Food and Drug Administration (FDA) at the present time there is no evidence that triclosan in personal care products provides an extra benefit to health beyond its anti-gingivitis effect in toothpaste. The FDA does not recommend changing consumer use of triclosan containing products one way or the other due to currently insufficient safety evidence. Studies by the Environmental Protection Agency (EPA) found triclosan to be an effective antibacterial. This molecule safety is currently under review by the FDA and Health Canada.",CHEMBL849
OCC1C[NH2+]CC(OC2OC(CO)C(O)C(O)C2O)C1O,6.2,,
COc1ccc(C2(c3cccc(-c4cncnc4)c3)NC(=[NH2+])c3nc(C)sc32)cc1,6.2,,
COc1nc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n(-c3ccccc3OC(F)(F)F)c12,6.2,,
Cc1nc2ccc(Br)cc2c(-c2ccc(Cl)cc2)c1C(OC(C)(C)C)C(=O)[O-],6.2,,
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCC(N)=O)NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCC(=O)[O-])NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(C)C)NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(=O)[O-],6.2,,
COc1ccc(C(=O)Nc2ccc(Oc3ccc(N(C(=O)C4CCC(C)CC4)C(C)C)c(C(=O)[O-])c3)cc2)cc1,6.2,,
C=C(c1ccc(C(=O)[O-])cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,6.2,,
NC(=[NH2+])c1ccc(CC(O)C(=O)[O-])cc1,6.21,,
[NH3+]CCCCC([NH3+])C(=O)NC(CC1CCCCC1)C(=O)NC(CCCC[NH3+])C(=O)[O-],6.21,,
O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl,6.21,,
N=C1NC(=O)C(=Cc2ccc(-c3ccc(S(N)(=O)=O)c(C(F)(F)F)c3)o2)S1,6.21,,
Nc1cc(C(=O)NC2c3ccccc3-c3c(-c4nc5ccncc5[nH]4)cccc32)ccn1,6.21,,
O=C1NC(=O)c2ccc(Br)cc2C1=CNc1ccc(C[NH+]2CCCC2)cc1,6.21,,
CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1OC(CO)CC(O)C1O)C(O)CCCCCCCCCCCCCCC,6.21,,
CCCCC(C[NH2+]C(CCCC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)CC,6.21,,
CNC(=O)C(NC(=O)c1ccc(-c2ccc(NC(=O)c3cc4ccccc4o3)cc2)o1)C1CCCCC1,6.21,,
COc1cc(O)c2c(c1C(=O)NCc1cccc3ccccc13)OC1=CC(O)=C(C(C)=O)C(=O)C12C,6.21,,
C[NH2+]CCCCC(NC(=O)C(CO)NC(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(C)=O)C(=O)NC(CC(=O)[O-])C(=O)NC(CCC[NH3+])C(=O)NC(C)C(=O)[O-],6.21,,
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,6.21,"This molecule is an odorless white powder. Bitter taste. (NTP, 1992) This molecule is an aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge. It has a role as an EC 1.5.1.3 (dihydrofolate reductase) inhibitor, a xenobiotic, an environmental contaminant, a drug allergen, an antibacterial drug and a diuretic. It is a member of methoxybenzenes and an aminopyrimidine. This molecule is an antifolate antibacterial agent that inhibits bacterial dihydrofolate reductase (DHFR), a critical enzyme that catalyzes the formation of tetrahydrofolic acid (THF) - in doing so, it prevents the synthesis of bacterial DNA and ultimately continued bacterial survival. This molecule is often used in combination with [sulfamethoxazole] due to their complementary and synergistic mechanisms but may be used as a monotherapy in the treatment and/or prophylaxis of urinary tract infections. It is structurally and chemically related to [pyrimethamine], another antifolate antimicrobial used in the treatment of plasmodial infections. This molecule is a Dihydrofolate Reductase Inhibitor Antibacterial. The mechanism of action of trimethoprim is as a Dihydrofolate Reductase Inhibitor, and Cytochrome P450 2C8 Inhibitor, and Organic Cation Transporter 2 Inhibitor. This molecule is a synthetic derivative of trimethoxybenzyl-pyrimidine with antibacterial and antiprotozoal properties.  As a pyrimidine inhibitor of bacterial dihydrofolate reductase, trimethoprim binds tightly to the bacterial enzyme, blocking the production of tetrahydrofolic acid from dihydrofolic acid.  The antibacterial activity of this agent is potentiated by sulfonamides. (NCI04)",CHEMBL22
COC(C(=O)NCC(N)=O)C(O)C(O)C(O)C=CC(C)(C)C,6.21,,
CC(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)[O-],6.21,,
OCC1C[NH2+]CC(O)C1OC1OC(CO)C(O)C(O)C1O,6.21,,
CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OC1CC1CCCCCc1nc3ccc(OC)cc3nc1O2)C(=O)NS(=O)(=O)C1C=C1,6.21,,
c1ccc2c3c([nH]c2c1)-c1[nH]ncc1CCC3,6.21,,
Cc1cc(C(=O)NS(=O)(=O)c2ccc(NC(CC[NH+](C)C)CSc3ccccc3)c([N+](=O)[O-])c2)ccc1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)[O-])nn12,6.21,,
C[N+](C)(CCF)CCCC(=O)[O-],6.21,,
C[N+](C)=c1ccn(Cc2ccc(-c3ccccc3)cc2)cc1,6.21,,
O=C1c2c(nnn2Cc2ccc3ncccc3c2)CCN1c1ccccc1,6.21,,CHEMBL2029688
Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Oc2ccncc2)cc1,6.21,,CHEMBL472620
O=c1cc(-c2cccc(O)c2)oc2cc(O)ccc12,6.21,,CHEMBL253786
CCC(C)C([NH3+])C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NCC(=O)NC(C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(CCC(N)=O)C(=O)[O-])C(C)O)C(C)CC)C(C)O,6.21,,
CCCc1cscc1CC(NC1=NC(C)(C)Cc2cc(Cl)ccc21)C(=O)[O-],6.21,,
CCC(CO)N1C(=O)C(CC(=O)[O-])OC(c2cccc(Cl)c2)C1c1ccc(Cl)cc1,6.21,,
CC(C)CC(NC(=O)C([NH3+])CO)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(C[NH2+]C(Cc1ccc(O)cc1)C(=O)NC(C(=O)N1CCCC1C(=O)[O-])C(C)O)Cc1ccccc1,6.21,,
COc1ccc2c(c1)N(C(=O)OC(C)C)C(CSC)C(=S)N2,6.22,,
CC(C=CC1C(C)CCCC1(C)C)=CCCC(C)CCO,6.22,,
O=C([O-])C1CC2(C(=O)[O-])C=CC(O)C(C2)O1,6.22,,
NC(=[NH2+])c1ccc2[nH]c(-c3ccccc3O)cc2c1,6.22,,
CCC(C)C(NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(CCC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)C,6.22,,
CCC(C)C(NC(C)=O)C(=O)NC(C)C(=O)NC(CO)Cc1ccccc1,6.22,,
O=C([O-])C(=O)Nc1sc2c(c1C(=O)[O-])CCOC2COC1=NS(=O)(=O)c2ccccc21,6.22,,
CC(C)CC(NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CO)C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(C(=O)O)C(C)O)C(C)O,6.22,,
CC(C)(C)Nc1nc(C(F)(F)F)nc2ccc(-c3cccc(N)c3)cc12,6.22,,CHEMBL278894
Cc1nc(-c2ccccn2)nc(NCCc2ccccc2)c1Cl,6.22,,CHEMBL472879
CC(C)COC(=O)NC(CCC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CC(F)F)C(=O)NCCc1ccc(C(=O)[O-])cc1Cl,6.22,,
OCc1cnn2c(NCc3cccnc3)cc(-c3ccccc3)nc12,6.22,,CHEMBL400520
CCCOc1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]C(C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1,6.22,,
O=C([O-])C1(O)CC(O)C(O)c2sc(CCC3CC3)cc21,6.22,,
CC(NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],6.22,,
O=S(=O)(Nc1ccc(O)c(-c2c(O)ccc3ccccc23)c1)c1cccs1,6.22,,CHEMBL200628
NC(=[NH2+])NC(=O)Cn1c(-c2ccccc2)ccc1-c1ccc(NC(=O)c2cccc(Br)c2)cc1,6.22,,
Cc1ccc(S(=O)(=O)N[S+](C)c2ccc(OCc3ccccc3)cc2)cc1,6.22,,
CCC(C)C(NC(=O)C(NC(=O)C(CCSC)NC(=O)C1CCCN1C(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)C[NH3+])C(C)C)C(C)C)C(=O)NC(C)C(=O)[O-],6.22,,
Cc1nc2c(N)ncnc2n1C1OC(C[NH+](C)C)C(O)C1O,6.22,,
Fc1ccc(-c2[nH]ncc2-c2ccncc2)cc1,6.22,,
CC([NH3+])C(=O)[O-],6.22,,
CC([NH3+])C(=O)[O-],6.22,,
CN1C(=[NH2+])NC(CCC2CCCCC2)(CC2CCCCC2)C1=O,6.22,,
O=S(=O)([O-])OC(C(O)C[S+]1CC(O)C(O)C1CO)C(O)C(O)C(O)CO,6.22,,
Nc1nc(Nc2ccc(Cl)cc2)sc1C(=O)c1cccc([N+](=O)[O-])c1,6.22,,CHEMBL1614763
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,6.22,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,6.22,,
O=C([O-])C1Cc2c(o[nH]c2=O)C[NH2+]1,6.22,,
[NH3+]CC[NH+]1CCCC(NC(=O)N2CCC(NS(=O)(=O)[O-])C2CO)CC1,6.22,,
O=C([O-])C(=O)C=C(O)c1ccccc1Br,6.22,,
CC(Oc1cc(-c2cnn(C3CC[NH2+]CC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,6.22,,
COc1cccc(COC(=O)c2oc3cccc(OC4CC[NH2+]CC4)c3c2C)c1,6.22,,
Oc1cc(O)cc(Oc2ccc(Cl)c(Cl)c2)c1,6.22,,CHEMBL2443027
COC(=O)C(Cc1c[nH]cn1)NC(=O)C[NH+](CCCc1ccccc1)CC(=O)[O-],6.22,,
COc1ccc2nc(-c3ccccc3F)sc2c1,6.22,,CHEMBL508666
Cc1cccc2c3c(ccc12)C1=C(C(=O)C3=O)C(C)CO1,6.22,"This molecule is a natural product found in Salvia miltiorrhiza, Salvia digitaloides, and Salvia yunnanensis with data available.",CHEMBL1358724
CC(C)(C)NC(=O)C1(c2c(C(=O)[O-])[nH]c3cc(Cl)ccc23)N2C(=O)C21c1ccc(OCc2ccc(Cl)cc2)cc1,6.22,,
CNC(=O)Nc1cc(Br)cc(NC(=O)NS(=O)(=O)c2cc(C)c(CCOC)s2)n1,6.22,,CHEMBL1778447
COC1OC(CO)C(O)C(OC2CC(OC3OC(C)C(O)C(O)C3O)C(O)C(C)O2)C1NC(C)=O,6.23,,
Oc1ccc(-c2cnc3ccc4ccncc4c3c2)cc1,6.23,"This molecule is a member of the class of phenanthrolines that is 2,7-phenanthroline substituted at position 9 by a 4-hydroxyphenyl group. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of phenanthrolines and a member of phenols.",CHEMBL248643
CCCOc1ccc(-c2csc(-c3ccccc3Cl)c2CC(=O)NC(N)=[NH2+])cc1,6.23,,
CCCCNC(=O)C(C)CC(O)C1CC(C)CCCCCCCC(=O)NC(C)C(=O)N1,6.23,,
O=C([O-])c1cccc2c3ccccc3n(Cc3ccccc3)c12,6.23,,
CCc1cc2c(cc1OS(N)(=O)=O)CCC1C2CCC2(C)C(=O)CCC12,6.23,,
CCc1nn(-c2ccccc2)c2cc(N3CC4C[NH2+]CC4C3)ccc12,6.23,,
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,6.23,"This molecule is an odorless white powder. Bitter taste. (NTP, 1992) This molecule is an aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge. It has a role as an EC 1.5.1.3 (dihydrofolate reductase) inhibitor, a xenobiotic, an environmental contaminant, a drug allergen, an antibacterial drug and a diuretic. It is a member of methoxybenzenes and an aminopyrimidine. This molecule is an antifolate antibacterial agent that inhibits bacterial dihydrofolate reductase (DHFR), a critical enzyme that catalyzes the formation of tetrahydrofolic acid (THF) - in doing so, it prevents the synthesis of bacterial DNA and ultimately continued bacterial survival. This molecule is often used in combination with [sulfamethoxazole] due to their complementary and synergistic mechanisms but may be used as a monotherapy in the treatment and/or prophylaxis of urinary tract infections. It is structurally and chemically related to [pyrimethamine], another antifolate antimicrobial used in the treatment of plasmodial infections. This molecule is a Dihydrofolate Reductase Inhibitor Antibacterial. The mechanism of action of trimethoprim is as a Dihydrofolate Reductase Inhibitor, and Cytochrome P450 2C8 Inhibitor, and Organic Cation Transporter 2 Inhibitor. This molecule is a synthetic derivative of trimethoxybenzyl-pyrimidine with antibacterial and antiprotozoal properties.  As a pyrimidine inhibitor of bacterial dihydrofolate reductase, trimethoprim binds tightly to the bacterial enzyme, blocking the production of tetrahydrofolic acid from dihydrofolic acid.  The antibacterial activity of this agent is potentiated by sulfonamides. (NCI04)",CHEMBL22
Cc1nc(-c2ccccn2)nc(N2CC[NH+](CCO)CC2)c1Cl,6.23,,
O=c1cc(-c2ccccc2)oc2ccc(Cl)cc12,6.23,,CHEMBL293478
CC(=O)NC(CC(C)C)C(=O)NC(C(=O)N1CC(O)CC1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C,6.23,,
NS(=O)(=O)c1ccc2c(c1)C[NH2+]CC2,6.24,,
O=C([O-])CCCn1c2ccccc2c2ccccc21,6.24,,
COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,6.24,This molecule is a member of the lclass of pyrrolidin-2-ones that is pyrrolidin-2-one bearing a 3-(cyclopentyloxy)-4-methoxyphenyl substituent at the 4-position. It is a type IV-specific phosphodiesterase (PDE4) inhibitor. It has a role as an antidepressant and an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor. A phosphodiesterase inhibitor with antidepressant properties.,CHEMBL63
O=C(Cc1cccs1)NC(B(O)O)c1cccc(C(=O)[O-])c1,6.24,,
CC1=CCC2(CO)COC(c3ccc(O)cc3)C1C2C,6.24,,
COc1cc(-c2cccc(N)c2)c2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc2c1,6.24,,CHEMBL205792
Nc1n[nH]c(N)c1N=Nc1ccc(F)cc1,6.24,This molecule is a member of phenylhydrazines.,CHEMBL1444178
O=C([O-])c1ccc(-c2cc3cccnc3c(-c3cccc([N+](=O)[O-])c3)n2)cc1,6.24,,
Clc1ccc2c(c1Nc1ccnc(Nc3cccc(N4CCOCC4)c3)n1)OCO2,6.24,,CHEMBL255874
Cn1cc(-c2cc3cccnc3[nH]2)c2cc(C(=O)NC(C)(C)CO)ccc21,6.24,,CHEMBL1229525
Fc1ccc(CSc2ncn[nH]2)cc1,6.24,,
O=C(Cn1cc(CNS(=O)(=O)c2ccc(I)cc2)nn1)N1CCC(c2nc(-c3cccs3)no2)CC1,6.24,,CHEMBL1234901
Oc1cccc2cccnc12,6.24,"This molecule appears as white to off-white or faintly yellow crystalline powder. Phenolic odor. (NTP, 1992) This molecule is a monohydroxyquinoline that is quinoline substituted by a hydroxy group at position 8. Its fungicidal properties are used for the control of grey mould on vines and tomatoes. It has a role as an antibacterial agent, an iron chelator, an antiseptic drug and an antifungal agrochemical. It derives from a hydride of a quinoline. This molecule is a heterocyclic phenol and derivative of quinoline with antiseptic, disinfectant, and pesticide properties. It is used as a stabilizer for hydrogen peroxide, where it is sometimes added in cosmetic products. This molecule is a natural product found in Cortinarius subtortus and Allium stipitatum with data available.",CHEMBL310555
CCN1CCN(c2nc(O)c(Cc3ccc(Cl)c(Cl)c3)s2)CC1,6.24,,
CNC(=O)NC(=[NH2+])NCCCC(NC(=O)CN=[N+2]#N)C(=O)N(Cc1ccccc1)Cc1ccccc1,6.24,,
N#CC(=Cc1ccc(O)c(O)c1)C([NH3+])O,6.24,,
O=C(CC=C1C=C(C(=O)c2ccc(F)cc2)C=N1)CC(O)C(=O)[O-],6.24,,
CC(=O)NC(CC1CCCCC1)C(O)CC(C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)C(C)C,6.25,,
CNS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccccc32)cc1,6.25,,
CCCn1nc(N)c2cc(-c3c(-c4ccccc4)[nH]c4ccccc34)nnc21,6.25,,
NS(=O)(=O)c1ccc(Nc2cn3cc(C(=O)c4c(Cl)cccc4Cl)ccc3n2)cc1,6.25,,CHEMBL182260
CC1=CC(C)C2(CO)COC(c3ccc(O)cc3)C1C2C,6.25,,CHEMBL1451012
NS(=O)(=O)NO,6.25,,CHEMBL195540
COc1ccccc1-c1ccc(C(=O)[O-])o1,6.25,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)CCC2CCCC2)cc1,6.25,,
N#Cc1ccc(C(=O)NC2CC2c2ccccc2)cc1,6.25,,
C[NH2+]CC(CC1CCCOC1)NC(=O)N1CCCC(C(OCCNC(=O)OC)c2cccc(Cl)c2)C1,6.25,,
NS(=O)(=O)c1cc(C(=O)[O-])c(NCc2ccco2)cc1Cl,6.25,,
CCCCCCOc1cccc(CCCNC(=O)CC(O)C(=O)[O-])c1,6.25,,
CC1CCc2nc3ccccc3c(C(=O)OC(C)C(=O)Nc3ccc(S(N)(=O)=O)cc3)c2C1,6.25,,
CNc1nc(C)c(-c2nc(Nc3cccc(N4CCC[NH2+]CC4)c3)ncc2C#N)s1,6.25,,
NC(=O)c1cccc2nc(-c3ccc(O)cc3)[nH]c12,6.25,,
CCC(C)C1NC(=O)C(CCCC[NH3+])NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C[NH3+])CSSCC(C(=O)NCC(=O)[O-])NC(=O)CNC(=O)C(Cc2c[nH]cn2)NC1=O,6.25,,
CC(C)CC(NC(=O)C(C)NC(=O)OCc1ccccc1)C(=O)NC(CCC(=O)N(C)C)C(=O)[O-],6.25,,
CCCS(=O)(=O)NCc1nc(-c2ccc(C(=O)NCCC(F)(F)F)cc2)cs1,6.25,,CHEMBL3286508
[NH3+]Cc1ccc(CNC(=O)c2csc3nc[nH]c(=O)c23)cc1,6.25,,
COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,6.26,This molecule is a member of the lclass of pyrrolidin-2-ones that is pyrrolidin-2-one bearing a 3-(cyclopentyloxy)-4-methoxyphenyl substituent at the 4-position. It is a type IV-specific phosphodiesterase (PDE4) inhibitor. It has a role as an antidepressant and an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor. A phosphodiesterase inhibitor with antidepressant properties.,CHEMBL63
CC(O)[NH2+]C1C(O)C=C(C(=O)[O-])OC1C(O)C(O)CO,6.26,,
CSCCC([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C,6.26,,
O=C(NCc1ccccc1)c1cc(-c2[nH]ncc2-c2cccc(Cl)c2)c[nH]1,6.26,,
CCC(C)C([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(C=O)CC(=O)[O-],6.26,,
O=C([O-])c1cccc2c(-c3ccccc3)c(-c3ccccc3)[nH]c12,6.26,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(=O)[O-])C(=O)[O-],6.26,,
O=C1NC(=O)C(c2cn3c4c(cccc24)CC=C3)C1c1c[nH]c2ccccc12,6.26,,
CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3cn(cc13)C(=O)O2)C(=O)NS(=O)(=O)C1CC1,6.26,,
NS(=O)(=O)c1cc(-c2nc3ccccc3s2)cs1,6.26,,CHEMBL2069711
CNC(=O)COc1ccc(-c2ccc(C#N)cc2)c(C[NH+]2CCN(c3ccccn3)CC2)c1,6.26,,
O=C1NC(=Nc2ccccc2Cl)SC1=Cc1ccc(O)c([N+](=O)[O-])c1,6.26,,
CCC(=O)Nc1ccc(OC)c(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)c1,6.26,,
Cc1nc(-c2ccc(S(=O)(=O)NCCC(F)(F)F)cc2)cs1,6.26,,CHEMBL3286505
CCCCC(C)(NC(=O)CNC(=O)C([NH3+])CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(C)(CCCC)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CO)C(=O)[O-],6.26,,
O=C([O-])c1cc(-c2ccc(CNC(=S)c3ccc(-c4ccc(C(=O)[O-])o4)cc3)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,6.26,,
OCC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1O,6.26,,
Cc1noc(C)c1-c1ccc(-c2[nH]c3cncc[n+]3c2NC(C)(C)C)cc1,6.26,,
CC(C)CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(CO)NC(=O)C([NH3+])CO)C(C)C)C(C)C)C(C)C)C(=O)[O-],6.27,,
CC([NH3+])C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(BO)Cc1ccccc1,6.27,,
O=C([O-])c1cc(O)c2c(Cl)cc(Cl)cc2n1,6.27,,
CC(C(=O)N1CCOCC1)N1CCC(NS(=O)(=O)c2nnc(-c3ccc(Cl)s3)[nH]2)C1=O,6.27,,
CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(C(=O)[O-])C(C)O)C(C)O,6.27,,
CC([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NCC(=O)NC(C)C(=O)[O-])C(C)C)C(C)C,6.27,,
Nc1ncnc2sc(-c3c(-c4ccccc4)ncn3CC3CCCCC3)nc12,6.27,,CHEMBL1079589
[NH3+]C(Cc1ns[nH]c1=O)C(=O)[O-],6.27,,
COC(C(=O)NCCOc1c(C)cc(C)cc1C)C(O)C(O)C(O)C=CC(C)(C)C,6.27,,
CCCCCCCCCCCC(=O)NCC(=O)NC(C)C(=O)NCC(=O)NC(C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)[O-],6.27,,
OCC1C[NH2+]CC(O)C1OC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O,6.27,,
O=C([O-])c1ccc(-c2cccc3c(CCCOc4cccc5ccccc45)c(C(=O)[O-])nn23)cc1,6.27,,
CCC(C)C(NC(C)=O)C(=O)NC(CC(=O)NC(C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(=O)[O-])CC(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])CC(=O)NC(C(=O)NCC(=O)NC(CC(=O)[O-])C(=O)NC(CCC(=O)[O-])CC(=O)NC(Cc1ccccc1)C(=O)NC(CC(N)=O)C(=O)NC(C)CC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(N)=O)C(C)CC)C(C)CC)Cc1c[nH]c2ccccc12,6.27,,
CC([NH3+])C(=O)NC(C(=O)NCC(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(CCC(=O)[O-])C(=O)NCC(=O)NC(Cc1ccc(O)cc1)C(=O)[O-])C(C)O,6.27,,
CN(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(C[NH+]3CCC(C(C)(C)O)CC3)n(C)c2n1,6.27,,
O=C([O-])c1cc(-c2ccc(Cn3ccc4cc(-c5ccc(C(=O)[O-])o5)ccc4c3=S)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,6.27,,
COc1ccc(CC(NC(=O)C(CS)CC(C)C)C(=O)[O-])cc1,6.28,,
CC12CCC3c4ccc(O)cc4CCC3C1CCC2O,6.28,This molecule is a steroid. It has a role as an estrogen. This molecule is a natural product found in Punica granatum with data available.,CHEMBL412
CC(C)CC(NC(=O)C([NH3+])CO)C(=O)NC(CCC(=O)[O-])C(=O)NC(C=O)C(C)C.CC(NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)O.CC(O[P+](O)(O)O)C([NH3+])CO,6.28,,
OCC1OC(OC2C(O)C(CO)OC(OC3C(O)C(CO)OC(OC4C(O)C(CO)OC(OC5C(O)C(CO)OC(OC6C(O)C(O)OC(CO)C6O)C5O)C4O)C3O)C2O)C(O)C(O)C1O,6.28,,
O=C1Nc2ccc(Cl)cc2C(C#CC2CC2)(C(F)(F)F)O1,6.28,,CHEMBL59507
[NH3+]C(Cn1cc(I)c(=O)[nH]c1=O)C(=O)[O-],6.28,,
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CC(N)=O)C(=O)NC(Cc1ccc(F)cc1)C(N)=O,6.28,,
OCC1OC(OC2C(CO)OC(OC3C(O)C[NH2+]OC3CO)C(O)C2O)C(O)C(O)C1O,6.28,,
CCCCC(C[NH2+]C(CCCC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)CC,6.28,,
O=S(=O)(c1cccc2cnccc12)N1CCC[NH2+]CC1,6.28,,
COC(=O)c1c(O)cc(O)c(Cl)c1CCC(=O)NC1=CC(=O)C(OC)=CC1=O,6.28,,CHEMBL3426786
CC(C)Oc1ccc(CCC2(C3CCCC3)CC(O)=CC(=O)O2)cc1F,6.28,,
Cc1cc(C(=O)Nc2cc(Cl)cc(N3CCCCC3)c2)cc(C)c1OCC[NH3+],6.28,,
O=C([O-])CC(O)CCc1ccc(-c2ccccc2)cc1,6.28,,
CCOC(=O)c1c(C(C#N)=CN)c2ccc(Cl)c(Cl)c2n1C,6.28,,CHEMBL3185999
CCCCC1C[N+]2CCc3cc(OC)c(OC)cc3C2CC1[NH3+],6.28,,
CC(COC(=O)CCCC(=O)[O-])(C(N=CCC=O)C(=O)[O-])[SH+](=O)[O-],6.28,,
CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)c(N2CCS(=O)(=O)CC2)s1,6.28,,CHEMBL1929207
CC(C)Nc1nc(N)c(C(O)c2cccnc2)s1,6.28,,
O=Cc1ccc(Oc2ccc(Cl)cc2Cl)c(O)c1,6.28,,CHEMBL240804
CN1C(=[NH2+])NC(c2ccccc2)(c2cccc(-c3cccnc3)c2)C1=O,6.28,,
CC1[NH2+]C(CC[NH2+]CC2=C3C4=C5C2[Fe+10]3452678C3=C2C6C7=C38)C(O)C1O,6.28,,
CC(C)=CCC[NH+](C)C1CC=C(C)CC1,6.29,,
CC(C)=CCC[NH+](C)C1CC=C(C)CC1,6.29,,
O=S(=O)(Nc1cc(-c2cccs2)nn1-c1ccc(F)cc1)c1cccc(F)c1,6.29,,CHEMBL378160
COc1cc2c3cc1Oc1cc(ccc1O)CC1c4c(cc(OC)c(O)c4Oc4ccc(cc4)CC3[NH+](C)CC2)CC[N+]1(C)C,6.29,,
CC([NH3+])C(=O)[O-],6.29,,
CSc1nc2ccccc2c(=O)n1-c1c(F)cccc1F,6.29,,CHEMBL1236215
NC(=[NH2+])NCCCC(NC(=O)C(CC=CCNC(=O)Cc1ccc(-c2ccccc2)cc1)NC(=O)CC1C=CC(C2CCCCC2)CC1)C(=O)NC(CC1C=CCCC1)C(=O)NCCC1CCCCC1,6.29,,
O=C(C[N+]1CCN(c2cc(-c3cc4ccccc4s3)ncn2)CC1)n1cccc1,6.29,,
CCCCCCCCCCCCCCCC(=O)[O-],6.29,,
O=C1COc2ccc(C3=Nn4cnnc4SC3c3ccccc3)cc2N1,6.29,,CHEMBL1928872
Cc1c(-c2nc3nc(N)nc(OCC4CCCCC4)c3[nH]2)cccc1S(N)(=O)=O,6.29,,
CC(CC(=O)[O-])c1nnc2nc(N)[nH]c(=O)c2c1O,6.29,,
Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC2(CCOCC2)c2ncc(N3CCOCC3)cc21,6.29,,CHEMBL2171931
CCCCCCCCOc1ccc(C(=O)CC(O)C(=O)[O-])cc1,6.29,,
CC(C=CC1(O)C(C)=CC(=O)CC1(C)C)=CC(=O)[O-],6.29,,
O=c1ncn(Cc2ccc(F)cc2F)c2ccc(Oc3ncccc3C(F)(F)F)cc12,6.29,,CHEMBL2403340
CCCCCCC(C)(NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)[NH2+]C(O)C(C)(CCCCCC)[NH2+]C(O)C[NH3+])C(=O)NC(CC(C)C)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CO)C(=O)[O-],6.29,,
COc1ncc(-c2ccc3c(Nc4cccc(C(=O)[O-])c4)c(C(N)=O)cnc3c2)c(OC)n1,6.29,,
C#CCC(NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(NC(=O)CNC(=O)C(NC(=O)CNC(=O)C(C)NC(=O)C(CCC)NC(=O)C(C)([NH3+])c1ccccc1)C(C)CC)C(C)CC)C(C)O)C(=O)[O-],6.29,,
CC(C)CC(NC(=O)C(O)Cc1ccc(O)cc1)C(=O)N1C(C(=O)NC(CO)CCCNC(N)=[NH2+])CC2CCC(O)CC21,6.3,,
NC(=[NH2+])c1ccc(CC2CCCCC(Cc3ccc(C(N)=[NH2+])cc3)C2=O)cc1,6.3,,
NC(=[NH2+])c1ccc2[nH]c(C(=O)N3CCC(Cc4ccccc4)CC3)cc2c1,6.3,,
CC(c1cccc(O)c1)[NH+](C)C,6.3,,
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C1CCC[NH2+]1)C(C)C)C(=O)NC(C=O)CCC(=O)[O-],6.3,,
[NH2+]=C(N=O)NCCC([NH3+])C(=O)[O-],6.3,,
[NH3+]C(Cc1c[nH]cn1)C(=O)[O-],6.3,,
[NH3+]C(Cc1o[nH]c(=O)c1Br)C(=O)[O-],6.3,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(C)[NH3+])C(C)C)C(=O)[O-],6.3,,
Cc1cc(N)c2cc(NC(=O)Nc3ccc4nc(C)cc(N)c4c3)ccc2n1,6.3,,CHEMBL87223
CCCN(CCC)C(=O)c1cccc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]Cc2cccc(OC)c2)c1,6.3,,
NC(=O)CCC([NH3+])C(=O)[O-],6.3,,
CC(C)(C)c1nnc(C(=O)C2CCC[NH2+]2)o1,6.3,,
CCC(C)C(NC(=O)C(NC(=O)C1CCCN1C(=O)C(Cc1c[nH]cn1)NC(=O)C([NH3+])CO)C(C)O)C(=O)NC(CC(C)C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)[O-])C(C)O,6.3,,
CC(C)C(NC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(O)c1nccs1,6.3,,
COc1ccc2ccccc2c1CN=NC(=O)c1ccc(O)c(O)c1,6.3,,
CSCCC1NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc2c[nH]cn2)NC(=O)C(CC(N)=O)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CO)NC(=O)C([NH3+])CSSCC(C(=O)[O-])NC1=O,6.3,,
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(CO)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)[O-],6.3,,
OCC1OC(OC2C(O)C(O)c3nccn3C2CO)C(O)C(O)C1O,6.3,,
CC1=NC(C(=O)[O-])C(O)CN1,6.3,,
Clc1cccc(-c2cc(NCc3ccncc3)n3nccc3n2)c1Cl,6.3,,CHEMBL403350
c1nc2nc(Nc3ccc(N4CCOCC4)cc3)nc(NC3CCCCC3)c2[nH]1,6.3,,
CCCCCCCCNC(=S)N1C2COC1C(O)C(O)C2O,6.3,,
OC1CN(C2=Nc3ccccc3C(c3ccccc3)=NC2c2cccs2)C1,6.3,,CHEMBL519285
C[N+]1(C)C2CCC1CC(OC1c3ccccc3CCc3ccccc31)C2,6.3,,CHEMBL490843
O=C([O-])c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,6.3,,
C=C1CC23CC1CCC2C12CCC(O)C(C)(C(=O)O1)C2C3C(=O)[O-],6.3,,
O=C(Cc1cccs1)N1CCC(c2nc(-c3cccs3)no2)CC1,6.3,,CHEMBL1235660
NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,6.3,This molecule is a member of pyrimidines.,CHEMBL483847
CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,6.3,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)[O-])C(C)O,6.3,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)[O-])C(C)O,6.3,,
CNC(NC)=[NH+]CCCC(NC(=O)C(C)[NH3+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(C)C(=O)[O-])C(C)O,6.3,,
CC1C(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C(=O)N1Cc1ccnc2ccccc12,6.3,,
COc1ccc(S(=O)(=O)NC(=O)c2sccc2SCc2ccc(Cl)c(Cl)c2)cc1C(=O)[O-],6.3,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)[O-])C(C)O)C(C)O,6.3,,
O=C1COc2c(CC[NH2+]CCN(C(=O)CC[NH2+]CCc3ccc(Cl)c(Cl)c3)C3CCCCC3)ccc(O)c2N1,6.3,,
O=C([O-])C(=O)NC(CSCc1ccc2ccccc2c1)C(=O)[O-],6.3,,
C[NH+](CC1OC(n2ccc(=O)[nH]c2=O)CC1O)C(c1ccccc1)c1ccccc1,6.3,,
Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,6.3,This molecule is a substituted aniline.,CHEMBL1076555
Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1,6.3,,CHEMBL2181721
COc1cc(OC)c(S(=O)(=O)NCc2ccccc2N2CCC(COC(=O)CCC(=O)[O-])CC2)cc1NC(=O)CCC(=O)[O-],6.3,,
COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n(C(C)c3ccccn3)c12,6.3,,
COc1nc2c(Nc3ccccc3C(C)(C)C)c(C(=O)[O-])cnc2cc1-c1c(C)noc1C,6.3,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(OC3(C(=O)[O-])CC(O)C(NC(C)=O)C(C(O)C(O)CO)O3)C2O)C1O,6.3,,
COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1O,6.3,,CHEMBL3343033
NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,6.3,,CHEMBL319467
Cc1cc(Nc2nc(NCCc3cccnc3)ncc2Br)[nH]n1,6.3,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(=O)[O-])C(=O)[O-],6.3,,
CN1c2ccc(-c3ccc(C(=O)N4CCC(CCO)CC4)cc3)cc2-c2[nH]ncc2S1(=O)=O,6.3,,CHEMBL2333434
Oc1cc2ccc(-c3ccc(F)cc3)cc2nc1O,6.3,,
C=CC(=O)N1CCC(Nc2nc(C[NH+]3CCOCC3)cc(Nc3nc4cccnc4s3)n2)C1,6.3,,
Cc1ccc(-c2ccc(C(=O)[O-])c(NS(=O)(=O)c3ccc(Oc4ccccc4)cc3)c2)c2ccccc12,6.3,,
NC(=[NH2+])NCCCC(C(=O)[O-])[NH+]1C(O)CCC1C(=O)[O-],6.3,,
C=C1CCC(OC2CC(O)(C(C)NC(=O)c3[nH]c(C)c(Cl)c3Cl)C(O)C(C)O2)C2C=CC(C)C(C(O)=C3C(=O)C(C(C)C)N(C4OC(C)C(OC(N)=O)C(OC(C)=O)C4OC)C3=O)C12,6.3,,
CC(=O)N1c2ccc(-c3ccc(C[NH+]4CCCCC4)cc3)cc2C(Nc2ccccc2)CC1C,6.3,,
Nc1c(C(=O)c2cccc(OC3CC[NH2+]CC3)c2)cnn1-c1ccc(F)cc1,6.31,,
O=CCOc1ccccc1-c1ccc(F)c(F)c1F,6.31,,CHEMBL387619
[NH3+]CCCCC([NH3+])C(=O)[O-],6.31,,
CC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(N)=O)NC(=O)C([NH3+])CC(N)=O)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)N1CCCC1C(=O)[O-])C(C)O,6.31,,
CSCCC1NC(=O)C(Cc2ccccc2)NC(=O)C2CCCN2C(=O)C(CC(=O)[O-])NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C2CCCN2C(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)CNC(=O)C([NH3+])CO)CSSCC(C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc2cnc[nH]2)C(=O)[O-])NC1=O,6.31,,
CC(C)CC(NC(=O)C(O)C([NH3+])Cc1ccc(OCc2ccccc2)cc1)C(=O)[O-],6.31,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.31,,
CCCCCCCCCCCCCCCC(=O)[O-],6.31,,
COC(=O)NC(CC(C)C)C(=O)NC(CO)CC1CCNC1=O,6.31,,
C[N+]1(CCCC(=O)[O-])CCCC1,6.31,,
CCC(CC)OC1C=C(C(=O)[O-])CC([NH3+])C1NC(C)=O,6.31,,
OCC1[NH2+]CC(O)C(O)C1O,6.31,,
O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,6.31,"This molecule is a trihydroxyflavone that is flavone substituted by hydroxy groups at positions 4', 5 and 7. It induces autophagy in leukaemia cells. It has a role as a metabolite and an antineoplastic agent. It is a conjugate acid of an apigenin-7-olate. This molecule is a natural product found in Camellia sinensis, Apis, and other organisms with data available. This molecule is a plant-derived flavonoid that has significant promise as a skin cancer chemopreventive agent. This molecule inhibits the expression of involucrin (hINV), a marker of keratinocyte differentiation, is increased by differentiating agents via a protein kinase Cdelta (PKCdelta), Ras, MEKK1, MEK3 cascade that increases AP1 factor level and AP1 factor binding to DNA elements in the hINV promoter. This molecule suppresses the 12-O-tetradeconylphorbol-13-acetate-dependent increase in AP1 factor expression and binding to the hINV promoter and the increase in hINV promoter activity. This molecule also inhibits the increase in promoter activity observed following overexpression of PKCdelta, constitutively active Ras, or MEKK1. The suppression of PKCdelta activity is associated with reduced phosphorylation of PKCdelta-Y311. Activation of hINV promoter activity by the green tea polyphenol, (-)-epigellocathecin-3-gallate, is also inhibited by apigenin, suggesting that the two chemopreventive agents can produce opposing actions in keratinocytes. (A7924). This molecule, a flavone abundantly found in fruits and vegetables, exhibits antiproliferative, anti-inflammatory, and antimetastatic activities through poorly defined mechanisms. This flavonoid provides selective activity to promote caspase-dependent-apoptosis of leukemia cells and uncover an essential role of PKCdelta during the induction of apoptosis by apigenin. (A7925). This molecule markedly induces the expression of death receptor 5 (DR5) and synergistically acts with exogenous soluble recombinant human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in malignant tumor cells. On the other hand, apigenin-mediated induction of DR5 expression is not observed in normal human peripheral blood mononuclear cells. Moreover, apigenin does not sensitize normal human peripheral blood mononuclear cells to TRAIL-induced apoptosis. (A7926).",CHEMBL28
CCc1cc(Sc2ncc(C(=O)[O-])[nH]2)nc(C2CCCCC2C(=O)NCc2ccc(Cl)c(Cl)c2)n1,6.31,,
CC(c1cccc2ccccc12)[NH+]1CCC(C(=O)NCc2ccc(F)cc2)CC1,6.31,,
Cn1c(O)c(Cc2c(Cl)ccc(Cl)c2Cl)sc1=S,6.31,,
O=C(CCCCCCC(=O)Nc1ccccc1)NO,6.32,"This molecule is an oral histone deacetylase inhibitor and antineoplastic agent that is approved for use in refractory or relapsed cutaneous T cell lymphoma. This molecule is associated with modest rate of minor serum enzyme elevations during therapy, but has not been linked to cases of clinically apparent liver injury. This molecule is a dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL). It has a role as an EC 3.5.1.98 (histone deacetylase) inhibitor, an apoptosis inducer and an antineoplastic agent. It is a hydroxamic acid and a dicarboxylic acid diamide. It is functionally related to a suberic acid, a hydroxylamine and an aniline. This molecule is a drug currently under investigation for the treatment of cutaneous T cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines. It is the first in a new class of agents known as histone deacetylase inhibitors.  A recent study suggested that vorinostat also possesses some activity against recurrent glioblastoma multiforme, resulting in a median overall survival of 5.7 months (compared to 4 - 4.4 months in earlier studies). Further brain tumor trials are planned using combinations of vorinostat with other drugs. This molecule is a Histone Deacetylase Inhibitor. The mechanism of action of vorinostat is as a Histone Deacetylase Inhibitor. This molecule is a synthetic hydroxamic acid derivative with antineoplastic activity. This molecule, a second generation polar-planar compound, binds to the catalytic domain of the histone deacetylases (HDACs). This allows the hydroxamic moiety to chelate zinc ion located in the catalytic pockets of HDAC, thereby inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors. Hyperacetylation of histone proteins results in the upregulation of the cyclin-dependant kinase p21, followed by G1 arrest. Hyperacetylation of non-histone proteins such as tumor suppressor p53, alpha tubulin, and heat-shock protein 90 produces additional anti-proliferative effects. This agent also induces apoptosis and sensitizes tumor cells to cell death processes. This molecule crosses the blood-brain barrier. This molecule is a natural product found in Humicola fuscoatra and Campanularia with data available. This molecule is a drug that has been approved by the U.S. Food and Drug Administration (FDA) under the brand name Zolinza for the treatment of a certain type of cancer.This molecule is also being studied as an investigational drug as part of a strategy to cure HIV infection.As an investigational HIV drug, vorinostat belongs to a group of drugs called latency-reversing agents.",CHEMBL98
OCC1O[NH2+]CC(O)C1O,6.32,,
CCN(CC)C(=O)c1c(NC(=O)c2cccs2)sc2c1CC(C)CC2,6.32,,CHEMBL388313
C[NH+]1C2CCC1CC(OC(=O)c1c[nH]c3ccccc13)C2,6.32,,
Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1,6.32,,CHEMBL273158
CC(C)=CCN(CC[NH3+])S(=O)(=O)c1ccc(C(N)=O)cc1,6.32,,
CC(C)=CCN(C1C[NH2+]CC1N(CC=C(C)C)S(=O)(=O)c1ccc(C(N)=O)cc1)S(=O)(=O)c1ccc(C(N)=O)cc1,6.32,,
CC(C)CC(NC(=O)C(O)C([NH3+])Cc1ccccc1)C(=O)[O-],6.32,,
Nc1ncnc2c1c(Cc1cccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c1)nn2C1CCCC1,6.32,,
OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC8C(CO)OC(OC1C(O)C2O)C(O)C8O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O,6.32,,
O=C(c1cc2cc(F)ccc2[nH]1)N1CC2(CC[NH+](C3CCC[NH2+]C3)C2)c2ccccc21,6.32,,
CCCCCCCCCCCCCC(=O)[O-],6.32,,
COc1cccc(C(=O)NC2CC3CCC(C2)N3c2ccc(C(=O)NCc3ccccc3)cn2)c1C,6.32,,CHEMBL2204507
O=C(c1ccc(O)cc1O)c1ccc(O)cc1O,6.32,,CHEMBL3185091
CCC(c1ccccc1)c1c(O)c2c(oc1=O)CCCCC2,6.32,,CHEMBL297888
CCC(C)C(NC(=O)C([NH3+])CO)C(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)CC,6.33,,
CC(C)=CCC[NH+](C)C1CC=C(C)CC1,6.33,,
O=C([O-])COc1c(C(=O)[O-])sc(-c2cccc(NCc3ccccc3)c2)c1Br,6.33,,
C[NH2+]CC[N+]1CCC(c2ccc3[nH]c(-c4ccccc4OC)c(F)c3c2)CC1,6.33,,
Cc1[nH]c2ccccc2c1CCNC(=O)c1cccs1,6.33,,CHEMBL1234574
Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ccnc4ccc(N)cc34)cc2)c1,6.33,,CHEMBL570904
CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)C[NH2+]C1(c2cc(CC(C)(C)C)cs2)CC1,6.33,,
CC1(C)Cc2cc(Cl)ccc2C(NC(Cc2ccccc2)C2=NC(=O)C(C#N)C=N2)=N1,6.33,,
Oc1cc(F)ccc1CNc1ncccc1-c1ncccn1,6.33,,CHEMBL3613794
CC(C)C(NC(=O)C(Cc1ccccc1)CC(O)C(Cc1ccccc1)NC(=O)OC(C)(C)C)c1ncc[nH]1,6.34,,
Cc1nc2ccc(CN(C)c3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])s3)cc2c(=O)[nH]1,6.34,,
CNC(=O)NC(=[NH2+])NCCCC1NC(=O)C(C)NC(=O)CC(C(=O)[O-])NC(=O)CC(C(=O)[O-])NC(=O)C(Cc2ccccc2)N(C)C1=O,6.34,,
N#Cc1ccc(N(Cc2ccc(OS(N)(=O)=O)c(Br)c2)n2cnnc2)cc1,6.34,,CHEMBL108483
NS(=O)(=O)c1ccc(CNC(=O)c2cn[nH]c2-c2cc(Cl)c(O)cc2O)cc1,6.34,,CHEMBL200255
CC1CC(C)CN(C(=O)c2cc(Br)ccc2NC(=O)CCC(=O)N2CCOCC2)C1,6.34,,
CCCCC(C(C)=O)n1cc(C(C)([NH2+]Cc2ccc3ncccc3c2)C(C)C)nn1,6.34,,
CC(=NNc1nc2ccccc2s1)c1ccc(-c2cccc(S(=O)(=O)NC(=O)CCCCCc3ccccc3)c2)o1,6.34,,
O=C(CC12CC3CC(CC(C3)C1)C2)NO,6.34,,CHEMBL2336721
CC1[NH2+]C(CC[NH2+]CCCC2=C3C4=C5C2[Fe+10]3452678C3=C2C6C7=C38)C(O)C1O,6.34,,
O=c1[nH]c2sccc2c2ccccc12,6.34,,CHEMBL3108871
Cc1ccc(C(=O)Nc2ccc(C[NH+]3CC[NH+](C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,6.34,,
O=C([O-])CC(Cc1ccccc1)C(=O)[O-],6.35,,
NC(=[NH2+])c1ccc2nc(-c3cccc(-c4ccccc4)c3O)[nH]c2c1,6.35,,
NC(=[NH2+])c1ccc2nc(-c3cccc(-c4ccccc4)c3O)[nH]c2c1,6.35,,
CC=CCC(C)C(O)C1C(=O)NC(CCCO)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,6.35,,
CC(=O)NC(Cc1ccc(CC(=O)[O-])c(C(=O)[O-])c1)C(=O)NC1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O,6.35,,
CC(C)CC(NC(=O)C(CO)NC(=O)C([NH3+])C(C)C)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)[O-],6.35,,
CC(C)C(CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,6.35,,
O=C([O-])c1cn2c(n1)C(O)C(O)C(O)C2CO,6.35,,
COc1cccc(CN2CC(C(=O)NC(Cc3ccccc3)C(O)C[NH2+]Cc3cccc(N(C)C)c3)NC2=O)c1,6.35,,
OCC1C(O)C(O)C2C(O)C(O)C[NH+]12,6.35,,
Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O,6.35,"This molecule appears as orange needles or powder. (NTP, 1992) This molecule is a trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by hydroxy groups at positions 1, 3, and 8 and by a methyl group at position 6. It is present in the roots and barks of numerous plants (particularly rhubarb and buckthorn), moulds, and lichens. It is an active ingredient of various Chinese herbs. It has a role as a tyrosine kinase inhibitor, an antineoplastic agent, a laxative and a plant metabolite. It is functionally related to an emodin anthrone. It is a conjugate acid of an emodin(1-). This molecule has been investigated for the treatment of Polycystic Kidney. This molecule is a natural product found in Hamigera avellanea, Setophoma terrestris, and other organisms with data available. This molecule is found in dock. This molecule is present in Cascara sagrada.This molecule is a purgative resin from rhubarb, Polygonum cuspidatum, the buckthorn and Japanese Knotweed (Fallopia japonica). The term may also refer to any one of a series of principles isomeric with the emodin of rhubarb. (Wikipedia) 

This molecule has been shown to exhibit anti-inflammatory, signalling, antibiotic, muscle building and anti-angiogenic functions (A3049, A7853, A7854, A7855, A7857).",CHEMBL289277
C[NH+](C)CC(O)COc1ccc(Nc2nccc(-c3cnn4nc(N5CCOCC5)ccc34)n2)cc1,6.35,,
NC(=O)c1cccc(Cn2c3c(c4cccc(C(=O)[O-])c42)CCCCC3)c1,6.35,,
[NH3+]C(Cn1cc(Cl)c(=O)[nH]c1=O)C(=O)[O-],6.35,,
O=C1N=C(Nc2ccccc2)N=C1Cc1ccc2c(c1)OCO2,6.35,,CHEMBL1738733
Nc1ncnc2c1ncn2C1OC(COS(=O)(=O)NC(=O)C([NH3+])CO)C(O)C1O,6.35,,
COc1ccc(-c2cc(=O)c3ccc(O)cc3o2)cc1,6.35,"This molecule is a natural product found in Hedysarum polybotrys, Fordia cauliflora, and other organisms with data available.",CHEMBL16751
CC1(C)Cc2cc(Cl)ccc2C(NC(Cc2cscc2-c2cn[nH]c2)C(=O)[O-])=N1,6.35,,
COc1cccc(-c2ccc(O)c(O)n2)c1,6.35,,
NC(=[NH2+])c1cc2c(I)cccc2s1,6.36,,
CC(C)c1ccc(NC(=O)C2CCCN2C(=O)C(CCCC[NH3+])NC(=O)C(F)(F)F)cc1,6.36,,
CC(C)COc1cccc(-c2nc3cc(C(N)=[NH2+])c(F)cc3[nH]2)c1O,6.36,,
O=C1CCCC=CCCOC(=O)c2c(O)cc(O)c(Cl)c2C1,6.36,,
C[NH+]1CCN(c2ccc(C(=O)Nc3[nH]nc4c3CN(C(=O)Cc3cccs3)C4)cc2)CC1,6.36,,
O=C([O-])C1(O)CC(O)C(O)C(OCc2ccc3sccc3c2)=C1Cc1ccc2sccc2c1,6.36,,
O=C1C(=NO)c2cc(F)ccc2N1Cc1cc(F)cc2c1OCOC2,6.36,,
CCc1cc2c(cc1OS(N)(=O)=O)CCC1C2CCC2(C)C(=O)CCC12,6.36,,
CC(C)C([NH3+])C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-])C(C)C,6.36,,
CC(C)C([NH3+])C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-])C(C)C,6.36,,
Cn1c(=O)[nH]c2ncc(-c3cccc(C(N)=O)c3)cc21,6.36,,CHEMBL1956642
CCCCCCCCCCCCCCCCCC(=O)[O-],6.36,,
COc1ccc(-c2cccc(S(=O)(=O)N3CCN(c4nccnc4-c4ccc(OC)cc4)CC3)c2)cc1,6.36,,CHEMBL2152124
COc1ccc2c(c1)C1=NN(C(=O)CO)C(c3ccc(OC(F)(F)F)c(F)c3)C1CC2,6.36,,
CC1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)NC(=[NH2+])OCC1F,6.36,,
Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)cc1N,6.36,,
CC1=CCC2(C)CCC(O)(C(C)C)C2C(OC(=O)c2ccc(O)cc2)C1,6.36,,
COc1ccc(-c2ccc[nH]c2=O)cc1C(C)(C)C,6.36,,CHEMBL2324313
CSCCC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(Cc1cnc[nH]1)NC(=O)C(CCC(N)=O)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(NC(=O)C([NH3+])CCC(=O)[O-])C(C)O)C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(=O)[O-],6.36,,
O=C(c1cn(Cc2ccccc2)cn1)N1CCN(c2ccccc2Cl)CC1,6.36,,CHEMBL3288135
OC1COC(O)C(O)C1O,6.36,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL14343
CCC(C)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(C)[NH3+])C(C)C)C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(CCC(=O)[O-])C(=O)[O-],6.37,,
CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,6.37,,
COC(=O)C(NC(=O)C(NC(=O)C(C)[NH+]1CCC(C(C)NC(=O)C(C)[NH3+])=CC(Cc2ccccc2)C1)C(C)C)C(C)C,6.37,,
CCCCCCCCC=CCCCCCCCC(=O)[O-],6.37,,
CCCCOC1CCCC2C(C(C=O)CC)N=C(C(=O)[O-])C12,6.37,,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],6.37,,
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,6.37,"This molecule is an odorless white powder. Bitter taste. (NTP, 1992) This molecule is an aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge. It has a role as an EC 1.5.1.3 (dihydrofolate reductase) inhibitor, a xenobiotic, an environmental contaminant, a drug allergen, an antibacterial drug and a diuretic. It is a member of methoxybenzenes and an aminopyrimidine. This molecule is an antifolate antibacterial agent that inhibits bacterial dihydrofolate reductase (DHFR), a critical enzyme that catalyzes the formation of tetrahydrofolic acid (THF) - in doing so, it prevents the synthesis of bacterial DNA and ultimately continued bacterial survival. This molecule is often used in combination with [sulfamethoxazole] due to their complementary and synergistic mechanisms but may be used as a monotherapy in the treatment and/or prophylaxis of urinary tract infections. It is structurally and chemically related to [pyrimethamine], another antifolate antimicrobial used in the treatment of plasmodial infections. This molecule is a Dihydrofolate Reductase Inhibitor Antibacterial. The mechanism of action of trimethoprim is as a Dihydrofolate Reductase Inhibitor, and Cytochrome P450 2C8 Inhibitor, and Organic Cation Transporter 2 Inhibitor. This molecule is a synthetic derivative of trimethoxybenzyl-pyrimidine with antibacterial and antiprotozoal properties.  As a pyrimidine inhibitor of bacterial dihydrofolate reductase, trimethoprim binds tightly to the bacterial enzyme, blocking the production of tetrahydrofolic acid from dihydrofolic acid.  The antibacterial activity of this agent is potentiated by sulfonamides. (NCI04)",CHEMBL22
[NH3+]CC1CN(c2ncnc3[nH]cc(-c4cccc(CO)c4)c23)CCO1,6.37,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)CCC2CCCCC2)cc1,6.37,,
CNC(=O)C(NC(=O)c1ccc(-c2ccc(Cl)cc2)o1)C1CCCCC1,6.37,,
Cn1c(=O)n(C2CC[N+](CCCn3nc(-c4ccc(Cl)c(CNC(=O)c5ccccc5)c4)ccc3=O)CC2)c2cc(Cl)ccc21,6.37,,
O=C([O-])c1cccc(CC(NS(=O)(=O)Cc2ccccc2)B(O)O)c1,6.37,,
CCCCCCCCCCCCCCCC(=O)[O-],6.37,,
CC(NC(=O)C(NC(=O)CNC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(C)NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])CCC(N)=O)C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)[O-],6.37,,
O=C([O-])C(=O)CC(=O)C1(Cc2ccc(Cl)cc2)CC[N+](Cc2ccccc2)CC1,6.37,,
CC(C)CC1NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(Cc2ccccc2)NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])CSSCC(C(=O)[O-])NC(=O)C(CCCC[NH3+])NC1=O,6.37,,
CCC(CC)OC1CC(C(=O)[O-])=CC(n2cc(CCCO)nn2)C1NC(C)=O,6.37,,
Fc1ccc(C2CC[NH2+]CC2COc2ccc3c(c2)OCO3)cc1,6.37,,
O=C1C=CC(S(=O)(=O)n2cc3ccc(O)cc3c2)C(O)=C1,6.37,,
CN1C(=[NH2+])NC(CCC2CCCCC2)(CC2CCCC([NH2+]C3CCCC3)C2)C1=O,6.37,,
CC(NC(=O)C(Cc1ccccc1)C(=O)NO)C(=O)NCCO,6.37,,CHEMBL354661
CCC(C)C(NC(C)=O)C(=O)N1CCCC1C(=O)NC(CO)Cc1ccccc1,6.38,,
CC(C)CC(NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C1CCC[NH2+]1)C(C)O)C(C)O)C(=O)NC(Cc1ccccc1)C(=O)[O-],6.38,,
CCCOc1cc(C2(C)CNC(=O)O2)ccc1OC,6.38,,
CC12C=CCC1C1CCC3CC(O)CCC3(C)C1CC2,6.38,,
CC(C)CC(=O)NC(Cc1c[nH]cn1)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CC1CCCCC1)C(O)CC(=O)NC(CC(C)C)C(N)=O,6.38,,
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)CNC(=O)C1CCCN1C(=O)C[NH3+])C(=O)N1CCCC1C(=O)NCC(=O)[O-],6.38,,
[NH3+]C(Cc1c[nH]cn1)C(=O)[O-],6.38,,
[NH2+]=C1NCC2C(O)C(O)C(O)C(O)N12,6.38,,
Cn1cnc2c1c(=O)n(CCCn1c(=O)c3nc[nH]c3n(C)c1=O)c(=O)n2C,6.38,,CHEMBL1738785
CCCCC(C[NH2+]C(CCCC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)CC,6.38,,
N#CCCCOc1ccc(-c2ccc(-c3ccccc3Cl)n2Cc2cccc(N)n2)cc1,6.38,,CHEMBL1089137
O=C(c1c(Oc2ccccc2)n(-c2ccccc2)c2ccccc12)N1CC[NH2+]CC1,6.38,,
NC(=O)c1ccc(I)c([N+](=O)[O-])c1,6.38,"This molecule is a carbonyl compound and an organohalogen compound. This molecule is a small molecule iodobenzamide with potential cytotoxic and antineoplastic activities. Although the mechanism of action is unknown, iniparib appears to be cytotoxic in cells with DNA alterations or DNA damage, like that found in tumor cells with mutations in the ataxia telangiectasia mutated (ATM) gene. ATM encodes a serine/threonine protein kinase and mutations of the gene are associated with ataxia telangiectasia and contribute to certain cancers such as T-cell acute lymphoblastic leukemia, B-cell chronic lymphocytic leukemia and B-cell non-Hodgkin lymphomas.",CHEMBL1170047
CC(C)CC(NC(=O)C(C)[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(CC(=O)[O-])C(=O)NC(C)C=O.CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CCCC[NH3+])C(=O)[O-],6.38,,
CN(C(=O)Oc1ccc(Cl)cc1)C1CCC(c2ccc(C[NH+]3CCCCC3)cc2)CC1,6.39,,
OCC1C[NH2+]CC(O)C1OC1OC(CO)C(O)C(O)C1O,6.39,,
COC(=O)C1CC(C(=O)[O-])OC1C(CC(C)C)NC(C)=O,6.39,,
O=C1NC(=O)c2cccc3cccc1c23,6.39,This molecule is a natural product found in Brickellia glutinosa with data available.,CHEMBL339586
CC(C)CCNC(=O)C1C[NH2+]CC(C[N+]2CC(=O)N(c3ccccc3Cl)CC2(C)C)C1,6.39,,
CCCc1scc(-c2cn[nH]c2)c1CC(N=C1NC(C)(C)Cc2cc(Cl)ccc21)c1nc(=O)cc[nH]1,6.39,,
O=c1nc[nH]c2cc3[nH]c(NCC[NH+]4CCCCC4)nc3cc12,6.39,,
[NH3+]C(CCC(=O)NC(CSCc1ccccc1)C(=O)NC(C(=O)[O-])c1ccccc1)C(=O)[O-],6.4,,
CCCCCN(CCCCC)C(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(C)=O,6.4,,
CC(C=CC(=O)NO)=CC(C)C(=O)c1ccc(N(C)C)cc1,6.4,,
C#CCC(CC(O)C(CC1CCCCC1)NC(=O)C(CSC)NC(=O)c1nc2ccccc2[nH]1)C(O)[NH2+]CC[NH+]1CCOCC1,6.4,,
[NH3+]CCCC[NH3+],6.4,,
COC(=O)C1C(OC(=O)c2ccccc2)CC2CCC1[NH+]2C,6.4,,
[NH3+]C(Cc1ccc(I)cc1)C(=O)NO,6.4,,
CC(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CO)CCCNC(N)=[NH2+],6.4,,
CCN1c2cc([N+](=O)[O-])ccc2N(C)C(=O)c2cccnc21,6.4,,CHEMBL71927
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(C)NC(=O)C(C)NC(=O)C[NH3+])C(=O)NC(CO[P+](O)(O)O)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)NC(C)C(=O)NC(C)C(=O)O)C(C)C,6.4,,
[NH3+]C(CC(=O)[O-])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)[O-],6.4,,
CC(C)CC([NH3+])C(=O)[O-],6.4,,
c1ccc2[nH]c(-c3cscn3)nc2c1,6.4,"This molecule appears as white or cream-colored odorless, tasteless powder. Sublimes above 590 °F. Fluoresces in acidic solution. Formulated as a dust, flowable powder or wettable powder for use as a systemic fungicide and anthelmintic. This molecule is a broad spectrum anthelmintic agent used predominantly in treatment of intestinal pinworm and strongyloides infection, which recently has been replaced by better tolerated agents. This molecule therapy has been shown to cause clinically apparent cholestatic liver injury which is rare, but can be severe. This molecule is a member of the class of benzimidazoles carrying a 1,3-thiazol-4-yl substituent at position 2. A mainly post-harvest fungicide used to control a wide range of diseases including Aspergillus, Botrytis, Cladosporium and Fusarium. It has a role as an antifungal agrochemical and an antinematodal drug. It is a member of benzimidazoles, a member of 1,3-thiazoles and a benzimidazole fungicide. It derives from a hydride of a 1H-benzimidazole. 2-Substituted benzimidazole first introduced in 1962. It is active against a variety of nematodes and is the drug of choice for strongyloidiasis. It has CNS side effects and hepatototoxic potential. (From Smith and Reynard, Textbook of Pharmacology, 1992, p919) This molecule is an Anthelmintic. This molecule is a benzimidazole derivative with anthelminthic property. Although the mechanism of action has not been fully elucidated, thiabendazole inhibits the helminth-specific mitochondrial enzyme fumarate reductase, thereby inhibiting the citric acid cycle, mitochondrial respiration and subsequent production of ATP, ultimately leading to helminth's death. In addition, it has been suggested that thiabendazole may lead to inhibition of microtubule polymerization by binding to beta-tubulin and has an overt ovicidal effect with regard to some trichostrongylids. This molecule is a fungicide and parasiticide. It is used primarily to control mold, blight, and other fungally caused diseases in fruits (e.g. oranges) and vegetables; it is also used as a prophylactic treatment for Dutch elm disease. As an antiparasitic, it is able to control roundworms (such as those causing strongyloidiasis), hookworms, and other helminth species which attack wild animals, livestock and humans.",CHEMBL625
CCC1(O)CC2C[NH+](CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CC[NH+]6CCC43C65)C2)C1,6.4,,
CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,6.4,,CHEMBL52387
OC[NH+](O)CCCc1ccccc1,6.4,,
O=S(=O)(NCC1CC(OCc2ccc(Cl)cc2)C[NH2+]1)c1cccc2cnccc12,6.4,,
CN(C)S(=O)(=O)c1ccc(-c2cc3c(c4c2CC[NH+](C)C4)NC(=O)C3=NOC(CCO)C(=O)[O-])cc1,6.4,,
OCC1[NH2+]CC(O)C1O,6.4,,
[NH3+]C(Cn1oc(=O)[nH]c1=O)C(=O)[O-],6.4,,
NS(=O)(=O)c1ccc(CCC(=O)[O-])cc1,6.4,,
N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2,6.4,"This molecule is a member of the class of benzamides obtained by formal condensation of the carboxy group of 2-fluorobenzoic acid with the amino group of 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carbonitrile. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of benzamides, a member of monofluorobenzenes, a nitrile and a member of 1-benzothiophenes.",CHEMBL234838
CC(C)CC(NC(=O)C(NC(=O)C(CCCC[N+](C)(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)O,6.4,,
COc1cc2ccnc(-c3cccc(Br)c3)c2cc1Cl,6.4,,
O=C(NCCO)C(CCOC(c1ccccc1)(c1ccccc1)c1ccccc1)Cn1ccc(=O)[nH]c1=O,6.4,,CHEMBL1766643
Cc1ccc(O)cc1Nc1ccnc2cc(-c3csc(C=O)n3)ccc12,6.4,,CHEMBL237127
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)COC2CCCC2)cc1,6.4,,
CC(=O)C1(O)CC2=C(C(=O)C3=C(C(=O)c4ccccc4C3=O)C2O)C(OC2CC([NH3+])C(O)C(C)O2)C1,6.4,,
Cc1nc2c(N)ncnc2n1C1OC(C[NH+](C)CCC(N)=O)C(O)C1O,6.4,,
N#Cc1c(-c2ccc3c(c2)OCO3)[nH]c2[nH]c(=[NH2+])[nH]c(=O)c12,6.4,,
CC(C)CC(CC(=O)NO)C(=O)NC(C(=O)NC(C)C(=O)NCC[NH3+])C(C)(C)C,6.4,,
CCC(C)C(NC(=O)C(C)NC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])CCC(=O)[O-])C(C)CC)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(CCC(=O)[O-])C(=O)[O-])C(C)O)C(C)O)C(C)CC)C(C)CC,6.4,,
N#Cc1ccc2[nH]cc(CCCC[N+]3CCC(NC(=O)c4cccc5c(C#N)c[nH]c45)CC3)c2c1,6.4,,
O=C(Cc1c[nH]c2ccc(Br)cc12)NO,6.4,,
CC(C)(C)OC(=O)NC(Cc1ccccc1)CN(O)C=O,6.4,,CHEMBL220470
NS(=O)(=O)c1nc2ccccc2[nH]1,6.4,,
O=C(CCCC(F)(F)F)N1CCC(c2nc(-c3nccs3)no2)CC1,6.4,,CHEMBL1946956
O=C([O-])c1cccc(O)c1O,6.4,,
Nc1c(O)n(Cc2ccccc2)c(=O)[nH]c1=O,6.4,,
CCc1c(C)c2n3c1[CH]c1c(C)c(CC)c4n1[Fe+5]31n3c(c(C)c(CCC(=O)[O-])c3[CH]c3c(CCC(=O)[O-])c(CSc5nc(=O)c6nc[nH]c6n5CCOC)c(n31)[CH]2)[CH]4,6.4,,
COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1,6.4,,CHEMBL1957085
CNC(=O)c1ccccc1Nc1ncnc(Nc2cc(OC)c(OC)c(OC)c2)n1,6.4,,CHEMBL2409605
N#Cc1c(O)nc2scc(-c3ccc(-c4ccccc4O)cc3)c2c1O,6.4,,
C[N+](C)=c1ccn(Cc2ccc(CCc3ccccc3)cc2)cc1,6.4,,
CC(C)c1cccc(C[NH2+]CC(O)C2COCC=CCC(c3ccccc3)NC(=O)c3cc(cc(N(C)S(C)(=O)=O)c3)C(=O)N2)c1,6.4,,
Oc1c(C(Nc2ccccn2)c2ccco2)cc(Cl)c2cccnc12,6.4,,CHEMBL581146
COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1,6.4,,CHEMBL2312301
CCC(=O)N1CCCC(n2nc(-c3cccc(C(=O)Nc4ccc(C(C)C)cc4)c3)c3c(N)ncnc32)C1,6.4,,
CCCCCC(CC(=O)NO)C(=O)NC(C(=O)N1CCCC1CO)C(C)C,6.4,,CHEMBL67311
CC(=O)NC(Cc1cccnc1)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(=O)NC(CCC(C)C)C(=O)NC(CC(=O)[O-])C(C)=O)CC(C)C,6.4,,
Cc1nc(-c2ccc(C(=O)NCCC(F)(F)F)cc2)cs1,6.4,,CHEMBL3286507
C=CCNC(=O)Nc1nc2cc(-c3cccnc3)c(OCC[NH+]3CCOCC3)nc2s1,6.4,,
CC(=O)NC1C[NH2+]CC(O)C(O)C1O,6.4,,
CCC(C)C([NH3+])C(=O)NC(C(=O)NCC(=O)NCC(=O)NC1CSSCC(C(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(=O)[O-])NC(=O)C(CCSC)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C2CCCN2C1=O)C(C)CC,6.4,,
Cc1nc2c(O)cccc2c(=O)[nH]1,6.4,This molecule is a member of the class of quinazolines that is quinazolin-4(1H)-one substituted by a hydroxy group at position 8 and a methyl group at position 2. It has been shown to exhibit inhibitory activity against poly(ADP-ribose) polymerase. It has a role as an EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor. It is a member of quinazolines and a member of phenols. This molecule is a natural product found in Streptomyces with data available.,CHEMBL123904
O=C(Nc1ccc(OC(F)(F)F)cc1)N(Cc1cccc(-c2nccs2)c1)C1CC1,6.4,,CHEMBL3298269
O=C(Nc1ccc2n[nH]c(-c3ccncc3)c2c1)C1CC[NH+](CC(=O)N2CCN(c3ccc(-c4ncccn4)cc3)CC2)C1,6.4,,
[NH3+]C1CCC(Nc2nccc(-c3cccnc3Oc3ccc(NS(=O)(=O)c4ccccc4)c4ccccc34)n2)CC1,6.4,,
O=c1[nH]cnc2cc[nH]c12,6.41,,CHEMBL1230671
Nc1[nH]c2ccc(C(=O)c3c(F)cccc3F)c[n+]2c1C(=O)c1ccccc1,6.41,,
[NH3+]C(Cn1c2c(c(=O)[nH]c1=O)CCC2)C(=O)[O-],6.41,,
COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F,6.41,"This molecule is a pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4. It has a role as an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor, a peripheral nervous system drug, an anti-asthmatic drug and a bronchodilator agent. It is an organofluorine compound and a pyridazinone.",CHEMBL313842
O=C1CCCCC=CCCOC(=O)c2c(O)cc(O)c(Cl)c2C1,6.41,,
Cc1cc(-n2ccnc2)cc2[nH]c(C3C(=O)N=CC=C3NCc3ccccn3)nc12,6.41,,
CCC(C)C([NH3+])C(=O)NC(CS)C(=O)NC(C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCC(N)=O)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NC(C)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CS)C(=O)NC(C(=O)O)C(C)O)C(C)C,6.41,,
O=S(=O)(c1ccccc1)N(Cc1ccc(I)cc1)C1C[NH2+]CC1N(Cc1ccc(I)cc1)S(=O)(=O)c1ccccc1,6.41,,
[NH3+]CC1CN(c2c(Br)cnc3[nH]ncc23)CCO1,6.41,,
CCC(C)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(NC(=O)C([NH3+])CO)C(C)C)C(=O)N1CCCC1C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(CCC(=O)[O-])C(=O)NCC(=O)NC(C)C(=O)NC(CO)C(=O)NC(C(=O)NC(CO)C(=O)NCC(=O)NC(CCSC)C(=O)[O-])C(C)O)C(C)C,6.41,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.41,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.41,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)COC2CCCCC2)cc1,6.41,,
NS(=O)(=O)c1ccc(NC(=O)Cc2cccs2)c(F)c1,6.41,,CHEMBL574246
Cc1cccc(S(=O)(=O)N(C)C2C(=N)N(Cc3ccccc3)C(=O)NC2=O)c1,6.41,,
Cc1noc(C)c1-c1cc(O)cc(C(O)c2ccccc2)c1,6.41,,CHEMBL2335143
OCC(Nc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12)c1ccccc1,6.41,,CHEMBL190396
O=C(C=Cc1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,6.41,,CHEMBL2131289
CC(C)CC(NC(=O)C(C)NC(=O)C(CC(N)=O)NC(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)C(C)NC(=O)C(NC(=O)C([NH3+])Cc1c[nH]cn1)C(C)C)C(C)C)C(=O)[O-],6.41,,
NC(=[NH2+])c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3O)cc2c1,6.42,,
CC(NC(=O)C[NH3+])C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(Cc1cnc[nH]1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)O,6.42,,
O=C([O-])C(CCc1ccccc1)CC1(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)[O-])CCCC1,6.42,,
CCCc1c(S(=O)C2CCCCC2)c2cc(Cl)ccc2[nH]c1=O,6.42,,
COc1cc(CNc2ccc(C(N)=[NH2+])cc2)c(NS(C)(=O)=O)cc1OCc1ccccc1,6.42,,
CCCCCCCCCCCCCCNC(=O)NC(CC(=O)[O-])C[N+](C)(C)C,6.42,,
OCC1NC(=NO)C(O)C(O)C1O,6.42,,
Cc1[nH]nc2ccc(F)c(Oc3cc(C#N)cc(C#N)c3)c12,6.42,,
CCC(C)C(NC(=O)CNC(=O)C1CCCN1C(=O)C(NC(=O)C(C)NC(=O)C(NC(=O)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CC(=O)[O-])C(C)O)C(C)O)C(C)CC)C(N)=O,6.42,,
COC(=O)CCCC=C(c1cc(C#N)c(OC)c(C(=O)OC)c1)c1cc(C#N)c(OC)c(C(=O)OC)c1,6.42,,CHEMBL110610
Nc1nc(NC2CCCCC2)sc1C(=O)c1cccnc1,6.42,,CHEMBL2377829
CCC1C(=O)N(C)c2cnc(-c3ccc[nH]3)nc2N1C1CCCC1,6.42,,
CC(NC(=O)c1ccc(C#N)n1C)c1c(F)cccc1Cl,6.42,,
Cc1noc(C)c1-c1cc(O)cc(C(O)c2ccccc2)c1,6.42,,CHEMBL2335143
O=C1N=C(c2ccccc2)C=CC1O,6.42,,
ON=C1NCC(OC2OCC(O)C(O)C2O)C(O)C1O,6.43,,
Ic1ccc2c(c1)C[NH2+]CC2,6.43,,
CC(C)c1cc(Oc2c(Cl)cc(CC(=O)[O-])cc2Cl)ccc1O,6.43,,
Cc1ccc(NC(=O)c2ccc(C[NH+]3CC[NH+](C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,6.43,,
O=C([O-])COc1c(C(=O)[O-])sc2c1sc1cc(NC3CCN(S(=O)(=O)Cc4ccccc4)CC3)ccc12,6.43,,
[NH3+]C(CCSCC(O)C(O)C(=O)NO)C(=O)[O-],6.43,,
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CC[NH+](C)CC1,6.43,,
O=C([O-])c1ccc(-c2ccccc2OC(F)(F)F)o1,6.43,,
NC(=O)c1nn(CC2CC[NH2+]CC2)c2c1ccc1cnc(Nc3ccccc3)nc12,6.43,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)[O-])C(C)O)C(C)O,6.43,,
Cc1cc2c3c(c4c5ccccc5n5c4c2[n+](c1)[Ru+9]51246(Cl)C5=C(C(=O)[O-])C1=C2C4=C56)C(=O)NC3=O,6.43,,
O=c1cc(C2CC[NH2+]C(Cc3ccccc3)C2)o[nH]1,6.43,,
NC(=O)c1ccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)cc1,6.43,,CHEMBL3899351
[NH3+]CCc1c[nH]c2ccccc12,6.43,,
Cc1cn(-c2cc(F)c(C(N)=O)c(NC3CCOC3)c2)c2c1C(=O)CC(C)(C)C2,6.43,,
O=c1[nH]cnc2cc3[nH]c(NCC[NH+]4CCOCC4)nc3cc12,6.43,,
CC[NH+](CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,6.44,,
COc1ccc2c3c1OC1CC(O)C=CC31CC[NH+](C)C2,6.44,,
COc1ccc(O)c(C(=O)c2ccc(C=CC3CCC[NH2+]CC3NC(=O)c3ccncc3)cc2)c1F,6.44,,
CC(C(=O)N1CCOCC1)N1CCC(NS(=O)(=O)C=Cc2ccc(Cl)s2)C1=O,6.44,,
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CCC(N)=O)C(C)O)C(=O)[O-],6.44,,
N#Cc1cnn2c(NCCc3cnc[nH]3)nc(Nc3ccccc3)nc12,6.44,,CHEMBL389767
O=C(c1ccc(C(O)(O)C(F)(F)F)s1)N1CCn2c(-c3ccccc3)cnc2C1,6.44,,
CC(Oc1cc(-n2cnc3cc(OC4CC[N+](C)CC4)ccc32)ccc1C(N)=O)c1ccccc1C(F)(F)F,6.44,,
O=C(NCB(O)O)c1ccccc1[N+](=O)[O-],6.44,,CHEMBL2035292
OC(c1ccc(Cl)s1)(c1ccc(Cl)s1)C1C[NH+]2CCC1CC2,6.44,,
CC(=CC[NH2+]CC[NH2+]C1C2CC3CC(C2)CC1C3)CC=CC(C)C,6.44,,
CC(C)=CCCC(C)=CC[NH2+]CC[NH2+]C1C2CC3CC(C2)CC1C3,6.44,,
CCC[NH2+]C(CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,6.44,,
COc1ccc(OCCN2CCC3CCCC(C2=O)N3S(=O)(=O)c2ccc3[nH]c(=O)sc3c2)cc1OC,6.44,,CHEMBL2348594
N#CC(Cc1ccc2[nH]ncc2c1)C(N)=O,6.44,,
O=c1cc(-c2ccc3c(c2)OCO3)oc2ccccc12,6.44,,CHEMBL483633
CC(C)CC(NC(=O)C1CSSCC2CC(NC(=O)C[NH3+])C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(CSS2)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(Cc2c[nH]cn2)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1)C(N)=O,6.44,,
Nc1nonc1C(=O)c1cccc(OCc2nc3ccccc3[nH]2)c1,6.44,,
[NH2+]=C(NO)NCCC([NH3+])C(=O)[O-],6.44,,
CCCCCCCCNc1cc(-c2ccc(OC)cc2)nc(N)n1,6.44,,
CC1(c2nc3cccc(C(N)=O)c3[nH]2)CCC[NH2+]1,6.44,,
CC(C)CC(NC(=O)C(Cc1cnc[nH]1)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C(C)NC(=O)C([NH3+])CC(=O)[O-])C(C)O)C(C)O)C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)N1CCCC1C(=O)O,6.45,,
NC(=[NH2+])NCCCC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(Cc1ccccc1)C(N)=O,6.45,,
CNc1nc2cc3c(=O)[nH]c(=[NH2+])[nH]c3c(CCC3OC(OC)C(O)C3OC)c2[nH]1,6.45,,
CCC(C)CCCC(C)(C)O,6.46,,CHEMBL3188990
Nc1ccc(N)c2c1C(=O)c1c(O)ccc(O)c1C2=O,6.46,,CHEMBL572879
Nc1ccc2nc(N)[nH]c(=O)c2c1,6.46,,
Nc1ccc2nc(N)[nH]c(=O)c2c1,6.46,,
COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,6.46,This molecule is a member of the lclass of pyrrolidin-2-ones that is pyrrolidin-2-one bearing a 3-(cyclopentyloxy)-4-methoxyphenyl substituent at the 4-position. It is a type IV-specific phosphodiesterase (PDE4) inhibitor. It has a role as an antidepressant and an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor. A phosphodiesterase inhibitor with antidepressant properties.,CHEMBL63
COc1ccc(C(Nc2ccc(C(N)=[NH2+])cc2)C(=O)NCc2ccccc2)cc1OC,6.46,,
CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)c(COc3cccnc3)c2)n[nH]1,6.46,,
NS(=O)(=O)c1ccc(Nc2cc(OC3CCCCC3)nc3ncnn23)cc1,6.46,,CHEMBL203407
[NH3+]C(CC(Cc1ccc2ccccc2c1)C(=O)[O-])C(=O)[O-],6.46,,
COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCC[NH+]1CCCCC1,6.46,,
CC=Cc1cc2c(s1)C(O)C(O)CC2(O)C(=O)[O-],6.46,,
COc1ccccc1-c1cc(Cl)nc(N)n1,6.46,,CHEMBL1236713
COc1ccc2c(c1)[nH]c1c(C)nccc12,6.46,"This molecule is a harmala alkaloid in which the harman skeleton is methoxy-substituted at C-7. It has a role as a metabolite, an anti-HIV agent and an EC 1.4.3.4 (monoamine oxidase) inhibitor. It derives from a hydride of a harman. This molecule is a natural product found in Passiflora phoenicia, Symplocos setchuensis, and other organisms with data available.",CHEMBL269538
COc1ccc2c3c1OC1CC(O)C=CC31CC[NH+](CCC[NH+]1CCCCC1)C2,6.46,,
Cc1ccc(OC(=O)N(CC(=O)[O-])Cc2cccc(OCc3nc(-c4ccc(Cl)cc4)oc3C)c2)cc1,6.46,,
Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1,6.46,"This molecule is a member of the class of phenylureas that is urea which is substituted at position 1 by a 3-tert-butyl-1-methylpyrazol-5-yl group and at position 3 by a p-chlorophenyl group. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of pyrazoles, a member of monochlorobenzenes and a member of phenylureas.",CHEMBL87277
O=C([O-])C1[NH2+]CCc2c1o[nH]c2=O,6.46,,
Nc1n[nH]c(N)c1N=Nc1ccc(O)cc1,6.46,,
O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,6.46,"These molecules is a tetrahydroxyflavone in which the four hydroxy groups are located at positions 3', 4', 5 and 7. It is thought to play an important role in the human body as an antioxidant, a free radical scavenger, an anti-inflammatory agent and an immune system modulator as well as being active against several cancers. It has a role as an EC 2.3.1.85 (fatty acid synthase) inhibitor, an antineoplastic agent, a vascular endothelial growth factor receptor antagonist, a plant metabolite, a nephroprotective agent, an angiogenesis inhibitor, a c-Jun N-terminal kinase inhibitor, an anti-inflammatory agent, an apoptosis inducer, a radical scavenger and an immunomodulator. It is a 3'-hydroxyflavonoid and a tetrahydroxyflavone. It is a conjugate acid of a luteolin-7-olate. This molecule is a naturally-occurring flavonoid, with potential anti-oxidant, anti-inflammatory, apoptosis-inducing and chemopreventive activities. Upon administration, luteolin scavenges free radicals, protects cells from reactive oxygen species (ROS)-induced damage and induces direct cell cycle arrest and apoptosis in tumor cells. This inhibits tumor cell proliferation and suppresses metastasis. This molecule is a natural product found in Camellia sinensis, Codonopsis lanceolata, and other organisms with data available. This molecule is a mineral with formula of Bi3+2O3 or Bi2O3. The IMA symbol is Bis.",CHEMBL151
CCC(C)C(NC(=O)C(CC1CCCCC1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C([NH3+])CC(C)C)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(N)=O,6.46,,
NC(=O)Nc1cn(-c2cccc3ccccc23)nc1C(N)=O,6.46,,
O=S1(=O)NCN(C2CC2)c2ccc(F)cc21,6.46,,CHEMBL2441067
CC1OC(O)C(O)C(O)C1O,6.46,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL273741
Nc1ncnc2c1ncn2C1OC(CC([NH3+])CCC([NH3+])C(=O)[O-])C(O)C1O,6.47,,
CCC(C)C(NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCC(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C[NH3+])C(C)C)C(=O)NC(C(=O)NCC(=O)NC(CC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)CC)C(C)CC,6.47,,
O=C1NCCC(OC2OCC(O)C(O)C2O)C1O,6.47,,
CCC(C)C(NC(=O)CNC(=O)C(CCC(=O)[O-])NC(=O)CNC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)NC(C)CC(=O)[O-],6.47,,
O=C(Nc1ccc2ccn(CCc3ccncc3)c2c1)c1cc(F)cc(N2CCOCC2)c1,6.47,"This molecule is a member of the class of benzamides obtained by formal condensation of the carboxy group of 3-fluoro-5-morpholin-4-ylbenzoic acid with the amino group of 1-[2-(pyridin-4-yl)ethyl]indol-6-amine It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of morpholines, a member of indoles, a member of benzamides, an aminoalkylpyridine and a member of monofluorobenzenes.",CHEMBL193264
O=C1C=CC(c2oc3cc(O)c(O)c(O)c3c(=O)c2O)=CC1O,6.47,,
N=CC1(NC(=O)C2CC(S(=O)(=O)c3ccccc3Cl)CN2C(=O)C2(c3ccc(F)cc3)CC2)CC1,6.47,,
CCC([NH3+])C(=O)NC1C(=O)N2C(CCC1C[NH3+])CCC2C(=O)NC(c1ccccc1)c1ccccc1,6.47,,
Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1,6.47,,CHEMBL497033
NS(=O)(=O)c1cccs1,6.47,This molecule is a member of thiophenes.,CHEMBL3265256
O=C([O-])c1ccccc1C(=O)NCc1c(Cl)cccc1Sc1ccc(Cl)cc1Cl,6.47,,
[NH3+]C(CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccccc1,6.47,,
c1cnc2cc3c(cc2n1)C1C[NH2+]CC3C1,6.47,,
CSC1=[S+][Cu+5]2(Cl)[N+](=C(c3ccccn3)c3cccc[n+]32)N1,6.47,,
O=C([O-])c1cc(Oc2ccccc2)ccc1NS(=O)(=O)c1ccc(Br)cc1F,6.47,,
COc1ccc(NC(S)=NCCCn2ccnc2)cc1OC,6.47,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(C(=O)NCC(=O)[O-])C(C)O)C(C)O)C(C)O,6.47,,
O=C(NC(Cc1ccc(F)cc1)C(=O)N1CCC(O)CC1)c1cc2cc(Cl)ccc2[nH]1,6.48,,
O=C([O-])CCNC(=O)C1CCCN1S(=O)(=O)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,6.48,,
CC1=CC2Cc3[nH]c(=O)ccc3C3(C1)[NH2+]CCCC23,6.48,,
COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,6.48,This molecule is a member of the lclass of pyrrolidin-2-ones that is pyrrolidin-2-one bearing a 3-(cyclopentyloxy)-4-methoxyphenyl substituent at the 4-position. It is a type IV-specific phosphodiesterase (PDE4) inhibitor. It has a role as an antidepressant and an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor. A phosphodiesterase inhibitor with antidepressant properties.,CHEMBL63
OCC1OC(O)C(O)C(O)C1O,6.48,,
CCCc1ccc(NC(=O)c2ccccc2NCC2=CCC(=O)N=C2)cc1C(F)(F)F,6.48,,
CCOC(=O)CC(O)C(=O)NC(CCC#N)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]c2ccccc12)C(N)=O,6.48,,
O=C([O-])C(=O)N(Cc1cccc(Cl)c1)Cc1ccc(S(=O)(=O)NCCC(c2ccccc2)c2ccccc2)s1,6.48,,
Cc1c(-c2ccccc2)ccc2nc(N)nc(N)c12,6.48,,
Cc1nc(-c2ccnc(N)n2)cn1Cc1c(Cl)cccc1Cl,6.48,,CHEMBL1233922
COc1ccc(C=C2CCCN=C2c2cccnc2)c(OC)c1,6.48,,
CC(C)(C)OC(=O)NCC1CCC(CNC(=O)c2cc(-c3ccc(C[NH3+])cc3)nc3ccccc23)CC1,6.48,,
O=C(Nc1ncc(Br)s1)NS(=O)(=O)c1cccc(Cl)c1,6.48,,CHEMBL595149
CCCCC(=O)NC1C(=N)OC(CO)C(O)C1O,6.48,,
COCC(NC(C)=O)C(=O)NCc1ccccc1,6.48,,CHEMBL57293
CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CC[NH2+]CC3)ccc12,6.48,,
O=C([O-])C1=CC(O)C(OS(=O)(=O)[O-])C(OC2C(COS(=O)(=O)[O-])OC(O)C(NS(=O)(=O)[O-])C2O)O1,6.48,,
CCOc1ccccc1-c1nc(-c2ccncc2)no1,6.48,,CHEMBL1581319
CC(=O)NC1C(O)CC(OCC2OC(O)C(O)C(O)C2O)(C(=O)[O-])OC1C(O)C(O)CO,6.48,,
CC1CCCC(O)CCCCCc2cc(O)cc(O)c2C(=O)O1,6.48,,
Cc1cccc(NC(=O)c2ccc(C(F)(F)F)cc2C(=O)[O-])n1,6.48,,
COc1cc(OC)nc(C2CCCCC2C(=O)NCc2ccc(Cl)c(Cl)c2)n1,6.48,,
CCc1cn(C2OC(CO)C(O)C2O)c2ncnc(N)c12,6.48,,
CC(CCC(=O)[O-])C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C,6.48,,
[NH2+]=C(NO)NCCCC([NH3+])C(=O)[O-],6.48,,
O=C(Cc1cccs1)NCB(O)O,6.49,,CHEMBL320049
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,6.49,,
CC(O)C(NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)CNC(=O)C(CC(N)=O)NC(=O)C([NH3+])CCC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccccc1)C(=O)NC(C=O)Cc1ccccc1,6.49,,
COC(=O)C(Cc1ccccc1)(Cc1ccc(NS(=O)(=O)[O-])cc1)C(=O)OC,6.49,,
Nc1nc(N)nc(-c2cc3ccccc3cc2Br)n1,6.49,,
CCCCCCC,6.49,"This molecule is a clear colorless liquids with a petroleum-like odor. Flash point 25 °F. Less dense than water and insoluble in water. Vapors heavier than air. This molecule is a straight-chain alkane with seven carbon atoms. It has been found in Jeffrey pine (Pinus jeffreyi). It has a role as a non-polar solvent and a plant metabolite. It is a volatile organic compound and an alkane. This molecule is a natural product found in Pinus ayacahuite, Pseudotsuga, and other organisms with data available. This molecule is found in cardamom. Heptane is an alkane hydrocarbon with the chemical formula CH3(CH2)8CH3. Heptane has 9 isomers, or 11 if enantiomers are counted. (Wikipedia) 

This molecule belongs to the family of Acyclic Alkanes. These are acyclic hydrocarbons consisting only of n carbon atoms and m hydrogen atoms where m=2*n + 2.",CHEMBL134658
O=C1CCN(CCCS(=O)(=O)N2CCCC2C(O)(c2ccccc2)c2ccccc2)C(=O)N1,6.49,,
[NH3+]C(Cc1ns[nH]c1=O)C(=O)[O-],6.49,,
Cc1ccc2cc(CC3CCN(C(=O)c4c5ccccc5cc5ccccc45)CC3)ccc2n1,6.49,,CHEMBL1092584
CSc1nc(Cl)c(C=O)c(Nc2ccc(S(N)(=O)=O)cc2)n1,6.49,,CHEMBL1233721
CC(c1cccc2ccccc12)[N+]1CCC(C(=O)NCc2ccc3c(c2)OCO3)CC1,6.49,,
CC(=O)NC1C(O)OC(CO)C(O)C1OC(C)C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)[O-],6.49,,
Cc1nc(N)nc(-n2c(Nc3ccn[nH]3)nc3ccccc32)n1,6.49,,
CC(C(=O)c1ccc(O)cc1)[N+]1CCC(Cc2ccccc2)CC1,6.49,,
c1ccc(Nc2cccc3ccccc23)cc1,6.49,"This molecule appears as white to slightly yellowish prisms or reddish brown crystalline powder. (NTP, 1992) This molecule is a member of naphthalenes. This molecule is a natural product found in Streptomyces, Arundo donax, and Triadica sebifera with data available.",CHEMBL170408
CN1CC(=N)NC(C)(c2cccc(NC(=O)c3ccc(Cl)cn3)c2)C1=O,6.49,,
O=C([O-])CCC(Cc1ccc(OCc2ccccc2)cc1)NC(=O)CCCCCCc1ccccc1,6.49,,
CNC(=O)c1ccccc1Nc1ncnc(Nc2ccc(N3CCOCC3)cc2OC)n1,6.49,,CHEMBL2409589
CCC(CC)OC1OC(C(=O)[O-])=CC(O)C1NC(C)=O,6.49,,
CC(C)CC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CC(N)=O)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],6.49,,
Cc1cc(OCCCc2c(C(=O)[O-])sc3ccccc23)cc(C)c1Cl,6.49,,
O=C(NCCC[NH2+]Cc1cc(Cl)sc1Cl)Nc1ccsc1,6.49,,
CCC1(O)CC2C[NH+](CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C5(CC6(CC)C=CC[NH+]7CCC43C76)OC(=O)N(CCCl)C5=O)C2)C1,6.5,,
O=S(=O)(c1ccc2c(c1)C[NH2+]C(CF)C2)N1CCSCC1,6.5,,
O=C(NC1Cc2ccccc2C1O)c1cc2cc(Cl)sc2[nH]1,6.5,,
NS(=O)(=O)c1ccccc1F,6.5,,
NC(=[NH2+])NCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)CCCCCNC(=O)C1OC(n2cnc3c(N)ncnc32)C(O)C1O)C(N)=O,6.5,,
Nc1nc(-c2ccc3c(N)[nH]nc3c2)cc(N2CCOCC2)n1,6.5,,CHEMBL1614772
CN1C(=O)NC(Cc2c[nH]c3c(Cl)cccc23)C1=O,6.5,,CHEMBL381230
O=c1cc(-c2ccc(Br)cc2)oc2ccccc12,6.5,This molecule is a natural product found in Bruguiera gymnorhiza and Nocardiopsis with data available.,CHEMBL294099
OC1(c2ccc(Cl)cc2)c2ccccc2C2=[N+]1CCN2,6.5,,
O=C(NCCC[NH2+]Cc1cc(Cl)cc(I)c1O)Nc1ccsc1,6.5,,
O=C(NC(CCCCNC(=O)c1ccc(I)cc1)C(=O)[O-])NC1(C(=O)[O-])CC1,6.5,,
C=CC[NH+](C)CCCCCCOc1ccc2c(-c3ccc(Br)cc3)nsc2c1,6.51,,
CC(=O)NC(CS)C(=O)NC(Cc1c[nH]cn1)C(=O)N1CCCC1C(=O)NC(CCC(N)=O)C(=O)NCC(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CS)C(N)=O,6.51,,
CC(=O)NC1C(O)C(OC2OC(C)C(O)C(O)C2O)C(CO)OC1n1cc(CO)nn1,6.51,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CO)NC(=O)C([NH3+])CCSC)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)O,6.51,,
O=C(CC(NC(=O)OCc1ccccc1)c1ccccc1)Nc1nnc(S)s1,6.51,,
COc1cc(-c2cnc(N)c(-c3ccc(C(N)=O)cc3)c2)ccc1O,6.51,,CHEMBL600441
CC1(C)CNc2cc(O)c(C(=O)N3Cc4ccccc4C3)cc21,6.51,,CHEMBL1215538
O=C(OC1CC2CCC(C1)[N+]2CC(O)c1ccccc1)c1ccccc1,6.51,,
CC1CC(C)CN(C(=O)c2cc(Br)ccc2NC(=O)CCC(=O)[O-])C1,6.51,,
CC(C)C([NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)[O-],6.51,,
Nc1nc(OC(c2ccc(-c3cccc(F)c3)cc2)C(F)(F)F)cc(-c2ccc(CC([NH3+])C(=O)[O-])cc2)n1,6.51,,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ccnc4ccc(N)cc34)c2)cc1,6.51,,CHEMBL570427
OCCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12,6.51,,CHEMBL189434
CCCC(NC(=O)CNC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CCCC[N+](C)(C)C)NC(=O)C(CCC)NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(C)[NH3+])C(C)O)C(C)O)C(=O)NC(C)C(=O)[O-],6.51,,
Cc1nnc(C[NH2+]CC[NH+]2C(O)c3cccc4c(N(C)C)ccc(c34)C2O)s1,6.51,,
c1ccc(-n2nnc(-c3ccccc3OCc3ccco3)n2)cc1,6.51,,
O=S(=O)(CCl)NCB(O)O,6.51,,
O=c1cc(-c2cccc(O)c2)oc2ccccc12,6.51,,CHEMBL147552
COc1ccc(CCc2cc(Nc3ccnc(NCc4cc(C)no4)n3)[nH]n2)cc1OC,6.51,,
O=C([O-])C(S)Cc1ccccc1,6.52,,
CC(=O)NC1CCCN2[OH+][Fe+7]345([O+]=C(CCCCOC1=O)N(CCCC1NC(=O)C(CCCN([OH+]3)C(CC(C)CCO)=[O+]4)NC1=O)[OH+]5)[O+]=C2CC(C)CCO,6.52,,
CCCCCCCCC=CCCCCCCCC(=O)[O-],6.52,,
CCCCCCCCCCC=O,6.52,"This molecule is a saturated fatty aldehyde formally arising from reduction of the carboxylic acid group of undecanoic acid. It is a component of essential oils from citrus plants like Citrus reticulata. It has a role as an antimycobacterial drug, a volatile oil component and a plant metabolite. It is a saturated fatty aldehyde, a n-alkanal and a medium-chain fatty aldehyde. It is a tautomer of an undec-1-en-1-ol. This molecule is a natural product found in Gymnodinium nagasakiense, Daphne odora, and other organisms with data available.",CHEMBL1236576
CC(C)CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C(C)NC(=O)C(CO)NC(=O)C[NH3+])C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NC(CCC(=O)[O-])C(=O)[O-],6.52,,
CSCCC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCC(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(CCCC[NH3+])NC(=O)C(C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CCCC[NH3+])C(C)O)C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(N)=O,6.52,,
C[n+]1cnc2c(C3OC(CO)C(O)C3O)n[nH]c2c1N,6.52,,
CC(C)CC(NC(=O)C(NC(=O)NC(Cc1ccccc1)C(=O)[O-])C1CCNC(=[NH2+])N1)C(=O)NC(CO)Cc1ccccc1,6.52,,
[NH3+]C(Cn1cc(Br)c(=O)[nH]c1=O)C(=O)[O-],6.52,,
COc1nccnc1CC(C)C,6.52,"This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Zygaena lonicerae, Zingiber mioga, and other organisms with data available. This molecule is a member of pyrazines and an aromatic ether.",CHEMBL97355
Nc1nc2nn(-c3cccc(C(=O)NCc4ccccc4Sc4ccccc4CO)c3)nc2c(=O)[nH]1,6.52,,
CC(C)CCCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C,6.52,"This molecule is a natural product found in Meyerozyma guilliermondii, Glycine max, and other organisms with data available.",CHEMBL3184306
Nc1ccc2[nH]c(-c3cc(CC(=O)[O-])cc(-c4cccc([N+](=O)[O-])c4)c3O)cc2n1,6.52,,
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CC(N)=O)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(C)(C)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)O,6.52,,
Cc1cc(S(=O)(=O)c2c([N+](=O)[O-])cc(C(F)(F)F)cc2[N+](=O)[O-])c(Cl)cc1Cl,6.52,,CHEMBL212218
O=C([O-])COc1c(C(=O)[O-])sc(-c2ccc(O)cc2)c1Br,6.52,,
O=C(C=Cc1ccc(Cl)cc1Cl)NO,6.52,,
CCOC(=O)CCc1ccc(S(N)(=O)=O)cc1,6.52,,
O=C([O-])COc1c(-c2nn[nH]n2)sc(-c2cccc(NC3CCN(S(=O)(=O)Cc4ccccc4)CC3)c2)c1Br,6.52,,
CCCCCCCCCC(=O)CC(=O)NC1CCNC1=O,6.52,,
O=C([O-])CC(OC(=O)C=Cc1ccc(O)cc1)C(OC(=O)C=Cc1ccc(O)cc1)C(=O)[O-],6.52,,
Brc1c(Br)c(Br)c2[nH]cnc2c1Br,6.52,,CHEMBL373937
O=C1CCC(C(=O)[O-])N1,6.52,,
[NH3+]C(CO)C(=O)[O-],6.52,,
CCCCCCCCC[NH+]1CC(O)C(O)C(O)C1CO,6.52,,
O=C1CC(c2ccc(CC(NS(=O)(=O)c3cccc(C(F)(F)F)c3)c3ncc(Cc4ccccc4)[nH]3)cc2)S(=O)(=O)N1,6.52,,CHEMBL252277
CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C)NC(=O)C(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)C)C(C)C)C(=O)NC(C(=O)[O-])C(C)O,6.52,,
CCC(C)C(NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(CCCC[NH3+])NC(=O)C(CC(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C([NH3+])C(C)C)C(C)CC)C(C)CC)C(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(CCSC)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C=O)C(C)C.[NH3+]C(CO)C(=O)[O-],6.52,,
Cc1cc(C)c(C=C2C(=O)Nc3ccc(N)cc32)[nH]1,6.52,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)C[NH2+]C2CCCC2)cc1,6.52,,
CCCCC(C[NH2+]C(CCCC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)CC,6.52,,
CC(C=CC(=O)NO)=CC(C)C(=O)c1ccc(N(C)C)cc1,6.52,,
[NH3+]C1C(O)C(O)C(O)C1O,6.52,,
C=C(CC)C(=O)c1ccc(OCC(=O)[O-])c(Cl)c1Cl,6.52,,
CCCOC1(C(=O)[O-])CC(OC2(C(=O)[O-])CC(O)C(O)C(C(O)CO)O2)C(O)C(C(O)CO)O1,6.52,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)C[NH2+]C2CCCC2)cc1,6.52,,
CC([NH3+])C(=O)NC(CCC(=O)NC(CCCC([NH3+])C(=O)[O-])C(=O)[O-])C(=O)[O-],6.52,,
O=C([O-])CC(=O)C(=O)[O-],6.52,,
CCOCCN(CC(O)C[N+]1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)cccc1C,6.52,,
CC(O)C(NC(=O)C([NH3+])CCC(N)=O)C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],6.52,,
O=C([O-])c1ccc(Nc2nccc(Nc3ccccc3-c3ccccc3)n2)cc1,6.52,,
N#Cc1c(NC(=O)c2cc(S(=O)(=O)N3CCOCC3)c(Cl)cc2Cl)sc2c1CC[NH+](Cc1ccc(-c3nn[nH]n3)cc1)C2,6.52,,
NS(=O)(=O)c1cccnc1Nc1cccc(C(F)(F)F)c1,6.52,,CHEMBL1330078
O=C([O-])CNC(=O)c1nc(Cl)c2ccccc2c1O,6.52,,
C[NH+]1C(C)(C)CC(NC(=O)C(=O)Nc2ccc(Cl)c(F)c2)CC1(C)C,6.52,,
NC(=[NH2+])NC1Cc2ccccc2C1NC(=O)C(=O)Nc1ccc(Cl)c(F)c1,6.52,,
C[NH+](C)C1CCN(c2ccc3[nH]c(C(=O)c4ccnc(-c5cncc6ccccc56)c4)nc3n2)CC1,6.52,,
CC(C)CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],6.52,,
CCC(NC(=O)CC(O)C(CC(C)C)NC(=O)C(NC(=O)C(Cc1cccc2ccccc12)NC(C)=O)C(C)C)C(=O)NC(Cc1cccc2ccccc12)C(N)=O,6.52,,
CC(C)(C)c1ccc(C(=O)Nc2nnc3n2CCS3)cc1,6.52,,CHEMBL1594868
COC(=O)C(Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)[O-])c2cc(-c3cccc(Cl)c3)ccc2n1,6.52,,
N#Cc1ccc(OCCC[NH+]2CCC(C(O)(c3ccccn3)C3CCCC3)CC2)cc1,6.52,,
O=C([O-])C(S)Cc1c(Cl)ccc(Cl)c1Cl,6.52,,
CSCCC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(CC(N)=O)C(=O)NC(CCSC)C(=O)[O-],6.52,,
CCC(C)C(NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)C)C(C)O)C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)[O-],6.52,,
CCC(C)C(BO)NC(=O)C(C)NC(=O)OCc1ccccc1,6.52,,
CC(C)(c1ccc(O)cc1)c1ccc(O)cc1,6.53,"This molecule appears as white to light brown flakes or powder. Has a weak medicine odor. Sinks in water. (USCG, 1999) These molecules is a bisphenol that is 4,4'-methanediyldiphenol in which the methylene hydrogens are replaced by two methyl groups. It has a role as a xenoestrogen, an environmental contaminant, a xenobiotic and an endocrine disruptor. This molecule is a diphenylmethane derivative with two hydroxyphenyl groups. This molecule (BPA) is a colorless solid that is used in the synthesis of commercial plastics, including polycarbonates and epoxy resins, which are incorporated into a wide variety of consumer goods. Ingested BPA may exhibit estrogenic effects. Exposure to BPA may increase the risk of certain cancers. This molecule is an organic compound with two phenol functional groups. It is a difunctional building block of several important plastics and plastic additives. With an annual production of 2-3 million metric tonnes, it is an important monomer in the production of polycarbonate. It is a potential food contaminant arising from its use in reusable polycarbonate food containers such as water carboys, baby bottles and kitchen utensils.



Suspected of being hazardous to humans since the 1930s, concerns about the use of bisphenol A in consumer products were regularly reported in the news media in 2008 after several governments issued reports questioning its safety, and some retailers removed baby bottles and other children's products made from it from their shelves.",CHEMBL418971
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,6.53,This molecule is a sulfonamide.,CHEMBL191003
OC1(c2ccc(Cl)cc2)c2ccccc2C2=[N+]1CCN2,6.53,,
c1ccc2c(Cc3ccc(OCC[NH+]4CCCC4)cc3)c(-c3ccc(OCC[NH+]4CCCC4)cc3)sc2c1,6.54,,
C=CC[NH+](C)CCCCCCOc1ccc2c(-c3ccc(Br)cc3)nn(C)c2c1,6.54,,
Cc1nc2ccc(CN(C)c3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])s3)cc2c(=O)[nH]1,6.54,,
NC(=[NH2+])c1ccc2[nH]c(-c3cc(CC(=O)[O-])cc(Br)c3O)cc2c1,6.54,,
O=C(Nc1cc(C2CC2)[nH]n1)c1ccccc1,6.54,,
O=NC(=O)CCC1CCCC1,6.54,,
O=C([O-])c1ccc(-c2ccccc2C(F)(F)F)o1,6.54,,
C[S+](CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,6.54,,
COC(=O)c1cn(C2OC(CO)C(OC3OC(C)C(O)C(O)C3O)C(O)C2NC(C)=O)nn1,6.54,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)C[NH2+]C2CCCCCC2)cc1,6.54,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)C[NH2+]C2CCCCCC2)cc1,6.54,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.54,,
O=C(NO)C1(S(=O)(=O)c2ccc(Oc3ccc(C(F)(F)F)cc3)cc2)CCOCC1,6.54,"This molecule is a solid. This compound belongs to the diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups. This substance is known to target a disintegrin and metalloproteinase with thrombospondin motifs 5.",CHEMBL1229868
COCCNc1cc(-n2c3c(c4ccccc42)C(=O)CCC3)ccc1C(N)=O,6.54,,CHEMBL410448
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.54,,
COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,6.54,This molecule is a member of the lclass of pyrrolidin-2-ones that is pyrrolidin-2-one bearing a 3-(cyclopentyloxy)-4-methoxyphenyl substituent at the 4-position. It is a type IV-specific phosphodiesterase (PDE4) inhibitor. It has a role as an antidepressant and an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor. A phosphodiesterase inhibitor with antidepressant properties.,CHEMBL63
NC(=[NH2+])c1ccc(OCCCCCOc2ccc(C(N)=[NH2+])cc2)cc1,6.54,,
CC(C)(C)c1ccc(C(=O)NNC(=O)Nc2cccc3ccccc23)cc1[N+](=O)[O-],6.54,,CHEMBL1230881
COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,6.54,This molecule is a member of methoxybenzenes and a substituted aniline.,CHEMBL475251
Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1,6.54,,CHEMBL1738877
CCOC(=O)N1CCc2c(sc(NC(=O)Cc3cccs3)c2C(=O)OC2CCCC2)C1,6.54,,CHEMBL1923060
CNc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,6.54,,
CCCCCc1cc(OC)c(CC=C(C)C)c(O)c1C(=O)[O-],6.54,,
CC(C)(C)OC(=O)N1CC([NH+]=c2[nH]c(=O)c3cccnc3[nH]2)C1,6.54,,
CC(C)Nc1cc(=O)n(-c2ccccc2)nc1-c1nnc[nH]1,6.54,,
Cc1cc(C)nc(Sc2c(F)c(F)c(S(N)(=O)=O)c(F)c2F)n1,6.54,,CHEMBL2333410
CNc1nc2c(CCC3OC(OC)C(O)C3O)c3[nH]c(=[NH2+])[nH]c(=O)c3cc2[nH]1,6.54,,
CSCCC(NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C)C(=O)[O-],6.54,,
COCCOCCc1c(C)c2cc(OC)c(O)c(C)c2oc1=O,6.54,,
Cc1cnc(Nc2ccc(OCC[NH+]3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,6.54,,
CCC(C)C(NC(=O)C(CC(N)=O)NC(=O)C([NH3+])Cc1ccccc1)C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(CS)C(=O)[O-])C(C)O)C(C)O)C(C)C,6.54,,
CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1CC(CO)C(O)C(O)C1O,6.54,,
CC(C)CC(NC(=O)C(NC(=O)CNC(=O)c1ccccc1)C(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(C(=O)[O-])C(C)C,6.54,,
CC(=O)NC(Cc1ccccc1)C(=O)NC(C(=O)N1CC(O)CC1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C,6.54,,
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,6.55,,
C=CC[NH+](C)CC=CCOc1cc2c(cc1F)c(-c1ccc(Br)cc1)nn2C,6.55,,
CCCCCCCCCCCCCCCCCC(=O)[O-],6.55,,
CC1=NC2C(OC(CO)C(O)C2O)S1,6.55,,
CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)[O-],6.55,,
CCc1cc(-c2[nH]ncc2-c2c[nH]cn2)c(O)cc1O,6.55,,
CC(=O)Nc1nnc(S(N)(=O)=O)s1,6.55,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
C[N+](C)(C)CCCN1C(=O)C2C(C1=O)C(c1ccc(C(N)=[NH2+])cc1)[NH+]1CCCC21,6.55,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.55,,
[NH3+]CC(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1,6.55,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.55,,
[NH3+]CC(=O)Nc1ccc(OCc2ccccc2)cc1,6.55,,
C=CCc1ccc(O)c(OC)c1,6.55,"This molecule appears as clear colorless pale yellow or amber-colored liquid. Odor of cloves. Spicy pungent taste. (NTP, 1992) This molecule is a phenylpropanoid formally derived from guaiacol with an allyl chain substituted para to the hydroxy group. It is a major component of clove essential oil, and exhibits antibacterial, analgesic and antioxidant properties. It has been widely used in dentistry to treat toothache and pulpitis. It has a role as an allergen, a human blood serum metabolite, a sensitiser, a volatile oil component, a flavouring agent, an EC 1.4.3.4 (monoamine oxidase) inhibitor, a radical scavenger, an antibacterial agent, an antineoplastic agent, an apoptosis inducer, an anaesthetic, an analgesic, a voltage-gated sodium channel blocker, a NF-kappaB inhibitor and an anti-inflammatory agent. It is a phenylpropanoid, a monomethoxybenzene, a member of phenols and an alkenylbenzene. It is functionally related to a guaiacol. This molecule is a naturally occurring phenolic molecule found in several plants such as cinnamon, clove, and bay leaves. It has been used as a topical antiseptic as a counter-irritant and in dental preparations with zinc oxide for root canal sealing and pain control. Although not currently available in any FDA-approved products (including OTC), eugenol has been found to have anti-inflammatory, neuroprotective, antipyretic, antioxidant, antifungal and analgesic properties. Its exact mechanism of action is unknown, however, it has been shown to interfere with action potential conduction.  There are a number of unapproved OTC products available containing eugenol that advertise its use for the treatment of toothache. This molecule is an aromatic oil extracted from cloves that is used widely as a flavoring for foods and teas and as an herbal oil used topically to treat toothache and more rarely to be taken orally to treat gastrointestinal and respiratory complaints. Eugenol in therapeutic doses has not been implicated in causing serum enzyme elevations or clinically apparent liver injury, but ingestions of high doses, as with an overdose, can cause severe liver injury. This molecule is a Standardized Chemical Allergen. The physiologic effect of eugenol is by means of Increased Histamine Release, and Cell-mediated Immunity. This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Magnolia officinalis, Senegalia berlandieri, and other organisms with data available. This molecule is an allyl chain-substituted guaiacol, i.e. 2-methoxy-4-(2-propenyl)phenol. This molecule is a member of the allylbenzene class of chemical compounds. It is a clear to pale yellow oily liquid extracted from certain essential oils especially from clove oil, nutmeg, cinnamon, and bay leaf. It is slightly soluble in water and soluble in organic solvents. It has a pleasant, spicy, clove-like odor. This molecule is used in perfumeries, flavorings, essential oils and in medicine as a local antiseptic and anaesthetic. It was used in the production of isoeugenol for the manufacture of vanillin, though most vanillin is now produced from petrochemicals or from by-products of paper manufacture (Wikipedia).",CHEMBL42710
C[NH2+]Cc1ccc(-c2ccc3c(c2)C(NC(=O)OC(C)C)CC(C)N3C(C)=O)cc1,6.55,,
COc1ccc2c(c1)C1(COC(=N)N1)c1cc(-c3cc(Cl)ccc3F)ccc1O2,6.55,,
Cc1cc(=O)[nH]c2cc(-c3ccccc3F)ccc12,6.55,,CHEMBL2381633
CCC(=O)OC(CCOCc1ccccc1)C(C)C(O)C(C)CCC(=O)C(C)C(OC(C)=O)C(C)C=CN(C)C=O,6.55,,
O=C(Cc1ccccc1C(F)(F)F)N1CCN(c2ncnc3sc4c(c23)CCC4)CC1,6.55,,CHEMBL3288147
N#Cc1ccc(OCCC[NH+]2CCC(C(O)(c3ccccc3)C3CCCC3)CC2)cc1,6.55,,
O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)C3C4C=CC(C4)C3C2=O)cc1,6.55,,
[NH3+]CCCCC(NC(=O)C(CO)NC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)C(CO)NC(=O)C([NH3+])CC(=O)[O-])C(=O)[O-],6.56,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)C[NH2+]C2CCCCCCC2)cc1,6.56,,
Nc1nc2nnc(CCC(=O)[O-])c(O)c2c(=O)[nH]1,6.56,,
CNc1nc2cc3c(=O)[nH]c(=[NH2+])[nH]c3c(CCC3OC(OC)C(OC)C3O)c2[nH]1,6.56,,
Cc1ccccc1S(=O)(=O)N(CCN(Cc1cncn1C)c1ccc(C=N)cc1)CC1CCN(C(=O)OC(C)(C)C)CC1,6.56,,
O=C1c2cc3sc(-c4cccc([N+](=O)[O-])c4)cc3n2C(=S)N1CCC[NH+]1CCOCC1,6.57,,
CC(=O)NC1CSSCC(C(N)=O)NC(=O)C(Cc2ccccc2)NC(=O)C(CCC(N)=O)NC(=O)C2CCCN2C(=O)C(Cc2cnc[nH]2)NC1=O,6.57,,
[NH3+]C(CSCC[B-](O)(O)O)C(=O)[O-],6.57,,
CCOC(=O)c1c(C)nn(-c2ccccc2)c1C,6.57,,CHEMBL1794670
CCC(C)C(NC(=O)CNC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C)C(=O)[O-],6.57,,
NS(=O)(=O)c1ccc(Nc2cc(NC3CCC([NH3+])CC3)nc3nc[nH][n+]23)cc1,6.57,,
CC(C)CC1NC(=O)C(NC(=O)C([NH3+])C(C)O)C(C)OC(=O)CC2NC(=O)C3COC(=O)CC(NC(=O)C(Cc4c[nH]c5ccccc45)NC2=O)C(=O)NC(C(=O)[O-])CC(=O)NCCCCC(NC1=O)C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)N3,6.57,,
Nc1ncnc2c1ncn2C1OC(CO)C(O)C1O,6.57,"This molecule is a purine nucleoside. This molecule is a natural product found in Acanthus ilicifolius, Acanthus ebracteatus, and other organisms with data available.",CHEMBL11909
CC(=O)C(=O)[O-],6.57,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O)C(C)O,6.57,,
O=C1NC(=NN=C2C(=O)Nc3ccc(S(=O)(=O)[O-])cc32)SC1=Cc1ccco1,6.57,,
Nc1ccc(S(=O)(=O)N(Cc2ccccc2)C2C[NH2+]CC2N(Cc2ccccc2)S(=O)(=O)c2ccc(N)cc2)cc1,6.57,,
CC(C)CC(C[NH2+]C(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(Cc1ccccc1)C(=O)[O-])NC(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C([NH3+])CCCC[NH3+],6.57,,
CN(c1nccc(-c2cnc3ccccn23)n1)C1CCCCC1,6.57,"This molecule is an aminopyrimidine that is N-cyclohexyl-N-methylpyrimidin-2-amine in which the pyrimidine ring is substituted at position 4 by an imidazo[1,2-a]pyridin-3-yl group. It is an inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK-4; EC 2.7.11.1). It has a role as an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor. It is an imidazopyridine and an aminopyrimidine.",CHEMBL482708
CCC([NH3+])C(=O)NC1C(=O)N2C(CCC1CO)CCC2C(=O)NC(c1ccccc1)c1ccccc1,6.57,,
CC1CC(C)CN(c2ccc(C(=O)Nc3ccccc3C(=O)[O-])cc2Oc2ccccc2)C1,6.57,,
NC(=[NH2+])c1cc2c(OC(c3ccccc3)c3nc(-c4ccccc4)no3)cccc2s1,6.57,,
Nc1ncnc2c1ncn2C1OC(CSCCC([NH3+])C(=O)[O-])C(O)C1O,6.57,,
CCc1cnc(SCC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)nc1,6.57,,CHEMBL2010999
O=C([O-])CC1(CC(=O)N2CC[NH+](C(c3ccccc3)c3ccccc3)CC2)CCCC1,6.57,,
CC(=O)NC1CCN(c2c(Cl)cnc3[nH]c(-c4cn(C)nc4C)nc23)C1,6.57,,
COc1cccc(-c2cccc(C3(C)CC(=O)N(C)C(=[NH2+])N3)c2)c1,6.57,,
CCCCCCCCC(=O)c1cc(O)c(O)c(O)c1,6.57,,CHEMBL464853
CCOC(=O)c1ccc(-c2cc(=O)c3ccccc3o2)cc1,6.57,,CHEMBL2431799
CCCN1C(=O)CCc2cc(NS(=O)(=O)Cc3ccc(C)cc3)ccc21,6.57,,
CC(C)CN(CC(O)C(CC1CCCCC1)NC(=O)C(Cc1cnc[nH]1)NC(=O)C(Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccccc1)C(=O)[O-],6.57,,
CC(NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(C)[NH3+])B(O)O,6.57,,
NC(=[NH2+])c1cccc(CC(NS(=O)(=O)c2ccc3ccccc3c2)C(=O)N2CCCCC2C(=O)[O-])c1,6.58,,
CCC(=C(c1ccc(O)cc1)c1ccc(OCC[NH+](C)C)cc1)c1ccccc1,6.58,,
c1ccc(Cn2ccnc2)cc1,6.58,"This molecule, an N-imidazole derivative, has been shown to have strong cardiotonic activity.",CHEMBL14192
Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,6.58,"This molecule is an aminopyridine that is 4-(trifluoromethyl)pyridin-2-amine substituted at position 5 by a 2,6-di(morpholin-4-yl)pyrimidin-4-y group. A selective PI3K inhibitor with anti-tumour properties. It has a role as an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor and an antineoplastic agent. It is a member of morpholines, an aminopyrimidine, an aminopyridine and an organofluorine compound. This molecule has been used in trials studying the treatment and basic science of Lymphoma, Metastases, Lung Cancer, Solid Tumors, and Breast Cancer, among others. This molecule is an orally bioavailable specific oral inhibitor of the pan-class I phosphatidylinositol 3-kinase (PI3K) family of lipid kinases with potential antineoplastic activity. This molecule specifically inhibits class I PI3K in the PI3K/AKT kinase (or protein kinase B) signaling pathway in an ATP-competitive manner, thereby inhibiting the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate and activation of the PI3K signaling pathway. This may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis. Dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.",CHEMBL2017974
OCC1C[NH2+]CC(O)C1OC1OC(CO)C(O)C(O)C1O,6.58,,
[NH3+]CCCCC([NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCC[NH3+])C(=O)[O-],6.59,,
Nc1nc2ccc(CC(C(=O)[O-])c3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc3)cc2c(=O)[nH]1,6.59,,
Nc1nc2ccc(CC(C(=O)[O-])c3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc3)cc2c(=O)[nH]1,6.59,,
CC(=O)NC(Cc1cccc2ccccc12)C(=O)NC(C(=O)NC(CC(C)C)C(O)CC(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1cccc2ccccc12)C(N)=O)C(C)C,6.59,,
[NH3+]C(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-],6.59,,
CC(C)(C)OC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)C(=O)NC(CCC(N)=O)C(=O)NC(Cc1ccccc1)C(N)=O,6.59,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(CC(N)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])C(C)O)C(C)O)C(C)CC)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)[O-],6.59,,
Clc1ccc2c(c1Cl)C[NH2+]CCC2,6.59,,
CC=C1NC(=O)C2NC(=O)C(NC(=O)C(C)C)CCCNC(=O)Nc3cc(O)c(O)cc3CC(C(=O)NC(C(C)C)C(=O)OC2C)N(C)C(=O)C(Cc2ccccc2)N2C(=O)C(CCC2O)NC1=O,6.59,,
CC(=O)c1ccc(NC(=O)c2cn[nH]c2-c2cc(Cl)c(O)cc2O)cc1,6.59,,CHEMBL200469
c1ccc(Nc2nc(Nc3ccccc3)n3nccc3n2)cc1,6.59,,CHEMBL231095
NC(=O)c1ccc(S(=O)(=O)N(Cc2ccccc2)C2C[NH2+]CC2N(Cc2ccccc2)S(=O)(=O)c2ccc(C(N)=O)cc2)cc1,6.59,,
CC(NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])Cc1ccc(O)cc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NC(CC(N)=O)C(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)[O-])C(C)O,6.59,,
CCCC(=O)NC1C(=NOC(=O)Nc2ccccc2)OC(CO)C(O)C1O,6.59,,
Cn1nc(-c2ccccc2)cc1C(=O)NC(Cc1nc2ccccc2[nH]1)C(=O)[O-],6.59,,
COC(=O)N(CC(=O)[O-])Cc1cccc(OCc2nc(-c3ccc(Cl)cc3)oc2C)c1,6.59,,
CC(COC(=O)CCCC(=O)[O-])(C(N=CCC=O)C(=O)[O-])[SH+](=O)[O-],6.59,,
CC(C)NC(=O)COCCOCCNC(=O)C(C)NC(=O)C(O)C([NH3+])Cc1ccc(OCc2ccccc2)cc1,6.59,,
CC(NC(=O)C(CO)NC(=O)C[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(C)C(=O)NCC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],6.59,,
Cn1cc(C(=O)Nc2ccccc2)c2ccccc21,6.59,,CHEMBL3989267
O=C([O-])c1ccc(Nc2ccnc(Nc3ccc(C(=O)[O-])cc3)n2)cc1,6.59,,
O=C([O-])C(O)C(O)C(=O)[O-],6.59,,
O=C(COc1ccc(-c2oc3cc(O)c(C(=O)[O-])cc3c2C#Cc2cccc(Cl)c2)cc1)NC1CC1,6.59,,
Cc1[nH]c2ccccc2c1CC(=O)NC(Cc1ccccc1)C(=O)N(C)c1ccccc1,6.59,,
C[NH2+]C(Cc1ccccc1)C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(O)C(F)(F)C(F)(F)F,6.6,,
CCCCCNC(=O)C(Cc1ccc(OCC(=O)[O-])c(C(=O)[O-])c1)NC(=O)C(Cc1ccccc1)NC(=O)CCC(=O)[O-],6.6,,
CC(C)CC(NC(=O)C(C)NC(=O)C([NH3+])CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CO)CC(=O)[O-],6.6,,
CC(=CC(=O)OCCCCCCCCC(=O)[O-])CC1OCC(CC2OC2C(C)C(C)O)C(O)C1O,6.6,,
Cn1sc(=O)c2cc(S(N)(=O)=O)ccc21,6.6,,CHEMBL334167
CC=C1C2C=C(C)CC1([NH3+])c1ccc(=O)[nH]c1C2,6.6,,
CC(C)C(NC(=O)C(O)c1cccc(Cl)c1)C(=O)NC(CCCNC(N)=[NH2+])C(O)c1nccs1,6.6,,
O=C1NC(=O)C(=Cc2ccc3c(c2)OC(F)(F)O3)S1,6.6,,CHEMBL3184236
O=[N+]([O-])c1cccc(Nc2nccc(-c3cccc(Cn4cncn4)c3)n2)c1,6.6,,
O=[N+]([O-])c1cccc(Nc2nccc(-c3cccc(Cn4cncn4)c3)n2)c1,6.6,,
CCCCCCCCC=CCCCCCCCCCCCCCC(=O)NC(COC1OC(CO)C(O)C(O)C1O)C(O)C=CCCCCCCCCCCCCC,6.6,,
CSC1C(O)C(O)C(O)C1[NH2+]Cc1ccccc1,6.6,,
Nc1n[nH]c(N)c1N=Nc1cccc(C(F)(F)F)c1,6.6,,CHEMBL1516511
Nc1n[nH]c(N)c1N=Nc1ccccc1C(F)(F)F,6.6,,
CCOC(Cc1ccc2c(ccn2Cc2nc(-c3ccccc3Cl)oc2C)c1)C(=O)[O-],6.6,,
CCCC1=NC2C(OC(CO)C(O)C2O)S1,6.6,,
COC1OC(C)C(O)C(O)C1O,6.6,,
CC(=S)NC1C(OC2C(CO)OC3SC(C)=NC3C2O)OC(CO)C(O)C1O,6.6,,
CC(C)(C)c1cc(C(=O)N2Cc3ccccc3C2)ccc1O,6.6,,CHEMBL1236159
O=C([O-])C1(O)CC(O)C(O)C(OCc2cc3ccccc3s2)=C1Cc1cccs1,6.6,,
CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)[O-],6.6,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.6,,
CC(C)(C)c1ccc(CCC2CCC(O)C3C(O)C(O)C[NH+]23)cc1,6.6,,
CC(C)(C)c1ccc(C(=O)CC2CCC(O)C3C(O)C(O)C[NH+]23)cc1,6.6,,
CCC([NH3+])C(=O)NC1C(=O)N2C(CCC1CC[NH3+])CCC2C(=O)NC(c1ccccc1)c1ccccc1,6.6,,
O=C([O-])C1CCC[NH2+]1,6.6,,
CC(C)CC([NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(CO)C(=O)[O-])C(C)O)C(C)O,6.6,,
CC1(C)OC2COC3(COS(N)(=O)=O)OC(C)(C)OC3C2O1,6.6,,
Cc1ccccc1C(=O)c1c[nH]c(C(=O)NCc2ccco2)c1,6.6,,CHEMBL1171204
CC(C)(C)NC(=O)C(c1c(C(=O)[O-])[nH]c2cc(Cl)ccc12)N(C=O)Cc1ccc(F)c(F)c1,6.6,,
CCCCCCCC(=O)c1cc(OC)c(OC)c(OC)c1CC(=O)OCC,6.6,,
N#Cc1c[nH]c2c(C(N)=O)ccc(OC3CC[NH2+]CC3)c12,6.6,,
Cc1cc2c(-c3ccc(S(=O)(=O)NCC[NH3+])s3)ccnc2[nH]1,6.6,,
O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,6.6,"This molecule appears as needles or white powder. (NTP, 1992) This molecule is a dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group. It is a member of piperidones and a member of phthalimides. This molecule was withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of inflammatory disorders and cancers. Thalidomide displays immunosuppressive and anti-angiogenic activity through modulating the release of inflammatory mediators like tumor necrosis factor-alpha (TNF-a) and other cytokine action. Due to severe teratogenicity, pregnancy must be excluded before the start of treatment and patients must enrol in the THALIDOMID Risk Evaluation and Mitigation Strategy (REMS) program to ensure contraception adherence. This molecule is by means of Decreased Immunologically Active Molecule Activity. This molecule is a synthetic derivative of glutamic acid (alpha-phthalimido-glutarimide) with teratogenic, immunomodulatory, anti-inflammatory and anti-angiogenic properties.  This molecule acts primarily by inhibiting both the production of tumor necrosis factor alpha (TNF-alpha) in stimulated peripheral monocytes and the activities of interleukins and interferons.  This agent also inhibits polymorphonuclear chemotaxis and monocyte phagocytosis.  In addition, thalidomide inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), thereby inhibiting angiogenesis. These molecules are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. These three agents are associated with a low rate of serum aminotransferase elevations during therapy and have been implicated in causing rare instances of clinically apparent liver injury which can be severe. A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppresive and anti-angiogenic activity. It inhibits release of tumor necrosis factor-alpha from monocytes, and modulates other cytokine action. [PubChem]",CHEMBL468
NC(=[NH2+])NC1Cc2ccccc2C1NC(=O)C(=O)Nc1ccc(Cl)c(F)c1,6.6,,
Cc1cccc(Cc2n[nH]c3cc(O)c(C(=O)N(C)Cc4ccccc4)cc23)c1,6.6,,CHEMBL2042870
c1cc2c(ncc3ncn(C4CC[NH2+]CC4)c32)[nH]1,6.6,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)O)C(C)O,6.6,,
COc1cc(OC)c2c(=O)nc(-c3cc(C)c(O)c(C)c3)[nH]c2c1,6.6,,
COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1,6.6,"This molecule has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.",CHEMBL2393130
O=C(NC(CCCCNC(=O)c1ccc(I)cc1)C(=O)[O-])NC(CC1CO1)C(=O)[O-],6.6,,
CC1=C(C(=O)Nc2ccc3n[nH]cc3c2)C(c2ccc(F)cc2)NC(=O)N1,6.6,,
COCCCNC(=O)c1cc(S(N)(=O)=O)cnc1Sc1ccccc1,6.61,,CHEMBL1099124
C#Cc1cccc(S(N)(=O)=O)c1,6.61,,CHEMBL1232090
COc1cc2c(NC3CC[N+](Cc4ccccc4)CC3)nc(NCCC[N+](C)C)nc2cc1OCCCCC[NH3+],6.61,,
COc1cc2ncnc(N3CCCC(c4ccccc4)C3)c2cc1OCCc1ccccn1,6.61,,CHEMBL1819128
CC(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)N1CCC(OC(C)C)C1C(=O)NC(C=O)CC(=O)[O-])C(C)C)C(C)C,6.61,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.62,,
CCC(C)C(NC(=O)C(C)[NH3+])C(=O)NC(C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)CC,6.62,,
CCC(=O)NCC(Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)cc1)NC(C)=CC(=O)c1ccc(C(F)(F)F)cc1,6.62,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(O)C2OC2OC(C)C(O)C(O)C2O)C1OC1OC(C)C(O)C(O)C1O,6.62,,
CC(C)Cn1c(=O)n(C)c(=O)c2nc[nH]c21,6.62,This molecule is a 3-isobutyl-1-methylxanthine. It is functionally related to a 9H-xanthine. It is a tautomer of a 3-isobutyl-1-methyl-7H-xanthine.,CHEMBL275084
CCCc1c(SC2CCCCC2)c2cc(Cl)ccc2[nH]c1=O,6.62,,CHEMBL191146
O=C([O-])c1ccc(-c2ccccc2Cl)o1,6.62,,
O=C1CC(c2ccc(CC(Nc3nc4ccccc4s3)c3nc4ccccc4[nH]3)cc2)S(=O)(=O)N1,6.62,,CHEMBL3901092
OCC1C(O)C(O)C(O)c2nnnn21,6.62,,
O=C([O-])CCCCC1SCC2NC(=O)NC21,6.62,,
COC1CC(C)C(OC)C2=CC(=O)C=C(NC(=O)C(C)=CC=CC(C)C(OC(N)=O)C(C)=CC(C)C1OC)C2=O,6.62,,
COc1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(OC)c1OC,6.62,,CHEMBL256725
CC(=NNC(N)=[NH2+])c1ccc(NC(=O)Nc2ccc(C(C)N=NC(N)=[NH2+])cc2)cc1,6.62,,
Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1,6.62,"This molecule is a member of the class of biphenyls that is the amide obtained by formal condensation of the carboxy group of 2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)[1,1'-biphenyl]-4-carboxylic acid with the amino group of 3-cyanoaniline. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of benzamides, a member of biphenyls, a member of 1,3,4-oxadiazoles and a nitrile.",CHEMBL270164
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)C[NH2+]C2CCCCC2)cc1,6.62,,
NC(=[NH2+])c1ccc(O)c(C[NH2+]CC[NH2+]Cc2cc(C(N)=[NH2+])ccc2O)c1,6.62,,
Nc1n[nH]c(SCc2ccc(Cl)cc2Cl)n1,6.62,,
CCCCC(C[NH2+]C(CCCC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C([NH3+])O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)CC,6.62,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)C[NH2+]C2CCCCC2)cc1,6.62,,
CC(C)Cn1c(C[NH3+])c(-c2ccccc2)c2cc(OCC(N)=O)ccc2c1=O,6.62,,
CC(=O)NC1C(=NOC(=O)Nc2ccccc2)OC(CO)C(O)C1O,6.62,,
O=C1c2ccc(O)c(C[N+]3CCCCCC3)c2OC1Cc1c[nH]c2ccccc12,6.62,,
COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC,6.62,,CHEMBL127907
CCC(C)CNC(=O)C(CC(C)C)CC(O)C(CC1CCCCC1)NC(=O)C(Cc1cnc[nH]1)NC(=O)C(Cc1cccc2ccccc12)Cc1cccc2ccccc12,6.62,,
O=C1CC(NC(=O)c2c(Cl)cccc2Cl)=CC=N1,6.62,,
O=S(=O)(c1ccc(O)cc1O)n1cc2cc(O)cc(O)c2c1,6.62,,
COc1cc(-c2ccc3[nH]cc(-c4cccc(C(O)[NH2+]CC[NH+](C)C)c4)[n+]3n2)ccc1O,6.62,,
CC([NH3+])C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)B(O)O,6.62,,
COC1CCC(C(=O)Nc2cc(-c3ccnc(Nc4ccc(F)cc4)c3)ccn2)CC1,6.63,,
C[NH+](C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.63,,
CCc1cc2c(cc1OS(N)(=O)=O)CCC1C2CCC2(C)C(OS(N)(=O)=O)CCC12,6.63,,
COc1cc(CCc2ccccc2)c(C(=O)[O-])c(O)c1CC=C(C)C,6.63,,
CCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1OC(CO)C(O)C(O)C1O)C(O)C(O)CCCCC,6.63,,
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)=O)CC3OC1CC([NH3+])C(O)C(C)O1,6.63,,
C#Cc1ccc(Nc2c(C(=O)NOCCO)cc(C[NH2+]OCCO)c(F)c2F)c(F)c1,6.63,,
NS(=O)(=O)c1ccc(NC(=O)COC(=O)c2c3c(nc4ccccc24)CCCCC3)cc1,6.63,,
CC(C)c1nc(CN(C)C(=O)NC(C(=O)NC(Cc2ccccc2)CC(O)C(Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,6.63,,
O=c1[nH]ccc2c(NC3CCCCC3)ncnc12,6.63,,CHEMBL2434989
O=c1cc(-c2ccc(Cl)cc2)oc2ccccc12,6.63,,CHEMBL16783
O=C([O-])Cc1ccc(Nc2nc(-c3cccc(Cl)c3)nc(C3CC3)n2)cc1,6.63,,
CC([NH2+]C(CCc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)Nc1ccccc1)C(=O)[O-],6.64,,
O=C1NS(=O)(=O)Nc2c1ncn2C1OC(CO)C(O)C1O,6.64,,
Cc1ccc(S(=O)(=O)Nc2cc(-c3ccc(F)cc3)sc2C(=O)[O-])cc1,6.64,,
CCOc1nc(C(=O)NCc2cc(OC)ccc2OC)ccc1C#N,6.64,,CHEMBL209740
O=S(=O)(NCC[NH2+]CCOCc1ccc(Cl)cc1)c1cccc2cnccc12,6.64,,
CC(C)C(NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(CO)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(C)O)C(=O)[O-],6.64,,
CC(=O)NC(Cc1cnc[nH]1)C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CC(C)C)C(N)=O,6.64,,
CC([NH2+]C(CCc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)Nc1ccccc1)C(=O)[O-],6.64,,
O=CN1CCC(Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1,6.64,,
CCc1cccc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)c1,6.64,,CHEMBL589137
CCNC(=O)c1cc2c(-c3ccc(Cl)cc3Cl)nc(N)nc2s1,6.64,,CHEMBL563168
COC(=O)c1c(C)cc(Oc2cc(C)cc(O)c2O)cc1O,6.64,,CHEMBL1234300
Cc1cc(-c2ccc3c4c(cccc24)COC3)nc(N)n1,6.64,,CHEMBL1834093
COc1cc(Nc2ncc3c(C)nc(-c4ccccc4)n3n2)cc(OC)c1OC,6.64,,CHEMBL519715
[NH3+]C(Cn1oc(=O)[nH]c1=O)C(=O)[O-],6.64,,
C[NH2+]C(C)C(=O)NC(C(=O)N1CCCC1Cn1nnnc1Sc1ccccc1)C(C)OC,6.64,,
OCCNc1cc(-c2n[nH]c3cnccc23)nc(C(F)(F)F)c1,6.64,,CHEMBL3099714
O=C([O-])COc1ccc2sc(CNc3nncc(-c4c(Cl)cccc4Cl)n3)nc2c1,6.64,,
N#Cc1ccc(COCC2OC(n3c(NCc4ccc(Cl)c(Cl)c4)nc4c(N)ncnc43)C(O)C2O)cc1,6.64,,CHEMBL2138026
OCC1OC(O)C(O)C(O)C1O,6.64,,
OCC1C[NH2+]C(O)C(O)C1O,6.65,,
CC(C)CC(NC(=O)C(O)CC(=O)[O-])C(=O)NCCCCNC(N)=[NH2+],6.65,,
[NH3+]C(CC(=O)N1CCCN(C(=O)c2ccc(C(=O)[O-])cc2)CC1)Cc1cc(F)c(F)cc1F,6.65,,
NS(=O)(=O)c1ccc(NC(=O)NC2CCCC2)cc1,6.65,,CHEMBL1615215
Cc1cc(N2CC[NH2+]CC2)nc2ccccc12,6.65,,
CS(=N)(=N)CC(Cc1ccccc1)C(=O)[O-],6.66,,
CC(C)c1ccc(NC(=O)C(Cc2ccccc2)NC(=O)C(CCCC[NH3+])NC(=O)C(F)(F)F)cc1,6.66,,
CCC(C)C(NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(C)[NH3+])C(=O)NC(CC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(C)C(=O)[O-])C(C)O,6.66,,
NC(=[NH2+])c1ccc2[nH]c(-c3cccc(OC4CCCC4)c3O)nc2c1,6.66,,
Cc1nc(C)c(-c2ccnc(Nc3ccc(N(C)C)cc3)n2)s1,6.66,,CHEMBL46817
Cc1nc(C)c(-c2ccnc(Nc3ccc(N(C)C)cc3)n2)s1,6.66,,CHEMBL46817
COc1cc(C)c(S(=O)(=O)NCC(O)C(Cc2ccccc2)[NH2+]Cc2cccc(Cl)c2)c(C)c1C,6.66,,
COc1ccc2[nH]c(C)c(CC(=O)NC(CCCCCC(=O)NO)C(=O)NCCc3c(-c4ccccc4)[nH]c4ccccc34)c2c1,6.66,,
NC(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1,6.66,,CHEMBL500724
CC(=O)NC1C[NH+]2CCC(O)C2C(O)C1O,6.66,,
CNC(=O)Nc1cc(OC)cc(NC(=O)NS(=O)(=O)c2cc(C)c(CCOC)s2)n1,6.66,,CHEMBL1738935
O=C([O-])C(CS)CCCc1ccccc1,6.66,,
Clc1ccccc1Nc1ncc(-c2ccccc2)n2cncc12,6.66,,CHEMBL462228
O=C(CO)N1CCc2c(c(-c3ccc(Cl)c(C#Cc4ccc(Cl)cc4)c3)nn2CCC[NH+]2CCOCC2)C1,6.66,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(C)[NH2+]C(O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1c[nH]c2ccccc12)[NH2+]C(O)C([NH3+])CC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],6.66,,
O=c1[nH]c2ccccc2n1-c1ccc(O)cc1O,6.66,,CHEMBL1802335
Cc1cc(=O)oc2cc3c([N+](=O)[O-])c(O)ccc3cc12,6.66,,CHEMBL270722
OCC1C(O)C(O)C(O)C1[NH2+]CC1CCCCC1,6.66,,
C[NH+](C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,6.66,,
COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2,6.66,This molecule is a member of quinazolines.,CHEMBL2179387
[NH3+]C(CC(=O)[O-])C(=O)[O-],6.66,,
Cc1ccc(S(=O)(=O)Nc2ccc(Oc3ccccc3)cc2C(=O)[O-])cc1,6.66,,
CC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(NC(CO)c4ccccc4)c23)c1,6.66,,
c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1,6.66,,CHEMBL1922082
OCC1C[NH2+]CC(OC2OC(CO)C(O)C(O)C2O)C1O,6.66,,
COc1cc(Nc2ncc3ccn(-c4ccccn4)c3n2)cc(OC)c1OC,6.67,,CHEMBL205098
O=C([O-])CCCCC1SCC2NC(=O)NC21,6.67,,
CC(C)CC([NH3+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)[O-],6.67,,
CC(C)C(NC(=O)C(Cc1ccccc1)CC(O)C(Cc1ccccc1)NC(=O)OC(C)(C)C)c1ncc[nH]1,6.68,,
NC(=[NH2+])c1cc2c(I)cccc2s1,6.68,,
NS(=O)(=O)c1cccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)c1,6.68,,CHEMBL123368
CCCc1cc2c(=O)n(C)oc2c(CCC)c1OC(C(=O)[O-])c1ccc(C(C)C)cc1,6.68,,
CC(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccc(C2CC(=O)NS2(=O)=O)cc1)C(N)=O,6.68,,
O=c1[nH]cnc2c1ncn2C1OC(CO)C(O)C1O,6.68,,
O=C1CCCCCC=CCCOC(=O)c2c(O)cc(O)c(Cl)c2C1,6.68,,
c1ccc(-c2oc3nccc(NCC[NH+]4CC[NH2+]CC4)c3c2-c2ccccc2)cc1,6.68,,
O=S(=O)(Nc1ccc(Cl)cc1)c1ccc2c(c1)C[NH2+]CC2,6.68,,
O=C([O-])COc1c(C(=O)[O-])sc(-c2cccc(NC3CCCCC3)c2)c1Br,6.68,,
NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Cl,6.68,,CHEMBL484510
CCCCCCCCCCCCCCCC(=O)NC(CC(=O)[O-])C[N+](C)(C)C,6.68,,CHEMBL35507
CCc1ccnc2c(N3CCCC3=O)cc(C(=O)NC(Cc3ccccc3)C(O)C[NH2+]Cc3cccc(C(F)(F)F)c3)cc12,6.68,,
NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1,6.68,,CHEMBL590335
CCCC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C([NH3+])CCC(=O)[O-])C(C)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)O,6.68,,
CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,6.68,,CHEMBL52387
O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21,6.68,,CHEMBL226403
O=[N+]([O-])c1ccc(SCCCCCCO)c2nonc12,6.68,,CHEMBL1234570
COc1cccc(NC(=S)N(CCO)Cc2cc3cc(C)c(C)cc3[nH]c2=O)c1,6.68,,CHEMBL1236932
Cc1ccccc1Nc1nc(N2CC[NH2+]CC2)nc2c(NCC3CC3)ncnc12,6.68,,
CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(C(=O)NS(=O)(=O)C2CC2)NC(=O)C2CC(OC(=O)n3cc4cccc(F)c4c3)CN2C1=O,6.68,,
COc1ccc(Nc2ncc3nc(Nc4ccccc4F)n(C4CCCC4)c3n2)cc1,6.68,"These molecules is a member of the class of purines that is carrying 9-cyclopentyl-9H-purine-2,8-diamine in which the amino groups at positions 2 and 8 are carrying 4-methoxyphenyl and 2-fluorophenyl substituents respectively. It has a role as a c-Jun N-terminal kinase inhibitor. It is a member of purines, a member of cyclopentanes, a monomethoxybenzene, a member of monofluorobenzenes, a substituted aniline and a secondary amino compound.",CHEMBL1946325
Cc1ccc2c(c1)nc(CCc1nc(C)c3ncccn13)n2-c1ccccc1,6.68,,CHEMBL3288410
C[N+](C)CCNS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3cccnc3)n2)cc1,6.68,,
CSC(CCCC1C(=[NH2+])NC(=[NH2+])NC1=O)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,6.68,,
CC(C)CC(NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C1CCC[NH2+]1)C(C)O)C(C)O)C(=O)NC(C)C(=O)[O-],6.68,,
O=c1cc(-c2ccccc2)oc2ccc(F)cc12,6.68,,CHEMBL61745
CC1CN(c2nnc(Cc3ccccc3)c3ccc(Cl)cc23)CCN1c1ccc(C#N)cn1,6.68,,
CC12CCCOC1C1(COC(=[NH2+])N1)c1cc(-c3cccnc3F)ccc1O2,6.68,,
CCCn1cnc(CC(CCC[NH3+])C(=O)[O-])c1,6.69,,
NS(=O)(=O)c1cc(C(=O)[O-])c(NCc2ccco2)cc1Cl,6.69,,
O=C(Nc1cccc(C(F)(F)F)c1)C1CCN(c2ncnc3nc[nH]c23)CC1,6.69,,
CN(C1C(=N)N(Cc2ccccc2)C(=O)NC1=O)S(=O)(=O)c1ccc(F)cc1,6.69,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(C)NC(C)=O)C(=O)NC(CO)CCCC[NH3+],6.69,,
C[NH2+]CCC(Oc1cccc2ccccc12)c1cccs1,6.69,,
[NH3+]CCCCC([NH3+])C(=O)NC(Cc1cccc2ccccc12)C(=O)NC(CCCC[NH3+])C(=O)[O-],6.7,,
CCC(C)C(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],6.7,,
Nc1nc(=O)c2c([nH]1)N=CC(CNc1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1)N2C=O,6.7,,
CC(NC(=O)C(Cc1ccccc1)NC(=O)C(F)(F)F)C(=O)Nc1ccc(C(F)(F)F)cc1,6.7,,
Nc1cc(N)c2c(=O)[nH][nH]c(=O)c2c1,6.7,,
O=C1NC2C(O)C(O)C(O)C(CO)N2C1=O,6.7,,
OCC1OC(O)C(O)C(O)C1O,6.7,,
Nc1nccc2c1ncn2C1OC(CO)C(O)C1O,6.7,,CHEMBL17777
CCOC(Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)[O-],6.7,,
Nc1ncnc2c1ncn2C1OC(CSC(CC[NH3+])CCCCC[NH3+])C(O)C1O,6.7,,
OB(O)c1ccc(-c2ccc(B(O)O)cc2)cc1,6.7,,CHEMBL109227
CCCCCCCC1=CC(=O)c2ccccc2[N+]1=O,6.7,,
CCCCCCCCC=CCCCCCCCC(=O)[O-],6.7,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(CC(N)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])C(C)O)C(C)O)C(C)CC)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)[O-],6.7,,
CC(=O)C(CC(=O)[O-])NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(C(=O)[O-])c2)cc1,6.7,,
CC([NH3+])C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(B(O)O)C(C)C,6.7,,
CCNC(=O)C1OC(n2cnc3c(N)ncnc32)C(O)C1O,6.7,This molecule is a purine nucleoside.,CHEMBL277076
CC1(C)CCC(C)(C)c2cc(C3CC=Cc4oc(C=CC(=O)[O-])cc43)ccc21,6.7,,
CCC(C)c1cc(C(=O)NC2C[NH2+]CCCC2OC(=O)c2ccc(C(=O)c3cc(OC)ccc3O)cc2)ccc1O,6.7,,
CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,6.7,,CHEMBL52387
CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)N3Cc3ccc4c(CO)c(OC)ccc4c3)C21,6.7,,
CC(C)CC([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(CO)C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-])C(C)O,6.7,,
O=C(Nc1ccc(Oc2ccc(C(=O)[O-])c(C(=O)[O-])c2)c(NC(=O)c2cccc([N+](=O)[O-])c2)c1)c1cccc([N+](=O)[O-])c1,6.7,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.7,,
CSCCC(NC(=O)C(Cc1cnc[nH]1)NC(=O)C(NC(=O)C(CCCC[NH3+])NC(=O)C(C)NC(=O)C(CO)NC(=O)C(C)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CO)C(=O)N1CCCC1C(=O)O)C(C)C,6.7,,
CCCCCCCCCCCCCC=CC(O)C(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)[NH2+]C(O)CCCCCCC,6.7,,
CCCCCC=CCC=CCCCCCCCC(=O)NC(COC1OC(CO)C(O)C(O)C1O)C(O)C=CCCCCCCCCCCCCC,6.7,,
CC(C)[NH2+]CCCn1c(Sc2cc3c(cc2Br)OCO3)nc2c(N)ncnc21,6.7,,
CC(NC(=O)c1cc(C(=O)OCC([NH3+])(CO)Cc2ccccc2)cc(N(C)S(C)(=O)=O)c1)c1ccc(F)cc1,6.7,,
C[NH+](C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,6.7,,
CC(C)CC([NH3+])C(=O)NC(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NC(CS)C(=O)NCC(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(=O)[O-])C(C)C,6.7,,
CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CCCC[NH3+])NC(=O)C[NH3+])C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C)C(=O)[O-],6.7,,
CCCCCCCCC=CCCCCCCCC(=O)[O-],6.7,,
O=C([O-])C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(-c2ccc(I)cc2)cc1,6.7,,
S=c1[nH]c2c(Br)c(Br)c(Br)c(Br)c2[nH]1,6.7,,CHEMBL608394
COc1cccc(-c2cccc(CCC3(C)CC(=O)N(C)C(=[NH2+])N3)c2)c1,6.7,,
CC1(C)CC(=O)C2=C(C1)NC(S)[NH2+]C2c1cccc(O)c1,6.7,,
O=C1CC(=O)C(Cl)C2=C1C(=O)NCCCC=CCCC(C(=O)NCc1ccccc1)C(=O)C2,6.7,,
O=C(c1c(O)cc(O)cc1O)n1cccc1,6.7,,CHEMBL513225
C=CCOC1(C(=O)[O-])CC(OC2(C(=O)[O-])CC(O)C(O)C(C(O)CO)O2)C(O)C(C(O)CO)O1,6.7,,
O=C([O-])c1ccccc1Nc1cc(Cl)c(OCCCCCCCCCCCOc2c(Cl)cc(Nc3ccccc3C(=O)[O-])cc2Cl)c(Cl)c1,6.7,,
CC(=O)N1CCC2c3cc(C)ccc3NC2C1c1cccc(O)c1,6.7,,
O=C([O-])c1cc2c(ccc3ccc4oc(C(=O)[O-])cc4c32)o1,6.7,,
NS(=O)(=O)c1ccc(CNc2ncnc(O)c2[N+](=O)[O-])cc1,6.7,,
CCN1CC(C)n2c(c(O)c3c(=O)n(Cc4ccc(F)c(Cl)c4)nc(C(=O)NC)c32)C1=O,6.7,,
O=C([O-])c1ccc(=O)n(O)c1,6.7,,
CC=CCCCCC=CCC(=O)[O-],6.7,,
NC(=O)c1ccc(Nc2nc(N)c(C(O)c3cccnc3)s2)cc1,6.7,,
[NH3+]C(Cc1cccc(Cl)c1)C(=O)N1CCN(C(=O)c2cc(F)ccc2F)CC1,6.7,,
O=c1ccn(C2CC(O)C(C[NH2+]C(c3ccccc3)(c3ccccc3)c3ccccc3)O2)c(=O)[nH]1,6.7,,
O=c1ccn(C2CC(O)C(C[NH2+]C(c3ccccc3)c3ccccc3)O2)c(=O)[nH]1,6.7,,
O=C(Nc1cccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)c1)Nc1cccc(C2(O)Nc3ccc(S(=O)(=O)[O-])c4cc(S(=O)(=O)[O-])cc(c34)S(=O)(=O)O2)c1,6.7,,
O=c1[nH]c(=S)n(Cc2ccc(F)cc2)c2[nH]cnc12,6.7,,
CC(C)CC(C=O)NC(=O)CC(O)C(CC(C)C)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(Cc1ccccc1)NC(=O)C1CCC[NH2+]1,6.7,,
[NH2+]=C1NC(c2ccnc(C(F)(F)F)c2)(c2ccc(F)c(-c3cncnc3)c2)c2cccc(F)c21,6.7,,
COc1ccccc1NC(=O)Nc1nn(C)c2cccc(OC)c12,6.7,,CHEMBL1323288
Cc1nc2cnc3[nH]ccc3c2n1C1CC[NH2+]CC1,6.7,,
OCC1[NH2+]CC(O)C(O)C1O,6.7,,
CCOC1CC2CN(C(=O)C(NC(=O)C(C)[NH2+]C)C3CCC(F)(F)CC3)C(C(=O)NC3CCOc4ccccc43)C[NH+]2C1,6.7,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.7,,
CC1CCC(C(=O)N(c2ccc(Oc3ccccc3C(F)(F)F)cc2C(=O)[O-])C(C)C)CC1,6.7,,
NC(=[NH2+])c1ccc(Oc2ccc(NS(=O)(=O)c3ccc(F)cc3)c(Oc3ccc(C(N)=[NH2+])cc3)n2)cc1,6.7,,
CC1(C)OC(=O)N(c2ccc(C(=O)Nc3cccc4cccnc34)cc2)C1c1ccccc1,6.7,,
Cc1nc2c(c(-c3ccc4c(c3)CCCO4)c1C(OC(C)(C)C)C(=O)[O-])CCCC2,6.7,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(OC3(C(=O)[O-])CC(O)C(NC(C)=O)C(C(O)C(O)CO)O3)C2O)C1O,6.7,,
CCCOc1ccc2cccc(-n3cc(NC(N)=O)c(C(N)=O)n3)c2c1,6.7,,
CC(C)Oc1ccc2cccc(-n3cc(NC(N)=O)c(C(N)=O)n3)c2c1,6.7,,
Cc1cc(NCCc2ccc(O)cc2)c2[nH]nc[n+]2n1,6.7,,
CCC(C)C1NC(=O)C(NC(=O)C(C)C(O)C(C)C)C(C)OC(=O)C2COC(=O)CNC(=O)C=CC3(CO3)C(C)Oc3ccc(cc3)C(NC1=O)C(=O)N(C)C(Cc1ccccc1)C(=O)NC(C(C)O)C(=O)N2,6.7,,
C=CCc1cc(Cl)cc(C[NH2+]CCCNC(=O)Nc2ccsc2)c1O,6.7,,
C#Cc1cn(C2OC(CO)C(O)C2O)c2ncnc(N)c12,6.7,,
CC(C)CC(NC(=O)C1CSSC2CSSCC(NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(NC(=O)C[NH3+])C2)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(Cc2c[nH]cn2)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1)C(N)=O,6.7,,
CC(C)(C)OC(=O)NC1C[NH2+]CC(C(=O)N(Cc2cccc(Cl)c2Cl)C2CC2)C1,6.7,,
O=C(Nc1ccc2n[nH]c(-c3ccncc3)c2c1)C1CC[NH+](CC(=O)N2CCN(c3ccc(-c4ncccn4)cc3)CC2)C1,6.7,,
O=C(Nc1ccc2n[nH]c(-c3ccncc3)c2c1)C1CC[NH+](CC(=O)N2CCN(c3ccc(-c4ncccn4)cc3)CC2)C1,6.7,,
CCC(C)C(NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)C)C(C)O)C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)[O-],6.7,,
CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccccc2)n1,6.71,,CHEMBL85860
OCC1OC(OC2C(O)C(O)c3nccn3C2CO)C(O)C(O)C1O,6.71,,
CC(C)(C)CC1[NH2+]C(C(=O)NCCC(O)CO)C(c2cccc(Cl)c2)C1(C#N)c1ccc(Cl)cc1,6.71,,
N#Cc1ccc(OCCC[NH+]2CCC(C(O)(c3cccc(F)c3)C3CCCC3)CC2)cc1,6.71,,
CCC(C)C(NC(=O)CNC(=O)C(CCC(=O)[O-])NC(=O)CNC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CO)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(=O)[O-])C(=O)[O-],6.72,,
CC([NH3+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)N1CCCC1C,6.72,,
CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,6.72,,
CCCCNC(=O)C(C)CC(O)C1CSCC=CCSC2CCC[NH2+]C2C(=O)NC(C)C(=O)N1,6.72,,
COC1OC(C)C(O)C(O)C1O,6.72,,
Cc1ccc(-n2cc(C[NH2+]CC3CCCCC3)c3ccccc32)cc1,6.72,,
CC1=NCCC(C(=O)[O-])N1,6.72,,
Cc1cc2[nH][nH]c(=O)[n+]2c2ccc(-c3cccc(O)c3)cc12,6.72,,
COc1ccc(NC(=O)C2CN(S(C)(=O)=O)CC2C(=O)Nc2ccc(-n3ccccc3=O)cc2F)cc1F,6.72,,
Clc1cnc2c(Nc3ccc(N4CCOCC4)cc3)nc(-c3cccnc3)cn12,6.72,,CHEMBL1231066
Oc1cccc(O)c1,6.72,"This molecule is a very white crystalline solid that becomes pink on exposure to light if not completely pure. Burns although ignition is difficult. Density approximately 1.28 g / cm3. Irritating to skin and eyes. Toxic by skin absorption. Used to make plastics and pharmaceuticals. This molecule is a benzenediol that is benzene dihydroxylated at positions 1 and 3. It has a role as an erythropoietin inhibitor and a sensitiser. It is a benzenediol, a member of resorcinols and a phenolic donor. This molecule is a 1,3-isomer (or meta-isomer) of benzenediol with the formula C6H4(OH)2. It is used as an antiseptic and disinfectant in topical pharmaceutical products in the treatment of skin disorders and infections such as acne, seborrheic dermatitis, eczema, psoriasis, corns, calluses, and warts. It exerts a keratolytic activity. This molecule works by helping to remove hard, scaly, or roughened skin.  Although it is primarily indicated for use as a topical application, resorcinol also possesses a well-documented anti-thyroidal activity that is generally not relied upon for any kind of formal therapeutic indication. This molecule is a natural product found in Dothiorella vidmadera, Maclura pomifera, and other organisms with data available. This molecule is found in alcoholic beverages. This molecule is present in roasted barley, cane molasses, coffee, beer and wine. This molecule is a flavouring ingredientThis molecule belongs to the family of Resorcinols. These are compounds containing a resorcinol moiety, which is a benzene ring bearing two hydrocyl groups at positions 1 and 3.",CHEMBL24147
Oc1ccc2c(-c3cc(Br)c(O)cc3O)noc2c1,6.72,,CHEMBL361078
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(N)=O)C(C)O)C(=O)[O-],6.72,,
O=C(c1ccc(OCC2CCC[NH2+]2)cc1)c1ccc(-c2ccsc2)cc1,6.72,,
CC(NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])CCCC[NH3+])C(C)O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)[O-],6.72,,
[NH3+]C(CCC(=O)NC(CSC1c2ccccc2-c2ccccc2C1O)C(=O)NCC(=O)[O-])C(=O)[O-],6.72,,
CC(C)CC(NC(=O)C(NC(=O)C([NH3+])CNC(=O)c1nnn[nH]1)C(C)C)C(=O)NCC(O)(CCc1ccccc1)C(=O)Nc1cccc(C(=O)[O-])c1,6.72,,
O=S(=O)([O-])OC(C(O)C[S+]1CC(O)C(O)C1CO)C(O)C(O)C(O)CO,6.72,,
O=S(=O)([O-])OC(CO)C(O)C[S+]1CC(O)C(O)C1CO,6.72,,
COCCNC(=O)c1ccc(Nc2ncc3cc(-c4ccncc4)ccc3n2)cc1,6.72,"This molecule is a member of the class of quinazolines that is quinazoline which is substituted by a {4-[(2-methoxyethyl)carbamoyl]phenyl}nitrilo group and a pyridin-4-yl group at positions 2 and 6, respectively. It is a B-Raf and MKNK2 kinase inhibitor. It has a role as a B-Raf inhibitor, an antineoplastic agent and an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor. It is a member of quinazolines, a member of pyridines, a secondary amino compound, a member of benzamides and an ether.",CHEMBL2335864
COc1cccc(-c2cccc(C3(c4ccccc4)NC(=[NH2+])N(C)C3=O)c2)c1,6.72,,
COC(=O)C1CCCN1C(=O)C(Cc1ccccc1)N(C)C(=O)C(C)NC(=O)C(CC(C)C)NC(=O)CC(O)C(Cc1ccccc1)NC(=O)C(CCC(N)=O)N(C)C(=O)C(NC(=O)C(C)O)C(C)C,6.72,,
Cc1ccnc2c(NC(=O)c3ccc(N4C(=O)C5C6C=CC(C6)C5C4=O)cc3)cccc12,6.72,,
Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)OC(C)(C)C)c1nnc(C)n1-2,6.72,"This molecule is an organonitrogen heterocyclic compound, an organosulfur heterocyclic compound and a tert-butyl ester.",CHEMBL2132936
COCC[NH2+]Cc1ccc(Nc2ncc3cc(-c4ccncc4)ccc3n2)cc1,6.72,,
O=c1[nH]cnc2c(C[NH+]3CC(O)C(O)C3CO)csc12,6.72,,
O=c1[nH]cnc2c(C[NH+]3CC(O)C(O)C3CO)csc12,6.72,,
O=C([O-])c1ccc(-c2ccc(C(=S)NCc3ccc(-c4ccnn4-c4ccc(Cl)c(Cl)c4)cc3)c(Cl)c2)o1,6.72,,
O=C([O-])c1cc(-c2ccc(C[NH2+]C(S)c3ccc(-c4ccc(C(=O)[O-])o4)cc3Cl)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,6.72,,
[NH3+]C(CCC(=O)NC(CSC1c2ccccc2-c2ccccc2C1O)C(=O)NCC(=O)[O-])C(=O)[O-],6.72,,
CCC(CC)NC(=O)CC(C(=O)NCC(O)C(Cc1ccccc1)NC(=O)C(NC(=O)c1ccc2ccccc2n1)C(C)O)C(C)(C)C,6.73,,
C=CC[NH+](C)CCCCCCOc1ccc2c(-c3ccc(Br)cc3)nccc2c1,6.73,,
[NH3+]C(CC1=CCCCc2o[nH]c(=O)c21)C(=O)[O-],6.73,,
CC(O)C(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)O,6.73,,
NC(=O)C(Cc1ccc(C2CC(=O)NS2(=O)=O)cc1)NC(=O)C(Cc1ccccc1)NC(=O)c1ccccc1,6.73,,
Cc1oc(-c2ccccc2)nc1CCCc1ccc(CC(C(=O)[O-])n2cccc2)cc1,6.73,,
CC(=O)c1cccc(C(SCC[NH3+])(c2ccccc2)c2ccccc2)c1,6.73,,
CCC(CC)C(NC(C)=O)C1C(NC(N)=[NH2+])CC(C(=O)[O-])C1O,6.73,,
CNc1nc2cc3c(=O)[nH]c(=[NH2+])[nH]c3cc2[nH]1,6.73,,
NS(=O)(=O)OC1CCN(S(=O)(=O)C2OC(CO)C(O)C(O)C2O)C1,6.73,,
CC(=O)NC(C(=O)N1CC(O)CC1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C,6.73,,
Nc1ccnc2c1ncn2C1OC(CO)C(O)C1O,6.74,,
Cc1ccc(NNC(=O)C(O)C([NH3+])CC2CCCCC2)cc1,6.74,,
NC(=[NH2+])NCCCC1NC(=O)C2CCCN2C(=O)C([NH2+]CO)CNC(=O)C=CC(Cc2ccc(O)cc2)NC(=O)C(Cc2ccccc2)NC(=O)C1=O,6.74,,
[NH3+]C(Cc1ccccc1)C(=O)[O-],6.74,,
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(Cc1ccccc1)C(O)C(O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(C)NC(=O)OCc1ccccc1)C(C)C)C(C)C,6.74,,
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(Cc1ccccc1)C(O)C(O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(C)NC(=O)OCc1ccccc1)C(C)C)C(C)C,6.74,,
Nc1ccc2c3c(cccc13)C(=O)NC2=O,6.74,This molecule is a benzoisoquinoline and a dicarboximide.,CHEMBL338790
N=C1NC(=O)C(=Cc2ccc(-c3ccc(S(N)(=O)=O)cc3)o2)S1,6.74,,
O=C1CC(c2ccc(CC(NS(=O)(=O)c3cccc(F)c3)C3=NC(CCc4ccccc4)CN3)cc2)S(=O)(=O)N1,6.74,,
CCNc1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]C2CCCCC2)cc(N2CCCC2=O)c1,6.74,,
COc1ccccc1-n1c(CSc2ncnc3nc[nH]c23)nc2cccc(Cl)c2c1=O,6.74,,
[NH3+]CCCCC([NH2+]C(CCc1ccccc1)C(=O)[O-])C(=O)N1CCCC1C(=O)[O-],6.74,,
CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CC[NH+](C)CC4)cc3OC(F)(F)F)nc1-2,6.74,,
[NH3+]C(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCc1cccc(Cl)c1,6.74,,
CCC([NH3+])C(=O)N1CCCC1C(=O)NCc1ccc(C(N)=[NH2+])cc1,6.74,,
CC[n+]1c(CC(C)=O)sc2ccc(O)cc21,6.74,,
c1ccc(Cc2ccc(OCC[NH+]3CCCC3)cc2)cc1,6.74,,
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,6.74,"This molecule is an oral multi-kinase inhibitor that is used in the therapy of advanced renal cell, liver and thyroid cancer. This molecule has been associated with a low rate of transient elevations in serum aminotransferase levels during therapy that are generally mild and asymptomatic. This molecule has also been linked to rare instances of clinically apparent liver injury which can be severe and even fatal. This molecule is a member of the class of phenylureas that is urea in which one of the nitrogens is substituted by a 4-chloro-3-trifluorophenyl group while the other is substituted by a phenyl group which, in turn, is substituted at the para position by a [2-(methylcarbamoyl)pyridin-4-yl]oxy group. It has a role as an antineoplastic agent, an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor, a tyrosine kinase inhibitor, an angiogenesis inhibitor, an anticoronaviral agent and a ferroptosis inducer. It is a pyridinecarboxamide, a member of monochlorobenzenes, an aromatic ether, a member of (trifluoromethyl)benzenes and a member of phenylureas. This molecule is a bi-aryl urea and an oral multikinase inhibitor. It targets cell surface tyrosine kinase receptors and downstream intracellular kinases that are implicated in tumour cell proliferation and tumour angiogenesis. First approved by the FDA and European Commission in 2007 for the treatment of hepatocellular carcinoma, sorafenib is also indicated to treat renal carcinoma and differentiated thyroid carcinoma. This molecule is a Kinase Inhibitor. The mechanism of action of sorafenib is as a Protein Kinase Inhibitor. This molecule is a synthetic compound targeting growth signaling and angiogenesis. This molecule blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis. This molecule is a natural product found in Aspergillus ochraceus, Curvularia lunata, and Asimina triloba with data available. This molecule is a drug approved for the treatment of advanced renal cell carcinoma (primary kidney cancer). It has also received 'Fast Track' designation by the FDA for the treatment of advanced hepatocellular carcinoma (primary liver cancer), and has since performed well in Phase III trials.
Sorafenib is a small molecular inhibitor of Raf kinase, PDGF (platelet-derived growth factor), VEGF receptor 2 & 3 kinases and c Kit the receptor for Stem cell factor. A growing number of drugs target most of these pathways. The originality of Sorafenib lays in its simultaneous targeting of the Raf/Mek/Erk pathway.",CHEMBL1336
O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1,6.74,,CHEMBL101683
NS(=O)(=O)c1cc(C(=O)CSc2nc3cc4c(cc3[nH]2)OCCO4)ccc1Cl,6.74,,CHEMBL1232443
Cc1c[nH]c2ncnc(N3CCC([NH3+])C3)c12,6.74,,
O=C([O-])Cn1c(C(=O)[O-])cc2ccc3ccccc3c21,6.74,,
CCc1cc2c(cc1OS(N)(=O)=O)CCC1C2CCC2(C)C(O)CCC12,6.74,,
CCC(=O)NCCCCC(NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(NC(=O)C(CO)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C([NH3+])CCCC[NH3+])C(C)O)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(Cc1ccccc1)C(=O)[O-],6.74,,
[NH3+]CCNC(=O)c1ccnc(-c2cc(C(=O)[O-])ccn2)c1,6.74,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(N)=O)NC(=O)C([NH3+])C(C)O)C(C)C)C(C)C)C(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)[O-],6.74,,
CS(=O)(=O)N(CC[NH3+])c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cn1,6.74,,
Cc1cccc2scc(Cn3c(=O)n(CCCC(=O)[O-])c4ccccc43)c12,6.74,,
C[NH+]1CCN(c2nc(O)c(Cc3ccc(Cl)c(Cl)c3)s2)CC1,6.74,,
N#Cc1c(NC(=O)c2cc(S(=O)(=O)N3CCOCC3)c(Cl)cc2Cl)sc2c1CC[NH+](Cc1ccc(O)cc1)C2,6.74,,
O=C(c1csc(-c2ccsc2)n1)n1ccc2ccccc21,6.74,,
CC(C)CC(NC(=O)C(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(C)NC(=O)C(NC(=O)C(CS)NC(=O)C(NC(=O)C[NH3+])C(C)O)C(C)C)C(C)O)C(C)C)C(=O)NC(CO)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-],6.74,,
CC(=O)NC1C(O)OC(CO)C(O)C1OC(C)C(=O)[O-],6.74,,
CSC(CCCC1C(=[NH2+])NC(=[NH2+])NC1=O)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,6.74,,
CN(C)c1cc(-c2ccncc2)c(-c2cccc3ccccc23)nn1,6.74,,CHEMBL4646628
CC(O)C([NH3+])C(=O)NS(=O)(=O)c1cccc(-c2ccc3[nH]ncc3c2)c1,6.74,,
CCOc1ccc(C(=O)Nc2ccc(F)c(C3(C)NC(=[NH2+])OCC3(F)F)c2)nc1,6.74,,
O=C(CCCCCCC(=O)Nc1ccccc1)NO,6.74,"This molecule is an oral histone deacetylase inhibitor and antineoplastic agent that is approved for use in refractory or relapsed cutaneous T cell lymphoma. This molecule is associated with modest rate of minor serum enzyme elevations during therapy, but has not been linked to cases of clinically apparent liver injury. This molecule is a dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL). It has a role as an EC 3.5.1.98 (histone deacetylase) inhibitor, an apoptosis inducer and an antineoplastic agent. It is a hydroxamic acid and a dicarboxylic acid diamide. It is functionally related to a suberic acid, a hydroxylamine and an aniline. This molecule is a drug currently under investigation for the treatment of cutaneous T cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines. It is the first in a new class of agents known as histone deacetylase inhibitors.  A recent study suggested that vorinostat also possesses some activity against recurrent glioblastoma multiforme, resulting in a median overall survival of 5.7 months (compared to 4 - 4.4 months in earlier studies). Further brain tumor trials are planned using combinations of vorinostat with other drugs. This molecule is a Histone Deacetylase Inhibitor. The mechanism of action of vorinostat is as a Histone Deacetylase Inhibitor. This molecule is a synthetic hydroxamic acid derivative with antineoplastic activity. This molecule, a second generation polar-planar compound, binds to the catalytic domain of the histone deacetylases (HDACs). This allows the hydroxamic moiety to chelate zinc ion located in the catalytic pockets of HDAC, thereby inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors. Hyperacetylation of histone proteins results in the upregulation of the cyclin-dependant kinase p21, followed by G1 arrest. Hyperacetylation of non-histone proteins such as tumor suppressor p53, alpha tubulin, and heat-shock protein 90 produces additional anti-proliferative effects. This agent also induces apoptosis and sensitizes tumor cells to cell death processes. This molecule crosses the blood-brain barrier. This molecule is a natural product found in Humicola fuscoatra and Campanularia with data available. This molecule is a drug that has been approved by the U.S. Food and Drug Administration (FDA) under the brand name Zolinza for the treatment of a certain type of cancer.This molecule is also being studied as an investigational drug as part of a strategy to cure HIV infection.As an investigational HIV drug, vorinostat belongs to a group of drugs called latency-reversing agents.",CHEMBL98
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCSC)NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)[O-],6.74,,
CC(C)CN(Cc1ccc(F)cc1)S(=O)(=O)c1ccc(NC2CCN(S(C)(=O)=O)CC2)nc1,6.74,,CHEMBL3361065
O=C(NC(Cc1ccc(F)cc1)C(=O)N1CCC(O)CC1)c1cc2cc(Cl)ccc2[nH]1,6.75,,
CC(C)(C)NC(=O)C1CC2CCCCC2C[N+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,6.75,,
Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,6.75,"This molecule is a dicarboximide that consists of 1-oxoisoindoline bearing an amino substituent at position 4 and a 2,6-dioxopiperidin-3-yl group at position 2. Inhibits the secretion of TNF-alpha. It has a role as an angiogenesis inhibitor, an antineoplastic agent and an immunomodulator. It is a member of isoindoles, a dicarboximide, a member of piperidones and an aromatic amine. This molecule is an immunomodulatory drug with potent antineoplastic, anti-angiogenic, and anti-inflammatory properties. It is a 4-amino-glutamyl analogue of [thalidomide] and like thalidomide, lenalidomide exists as a racemic mixture of the active S(-) and R(+) forms. However, lenalidomide is much safer and potent than thalidomide, with fewer adverse effects and toxicities. Thalidomide and its analogues, including lenalidomide, are referred to as immunomodulatory imide drugs (also known as cereblon modulators), which are a class of immunomodulatory drugs that contain an imide group. Lenalidomide works through various mechanisms of actions that promote malignant cell death and enhance host immunity. Available as oral capsules, lenalidomide is approved by the FDA and EU for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma in selected patients. Due to severe teratogenicity, pregnancy must be excluded before the start of treatment and patients must enroll in the lenalidomide Risk Evaluation and Mitigation Strategy (REMS) program to ensure contraception adherence. This molecule is a Thalidomide Analog. This molecule is a thalidomide analog with potential antineoplastic activity.  This molecule inhibits TNF-alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis.  This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells. This molecule is an immunomodulatory and antineoplastic agent that is used in the therapy of multiple myeloma. This molecule is associated with a low rate of serum aminotransferase elevations during therapy and has been implicated in causing rare instances of clinically apparent liver injury which can be severe.",CHEMBL848
Nc1n[n+]2c(Cc3ccc4c(c3)OCO4)nc3cc(F)cc(NCCO)c3c2[nH]1,6.75,,
Cc1cccc(-c2nn3c(c2-c2ccc(F)cc2)CCC3)n1,6.76,,CHEMBL121790
CN(c1ccc(C(=O)NO)cc1)S(=O)(=O)c1ccc(-c2ccccn2)s1,6.76,,
O=c1[nH]cnc2c(C3[NH2+]C(CO)C(O)C3O)c[nH]c12,6.76,,
CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1OC(CO)C(O)CC1O)C(O)CCCCCCCCCCCCCCC,6.76,,
CCCCS(=O)(=O)N(C)C1C(=N)N(Cc2ccccc2)C(=O)NC1=O,6.76,,
COc1cc(Nc2nccc(N3CCCC(C(=O)NCc4ccc(C)cc4)C3)n2)cc(OC)c1OC,6.76,,
C=C1NC(=O)C(CC)NC(=O)CNC(=O)C(Cc2c[nH]c3cccc(OC)c23)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)c2csc(n2)C(C)NC(=O)CN(C)C1=O,6.76,,
Cc1cccc(Oc2cc(S(=O)(=O)N3CCCC(n4cc(C)c(=O)[nH]c4=O)C3)ccc2C(=O)[O-])c1,6.76,,
COc1ccc(-c2ccc(C(=O)NC(CO)C(C)(C)C)cc2C(=O)[O-])c(C(=O)Nc2cccc(C(N)=O)c2)n1,6.76,,
CC(C)CC1NC(=O)C(Cc2ccc(OC(F)(C(=O)[O-])C(=O)[O-])cc2)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(C)NC(=O)C(CC(=O)[O-])NC(=O)CSCC(C(N)=O)NC1=O,6.77,,
[NH3+]C(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-],6.77,,
[NH3+]C(Cc1co[nH]c1=O)C(=O)[O-],6.77,,
[NH3+]C(Cc1co[nH]c1=O)C(=O)[O-],6.77,,
NC(=[NH2+])c1ccc2[nH]c(-c3cc(C(CC(=O)[O-])C(=O)[O-])cc(-c4ccccc4F)c3O)nc2c1,6.77,,
Cc1cc(Br)c(O)c(-c2nc3cc(C(N)=[NH2+])ccc3[nH]2)c1,6.77,,
Cc1cc(Br)c(O)c(-c2nc3cc(C(N)=[NH2+])ccc3[nH]2)c1,6.77,,
O=C([O-])Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12,6.77,,
CCCCCNC(=O)C(Cc1ccc(N(C(=O)C(=O)[O-])c2ccccc2C(=O)[O-])c(CCC(N)=O)c1)NS(C)(=O)=O,6.77,,
Cn1ccnc1-c1cccc(Oc2nc(Oc3cc(C(N)=[NH2+])ccc3O)c(F)c(N3CCCC(C(=O)[O-])C3)c2F)c1,6.77,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CO)C(C)C)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CO)C(=O)NC(C)C(=O)O,6.77,,
O=S(=O)(NCC[NH2+]CCOCc1ccc(Cl)cc1)c1cccc2cnccc12,6.77,,
Cc1ccc(NC(=O)c2ccc(C[NH+]3CC[NH+](C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,6.77,,
O=S(=O)(NCC[NH2+]CCOCc1ccc(Cl)cc1)c1cccc2cnccc12,6.77,,
[NH3+]C1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,6.77,,
CC(C)CC(C=O)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(CCCC[NH3+])NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C1CCC[NH2+]1)C(C)O,6.77,,
Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1,6.77,,CHEMBL2002702
COc1ccc(CC2C(=O)C(O)C(O)CC2(O)C(=O)[O-])cc1,6.77,,
[NH3+]C(CCC(=O)[O-])C(=O)[O-],6.77,,
[NH3+]C(CC1(C(=O)[O-])CC2OCCC(O)C2O1)C(=O)[O-],6.77,,
CCC(C)C(NC(C)=O)C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CO)CC(=O)[O-],6.77,,
COc1ccc(C2(C34CC5CC(CC(C5)C3)C4)NC(=[NH2+])N(C)C2=O)cc1C,6.77,,
NS(=O)(=O)c1ccc(Nc2ncnc(Cl)c2[N+](=O)[O-])cc1,6.77,,CHEMBL1233722
CC(NC(=O)CCCCC([NH3+])C(=O)[O-])C(O)C(F)(F)F,6.77,,
Nc1n[n+]2c(Cc3ccc4c(c3)OCO4)nc3ccccc3c2[nH]1,6.77,,
COCCCOc1cc(C(=O)N(CC2C[NH2+]CC2Cc2ccccc2)C(C)C)ccc1OC,6.77,,
O=c1cc(-c2ccc(O)c(O)c2)oc2ccccc12,6.77,,CHEMBL222556
CC1(C)Cc2cc(Cl)ccc2C(NC(Cc2ccccc2)c2nc(=O)c3cnccc3[nH]2)=N1,6.77,,
CC12CCC(O)CC1CCC1C2CC(O)C2(C)C(C3=CC(=O)OC3)CCC12O,6.77,,
CCCCN(Cc1cc(Cl)c(OC)c(OC)c1)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,6.78,,CHEMBL493033
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)cc1,6.78,,CHEMBL569943
[NH3+]C(CNc1ncc(-c2ccc3c(c2)CC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1,6.78,,
C=C(C)C(O)C(CC(C)C)NC(=O)C(CCC(=O)N(C)C)NC(=O)C(NC(=O)CCCCC)C(C)C,6.78,,
CCN1CCN(C(=O)NC(C(=O)NC(C=O)C2[NH2+]C(C(=O)[O-])C(C)(C)S2)c2ccccc2)C(=O)C1=O,6.78,,
[NH3+]C(CO)C(=O)[O-],6.79,,
CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(C(=O)NS(=O)(=O)C2CC2)NC(=O)C2CC(OC(=O)n3cc4cccc(F)c4c3)CN2C1=O,6.79,,
CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,6.79,,
COC(=O)c1ccc(-c2cc(=O)c3ccccc3o2)cc1,6.79,,CHEMBL2431800
Cc1cnc(Nc2ccc(OCC[NH+]3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,6.79,,
Fc1ccc(-c2ncn(CC3CC3)c2-c2ccncc2)cc1,6.8,,CHEMBL96741
O=C([O-])CCCC(=O)Nc1ccc(C=Cc2ccccc2)cc1,6.8,,
COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F,6.8,"This molecule is a pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4. It has a role as an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor, a peripheral nervous system drug, an anti-asthmatic drug and a bronchodilator agent. It is an organofluorine compound and a pyridazinone.",CHEMBL313842
CC(C=CC=C(C)c1cc(C(C)(C)C)cc(C(C)(C)C)c1)=CC(=O)[O-],6.8,,
CCCC(=O)NC(C)C(=O)NC(C(=O)NC1C(=O)NC(CC(C)C)C(=O)NC2CCC(O)N(C2=O)C(C(C)O)C(=O)NC(Cc2ccc(O)c(Cl)c2)C(=O)NC(C(C)C)C(=O)OC1C)C(C)O,6.8,,
C=C(C)C1C[NH2+]C(C(=O)[O-])C1CC(=O)[O-],6.8,,
COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2)c(OC(C)C)c1,6.8,,CHEMBL515487
CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12,6.8,This molecule is a member of quinomethanes.,CHEMBL75680
CCOC(=O)c1c(C)nn(-c2ccc(N)cc2)c1C,6.8,,CHEMBL1230397
OC[NH+](O)CCCc1ccccc1,6.8,,
Cc1cc(C2C(=O)Nc3ccc(Cl)cc3C2c2ccccc2)on1,6.8,,
Oc1ccccc1-c1nc(NC2CC[NH2+]C2)c2ccccc2n1,6.8,,
CC(Oc1cc(-n2cnc3ccc(OC4CC[N+](C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,6.8,,
N=CC1(NC(=O)C2CC(S(=O)(=O)c3ccccc3Cl)CN2C(=O)C2(c3ccc(Cl)s3)CC2)CC1,6.8,,
CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,6.8,"This molecule is a pyrrolopyridine that is vemurafenib in which the p-chlorophenyl group has been replaced by chlorine. It is a potent and selective inhibitor of the Raf kinase B-Raf(V600E). It has a role as a B-Raf inhibitor and an antineoplastic agent. It is a pyrrolopyridine, a sulfonamide, a difluorobenzene, an organochlorine compound and an aromatic ketone.",CHEMBL1230020
NC(=[NH2+])NCCCC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(CS)C(=O)O,6.8,,
C[NH+]1CC[NH+](C2CC(c3nc(-c4ccc5ccc(-c6ccccc6)nc5c4)c4c(N)nccn34)C2)CC1,6.8,,
c1ccc(CNc2ccc(OCC3CCC[NH2+]3)cc2)cc1,6.8,,
C=CC[NH+]1CCN(c2c(Cl)cccc2NC(=O)c2ccc(Br)o2)CC1,6.8,,
O=C([O-])C(Cc1ccccc1)CC(O)(O)C[N+](=O)[O-],6.8,,
CCCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(C)CC2OC)C(O)C(=O)N2CCCCC2C(=O)OC(C(C)=CC2CCC(O)C(OC)C2)C(C)C(O)CC1O,6.8,,
Nc1nccc(Nc2cc(-c3cc4ccccc4o3)c3[nH]ncc3c2)n1,6.8,,CHEMBL590110
OCC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1O,6.8,,
CCNc1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1,6.8,,CHEMBL1614771
CC([NH3+])C(=O)NC1CSCc2cc3cc(c2)CSCC(NC(=O)C(CC(=O)[O-])NC(=O)C(C(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC1=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(CO)C(=O)NC(C)C(=O)NC(C(=O)[O-])CSC3,6.8,,
[NH3+]C(Cn1c(=O)n(Cc2ccsc2C(=O)[O-])c(=O)c2cscc21)C(=O)[O-],6.8,,
Cc1ccc(CNC(=O)C(CCc2ccccc2)NC(=O)C(Cc2nc(C(C)(C)C)no2)NC(=O)c2cc(C)on2)cc1,6.8,,
COc1ccc(Br)cc1CC1SC(=O)N(Cc2ccc(C)cc2)C1=O,6.8,,
C[S+](O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,6.8,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C1CCCN1C(=O)C(CCC(=O)[O-])NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(CS)NC(=O)C[NH3+])C(=O)NC(CC(C)C)C(=O)NC(C(=O)[O-])C(C)O,6.8,,
CSCCC(NC(=O)CNC(=O)C([NH3+])C(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NCC(=O)NC(C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O,6.8,,
O=c1[nH]cc(Br)c2sc(-c3ccncc3)cc12,6.8,,CHEMBL1738952
O=S(=O)([O-])OC1C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C1OS(=O)(=O)[O-],6.8,,
CCC(C)C(NC(=O)C([NH2+]CC(CC(C)C)NC(=O)C(Cc1cnc[nH]1)NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(Cc1cnc[nH]1)NC(=O)C1CCC[NH2+]1)C(C)C)C(=O)NC(Cc1cnc[nH]1)C(N)=O,6.8,,
Cc1ccc(O)cc1N1C(O)=C2CCCCC2c2c(N)ncnc21,6.8,,
Cc1ccc(S(=O)(=O)Nc2cc(Oc3ccccc3)ccc2C(=O)[O-])cc1,6.8,,
O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(NC3CCC(O)CC3)c3nccn3c2c1,6.8,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(OC3(C(=O)[O-])CC(O)C(NC(C)=O)C(C(O)C(O)CO)O3)C2O)C1O,6.8,,
CC(=O)OCC1OC(OCCCOc2cccc(OCc3cc(-c4ccc(Cl)s4)on3)c2NC(=O)C2CC[NH+](C(C)C)CC2)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O,6.8,,
CCCCNC(=O)C(NC(=O)C(C)CC(O)C1CSCC=CCSCC(NC(=O)OC(C)(C)C)C(=O)NC(C)C(=O)N1)C(C)C,6.81,,
CC(C(=O)N1CCOCC1)N1CCC(NS(=O)(=O)CCc2ccc(Cl)s2)C1=O,6.81,,
NC(=[NH2+])NC=CCC(NC(=O)C(CSCc1ccccc1)NC(=O)Cc1ccc(C2C=CCCC2)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCCc1ccccc1,6.81,,
COc1cc2nc(NCCC[N+](C)C)nc(NC3CC[N+](Cc4ccccc4)CC3)c2cc1OC,6.81,,
Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,6.81,"This molecule is an immunomodulatory and antineoplastic agent that is used in the therapy of multiple myeloma. This molecule, like the structurally related agents thalidomide and lenalidomide, is associated with a low rate of serum aminotransferase elevations during therapy and has been implicated in causing rare instances of clinically apparent liver injury which can be severe. This molecule is an aromatic amine that is thalidomide substituted at position 4 on the isoindole ring system by an amino group. Used for the treatment of multiple myeloma in patients who failed to respond to previous therapies. It has a role as an antineoplastic agent, an immunomodulator and an angiogenesis inhibitor. It is a dicarboximide, a member of isoindoles, a member of piperidones and an aromatic amine. It is functionally related to a thalidomide. This molecule is an immunomodulatory antineoplastic agent. FDA approved on February 8, 2013. This molecule is a Thalidomide Analog. This molecule is an orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities. Although its exact mechanism of action has yet to be fully elucidated, pomalidomide appears to inhibit TNF-alpha production, enhance the activity of T cells and natural killer (NK) cells and enhance antibody-dependent cellular cytotoxicity (ADCC). In addition, pomalidomide may inhibit tumor angiogenesis, promote cell cycle arrest in susceptible tumor cell populations, and stimulate erythropoeisis.",CHEMBL43452
CC(C)CC(NC(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)[O-],6.81,,
C[NH2+]CCC=C1c2ccccc2CCc2ccccc21,6.81,,
Cc1c(CC(N)=O)c2cc(OCCCC(=O)[O-])ccc2n1Cc1ccccc1,6.82,,
OC1COC(O)C(O)C1O,6.82,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL14343
OC1COC(OC2Cn3ccnc3C(O)C2O)C(O)C1O,6.82,,
Cc1onc(-c2ccccc2Cl)c1C(=O)NCB(O)O,6.82,,CHEMBL324688
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)[O-],6.82,,
[NH3+]CCCCC([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)[O-],6.82,,
COc1cc(C)c(S(=O)(=O)NC(CC(=O)[O-])C(=O)NC(Cc2ccc(C(N)=[NH2+])cc2)C(=O)N2CCCCC2)c(C)c1C,6.82,,
O=C([O-])Cc1cccc2ccccc12,6.82,,
CC(C)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)C([NH3+])C(C)O)C(C)O)C(=O)[O-],6.82,,
Oc1ccc2cc(Oc3ccc(Cl)cc3O)ccc2c1,6.82,,
NC(=[NH2+])c1ccc2[nH]c(-c3cc(CC[NH3+])cc(-c4ccccc4)c3O)nc2c1,6.82,,
NC(=[NH2+])c1ccc2[nH]c(-c3cc(CC[NH3+])cc(-c4ccccc4)c3O)nc2c1,6.82,,
O=C1c2ccccc2-c2n[nH]c3cccc1c23,6.82,"This molecule is a member of the class of anthrapyrazoles that is anthra[1,9-cd]pyrazole substituted at position 6 by an oxo group. An inhibitor of c-Jun N-terminal kinase. It has a role as a c-Jun N-terminal kinase inhibitor, a geroprotector and an antineoplastic agent. It is an anthrapyrazole, a cyclic ketone and an aromatic ketone.",CHEMBL7064
[NH3+]C(Cn1oc(=O)[nH]c1=O)C(=O)[O-],6.82,,
CCCCOC1OC(CO)C(O)C(O)C1O,6.82,,
CCCCOC1OC(CO)C(O)C(O)C1O,6.82,,
CC1(C)CCCN(c2ccc(O)c(C(=O)c3ccc(C(=O)NC4CCC[NH2+]CC4NC(=O)c4ccncc4)cc3)c2)C1,6.82,,
CCCc1c(OCCCOc2ccc3c(ccn3CC(=O)[O-])c2)ccc2c(C(F)(F)F)noc12,6.82,,
CC(=O)c1ccc(-c2cc(NS(=O)(=O)c3ccc(C)cc3C)c(C(=O)[O-])s2)s1,6.82,,
O=c1[nH]ccc2c(S(=O)(=O)N3CCC[NH2+]CC3)cccc12,6.82,,
CC([NH3+])C1CCC(C(=O)Nc2ccncc2)CC1,6.82,,
O=C(C=Cc1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,6.82,,CHEMBL2131289
CC(C)CC(NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(C)C(=O)N1CCCC1C(=O)[O-],6.82,,
O=c1[nH]c2c(Br)c(Br)c(Br)c(Br)c2[nH]1,6.82,,CHEMBL221360
Cc1c(O)cccc1C(=O)NC(CSc1ccccc1)C(O)C[NH+]1CC2CCCCC2CC1C(=O)NC(C)(C)C,6.82,,
CC(C)(C)NS(=O)(=O)c1ccc(C2C[NH2+]C3CCCC([NH2+]C4CCCC[NH2+]4)C3C2)cc1,6.82,,
O=C([O-])C(Cc1ccccc1)C[N+](=O)[O-],6.82,,
Nc1ncc2cc(-c3ccccc3)c(N3CCCC3)nc2n1,6.82,,
CC(=S)NC1C(OC2C(CO)OC(OC3C(CO)OC4SC(C)=NC4C3O)C(NC(C)=S)C2O)OC(CO)C(O)C1O,6.82,,
C[NH+](C)CCOc1ccc(-c2cc(C(N)=O)c(NC(N)=O)s2)cc1,6.82,,
CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,6.82,,
Cc1nc(-c2ccccc2Nc2ncnc3[nH]ccc23)n[nH]1,6.82,,
CC(C)CC(NC(=O)C([NH3+])Cc1ccc(O)cc1)C(=O)NC(C)C(=O)[O-],6.82,,
C[S+](O)C1C([NH3+])C(O)C(O)C1O,6.82,,
O=C([O-])c1ccccc1Nc1cc(Cl)c(OCCCCCCCOc2c(Cl)cc(Nc3ccccc3C(=O)[O-])cc2Cl)c(Cl)c1,6.82,,
CC(C=CC1(O)C(C)=CC(=O)CC1(C)C)=CC(=O)[O-],6.82,,
CC(=O)N1CCc2c(c(-c3ccc(C(F)(F)F)c(SCC(=O)n4cccc4)c3)nn2CC(O)C[N+]2CCC(C(C)(C)O)CC2)C1,6.82,,
COc1ncnc(NCCc2ccc(S(N)(=O)=O)cc2)c1[N+](=O)[O-],6.82,,CHEMBL1233768
CC(C)CC([NH3+])C(=O)NC(CO)C(=O)NC(CS)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],6.82,,
CC(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,6.82,,CHEMBL1231370
CCCN1C(=O)OCC1Cc1cc(CC2CS(=O)(=O)CC([NH2+]Cc3cccc(C(C)C)c3)C2O)ccc1O,6.82,,
NS(=O)(=O)c1ccco1,6.82,,
Cc1cc(C)nc(SCC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)n1,6.82,,CHEMBL2010997
COC(=O)C(CS)NC(=O)C(CO)NC(=O)C([NH3+])CO,6.82,,
CCC(C)C(NC(=O)C(CC[Se]C)NC(C)=O)C(=O)NC(CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NC1(C)CCCC=CCCCC(C)(C(=O)NC(CCC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)[O-])NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(CO)NC1=O,6.82,,
O=C(C1C[NH2+]CC12CCCc1ccccc12)N1CCC(c2ccccc2)CC1c1ccccc1,6.82,,
[NH3+]CCCNc1nc(-c2ccccc2O)nc2ccccc12,6.82,,
CCOc1cc2[nH]c(-c3[nH]ncc3NC(=O)N(CC)CC)nc2cc1F,6.82,,
O=C(NC(CSCc1ccccn1)C(=O)[O-])c1ncccc1O,6.82,,
CCCN(CCC)C(=O)c1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]C(C)(C)c2cccc(OC)c2)cc(N2CCCCS2(=O)=O)c1,6.82,,
CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,6.82,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)[O-])C(C)O)C(C)O,6.82,,
[NH3+]CCCNc1nc(-c2ccccc2O)nc2ccccc12,6.82,,
CC1(C)CC(=O)Nc2cc(NC(=O)c3cc(-c4ccc5nc(N)ncc5c4)ccc3F)ccc21,6.82,,CHEMBL3099719
CC1=C(N)C(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)=CC(C)C1=O,6.82,,
CC(c1cccc2ccccc12)[NH+]1CCC(C(=O)NCc2cccc(F)c2)CC1,6.82,,
O=C([O-])c1ccccc1[S+](O)Cc1ccccc1,6.82,,
O=c1nc(-c2ccc(-c3nnn[nH]3)cc2)[nH]cc1O,6.82,,
CC1(C)SC(C(NC(=O)Cc2ccccc2)C(=O)NCc2ccccc2)[NH2+]C1C(=O)NC(CO)Cc1ccccc1,6.83,,
Cc1cncc2cccc(S(=O)(=O)N3CCC[NH2+]CC3C)c12,6.83,,
Cc1c(-c2ccnc(Nc3ccc(N4CC[NH2+]CC4)cc3)n2)sc(=O)n1C,6.83,,
O=C1NC(=O)c2ccccc2C1=O,6.83,,CHEMBL206435
[NH3+]C(CCCC[Br+3]([O-])([O-])[O-])C(=O)[O-],6.83,,
Fc1cc(-c2ccnc(Nc3ccc(-n4cnc(N5CCOCC5)n4)cc3)n2)cc(N2CCOCC2)c1,6.83,,
c1ccc(C2CC[NH2+]C3(CCN(c4ncnc5nc[nH]c45)CC3)C2)cc1,6.83,,
CNc1nc(C)c(-c2nc(Nc3cccc(C(=O)N4CCOCC4)c3)ncc2C#N)s1,6.83,,CHEMBL2312191
CC[NH+]1CC[NH+](Cc2ccc(NC(=O)c3ccc(C)c(Oc4ccnc5[nH]ccc45)c3)cc2C(F)(F)F)CC1,6.83,,
CCC(C)C(NC(=O)C(CO)NC(=O)C([NH3+])Cc1ccccc1)C(=O)NC(C(=O)NCC(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(=O)[O-])C(=O)NC(CS)C(=O)[O-])C(C)C,6.83,,
NC(=[NH2+])NCCCNC(=O)C1CSC2CCC(NS(=O)(=O)Cc3ccccc3)C(=O)N21,6.84,,
O=C(NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)CO)OCc1ccccc1,6.84,,
[NH3+]CC1CC[NH+](Cc2ccc3[nH]c(-c4cc5ccccc5[nH]c4=O)cc3c2)CC1,6.84,,
C[N+](C)(C)CCCN1C(=O)C2C(C1=O)C(c1ncc(-c3ccc(Cl)s3)o1)[NH+]1CCCC21,6.84,,
Nc1nccc(-c2cc3c([nH]2)C(CCF)CNC3=O)n1,6.84,,CHEMBL443669
CC(C)CC(CC(=O)NO)C(=O)NC(C(=O)NC(C)C(=O)NCC[NH3+])C(C)(C)C,6.84,,
COc1ccc(COc2cnc(COc3nc(-c4cnn(C)c4)cnc3N)cc2OC)cc1,6.84,,CHEMBL1087662
O=C1Nc2ccc(S(=O)(=O)c3ccccc3)cc2C(=O)[N+]1=O,6.84,,
Nc1nc(N)c2nc(CNc3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc3)cnc2n1,6.84,,
N#Cc1ccc(-c2cc(=O)c3ccccc3o2)cc1,6.84,,CHEMBL2431802
C[NH+]1CCN(C(=O)c2ccc(-c3cc(=O)c4ccccc4o3)cc2)CC1,6.84,,
CNc1nc2cc3c(=O)[nH]c(=[NH2+])[nH]c3cc2[nH]1,6.84,,
OC1COC(O)C(O)C1O,6.85,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL14343
CC(NC(=O)C(NC(=O)C(F)(F)F)C(C)C)C(=O)Nc1ccc(C(F)(F)F)cc1,6.85,,
CCOC(=O)CON=C(c1ccccn1)C1(c2ccc3c(c2)nc(CNc2ccc(C(N)=[NH2+])cc2)n3C)CC1,6.85,,
C=CC[NH+](C)CCCCCCOc1ccc(-c2nsc3cc(Br)ccc23)cc1,6.85,,
Cc1cc(SC2=C(O)CC(CCc3ccc(O)cc3)(C3CCCC3)OC2=O)c(C(C)(C)C)cc1N,6.85,,
COC(=O)C1C(OC(=O)c2ccccc2)CC2CCC1[NH+]2C,6.85,,
C[NH+]1C2CCC1C(C(=O)[O-])C(OC(=O)c1ccccc1)C2,6.85,,
CCOc1cc(OC)ccc1C1=NC(c2ccc(Br)cc2)C(c2ccc(Br)cc2)N1C(=O)N1CC[NH+](CCO)CC1,6.85,,
CCCCCCCCCCCC[N+](C)(C)O,6.85,,
Nc1n[nH]c2nnc(-c3c(-c4ccccc4)[nH][n+]4ccccc34)cc12,6.85,,
C[NH+](C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,6.85,,
[NH3+]C(CS)C(=O)[O-],6.85,,
CCOCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccnc(Oc2ccccc2O)n1,6.85,,CHEMBL371491
O=S(=O)([O-])CCC[NH+]1CCOCC1,6.85,,
CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)[O-])cc3)ccc21,6.85,,
Cc1ccc(Cl)c(N(CC#N)c2cc(Nc3ccc(OCC(O)C[NH+](C)C)cc3)ncn2)c1,6.85,,
CNC(=O)c1ccc(Nc2ncc(Br)s2)cc1,6.85,,
O=C(Nc1cn[nH]c1C(=O)Nc1ccc(F)cc1)c1ccccc1,6.85,,
O=C(NC1CC[NH2+]CC1)c1[nH]ncc1NC(=O)c1c(F)cccc1F,6.85,,
O=c1c(Cc2ccccc2)c(Cl)[nH]c2ncnn12,6.85,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(Cc1c[nH]cn1)C(=O)[O-])C(C)C,6.85,,
COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1OCCC[NH+](C)CCO,6.85,,
C#CCOc1ccc(S(=O)(=O)NC(Cc2c[nH]c3ccc(C)cc23)C(=O)[O-])cc1,6.85,,
CNS(=O)(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NC3CCCC3[NH+](C)C)n2)cc1,6.85,,
CC(=O)NC1C(OC(C)C(NC(=O)C[NH3+])C(=O)NC(CCCC[NH3+])C(=O)N2CCCC2C(=O)N2CCCC2C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(C)C)C(=O)[O-])OC(CO)C(O)C1O,6.85,,
O=C([O-])C1(O)C=C(C=CCOc2ccccc2)C(O)C(O)C1,6.85,,
CCCCCC(CC(=O)NO)C(=O)NC(C(=O)N1CCCC1CO)C(C)C,6.85,,CHEMBL67311
COc1ccc(S(=O)(=O)N2Cc3cc(-c4ccc(CO)o4)ccc3N(Cc3cncn3C)CC2Cc2ccc(OC(=O)NCc3ccccc3)cc2)cc1,6.85,,
CC([NH3+])C(=O)NC(C)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CO)C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O)C(C)O,6.85,,
C[NH2+]C1C(=O)NC2Cc3ccc(cc3)Oc3cc4cc(c3O)Oc3ccc(cc3Cl)C(O)C3NC(=O)C(NC(=O)C4NC(=O)C(NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1ccc(O)cc1C(C(=O)NCCC[N+](C)C)NC3=O,6.85,,
O=C(Cc1ccccc1)Nc1nnc(CC=S)s1,6.85,,
CC(C)CC(NC(=O)C(NC(=O)C([NH3+])C(C)O)C(C)C)C(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)[O-],6.85,,
CC(C)(C)c1cccc(C[NH2+]C2CS(=O)(=O)CC(Cc3cc(F)c4c(c3)C3(CCC(F)(F)CC3)CN4)C2O)c1,6.85,,
N#Cc1ccc2nc(Nc3ccc(Oc4ncccc4C(F)(F)F)cc3)[nH]c2c1,6.85,,CHEMBL2071607
CCCCC(NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)[NH2+]CC(Cc1ccccc1)NC(=O)C(NC(=O)C([NH3+])CCCNC(C)=[NH2+])C(C)C)C(=O)[O-],6.85,,
O=c1cc(-c2ccccc2)oc2ccccc12,6.85,"This molecule is the simplest member of the class of flavones that consists of 4H-chromen-4-one bearing a phenyl substituent at position 2. It has a role as a metabolite and a nematicide. This molecule is a natural product found in Camellia sinensis, Anaphalis lactea, and other organisms with data available. This molecule is a flavonoid that forms the ""backbone"" for many other flavonoids, including the citrus flavonoids rutin, hesperidin, naringin and tangeritin. In studies, quercetin is found to be the most active of the flavonoids, and many medicinal plants owe much of their activity to their high quercetin content. This molecule has demonstrated significant anti-inflammatory activity because of direct inhibition of several initial processes of inflammation. For example, it inhibits both the manufacture and release of histamine and other allergic/inflammatory mediators. In addition, it exerts potent antioxidant activity and vitamin C-sparing action.",CHEMBL275638
CN(C)c1ccc(C(c2ccc(O)cc2)c2ccc(N(C)C)cc2)cc1,6.85,,
NC(=O)C1=CN(C2OC(CO)C(O)C2O)C=CC1,6.85,,
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2C=C2)CC1,6.85,,
C=CC1CN(CCOc2ccc(OC)c(OC)c2)C(=O)C2CCCC1N2S(=O)(=O)c1cc(Cl)cc(Cl)c1,6.85,,
Cc1cc(-c2csc(Nc3ccc(C(=O)[O-])c(O)c3)n2)ccc1F,6.86,,
CC(C)(C)OC(=O)NC(Cc1ccccc1)C(O)C[N+](C)(Cc1ccccc1)NC(=O)c1ccccc1,6.86,,
O=C1NC(=O)C(c2cn(-c3ccccc3)nc2-c2ccc(F)cc2)N1,6.86,,CHEMBL1311135
CC(C)CC([NH2+]C(CCNC(=O)OCc1ccccc1)C(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NCC[NH+]1CCOCC1,6.87,,
CCC(C)C(NC(=O)C([NH3+])CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)[O-],6.87,,
COc1cc2c(NC3CC[N+](CCCCC[NH3+])CC3)nc(NCCC[N+](C)C)nc2cc1OCCCCC[NH3+],6.87,,
COc1ccc(Cc2nc(O)c(O)c(C(=O)[O-])n2)cc1Br,6.87,,
COc1ccc(N=C(S)NCCCn2ccnc2)cc1OC,6.87,,
NC(=[NH2+])c1cccc(-c2cccc(C(CCCNc3ccncc3)C(=O)[O-])c2)c1,6.88,,
[NH3+]CCCCC([NH2+]C(CCc1ccccc1)C(=O)[O-])C(=O)N1CC=CC1C(=O)[O-],6.88,,
O=C(NCC=CC1OC(Sc2ccncc2)C(O)C1O)c1cc([N+](=O)[O-])cc(O)c1O,6.88,,
CCCCCC=CCC=CC=CC=CCC(O)CCCC(=O)[O-],6.88,,
CNc1nc(C)c(-c2nc(Nc3cccc(N4CCCN(C(C)=O)CC4)c3)ncc2C#N)s1,6.88,,CHEMBL2348651
CCc1ccccc1NC(=O)CSc1nc2cccnc2[nH]1,6.88,,
COc1ccc(C2OCC(C)C(C(C)C(OC)C(C)CCC(=O)C(C)C(CC=CN(C)C=O)OC)O2)cc1,6.88,,
Cc1cc(-c2nn(C(C)C)c3ncnc(N)c23)cc2ccc(OCc3ccccc3)nc12,6.88,,
CC(=O)NCCCCNc1ncnc2c1ncn2C1OC(C[NH+](CCCNC(=O)Nc2ccc(C(C)(C)C)cc2)C(C)C)C(O)C1O,6.88,,
[NH3+]CCCCC([NH3+])C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CCCC[NH3+])C(=O)[O-],6.89,,
OC1C[NH2+]CCC1OC1OCC(O)C(O)C1O,6.89,,
[NH3+]CCCCC([NH3+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCC[NH3+])C(=O)[O-],6.89,,
NC(=[NH2+])CCCCC(C=O)C1CCCC1O,6.89,,
Nc1nc2c(s1)CC(NC(=O)C1CCCN1C(=O)C(CC1CCCCC1)NS(=O)(=O)Cc1ccccc1)CC2,6.89,,
O=C1NCC(CO)C(O)C1O,6.89,,
CC(C)C(CO)Nc1nc(Nc2ccc(C(=O)[O-])c(Cl)c2)c2ncn(C(C)C)c2n1,6.89,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)[O-],6.89,,
CCCS(=O)(=O)NC(C(=O)NC(CCSC)C(=O)NCc1ccc(C(N)=[NH2+])cc1)C(C)O,6.89,,
OC1COC(O)C(O)C1O,6.89,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL14343
Cc1cn(CC([NH3+])C(=O)[O-])c(=O)n(Cc2ccsc2C(=O)[O-])c1=O,6.89,,
O=C1NS(=O)(=O)Nc2nc[nH]c21,6.89,,CHEMBL484860
COc1ccc(S(=O)(=O)N(CC(=O)N=O)CC(C)C)cc1,6.89,,
Nc1ccc(S(=O)(=O)N(Cc2ccccc2)C2C[NH2+]CC2N(Cc2ccccc2)S(=O)(=O)c2ccc(N)cc2)cc1,6.89,,
OC=C(O)C1OC(O)C(O)=C1O,6.89,,
Cc1ccc2sc(COC3=CC(O)(C(=O)[O-])CC(O)C3O)cc2c1,6.89,,
Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O,6.89,"This molecule is a member of the class of quinazolines that is quinazolin-4(3H)-one carrying (6-amino-9H-purin-9-yl)methyl, 2-methylphenyl and methyl substituents at positions 2, 3 and 5 respectively. It has a role as an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor. It is a member of quinazolines, a member of 6-aminopurines and a biaryl.",CHEMBL1213082
Cc1ccc(C2(C(=O)N3CC(S(=O)(=O)c4ccccc4Cl)CC3C(=O)NC3(C=N)CC3)CC2)cc1,6.89,,
O=C(OC1CC2CCC(C1)[N+]2CCc1ccccc1)c1ccccc1,6.89,,
CC=C(C)C=CC=CC(OC)C(C)C(OC)C(C)CCc1oc2c(O)c(OC)cc(OC)c2c(=O)c1C,6.89,,
N#Cc1cnc(Nc2cc(NCC3CC[NH2+]CC3)ncn2)cn1,6.89,,
NC(=[NH2+])NC1CCC(CNC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)Cc2ccc(Cl)c(Cl)c2)CC1,6.89,,
CC(C=CC(=O)NO)=CC(C)C(=O)c1ccc(N(C)C)cc1,6.89,,
[NH3+]C(CC1(C(=O)[O-])CC2OCCCC2O1)C(=O)[O-],6.89,,
O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12,6.89,,CHEMBL583144
O=C([O-])c1ccc2[nH]c(C3C(=O)Nc4c(Br)cccc43)c(NO)c2c1,6.89,,
O=S(=O)([O-])OC(C(O)C[S+]1CC(O)C(O)C1CO)C(O)C(O)C(O)CO,6.89,,
O=C(CC(Cc1ccc(-c2ccc3c(c2)OCO3)cc1)C(=O)NC1c2ccccc2CC1O)NO,6.89,,
CCC(NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(C)=O)C(C)O)C(=O)[O-],6.89,,
COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2,6.89,,CHEMBL2002649
COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2,6.89,,CHEMBL2002649
O=C([O-])c1nc(Cc2c(-c3ccccc3)[nH]c3ccccc23)nc(O)c1O,6.89,,
Cc1cc(-c2c(Cl)cccc2OCCCC(F)(F)F)nc(N)n1,6.89,,CHEMBL1738804
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(O)c1ccccc1,6.89,,
COC(C(O)COC=O)C1OC(C(=O)[O-])CC(NC(N)=[NH2+])C1NC(C)=O,6.89,,
COCCCOc1ccccc1N1CC[N+](CC([NH3+])C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)CC1=O,6.89,,
O=c1[nH]ccc2oc(-c3ccncc3)cc12,6.89,,CHEMBL1738951
O=c1[nH]cc(-c2ccc(O)cc2)c2sc(-c3ccncc3)cc12,6.89,,CHEMBL1738953
Cc1nc2ccc(NC(=O)CCNC(=O)NCCOc3ccc(CC(C(=O)[O-])C(=O)[O-])cc3)cc2s1,6.89,,
O=C([O-])C(=O)CC(=O)C1(Cc2ccc(Cl)cc2)CCCN(S(=O)(=O)Cc2ccccc2)C1,6.89,,
COc1ccccc1NC(=O)N1CCCc2ccccc21,6.89,,
CC=CCCCC(C(=O)N1CCCC1C(=O)OC)N(C)C(=O)C(C)NC(=O)C(CC(C)C)NC(=O)CC(O)C(Cc1ccccc1)NC(=O)c1cc(NS(C)(=O)=O)cc(C(=O)NC(C)c2ccccc2)c1,6.89,,
NC(=O)CCC([NH3+])C(=O)[O-],6.89,,
CCC(CC)OC1CC(C(=O)[O-])=CC(n2cc(C(C)(C)O)nn2)C1NC(C)=O,6.89,,
Cc1cnc(Nc2ccc(N3CC[NH+](C)CC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,6.89,,
CC(O)(c1cnc(-c2ccc(S(=O)(=O)c3ccc(N)nc3)s2)c(Cl)c1)C(F)(F)F,6.89,,CHEMBL3578099
NC(=[NH2+])c1cccc(CC(NS(=O)(=O)c2ccc3ccccc3c2)C(=O)N2CC[NH2+]CC2)c1,6.9,,
CCC(=O)Nc1ccc2ncnc(Nc3ccccc3)c2c1,6.9,,
O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21,6.9,,CHEMBL226471
Nc1ncc(C(=O)N(Cc2ccccc2)Cc2ccccc2)o1,6.9,,CHEMBL1234905
CC(C)(C)C(O)C(=O)NS(=O)(=O)OCC1OC(n2cnc3c(N)ncnc32)C(O)C1O,6.9,,
O=C(Nc1ccccc1C(=O)[O-])c1cccc(S(=O)(=O)N2CCc3ccccc3C2)c1,6.9,,
[NH3+]C(CC1(C(=O)[O-])CC2OCCCC2O1)C(=O)[O-],6.9,,
CSCCC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)[O-],6.9,,
CC1CCCN1c1cccc(Nc2cc(-c3ccccc3)nn3ccnc23)n1,6.9,,CHEMBL2177733
CCc1ccccc1NC(=O)CSc1nc2cccnc2[nH]1,6.9,,
CC(=O)NC(BO)Cc1cccc2ccccc12,6.9,,
CC(c1nc(-c2ccc(S(C)(=O)=O)cc2)no1)C([NH3+])C(=O)n1cccc1,6.91,,
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCC[NH+]1CCOCC1,6.91,,
COC(c1ccccc1)C1NC(=O)C(C)NC(=O)C(CC(C)CO)N(C)C(=O)C(C(O)c2cn(C(C)(C)C(C)O)c3ccccc23)NC(=O)C(C(C)C=C(C)C)NC(=O)C(CC(C)C)N(C)C(=O)C(C(C)C)NC1=O,6.91,,
CNc1nc(C)c(-c2nc(Nc3ccc(C)c(S(=O)(=O)N4CCOCC4)c3)ncc2C#N)s1,6.91,,CHEMBL2312189
[NH3+]C1CCC(Nc2nc3c(c(Nc4cccc(C(F)(F)F)c4)n2)C(=O)N=CC3)CC1,6.91,,
CC(=O)NC(CC1CCCCC1)C(O)CC(C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)C(C)C,6.92,,
CC(C)CC(NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])Cc1c[nH]cn1)C(=O)NC(CCC(=O)O)C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)O,6.92,,
CC(c1ccccc1)C(CC(O)C[NH+]1CC[NH+](Cc2ccc3c(c2)OCO3)CC1C(=O)NC(C)(C)C)C(=O)NC1c2ccccc2CC1O,6.92,,
CC(C)COc1cccc(-c2nc3cc(C(N)=[NH2+])ccc3[nH]2)c1O,6.92,,
CC(C)COc1cccc(-c2nc3cc(C(N)=[NH2+])ccc3[nH]2)c1O,6.92,,
CC(=O)NC(Cc1ccc(C(=O)[O-])c(CO)c1)C(=O)NC1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O,6.92,,
COC(=O)c1c(O)cccc1OCCCCNC(=O)C(Cc1ccc(N(C(=O)C(=O)[O-])c2ccccc2C(=O)[O-])cc1)NC(=O)[O-],6.92,,
O=C([O-])CCCCC1SCC2NC(=O)NC21,6.92,,
O=C(Nc1ccc(I)cc1)NC1CCCCC1,6.92,This molecule is a member of the class of phenylureas that is urea in which a hydrogen attached to one nitrogen is replaced by a cyclohexyl group and a hydrogen attached to the other nitrogen is replaced by a p-iodophenyl group. It is an organoiodine compound and a member of phenylureas.,CHEMBL1231797
CC1(C(=O)[O-])OCC(OC(=O)N2CCN(C(=O)OC3COC(C)(C(=O)[O-])OC3)CC2)CO1,6.92,,
Cc1ccccc1S(=O)(=O)Nc1cc(-c2ccc(C#N)cc2)sc1C(=O)[O-],6.92,,
CC(C=CC=C(C)CCC1=C(C)CCCC1(C)C)=CC(=O)[O-],6.92,,
CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,6.92,,
CC(=O)C1=C(O)N2C(C1=O)C1c3c[nH]c4cccc(c34)CC1C2(C)C,6.92,,
CC(=O)C1=C(O)N2C(C1=O)C1c3c[nH]c4cccc(c34)CC1C2(C)C,6.92,,
COC(=O)NC(C(=O)NN(Cc1ccc(Br)cc1)C(=O)CCC(O)(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O)C(C)(C)C,6.92,,
CNS(=O)(=O)c1ccc(-c2ccc(C=C3SC(=N)NC3=O)o2)cc1,6.92,,
CC(C)(C)C(NC(=O)OC1CCCC1)C(=O)N1CC(Oc2nccc3ccccc23)CC1C(=O)NC(CCO)B(O)O,6.92,,
CN(C)c1nnc(CS(N)(=O)=O)s1,6.92,,CHEMBL403287
CC(C)CC(NC(=O)C(CC(N)=O)NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CO)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCC(N)=O)C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)O)C(C)C,6.92,,
Oc1ccc(Cc2nnc3ccc(-c4ccccc4)nn23)cc1,6.92,,CHEMBL495898
O=C(Nc1cccc(-c2n[nH]c3ccc(-c4ncn[nH]4)cc23)c1)c1ccco1,6.92,,
c1cnn2ncc(-c3ccnc(NC4CC4)n3)c2c1,6.92,,CHEMBL525194
N=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,6.92,,
O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,6.92,,CHEMBL583972
CCC(C)C(NC(=O)C(NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCCC[NH3+])C(C)CC)C(C)C)C(C)C)C(=O)[O-],6.92,,
NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)CCc1cc(-c2ccccc2)no1,6.92,,
CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.92,,CHEMBL188762
CCCN(CCC)C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C2C[NH+](Cc3ccccc3)CC[NH2+]2)c1,6.92,,
[NH3+]C1CCC(Nc2cncc(-c3ccc4oc(C(=O)[O-])cc4c3)n2)CC1,6.92,,
CC(C)c1ccc(N=Nc2ccc(O)cc2)cc1,6.92,,
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C(C)NC(=O)C(NC(=O)C1C=CCN1C(=O)CNC(=O)C(C)[NH3+])C(C)O)C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(N)=O)C(=O)[O-])C(C)O,6.92,,
CC(C)C(=O)C(=O)[O-],6.92,,
CCCCCCCCCCCCCCCCCC(=O)[O-],6.92,,
CC1OC(=O)C(c2ccc(F)cc2)=C1c1ccc2c(c1)NC(=O)CO2,6.92,,CHEMBL2419306
N#Cc1ccc(-c2ccc(OCC(=O)[O-])cc2C[NH+]2CCN(c3ccccn3)CC2)cc1,6.92,,
Nc1nc(-c2ccccc2)cn1NC(=O)Nc1ccccc1F,6.92,,CHEMBL3989093
Cc1cn(C2CCC[N+](Cc3ccc(C(=O)[O-])c(Oc4cccc(C(F)(F)F)c4)c3)C2)c(=O)[nH]c1=O,6.92,,
Cn1cnc2nc(N)[nH]c(=O)c21,6.92,,
CC(C)CC(NC(=O)OCc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(C=O)CCC(=O)N(C)C,6.92,,
N#CC(Cc1cccc(C(=O)c2c[nH]c3ncccc23)c1)C(N)=O,6.92,,
COc1ccc2cc(C(C)C(=O)[O-])ccc2c1,6.92,,
CCC(C)C(NC(=O)C(CO)NC(C)=O)C(=O)NC(CO)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)CC)C(C)O,6.92,,
O=C([O-])c1sc(-c2ccccc2)cc1N1C(=O)CCC1C1CCCCC1,6.92,,
Cc1[nH]c2ccccc2c1CC(=O)NC(Cc1ccccc1)C(=O)N(C)c1ccccc1,6.92,,
Cc1ncccc1-c1nc2c(Cl)cccc2cc1C(C)Nc1ncnc2nc[nH]c12,6.92,,
CCC(C)C(NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(C)[NH3+])C(=O)NC(CC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)[O-])C(C)O,6.93,,
NS(=O)(=O)c1cccc(F)c1,6.93,,
CNC(=O)c1cccc(C)c1Nc1nc(N2CCN(c3ccccc3Cl)CC2)nc(N2CSCC2C(=O)NC)n1,6.93,,
COc1cc(N2CCC([NH+]3CC[NH+](C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,6.93,,
CC(C)CC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CO)NC(=O)C[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CCC(N)=O)C(=O)NCC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-])C(C)C,6.94,,
CCS(=O)(=O)Nc1cccc(Cc2nn(C(C)C)c3ncnc(N)c23)c1,6.94,,CHEMBL3907668
CN(C)c1cc(-c2ccncc2)c(-c2ccc3ccccc3c2)nn1,6.94,,CHEMBL4648060
O=c1cc(-c2ccc(-c3nnn[nH]3)cc2)oc2ccccc12,6.94,,CHEMBL2431804
Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cccc(S(=O)(=O)[O-])c23)cc1NC(=O)c1cccc([N+](=O)[O-])c1,6.94,,
NS(=O)(=O)c1ccc(OCCC[NH+]2CCC(C(O)(c3ccccn3)C3CCCC3)CC2)cc1,6.94,,
NC(=[NH2+])NCCCC(NC(=O)C[NH3+])C(=O)NCC(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(=O)N1CCCC1C(=O)[O-],6.94,,
COc1ccc(OC)c(C=Cc2cnc3nc(N)nc(N)c3c2C)c1,6.95,,
CC(C)C(NC(=O)C(Cc1ccccc1)CC(O)C(Cc1ccccc1)NC(=O)OC(C)(C)C)c1ncc[nH]1,6.95,,
CCCC(CCC)S(=O)(=O)CC(NC(=O)OCc1ccccc1)C(=O)NC(Cc1ccccc1)C(O)C[NH2+]Cc1cccc(OC)c1,6.95,,
CCCCCc1ccc(C(=O)N(Cc2ccc(N(C)c3ccncc3)cc2)C2CC[NH+](CCC(C)C)CC2)cc1,6.95,,
CC(C)c1onc(-c2c(Cl)cccc2Cl)c1COc1ccc(C=Cc2cccc(C(=O)[O-])c2)c(Cl)c1,6.95,,
C=C1CC23C=CC(=O)C(C)(CCC(=O)NC4C(=O)CC=C(C(=O)[O-])C4=O)C2CC1CC3,6.95,,
CC(C)CC(NC(=O)C(C)[NH2+]C(O)CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(C)C(=O)Nc1ccc([N+](=O)[O-])cc1,6.95,,
CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,6.95,,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1,6.95,,CHEMBL2425144
CNc1nc2cc3c(=O)[nH]c(=[NH2+])[nH]c3cc2[nH]1,6.95,,
CC(=O)Nc1ccc2c(S(=O)(=O)[O-])cccc2c1S(=O)(=O)[O-],6.96,,
[NH3+]C(CCCC[B-](O)(O)O)C(=O)[O-],6.96,,
CC(C)COc1cccc(-c2nc3cc(F)c(C(N)=[NH2+])cc3[nH]2)c1O,6.96,,
CC(C)CC(NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CS)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)[O-],6.96,,
Nc1nc2[nH]cc(CCc3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc3)c2c(=O)[nH]1,6.96,,
OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O,6.96,,
CCOC(=O)CON=C(c1ccccn1)C1(c2ccc3c(c2)nc(CNc2ccc(C(N)=[NH2+])cc2)n3C)CC1,6.96,,
CC(C)SCCC([NH3+])C(O)C(=O)NNC(=O)c1cccc(Cl)c1,6.96,,
CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2=O,6.96,,
Cc1ccccc1CNC(=O)C1N(C(=O)C(O)C(Cc2ccccc2)NC(=O)c2cccc(O)c2C)CSC1(C)C,6.96,,CHEMBL185500
O=C1CC(c2ccc(CC(NC(=O)C(F)(F)F)c3nc4ccc(C(F)(F)F)cc4[nH]3)cc2)S(=O)(=O)N1,6.96,,
CC1=C(C(=O)c2ccccc2)C(c2cccc(O)c2)NC(=S)N1C,6.96,,CHEMBL1213953
[NH3+]C(COc1cncc(-c2cc3c[nH]nc3cn2)c1)Cc1c[nH]c2ccccc12,6.96,,
CCN=C1OCC2C(O)C(O)C(O)C(O)N12,6.96,,
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(N)(=O)=O)sc3OCC)nc12,6.96,,CHEMBL1236703
Nc1cc(Oc2ccc(NC(=O)NC(=O)Cc3ccc(F)cc3)cc2F)ccn1,6.96,,CHEMBL527066
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C([NH3+])CCC(=O)[O-])C(C)O)C(=O)NC(CO)C(=O)[O-],6.96,,
CCOC(=O)C1=C(O)N(O)c2ncccc2C1O,6.96,,
CCC(CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C(C)C)c2n1,6.96,,
CC(C)(C)c1cc(C(=O)N2CCS(=O)(=O)CC2)c(NC(=O)Nc2ccc3ccccc3c2)s1,6.96,,CHEMBL1929196
CCCCSc1nc(N)c2ncn(C3OC(CO)C(O)C3O)c2n1,6.96,,
Cc1c2c(n3c1CCC[NH2+]CC(C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,6.96,,
CC(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C,6.96,,
CCCS(=O)(=O)Nc1ccc(F)c(C(=O)Nc2cnc(N)c(Br)c2)c1F,6.96,,CHEMBL1945020
CN(c1ccc(Cl)cc1)C1C=CN(Cc2ccc(CCCCc3ccc(Cn4ccc(=[N+](C)C)cc4)cc3)cc2)C=C1,6.96,,
[NH2+]=C1NC(=O)C2C(=O)C(CC(=O)[O-])=NN=C2N1,6.96,,
NC(=[NH2+])NCC1Cc2ccccc2C1NC(=O)C(=O)Nc1ccc(Cl)c(F)c1,6.96,,
[NH2+]=C1NC2(CO1)c1cc(-c3cncc(Cl)c3)ccc1OC1COCCC12,6.96,,
Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl,6.96,"This molecule is a manufactured chemical that does not occur naturally. Pure pentachlorophenol exists as colorless crystals. Impure pentachlorophenol (the form usually found at hazardous waste sites) is dark gray to brown and exists as dust, beads, or flakes. Humans are usually exposed to impure pentachlorophenol (also called technical grade pentachlorophenol). This molecule was widely used as a pesticide and wood preservative. Since 1984, the purchase and use of pentachlorophenol has been restricted to certified applicators. It is no longer available to the general public. It is still used industrially as a wood preservative for utility poles, railroad ties, and wharf pilings. This molecule appears as a white crystalline solid. Slightly soluble in water. Noncombustible. Toxic by inhalation, ingestion, and skin absorption. Used as a fungicide and as a wood preservative. This molecule is a chlorophenol that is phenol substituted by 5 chloro groups. It has a role as a human xenobiotic metabolite. It is an organochlorine pesticide, a member of pentachlorobenzenes, an aromatic fungicide and a chlorophenol. It is functionally related to a pentachlorobenzene. It is a conjugate acid of a pentachlorophenolate. This molecule was once one of the most widely used biocides in the United States, but it is now a restricted use pesticide and is no longer available to the general public. It was primarily used as a wood preservative. This molecule is extremely toxic to humans from acute (short-term) ingestion and inhalation exposure. Acute inhalation exposures in humans have resulted in neurological, blood, and liver effects, and eye irritation. Chronic (long-term) exposure to pentachlorophenol by inhalation in humans has resulted in effects on the respiratory tract, blood, kidney, liver, immune system, eyes, nose, and skin. Human studies are inconclusive regarding pentachlorophenol exposure and reproductive effects. Human studies suggest an association between exposure to pentachlorophenol and cancer. Oral animal studies have reported increases in liver tumors and two uncommon tumor types. EPA has classified pentachlorophenol as a Group B2, probable human carcinogen. This molecule is a natural product found in Bos taurus with data available. This molecule is an organochlorine compound used as a pesticide and a disinfectant. First produced in the 1930s, it is marketed under many trade names. It can be found in two forms: PCP itself or as the sodium salt of PCP, which dissolves easily in water. Short-term exposure to large amounts of PCP can cause harmful effects on the liver, kidneys, blood, lungs, nervous system, immune system, and gastrointestinal tract. Elevated temperature, profuse sweating, uncoordinated movement, muscle twitching, and coma are additional side effects. Contact with PCP (particularly in the form of vapor) can irritate the skin, eyes, and mouth. Long-term exposure to low levels such as those that occur in the workplace can cause damage to the liver, kidneys, blood, and nervous system. Finally exposure to PCP is also associated with carcinogenic, renal, and neurological effects. The U.S. Environmental Protection Agency Toxicity Class classifies PCP in group B2 (probable human carcinogen).",CHEMBL75967
CNC(=O)C(NC(=O)C(CC(C)C)C(O)C(=O)NO)C(C)(C)C,6.97,,CHEMBL3828531
CN(C(=O)c1cc2c(s1)-c1ccccc1OC2)c1ccccc1Cl,6.97,,CHEMBL1796267
CC(=O)OC1C(COS(N)(=O)=O)OC(O)C(O)C1O,6.97,,
O=C(CCc1ccccc1)N(Cc1nc2ccccc2c(=O)[nH]1)Cc1cccs1,6.97,,CHEMBL2419711
COCCN1CCCCC(NC(=O)C(CC(C)C)C(CCCO)C(=O)NO)C1=O,6.98,,
[NH3+]C(Cn1cc(I)c(=O)[nH]c1=O)C(=O)[O-],6.98,,
Cc1ccc2c(c1C)CN(C(=O)N(C)C)CC2c1cccc(O)c1,6.98,,CHEMBL380367
Nc1nc2ncc(CO)nc2c(=O)[nH]1,6.98,This molecule is a natural product found in Arabidopsis thaliana with data available.,CHEMBL101541
CCC(=O)OC1C(=O)OC(COS(N)(=O)=O)C(OC(=O)CC)C1OC(=O)CC,6.98,,
COc1ccc(C#CCOC2OC(CO)C(O)C(O)C2O)cc1,6.98,,
COc1ccc(C#CCOC2OC(CO)C(O)C(O)C2O)cc1,6.98,,
CC[NH+]1CC[NH+](Cc2ccc(C(=O)Nc3ccc(C)c(Oc4ccc5c(c4)CC(=O)N5)c3)cc2C(F)(F)F)CC1,6.98,,
O=C(NC(CCCCNC(=O)c1ccc(I)cc1)C(=O)[O-])NC(Cc1ccncc1)C(=O)[O-],6.98,,
NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,6.99,,CHEMBL319467
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(C(=O)NC(C)C(=O)NCC(=O)NC(C(=O)NC(C)C(=O)NCC(=O)NC(CC(C)C)C(=O)[O-])C(C)C)C(C)CC)C(C)O)C(C)O,6.99,,
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(Cc1ccccc1)C(O)C(O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(C)NC(=O)OCc1ccccc1)C(C)C)C(C)C,6.99,,
CCCCCCC(O)C(CCCCCC)C(=O)[O-],6.99,,
CC(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(Cc1ccccc1)C(N)=O,6.99,,
O=C([O-])CCCCC1SCC2NC(=O)NC21,6.99,,
CC(NC(=O)C(CS)NC(=O)C[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(CCC(=O)[O-])C(=O)NCC(=O)[O-],6.99,,
COc1ccc(NC(=S)NCCCn2ccnc2)cc1OC,6.99,,CHEMBL201747
COc1ccc(NC(S)=NCCCn2ccnc2)cc1OC,6.99,,
CC1(C)COC(=O)CCCCCCCCCCCOC(=O)C2CCCCN2C(=O)C1=O,7.0,,CHEMBL109750
CCC1CCN(C(=O)C(CCCNC(N)=[NH2+])NS(=O)(=O)c2cccc3c(N(C)C)cccc23)CC1,7.0,,
NC(=[NH2+])c1cc2cc(-c3cccc(-c4ccccc4)c3O)[nH]c2cc1Cl,7.0,,
Cc1ccc(NC(=O)c2ccc(C[NH+]3CC[NH+](C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,7.0,,
CC(C)CC(NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])Cc1c[nH]cn1)C(=O)NC(CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)[O-],7.0,,
CC(C)CC(NC(=O)C([NH3+])CCC(N)=O)C(=O)NC(CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)[O-],7.0,,
COc1cc(C(=O)NC(Cc2ccccc2)C(O)CN(CCc2ccc3c(c2)OCO3)C(=O)CCN2C(=O)c3ccccc3C2=O)cc(OC)c1OCc1ccccc1,7.0,,
O=S(=O)(c1ccccc1)N(CC(F)(F)F)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,7.0,This molecule is an LXRalpha and LXRbeta agonist. This molecule is a natural product found in Aspergillus puniceus with data available.,CHEMBL62136
CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)[O-],7.0,,
O=NC1=c2ccccc2=NC1=C1C(=O)Nc2ccccc21,7.0,,
CC(=O)c1ccc(C)cc1NC(C(N)=O)c1c(Cl)cccc1Cl,7.0,,CHEMBL37624
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(C)NC(=O)C([NH3+])CO)C(C)C)C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1cnc[nH]1)C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)O,7.0,,
O=C([O-])C(=Cc1ccc(Oc2ccccc2Br)cc1)NC(=O)c1ccccc1,7.0,,
OCC1OC(OC2C(OC3C(OC4C(O)C(O)OC(CO)C4O)OC(CO)C(O)C3O)OC(CO)C(O)C2O)C(O)C(O)C1O,7.0,,
OCC1OC(OC2C(OCC3OC(O)C(O)C(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4O)C3O)OC(CO)C(O)C2O)C(O)C(O)C1O,7.0,,
CN1CCn2c1nc1c(Br)c(Br)c(Br)c(Br)c12,7.0,,
C=C(C)C1CCC2(C)OC2C1,7.0,This molecule is an epoxide resulting from the formal epoxidation of the cyclic double bond of limonene. It has a role as a plant metabolite. It is a limonene monoterpenoid and an epoxide.,CHEMBL2268547
NC(=O)C1Cc2ccccc2CN1C(=O)CC([NH3+])Cc1ccccc1F,7.0,,
Cc1ccc(C(=O)N(CCC[NH3+])C(c2nn3ccc(Cl)c3c(=O)n2Cc2ccccc2)C2CC2)cc1,7.0,,
O=C(NO)C(O)C(O)CO,7.0,,
O=C([O-])Cc1cn2c(n1)C(O)C(O)C(O)C2CO,7.0,,
Cc1c(Br)c(=O)oc2c(Br)c(O)ccc12,7.0,This molecule is a hydroxycoumarin.,CHEMBL273101
Brc1cnn2c(NCc3cncnc3)cc(-c3ccccc3)cc12,7.0,,
Brc1cnc2c(NCc3cncnc3)cc(-c3ccccc3)cn12,7.0,,
CC(C)C(=O)c1ccc(OCc2ccc(-c3ccc(S(=O)(=O)NC(C(=O)[O-])C(C)C)cc3)cc2)cc1,7.0,,
O=C1CC(c2ccc(CC(NS(=O)(=O)c3cccc(C(F)(F)F)c3)c3nc(-c4ccccc4)c[nH]3)cc2)S(=O)(=O)N1,7.0,,
CC(C)CC(NC(=O)C(NC(=O)OCc1ccccc1)C(C)OC(C)(C)C)C(=O)NC(CCC(=O)C1CC1)CC1CCNC1=O,7.0,,
CC(Nc1cc2c(-c3cc(Cl)cc(CCCO)c3)noc2cn1)c1ccccc1,7.0,,
O=C1CC=C(Cc2ccc(Cl)c(Oc3ccccc3)c2F)N=N1,7.0,,
CCC(C)C(NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(C)[NH3+])C(=O)NC(C)C(=O)NC(CO)C(=O)NCC(=O)[O-],7.0,,
CC(NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)[O-],7.0,,
[NH3+]C(CC1CCCCC1)C(=O)N1CCCC1C(=O)NCc1cccc(Cl)c1,7.0,,
CCCCC(C[NH2+]C(CCCC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)CC,7.0,,
C[N+]1(C)CCOC(O)(c2ccc(-c3ccc(C4(O)C[N+](C)(C)CCO4)cc3)cc2)C1,7.0,This molecule is a member of morpholines.,CHEMBL268697
CCCCC(CCS(=O)(=O)c1ccccc1)NC(=O)C1CCCCC1C(=O)c1ccc(Cl)cc1,7.0,,
CC=COC1(C(=O)[O-])CC(OC2(C(=O)[O-])CCC(O)C(C(O)CO)O2)C(O)C(C(O)CO)O1,7.0,,
CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,7.0,This molecule is a 3-hydroxy steroid. It has a role as an androgen. This molecule is a natural product found in Punica granatum with data available.,CHEMBL268313
N=Cc1nc(CCC[NH+]2CCCCC2)cc(C2CCCCCC2)n1,7.0,,
Nc1cccc(Cn2c(-c3ccc(Oc4cncnc4)cc3)ccc2-c2ccccc2Cl)n1,7.0,,CHEMBL1091999
O=S(=O)([O-])OC(C(O)C[S+]1CC(O)C(O)C1CO)C(O)C(O)C(O)CO,7.0,,
NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCC[N+]1CCCC1,7.0,,
O=C([O-])c1cc2cc3ccc4oc(C(=O)[O-])cc4c3cc2o1,7.0,,
NS(=O)(=O)c1ccc(CNc2ncnc(NCc3ccccc3)c2[N+](=O)[O-])cc1,7.0,,CHEMBL1233727
Cc1cc(Nc2nn(C(C)C)c(=O)c3cc(N4CC[NH+](C)CC4)ccc23)[nH]n1,7.0,,
N#CCNc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1,7.0,,CHEMBL1615182
CCn1c(=O)n(C2CCCN(c3nccc(-c4cc5ccccc5o4)n3)C2)c2ccccc21,7.0,,CHEMBL1761282
COc1cccc(C(O)c2sc(Nc3ccc(S(N)(=O)=O)cc3)nc2N)c1,7.0,,
[NH3+]C(CCC(=O)[O-])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCC(=O)[O-])C(=O)[O-],7.0,,
CC(=O)OC1C(COS(N)(=O)=O)OC(O)C(O)C1OC(C)=O,7.0,,
O=C(Nc1ccccc1N1CC[NH2+]CC1)c1csc(-c2ccc3occc3c2)n1,7.0,,
CC(NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C([NH3+])CS)C(=O)NC(C)C(=O)NC(C(=O)[O-])C(C)O,7.0,,
Nc1ccccc1Nc1ccc2c(c1)CCc1ccccc1C2O,7.0,,
COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n(C(C)c3ccccn3)c12,7.0,,
CNC(NC)=[NH+]CCCC(NC(=O)C(C)[NH3+])C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(C(N)=O)C(C)O)C(C)O,7.0,,
OCC1C[NH2+]C(O)C(O)C1O,7.0,,
COc1ccc(CC2C(=O)C(O)C(O)CC2(O)C(=O)[O-])cc1,7.0,,
c1cc2c(cc1Nc1ccc3nnnn3n1)CCC2,7.0,,
CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(=O)[O-])NC(=O)C(C)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CO)NC(=O)C(C)[NH3+])C(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(=O)[O-])C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)[O-],7.0,,
O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,7.0,"These molecules is a tetrahydroxyflavone in which the four hydroxy groups are located at positions 3', 4', 5 and 7. It is thought to play an important role in the human body as an antioxidant, a free radical scavenger, an anti-inflammatory agent and an immune system modulator as well as being active against several cancers. It has a role as an EC 2.3.1.85 (fatty acid synthase) inhibitor, an antineoplastic agent, a vascular endothelial growth factor receptor antagonist, a plant metabolite, a nephroprotective agent, an angiogenesis inhibitor, a c-Jun N-terminal kinase inhibitor, an anti-inflammatory agent, an apoptosis inducer, a radical scavenger and an immunomodulator. It is a 3'-hydroxyflavonoid and a tetrahydroxyflavone. It is a conjugate acid of a luteolin-7-olate. This molecule is a naturally-occurring flavonoid, with potential anti-oxidant, anti-inflammatory, apoptosis-inducing and chemopreventive activities. Upon administration, luteolin scavenges free radicals, protects cells from reactive oxygen species (ROS)-induced damage and induces direct cell cycle arrest and apoptosis in tumor cells. This inhibits tumor cell proliferation and suppresses metastasis. This molecule is a natural product found in Camellia sinensis, Codonopsis lanceolata, and other organisms with data available. This molecule is a mineral with formula of Bi3+2O3 or Bi2O3. The IMA symbol is Bis.",CHEMBL151
CSc1nc(-c2ccc(C)cc2C)c2c(C#N)c[nH]c2n1,7.0,,CHEMBL2158581
CCC(CC)(c1ccc(OCC(=O)NO)c(C)c1)c1ccc(OCC(O)C(C)(C)C)c(C)c1,7.0,,
CNC(=O)C(Cc1cnc[nH]1)NC(=O)C[NH+](CCCc1ccccc1)CC(=O)[O-],7.0,,
CCC(=O)NCCCCC(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(NC(=O)C(CCSC)NC(=O)C(C)NC(=O)C(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(C)=O)C(C)C)C(C)C)C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)C,7.0,,
CCOP(=O)(COc1ccc(CCc2cnc3c(c2)C(=O)N(C)c2cccnc2N3CC)cc1)OCC,7.0,,CHEMBL2335856
Nc1ncc2c(n1)-c1c([nH]c3ccc(Br)cc13)CCC2,7.0,,CHEMBL2334583
CC(=O)NC1C(OC2C(O)C(O)OC(CO)C2O)OC(CO)C(OC2OC(CO)C(O)C(OC3(C(=O)[O-])CC(O)C(NC(C)=O)C(C(O)C(O)CO)O3)C2O)C1O,7.0,,
CC(C)[NH+]1CCC(C(=O)Nc2c(OCCCOC3OC(CO)C(O)C(O)C3O)cccc2OCc2cc(-c3ccc(Cl)s3)on2)CC1,7.0,,
CC(Nc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1F)C(=O)N(C)C,7.0,,
CN(C)c1ccc2c(c1)CCN(c1cccc(-c3cc(Nc4ccc(C(=O)N5CCOCC5)cn4)c(=O)n(C)c3)c1CO)C2=O,7.0,,CHEMBL4116421
CC(=O)NC(CCC(N)=O)C(=O)NC(CC1CCCCC1)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(Cc1ccc(Cl)c(Cl)c1)C(=O)[O-],7.0,,
C=C1C(O)C2OC3(CCC(C=CC(C)C4CC(C)=CC5(OC(CC(C)(O)C(=O)[O-])CCC5O)O4)O3)CCC2OC1C(O)CC(C)C1OC2(CCCCO2)CCC1C,7.01,,
O=C1C=Cc2[nH]c3cc(-c4ccccc4)c4c(c3c2C1)C(=O)NC4=O,7.01,,
CN(c1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]C2CC2)cc(C(=O)c2ccccc2)c1)S(C)(=O)=O,7.01,,
O=C1c2ccccc2-c2[nH]nc3cccc1c23,7.01,,
CC(=O)NC(C(=O)NC(C(=O)NC(CC1CCCCC1)C(=O)NC(Cc1c[nH]cn1)C(=O)[O-])C(C)C)C(C)O,7.01,,
CNc1nc2cc3c(=O)[nH]c(=[NH2+])[nH]c3c(CCO)c2[nH]1,7.01,,
CCCCCCC=CC1C(CC=CCCCCO)C2C3OC1C32,7.01,,
CC(C)CC(NC(=O)C(O)CC(=O)[O-])C(=O)NCCCCNC(N)=[NH2+],7.01,,
COC(=O)c1ccc(Cl)c(NC(=O)c2cc3cnc(OC)nc3[nH]c2=O)c1,7.01,,CHEMBL3094442
CCC1C2C(C(=O)N1Cc1ccc3c(c1)OCO3)C(c1ccc(C(N)=[NH2+])cc1)[NH+](C)C2(C)C,7.02,,
[NH3+]CC1CC[NH+](CC(=O)Nc2cccc3c2C(=O)c2c(C4CCCCC4)n[nH]c2-3)CC1,7.02,,
CC(C)c1cnc(NC(=O)Cc2cccnc2)s1,7.02,,
O=C(C[NH+]1CC(NC(=O)c2ccc(Cl)s2)CC1CO)Nc1ccc(-n2ccccc2=O)cc1F,7.02,,
N=CC1(NC(=O)C2CC(S(=O)(=O)c3ccccc3Cl)CN2C(=O)C2(c3ccc(C(F)(F)F)cc3)CC2)CC1,7.02,,
N=CC1(NC(=O)C2CC(S(=O)(=O)c3ccccc3Cl)CN2C(=O)C2(c3ccc(C(F)(F)F)cc3)CC2)CC1,7.02,,
CC(C)c1c(S(=O)(=O)Nc2ccc(C(N)=O)cc2)c(-c2ccc(F)cc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)[O-],7.02,,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ccnc4ccc([N+](=O)[O-])cc34)c2)cc1,7.02,,CHEMBL568874
COc1cc2c(cc1OC)CN(S(N)(=O)=O)CC2,7.02,,CHEMBL1089044
NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(F)cc2)cc1,7.02,"This molecule is a sulfonamide carbonic anhydrase inhibitor with potential antineoplastic activity. Upon administration, CAIX inhibitor SLC-0111 inhibits tumor-associated carbonic anhydrase IX (CAIX), an hypoxia-inducible transmembrane glycoprotein that catalyzes the reversible reaction and rapid interconversion of carbon dioxide and water to carbonic acid, protons, and bicarbonate ions. This prevents both the acidification of the tumor's extracellular microenvironment and cytoplasmic alkalization. This increases cell death in CAIX-expressing, hypoxic tumors. CAIX is overexpressed in various tumors and plays a key role in intra- and extracellular pH regulation, cancer cell progression, survival, migration and invasion; it is also involved in resistance to both chemo- and radiotherapy.",CHEMBL1615281
COc1ccc(OCCc2ccccc2)cc1Cc1cnc2nc(N)nc(N)c2c1C,7.02,,
COc1ccc(N=C(S)NCCCn2ccnc2)cc1OC,7.02,,
Cc1c2c(n3c1CCC[NH+]1CCCC1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,7.02,,
CC1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)CC2CC2C(=[NH2+])N1,7.02,,
C#Cc1cccc(C[NH2+]CCCNC(=O)Nc2ccsc2)c1,7.02,,
[NH3+]CCCCC([NH3+])C(=O)NC(CCc1ccccc1)C(=O)NC(CCCC[NH3+])C(=O)[O-],7.03,,
CCS(=O)(=O)NC(Cc1ccc(-c2ccccc2)cc1)C(=O)NC(CCC(N)=O)C(=O)NCc1ccc(C(N)=[NH2+])cc1,7.03,,
O=C(C[N+]1=CC(NC(=O)c2ccc(Cl)s2)CC1C(=O)NCC1CC1)Nc1ccc(-n2ccccc2=O)cc1F,7.03,,
CCC(C)C(NC(=O)C([NH3+])C(C)O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(N)=O)C(C)O)C(C)O,7.03,,
Cc1cc(OCc2c(-c3c(Cl)cncc3Cl)noc2C(C)C)ccc1-c1ccc2c(C(=O)[O-])cn(C)c2c1,7.03,,
CC(=O)N1c2cccc(O)c2NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(OCc2ccccc2)cc1Cl,7.03,,CHEMBL512949
O=C(CC(Cc1cccc(O)c1)C(=O)NC1c2ccccc2CC1O)NO,7.03,,
CCCCN(CCCC)C(=O)n1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]Cc2cccc(OC)c2)c2ccccc21,7.03,,
Cc1nc2ccc(NC(=O)CCNC(=O)CCCc3ccc(CC(C(=O)[O-])C(=O)[O-])cc3)cc2s1,7.03,,
OCC1OC(OCC#Cc2cccnc2)C(O)C(O)C1O,7.03,,
CC(C)CC([NH3+])C(=O)[O-],7.03,,
CN1C(=[NH2+])NC2(CC(C)(C)Oc3ccc(-c4cccc(C#N)c4)cc32)C1=O,7.03,,
COC1CCN(c2nccc(Nc3cc4c(ccn4C4CCCC4)cn3)n2)CC1,7.03,,CHEMBL3354189
CCCCCC=CCC=CCC=CCC=CCCCC(=O)[O-],7.04,,
CCOC(Cc1ccc(OCCN2c3ccccc3Oc3ccccc32)cc1)C(=O)[O-],7.04,,
Cc1nc(N)nc(N)c1-c1ccc(Cl)c(Cl)c1,7.04,"This molecule is a diaminopyrimidine folate antagonist with potential antineoplastic activity.  This molecule inhibits dihydrofolate reductase, resulting in decreased cellular folate metabolism and cell growth; it also inhibits histamine-N-methyltransferase, resulting in decreased histamine catabolism. Lipid-soluble metoprine is capable of crossing the blood-brain barrier. (NCI04)",CHEMBL264373
NC(=O)c1ccc(-c2cc([C]3SCC4OCCOC34)cnc2N)cc1,7.04,,
Nc1nccc(-c2ccc3noc(-c4ccc(Cl)cc4)c3c2)n1,7.04,,CHEMBL409038
O=C(c1c(Cc2ccccc2)n(-c2ccccc2)c2ccccc12)N1CC[NH2+]CC1,7.04,,
Cc1c2c(n3c1CCCN(C)C(=O)C(C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,7.04,,
CCCOc1ccc(S(=O)(=O)N2CC[N+](C)CC2)cc1-c1nc(CC)c(F)c(=O)[nH]1,7.04,,
CC(N=NC(=O)c1cc(Br)ccc1O)c1nc2ccccc2[nH]1,7.04,,
CC(C)CCCCCCC(=O)NC1C(Oc2c3cc4cc2Oc2ccc(cc2Cl)CC2NC(=O)C([NH3+])c5ccc(O)c(c5)Oc5cc(O)cc(c5)C(NC2=O)C(=O)NC4C(=O)NC2C(=O)NC(C(=O)NC(C(=O)[O-])c4cc(O)cc(O)c4-c4cc2ccc4O)C(O)c2ccc(cc2)O3)OC(CO)C(O)C1O,7.04,,
CC(C)c1nc2ccc(OCc3ccc4ccccc4n3)cc2n1-c1ccccc1,7.04,,CHEMBL3091492
Cc1ccc2c(c1)nc(CCc1ncc3cccnn13)n2-c1ccccc1,7.04,,CHEMBL3288411
[NH3+]C(Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)[O-],7.04,,
CC(=O)Nc1nc(C(=O)Nc2ccccc2N2CCCCC2)cs1,7.04,,CHEMBL3103881
CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,7.04,This molecule is a 21-hydroxy steroid.,CHEMBL1730629
CN(Cc1ccc(C(O)CO)cc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1,7.04,,CHEMBL3355498
NC(=O)CC(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],7.05,,
C#CCN(Cc1ccc2[nH]c(N)nc(=O)c2c1)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,7.05,,
CSCCC(NC(=O)C1CCCN1C(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(Cc1cnc[nH]1)NC(=O)C(CC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CO)C(C)O)C(=O)[O-],7.05,,
NC(=[NH2+])c1ccc2nc(Cc3nc4ccc(C(N)=[NH2+])cc4[nH]3)[nH]c2c1,7.05,,
COc1cccc(Cn2c(C(=O)NC3CC[NH+](C(C)C)CC3)cc3ccccc32)c1,7.05,,
[NH3+]C(CC(=O)N1CCCC1CNC(=O)c1ccccc1)Cc1ccccc1F,7.05,,
CCC(C)C(NC(=O)C(CO)NC(=O)C([NH3+])Cc1ccccc1)C(=O)NC(C(=O)NCC(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(C)C)C(=O)O)C(C)C,7.05,,
CCc1nc(N)nc(N)c1-c1ccc2c(c1)N(CCCOC)C(=O)C(C)(C)O2,7.05,,CHEMBL400431
CCOC(=O)C(CCNC(=O)OC(C)(C)C)(Cc1ccc(NS(=O)(=O)[O-])cc1)C(=O)OCC,7.05,,
CCCCC(NC(=O)C(Cc1ccccc1)NC(=O)N1CCOCC1)C(=O)NC(CC1CCCCC1)C(O)(O)C(F)(F)C(=O)NC,7.05,,
CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1,7.05,,CHEMBL445162
CC1CC2OC2C=CC=CC(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1,7.05,This molecule is a macrocyclic antifungal antibiotic that inhibits signal-dependent transcriptional activation and induces differentiation in leukemia. (NCI),CHEMBL3972342
COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(F)cc2)cc(OC)c1,7.05,,CHEMBL1213168
Oc1cc(Cl)cc(Cl)c1O,7.05,,
CC(=O)NC(CCC(N)=O)C(=O)NC(CC1CCCCC1)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(Cc1ccc(Cl)cc1)C(=O)[O-],7.05,,
C=C(C)CCCC(C)CC[NH3+],7.05,,
[NH3+]C(Cc1ccc(Cl)cc1Cl)C(=O)N1Cc2ccccc2C1,7.05,,
Cc1ccc2oc(=O)n(CCCCn3cc(CCCCCC4SCC5NC(=O)NC54)nn3)c2c1,7.05,,
C[NH+](CCC(=O)[O-])[N+](C)(C)C,7.05,,
Oc1ccc(O)cc1,7.05,"This molecule appears as light colored crystals or solutions. May irritate the skin, eyes and mucous membranes. Mildly toxic by ingestion or skin absorption. This molecule is a benzenediol comprising benzene core carrying two hydroxy substituents para to each other. It has a role as a cofactor, a carcinogenic agent, an Escherichia coli metabolite, a human xenobiotic metabolite, a skin lightening agent, an antioxidant and a mouse metabolite. It is a benzenediol and a member of hydroquinones. This molecule is a topical lightening product found in  OTC products, and is used to correct skin discoloration associated with disorders of hyperpigmentation including melasma, post-inflammatory hyperpigmention, sunspots, and freckles. It can be used alone, but is more frequently found in combination with other agents such as alpha-hydroxy acids, corticosteroids, retinoids, or sunscreen.    This molecule has come under scrutiny due to several complications associated with its use, including dermal irritation, exogenous onchronosis, and carginogenicity. As a result of these concerns, hydroquinone has been banned in the EU and UK. This molecule is a Melanin Synthesis Inhibitor. The mechanism of action of hydroquinone is as a Melanin Synthesis Inhibitor. The physiologic effect of hydroquinone is by means of Depigmenting Activity. This molecule is used as a developing agent in photography and as an antioxidant in rubber and food. Tinnitus (ringing in the ears), dizziness, headache, nausea, vomiting, dyspnea, erosion of the gastric mucosa, edema of internal organs, cyanosis, convulsions, delirium, and collapse may result from the ingestion of a large amount of hydroquinone in humans. This molecule is also a skin irritant in humans. Chronic (long-term) occupational exposure to hydroquinone dust can result in eye irritation, corneal effects, and impaired vision. No information is available on the reproductive, developmental, or carcinogenic effects of hydroquinone in humans. There was some evidence of carcinogenic activity in orally-exposed rodents. Increased skin tumor incidence has been reported in mice treated dermally. EPA has not classified hydroquinone for carcinogenicity. This molecule is produced as an inhibitor, an antioxidant, and an intermediate in the synthesis of dyes, motor fuels, and oils; in photographic processing; and naturally in certain plant species, This molecule is a phenol derivative with antioxidant properties that can cause toxicity in several organs, notably the kidney. Used as a topical treatment for skin hyperpigmentation and in various cosmetic products, it is metabolized mainly to glutathione conjugates and forms mutagenic DNA adducts in in-vitro systems. (NCI04) This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a natural product found in Spiranthes vernalis, Phomopsis velata, and other organisms with data available. This molecule is an aromatic organic compound which is a type of phenol. Hydroquinone is commonly used as a biomarker for benzene exposure. The presence of hydroquinone in normal individuals stems mainly from direct dietary ingestion, catabolism of tyrosine and other substrates by gut bacteria, ingestion of arbutin containing foods, cigarette smoking, and the use of some over-the-counter medicines. In human medicine, hydroquinone is used as a topical application in skin whitening to reduce the color of skin. In 2006, the United States Food and Drug Administration revoked its previous approval of hydroquinone and proposed a ban on all over-the-counter preparations. The FDA stated that hydroquinone cannot be ruled out as a potential carcinogen. This conclusion was reached based on the extent of absorption in humans and the incidence of neoplasms in rats in several studies where adult rats were found to have increased rates of tumours, including thyroid follicular cell hyperplasias, anisokaryosis, mononuclear cell leukemia, hepatocellular adenomas and renal tubule cell adenomas. Numerous studies have revealed that hydroquinone can cause exogenous ochronosis, a disfiguring disease in which blue-black pigments are deposited onto the skin, if taken orally; however, skin preparations containing the ingredient are administered topically. The FDA has classified hydroquinone currently as a safe product, as currently used. (Wikipedia)",CHEMBL537
COc1cc(C=C2SC(Nc3ccccc3Cl)=NC2=O)ccc1O,7.05,,
Cc1ccc(S(=O)(=O)NC2C[NH2+]CC(C(=O)NCC3c4ccccc4Oc4ccccc43)C2)cc1,7.05,,
CN1C(=[NH2+])NC2(c3ccc(-c4ccc(F)c(C#N)c4)s3)CN(c3ccccc3)CC2C1=O,7.05,,
COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,7.05,This molecule is a stilbenoid. This molecule is a small molecule inhibitor that targets p53-Mdm2 interaction.,CHEMBL211045
COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1,7.05,"This molecule has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.",CHEMBL2393130
COC(C(O)CO)C1OC(C(=O)[O-])CC(NC(N)=[NH2+])C1NC(C)=O,7.05,,
Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)OC(C)(C)C)c1nnc(C)n1-2,7.05,"This molecule is an organonitrogen heterocyclic compound, an organosulfur heterocyclic compound and a tert-butyl ester.",CHEMBL2132936
O=c1cc[nH]c(=O)[nH]1,7.06,"This molecule is a common and naturally occurring pyrimidine nucleobase in which the pyrimidine ring is substituted with two oxo groups at positions 2 and 4. Found in RNA, it base pairs with adenine and replaces thymine during DNA transcription. It has a role as a prodrug, a human metabolite, a Daphnia magna metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a mouse metabolite and an allergen. It is a pyrimidine nucleobase and a pyrimidone. It is a tautomer of a (4S)-4-hydroxy-3,4-dihydropyrimidin-2(1H)-one. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Hamigera avellanea, Paraphaeosphaeria minitans, and other organisms with data available.",CHEMBL566
Cc1cc(N2CCCS2(=O)=O)c2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1,7.06,,CHEMBL232557
CN(C)C(=O)c1ccc(S(=O)(=O)c2ccc(NC(=O)C(C)(O)C(F)(F)F)c(Cl)c2)cc1,7.06,,CHEMBL3392645
O=C([O-])CCCCC1SCC2NC(=O)NC21,7.06,,
c1ccc(Cc2ccc(OCC3CCC[NH2+]3)cc2)cc1,7.06,,
Cc1ccccc1-n1ncc2c(=O)nc(CC(C)C(F)(F)F)[nH]c21,7.06,,
COc1cc2c(cc1OC)C(C)N(S(N)(=O)=O)CC2,7.06,,CHEMBL1089045
CC1CCOC2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,7.06,,
Nc1n[n+]2c(Cc3ccc4c(c3)OCO4)nc3cc(S(N)(=O)=O)ccc3c2[nH]1,7.06,,
CC(=O)NC1C(O)CC(OC2C(O)C(CO)OC(OC3C(CO)OC(O)C(NC(C)=O)C3OC3OC(C)C(O)C(O)C3O)C2O)(C(=O)[O-])OC1C(O)C(O)CO,7.06,,
CC([NH3+])C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)NC(Cc1c[nH]cn1)C(=O)NCC(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-])C(C)C,7.06,,
COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,7.06,This molecule is a stilbenoid. This molecule is a small molecule inhibitor that targets p53-Mdm2 interaction.,CHEMBL211045
CC(C)(C)c1cccc(C[NH2+]C2C[S+](O)CC(Cc3cc(F)c(N)c(OC(C(F)(F)F)C(F)(F)F)c3)C2O)c1,7.06,,
Nc1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)cn1,7.06,,CHEMBL3114000
CC(=O)Nc1nnc(S(N)(=O)=O)s1,7.07,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
CC(CCc1ccccc1)Nc1c(F)c(Oc2cccc(C(N)=[NH2+])c2)nc(Oc2ccccc2C(=O)[O-])c1F,7.07,,
O=c1[nH]cnc2c(C3[NH2+]C(CO)C(O)C3O)c[nH]c12,7.07,,
O=C(NCc1ccccc1)c1cc(-c2n[nH]cc2-c2cccc(Cl)c2)c[nH]1,7.07,,CHEMBL220320
N#Cc1ccc(Cn2cncn2)cc1-c1ccc(OS(N)(=O)=O)c(Cl)c1,7.07,,CHEMBL592131
CCC(CC)OC1C=C(C(=O)[O-])CC([NH3+])C1NC(C)=O,7.07,,
CCNC(=O)c1ccc(S(N)(=O)=O)cc1,7.07,,CHEMBL310253
COc1ccccc1NC(=O)NC(C(=O)N(CC(=O)NO)CC1CCCC1)C(C)(C)C,7.07,,
CCC(C)C(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(NC(=O)C(CC(N)=O)NC(=O)C([NH3+])CCCC[NH3+])C(C)CC)C(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCSC)C(=O)NC(C(=O)[O-])C(C)C,7.07,,
CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,7.07,This molecule is a corticosteroid hormone.,CHEMBL125608
Cc1ccc(S(=O)(=O)Nc2ccc(Oc3ccc(C(=O)[O-])cc3)cc2C(=O)[O-])cc1,7.07,,
CCCC(C(=O)[O-])N1C(=O)C(Cc2ccc(F)cc2)OC(c2ccc(Cl)cc2)C1c1ccc(Cl)cc1,7.07,,
CC1C=C(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)C(N)=CC1=O,7.07,,
O=C(NC(CCCCNC(=O)c1ccc(I)cc1)C(=O)[O-])NC(C(=O)[O-])c1ccc(O)cc1,7.07,,
COc1cc(Br)c(C(=O)NC(Cc2cccc(Oc3ccccc3)c2)C(O)CN(CCc2ccc(Cl)cc2Cl)C(=O)CCN2C(=O)c3ccccc3C2=O)cc1OC,7.07,,
CC(C)CC(NC(=O)C1CCC(=O)N1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(C=O)CC(N)=O.CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCC[NH2+]1)C(=O)NC(CC(C)C)C(=O)[O-],7.07,,
O=S(=O)(Nc1cccc(B(O)O)c1)c1cc(S(=O)(=O)c2ccccc2)cs1,7.08,,CHEMBL113381
N#Cc1ccc(N(Cc2ccc(OS(N)(=O)=O)cc2)n2cnnc2)cc1,7.08,,CHEMBL430879
CCCCCCCCCCCCCCCC(=O)[O-],7.08,,
CC(CCc1ccc(C(N)=O)cc1)[NH2+]CC(=O)c1ccc(F)cc1,7.08,,
CNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C3CC3)n2)cc1,7.08,,
CCC(CC)OC1C=C(C(=O)[O-])CC([NH3+])C1NC(C)=O,7.08,,
Cc1c2c(n3c1CCN(C(=O)C(C)[NH3+])CC(C)C(C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,7.08,,
COc1cc(-c2cc(C)nc(N)n2)c(Cl)cc1Cl,7.08,,CHEMBL1738736
COc1ccc2c(-n3c(=O)n(Cc4cccc(C5(C)OC(=O)NC5=O)c4)c4ccccc43)noc2c1,7.08,,
O=C1NC(=O)c2cc3c(cc21)-c1cccc[n+]1[Ru+7]312(N=C=S)[S+]3CC[S+]1CC[S+]2CC3,7.08,,
CSCCC(NC(=O)C(NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]cn1)NC(=O)CNC(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CCCC[NH3+])NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C([NH3+])Cc1ccccc1)C(C)C)C(C)C)C(C)O)C(=O)[O-],7.08,,
Cc1cnc(Cl)nc1-c1ccc(N(Cc2ccc(CNC(=O)C(F)F)cc2)C(=O)c2ccc(O)cc2O)cc1,7.08,,CHEMBL3727577
C[N+](C)(C)c1ccc(CNC(=O)c2cc3cc(OCc4ccccc4)ccc3n2Cc2cccc(C(N)=[NH2+])c2)cc1,7.09,,
CCOc1cc(OC2CCOC2)c(F)c(C(Nc2ccc(C(N)=[NH2+])cc2)C(=O)[O-])c1,7.09,,
c1ccc(-c2oc3ncnc(NCC[NH+]4CC[NH2+]CC4)c3c2-c2ccccc2)cc1,7.09,,
NC(=O)c1cnc2ccn(S(=O)(=O)c3ccccc3[N+](=O)[O-])c2c1,7.09,,CHEMBL561660
CC(C)CC(CC(O)C(CC1CCCCC1)NC(=O)C(Cc1cnc[nH]1)NC(=O)C(Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)NC(CCCC[NH3+])C(=O)[O-],7.09,,
C[NH2+]C(C)C(=O)NC(C(=O)N1CCC2CCC(NC(=O)C(c3ccccc3)c3ccccc3)C21)C(C)(C)C,7.09,,
CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(CCO)S(C)(=O)=O)c(C3CC3)cc12,7.09,This molecule has been investigated for the treatment of Hepatitis C. This molecule is a non-nuceoside polymerase inhibitor with activity against hepatitis C virus (HCV). This molecule binds to the palm site II pocket of HCV NS5B polymerase and inhibits viral genome replication.,CHEMBL1092581
CC(=O)N1c2cccc(O)c2NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(Cl)cc1Cl,7.09,,CHEMBL466268
c1ccc2[nH]c(C3CCN(c4ncnc5n[nH]cc45)CC3)nc2c1,7.09,,
Cc1cc(C(=O)NC2CC3CCC(C2)N3c2ccc(C(=O)NCc3ccccc3)cn2)c(C)cc1C(N)=O,7.09,,CHEMBL2204517
OCC1OC(OC2C(O)COC(OC3COC(O)C(O)C3O)C2O)C(O)C1O,7.09,,
O=[N+]([O-])c1c(Nc2cc(F)cc(Cl)c2)ccc2nonc12,7.09,,CHEMBL2311933
O=C(Cc1ccccc1)Nc1nnc(CCSCCc2nnc(NC(=O)Cc3ccccc3)s2)s1,7.09,,CHEMBL2177757
CSCCC(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],7.1,,
NC(=[NH2+])NCCCC(=O)NCC1CCCN1C(=O)C(CO)NS(=O)(=O)c1ccc2ccccc2c1,7.1,,
CCC(C)C(NC(C)=O)C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CO)CC(=O)[O-],7.1,,
CSCCC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCC(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(CCCC[NH3+])NC(=O)C(C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CCCC[NH3+])C(C)O)C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(N)=O,7.1,,
CC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NC(CCC[NH3+])B(O)O,7.1,,
C=CC[NH+](C)CCCCCCOc1ccc2c(-c3ccc(Br)cc3)coc2c1,7.1,,
O=C([O-])C(c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)C1c1ccc(Cl)cc1,7.1,,
Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,7.1,"This molecule is a nonnucleoside reverse transcriptase inhibitor used in combination with other agents in the therapy of human immunodeficiency virus (HIV) infection and the acquired immune deficiency syndrome (AIDS). This molecule is associated with a high rate of serum aminotransferase elevations during therapy and is a well established cause of acute, clinically apparent liver injury. This molecule is a dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection. It has a role as an antiviral drug and a HIV-1 reverse transcriptase inhibitor. It is a dipyridodiazepine and a member of cyclopropanes. A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. Structurally, nevirapine belongs to the dipyridodiazepinone chemical class. This molecule is a Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor. The mechanism of action of nevirapine is as a Non-Nucleoside Reverse Transcriptase Inhibitor, and Cytochrome P450 3A Inducer, and Cytochrome P450 2B6 Inducer. This molecule is a benzodiazepine non-nucleoside reverse transcriptase inhibitor. In combination with other antiretroviral drugs, nevirapine reduces HIV viral loads and increases CD4 counts, thereby retarding or preventing the damage to the immune system and reducing the risk of developing AIDS. This molecule is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults and children. This molecule comes in three different forms: immediate-release tablets, oral suspension (a liquid), and extended-release tablets. The immediate-release tablet and liquid forms of nevirapine are approved for use in adults and children. The extended-release tablets are approved for use in adults and in children 6 years of age and older who meet certain height and weight requirements. This molecule is always used in combination with other HIV medicines. This molecule is a natural product found in Stachybotrys chartarum with data available.",CHEMBL57
CC1(O)CCC2c3ccc4cc(O)ccc4c3CCC21C,7.1,,
C[NH+](C)CCOc1ccc(C(=C(CCCO)c2ccccc2)c2ccc(O)cc2)cc1,7.1,,
O=C([O-])c1ccc(-c2c(F)cccc2F)cc1,7.1,,
CCc1nc(N)nc(N)c1-c1ccc2c(c1)N(CCCOC)C(c1ccccc1)CC2,7.1,,CHEMBL2437490
CCc1nc(N)nc(NCCNS(=O)(=O)c2ccc3ccccc3c2)c1-c1ccc2c(c1)N(CCCOC)C(=O)C(C)(C)O2,7.1,,CHEMBL1234021
CC(=C1C(=O)Nc2ccc(O)cc21)c1ccc[nH]1,7.1,,
Nc1ccc2cc3ccc(N)cc3nc2c1,7.1,"This molecule is an aminoacridine that is acridine that is substituted by amino groups at positions 3 and 6. A slow-acting bacteriostat that is effective against many Gram-positive bacteria (but ineffective against spores), its salts were formerly used for treatment of burns and infected wounds. It has a role as an antiseptic drug, a carcinogenic agent, an antibacterial agent, a chromophore and an intercalator. It is a conjugate base of a This molecule(1+). 3,6-Diaminoacridine. Topical antiseptic used mainly in wound dressings.",CHEMBL55400
O=c1c(-c2ccc(O)cc2)coc2cc(OC3OC(CO)C(O)C(O)C3O)ccc12,7.1,"This molecule is a natural product found in Glycine max, Pueraria montana var. lobata, and other organisms with data available.",CHEMBL115316
CC(=O)NC1C(OC2C(O)C(OC3C(O)C(COC4OC(CO)C(O)C(O)C4O)OC(O)C3NC(C)=O)OC(CO)C2OC2OC(COC3OC(C)C(O)C(O)C3O)C(O)C(O)C2O)OC(CO)C(O)C1O,7.1,,
CCOC(=O)C1CCCC=CCCNC(=O)c2c(O)cc(O)c(Cl)c2CC1=O,7.1,,
O=C([O-])CNC(=O)c1nc(Cl)c2ccccc2c1O,7.1,,
O=CN(O)C(CCCc1ncccn1)CS(=O)(=O)N1CCN(c2ccc(Br)cn2)CC1,7.1,,
O=C(NCc1ccncc1)c1ccc(Oc2ccc(C#CC3(O)C[N+]4CCC3CC4)cc2)cc1,7.1,,
C=C(C)COc1ccc(C2C3=C(CC(C)(C)CS3(=O)=O)Nc3c(O)cccc3N2C(=O)c2nc(C)oc2C)c(F)c1,7.1,,
O=C([O-])c1cnn(-c2nc3cc(Cl)c(F)cc3[nH]2)c1,7.1,,
NS(=O)(=O)c1ccc(-n2cc(C3=C4C5=C6C3[Fe+10]4563789C4=C3C7C8=C49)nn2)cc1,7.1,,
CCn1cc(C2(c3cccc(-c4cncnc4)c3)NC(=[NH2+])N(C)C2=O)cn1,7.1,,
CCCCCCCCOc1cccc(CSc2ccc(Br)cc2C(=O)[O-])c1,7.1,,
COc1ccc(-c2noc(CSc3nnc(C)n3-c3ccc(OC)cc3)n2)cc1,7.1,,CHEMBL1898239
O=C(Cc1ccccc1)Nc1nnc(CCSCCc2nnc(NC(=O)Cc3ccccc3)s2)s1,7.1,,CHEMBL2177757
COC1=CC2=C(C(=O)C1)C(=O)OC(C)CCCC(=O)C(O)C(O)CC=C2,7.1,,
CC(CCOC(=O)N(C)C)[NH+](C)C,7.1,,
c1nc(N2CCC3(CCC[NH2+]C3)CC2)c2[nH]cnc2n1,7.1,,
CC(=O)Nc1nc2ccc(-c3cncc(S(C)(=O)=O)c3)cn2n1,7.1,,CHEMBL2059907
CC(=O)NC1C(=NOC(=O)Nc2ccccc2)OC(CO)C(O)C1O,7.1,,
CC#Cc1cncc(-c2cccc(C3(C4CC4)N=C(C)C(=[NH2+])N3)c2)c1,7.1,,
COc1cccc(COC(=O)c2sc3ccccc3c2OC2CC[NH2+]CC2)c1,7.1,,
c1ccc(-c2nc(N3CCOCC3)c3sccc3n2)cc1,7.1,,CHEMBL3989108
Clc1ccccc1Nc1ncnc(-n2cccc2)n1,7.1,This molecule is a substituted aniline.,CHEMBL1520731
CC(C)CC([NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NC(C(N)=O)C(C)O,7.1,,
CC(O)C(NC(=O)Cc1cc(Cl)cc(Cl)c1)C(=O)NCC(=O)NCC=N,7.1,,
O=C(NC(Cc1nc2ccc(F)cc2[nH]1)C(=O)[O-])c1ccc2ccccc2c1,7.1,,
CCOc1nc(NC(=O)Cc2cc(OC)c(Br)cc2OC)cc(N)c1C#N,7.11,,CHEMBL382639
CC(C)(C)NS(=O)(=O)c1ccc(-c2ccc3n[nH]c(N)c3c2)cc1,7.11,,
Cc1c(Cl)ccc2c(C=C3NC(=O)N(Cc4ccc(F)c(F)c4)C3=O)c[nH]c12,7.11,,
COCC#Cc1cccc(C2(c3ccc(OC(F)F)cc3)NC(=[NH2+])N3CC(F)(F)CN=C32)c1,7.11,,
Cc1cc2cc(c1)C(O)[NH2+]C(c1ccccc1)CC=CCOCC(C(O)C[NH2+]Cc1cccc(C(C)C)c1)NC2=O,7.11,,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3cc(C(=O)NC(C)C)[nH]c23)cc1,7.11,,CHEMBL2207427
CCCCCCCCc1nc(-c2cc(S(=O)(=O)N3CC[NH+](C)CC3)ccc2OCC)[nH]c(=O)c1Br,7.11,,
N#Cc1ccc(C(=O)Nc2ccc(F)c(C3(CF)NC(=[NH2+])OCC3F)c2)nc1,7.11,,
O=C(NCc1ccc(S(=O)(=O)c2cc(F)cc(F)c2)cc1)c1ccn2cccc2c1,7.11,,
Nc1ncnc2ccc(-c3cccc(Cl)c3)cc12,7.11,,CHEMBL3262583
[NH3+]CCCCC([NH3+])C(=O)NC(CS)C(=O)NC(CCCC[NH3+])C(=O)[O-],7.12,,
CC(O)C(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],7.12,,
CCC(C)C(NC(=O)C(C)[NH3+])C(=O)NC(CC(C)C)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C)C(=O)[O-],7.12,,
CCc1cc(CC(NC(C)=O)C(=O)NCCCCC(=O)NC(CCSC)C(=O)[O-])ccc1N(C(=O)C(=O)[O-])c1ccccc1C(=O)[O-],7.12,,
CC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1[NH2+]C1CC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O,7.12,,
CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.12,"This molecule is a second generation, oral nonsteroidal antiandrogen similar in structure to flutamide that has been used widely in the therapy of prostate cancer. This molecule is associated with a low rate of serum enzyme elevations during therapy and has been linked to rare instances of liver injury. This molecule is a member of the class of (trifluoromethyl)benzenes that is 4-amino-2-(trifluoromethyl)benzonitrile in which one of the amino hydrogens is substituted by a 3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanoyl group. It is a member of (trifluoromethyl)benzenes, a monocarboxylic acid amide, a member of monofluorobenzenes, a nitrile, a sulfone and a tertiary alcohol. This molecule is an oral non-steroidal anti-androgen for prostate cancer. It is comprised of a racemic mixture that is a 50:50 composition of the (R)-bicalutamide and (S)-bicalutamide enantionmers. This molecule binds to the androgen receptor. This molecule is an Androgen Receptor Inhibitor. The mechanism of action of bicalutamide is as an Androgen Receptor Antagonist. This molecule is a synthetic, nonsteroidal antiandrogen.  This molecule competitively binds to cytosolic androgen receptors in target tissues, thereby inhibiting the receptor binding of androgens. This agent does not bind to most mutated forms of androgen receptors. (NCI04) This molecule is an oral non-steroidal anti-androgen for prostate cancer. It binds to the androgen receptor.",CHEMBL409
Nc1cc(Cl)c(S(N)(=O)=O)cc1S(N)(=O)=O,7.12,This molecule is a sulfonamide.,CHEMBL266240
COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,7.12,"This molecule is a benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum. It has a role as a vasodilator agent and an antispasmodic drug. It is a benzylisoquinoline alkaloid, a member of isoquinolines and a dimethoxybenzene. An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels. This molecule is an opiate alkaloid isolated from the plant Papaver somniferum and produced synthetically.  As a direct-acting smooth muscle relaxant, papaverine is not closely related to the other opium alkaloids in structure or pharmacological actions; its mechanism of action may involve the non-selective inhibition of phosphodiesterases and direct inhibition of calcium channels. This agent also exhibits antiviral activity against respiratory syncytial virus, cytomegalovirus, and HIV. (NCI04) This molecule is a natural product found in Papaver rhoeas, Papaver armeniacum, and other organisms with data available.",CHEMBL19224
CCC(C)C(SCC([NH3+])C(=O)[O-])(c1ccccc1)c1ccccc1,7.12,,
CC(C)CC(NC(=O)C(O)CC(=O)[O-])C(=O)NCCCCNC(N)=[NH2+],7.12,,
O=C([O-])c1cc(-c2ccc(F)cc2F)ccc1O,7.12,,
CS(=O)(=O)N1CC[NH+](Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,7.12,,
COC1C([NH3+])C(O)C(O)C1O,7.12,,
O=C([O-])CCC(=O)C(=O)[O-],7.12,,
O=C([O-])c1ccc(Cn2nnc(-c3ccnc(C(=O)NCc4cccc(F)c4)c3)n2)cc1,7.12,,
COc1cccc(Nc2nc(N3CCS(=O)(=O)CC3)nc3c2cnn3C)c1,7.12,,CHEMBL1234877
CC(C)(C)c1cc(C(=O)N2CCS(=O)(=O)CC2)c(NC(=O)Nc2cccc3ccccc23)s1,7.12,,CHEMBL1929195
CS(=O)(=O)CCNC(=O)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc(C(F)(F)F)c3)c(Cl)c2)NCC1,7.12,,CHEMBL2348415
Cc1n[nH]c(C)c1Cc1nnc(-c2sc3ccccc3c2OC2CC[NH2+]CC2)o1,7.12,,
CC(C(=O)[O-])c1nnc2nc(N)[nH]c(=O)c2c1O,7.12,,
C=C(C)C1C[NH2+]C(C(=O)[O-])C1CC(=O)[O-],7.12,,
CCC(C)C([NH3+])C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)NC(CS)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)[O-])C(C)CC)C(C)O,7.12,,
O=C(NC(Cc1ccccc1)C(O)C[NH2+]Cc1cccc(C(F)(F)F)c1)c1cc(N2CCCC2=O)c(=O)n(C2CCCC2)c1,7.12,,
O=C(NNC(=O)C12CC3CC(CC(C3)C1)C2)c1ccncc1,7.12,,CHEMBL1606228
CC(=O)NC1C(NC(N)=[NH2+])CC(C(=O)[O-])OC1C(O)C(O)CO,7.12,,
CCOc1cc(C(Nc2ccc3c(N)nccc3c2)C(=O)NCc2cccc(S(N)(=O)=O)c2)ccc1OC(C)C,7.12,,CHEMBL3114854
CC12CCCOC1C1(COC(=[NH2+])N1)c1cc(-c3cccnc3F)ccc1O2,7.12,,
COC1CCN(c2nccc(Nc3cc4[nH]c(-c5cn[nH]c5)nc4cn3)n2)CC1,7.12,,CHEMBL3354185
CCC(c1ccccc1)c1c(O)c2c(oc1=O)CCCCCC2,7.12,,CHEMBL275899
NC(=[NH2+])c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3O)nc2c1,7.13,,
NC(=[NH2+])c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3O)nc2c1,7.13,,
NC(=[NH2+])c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3O)nc2c1,7.13,,
NC(=[NH2+])c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3O)nc2c1,7.13,,
COC(O)c1cn2c(n1)C(O)C(O)C(O)C2CO,7.13,,
C=C1SC(=S)N(CCS(=O)(=O)[O-])C1=O,7.13,,
Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1,7.13,,CHEMBL497615
Cc1ccccc1-c1ccc2nc(N)c(CCC(=O)NC3CCCCC3)cc2c1,7.13,,CHEMBL1821811
NS(=O)(=O)Nc1ccc(S(N)(=O)=O)cc1,7.13,,CHEMBL2164729
CC(c1ccc2ncccc2c1)c1nnc2ccc(-c3cnn(C)c3)nn12,7.13,,
CCCCN1C(=N)C(N(C)S(=O)(=O)c2ccccc2)C(=O)NC1=O,7.13,,
O=C1C(O)C(O)CC(O)(C(=O)[O-])C1Cc1c(F)c(F)c(F)c(F)c1F,7.13,,
Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(CC(O)C(O)C(O)CO)c2cc1C,7.13,"This molecule is a natural product found in Aspergillus unilateralis, Syzygium, and Eremothecium gossypii with data available.",CHEMBL511565
CC(C)(C)CC1[NH2+]C(C(=O)NCCC(O)CO)C(c2cccc(Cl)c2F)C1(C#N)c1ccc(Cl)cc1F,7.13,,
CC(C)CC([NH3+])C(O)C(=O)NC(C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C)C(C)C,7.13,,
CC1(CNC(=O)COc2ccc(Cl)cc2)NC(=O)NC1=O,7.13,,
CC(C)(C)NC(=O)N1CCN(C(=O)NC(C(=O)[O-])C(C=O)CCCNC(N)=[NH2+])CC1,7.14,,
Cc1cccc(CNC(=O)c2cc(C(=O)NCc3cccc(C)c3)ncn2)c1,7.14,,CHEMBL511942
CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.14,,CHEMBL188762
CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])Cc1c[nH]c2ccccc12)C(=O)N1CCCC1C(=O)NC(CC(N)=O)C(=O)NC(C(=O)[O-])C(C)C,7.14,,
CCOc1c(Cl)cc(N2CCCCC2)cc1NC(=O)c1cc(C)c(OCC[NH3+])c(C)c1,7.14,,
OCC1C(O)C(O)C(O)c2nc(CNc3ccccc3)cn21,7.14,,
Cc1ccc(Oc2ccnc(Nc3ccc(S(N)(=O)=O)cc3)c2)c(C)n1,7.14,,CHEMBL585367
CCC(CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C(C)C)c2n1,7.14,,
Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1,7.14,,CHEMBL497033
NS(=O)(=O)c1ccc2[nH]c(-c3cscn3)nc2c1,7.14,,CHEMBL455271
CC(C=CC(F)(F)F)Oc1cc(-c2cc(-c3cc(C[N+](C)C)cs3)cnc2N)ccc1C(N)=O,7.14,,
CC(C)CC(NC(=O)CC(O)C(Cc1ccccc1)NC(=O)C(CCC(N)=O)N(C)C(=O)C(NC(=O)C(C)O)C(C)C)C(=O)NC(C)C(=O)N(C)C(Cc1ccccc1)C(=O)[O-],7.14,,
C=CC(=O)N1CCCC(n2nc(-c3cccc(C(=O)Nc4cccc(C(C)(C)C)c4)c3)c3c(N)ncnc32)C1,7.14,,CHEMBL2179790
CCC(CC)OC1CC(C(=O)[O-])=CC(n2cc(C(O)CC)nn2)C1NC(C)=O,7.14,,
N#Cc1cccc(Cn2cc(NC(=O)c3n[nH]c4cc(-c5cn[nH]c5)ccc34)cn2)c1,7.14,,CHEMBL3263036
NC1=NC(=O)C(C2CCNC(=O)c3[nH]c(Br)cc32)=N1,7.15,,
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C(F)(F)F)C(=O)Nc1ccc(C(C)C)cc1,7.15,,
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])Cc1ccc(O)cc1)C(=O)[O-],7.15,,
CNc1nc(C)c(-c2ccnc(Nc3ccc(O)cc3)n2)s1,7.15,,CHEMBL47590
CCC(C)C([NH3+])C(=O)NC(CC(C)C)C(=O)NCC(=O)N1CCCC1C(=O)N1CCCC1C(=O)NCC(=O)NC(CO)C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-])C(C)C,7.15,,
O=C([O-])C(=Cc1ccc(Oc2ccccc2Br)cc1)NC(=O)C12CC3CC(CC(C3)C1)C2,7.15,,
CSc1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1,7.15,,CHEMBL222476
CCC(C)C(NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(N)=O)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C([NH3+])CC(N)=O)C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],7.15,,
Cc1nc(N)ccc1C[NH2+]CCn1c(Cl)cnc(NCC(F)(F)c2ccccn2)c1=O,7.15,,
Nc1nc2c(ncn2C2OC(CO)C(O)C2O)c(=O)[nH]1,7.15,,
Cc1cc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)ccc1F,7.15,,CHEMBL574058
CC(NC(=O)c1cc(C(=O)NC(Cc2ccccc2)C(O)C2[NH2+]C(C)(C)N(C)C2=O)cc(N(C)S(C)(=O)=O)c1)c1ccc(F)cc1,7.15,,
NC(=O)c1ccc(S(=O)(=O)N(Cc2ccc(C(F)(F)F)cc2)C2C[NH2+]CC2N(Cc2ccc(C(F)(F)F)cc2)S(=O)(=O)c2ccc(C(N)=O)cc2)cc1,7.15,,
c1ccc(-c2cc(NCc3cccnc3)n3ncc(C4CC4)c3n2)cc1,7.15,,CHEMBL249736
CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,7.15,,
Cc1cc(=N)c2ccccc2n1CCCCCCCCC=CN1c2ccccc2C(N)=CC1C,7.15,,
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCC[NH2+]CC1,7.15,,
O=C(c1c2ccccc2cc2ccccc12)N1CCC([NH+]2CCCC(C(=O)N3CCOCC3)C2)CC1,7.15,,
CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(CCO)S(C)(=O)=O)c(C3CC3)cc12,7.15,This molecule has been investigated for the treatment of Hepatitis C. This molecule is a non-nuceoside polymerase inhibitor with activity against hepatitis C virus (HCV). This molecule binds to the palm site II pocket of HCV NS5B polymerase and inhibits viral genome replication.,CHEMBL1092581
COCCOc1cc2ncc3c(N)nc(-n4ccnc4)cc3c2cc1OC,7.15,,CHEMBL571159
O=C1N=CN2NC(Sc3ccc(F)cc3F)=CC=C2C1c1c(Cl)cccc1Cl,7.15,,
O=S(=O)(Cc1ccccc1)NCB(O)O,7.15,,CHEMBL1231476
O=C(NC1CCCCC1)C(C1CCCCC1)n1c(-c2ccc(Cl)cc2)nc2ccccc21,7.15,,CHEMBL1642346
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1ccc(S(N)(=O)=O)cc1,7.15,,CHEMBL2377821
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(O)c1cccc([N+](=O)[O-])c1,7.15,,
Nc1cccc(C(=O)c2sc(Nc3ccc(S(N)(=O)=O)cc3)nc2N)c1,7.15,,CHEMBL2377820
[NH3+]C(Cn1cc(F)c(=O)[nH]c1=O)C(=O)[O-],7.15,,
OCC1[NH2+]CC(O)C(O)C1O,7.15,,
COc1ccc(-c2nc3c(NCCCNC(=O)C4(C[NH3+])C=C4)c(Br)cnc3[nH]2)cc1,7.15,,
CC(=O)Nc1ccc(S(=O)(=O)[O-])c2cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c12,7.15,,
NC(=O)c1ccc2nc(-c3ccc(OCC4CC[NH2+]CC4)cc3)[nH]c2c1,7.15,,
Oc1cc(=NC2CCCCC2)c(-c2nc[nH]n2)nn1-c1ccccc1,7.15,,
OCC1OC(OC2C(OC3COC(OC4COC(O)C(O)C4O)C(O)C3O)OCC(O)C2O)C(O)C1O,7.15,,
CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,7.15,,
COc1cc(O)c2c(c1)C=CCC(O)C(O)C(O)CCCC(C)OC2=O,7.15,,
COc1ccc(-c2cc(=O)c3ccccc3o2)cc1,7.15,This molecule is a member of flavonoids and an ether. This molecule is a natural product found in Ammopiptanthus mongolicus and Cullen corylifolium with data available.,CHEMBL16312
C#CC1[NH2+]C(C)C(O)C1O,7.15,,
CCCCCCCC1SC(CC(=O)N(Cc2ccccc2)Cc2ccccc2)C(=O)N1CCCCc1ccc(C(=O)[O-])cc1,7.15,,
CCC(C)CNC(=O)CC(O)C(CC(C)C)NC(=O)C(CCCCNC(=S)NC)NC(=O)C(Cc1ccccc1)NS(=O)(=O)N(C)C,7.16,,
COC(=O)C(Cc1cccc(C(N)=[NH2+])c1)C(C)NC(=O)c1ccc(-c2cccc(C[NH3+])c2)cc1,7.16,,
Oc1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,7.16,,CHEMBL340813
CNC(=O)C(Cc1ccc2ccccc2c1)N1CCC(=O)N(Cc2cnc3ccccc3c2)C(CC(C)C)C1=O,7.16,,
CC(C)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)NC(Cc1ccccc1)C(=O)[O-])C(=O)NC(CO)CCCNC(N)=[NH2+],7.16,,
CC(=NN=C1N=CCN1)c1ccc(NC(=O)Nc2ccc(C(C)=NNC3N=CC[NH2+]3)cc2)cc1,7.16,,
CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccc(C(F)(F)F)cc4[nH]3)c3ccccc23)n1,7.16,,CHEMBL463323
CSCCC([NH3+])C(=O)[O-],7.16,,
Cc1nc2ccc(NC(=O)CCNC(=O)NCCc3ccc(CC(C(=O)[O-])C(=O)[O-])cc3)cc2s1,7.16,,
CN(c1ccc(F)c(NC(=O)c2cccc(OC(C)(C)C#N)c2Cl)c1)c1ccc2nc(NC(=O)C3CC3)sc2n1,7.16,,CHEMBL2204532
CC(NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CCCCC1,7.16,,
CC(O)c1nc2cnc3[nH]ccc3c2n1C1CCC(C#N)CC1,7.16,,
CCC(c1ccc(C(=O)[O-])c(Oc2cccc(Cl)c2)c1OC)[NH+]1CCCC(n2cc(C)c(=O)[nH]c2=O)C1,7.16,,
Cc1nc2ccccc2n1Cc1ccc2c(c1)nc(CNc1ccc(C(N)=[NH2+])cc1)n2C,7.17,,
NC(=[NH2+])c1ccc2[nH]c(-c3cccc(OC4CCCC4)c3O)cc2c1,7.17,,
CC(NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(C)[NH3+])B(O)O,7.17,,
Nc1nc2nn(-c3cccc(C(=O)NCc4cc(Cl)cc(Cl)c4)c3)nc2c(=O)[nH]1,7.17,,
CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CC[NH3+])cc2)C1C(=O)NO,7.17,,
CN(C)c1cccc2c(S(=O)(=O)NCCCCNC(=O)CCS)cccc12,7.17,,
O=C(Nc1nccs1)C(=O)NC1CCCC1,7.17,,CHEMBL1092824
CN(C)c1ccc(-c2c(N)ncnc2C#Cc2ccc(N3CCOCC3)nc2)cc1,7.17,,CHEMBL216697
CCC([NH2+]C)C(=O)NC1CCCCC2CCC(C(O)[NH2+]C(c3ccccc3)c3ccccc3)N2C1=O,7.17,,
CC1(C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NC(C)(C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1,7.17,,CHEMBL387141
COc1cc(Nc2ncnc(-c3cccnc3Nc3ccccc3)n2)cc(OC)c1OC,7.17,,CHEMBL218057
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,7.17,,
CC(C)c1cc(-c2cc(N3CC(O)C(O)C3)ccc2O)nc(N)n1,7.17,,
NC(=O)CCC(NC(=O)CCc1ccc(-c2cc(-c3ccccc3)cs2)cc1)C(=O)NC(CCC(=O)[O-])C(N)=O,7.17,,
c1cc(N2CC[NH2+]CC2)c2cc[nH]c2c1,7.17,,
Cc1nc2ccccc2c(-c2cc(F)c3c(c2C)CCCO3)c1C(OC(C)(C)C)C(=O)[O-],7.17,,
COc1cc(OCC(O)C(O)C(O)C(O)COc2cc(F)cc(-c3ccc(C(=O)[O-])cn3)c2)c(Cl)cc1NC(=O)CSc1ccc(C(=O)[O-])cn1,7.17,,
CN(C)c1ccc(-c2cc(=O)c3ccccc3o2)cc1,7.17,,CHEMBL2431868
Cc1cc(CNc2nccc(Nc3cc(CCc4ccccc4)n[nH]3)n2)on1,7.17,,
Cc1nc2ccc(C#CC3(O)CCCCC3)cc2n1-c1ncnc(N)n1,7.17,,CHEMBL3128050
CCCC(NC(=O)C(CC(C)C)NC(=O)C(NC(=O)OCC(C)C)C1CCCCC1)C(O)C(=O)NCC(=O)NC(C(N)=O)c1ccccc1,7.18,,
CCCC(NC(=O)C1Cc2cccc(c2)CCCCCCCC(=O)NC(C2CCCCC2)C(=O)N1)C(O)C(=O)NCC(=O)NC(C(=O)[O-])c1ccccc1,7.18,,
Cc1c(O)cccc1C(=O)NC(CSc1ccccc1)C(O)C[NH+]1CC2CCCCC2CC1C(=O)NC(C)(C)C,7.18,,
C=Cc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2s1,7.18,,
C[NH+]1CCCN(c2cncc(-c3cccc(C=CC(=O)[O-])c3)n2)CC1,7.18,,
Nc1nc(N)c2c(OCC3CC[NH+](Cc4cccc(Cl)c4Cl)CC3)cccc2n1,7.18,,
CC(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,7.18,,CHEMBL1231370
COc1ccc(CC(=O)Nc2cn(C3CC(O)C3)cn2)cc1,7.18,,
CC1C[NH+](Cc2ccccc2)CC1c1nc(=O)c2cnn(C(C)C)c2[nH]1,7.18,,
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)CCC[NH+](C)C,7.18,,
O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2ccccc12,7.18,,CHEMBL64780
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)[O-])C(C)O)C(C)O,7.18,,
Cc1onc(-c2ccccc2Cl)c1C(=O)Nc1ccc(C(C)C)cc1,7.18,,
COC1CCN(c2nccc(Nc3cc4[nH]c(-c5cn[nH]c5)cc4cn3)n2)CC1,7.18,,CHEMBL3354186
CC(C)CC(NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(C)[NH3+])B(O)O,7.18,,
CC1(C)CCC(C)(C)c2cc(C(O)c3ccc4cc(C(=O)[O-])ccc4c3)ccc21,7.19,,
NC(=[NH2+])c1ccc2nc(-c3ccccc3O)[nH]c2c1,7.19,,
[NH3+]C(Cc1c[nH]cn1)C(=O)[O-],7.19,,
CC(C)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC1CSSCC(C(=O)N2CCCC2C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)N2CCCC2C(=O)NC(Cc2ccc(O)cc2)C(=O)O)C(C)O)NC1=O)C(C)O,7.19,,
CC(C)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC1CSSCC(C(=O)N2CCCC2C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)N2CCCC2C(=O)NC(Cc2ccc(O)cc2)C(=O)O)C(C)O)NC1=O)C(C)O,7.19,,
O=C(NC(Cc1ccccc1)C(=O)NC(CCc1ccccc1)C(=O)CO)OCc1cccnc1,7.19,,
O=C(Cc1cccs1)NC(B(O)O)c1cccc(C(=O)[O-])c1,7.19,,
NC(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,7.19,,CHEMBL121941
CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O,7.19,"This molecule is a metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, an antipyretic, a gout suppressant, a drug metabolite, a xenobiotic metabolite, an antineoplastic agent and an antimicrobial agent. It is a member of pyrazolidines and a member of phenols. It is functionally related to a phenylbutazone. This molecule was withdrawn from the Canadian market in March 1985 due to concerns regarding bone marrow suppression.",CHEMBL1228
O=C(Nc1ccc(Cl)c(COc2cccnc2)c1)c1cc(F)cc(N2CCOCC2)c1,7.19,,CHEMBL194436
NS(=O)(=O)c1cc(C(=O)[O-])c(NCc2ccco2)cc1Cl,7.19,,
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(CO)Cc1ccccc1)C(C)C,7.19,,
NC(=O)C(Cc1ccc(C2=CC(=O)NS2(=O)=O)cc1)NC(=O)C(Cc1ccccc1)NC(=O)Cc1ccc(C2=CC(=O)NS2(=O)=O)cc1,7.19,,
C[NH+]1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)Cc3cccs3)C4)cc2)CC1,7.19,,
OCC1[NH2+][NH2+]CC(O)C1O,7.19,,
[NH3+]C1CN(C(=O)c2cnc3ccccc3n2)CC1C(=O)N1CCCC1,7.19,,
O=C1CC(c2ccc(CC(NS(=O)(=O)c3cccc(F)c3)C3=NC(Cc4ccccc4F)CN3)cc2)S(=O)(=O)N1,7.19,,
CCCCCC=CCC=CCCCCCCCCCC(=O)NC(COC1OC(CO)C(O)C(O)C1O)C(O)C(O)CCCCCCCCCCCCCC,7.19,,
CC(=O)NC(CO)C(=O)NC(C)C(=O)NC(C(=O)NC(CC1CCCCC1)C(=O)NC(C=O)Cc1c[nH]cn1)C(C)C,7.19,,
O=C(CNS(=O)(=O)c1ccc(F)cc1)NO,7.19,,CHEMBL4087610
NS(=O)(=O)c1cnc(Sc2ccccc2)c(C(=O)NCCc2ccccc2)c1,7.19,,CHEMBL1094898
COc1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1F,7.19,,CHEMBL456218
CCCc1c(OCCCSc2ccc(CC(=O)[O-])cc2Cl)ccc2c(C(F)(F)F)noc12,7.19,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(OC4OC(CO)C(O)C(O)C4[N+](C)(C)C)C(O)C3NC(C)=O)C(O)C2NC(C)=O)C1O,7.19,,
N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1C#N,7.19,This molecule is under investigation in clinical trial NCT01301508 (Efficacy and Safety of This molecule and AN2728 Topical Ointments to Treat Mild-to-moderate Atopic Dermatitis).,CHEMBL4467344
CCCNC(=O)C(O)CC(=O)NC(C(=O)N1CCCC1C(=O)[O-])C(C)CC,7.19,,
CSCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C([NH3+])CO)C(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCSC)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],7.19,,
C[NH+]1CCN(C(=O)N2Cc3c(NC(=O)c4cccc(Oc5ccccc5)c4)n[nH]c3C2(C)C)C(Cc2ccccc2)C1,7.19,,
CSCCC([NH3+])C(=O)[O-],7.19,,
CCCS(=O)(=O)Nc1ccc(F)c(NC(=O)Nc2cc(NCCO)ncn2)c1F,7.19,,CHEMBL2047869
CCC1NC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)C2CSCc3cc(cc(c3)CSCC(C(=O)NCC(N)=O)NC(=O)C(C)NC(=O)C(CO)NC1=O)CSCC(NC(=O)C(C)[NH3+])C(=O)NC(CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(C)C)C(=O)NC(CC(=O)[O-])C(=O)N2,7.19,,
Nc1ncnc2ccc(-c3cc(F)cc(NC(=O)C[NH+]4CCCC4)c3)cc12,7.19,,
O=C(c1cc(CO)ccc1Cl)c1c[nH]c2ncc(-c3cnn(C4CC[NH2+]CC4)c3)cc12,7.19,,
COc1ccc(OC)c(Sc2ccc3nnc(-c4cnn(C)c4)n3n2)c1,7.19,,CHEMBL3326128
[NH3+]C(CCC(=O)[O-])C(=O)[O-],7.2,,
Oc1ccc2c(c1)CCN(c1ccccc1)C2c1ccc(N2CC[NH+]3CCCCC3C2)cc1,7.2,,
O=S(=O)(Nc1ccc(Cl)cc1)c1ccc2c(c1)C[NH2+]C(CO)C2,7.2,,
OCC1C[NH2+]CC(O)C1O,7.2,,
Nc1cc(C(F)(F)F)c(S(N)(=O)=O)cc1S(N)(=O)=O,7.2,,CHEMBL418
CC1[NH2+]C(CNC(=O)c2cccc3c2C(=O)c2ccccc2-3)C(O)C(O)C1O,7.2,,
O=[N+]([O-])Nc1nccn1Cc1ccc(Cl)nc1,7.2,,CHEMBL95367
CCCCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,7.2,,
O=C([O-])Cc1ccc(-c2c[nH]c3ncc(-c4ccc5ccccc5c4)cc23)cc1,7.2,,
COc1ccc(CC(=O)Nc2cn(C3CC(NC(C)=O)C3)cn2)cc1,7.2,,
CCN(C(=O)OCC(CO[N+](=O)[O-])O[N+](=O)[O-])C1CC(C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,7.2,,
O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1,7.2,,CHEMBL1090356
CN(C)c1ccc(C(=O)NCCCCCCC(=O)N=O)cc1,7.2,,
CC1COCCN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1,7.2,,
NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1OCCC(O)CO,7.2,,
COCCCc1cc(Nc2nc(NCc3cc(C)no3)ncc2Br)n[nH]1,7.2,,CHEMBL2088093
[NH3+]C(C(=O)[O-])C1CCC1C(=O)[O-],7.2,,
CN(O)C(=O)CCC(CC([NH3+])C(=O)[O-])C(=O)[O-],7.2,,
O=C(CCc1nc2ccccc2c(=O)[nH]1)Nc1ccc(-c2nnc(-c3ccccc3)o2)cc1,7.2,,CHEMBL3110107
CC(=O)NC(C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC1(C)CCCCCCC=CCCCC(C)(C(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CCC(=O)[O-])NC1=O)C(C)O,7.2,,
C=CC[NH+](C)CCCCCCOc1ccc(C(=O)c2ccc(Br)cc2)c(F)c1,7.21,,
CCS(=O)(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCC(N)=O)C(=O)NCc1ccc(C(N)=[NH2+])cc1,7.21,,
Cc1ccc(NC(=O)c2ccc(C[NH+]3CC[NH+](C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,7.21,,
CCC(C=O)C1NC(C(=O)[O-])=C2C(OC)CCCC21,7.21,,
CC(=O)c1ccc(-c2ccc(CCC(O)CC(=O)[O-])cc2)cc1,7.21,,
CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4n[nH]cc34)n2)c1,7.21,,
CCNC(=O)CC1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21,7.21,,
CC(C)CCn1nc(-c2cccs2)c(O)c(C2=Nc3ccc(OC(C)C(N)=O)cc3S(=O)(=O)N2)c1=O,7.21,,
[NH3+]CCCC(=O)Nc1ccc(OCc2ccccc2)cc1,7.21,,
O=C(CNS(=O)(=O)c1ccccc1)NO,7.21,,CHEMBL2385479
CC(C)CCC1(C)CN(C2CCCC2)C(=O)C(C2=Nc3ccc(NS(C)(=O)=O)cc3S(=O)(=O)N2)=C1O,7.21,,
Nc1nn(-c2cccc(-c3ccc4cc[nH]c4c3)c2)cc1-c1ccc2c(c1)CCNC2=O,7.21,,CHEMBL597839
C=CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,7.21,,
NS(=O)(=O)c1nccs1,7.21,,
CCCOc1sc(C(=O)N2C3CCC2CC(c2cc(C[NH3+])ccc2F)C3)c(C)c1Br,7.21,,
NC(=O)c1ccc2[nH]c(-c3ccc(Oc4cccc(O)c4)cc3)nc2c1,7.21,,CHEMBL367263
OCC1OC(OCC#Cc2ccc(-c3ccccc3)cc2)C(O)C(O)C1O,7.21,,
CCC([NH2+]C(C)CC(N)=O)c1ccc(Cl)c(Oc2ccccc2)c1F,7.21,,
COc1cnc2[nH]cc(Cc3ccc(NCc4ccc(C(F)(F)F)cc4)nc3)c2c1,7.21,,CHEMBL4226338
CC(O)C(C=O)C1CC(S)=C(C(=O)[O-])N1,7.21,,
CCCS(=O)(=O)Nc1ccc(F)c(C(=O)Nc2cnc3nc[nH]c3c2)c1F,7.21,,
CC(C)n1ncc2c1C(=O)CC1(CCN(C(=O)c3ccc4n[nH]cc4c3)CC1)C2,7.21,,
NS(=O)(=O)c1ccc(NN=C2C(=O)Nc3ccc(Br)cc32)cc1,7.22,,
CC(O)C(NC(=O)C1CCC[NH2+]1)C(=O)NC(CCC(=O)[O-])C(=O)NC(C[NH2+]C(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCC(=O)[O-])C(=O)[O-])Cc1ccccc1,7.22,,
CC(C)CC([NH3+])C(=O)[O-],7.22,,
CC(=O)NC1C(OC2C(CO)OC(OC3C(O)C4[NH+]=C(N(C)C)OC4C3CO)C(NC(C)=O)C2O)OC(CO)C(O)C1O,7.22,,
Cc1nc(C)c(-c2ccnc(Nc3cccc(O)c3)n2)s1,7.22,,CHEMBL47527
CC(C)CC(NC(N)=[NH2+])C(=O)NCC(=O)N1CCC(c2cc(-c3ccc(OCc4ccc(C(=O)[O-])o4)c(Cl)c3Cl)nn2C)CC1,7.22,,
C[N+](C)(C)CC(=O)[O-],7.22,"This molecule is a modified amino acid consisting of glycine with three methyl groups that serves as a methyl donor in several metabolic pathways and is used to treat the rare genetic causes of homocystinuria. This molecule has had only limited clinical use, but has not been linked to instances of serum enzyme elevations during therapy or to clinically apparent liver injury. This molecule is the amino acid betaine derived from glycine. It has a role as a fundamental metabolite. It is an amino-acid betaine and a glycine derivative. It is a conjugate base of a N,N,N-trimethylglycinium. This molecule is a methyl group donor that functions in the normal metabolic cycle of methionine. It is a naturally occurring choline derivative commonly ingested through diet, with a role in regulating cellular hydration and maintaining cell function. Homocystinuria is an inherited disorder that leads to the accumulation of homocysteine in plasma and urine. Currently, no treatments are available to correct the genetic causes of homocystinuria. However, in order to normalize homocysteine levels, patients can be treated with vitamin B6 ([pyridoxine]), vitamin B12 ([cobalamin]), [folate] and specific diets. This molecule reduces plasma homocysteine levels in patients with homocystinuria. Although it is present in many food products, the levels found there are insufficient to treat this condition. The FDA and EMA have approved the product Cystadane (betaine anhydrous, oral solution) for the treatment of homocystinuria, and the EMA has approved the use of Amversio (betaine anhydrous, oral powder). This molecule is a Methylating Agent. The mechanism of action of betaine is as a Methylating Activity. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Amaranthus hybridus, Cornulaca leucacantha, and other organisms with data available.",CHEMBL1182
O=c1[nH]c(=O)n(CCCC[NH+]2CC=C(c3ccccc3)CC2)c2cccc(F)c12,7.22,,
CC1=NC2C(OC(CO)C(O)C2O)S1,7.22,,
CC(O)C(NC(=O)C1CCC[NH2+]1)C(=O)NC(CCC(=O)[O-])C(=O)NC(C[NH2+]C(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCC(=O)[O-])C(=O)[O-])Cc1ccccc1,7.22,,
CC(C)CC(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)[O-])NC(=O)C1CCCN1C(=O)C(C)NC(=O)C([NH3+])CO)C(=O)[O-],7.22,,
CC(C)CC(CC(=O)NO)C(=O)NC(C(=O)NC(C)C(=O)NCC[NH3+])C(C)(C)C,7.22,,
CC(C)CC(=O)NC(C(=O)NC(C(=O)NC(CC(C)C)C(O)CC(=O)NC(C)C(=O)NC(CC(C)C)C(O)CC(=O)[O-])C(C)C)C(C)C,7.22,,
NS(=O)(=O)c1n[nH]c(=[NH2+])s1,7.22,,
CC(=O)CCC(NC(=O)C1CCC[NH2+]1)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)O,7.22,,
COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC,7.22,,CHEMBL235157
CS(=O)(=O)NCc1cccc(C2C[N+]3C(Cl)C[NH2+]C3C(NC3=CCC([N+]4CCOCC4)C=C3)[NH2+]2)c1,7.22,,
C=Cc1c(C)c2n3c1[CH]c1c(C)c(C=C)c4n1[Fe+5]31n3c(c(C)c(CCC(=O)[O-])c3[CH]c3c(CCC(=O)[O-])c(C)c(n31)[CH]4)[CH]2,7.22,,
Cn1c2c(c3ccc(Cl)cc31)C(C#N)C1(CC[NH2+]CC1)NC2=O,7.22,,
COc1cc2c3cc1OC=COc1cc4c(cc1OCc1cn(CCC(=O)[O-])nn1)Cc1cc5c(OCc6cn(CCc7ccc(S(N)(=O)=O)cc7)nn6)cc1Cc1cc(c(OCc6cn(CCC(=O)[O-])nn6)cc1C4)OCCOc1cc(c(cc1OC)Cc1cc(c(OC)cc1C3)OC=CO5)C2,7.22,,
CC(=O)CCCCCC=CC(=O)[O-],7.22,,
CCCCCC=CCC=CCCCCCC(O)CCCC(=O)[O-],7.22,,
CN1C(=[NH2+])NC(c2ccncc2)(c2cccc(-c3cccnc3)c2)C1=O,7.22,,
O=C1C=CC(C(=O)N2Cc3ccccc3C2)=C(O)C1,7.22,,
CS(=O)(=O)c1ccccc1-c1ccc(NC(=O)c2cc(C(F)(F)F)nn2-c2cccc(C[NH3+])c2)c(F)c1,7.22,,
NS(=O)(=O)c1cc(C(=O)CSc2nc3cc(Br)ccc3[nH]2)ccc1Cl,7.22,,CHEMBL1271638
O=C([O-])c1cc2cc3ccc4oc(C(=O)[O-])cc4c3cc2o1,7.22,,
O=C([O-])c1ccn(O)c(=O)c1,7.22,,
CCC(C)C([NH3+])C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)[O-],7.22,,
CC(C[N+]1CCC(Cc2ccccc2)CC1)C(O)c1ccc(O)cc1,7.22,,
Clc1cc(Cl)c2[nH]nnc2c1,7.22,,
CN1C(=[NH2+])NC(C)(c2cccc(NC(=O)c3ccc(OCC(F)(F)F)cn3)c2)CC1=O,7.22,,
NC(=O)c1ccc2nc(-c3ccc(OCC4CC[NH2+]CC4)cc3)[nH]c2c1,7.22,,
O=C([O-])CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1,7.22,,
O=C([O-])C(=O)CC(=O)C1(Cc2ccc(Cl)cc2)CC[NH+](CC2CCCCC2)CC1,7.22,,
Cc1ccc(Oc2nc3cc(Cl)c(-c4ccc5c(ccn5C)c4)cc3[nH]2)cc1C(=O)[O-],7.22,,
O=C1CC(NC(=O)c2c(Cl)cccc2Cl)=CC=N1,7.22,,
NC(=O)C(CCCCNC(=O)C(Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)CCC1CCCCC1)NC(=O)C=CC(=O)[O-],7.22,,
CC(C(=O)Nc1ncc(SCc2ncc(C(C)(C)C)o2)s1)c1ccccc1,7.22,,
O=S(=O)(c1ccccc1)N(CC(F)(F)F)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,7.22,This molecule is an LXRalpha and LXRbeta agonist. This molecule is a natural product found in Aspergillus puniceus with data available.,CHEMBL62136
CCNc1nc2ccc(C#CC(C)(C)O)cc2n1-c1ncnc(N)n1,7.22,,CHEMBL3128055
CCC(C)C(NC(=O)C(c1cc(Cl)cc(Cl)c1)[NH+](C)C)C(=O)NCc1ccnc(C=N)n1,7.22,,
C=CC[NH+](CC1CC1COc1ccc(C(=O)c2ccc(Br)cc2)cc1)C1CC1,7.23,,
CC(C)c1c[nH][n+]2c(Nc3ccc(S(=O)(=O)N(C)C)cc3)cc(NC3CCC([NH3+])CC3)nc12,7.23,,
CN1CCOc2cc(S(=O)(=O)NC(Cc3ccc(C4CC(=O)NS4(=O)=O)cc3)c3nc4ccccc4[nH]3)ccc21,7.23,,
COc1cc(O)c(CCC(=O)[O-])cc1C(O)CC(C)C,7.23,,
CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)C[NH2+]C1(c2cccc(-n3cccn3)c2)CCCCC1,7.23,,
CC(Oc1cc(-c2cc(-c3cc(C[NH+](C)C)cs3)cnc2N)ccc1C(N)=O)c1ccccc1C(F)(F)F,7.23,,
CCCSCCCOC1OC(CO)C(O)C(O)C1O,7.23,,
CN1C(=[NH2+])NC(c2cccc(-c3cncc(Cl)c3)c2)(C2CC2)C1=O,7.23,,
O=C(NS(=O)(=O)c1ccc(NC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CC[NH+](CC3=C(c4ccc(Cl)cc4)CCOC3)CC2)cc1,7.23,,
N#Cc1ccc(NC(NCC(=O)[O-])=[NH+]C(c2ccccc2)c2ccccc2)cc1,7.24,,
CCOC(=O)CON=C(c1ccccn1)C1(c2ccc3c(c2)nc(CNc2ccc(C(N)=[NH2+])cc2)n3C)CC1,7.24,,
NC(=[NH2+])c1ccc(C2C3C(=O)N(Cc4ccc(F)cc4)C(=O)C3C3CCC[NH+]32)cc1,7.24,,
Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl,7.24,"This molecule is a manufactured chemical that does not occur naturally. Pure pentachlorophenol exists as colorless crystals. Impure pentachlorophenol (the form usually found at hazardous waste sites) is dark gray to brown and exists as dust, beads, or flakes. Humans are usually exposed to impure pentachlorophenol (also called technical grade pentachlorophenol). This molecule was widely used as a pesticide and wood preservative. Since 1984, the purchase and use of pentachlorophenol has been restricted to certified applicators. It is no longer available to the general public. It is still used industrially as a wood preservative for utility poles, railroad ties, and wharf pilings. This molecule appears as a white crystalline solid. Slightly soluble in water. Noncombustible. Toxic by inhalation, ingestion, and skin absorption. Used as a fungicide and as a wood preservative. This molecule is a chlorophenol that is phenol substituted by 5 chloro groups. It has a role as a human xenobiotic metabolite. It is an organochlorine pesticide, a member of pentachlorobenzenes, an aromatic fungicide and a chlorophenol. It is functionally related to a pentachlorobenzene. It is a conjugate acid of a pentachlorophenolate. This molecule was once one of the most widely used biocides in the United States, but it is now a restricted use pesticide and is no longer available to the general public. It was primarily used as a wood preservative. This molecule is extremely toxic to humans from acute (short-term) ingestion and inhalation exposure. Acute inhalation exposures in humans have resulted in neurological, blood, and liver effects, and eye irritation. Chronic (long-term) exposure to pentachlorophenol by inhalation in humans has resulted in effects on the respiratory tract, blood, kidney, liver, immune system, eyes, nose, and skin. Human studies are inconclusive regarding pentachlorophenol exposure and reproductive effects. Human studies suggest an association between exposure to pentachlorophenol and cancer. Oral animal studies have reported increases in liver tumors and two uncommon tumor types. EPA has classified pentachlorophenol as a Group B2, probable human carcinogen. This molecule is a natural product found in Bos taurus with data available. This molecule is an organochlorine compound used as a pesticide and a disinfectant. First produced in the 1930s, it is marketed under many trade names. It can be found in two forms: PCP itself or as the sodium salt of PCP, which dissolves easily in water. Short-term exposure to large amounts of PCP can cause harmful effects on the liver, kidneys, blood, lungs, nervous system, immune system, and gastrointestinal tract. Elevated temperature, profuse sweating, uncoordinated movement, muscle twitching, and coma are additional side effects. Contact with PCP (particularly in the form of vapor) can irritate the skin, eyes, and mouth. Long-term exposure to low levels such as those that occur in the workplace can cause damage to the liver, kidneys, blood, and nervous system. Finally exposure to PCP is also associated with carcinogenic, renal, and neurological effects. The U.S. Environmental Protection Agency Toxicity Class classifies PCP in group B2 (probable human carcinogen).",CHEMBL75967
Cc1cncc2cccc(S(=O)(=O)N3CCC[NH2+]CC3C)c12,7.24,,
CC(C)(C)OC(=O)NC(C(=O)N1CC2C(C1C(=O)NC(CC1CC1)C(O)C(N)=O)C2(C)C)C(C)(C)C,7.24,,
CCNC(=O)N1CCC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)CC1,7.24,,CHEMBL248176
CNC(=O)CCC(=O)NC(Cc1ccccc1)C(O)CN(CC1CC1)S(=O)(=O)c1ccco1,7.24,,
CCNC(=O)c1cc2c(-c3cc(OCC[NH+]4CCCC4)c(Cl)cc3Cl)nc(N)nc2s1,7.24,,
Cn1c2c(c3c4c(c(-c5ccccc5Cl)cc31)C(=O)NC4=O)CC(=O)C(OCCC[N+](C)C)=C2,7.24,,
CC(C=Cc1c(C)cc(O)c(C)c1C)=CC=CC(C)=CC(=O)[O-],7.24,,
N=C1C(=O)C(=O)C1[NH+]1CCc2ccc(CNC(=O)c3nc4sc5c(c4c(=O)[nH]3)CCS(=O)(=O)C5)cc2C1,7.24,,
N=C1C(=O)C(=O)C1[NH+]1CCc2ccc(CNC(=O)c3nc4sc5c(c4c(=O)[nH]3)CCS(=O)(=O)C5)cc2C1,7.24,,
C[NH+]1CCCN(c2cncc(-c3cccc(C=CC(=O)[O-])c3)n2)CC1,7.24,,
COc1ccc(Cn2nnc(-c3cccc(C(=O)NCc4ccc(C(=O)[O-])cc4)c3)n2)cc1,7.24,,
O=C([O-])c1ccc2c(C3CCCCC3)c(-c3ccoc3)n(CC(=O)N3CCC(C(=O)[O-])CC3)c2c1,7.24,,
C[NH+]1CC[NH+](CCCOc2ccc(-c3cccc(C#N)n3)cc2C(F)(F)F)CC1,7.24,,
O=C([O-])c1cc(-c2ccccc2)nc2c1cnn2Cc1ccncc1,7.24,,
O=c1[nH]c2ccccc2n1C1CC[N+](Cc2ccc(-c3nc4cc5nc[nH]c5cc4nc3-c3ccccc3)cc2)CC1,7.24,,
Cc1n[nH]c(C)c1CCCOc1ccccc1F,7.24,,CHEMBL3695460
CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2ccc3c(c2)CC(C(=O)[O-])[NH2+]C3)n1,7.24,,
COC(=O)C1CCCN1C(=O)C(Cc1ccccc1)N(C)C(=O)C(C)NC(=O)C(CC(C)C)NC(=O)CC(O)C(Cc1ccccc1)NC(=O)c1cc(C(=O)NC(C)c2ccccc2)cc(N(C)S(C)(=O)=O)c1,7.24,,
CCC1CCC(C(=O)N2CCN(C(C)=O)C(C)C2)N1C(=O)c1sc2[n+](c1C(C)C)C(c1ccc(Cl)cc1)C(C)(c1ccc(Cl)cc1)N2,7.24,,
CC(=O)NC1C(=NOC(=O)Nc2ccccc2)OC(CO)C(O)C1O,7.24,,
CC(C)Oc1cc(C[NH+]2CCC3(CC2C)CN(C)S(=O)(=O)N3c2cccc(F)c2)ccc1O,7.24,,
CN1C(=[NH2+])NC(C)(c2cc(-c3cccc(C#N)c3)cs2)CC1=O,7.24,,
CCC(C)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(CO)NC(=O)CNC(=O)C[NH3+])C(C)C)C(C)C)C(C)CC)C(C)C)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)[O-])C(C)CC,7.24,,
Clc1cc(-c2c[nH]c3ncccc23)cc(NC2CCCCC2)n1,7.24,,CHEMBL2322677
O=C(NCCC[NH2+]Cc1cc(Cl)cc(Cl)c1)Nc1ccccc1,7.24,,
O=C(NCc1ccc(S(=O)(=O)c2cc(F)cc(F)c2)cc1)c1ccc2cccn2c1,7.24,,
COc1ccc(CNC(=O)C(Cc2ccccc2)NC(=[NH2+])NC(=O)Cc2ccc(OC)c(OC)c2)cc1OC,7.24,,
CC(C)(C)CN1C(=O)C(CC(=O)NC(CC(=O)[O-])C(=O)[O-])OC(c2cccc3ccccc23)c2cc(Cl)ccc21,7.25,,
CC(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],7.25,,
CC(C)CC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CO)Cc1ccc(O)cc1,7.25,,
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,7.25,,
CCOC(=O)c1c(C)nn(-c2ccccc2Cl)c1C,7.25,,CHEMBL519827
OCC1C(O)C(O)C(O)c2nccn21,7.25,,
CC#CC1CCC(C=N)N1C(=O)C([NH3+])C1CCCC1,7.25,,
[NH3+]C(CC(=O)N1CCCCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F,7.25,,
CC(C)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C1CCCN1C(=O)C(C=CC(N)=O)NC(=O)C1CCC[NH2+]1)C(C)C)C(=O)[O-],7.25,,
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,7.25,"This molecule is an oral multi-kinase inhibitor that is used in the therapy of advanced renal cell, liver and thyroid cancer. This molecule has been associated with a low rate of transient elevations in serum aminotransferase levels during therapy that are generally mild and asymptomatic. This molecule has also been linked to rare instances of clinically apparent liver injury which can be severe and even fatal. This molecule is a member of the class of phenylureas that is urea in which one of the nitrogens is substituted by a 4-chloro-3-trifluorophenyl group while the other is substituted by a phenyl group which, in turn, is substituted at the para position by a [2-(methylcarbamoyl)pyridin-4-yl]oxy group. It has a role as an antineoplastic agent, an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor, a tyrosine kinase inhibitor, an angiogenesis inhibitor, an anticoronaviral agent and a ferroptosis inducer. It is a pyridinecarboxamide, a member of monochlorobenzenes, an aromatic ether, a member of (trifluoromethyl)benzenes and a member of phenylureas. This molecule is a bi-aryl urea and an oral multikinase inhibitor. It targets cell surface tyrosine kinase receptors and downstream intracellular kinases that are implicated in tumour cell proliferation and tumour angiogenesis. First approved by the FDA and European Commission in 2007 for the treatment of hepatocellular carcinoma, sorafenib is also indicated to treat renal carcinoma and differentiated thyroid carcinoma. This molecule is a Kinase Inhibitor. The mechanism of action of sorafenib is as a Protein Kinase Inhibitor. This molecule is a synthetic compound targeting growth signaling and angiogenesis. This molecule blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis. This molecule is a natural product found in Aspergillus ochraceus, Curvularia lunata, and Asimina triloba with data available. This molecule is a drug approved for the treatment of advanced renal cell carcinoma (primary kidney cancer). It has also received 'Fast Track' designation by the FDA for the treatment of advanced hepatocellular carcinoma (primary liver cancer), and has since performed well in Phase III trials.
Sorafenib is a small molecular inhibitor of Raf kinase, PDGF (platelet-derived growth factor), VEGF receptor 2 & 3 kinases and c Kit the receptor for Stem cell factor. A growing number of drugs target most of these pathways. The originality of Sorafenib lays in its simultaneous targeting of the Raf/Mek/Erk pathway.",CHEMBL1336
COc1ncnc(NCc2ccc(S(N)(=O)=O)cc2)c1[N+](=O)[O-],7.25,,CHEMBL1233725
O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F,7.25,,CHEMBL1256291
O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)C3C4CCC(C4)C3C2=O)cc1,7.25,,
CCCCn1c(-c2ccccc2C)c[n+]2c3c(=O)[nH]c(=O)n(C)c3[nH]c12,7.25,,
N#Cc1ccc(OCCC[NH+]2CCC(C([NH3+])(c3ccccc3)C3CCCC3)CC2)cc1,7.25,,
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,7.26,,
C[NH+](CCO[NH3+])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,7.26,,
Cc1c(O)cccc1C(=O)NC(Cc1ccccc1)C(O)C(=O)N1CSC(C)(C)C1C(=O)NC(C)(C)C,7.26,,CHEMBL184415
CCCOc1ccc2[nH]cc(CC(NS(=O)(=O)CC)C(=O)NC(CCC(N)=O)C(=O)NCc3ccc(C(N)=[NH2+])cc3)c2c1,7.26,,
O=C([O-])c1ccc2nc(-c3c(Cl)cccc3Cl)oc2c1,7.26,,
Nc1nc2cc3nc(NCc4cccc5ccccc45)[nH]c3cc2c(=O)[nH]1,7.26,,
CC1[NH2+]CC(O)C(O)C1O,7.26,,
CCCCCC=CCC=CCCCCCCCCCC(=O)NC(COC1OC(CO)C(O)C(O)C1O)C(O)C(O)CCCCCCCCCCCCCC,7.26,,
CCCCNS(=O)(=O)c1ccccc1,7.26,"This molecule is a sulfonamide that is benzenesulfonamide substituted by a butyl group at the nitrogen atom. It has been isolated from the plant Prunus africana and has been shown to exhibit antiandrogenic activity. It has a role as a neurotoxin and a plant metabolite. This molecule is a natural product found in Streptomyces, Pseudomonas, and other organisms with data available. N-Butyl benzenesulfonamide (NBBS), a plasticizer used commercially in the polymerization of polyamide compounds. It is neurotoxic and has been found to induce spastic myelopathy in rabbits.",CHEMBL479880
CNc1nc2c(CC[NH3+])c3[nH]c(=[NH2+])[nH]c(=O)c3cc2[nH]1,7.26,,
CC([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CC(=O)[O-])C(=O)[O-],7.26,,
CC(=O)NC(CCC(N)=O)C(=O)NC(CC1CCCCC1)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(Cc1ccc(Cl)c(Cl)c1)C(=O)[O-],7.26,,
CCC([NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC1(C)CCCCCC=CCCCCC(C)(C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC1=O)C(C)O,7.26,,
CCC[NH+]1CCCC12CCN(C(C)C(=O)NC(Cc1ccccc1)C(O)C[NH2+]Cc1cccc(C(C)C)c1)C2=O,7.26,,
CC(C)(C)c1cccc(C[NH2+]C2CS(=O)(=O)CC(Cc3ccc4[nH]cc(CC(F)F)c4c3)C2O)c1,7.26,,
CC(C)(C)c1cccc(C[NH2+]C2CS(=O)(=O)CC(Cc3ccc4[nH]cc(CC(F)F)c4c3)C2O)c1,7.26,,
Cc1ccc(-c2c(C(OC(C)(C)C)C(=O)[O-])c(C)nc3ccccc23)cc1C,7.26,,
CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,7.26,,
Cc1cc(OCCCc2c(C(=O)[O-])[nH]c3cc(Cl)ccc23)cc(C)c1Cl,7.26,,
OC1CCC(Nc2nccc(-n3ncc4ccccc43)n2)CC1,7.26,,
CCC(C)C(NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)O)C(C)C)C(=O)NC(CO)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(=O)[O-])C(=O)[O-],7.26,,
O=C1CC(c2oc3cc(O)cc(O)c3c(=O)c2O)=CC=C1O,7.26,,
CC(=O)Nc1ccc(C(=O)Nc2cc(-c3cccs3)ccc2N)cc1,7.26,This molecule is a member of benzamides.,CHEMBL235842
CCCC1CC(C)CC(C)CC(OC)C2OC(O)(C(C)CC2OC)C(O)C(=O)N2CCCCC2C(=O)OC(C(C)=CC2CCC(O)C(OC)C2)C(C)C(O)CC1O,7.26,,
Cc1cc2c(cc1NC1C[NH2+]C1)N1C(=NNC(=O)C1C)CO2,7.26,,
CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)[O-],7.269999999999999,,
CCCCCc1ccc(C(=O)N(Cc2ccc(-c3ccc(C(=O)N4CCCCC4)cc3)cc2)C2CC[NH+](Cc3ccccn3)CC2)nc1,7.269999999999999,,
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCC[NH+]1CCOCC1,7.269999999999999,,
CCCC1c2ccccc2C[NH2+]N1C(=O)C=CC1CC(Cc2cnc(N)nc2N)CC(OC)C1OC,7.269999999999999,,
CC(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1ccccc1)NC(=O)C1CCC[NH2+]1)C(=O)[O-],7.269999999999999,,
CCCn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccncn1,7.269999999999999,,CHEMBL1738878
CSCCC(NC(=O)C(CCCC[NH3+])NC(=O)C1CCCN1C(=O)C(CCC(=O)[O-])NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(CS)NC(=O)CNC(=O)C(NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C([NH3+])C(C)C)C(C)O)C(=O)NC(CO)C(=O)[O-],7.269999999999999,,
NS(=O)(=O)c1ccc(CNC(=O)Cc2ccccc2)cc1,7.269999999999999,,CHEMBL574783
N#Cc1ccc(C(=O)Nc2ccc(F)c(C3(C(F)F)CCOC(=[NH2+])N3)c2)nc1,7.269999999999999,,
[NH2+]=c1[nH]c(=O)c2c(CCc3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc3)c[nH]c2[nH]1,7.269999999999999,,
CC(C)(ON=C(C(=O)NC(C=O)C(CNC(=O)NCc1cc(=O)c(O)cn1O)NS(=O)(=O)[O-])c1csc(N)n1)C(=O)[O-],7.269999999999999,,
O=C(NCc1ccc(S(=O)(=O)c2ccccc2)cc1)c1cnc2[nH]ncc2c1,7.269999999999999,,CHEMBL3260347
[NH3+]CCCCC([NH3+])C(=O)NC(Cc1ccccc1)C(=O)NC(CCCC[NH3+])C(=O)[O-],7.28,,
CC(=O)NC(C(=O)NC(Cc1ccccc1)C(O)C[NH+](CC1CCCCC1)NC(=O)C(NC(C)=O)C(C)C)C(C)C,7.28,,
OCC1C(O)C(O)C(O)c2nccn21,7.28,,
N#Cc1ccc(NC(NC(c2ccccc2)c2ccccc2)=[NH+]CC(=O)[O-])cc1,7.28,,
[NH3+]CCc1c[nH]c2ccccc12,7.28,,
CC(=CC(=O)NC(Cc1ccccc1)C(O)CN(Cc1cccs1)S(=O)(=O)c1cc(F)c(F)cc1F)C(F)(F)F,7.28,,
NS(=O)(=O)c1ccc2c(c1)CCC2,7.28,,CHEMBL364869
O=C(Nc1c[nH]nc1-c1nc2ccccc2[nH]1)c1ccccc1,7.28,,CHEMBL522891
Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1,7.28,,CHEMBL2153434
O=C1c2ccc(O)c(O)c2C(=O)c2c(O)ccc(O)c21,7.28,"This molecule is a tetrahydroxyanthraquinone having the four hydroxy groups at the 1-, 2-, 5- and 8-positions. It has a role as an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor.",CHEMBL29898
CC(C)CC(NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],7.28,,
CCCCNC(=O)C(C)CC(O)C(CC(C)C)NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(C)=O,7.28,,
NP1(=O)C=CNC(=O)N1,7.28,,
Cc1cc(C)nc(SCC(=O)c2ccc(S(N)(=O)=O)cc2)n1,7.28,,CHEMBL2010998
Nc1cc(Cn2c(C(=O)[O-])c(C3C=CC=NC3=O)c3cc(Cl)ccc32)ccn1,7.28,,
CC(C)(C)C(NC(=O)Nc1cc(F)cc(F)c1)C(=O)N(CC(=O)NO)CC1CCCC1,7.28,,
COC1CC=C2CC[NH+]3CCC4=C(CC(=O)OC4)C23C1,7.28,,
CC(NC(=O)C([NH3+])CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NCC(=O)NC(C(=O)[O-])C(C)O,7.28,,
CC[NH2+]C1CC(C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,7.28,,
CNc1nc2cc3c(=O)[nH]c(=[NH2+])[nH]c3cc2[nH]1,7.28,,
CCC(C)C(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C[NH3+])C(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCSC)C(=O)NC(C(=O)[O-])C(C)C,7.28,,
c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,7.29,"This molecule is a member of the class of pyrazoles carrying pyridin-2-yl and quinolin-4-yl substituents at positions 3 and 4 respectively. It has a role as a TGFbeta receptor antagonist. It is a member of pyrazoles, a member of pyridines and a member of quinolines. This molecule is a natural product found in Exserohilum rostratum with data available.",CHEMBL261454
CC(C)c1c(C(=O)NC(CO)c2ccccc2)nc(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)[O-],7.29,,
CCCCN1CC=C(O)c2c1cc(-c1ccccc1)nc2N,7.29,,
N#Cc1ccccc1Nc1ccnc(Nc2ccc(C(=O)[O-])cc2)n1,7.29,,
C=C(C)C=CC1C(C)CCCC1(C)C,7.29,,
CC(=O)NC1C[NH2+]C(CO)C(O)C1O,7.29,,
NS(=O)(=O)c1nnc(NC(=O)Cc2cccs2)s1,7.29,,CHEMBL574780
CC1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)CCOC(=[NH2+])N1,7.29,,
Cc1nn(CC(F)(F)CO)c(-c2ccc(F)cc2)c1-c1ccc2c(c1)NC(=O)CO2,7.29,,CHEMBL3337829
Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl,7.3,"This molecule is an aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items such as plastic chopping boards, sports equipment and shoes. It has a role as an antibacterial agent, a fungicide, an EC 1.5.1.3 (dihydrofolate reductase) inhibitor, an antimalarial, an EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor, a xenobiotic, a persistent organic pollutant and a drug allergen. It is a member of phenols, an aromatic ether, a dichlorobenzene and a member of monochlorobenzenes. This molecule is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items such as plastic chopping boards, sports equipment and shoes. This molecule is a polychloro phenoxy phenol with antibacterial and antifungal activity. This molecule is added to toothpastes to prevent gingivitis and has been added to many household products for its topical antibiotic activity. This molecule is an antibacterial and antifungal agent. It is a polychloro phenoxy phenol. Though many consumer products contain triclosan, according to the Food and Drug Administration (FDA) at the present time there is no evidence that triclosan in personal care products provides an extra benefit to health beyond its anti-gingivitis effect in toothpaste. The FDA does not recommend changing consumer use of triclosan containing products one way or the other due to currently insufficient safety evidence. Studies by the Environmental Protection Agency (EPA) found triclosan to be an effective antibacterial. This molecule safety is currently under review by the FDA and Health Canada.",CHEMBL849
Nc1ncnc2c1ncn2C1OC(COS(=O)(=O)NC(=O)C2CCC[NH2+]2)C(O)C1O,7.3,,
CCC(NC(=O)C(O)C(C)NC(=O)C(CC(=O)N(C)C)NC(=O)C(NC(=O)C(NC(=O)CCCCC[NH3+])C(C)(C)C)C(C)(C)C)c1ccccc1,7.3,,
CCC(NC(=O)C(O)C(C)NC(=O)C(CC(=O)N(C)C)NC(=O)C(NC(=O)C(NC(=O)CCCCC[NH3+])C(C)(C)C)C(C)(C)C)c1ccccc1,7.3,,
O=CC(CSCc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)N1CCOCC1,7.3,,
Cc1cc(Br)c(O)c(-c2cc3cc(C(N)=[NH2+])ccc3[nH]2)c1,7.3,,
Cc1cc(Br)c(O)c(-c2cc3cc(C(N)=[NH2+])ccc3[nH]2)c1,7.3,,
NC(=[NH2+])NCCCC(NC(=O)C(CO)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(=O)C1CCC[NH2+]1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(N)=O)C(=O)NC(CCC(N)=O)C(=O)NC(CC(=O)[O-])C(=O)[O-],7.3,,
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],7.3,,
OC1CSSCC1O,7.3,,
C[N+]1(C)CCCC1C(=O)[O-],7.3,"This molecule is a proline derivative. This molecule is a natural product found in Achillea virescens, Leonurus turkestanicus, and other organisms with data available.",CHEMBL1986864
CC(C)CC([NH2+]C(CCc1ccccc1)C(=O)[O-])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],7.3,,
CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(CC(=O)NC)N(Cc4ccc(O)c(OC)c4)C(=O)O3)C21,7.3,,
COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,7.3,This molecule is a member of the lclass of pyrrolidin-2-ones that is pyrrolidin-2-one bearing a 3-(cyclopentyloxy)-4-methoxyphenyl substituent at the 4-position. It is a type IV-specific phosphodiesterase (PDE4) inhibitor. It has a role as an antidepressant and an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor. A phosphodiesterase inhibitor with antidepressant properties.,CHEMBL63
Nc1c(Cl)cc(S(N)(=O)=O)cc1Cl,7.3,,CHEMBL70020
CCC(CO)Nc1nc(NCc2ccccc2O)c2ncn(C(C)C)c2n1,7.3,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C([NH3+])Cc1c[nH]c2ccccc12)C(=O)NC(C)C(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],7.3,,
CSCCC(NC(=O)C(NC(=O)CC(O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(C)NC(C)=O)C(C)C)C(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)N1CCCC1C(=O)[O-],7.3,,
CCCc1c(OCCCOc2ccc3c(ccn3CC(=O)[O-])c2)ccc2cc(C(=O)c3ccccc3)ccc12,7.3,,
CC(C)[NH2+]CCCn1c(Sc2cc3c(cc2I)OCO3)nc2c(N)ncnc21,7.3,,
C[NH2+]C(C)C(=O)NC1CCCC2SC(C)(C)C(C(=O)Nc3cc(C)nn3-c3ccccc3)N2C1=O,7.3,,
N#Cc1c(-c2ccccc2)cc(-c2cc(Br)ccc2O)nc1O,7.3,,
CCCC(NC(=O)C1CC2CCCCC2N1C(=O)C(NC(=O)C(NC(=O)c1cc([N+](=O)[O-])c[nH]1)C1CCCCC1)C(C)(C)C)C(O)C(=O)NC1C=C1,7.3,,
COc1cccc(S(=O)(=O)N(Cc2cccs2)CC(O)C(Cc2ccccc2)NC(=O)c2ccc(O)c(O)c2)c1,7.3,,
O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O,7.3,"This molecule is a member of the class of dihydrochalcones that is dihydrochalcone substituted by hydroxy groups at positions 4, 2', 4' and 6'. It has a role as a plant metabolite and an antineoplastic agent. It is functionally related to a dihydrochalcone. This molecule is a natural dihydrochalcone found in apples and many other fruits. This molecule is a natural product found in Malus, Boesenbergia rotunda, and other organisms with data available.",CHEMBL45068
CCNC1=NC2C(OC(CO)C(O)C2O)S1,7.3,,
[NH3+]C(CSC(c1ccccc1)(c1ccccc1)c1ccc(Cl)cc1)C(=O)[O-],7.3,,
O=C1CCCCCCCCNC(=O)c2c(O)cc(O)c(Cl)c2C1,7.3,,
CC1CCc2c(sc(NC(=O)c3ccccc3[N+](=O)[O-])c2C(N)=O)C1,7.3,,CHEMBL568465
COc1ccc2c3c1OC1CC(O)C=CC31CC[NH+](CCCCCCN1C(=O)c3ccccc3S1(=O)=O)C2,7.3,,
Cc1ccc(CC([NH3+])CNc2nnc(-c3ccc4[nH]nc(C)c4c3)s2)cc1,7.3,,
NS(=O)(=O)c1ccc(NC(=O)Nc2c(F)c(F)c(F)c(F)c2F)cc1,7.3,,CHEMBL316779
O=C([O-])c1ccc(NC(=O)C(C2CCCCC2)n2c(-c3ccc(Cl)cc3)nc3cc(F)c(F)cc32)cc1,7.3,,
CCNC(=O)CC1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21,7.3,,
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1cccc(F)c1,7.3,,CHEMBL2377823
NS(=O)(=O)c1ccc(NC(=O)Cc2cccs2)cc1,7.3,,CHEMBL573127
Cc1cc(=O)[nH]c(SCC(=O)c2ccc(S(N)(=O)=O)cc2)n1,7.3,,CHEMBL2010988
C[N+]1=C(CC=Cc2cc[n+](CCCS(=O)(=O)[O-])c3ccccc23)C(C)(C)c2ccccc21,7.3,,
CCC(C)C(CC(=O)NCC(=O)NC(CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(=O)NC(CC(N)=O)C(=O)NC(C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(N)=O)Cc1ccc(O)cc1)Cc1ccccc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)CC(CCC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C(C)NC(=O)C(NC(=O)CC(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])C(C)CC)C(C)CC,7.3,,
[NH3+]CCNS(=O)(=O)c1ccc(-c2c[nH]c3ncccc23)s1,7.3,,
COc1cc(NC(=O)c2cccc3cccnc23)c(OC)cc1Cl,7.3,,CHEMBL3988922
CCn1c(NC(=O)Nc2ccccc2OC)nc2ccccc21,7.3,,CHEMBL1413141
O=C(NO)C1C(c2ccccc2)C1c1ccc(-c2ncc(F)cn2)cc1,7.3,,
CC(=O)N1c2ccc(-c3ccc(NC(=O)CCCCCCC(=O)NO)cc3)cc2C(NC(=O)OC(C)C)CC1C,7.3,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(Cc1c[nH]cn1)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)[O-],7.3,,
O=C(Nc1ccc(NC(=O)c2ccccn2)cc1)c1ccc(O)c([N+](=O)[O-])c1,7.3,,CHEMBL3343045
CC=CNC(=O)Nc1nc2cc(-c3cccnc3)c(=O)n(CCC(C)C)c2s1,7.3,,
CC(=O)c1ccc(N2CCN(C(=O)C[NH+]3CCC(C(=O)Nc4ccc(O)c(Cl)c4)C3)CC2)cc1,7.3,,
Cn1cc(-c2cccc(N3CCc4cc(C(C)(C)C#N)cc(F)c4C3=O)c2CO)cc(Nc2ccc(N3CC[NH+](C)CC3)cn2)c1=O,7.3,,
CC(=O)N1CCCC1C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)[O-],7.3,,
CCCCC(NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(C)[NH3+])B(O)O,7.3,,
Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)OC(C)(C)C)c1nnc(C)n1-2,7.309999999999999,"This molecule is an organonitrogen heterocyclic compound, an organosulfur heterocyclic compound and a tert-butyl ester.",CHEMBL2132936
O=C([O-])c1ccc(Nc2nccc(Nc3ccccc3C(F)(F)F)n2)cc1,7.309999999999999,,
COC(=O)C1CCCN1C(=O)C(Cc1ccccc1)N(C)C(=O)C(C)NC(=O)C(CC(C)C)NC(=O)CC(O)C(Cc1ccccc1)NC(=O)C(CCC(N)=O)N(C)C(=O)C(NC(=O)OC(C)(C)C)C(C)C,7.309999999999999,,
CC(=O)SC1CC2=CC(=O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,7.309999999999999,This molecule is a steroid lactone.,CHEMBL1562223
COc1ccc2cc(-c3nc(C(C)(C)C)[nH]c3-c3ccnc(N)c3)ccc2c1,7.309999999999999,,CHEMBL2030513
CC(C)(C)c1cccc(C[NH2+]C2CS(=O)(=O)CC(Cc3cc(F)c(N)c(CC(O)C(F)(F)F)c3)C2O)c1,7.309999999999999,,
N#Cc1ccc(C(=O)Nc2ccc(F)c(C3(CF)NC(=[NH2+])OCC3(F)F)c2)nc1,7.309999999999999,,
N#Cc1c(Oc2ccc(F)c(NC(=O)Nc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12,7.309999999999999,,CHEMBL3125885
CC(C)(C)n1nc(-c2ccc3ccccc3n2)c(C(N)=O)c1N,7.309999999999999,,CHEMBL3109007
CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)C1c1ccccc1,7.309999999999999,,
Cc1nc2ccccc2c(-c2ccc(Cl)cc2)c1C(OC(C)(C)C)C(=O)[O-],7.309999999999999,,
CS(=O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,7.32,,
[NH3+]C1CCC(Nc2nc(NCc3ccccc3)c3ncn(C4CCCC4)c3n2)CC1,7.32,,
CC(C)C(NC(=O)c1ccc(CCc2c[nH]c3nc(N)[nH]c(=O)c23)cc1)C(=O)[O-],7.32,,
CC(C)C1=NCCc2ccc(NC(=O)c3ccc4cc(C(N)=[NH2+])ccc4c3)cc21,7.32,,
CCCCCC(S)C(=O)NC(Cc1ccccc1)C(=O)NC(C)C(=O)[O-],7.32,,
O=C(NC1CCC[NH2+]CC1NC(=O)c1ccncc1)c1ccc(C(=O)c2cc(N3CCCCC3)ccc2O)cc1,7.32,,
O=S(=O)(NCC[NH2+]CC=Cc1ccc(Br)cc1)c1cccc2cnccc12,7.32,,
COC(=O)Cc1cn2c(n1)C(O)C(O)C(O)C2CO,7.32,,
Cc1ccn(-c2ccc3c(c2)NCC3(C)C)c(=O)c1-c1ccc2nc(N)ncc2c1,7.32,,CHEMBL493986
CCCc1c(OCCCN(C)C(=O)Nc2ccc(C(=O)[O-])cc2)ccc2c(C(F)(F)F)noc12,7.32,,
NC(=NO)NCCC([NH3+])C(=O)[O-],7.32,,
CCCCCC(CC(=O)NO)C(=O)NC(C(=O)N1CCCC1CO)C(C)C,7.32,,CHEMBL67311
CC1(C)OB(c2ccc(NS(N)(=O)=O)cc2)OC1(C)C,7.32,,CHEMBL190447
NC(=O)Cc1cccc(-n2nc(-c3cccs3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1,7.32,,CHEMBL1269839
CCC1CC2C(=O)CCC2C(C(=O)NC2(C(=O)[O-])CC2CC)C1,7.32,,
CC[N+](CC)CCOc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2c(Cl)cccc2Cl)C3)cc1,7.32,,
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,7.32,,
CC(Oc1cc(-c2cnn(C3CC[NH2+]CC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,7.32,,
O=C(Nc1ccc(Nc2nccc(Nc3cc(C4CCCC4)[nH]n3)n2)cc1)Nc1cccc(C(F)(F)F)c1,7.32,,
CN1C(=[NH2+])NC2(CC(C)(C)Cc3ccc(-c4cncnc4)cc32)C1=O,7.32,,
CN1C(=[NH2+])NC2(C1=O)c1cc(-c3cccnc3F)ccc1OC1CCCOC12,7.32,,
CCCCCCCCCCCCCCCCCC(=O)[O-],7.33,,
NC(=[NH2+])c1ccc(CNC(=O)C2(NC(=O)C(CC3CCCCC3)[NH2+]CC(=O)[O-])CCCC2)cn1,7.33,,
CC(C(=O)N1CCOCC1)N1CCC(NS(=O)(=O)c2cc3cc(Cl)ccc3[nH]2)C1=O,7.33,,
NC(=[NH2+])NOCCNC(=O)Cc1c(Cl)ccc(NCC(F)(F)c2ccccc2)c1F,7.33,,
O=C(NC1CC[NH2+]CC1)c1[nH]ncc1NC(=O)c1c(Cl)cccc1Cl,7.33,,
[NH3+]C(C(=O)N1CCCC1C(=O)NCc1cccc(Cl)c1)C(c1ccccc1)c1ccccc1,7.33,,
CC(C)CC([NH3+])C(=O)[O-],7.33,,
CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)C[NH2+]C1(c2cccc(C(C)(C)C)c2)CCCCC1,7.33,,
O=C(C[NH+]1CCN(c2ccnc(Nc3ncc(-c4cccnc4)s3)c2)CC1)N1CCOCC1,7.33,,
OCC1C(O)C(O)C(O)c2nccn21,7.33,,
NC(=[NH2+])N1CCCC(CNC(=O)C(Cc2ccccc2)NS(=O)(=O)c2ccc3ccccc3c2)C1,7.33,,
COc1ccc(Nc2nc(N3CCC(NC(=O)c4ccc(C(=O)[O-])cc4)C3)nc3scnc23)cc1OC,7.33,,
CC(Oc1c(N)ncc2c(-c3cnn(C4CC[NH2+]CC4)c3)coc12)c1c(Cl)ccc(F)c1Cl,7.33,,
C[NH+]1CCCC1c1cccnc1,7.34,,
CCC(C)C(NC(=O)CNC(=O)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(=O)C(NC(=O)C(CCCC[NH3+])NC(=O)C[NH3+])C(C)CC)C(C)O)C(=O)[O-],7.34,,
CC(C)(NC(=O)c1ccc2c(C3CCCCC3)c3n(c2c1)CCOc1ccccc1-3)C(=O)[O-],7.34,,
CCc1ccc(NS(=O)(=O)c2ccc(F)cc2)c(C(=O)[O-])c1OCC[NH3+],7.34,,
CC[NH+](CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,7.34,,
NC(=[NH2+])NCCC1CCN(C(=O)C(Cc2cccc(C(N)=[NH2+])c2)NS(=O)(=O)c2ccc3ccccc3c2)CC1,7.34,,
CC[NH+](CC)CCNc1cc(Nc2cc(O)ccc2C)nc(-n2cnc3ccccc32)n1,7.34,,
CC(=O)NC1C(=NOC(=O)Nc2ccccc2)OC(CO)C(O)C1O,7.34,,
Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1,7.34,,CHEMBL2153434
C[NH2+]C(C)C(=O)NC(C(=O)N1CCC2CCC(NC(=O)c3cccc4ccccc34)C21)C(C)(C)C,7.34,,
CC[NH2+]C1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,7.34,,
CSCCC([NH3+])C(=O)[O-],7.34,,
CSCCC(NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C([NH3+])Cc1ccccc1)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NCC(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C(=O)[O-])C(C)O)C(C)O,7.34,,
CC(=O)NC1C(O)CC(O)(C(=O)[O-])OC1C(O)C(O)CO,7.34,,
CCC(C)C(NC(=O)C(CC(N)=O)NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(N)=O)NC(C)=O)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC1(C)CCCCCCC(C)(C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)CC)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CC(C)C)NC1=O)C(C)O,7.34,,
COc1ccc2c(c1)N(C(=O)OC(C)C)C(CSC)C(=S)N2,7.349999999999999,,
O=C(NC(Cc1ccccc1)C(=O)N1CC(C(=O)[O-])C1)c1cc2cc(Cl)ccc2[nH]1,7.349999999999999,,
Cc1cccc(CC(NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCC=N)c1,7.349999999999999,,
CC(C)CC(NC(=O)C([NH3+])C1CCNC(=[NH2+])N1)C(=O)NC(CO)Cc1ccccc1,7.349999999999999,,
NC(=[NH2+])NCCCC(NC(=O)C(CS)NC(=O)Cc1ccc(-c2ccccc2)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCCc1ccccc1,7.349999999999999,,
CC(C)C(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],7.349999999999999,,
NS(=O)(=O)Oc1ccc2c3c(c(=O)oc2c1)CCCCC3,7.349999999999999,"This molecule has been investigated for the treatment of Metastatic Breast Cancer and Locally Advanced Breast Cancer. This molecule is steroid sulfatase inhibitor BN 83495 selectively binds to and inhibits steroid sulfatase (STS), which may inhibit the production of locally active estrogens and so inhibit estrogen-dependent cell growth in tumor cells, such as those of the breast, ovary, and endometrium. STS is a cytoplasmic enzyme responsible for the conversion of circulating inactive estrone sulfate and estradiol sulfate to biologically active unconjugated estrone and estradiol, respectively.",CHEMBL286738
O=S(=O)(CC[NH2+]CCCO)c1ccc(Nc2nc(OCC3CCCCC3)c3[nH]cnc3n2)cc1,7.349999999999999,,
COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCC[NH+]1CCOCC1,7.349999999999999,,
CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CC[NH+](C)CC4)cc3)nc1-2,7.349999999999999,,
CCC(C)C(NC(=O)C(C)[NH3+])C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC1(C)CCCC=CCCCC(C)(C(=O)NC(Cc2ccccc2)C(=O)NC(CC(N)=O)C(=O)NC(C)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(C)C(N)=O)NC(=O)C(CC(=O)[O-])NC(=O)CNC(=O)C(C(C)CC)NC1=O,7.349999999999999,,
[NH3+]C1CC[NH+](Cc2ccn3ncnc(Oc4ccc(NC(=O)NC(=O)Cc5ccc(F)cc5)cc4F)c23)CC1,7.349999999999999,,
CSCCC(NC(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(N)=O)C(=O)[O-],7.349999999999999,,
[NH3+]C(Cn1cc(Cl)c(=O)[nH]c1=O)C(=O)[O-],7.349999999999999,,
CC(=O)NC1C(=NOC(=O)Nc2ccccc2)OC(CO)C(O)C1O,7.349999999999999,,
CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(C(=O)NS(=O)(=O)C2CC2)NC(=O)C2CC(OC(=O)n3cc4cccc(F)c4c3)CN2C1=O,7.349999999999999,,
CC(CCOc1nccn1C)[NH+](C)C,7.349999999999999,,
Nc1ncnc2c1ncn2C1OC(C(=O)N2CC[NH+](CC(=O)Nc3cccc4c3CNC4=O)CC2)C(O)C1O,7.349999999999999,,
CCC(C)(C)c1nn(CCO)c2c1NC(c1ccc(-n3ccnc3C)cc1)CNC2=O,7.349999999999999,,
COc1cc(Cl)cc(C[NH2+]CCCNC(=O)Nc2ccccc2)c1,7.349999999999999,,
CC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CCCC[N+](C)(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCNC(=[NH2+])N(C)C)C(=O)NC(CCCC[NH3+])C(=O)[O-])C(C)O)C(C)O,7.349999999999999,,
C#Cc1csc2c1[NH+]=C(NC1CCCC1)N(CC)C2O,7.349999999999999,,
CC(C)(C)NC(=O)C1C[NH+](Cc2ccc3c(c2)OCO3)CC[NH+]1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O,7.36,,
O=C([O-])CCCCC1SCC2NC(=O)NC21,7.36,,
CCNC(=O)N1N=C(c2cc(F)ccc2F)CC1(CCC[NH3+])c1ccccc1,7.36,,
O=C(NC1CCC[NH2+]C1)c1[nH]ncc1NC(=O)c1c(F)cccc1F,7.36,,
COc1cc(Nc2cc(Oc3cc(C)c(C)nc3-c3ccccn3)ccn2)cc(OC)c1OC,7.36,,CHEMBL575099
CC(C)(C)c1ccc(CCC2CCC(O)C3C(O)C(O)C[NH+]23)cc1,7.36,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(CCCNC(N)=O)NC(=O)C(CC(C)C)NC(=O)C([NH3+])C(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C)C(=O)[O-],7.36,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CC(C)C)NC(=O)C([NH3+])C(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C)C(=O)[O-],7.36,,
O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)C1,7.36,,CHEMBL2146887
CC(=O)NC(Cc1ccccc1)C(O)C[NH2+]C1CC(C)(C)Cc2nn(CC(C)(C)C)cc21,7.36,,
CN(c1ncccc1CNc1c(C#N)cnc2[nH]c(-c3ccccc3)cc12)S(C)(=O)=O,7.36,,CHEMBL2315579
CC(=O)Nc1c(Cl)cc(CNC(=[NH2+])NC(=O)Cn2ccc3ccc(C#N)cc32)cc1Cl,7.36,,
CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C,7.36,,CHEMBL2419490
NS(=O)(=O)c1ccc(N=NN2CCCCCC2)cc1,7.36,,
[NH3+]CCCCC([NH3+])C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)[O-],7.37,,
NS(=O)(=O)c1ccc(C(=O)NCCOCCOCC[NH3+])cc1,7.37,,
O=CC(CC(=O)[O-])NC(=O)C(CCCCNC(=O)c1ccc(Oc2cnc3ccccc3n2)cc1)c1cccs1,7.37,,
Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,7.37,"This molecule is a member of the class of isoxazoles that is isoxazole which is substituted at positions 3, 4 and 5 by phenyl, p-sulfamoylphenyl and methyl groups, respectively. A selective cyclooxygenase 2-inhibitor, it used as a nonsteroidal anti-inflammatory drug (NSAID) for the treatment of arthritis from 2001 until 2005, when it was withdrawn following concerns of an associated increased risk of heart attack and stroke. It has a role as a non-steroidal anti-inflammatory drug, a cyclooxygenase 2 inhibitor, a non-narcotic analgesic, an antirheumatic drug and an antipyretic. It is a member of isoxazoles and a sulfonamide. This molecule was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about a possible increased risk of heart attack and stroke. This molecule is a sulfonamide derivative and non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic activities. This molecule selectively binds to and inhibits cyclooxygenase (COX)-2, thereby preventing the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever. This NSAID does not inhibit COX-1 at therapeutic concentrations and therefore does not interfere with blood coagulation.",CHEMBL865
CC(C)CC(NC(=O)C(CS)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)[O-],7.37,,
O=C1CC(c2ccc(CC(NS(=O)(=O)c3cccc(F)c3)c3ncc(CCCc4ccccc4)[nH]3)cc2)S(=O)(=O)N1,7.37,,CHEMBL253500
CC1(C)CCCCc2cccc3c2CN(C3)C(=O)OC2CC(C(=O)NC(CCO)B(O)O)N(C2)C(=O)C(C(C)(C)C)NC(=O)OC1,7.37,,
Cc1ccc2sc(COC3=CC(O)(C(=O)[O-])CC(O)C3O)cc2c1,7.37,,
Cc1o[nH]c(=O)c1CC([NH3+])C(=O)[O-],7.37,,
CC([NH3+])C(=O)NC(C(=O)N1CCCC1C(=O)NCC(c1ccccc1)c1ccccc1)C(C)C,7.37,,
CC[NH2+]C1CC(C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,7.37,,
O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1,7.37,,CHEMBL1173731
CSc1nc(Cl)c(C=O)c(NCc2ccc(S(N)(=O)=O)cc2)n1,7.37,,CHEMBL1233735
COc1ccc(CC([NH3+])C(O)C(=O)NC(CC(C)C)C(=O)[O-])cc1,7.37,,
CSCCC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])Cc1ccccc1)C(=O)NCC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],7.37,,
CSCCC([NH3+])C(=O)[O-],7.37,,
OCC1C(O)C(O)C(O)CN1C(=S)Nc1ccc(F)cc1,7.37,,
CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12,7.37,,CHEMBL234085
N#Cc1cccc(Cn2cc(NC(=O)c3n[nH]c4ccccc34)cn2)c1,7.37,,CHEMBL3262780
O=C(NC(Cc1ccccc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)[O-])C(S)Cc1ccccc1,7.38,,
O=c1[nH]c(NCC(O)C(O)C(O)CO)c([N+](=O)[O-])c(=O)[nH]1,7.38,,
O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1,7.38,,CHEMBL383899
COc1cccc(S(=O)(=O)N(Cc2cccs2)CC(O)C(Cc2ccccc2)NC(=O)c2cccc(F)c2C)c1,7.38,,
Clc1c[nH]c2ncnc(N3CCc4[nH]cnc4C3)c12,7.38,"This molecule is an imidazopyridine that is 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine in which the amino hydrogen is replaced by a 5-chloro-1H-pyrrolo[2,3-d]pyrimidin-4-yl group. A potent inhibitor of AKT1 kinase. It has a role as an AKT1 kinase inhibitor. It is a pyrrolopyrimidine, an imidazopyridine, an organochlorine compound, a tertiary amino compound and an aromatic amine.",CHEMBL259833
Cc1nn(-c2cc(Cl)cc(-c3ccccc3C(N)=O)c2)c2cc(NC(C)c3ccccc3)ncc12,7.38,,
O=C(NC1C[NH2+]CCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)[O-])c(O)c1)c1ccc(O)cc1,7.38,,
O=C(NC1C[NH2+]CCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)[O-])c(O)c1)c1ccc(O)cc1,7.38,,
CNS(=O)(=O)c1ccc(-c2cccc3ncc(-c4cc(OC)c(OC)c(OC)c4)nc23)cc1,7.38,,CHEMBL1093749
CC1OC(OC2C(CO)OC(OC3C(CO)=CC([NH2+]C4C(C)OC(OC5C(CO)OC(OC6C(CO)OC(=O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,7.38,,
CC(NC(=O)C([NH3+])CO)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)NCC(=O)NC(CO)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)[O-])C(C)O)C(C)O,7.38,,
Cc1cc(C(F)(F)F)c(-c2ccc(CC(NC(=O)c3c(Cl)cccc3Cl)C(=O)[O-])cc2)c(O)[n+]1C,7.38,,
CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,7.38,,
CC(COC(=O)Cc1ccccc1)(C(Nc1c(C=O)cc2ccccn12)C(=O)[O-])[SH](=O)=O,7.38,,
CC1CNc2c(cccc2S(=O)(=O)NC(CCCNC(N)=[NH2+])C(=O)N2CCC(C)CC2C(=O)[O-])C1,7.38,,
CC(C)Cc1cc(-n2c3c(c4c2CC(C)(C)CC4=O)CC[NH+](C)C3)cc2c1C(=O)NCC2,7.38,,
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(CO)Cc1ccccc1)C(C)C,7.389999999999999,,
Oc1ccc2c(Cc3ccc(OCC[NH+]4CCCC4)cc3)c(-c3ccc(OCC[NH+]4CCCC4)nc3)sc2c1,7.389999999999999,,
CC(=[NH2+])N1CCC(Oc2ccc(C(Cc3ccc4ccc(C(N)=[NH2+])cc4c3)C(=O)[O-])cc2)C1,7.389999999999999,,
CCOP(=O)(OCC)C(=Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)P(=O)(OCC)OCC,7.389999999999999,"This molecule is an organic phosphonate that is the tetraethyl ester of [2-(3,5-di-tert-butyl-4-hydroxyphenyl)ethene-1,1-diyl]bis(phosphonic acid). It has a role as a pregnane X receptor agonist. It is a member of phenols and an organic phosphonate.",CHEMBL458767
CC(C)CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(NC(=O)C(C)[NH3+])C(C)C)C(=O)N1CCCC1C(=O)NC(C=O)CCC(=O)[O-],7.389999999999999,,
COC(=O)C1CC(C(=O)[O-])[NH2+]C1C(CC(C)C)NC(C)=O,7.389999999999999,,
CC(C)CC(CC(=O)NO)C(=O)NC(C(=O)NC(C)C(=O)NCC[NH3+])C(C)(C)C,7.389999999999999,,
C[NH+]1CCc2nc(C(=O)NC3CCCCC3NC(=O)c3cc4cc(Cl)ccc4[nH]3)sc2C1,7.389999999999999,,
CCCCC(NC(=O)C1C2CCC(C2)N1C(=O)C(NC(=O)OC(C)(C)C)C1CCCCC1)C(O)C(=O)NCC(=O)NC(C(=O)N(C)C)c1ccccc1,7.389999999999999,,
O=C(NC1Cc2ccccc2NC1=O)c1cc2cc(Cl)sc2[nH]1,7.389999999999999,,CHEMBL218287
O=C(Nc1ccc(Oc2ccncc2)cc1)Nc1cccc(C(F)(F)F)c1,7.389999999999999,,
CC(C)C([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(N)=O)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)O,7.389999999999999,,
CCC(Cc1ccccc1)c1cc(O)c(C(c2cccc(NC(=O)CCNC(=O)OC(C)(C)C)c2)C2CC2)c(=O)o1,7.389999999999999,,CHEMBL331229
CSCCC(NC(=O)C(CC[NH3+])NC(=O)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CCNc1ccc([N+](=O)[O-])cc1[N+](=O)[O-])C(C)O)C(=O)NC(CC(C)C)C(N)=O,7.389999999999999,,
NC(=[NH2+])NCCCC(CO)NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)c1ccc2ccccc2c1,7.389999999999999,,
O=C(C1CCCN1C(=O)CCCN1C(=O)NC(c2ccccc2)(c2ccccc2)C1=O)N1CCCC1,7.389999999999999,,
COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,7.389999999999999,This molecule is a member of methoxybenzenes and a substituted aniline.,CHEMBL475251
CCOC(=O)NCc1ccc(-[n+]2c(-c3cc(C(C)C)c(O)cc3O)[nH][nH]c2=S)cc1,7.389999999999999,,
COC(=O)CNc1nc(Cl)nc(Nc2ccc(S(N)(=O)=O)cc2)n1,7.389999999999999,,CHEMBL1738792
CCc1cc(-c2cccnc2)nn1-c1ccc(NC(=O)c2cccnc2)cc1,7.389999999999999,,CHEMBL1234565
N#CC1(c2ccccc2)CCN(C(=S)S)CC1,7.389999999999999,,CHEMBL2027833
CC[N+]1CC2(COC(=O)c3ccccc3N3C(=O)CC(C)C3=O)CCC(OC)C34C5CC6C(OC)CC(O)(C5C6OC)C(O)(C(OC)C23)C14,7.389999999999999,,
Nc1c(S(=O)(=O)[O-])cc(Nc2ccc(Nc3nc(Cl)nc(Nc4ccccc4S(=O)(=O)[O-])n3)c(S(=O)(=O)[O-])c2)c2c1C(=O)c1ccccc1C2O,7.389999999999999,,
COc1cccc(-c2cccc(C3(c4ccncc4)NC(=[NH2+])[N+]4=C3NCC(F)(F)C4)c2)c1F,7.389999999999999,,
O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCC[NH+]5CCC(O)CC5)cc4)cc23)cc1,7.389999999999999,,
Oc1cc(-c2ccc(F)cc2)c(-c2ccc(F)cc2)nc1O,7.389999999999999,,
NC(=[NH2+])c1ccc2c(c1)C(c1ccccc1)CC(c1cc(N)cc(-c3ccccc3C(=O)[O-])c1)N2,7.389999999999999,,
OC1COC(O)C(O)C1O,7.4,This molecule is a natural product found in Ascophyllum nodosum with data available.,CHEMBL14343
CC(=O)NC1C([NH3+])C=C(C(=O)[O-])OC1C(O)C(O)CO,7.4,,
Cc1nc2ccccc2n1Cc1ccc2c(c1)nc(CNc1ccc(C(N)=[NH2+])cc1)n2C,7.4,,
CC(=O)NC1C(OC2C(CO)OC(OC3C(O)C4[NH+]=C(N(C)C)OC4C3CO)C(NC(C)=O)C2O)OC(CO)C(O)C1O,7.4,,
CC(=O)N1CCN(C(=O)C(Cc2cccc(C(N)=[NH2+])c2)NS(=O)(=O)c2ccc3ccccc3c2)CC1,7.4,,
O=C1c2ccccc2C(=O)c2c1cc(S(=O)(=O)[O-])c(O)c2O,7.4,,
NC(=[NH2+])c1ccc2cc(C(=O)Nc3ccc(C[NH3+])cc3)ccc2c1,7.4,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(C)[NH3+])B(O)O,7.4,,
O=C([O-])c1cc(NC2C(=O)NC(=O)C2c2cccc(Cl)c2)ccc1Cl,7.4,,
Cc1ccc2c(c1)C(=O)C1(OC(c3ccc(Cl)c(Cl)c3)C(C(=O)Nc3ccc(-c4csnn4)cc3)C1C(=O)[O-])C2=O,7.4,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)C([NH3+])CCCC[NH3+])C(C)O)C(=O)NC(CO)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(O)CC(=O)NC(C(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)[O-])C(C)C)C(C)C,7.4,,
CC(C)CC(C[Si](O)(O)CNC(=O)CCc1ccccc1)C(=O)NC(CC(C)C)C(=O)[O-],7.4,,
CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1,7.4,,CHEMBL376505
CC1CCC(O)C1NC(=O)C(Cc1ccccc1)CC(O)C[NH+]1CCN(C(=O)c2cnc(N3CC[NH+](C)CC3)c(Cl)n2)CC1C(=O)NC(C)(C)C,7.4,,
CC(C)CC(NC(=O)CC(O)C(CC(C)C)NC(=O)C(Cc1cnc[nH]1)NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(Cc1cnc[nH]1)NC(=O)OC(C)(C)C)C(N)=O,7.4,,
CC([NH3+])C(=O)NC(C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-])C(C)C,7.4,,
CC1NC(=[NH+]CCCC([NH3+])C(=O)[O-])NC1O,7.4,,
O=S(=O)(c1ccccc1)N(CC(F)(F)F)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,7.4,This molecule is an LXRalpha and LXRbeta agonist. This molecule is a natural product found in Aspergillus puniceus with data available.,CHEMBL62136
[NH3+]C1(C(=O)[O-])CC1,7.4,,
CCNc1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]Cc2cccc(C(F)(F)F)c2)cc(N2CCCC2=O)c1,7.4,,
NS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1,7.4,,CHEMBL257553
CC(C)n1nc(C#Cc2cccnc2)c2c(N)ncnc21,7.4,This molecule is a pyrazolopyrimidine.,CHEMBL1213119
O=C(NC1COC(=O)C(NC(=O)c2cccc(O)c2O)COC(=O)C(NC(=O)c2cccc(O)c2O)COC1=O)c1cccc(O)c1O,7.4,,
COc1c(NC(=O)c2ccc(C)c(-n3cc(C(=O)NCc4ccccc4)nn3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O,7.4,,
O=C(C1CCC2C(Cl)=NC(OCc3ccc(F)cc3)C(=O)N12)N1CCCC1,7.4,,
CC(=O)OC(C(=O)Nc1cccc2c1C(=O)C(=O)NC2=O)c1ccccc1,7.4,,CHEMBL439872
CCC(CO)Nc1nc(NCc2ccccc2)[n+]2[nH]cc(C(C)C)c2n1,7.4,,
O=C(CN(CCO)S(=O)(=O)c1ccc(F)cc1)NO,7.4,,CHEMBL1632641
COc1ccc2sc3c(c2c1)NCC(C[NH3+])NC3=O,7.4,,
O=C([O-])c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1,7.4,,
COc1ccc(C2(c3cccc(-c4cccnc4)c3)NC(=[NH2+])N(C)C2=O)cc1C,7.4,,
Cc1ccc(C(N)=O)cc1-c1nnc2ccc(CCc3ccc(F)cc3F)cn12,7.4,,
Nc1ncc(-c2ccc(C(=O)N3CCCC3C[NH+]3CCCC3)cc2)nc1NCc1c(Cl)cccc1Cl,7.4,,
CC(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccccc1)C(=O)NC1C(=O)NC(C(C)O)C(=O)NCC(=O)NC(Cc2c[nH]cn2)C(=O)NC(Cc2ccccc2)C(=O)NCC(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(Cc2ccc(O)cc2)C(=O)N2CCCC2C(=O)NC(C(N)=O)CSSC1(C)C,7.4,,
Cn1c(=O)n(C2CC[N+](CCC[n+]3c[nH]cc(-c4ccc(Cl)c(CNC(=O)c5ccc(F)cc5)c4)c3=O)CC2)c2cc(Cl)ccc21,7.4,,
CCC(CO)Nc1nc(NCc2ccccc2)c2n[nH]c(C(C)C)c2n1,7.4,,
N#Cc1cn(C2OC(CO)C(O)C2O)c2ncnc(N)c12,7.4,,CHEMBL102397
COc1cc(-c2nc(C)nc3[nH]cc(C#N)c23)c(Cl)cc1Cl,7.4,,CHEMBL1738737
CSCCC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]cn1)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)[O-])C(C)C,7.4,,
CC1CCOC2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,7.4,,
O=C([O-])c1ccc(Nc2nccc(Nc3ccccc3OC(F)(F)F)n2)cc1,7.4,,
O=C(Nc1cccc(Nc2ccc3c(c2)NC(=O)C3=Cc2ccc[nH]2)c1)Nc1cccc(C(F)(F)F)c1,7.4,,
Cc1ccc2cc1-c1cc(nc(N)n1)Sc1cccc(c1)OCCCCO2,7.4,,CHEMBL1939371
O=C(NC1CCCS(=O)(=O)C1)c1ccc(Oc2ccc(C#CC3(O)C[NH+]4CCC3CC4)cc2)cc1,7.4,,
COC1CCC(c2nsc(C)c2C(=O)NC(=[NH2+])NCc2cc(Cl)c(N)c(Cl)c2)CC1,7.4,,
COc1cnc(COc2ccc(F)c(F)c2)cc1-c1cc2c([nH]1)CCNC2=O,7.4,,CHEMBL2203563
COCCOc1cnc(N)nc1-c1c[nH]c2ccc(C#CC(C)(C)O)cc12,7.4,,CHEMBL2334589
CC1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)NC(=[NH2+])OC(C(F)(F)F)C1F,7.4,,
NC(=[NH2+])c1ccc(Oc2ccc(NS(=O)(=O)c3ccc4ccccc4c3)c(Oc3ccc(C(N)=[NH2+])cc3)n2)cc1,7.4,,
NC(=[NH2+])c1ccc(Oc2cc(C(=O)NC3CCC([NH3+])CC3)cc(Oc3ccc(C(N)=[NH2+])cc3)n2)cc1,7.4,,
N#CC(c1ccc(Cl)cc1)c1cccc(Cl)n1,7.4,,CHEMBL1605691
CCCC(CC(=O)[O-])n1c(=O)n(Cc2cc(Br)cc3c2CC(=O)N3)c2ccccc21,7.4,,
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,7.4,,
Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)[O-])c1,7.4,,
CN(C)c1cc(F)c2c(=O)n(-c3cccc(-c4cc(Nc5ccc(C(=O)N6CCOCC6)cn5)c(=O)n(C)c4)c3CO)ccc2c1,7.4,,CHEMBL3358339
CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(C)NC(=O)C(C)NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CCSC)C(=O)NC(C)C(=O)[O-],7.4,,
O=C(Nc1nc2cc(C(F)(F)F)ccc2[nH]1)c1csc(NC(=O)c2ccccc2OC(F)(F)F)n1,7.4,,
CCC(C)C(NC(=O)C1CCC[NH+]1CC(O)C1Cc2ccc(cc2)OCCCC(=O)NC(CC(N)=O)C(=O)N1)C(=O)NC(C(N)=O)C(C)C,7.41,,
CC1CNc2c(cccc2S(=O)(=O)NC(CCCNC(N)=[NH2+])C(=O)N2CCC(C)CC2C(=O)[O-])C1,7.41,,
COc1ccc(O)c(C(=O)c2ccc(COC3CCC[NH2+]CC3NC(=O)c3ccncc3)cc2)c1F,7.41,,
CC(C)CC(NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C([NH3+])CCC(=O)[O-])C(C)C)C(O)C1CCCC1C(=O)NC(C)C(=O)[O-],7.41,,
COc1cc2c(cc1OS(N)(=O)=O)CCC1C2CCC2(C)C(OS(N)(=O)=O)CCC12,7.41,,
NC(=[NH2+])NCCCC([NH3+])C(=O)[O-],7.41,,
COc1ccc(C2SN=NC2c2cc(Cl)c(O)cc2O)cc1OC,7.41,,
CCS(=O)(=O)NC(Cc1c[nH]c2ccc(OCc3cccc(C(=O)[O-])c3)cc12)C(=O)NC(CCC(N)=O)C(=O)NCc1ccc(C(N)=[NH2+])cc1,7.41,,
COc1cc2nccc(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)c2cc1OC,7.41,,CHEMBL461648
OCC1[NH2+]CC(O)C(O)C1O,7.41,,
CS(=O)(=O)Nc1cccc(S(=O)(=O)NC(=O)c2c(C3=CCC=NC3=O)c3cc(Cl)ccc3n2Cc2ccnc(N)c2)c1,7.41,,
O=C([O-])c1ccc(Nc2nccc(Nc3ccccc3)n2)cc1,7.41,,
C[NH+]1CCC(CNC(=O)c2cccc(-c3noc(C(F)(F)F)n3)c2)(c2nc(-c3ccccc3)cs2)CC1,7.41,,
Cc1cc(=O)[nH]c2cc(-c3ccc(N)cc3Cl)ccc12,7.41,,CHEMBL2381636
CCCC(COc1ccc(-c2nc3ccccc3n2Cc2ccccc2)cc1)n1c(-c2ccccc2)nc2ccccc21,7.41,,
O=C(NCCC[NH2+]Cc1cc(Cl)cc(Cl)c1)Nc1ccccc1O,7.41,,
NC(=O)c1c(N)n(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2nc3ccccc3nc12,7.41,,CHEMBL3321822
Cc1cc(Oc2cccc(O)c2)cc(-c2ccccc2)n1,7.41,,CHEMBL2178856
CC(=O)Nc1nc2ccc(-c3cccnc3)cc2s1,7.41,,CHEMBL2418961
COc1ncc(-c2ccc3c(Nc4cccc(C(=O)[O-])c4)c(S(N)(=O)=O)cnc3c2)c(OC)n1,7.41,,
CN1C(=[NH2+])NC(CCC2CCCCC2)(CC2CCCC(NC(=O)c3ccncc3)C2)C1=O,7.41,,
CC(C)C(NC(=O)c1ccc2ccccc2c1)C(=O)N1CCCC1C(=O)NC(CO)CC(=O)NS(C)(=O)=O,7.42,,
COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,7.42,,CHEMBL259850
COc1ccc(S(=O)(=O)NCC2CC2)cc1Nc1ncc(-c2cccc(-c3cccnc3)c2)o1,7.42,,
Nc1c2c(nc3ccccc13)CCCC2,7.42,"This molecule is an oral acetylcholinesterase inhibitor previously used for therapy of Alzheimer disease. This molecule therapy is associated with a very high rate of serum aminotransferase elevations during therapy and has been linked to several instances of clinically apparent, acute liver injury. This molecule is a member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease. It has a role as an EC 3.1.1.7 (acetylcholinesterase) inhibitor. It is a member of acridines and an aromatic amine. It is a conjugate base of a tacrine(1+). A centerally active cholinesterase inhibitor that has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. Tacrine has been discontinued for the United States market. This molecule is a Cholinesterase Inhibitor. The mechanism of action of tacrine is as a Cholinesterase Inhibitor. This molecule is only found in individuals that have used or taken this drug. It is a centerally active cholinesterase inhibitor that has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. The mechanism of tacrine is not fully known, but it is suggested that the drug is an anticholinesterase agent which reversibly binds with and inactivates cholinesterases. This inhibits the hydrolysis of acetylcholine released from functioning cholinergic neurons, thus leading to an accumulation of acetylcholine at cholinergic synapses. The result is a prolonged effect of acetylcholine.",CHEMBL95
Nc1c2c(nc3ccccc13)CCCC2,7.42,"This molecule is an oral acetylcholinesterase inhibitor previously used for therapy of Alzheimer disease. This molecule therapy is associated with a very high rate of serum aminotransferase elevations during therapy and has been linked to several instances of clinically apparent, acute liver injury. This molecule is a member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease. It has a role as an EC 3.1.1.7 (acetylcholinesterase) inhibitor. It is a member of acridines and an aromatic amine. It is a conjugate base of a tacrine(1+). A centerally active cholinesterase inhibitor that has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. Tacrine has been discontinued for the United States market. This molecule is a Cholinesterase Inhibitor. The mechanism of action of tacrine is as a Cholinesterase Inhibitor. This molecule is only found in individuals that have used or taken this drug. It is a centerally active cholinesterase inhibitor that has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. The mechanism of tacrine is not fully known, but it is suggested that the drug is an anticholinesterase agent which reversibly binds with and inactivates cholinesterases. This inhibits the hydrolysis of acetylcholine released from functioning cholinergic neurons, thus leading to an accumulation of acetylcholine at cholinergic synapses. The result is a prolonged effect of acetylcholine.",CHEMBL95
CN(C)C(=O)N1CC(c2cc(F)ccc2F)CC1c1ccccc1,7.42,,
O=C(Nc1ccc(Oc2ccccc2)cc1)c1cccnc1NCc1ccncc1,7.42,,CHEMBL385178
NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1,7.42,"These molecules is a sulfonamide that is benzene-1,3-disulfonamide in which the hydrogens at positions 4 and 5 are substituted by chlorine. An oral carbonic anhydrase inhibitor, it partially suppresses the secretion (inflow) of aqueous humor in the eye and so reduces intraocular pressure. It is used for the treatment of glaucoma. It has a role as an EC 4.2.1.1 (carbonic anhydrase) inhibitor, an antiglaucoma drug and an ophthalmology drug. It is a sulfonamide and a dichlorobenzene. This molecule is used in the treatment of glaucoma. This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of dichlorphenamide is as a Carbonic Anhydrase Inhibitor.",CHEMBL17
OC1CC2OCC=C3C[NH+]4CCC56c7ccccc7N1C5C2C3CC46,7.42,,
CC(=O)CCC(CC1CCNC1=O)NC(=O)C(CC(C)C)NC(=O)C(CNC(=O)C(C)(C)C)NC(=O)OCc1ccccc1,7.42,,
COC(Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)c2ccsc12)C(=O)[O-],7.42,,
O=c1c(-c2ccc(O)c(O)c2)coc2cc(O)ccc12,7.42,"This molecule is a 7-hydroxyisoflavone that is daidzein substituted by a hydroxy group at position 3'. It has a role as a metabolite, an antineoplastic agent and an EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor. It is functionally related to a daidzein. This molecule is a natural product found in Dalbergia spruceana, Hibiscus syriacus, and other organisms with data available.",CHEMBL13486
CCOCCN(CC(O)C[NH+]1CCCC2(CCN(c3ncnc4ccccc34)C2)C1)S(=O)(=O)c1c(C)cccc1C,7.42,,
CCCNC(=O)c1ccc(S(N)(=O)=O)cc1,7.42,,CHEMBL74090
CN(C)C1=CCN(Cc2ccc(CCCCc3ccc(Cn4cnc5c(N)ncnc54)cc3)cc2)C=C1,7.42,,
COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,7.42,,CHEMBL261849
Cc1ccccc1C(CC(=O)[O-])NC(=O)c1cc(O)n(-c2ccccc2F)n1,7.42,,
NC(=O)c1ccc(Nc2nccc(Nc3ccccc3C(N)=O)n2)cc1,7.42,,CHEMBL2170596
CCN(CC)C(=O)Oc1ccc(CC2CN(Cc3cncn3C)c3ccc(C#N)cc3CN2S(=O)(=O)c2ccc(OC)cc2)cc1,7.42,,
Cc1c(-c2c(C(OC(C)(C)C)C(=O)[O-])n(C)c(=O)c3ccccc23)cc(F)c2c1CCCO2,7.42,,
COc1ccc(-c2cc(Oc3cc(C)cc(OC)c3)cc(C)n2)cc1,7.42,,CHEMBL2178862
CC(Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2nc1-c1cccc(F)c1,7.42,,
NC(=O)CCC(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],7.429999999999999,,
O=C(Cc1cccs1)NC(B(O)O)c1ccccc1,7.429999999999999,,
O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)[nH]n1,7.429999999999999,,
COc1cc2ncnc(Nc3cc(NC(=O)c4ccnc(N5CCOCC5)c4)ccc3C)c2cc1OCC[NH+]1CCCC1,7.429999999999999,,
COc1ccccc1COCCCOc1ccc(N2C(=O)C[NH2+]CC2COc2ccc3c(c2)N(CCCO)CCC3)cc1,7.429999999999999,,
O=CN(C=O)Cc1ccc2sc(B(O)O)cc2c1,7.429999999999999,,CHEMBL235073
CC(NC(=O)c1cc(C(=O)NC(COc2cc(F)cc(F)c2)C(O)CC(=O)NC(C(=O)Nc2cc(C(=O)[O-])cc(C(=O)[O-])c2)C(C)C)cc(N(C)S(C)(=O)=O)c1)c1ccccc1,7.429999999999999,,
NS(=O)(=O)c1ccc(Nc2nc(Cl)nc(NCCO)n2)cc1,7.429999999999999,,CHEMBL1738787
O=C([O-])c1ccc(NC(=O)C(C2CCCCC2)n2c(-c3ccc(Cl)cc3)nc3cc(F)c(F)cc32)c(F)c1,7.429999999999999,,
COCCCCC(O)(c1ccccc1-c1ccccc1)C1CCCN(C(=O)C2CC([NH3+])C(O)C2)C1,7.429999999999999,,
CCOc1nc(Nc2ccc(C(N)=O)cc2)cc(N)c1C#N,7.429999999999999,,CHEMBL2089254
CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(I)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl,7.429999999999999,,CHEMBL2031018
COc1cc(-c2cn[nH]c2)ccc1C(=O)Nc1ccc2c(c1)CC[NH2+]CC2,7.429999999999999,,
CC(C)Nc1cc(-n2c3c(c4c2CC(C)(C)CC4=O)CC[NH+](C)C3)cc2c1C(=O)NCC2,7.429999999999999,,
CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CC[NH+](C)CC4)cc3OC)nc2N1C1CCCC1,7.429999999999999,,
CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(CC(=O)[O-])NC(=O)C(CO)NC(=O)C[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CC(C)C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C)C(=O)[O-],7.429999999999999,,
C[NH+](C)Cc1c[nH]c2c(CCCO)cccc12,7.429999999999999,,
O=C([O-])C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(N2CCC(c3ccccc3)CC2)cc1,7.44,,
CC1(C)OC2C3OS(=O)(=O)OC3COC2(COS(N)(=O)=O)O1,7.44,,
CC(=N)N1CCC(Oc2ccc3c4ccccc4n(Cc4ccc5ccc(C(N)=[NH2+])cc5c4)c3c2)CC1,7.44,,
NC(=[NH2+])c1ccc(CNC(=O)CNC(=O)C(CO)NS(=O)(=O)Cc2ccccc2)cc1,7.44,,
NC(=[NH2+])c1ccc(C2C3C(=O)N(Cc4ccc5c(c4)OCO5)C(=O)C3C3CC(O)C[NH+]32)cc1,7.44,,
O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1,7.44,,CHEMBL371861
CN(C)c1cccc(OCCCCc2cc[n+]3c4c2ccc2ccc[n+](c24)[Ru+7]324([n+]3ccccc3-c3cccc[n+]32)[n+]2ccccc2-c2cccc[n+]24)c1,7.44,,
CSC1C([NH3+])C(O)C(O)C1O,7.44,,
CC(=O)NC1C(=NOC(=O)Nc2ccccc2)OC(CO)C(O)C1O,7.44,,
CC1(C)CC(Nc2cccc(-c3sc(C(=O)[O-])c(OCC(=O)[O-])c3Br)c2)CC(C)(C)C1,7.44,,
NC(=O)c1ccc(S(=O)(=O)N(Cc2ccccc2)C2C[NH2+]CC2N(Cc2ccccc2)S(=O)(=O)c2ccc(C(N)=O)cc2)cc1,7.44,,
Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(CC(O)C(O)C(O)CO)c2cc1C,7.44,"This molecule is a natural product found in Aspergillus unilateralis, Syzygium, and Eremothecium gossypii with data available.",CHEMBL511565
CC(=O)NC1[NH2+]C(C)[C](c2ccc(Cl)c(S(=O)(=O)NCCO)c2)S1,7.44,,
C=C(C[Se-])C(=O)N1CCCC1C(=O)[O-],7.44,,
CS(=O)(=O)n1ccc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21,7.44,,
CSC1C([NH3+])C(O)C(O)C1O,7.44,,
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,7.44,"This molecule is a selective tyrosine kinase receptor inhibitor used in the therapy of chronic myelogenous leukemia. This molecule therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury. This molecule is a member of (trifluoromethyl)benzenes, a member of pyrimidines, a member of pyridines, a member of imidazoles, a secondary amino compound and a secondary carboxamide. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor and an anticoronaviral agent. This molecule is a tyrosine kinase inhibitor under investigation as a possible treatment for chronic myelogenous leukemia (CML). A Phase I clinical trial in 2006 showed that this drug was relatively safe and offered significant therapeutic benefits in cases of CML which were found to be resistant to treatment with imatinib (Gleevec), another tyrosine kinase inhibitor used as a first-line treatment for CML. This molecule is a Kinase Inhibitor. The mechanism of action of nilotinib is as a Bcr-Abl Tyrosine Kinase Inhibitor, and Cytochrome P450 2C8 Inhibitor, and Cytochrome P450 2D6 Inhibitor, and Cytochrome P450 2B6 Inducer, and Cytochrome P450 2C8 Inducer, and UGT1A1 Inhibitor, and P-Glycoprotein Inhibitor. This molecule is an orally bioavailable aminopyrimidine-derivative Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. Designed to overcome imatinib resistance, nilotinib binds to and stabilizes the inactive conformation of the kinase domain of the Abl protein of the Bcr-Abl fusion protein, resulting in the inhibition of the Bcr-Abl-mediated proliferation of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) cells. This agent also inhibits the receptor tyrosine kinases platelet-derived growth factor receptor (PDGF-R) and c-kit, a receptor tyrosine kinase mutated and constitutively activated in most gastrointestinal stromal tumors (GISTs). With a binding mode that is energetically more favorable than that of imatinib, nilotinib has been shown to have an approximately 20-fold increased potency in kinase and proliferation assays compared to imatinib.",CHEMBL255863
CC(C)CC([NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(CO)C(=O)[O-])C(C)O)C(C)O,7.44,,
CC(C)(C)CC1[NH2+]C(C(N)=O)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12,7.44,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,7.44,,
NS(=O)(=O)c1ccc(-n2nncc2C2=C3C4=C5C2[Fe+10]3452678C3=C2C6C7=C38)cc1,7.44,,
OC[N+]1CCC2(CC1)OCc1cc(Br)ccc1O2,7.44,,
CCCOc1ccc(S(=O)(=O)N2CC[N+](C)CC2)cc1-c1nc(CC)c(Cl)c(=O)[nH]1,7.44,,
O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1,7.44,,CHEMBL2348417
O=C(NCC1([C]2NC(c3ccccc3)=CS2)CCOCC1)c1cccc(-c2noc(C(F)(F)F)n2)c1,7.44,,
OCc1cn(CCc2ccc(OC3OC(CO)C(O)C(O)C3O)cc2)nn1,7.44,,
COC(=O)CC1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc21,7.44,,
CC(C)NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12,7.44,,CHEMBL2348852
CCc1ccc2c(c1)C([NH2+]CC(O)C1Cc3cccc(c3)CCCCCCCC(=O)N1)CC1(CCC1)O2,7.44,,
CC[NH2+]C1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,7.44,,
Cc1nc(Nc2[nH]nc3c2CN(C(=O)NC(C[NH+](C)C)c2ccccc2)C3(C)C)c2sccc2n1,7.44,,
COc1ccc(CC(NC(=O)C(C)NC(=O)C[NH+]2CCOCC2)C(=O)NC(CC2CCCCC2)C(O)C(C)CO)cc1,7.44,,
O=C([O-])c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12,7.45,,
Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(CC(O)C(O)C(O)CO)c2cc1C,7.45,"This molecule is a natural product found in Aspergillus unilateralis, Syzygium, and Eremothecium gossypii with data available.",CHEMBL511565
Cc1ccc(C(=O)Nc2ccc(C[NH+]3CC[NH+](CCO)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc(C(N)=O)n1C,7.45,,
CCCCC(CN(O)C=O)C(=O)C(NC(=O)Nc1ccccc1F)C(C)C,7.45,,
CC(=O)NC1C(=NOC(=O)Nc2ccccc2)OC(CO)C(O)C1O,7.45,,
O=C1Nc2ccc(S(=O)(=O)[O-])cc2C1=C1Nc2ccccc2C1=O,7.46,,
CC(C)CC(NC(=O)C(C)[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(N)=O)C(=O)NC(C(=O)O)C(C)C,7.46,,
O=C(Cc1cccs1)NC(B(O)O)c1ccccc1,7.46,,
NC(=[NH2+])c1ccc2cccc(Nc3ncccn3)c2c1,7.46,,
O=S(=O)(NCCC(F)(F)F)c1ccc2c(c1)C[NH2+]C(CF)C2,7.46,,
N#Cc1cnn2c1N=C(Cl)C(Cc1ccccc1)C2=O,7.46,,
CCC(C)C1NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(N)=O)NC(=O)C(C)NC(=O)C(NC(=O)C(Cc2c[nH]c3ccccc23)NC(C)=O)C(C)CC)CCC(=O)NCCCCC(C(=O)NC(Cc2ccccc2)C(=O)NC(CC(N)=O)C(=O)NC(C)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(C)C(N)=O)NC(=O)C(CC(=O)[O-])NC(=O)CNC1=O,7.46,,
O=C(Cc1ccc(F)cc1)NC(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1,7.46,,CHEMBL503090
CSCCC1NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(C)NC(=O)CNC(=O)C([NH3+])CSSCC(C(=O)[O-])NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC1=O,7.46,,
COc1ccc(-c2nc(-c3cccs3)[nH]c2-c2ccc(OC)cc2)cc1,7.46,,CHEMBL1235237
CC=COC1(C(=O)[O-])CC(O)C(O)C(C(COC2(C(=O)[O-])CC(O)C(O)C(C(O)CO)O2)OC)O1,7.46,,
COCc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1,7.46,,CHEMBL606919
CC1(C)CC(NC(=O)c2cccc(-c3cc4nccc(Nc5cccc(O)c5)n4n3)c2)CC(C)(C)[NH+]1O,7.46,,
Cc1nnc2nc3ccc([N+](=O)[O-])cc3c(-c3ccccc3Cl)nc1-2,7.46,,
Cc1[nH]nc(-c2nc3cc(C(C)C)ccc3[nH]2)c1C(=O)NC1CC[N+](C)CC1,7.46,,
CCCCCCCCCCC#CCOCc1ccc(CCC(=O)[O-])cc1,7.46,,
CC(C)n1cc(C(=O)c2cncc(NCCc3cccnc3)n2)c2c(N)ncnc21,7.46,,CHEMBL1940244
CCCC(NC(=O)C1C2CCCC2CN1C(=O)C(NC(=O)C(NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(O)C(=O)NC1CC1,7.46,,
O=C([O-])CCCCC1SCC2NC(=O)NC21,7.46,,
O=C(Nc1cc(Nc2ccc3c(c2)CCCCC3=O)ccc1F)c1ccccc1,7.46,,CHEMBL2177219
Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-n1cnc2ccc(N3CC[NH+](C)CC3)cc2c1=O,7.46,,
C=CCNC(=O)C(NC(=O)C(O)(CCC[NH+](Cc1ccc(-c2cccs2)cc1)NC(=O)C(NC(=O)OC)C(C)(C)C)Cc1ccc(CC=C)cc1)C(C)C,7.46,,
COc1cc2c(cc1OC)-c1c(-c3cncs3)ncn1CC2,7.46,,CHEMBL2017087
CCC(CC)(c1ccc(OCC(=O)NO)c(C)c1)c1ccc(OCC(O)C(C)(C)C)c(C)c1,7.46,,
CCC(CC)Nc1ncnc2c(OC)c(OC)c(OC)cc12,7.46,,CHEMBL3601554
CC#CC1CN(S(=O)(=O)c2ccc(N)nc2)CCN1c1ccc(S(=O)(=O)NC)cc1,7.46,,
COc1ccc2cc(C(C)C(=O)[O-])ccc2c1,7.46,,
[NH2+]=c1[nH]c(=O)c2cc3nc(NCC[NH+]4CCOCC4)[nH]c3cc2[nH]1,7.46,,
[NH2+]=c1[nH]c(=O)c2cc3nc(NCC[NH+]4CCCCC4)[nH]c3cc2[nH]1,7.46,,
NC(=[NH2+])NCCSC(CC(=O)[O-])C(=O)[O-],7.47,,
NC(=O)c1ccc(Nc2nc(N)c(N=O)c(OCC3CCCCC3)n2)cc1,7.47,,CHEMBL101801
CN(C)c1ccc(O)c(C(=O)c2ccc(C(=O)NC3CCC[NH2+]CC3NC(=O)c3ccncc3)cc2)c1,7.47,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(N)=O)NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)C(CCCC[NH3+])NC(=O)C(CC(=O)[O-])NC(=O)C(CCCC[NH3+])NC(=O)C(CC(C)C)NC(=O)C(CCCC[NH3+])NC(=O)C(C)NC(=O)C(Cc1ccccc1)NC(=O)C(CCSC)NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)[O-],7.47,,
CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)NCC[NH+](C)C)cs4)cc3c21,7.47,,
COc1ccccc1-n1c(SCC(=O)Nc2ccc3nccnc3c2)nc2c(c1=O)CCCC2,7.47,,CHEMBL1213169
CCN(C)C(=O)c1ccc2c(c1)NC(=O)C2=C(Nc1ccc(C[N+]2CCCCC2)cc1)c1ccccc1,7.47,,
CC1C(=O)C=CC=C1C(=O)NC(CSc1ccccc1)C(O)C[N+]1CC2CCCCC2CC1C(=O)NC(C)(C)C,7.47,,
Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1,7.47,,CHEMBL497033
Cc1nnc(-c2ccc3occ(-c4ccc([S+](C)O)cc4)c3c2)o1,7.47,,
O=C(NCC=CC1OC(n2cnc3cncnc32)C(O)C1O)c1cc([N+](=O)[O-])cc(O)c1O,7.47,,
CC(C)CNC(=O)C(CC(O)C1COCc2cccc(c2)C(c2ccccc2)NC(=O)c2cc(cc(N(C)S(C)(=O)=O)c2)C(=O)N1)C(C)C,7.47,,
CC(C#Cc1cccc(OC23CC4CC(CC(C4)C2)C3)c1)[N+](=O)C(N)=O,7.47,,
[NH3+]CCCCCC(CS)C(=O)[O-],7.47,,
CC(=O)Nc1cn2cc(C=C3SC(=O)NC3=O)ccc2n1,7.47,,
CCC(C)C1NC(=O)C2CCCN2C(=O)C(C)n2nncc2C(C(C)CC)NC(=O)C(CO)NC(=O)C(CCCC[NH3+])NC(=O)C(C(C)O)NC(=O)C(NC(=O)C([NH3+])CCCNC(N)=[NH2+])CSSCC(C(=O)NC(Cc2ccccc2)C(=O)[O-])NC1=O,7.47,,
COc1ccc(S(=O)(=O)N(Cc2cccnc2)c2c(C)cccc2C(=O)NO)cc1,7.48,,CHEMBL70176
CC(C)(C)OC(=O)NC(Cc1ccccc1)C(O)C[NH2+]C(Cc1ccccc1)C(=O)NC(CCC(N)=O)C(=O)NC(Cc1ccccc1)C(N)=O,7.48,,
CC(C)(C)NC(=O)C1C[NH+](Cc2cccnc2)CC[NH+]1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O,7.48,,
CC(C)=CC[NH+]1Cc2cc(Cl)cc3[nH]c(=S)n(c23)CC1C,7.48,,
CC(C)=CC[NH+]1Cc2cc(Cl)cc3[nH]c(=S)n(c23)CC1C,7.48,,
COc1ccc(OC)c(Cc2cnc3nc(N)nc(N)c3c2C)c1,7.48,"This molecule has been used in trials studying the treatment of Bladder Cancer, Urethral Cancer, and Transitional Cell Cancer of the Renal Pelvis and Ureter. This molecule is a synthetic antifolate agent with antiparasitic, antipsoriatic and antitumor properties. This molecule inhibits the enzyme dihydrofolate reductase enzyme, thereby disrupting folate metabolism and DNA synthesis and cell division. (NCI04)",CHEMBL7492
NC(=O)c1cccc2ncc(-c3ccc(Cl)cc3)nc12,7.48,,
CCOC(=O)c1c(C)nn(-c2cccc([N+](=O)[O-])c2)c1C,7.48,,CHEMBL1230564
CC1NC(=O)C2CSSCC(NC(=O)C[NH3+])C(=O)NC(CSSCC(C(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc3c[nH]c4ccccc34)NC1=O)C(=O)NC(CO)C(=O)NC(CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)N2,7.48,,
CC(=O)NC(C)C(=O)NC(Cc1ccccc1)C(O)CN(Cc1cccs1)S(=O)(=O)c1cc(F)c(F)cc1F,7.48,,
CC(=O)NC1C(NC(N)=[NH2+])C=C(C(=O)[O-])OC1C(O)C(O)CO,7.48,,
CCNc1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]C(C)(C)CCCC(C)C)cc(N2CCCC2=O)c1,7.48,,
CN(C)c1ccc2c(c1)Sc1cc(N(C)C)ccc1N2,7.48,"This molecule is a member of the class of phenothiazines that is 10H-phenothiazine in which the ring hydrogens at positions 3 and 7 have been replaced by dimethylamino groups. It has a role as a fluorochrome, a bacterial xenobiotic metabolite, a rat metabolite and a mouse metabolite. It is a member of phenothiazines, an aromatic amine and a tertiary amino compound. This molecule is a natural product found in Apis cerana with data available.",CHEMBL549963
COc1ccc(CN=Nc2n[nH]c(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1,7.48,,
CCC#CCOc1cc(COc2ccc(C(F)(F)F)cc2)ccc1Sc1ccc(OCC(=O)[O-])c2c1CCCC2,7.48,,
CS(=O)(=O)N1CC[N+](Cc2cc3nc(-c4ccc(N)nc4)nc(N4CCOCC4)c3s2)CC1,7.48,,
NC(=O)c1cccc2c1C(=O)N(C1CC[NH2+]CC1)C2,7.48,,
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C1CCC[NH2+]1)C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1c[nH]cn1)C(=O)N1CCCC1C(=O)[O-],7.48,,
[NH3+]C(CC1(C(=O)[O-])CC2OCC(O)C(O)C2O1)C(=O)[O-],7.48,,
C=C(C)C1C[NH2+]C(C(=O)[O-])C1CC(=O)[O-],7.48,,
Cc1c(Cl)ccc2c(C=C3NC(=O)N(Cc4ccc(F)c(F)c4)C3=O)c[nH]c12,7.48,,
C1=C(c2c[nH]c3ccccc23)CCN(c2ncnc3n[nH]cc23)C1,7.48,,
O=C(C1CC(n2cc(-c3ccc(F)cc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,7.48,,
Cn1c(=O)c(C(=O)NCC(=O)[O-])c(O)c2ccccc21,7.48,,
C=C(C)C1C[NH2+]C(C(=O)[O-])C1CC(=O)[O-],7.48,,
CC(C)(C)C(=O)NCCC1CCN(c2ncnc3cc(C(N)=O)sc23)CC1,7.48,,CHEMBL2332055
Cc1c(N)nc(C(CC(N)=O)[NH2+]CC([NH3+])C(N)=O)nc1C(=O)NC(C(=O)NC(C)C(O)C(C)C(=O)NC(C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)C(C)O)C(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)c1cnc[nH]1,7.49,,
Cc1[nH]c2cccc[n+]2c1-c1ccnc(Nc2ccc(OCC(O)C[NH+](C)C)cc2)n1,7.49,,
CC(C)CC1NC(=O)C(C)NC(=O)C2CSSCC(NC(=O)C[NH3+])C(=O)NC(CSSCC(C(=O)O)NC(=O)C(Cc3ccc(O)cc3)NC(=O)C(CCCC[NH3+])NC(=O)C3CCCN3C(=O)C(CC(N)=O)NC(=O)C(CC(N)=O)NC1=O)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N2,7.49,,
CN(C)c1cccc(OCCCCc2cc[n+]3c4c2ccc2ccc[n+](c24)[Ru+7]324([n+]3ccccc3-c3cccc[n+]32)[n+]2ccccc2-c2cccc[n+]24)c1,7.49,,
CC(C)CCn1c(=O)c(C2=Nc3ccccc3S(=O)(=O)N2)c(O)c2ccccc21,7.49,,
CC(CNc1ccc(OC(F)(F)F)cc1)NC(=O)C(CS(=O)(=O)Cc1ccccc1)NC(=O)N1CCOCC1,7.49,,
CC(CNc1ccc(OC(F)(F)F)cc1)NC(=O)C(CS(=O)(=O)Cc1ccccc1)NC(=O)N1CCOCC1,7.49,,
CC(NC(=O)CCCCC([NH3+])C(=O)[O-])B(O)O,7.49,,
Cc1nn(C)c(C)c1NS(=O)(=O)c1c(Cl)cc(-c2ccnc(N3CC[NH2+]CC3)c2)cc1Cl,7.49,,
NC(=O)c1cccc(-c2ccc(C([NH3+])Cc3cc(F)ccc3F)cc2)c1,7.49,,
CCCCCC(CC(=O)NO)C(=O)NC(C(=O)N1CCCC1CO)C(C)C,7.49,,CHEMBL67311
O=C(Nc1nnc(Sc2ccnc3cc(Cl)ccc23)s1)c1cccs1,7.49,,
O=C(CC1CCCC1)Nc1nc2cc(Cl)ccc2o1,7.49,,CHEMBL1689794
Nc1cc(Cn2c(C(=O)[O-])c(-c3ccc[nH]c3=O)c3cc(C(F)(F)F)ccc32)ccn1,7.49,,
COc1c(C)cc(C2(c3cccc(-c4cncnc4)c3)N=C(C)C(=[NH2+])N2)cc1C,7.49,,
CC(c1nc2c(cnn2C2CCCC2)c(=O)[nH]1)[NH+]1CC(c2ncccn2)C1,7.49,,
Nc1ncnc2c1c(COc1cccc(Cl)c1)nn2C1CCOCC1,7.49,"This molecule is a pyrazolopyrimidine that is 1H-pyrazolo[3,4-d]pyrimidin-4-amine which is substituted at positions 1 and 3 by tetrahydro-2H-pyran-4-yl and (m-chlorophenoxy)methyl groups, respectively. It is a selective inhibitor of the epsilon isoform of casein kinase 1 (CK1epsilon). It has a role as an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor. It is a pyrazolopyrimidine, a member of monochlorobenzenes, an aromatic ether and a member of oxanes.",CHEMBL2069623
OCC1OC(n2cnc3c(Br)c(Br)c(Br)c(Br)c32)CC1O,7.49,,
CC(=O)NC1C(O)CC(OC2C(O)C(OC3C(CO)OC(O)C(O)C3O)OC(CO)C2OC2OC(CO)C(O)C(OC3OC(CO)C(O)C(O)C3O)C2NC(C)=O)(C(=O)[O-])OC1C(O)C(O)CO,7.49,,
CCc1c(C)nc(-c2ccc(Cl)s2)nc1Nc1ccc(CC(=O)[O-])cc1,7.49,,
Nc1ncnc2c1ncn2C1OC(C(=O)N2CC[NH+](CC(=O)Nc3cccc4c3CNC4=O)CC2)C(O)C1O,7.49,,
CC(C)([NH3+])CNc1nc(-c2ccc3n[nH]cc3c2)nc2cnccc12,7.49,,
CCCCN(c1cccc(-c2ccc(SC)cc2)c1C)S(=O)(=O)c1ccc(OCC(=O)[O-])c2ccccc12,7.5,,
Cc1ccc(Nc2nc(NC3CCOCC3[NH3+])ncc2C(N)=O)cc1,7.5,,
COC(=O)NC(C(=O)N[N+](=Cc1ccc(-c2ccsc2)cc1)CCCC1(O)Cc2ccc(cc2)CCC=CNC(=O)C(C(C)C)NC1=O)C(C)(C)C,7.5,,
COc1ccc2c(c1)C(=Cc1cnc[nH]1)C(=O)N2,7.51,,
[NH3+]CC(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1,7.51,,
O=C(C[NH+]1CC(F)C(NC(=O)c2ccc(Cl)s2)C1)Nc1ccc(-n2ccccc2=O)cc1F,7.51,,
CCC(NC(=O)c1cc2[nH]nc(NC(=O)c3ccc(N4CC[N+](C)CC4)cc3)c2s1)c1ccccc1,7.51,,
Nc1ncnc2c1ncn2C1OC(CO)C(O)C1O,7.51,"This molecule is a purine nucleoside. This molecule is a natural product found in Acanthus ilicifolius, Acanthus ebracteatus, and other organisms with data available.",CHEMBL11909
O=C(CN(CCO)S(=O)(=O)c1ccc(-c2ccccc2)cc1)NO,7.51,,CHEMBL1233772
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C1CCCN1C(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C1CCCN1C(=O)C([NH3+])CCC(=O)[O-])C(C)C)C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCC[NH3+])C(=O)NC(Cc1c[nH]cn1)C(=O)N1CCCC1C(=O)NCC(=O)NC(CO)C(=O)[O-],7.51,,
Cc1ccccc1CCC(=O)NC(C(=O)NC(CCc1ccccc1)C(=O)NCc1ccccc1Cl)C(C)O,7.51,,
CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,7.51,"This molecule is a selective inhibitor of BRAF kinase that is used in the therapy of patients with metastatic and advanced malignant melanoma. This molecule therapy is commonly associated with transient elevations in serum aminotransferase during therapy and has been linked to rare, but occasionally severe cases of clinically apparent acute liver injury. This molecule is a pyrrolopyridine that is 1H-pyrrolo[2,3-b]pyridine which is substituted at position 5 by a p-chlorophenyl group and at positions 3 by a 3-amino-2,6-difluorobenzoyl group, the amino group of which has undergone formal condensation with propane-1-sulfonic acid to give the corresponding sulfonamide. An inhibitor of BRAF and other kinases. It has a role as an antineoplastic agent and a B-Raf inhibitor. It is a pyrrolopyridine, a sulfonamide, a member of monochlorobenzenes, a difluorobenzene and an aromatic ketone. This molecule is a competitive kinase inhibitor with activity against BRAF kinase with mutations like V600E. It exerts its function by binding to the ATP-binding domain of the mutant BRAF. This molecule was co-developed by Roche and Plexxikon and it obtained its FDA approval on August 17, 2011, under the company Hoffmann La Roche. After approval, Roche in collaboration with Genentech launched a broad development program. This molecule is a Kinase Inhibitor. The mechanism of action of vemurafenib is as a Protein Kinase Inhibitor, and Cytochrome P450 1A2 Inhibitor, and P-Glycoprotein Inhibitor. This molecule is a Kinase Inhibitor. The mechanism of action of vemurafenib is as a Protein Kinase Inhibitor. This molecule is an orally bioavailable, ATP-competitive, small-molecule inhibitor of BRAF(V600E) kinase with potential antineoplastic activity. This molecule selectively binds to the ATP-binding site of BRAF(V600E) kinase and inhibits its activity, which may result in an inhibition of an over-activated MAPK signaling pathway downstream in BRAF(V600E) kinase-expressing tumor cells and a reduction in tumor cell proliferation. Approximately 90% of BRAF gene mutations involve a valine-to-glutamic acid mutation at residue 600 (V600E); the oncogene protein product, BRAF(V600E) kinase, exhibits a markedly elevated activity that over-activates the MAPK signaling pathway. The BRAF(V600E) gene mutation has been found to occur in approximately 60% of melanomas, and in about 8% of all solid tumors, including melanoma, colorectal, thyroid and other cancers.",CHEMBL1229517
CCC(CO)NC(=O)c1cccc(C(F)(F)F)c1Cl,7.51,,
Cc1cc(N=c2[nH]n(-c3ccccc3)c(=O)c3ccccc23)n[nH]1,7.51,,
CNC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12,7.51,,CHEMBL1938643
Cc1cc(Nc2cc(N3CC[N+](C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,7.51,,
COc1ccc(S(=O)(=O)N(CC(C)C)CC(O)C(Cc2ccccc2)NC(=O)OC2COC3OC4OCCC4C23)cc1,7.51,,
[NH3+]C(CCNC(=O)N1CCn2c(ccc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,7.51,,
[NH3+]CCCC[NH2+]CCC[NH3+],7.51,,
O=C([O-])c1ccccc1Nc1cccc(C(F)(F)F)c1,7.519999999999999,,
CCC(C)C(NC(=O)C(C(C)C)C(O)C(=O)C(CC1CCCCC1)NC(=O)C(Cc1cnc[nH]1)NC(=O)COc1cccc2ccccc12)C(=O)NCc1ccccn1,7.519999999999999,,
[NH3+]CCCC([NH3+])C(=O)[O-],7.519999999999999,,
Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(CC(C)C)NC(=O)c1ccc(N)cc1,7.519999999999999,,
CC12CCC(O)CC1CCC1C2CC(O)C2(C)C(C3=CC(=O)OC3)CCC12O,7.519999999999999,,
CC(C)CC(CC(=O)NO)C(=O)NC1Cc2cn(c3ccccc23)CCCCCCNC1=O,7.519999999999999,,
CC(C)CC1NC(=O)C(CC(=O)[O-])NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2cnc[nH]2)NC(=O)C([NH3+])CSSCC(C(=O)O)NC(=O)C(C(C)C)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2cnc[nH]2)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC1=O,7.519999999999999,,
[NH3+]C(CSCC[B-](O)(O)O)C(=O)[O-],7.519999999999999,,
NC(=[NH2+])NCCCC(NC(=O)C1CCCC1)C(O)c1nc2ccccc2s1,7.519999999999999,,
CCSCCC([NH3+])C(O)C(=O)NC(C)c1cccc2ccccc12,7.519999999999999,,
NC(=O)c1cn(C(CO)CCn2ccc3ccc(NC(=O)CCc4ccccc4)cc32)cn1,7.519999999999999,,
[NH3+]C(Cc1cnc[nH]1)C(=O)Nc1ccc2ccccc2c1,7.519999999999999,,
CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br,7.519999999999999,,CHEMBL573108
NS(=O)(=O)c1nc2ccc(O)cc2s1,7.519999999999999,,CHEMBL6685
CC(NC(=O)NC(CCCNC(N)=O)C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(O)c1nccs1)C(C)C)c1ccc(Br)cc1,7.519999999999999,,
COc1ccccc1-c1cc2c(c3c1C(=O)NC3=O)c1cc(O)ccc1n2CCCO,7.519999999999999,,CHEMBL512341
CCC(C)C(NC(=O)C1CSCC(=O)Nc2ccc(cc2S(=O)(=O)[O-])N=Nc2ccc(c(S(=O)(=O)[O-])c2)NC(=O)CSCC(NC(=O)CNC(C)=O)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(Cc2ccccc2)C(=O)NCC(=O)NC(CC(=O)[O-])C(=O)N1)C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O,7.519999999999999,,
Nc1ccc(C2[NH2+]C(CO)C(O)C2O)cc1,7.519999999999999,,
CCOC(=O)CCc1ccc(S(N)(=O)=O)cc1,7.519999999999999,,
O=C(OCc1ccccc1)c1cn2c(=O)n(Cc3ccccc3)c(=O)cc2s1,7.519999999999999,,CHEMBL409536
O=C(Cc1ccc(N2CCCCC2)cc1)Nc1[nH]nc2ccc(N3CCCS3(=O)=O)cc12,7.519999999999999,,
Nc1ncnc(Nc2ccc3c(cnn3Cc3cccc(F)c3)c2)c1C=NN1CCCCC1,7.519999999999999,,
CC(=C1SC(=N)NC1=O)c1ccc(-c2ccc(S(N)(=O)=O)cc2)o1,7.519999999999999,,
CC(C)Nc1cc(NC2CCC([NH3+])CC2)nc2c(C#N)cnn12,7.519999999999999,,
Cc1c(Cl)c(C(=O)N(c2ccccc2)c2ccccc2)nn1-c1ccccc1C(=O)N1Cc2ccccc2CC1C[NH3+],7.519999999999999,,
C=C1C(O)CC(=CC=C2CCCC3(C)C2CCC3C(C)C=CCC(O)CC23CC4CC(CC(C4)C2)C3)CC1O,7.519999999999999,,
Oc1cc(O)c(-c2noc3ccc(NCC[NH+]4CCOCC4)cc23)cc1Cl,7.519999999999999,,
Cc1cc(C#N)cc(Oc2ccc(Cc3n[nH]c4nnccc34)cc2Br)c1,7.519999999999999,,CHEMBL459170
Cc1ccccc1C1CCCN1C(=O)c1ccc(O)cc1O,7.519999999999999,,CHEMBL511998
Cc1nc(N)nc2c1C(=NO)CC(c1ccc(F)cc1-c1cccnc1)C2,7.519999999999999,,
Cc1ccccc1-c1ccccc1CNc1cnc(-c2ccc(CC([NH3+])C(=O)[O-])cc2)cn1,7.519999999999999,,
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,7.519999999999999,,
CC=COC1(C(=O)[O-])CC(OC2(C(=O)[O-])CCC(O)C(C(O)CO)O2)C(O)C(C(O)CO)O1,7.519999999999999,,
CCc1cc(C2(c3cccc(-c4cncnc4)c3)NC(=[NH2+])N(C)C2=O)cc(CC)n1,7.519999999999999,,
OCC(O)C(O)C(O)C(O)C(O)C[S+]1CC(O)C(O)C1CO,7.519999999999999,,
C[NH+]1CCN(c2cccc(-c3c[nH][n+]4c(N)c(-c5ccc(O)cc5)cnc34)c2)CC1,7.519999999999999,,
NS(=O)(=O)c1cc(C(=O)CSc2nc3cnc4ccccc4c3[nH]2)ccc1Cl,7.519999999999999,,CHEMBL1271639
Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCCNC1=O,7.519999999999999,,
O=c1[nH]c2cc(CNS(=O)(=O)c3cccc4ccccc34)ccc2n1-c1cc(Cl)c(O)cc1O,7.519999999999999,,CHEMBL1801578
COc1cc(-c2nc(C)nc3[nH]c(C)c(C#N)c23)c(Cl)cc1Cl,7.519999999999999,,CHEMBL1738738
COc1cccc(C(C)NC(=O)Nc2nc(-c3ccncc3)cs2)c1,7.519999999999999,,
Cc1[nH]c(C(=O)NC2CCN(c3cc(C(N)=O)cc(Cl)n3)CC2)c(Cl)c1Cl,7.519999999999999,,CHEMBL1923431
CC(C)CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C(C)NC(=O)C[NH3+])C(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],7.519999999999999,,
CC(Oc1cc(-c2cnn(C3CC[NH2+]CC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,7.519999999999999,,
Cn1c(NC(=O)Nc2ccccc2Cl)nc2ccccc21,7.519999999999999,,CHEMBL3988806
O=C(NCC[NH+]1CCOCC1)c1[nH]c2cc(Cl)ccc2c1-c1c(-c2ccccc2)ncn1Cc1ccc(Cl)cc1,7.519999999999999,,
CCC(C)C(NC(=O)C(CC(=O)[O-])NC(=O)C1CCCN1C(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(=O)C([NH3+])CO)C(=O)NC(C(=O)NCC(=O)[O-])C(C)C,7.519999999999999,,
CC=C1NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)CCCCC)C(C)OC(O)C(C(C)C)[NH2+]C(O)C(Cc2ccc(O)cc2)[NH+](C)C(O)C(Cc2ccccc2)[NH+]2C(O)CCC(NC1=O)C2O,7.519999999999999,,
CCC(C)C(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(N)=O)C(C)CC)C(C)O)C(=O)NC(CC(N)=O)C(=O)[O-],7.519999999999999,,
CC(NC(=O)c1c[nH]c2ncc(Oc3ccccc3)nc12)C1CC1,7.519999999999999,,CHEMBL2376337
CC(C)(C)OC(=O)NC(C(=O)NO)c1ccc(-n2cccn2)cc1,7.519999999999999,,CHEMBL3359688
NC(=O)c1ccc(-c2c[nH]c(C(Cc3ccccc3)NC(=O)C3CCC(C[NH3+])CC3)n2)cc1,7.519999999999999,,
CC([NH3+])C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(=O)NC1CSSCC(C(N)=O)NC(=O)C(CO)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CO)NC(=O)CCNC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(C(C)C)NC1=O,7.519999999999999,,
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F,7.53,,CHEMBL261720
N=CC1CCCN1C(=O)C[NH2+]C12CC3CC(CC(O)(C3)C1)C2,7.53,,
COC(=O)NC(C(=O)N[N+](=Cc1ccc(C2=CCSC2)cc1)CCCC1(O)Cc2ccc(cc2)CC=CCNC(=O)C(C(C)C)NC1=O)C(C)(C)C,7.53,,
CCC(C)C(NC(=O)C(CC(N)=O)NC(=O)C(CCSC)NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(=O)NC(CCC(N)=O)C(=O)NC(CCSC)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C)C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-],7.54,,
C=CC[NH+](C)Cc1ccc(-c2ccc(C(=O)c3ccc(Br)cc3)cc2)cc1,7.54,,
O=C([O-])CCC(Cc1ccc(OCc2ccccc2)cc1)NC(=O)CCCCCCc1ccccc1,7.54,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C)C(=O)NC(C)C(N)=O,7.54,,
CC(C)c1c(OC#CC2CC2)c2cc(F)ccc2[nH]c1=O,7.54,,CHEMBL365845
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(N)=O)C(=O)O,7.54,,
COc1ccc(NCCNC(=O)C(CC2CCCCC2)Nc2nc3ccccc3o2)cc1,7.54,,
Cc1nc2ccc(CN(C)c3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])s3)cc2c(=O)[nH]1,7.54,,
C=CCCCC(=O)NCCCCC(NC(=O)C(Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)COCCOCCNC(=O)C(Cc1ccc2ccccc2c1)NC(=O)C(O)C([NH3+])Cc1ccccc1)C(N)=O,7.54,,
CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,7.54,,
CC(NC(=O)NC1C2CC3CC(C2)CC1C3)C(=O)N1CCC(c2ccccc2Cl)N1c1ccccc1F,7.54,,
CC(C)(C)c1ccc(Nc2nc3ccc(C#N)cc3[nH]2)cc1,7.54,,CHEMBL2071612
NS(=O)(=O)c1c(F)c(F)c(S(=O)(=O)CCO)c(F)c1F,7.54,,CHEMBL2333417
Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cc(F)ccc5F)c4)c3c2)cn1,7.54,,CHEMBL2418761
C[NH+](C)CCCC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(NC(CO)c4ccccc4)c23)c1,7.54,,
O=C(NCc1ccc(S(=O)(=O)c2ccccc2)cc1)c1cc2cnccc2[nH]1,7.54,,CHEMBL2419503
O=C(NCCC[NH2+]Cc1cc(Cl)cc(Cl)c1)Nc1cccc(O)c1,7.54,,
O=C(NCc1ccc(S(=O)(=O)c2cc(F)cc(F)c2)cc1)c1ccc2nccn2c1,7.54,,CHEMBL2420629
Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,7.54,"This molecule is a natural product found in Maclura pomifera, Caragana sinica, and other organisms with data available.",CHEMBL2019155
COC(=O)C1CCN(C(=O)C(Cc2cccc(C(N)=[NH2+])c2)NS(=O)(=O)c2ccc3ccccc3c2)CC1,7.55,,
NC(=[NH2+])c1cccc(COC(=O)c2cc3ccccc3n2Cc2cccc(C(N)=[NH2+])c2)c1,7.55,,
NC(=[NH2+])c1ccc2cc(C(=O)Nc3cccc(OC4CCCC4)c3)ccc2c1,7.55,,
NC(=[NH2+])n1ccc(CCNC(=O)C2CC3CCC(O)CC3N2C(=O)C(Cc2ccccc2)NC(=O)C(O)Cc2ccccc2)c1,7.55,,
OC1C[NH2+]CCC1OC1OCC(O)C(O)C1O,7.55,,
OC1C[NH2+]CCC1OC1OCC(O)C(O)C1O,7.55,,
NC(=[NH2+])c1ccc(CNC(=O)C(COCc2ccccc2)NC(=O)C(CO)NS(=O)(=O)Cc2ccccc2)cc1,7.55,,
CC(C)COC(=O)NC(CO)C(=O)NC(C)C(=O)NC(C=O)CCCNC(N)=[NH2+],7.55,,
c1ccc2c(NCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,7.55,,CHEMBL179732
CC#CCOc1ccc(S(=O)(=O)N2CCC(S)C2)cc1,7.55,,
[NH3+]C1CCC(Nc2cncc(-c3cccc(C=CC(=O)[O-])c3)n2)CC1,7.55,,
CNC(=O)C=Cc1cnc2ccc(OC(C)c3c(Cl)ccc(F)c3Cl)cc2c1,7.55,,
CC(=O)NC1C(O)CC(O)(C(=O)[O-])OC1C(O)C(O)CO,7.55,,
Nc1ncnc2c1ncn2C1OC(COS(=O)(=O)NC(=O)C([NH3+])CCCC[NH3+])C(O)C1O,7.55,,
O=C(Cn1c(-c2nccs2)nc2ccccc21)Nc1ccc(Br)cc1,7.55,,CHEMBL1231618
NS(=O)(=O)c1nnc(NS(=O)(=O)c2cccc(C(=O)OCCCCO[N+](=O)[O-])c2)s1,7.55,,CHEMBL1738778
CCCCNC(=O)c1ccc(S(N)(=O)=O)cc1,7.55,,CHEMBL75131
O=c1[nH]c(C[NH+]2CCC(O)C2)nc2c1oc1ccc(Br)cc12,7.55,,
CN(C1C(=N)N(Cc2ccccc2)C(=O)NC1=O)S(=O)(=O)c1ccccc1,7.55,,
O=C1C(O)C(O)CC(O)(C(=O)[O-])C1Cc1ccc2sccc2c1,7.55,,
Cn1cc(Nc2ncc3cc(C(N)=O)n(C4CCCC4)c3n2)cc1C(=O)N1CC[N+](C)CC1,7.55,,
O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cccc1Cl,7.55,,CHEMBL2387224
CC1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)NC(=[NH2+])OCC1F,7.55,,
CC([NH3+])C(=O)NC1CSCc2cc3cc(c2)CSCC(NC(=O)C(CC(=O)[O-])NC(=O)C(C(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC1=O)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(C(=O)NCC(N)=O)CSC3,7.55,,
Nc1ncc(-c2cnn(C3CCC(O)CC3)c2)c2c(Cl)c(-c3cccc4nnsc34)oc12,7.55,,
O=C(NCCC[NH2+]Cc1cc(Cl)cc(Cl)c1)Nc1ccsc1,7.55,,
O=CNCCCCC(NC(=O)NC(CCC(=O)[O-])C(=O)[O-])C(=O)[O-],7.55,,
CC(=O)NCCOc1cc(Br)ccc1C(=O)NCCCCC(NC(=O)NC(CCC(=O)[O-])C(=O)[O-])C(=O)[O-],7.55,,
CC#CC1CN(S(=O)(=O)c2ccc(N)nc2)CCN1c1ccc(C(O)(CO)C(F)(F)F)cc1,7.55,,
CC[NH+]1CC[NH+](Cc2ccc(-c3cc4c(NC(C)c5ccccc5)ncnc4[nH]3)cc2)CC1,7.559999999999999,,
CC(C)c1c(C(=O)Nc2ccccc2O)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)[O-],7.559999999999999,,
CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OC1CC1CCCCCc1nc3ccc(OC)cc3nc1O2)C(=O)NS(=O)(=O)C1C=C1,7.559999999999999,,
OB(O)c1cc2ccccc2s1,7.57,,CHEMBL34964
CCC(C)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(CO)NC(=O)C[NH3+])C(C)C)C(C)C)C(C)CC)C(C)C)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)O)C(C)CC,7.57,,
CC(C)=CCCC1(C)C(CC=C(C)C)CC2(CC=C(C)C)C(=O)C(CC=C(C)C)=C(O)C1(C(=O)C(C)C)C2=O,7.57,,
CC(C)(C)NC(=O)C1C[NH+](Cc2cccnc2)CC[NH+]1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O,7.57,,
CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,7.57,"This molecule is a metabolite of flutamide. Flutamide is an oral nonsteroidal antiandrogen drug primarily used to treat prostate cancer. It competes with testosterone and its powerful metabolite, dihydrotestosterone (DHT) for binding to androgen receptors in the prostate gland. By doing so, it prevents them from stimulating the prostate cancer cells to grow. Flutamide has been largely replaced by a newer member of this class, bicalutamide, due to a better side-effect profile. (Wikipedia)",CHEMBL491
CCc1cccc(CC)c1NC(=O)n1cc2c(c1)C(NC(=O)c1ccc(N3CC[NH+](C)CC3)cc1)[NH2+]N2,7.57,,
CC(NC(=O)c1cc(COC(=O)C(C)([NH3+])Cc2ccccc2)cc(N(C)S(C)(=O)=O)c1)c1ccc(F)cc1,7.57,,
Cc1c(O)cccc1C(=O)NC(CSc1ccccc1)C(O)C[NH+]1CC2CCCCC2CC1C(=O)NC(C)(C)C,7.57,,
CC1([NH3+])Cc2cccc(c2)CCC(c2ccccc2)NC(=O)c2cc(cc(-c3ccccc3C#N)c2)COC1=O,7.57,,
CC(C)(C)c1ccc(CC2([NH3+])CCN(c3ncnc4[nH]ccc34)CC2)cc1,7.57,,
CC([NH3+])C(=O)NCc1cccc(-n2nc(C(F)(F)F)cc2-c2nnc(-c3cccc4[nH]ccc34)o2)c1,7.57,,
CC(C)n1c(C(=O)NCc2ccc(F)cc2)nc(-c2ccc(F)cc2)c1CCC(O)CC(O)CC(=O)[O-],7.57,,
O=C(CCC(=O)Nc1ccc2c(c1)C(=O)C(=O)NC2=O)Nc1cccc(OCCF)c1,7.57,,
OB(O)c1cc2ccccc2s1,7.57,,CHEMBL34964
COc1cc(N2CCC(O)CC2)ccc1Nc1cc(Nc2ccccc2S(=O)(=O)C(C)C)c2cc[nH]c2n1,7.57,This molecule is a member of piperidines.,CHEMBL1235786
O=C([O-])Cc1cccc(OCCC[NH+](Cc2cccc(C(F)(F)F)c2Cl)CC(c2ccccc2)c2ccccc2)c1,7.57,,
OB(O)c1cc2ccccc2s1,7.57,,CHEMBL34964
CCCC1CN(Cc2ccc(CN3C(=[NH2+])NC(CCC4CCCCC4)(CC4CCCCC4)C3=O)cc2)C(=O)N1,7.57,,
CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2ccc(CO)cc2)n1,7.57,,CHEMBL1271167
O=C1CCN(c2ncc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)n2)CC1,7.57,,CHEMBL1235315
O=C(CCc1ccc2ccc3ncc(-c4cnn(C5CC[NH2+]CC5)c4)cc3c(=O)c2c1)NCc1ccccn1,7.57,,
COc1cc2c(NC3CC[N+](C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCC[N+]1CCCC1,7.57,,
CC1CCOC2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,7.57,,
CCNC(=O)N1CCc2c(sc(NC(=O)Cc3ccccc3)c2C(=O)OCC)C1,7.57,,CHEMBL1923066
C[NH+]1CC[NH+](Cc2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)CC1,7.57,,
[NH3+]CCCNC(=O)c1n[nH]c2c1ccc1n[nH]c(Nc3cccc(F)c3)c12,7.57,,
CCCCCCCCCCCCCCCCCC(=O)[O-],7.57,,
CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,7.57,,
COc1cc(-c2cn(CC(=O)Nc3cc(C4C=C4)nn3-c3ccccc3)nn2)ccc1-n1cnc(C)c1,7.57,,
CCc1c2c(nc3ccc(OC(=O)N4CCC([NH+]5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CC,7.58,,
CC(C)n1c(CCC(O)CC(O)CC(=O)[O-])c(-c2ccc(F)cc2)c(-c2ccccc2)c1C(=O)Nc1ccc(S(N)(=O)=O)cc1,7.58,,
[NH2+]=C1NC(c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)F)c2)c2cccc(F)c21,7.58,,
CC(C)(C)OC(=O)NC(C=O)C1CCCCC1,7.59,,CHEMBL2316591
COc1cc(-c2ccc3c(-c4nc5ccccc5[nH]4)n[nH]c3c2)ccc1O,7.59,,
CCCN(CCC)C(=O)c1cccc(C(=O)NC(Cc2ccccc2)C([NH3+])CC(C)C(=O)Nc2ccc(F)cc2)c1,7.59,,
CCCCCCCCCCCCCCCCCCCC(=O)[O-],7.59,,
CCCCNC(=O)C(C)CC(O)C([NH3+])CC(C)CNC(=O)c1ccccc1OCCCOC,7.59,,
CCN1CCN2CCS(=O)(=O)N(C)c3cc(C(=O)NC(Cc4ccccc4)C(O)C[NH2+]Cc4cccc(OC)c4)cc1c32,7.59,,
COc1ccc(CC2C(=O)C(O)C(O)CC2(O)C(=O)[O-])cc1,7.59,,
O=C([O-])c1ccc(B(O)O)cc1NS(=O)(=O)c1cc(S(=O)(=O)c2ccccc2)cs1,7.59,,
CCC(CC)OC1C=C(C(=O)[O-])CC([NH3+])C1NC(C)=O,7.59,,
CC(C)Oc1ccc2c(ccc3c2c2c(c4c5ccccc5n(CCO)c34)C=NC2=O)c1,7.59,,
CC(Nc1nc(N)nc(-c2ccc(CC([NH3+])C(=O)[O-])cc2)n1)c1ccc2ccccc2c1,7.59,,
CN1C(=[NH2+])NC(=O)C1=Cc1cc(Br)c(O)c(Br)c1,7.59,,
Cc1nc(N)c2cccc(C(=O)Nc3ccn[nH]3)c2n1,7.59,,
CCCCc1cnc(SCC(=O)c2ccc(S(N)(=O)=O)cc2)nc1,7.59,,CHEMBL2011154
O=S(=O)(NO)c1ccccc1,7.59,This molecule is a sulfonamide.,CHEMBL55310
COc1ccccc1Nc1cc2[nH]c(-c3cnco3)cc2cn1,7.59,,CHEMBL3109962
OCC1C[NH2+]CC(O)C1O,7.59,,
CC(C)(C)NC(=O)c1c[nH]c2ncc(-c3ncn4c3CCCC4)nc12,7.59,,CHEMBL2347996
CC12CCC3c4ccc(O)cc4CC(CCCCCCCCC[S+](O)CCCC(F)(F)C(F)(F)F)C3C1CCC2O,7.59,,
CC12OC(CC1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,7.59,,CHEMBL2140769
CN1C(=[NH2+])NC2(C1=O)c1cc(-c3cccnc3F)ccc1OC1(C)CCCOC12,7.59,,
COc1ccc(CCC(OC(=O)C2CCCCN2C(=O)C(c2cc(OC)c(OC)c(OC)c2)C2C=CCCC2)c2cccc(OCC[NH+]3CCOCC3)c2)cc1OC,7.59,,
Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CC2CC2)n1,7.599999999999999,,CHEMBL590753
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C[NH3+])C(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C)C(C)O,7.599999999999999,,
Cc1cccc2c1cc(C(=O)NCc1cc(Cl)cc(Cl)c1)n2Cc1cccc(C(N)=[NH2+])c1,7.599999999999999,,
Nc1ncnc2c1ncn2C1OC(COS(=O)(=O)NC(=O)C([NH3+])CS)C(O)C1O,7.599999999999999,,
[NH3+]CC1CCCN1C(=O)C([NH3+])Cc1ccc(I)cc1,7.599999999999999,,
CCC(C)C(NC(=O)C(CS)NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CC(C)C)C(=O)NC(CS)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)[O-],7.599999999999999,,
COc1ccc(C2(C#N)CCC(C(=O)[O-])CC2)cc1OC1CCCC1,7.599999999999999,,
CC(C)CC(NC(=O)C1CC(=O)NCCCCCCOC(=O)NC(C(C)C)C(=O)N1)C(O)CC(C)C(=O)NC(C(=O)NCc1ccccc1)C(C)C,7.599999999999999,,
CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1,7.599999999999999,,CHEMBL200528
CCCOC(=O)NC(CCC1CC[NH2+]C1)C(O)c1noc(Cc2ccc(C(=O)NC3Cc4ccccc4C3)cc2)n1,7.599999999999999,,
C=CCOC(=O)NC(CCC1CC[NH2+]C1)C(O)c1noc(Cc2ccc(C(=O)NC3Cc4ccccc4C3)cc2)n1,7.599999999999999,,
CCCC(NC(=O)C1CC2CN1C(=O)C(C1CCCCC1)NC(=O)CCc1cccc(c1)OCCO2)C(O)C(=O)NCC(=O)NC(C(=O)N(C)C)c1ccccc1,7.599999999999999,,
N#Cc1ccc(-c2ccc(OCCC(=O)NO)cc2)cc1,7.599999999999999,,CHEMBL38851
COc1cc2ncnc(N3CCc4cccc(S(=O)(=O)N5CC[NH+](C)CC5)c4C3)c2cc1OC,7.599999999999999,,
CC1c2nc(C(F)(F)F)nn2CCN1C(=O)CC([NH3+])Cc1cc(F)c(F)cc1F,7.599999999999999,,
Cn1c(-c2ccccc2)c(C2CCCCC2)c2sc(C(=O)[O-])cc21,7.599999999999999,,
Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CC[NH+](CCO)CC2)n1,7.599999999999999,,
CC(C)CC(NC(=O)C(NC(=O)C([NH3+])CO)C(C)C)C(=O)NCC(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1cnc[nH]1)C(=O)[O-],7.599999999999999,,
CNC(=O)N(c1cccc(-c2sc(C(=O)[O-])c(OCC(=O)[O-])c2Br)c1)C1CCCCC1,7.599999999999999,,
CCC(C)C(NS(=O)(=O)Cc1ccccc1)C(=O)NC(CCC(N)=O)C(=O)NCc1ccc(C(N)=[NH2+])cc1,7.599999999999999,,
CC(C)CC(NS(=O)(=O)c1ccc(-c2ccccc2)cc1)C(=O)[O-],7.599999999999999,,
CC(C)n1nc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)ncnc21,7.599999999999999,,
O=C([O-])CCC[NH+]1CCCC1COc1ccc(Oc2ccc(Cl)cc2)cc1,7.599999999999999,,
COc1cc(NC(=O)c2cccc(N3CC([NH2+]C(O)Nc4ccccc4)C[NH2+]3)c2)cc(OC)c1OC,7.599999999999999,,
CNc1nc2cc3c(=O)[nH]c(=[NH2+])[nH]c3c(CC[NH2+]Cc3ccccc3)c2[nH]1,7.599999999999999,,
Cc1cccc(-c2nc(Nc3ccc4n[nH]cc4c3)c3ccccc3n2)n1,7.599999999999999,,
Cc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1,7.599999999999999,"This molecule is a member of the class of quinazolines that is quinazoline which is substituted at positions 2 and 4 by 6-methylpyridin-2-yl and pyridin-4-ylnitrilo groups, respectively. It is an ALK5 and PKN3 kinase inhibitor. It has a role as an EC 2.7.11.30 (receptor protein serine/threonine kinase) inhibitor and an EC 2.7.11.13 (protein kinase C) inhibitor. It is a member of quinazolines, a member of pyridines, a secondary amino compound, an aromatic amine and a member of methylpyridines.",CHEMBL570533
CN(C)c1ccc(C(=O)[O-])c(Oc2nc(Oc3cccc(-c4cccc(C[NH3+])c4)c3)c(F)c(N3CCC([NH+](C)C)C3)c2F)c1,7.599999999999999,,
CCC1CC(O)=C(C2=NS(=O)(=O)c3cc(NS(C)(=O)=O)ccc3N2)C(=O)N1Cc1ccc(F)cc1,7.599999999999999,,
Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2C=C2)cn1,7.599999999999999,,
CC(C)CC(NC(=O)C1CSSCC2NC(=O)C(CC(N)=O)NC(=O)C([NH3+])CSSCC(NC(=O)C(CC(C)C)NC(=O)C(Cc3ccccc3)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)[O-])NC(=O)C3CCCN3C(=O)C(C)NC(=O)C(CCCC[NH3+])NC2=O)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1)C(=O)NC(CCC(N)=O)C(=O)NC(Cc1c[nH]cn1)C(N)=O,7.599999999999999,,
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CC[NH+](C)CC4)ccc3OCC)nc12,7.599999999999999,,
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(C=Cn4cnc5c(NC6CC6)ncnc54)c3)cc(C(F)(F)F)c2)cn1,7.599999999999999,,
CC(C)CC(NC(=O)C(O)C([NH3+])Cc1ccccc1)C(=O)[O-],7.599999999999999,,
NC(=[NH2+])c1cccc(CC(NC(=O)NC2C3CC4CC(C3)CC2C4)C(=O)NCCc2ccccc2)c1,7.599999999999999,,
CCCNc1ncnc2c1ncn2C1OC(C=CCNC(=O)c2cc(-c3ccc(F)cc3)cc(O)c2O)C(C)C1O,7.599999999999999,,
O=C([O-])c1ccc(CS(=O)(=O)NCB(O)O)cc1,7.599999999999999,,
CCN1CC(C)n2c(c(O)c3c(=O)n(Cc4ccc(F)c(Cl)c4)nc(C(=O)NC)c32)C1=O,7.599999999999999,,
CN(Cc1ccccc1)C(=S)S,7.599999999999999,,CHEMBL2010499
Cc1csc(NC(=O)CN2C(=O)CCc3ccccc32)c1-c1nnc[nH]1,7.599999999999999,,
CC(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C)C(C)C,7.599999999999999,,
NS(=O)(=O)c1ccc(CNC(=O)C23C4=C5C6=C2[Re+9]5643(C#[O+])(C#[O+])C#[O+])cc1,7.599999999999999,,
CCCCCC=CCC=CCCCCCCCCCC(=O)NC(COC1OC(CO)C(O)C(O)C1O)C(O)C(O)CCCCCCCCCCCCCC,7.599999999999999,,
O=C(NOCC(O)CO)c1oc2ccncc2c1Nc1ccc(I)cc1F,7.599999999999999,,
Nc1c2ccccc2nc2ccccc12,7.599999999999999,"This molecule appears as yellow needles. Free soluble in alcohol. This molecule is an aminoacridine that is acridine in which the hydrogen at position 9 is replaced by an amino group. A fluorescent dyd and topical antiseptic agent, it is used (usually as the hydrochloride salt) in eye drops for the treatment of superficial eye infections. It has a role as an antiinfective agent, an antiseptic drug, a fluorescent dye, a MALDI matrix material, an acid-base indicator and a mutagen. It is a member of aminoacridines and a primary amino compound. It is a conjugate base of a This molecule(1+). A highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA. It is also used as an intracellular pH indicator.",CHEMBL43184
COc1ccc(Nc2cc3[nH]c(-c4cn[nH]c4)cc3cn2)cc1OC,7.599999999999999,,CHEMBL3109932
CCC([NH2+]C)C(=O)NC1C(=O)N2C(CCC1CO)CCC2C(=O)NC(c1ccccc1)c1cn(CCCCc2ccc(CCCCn3cc(C(NC(=O)C4CCC5CCC(CO)C(NC(=O)C(CC)[NH2+]C)C(=O)N54)c4ccccc4)nn3)cc2)nn1,7.599999999999999,,
CS(=O)(=O)c1ccc(-c2nnc(C=Cc3nnc(-c4ccc(C#N)cc4)o3)n2-c2ccccc2Cl)nc1,7.599999999999999,,
CC(=CC=CC(C)=CC(=O)[O-])C=C1CCC(C)c2ccccc21,7.599999999999999,,
CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CC[NH+](C)CC4)cc3OC)nc2N1C1CCCC1,7.599999999999999,,
CC(=O)N1c2ccc(-c3ccc(C(=O)[O-])cc3)cc2C(Nc2ccc(Cl)cc2)CC1C,7.599999999999999,,
CC(=O)N1c2ccc(-c3ccc(C(=O)[O-])cc3)cc2C(Nc2ccc(Cl)cc2)CC1C,7.599999999999999,,
Cc1o[nH]c(=O)c1CC([NH3+])C(=O)[O-],7.61,,
NS(=O)(=O)OCCCCCCCCCCOS(N)(=O)=O,7.61,,CHEMBL171476
CC([NH3+])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CC(=O)[O-])C(=O)[O-],7.61,,
Nc1nc(N)c2cc(CNc3cc(Cl)ccc3Cl)cnc2n1,7.61,,CHEMBL145979
CC(c1ccccc1)C(CC(O)C[NH+]1CC[NH+](Cc2cccnc2)CC1C(=O)NC(C)(C)C)C(=O)NC1c2ccccc2CC1O,7.62,,
O=CN(c1ccccc1)c1ccccc1,7.62,,
C[NH+]1CCc2nc(C(=O)N3CCN(S(=O)(=O)c4ccc5cc(Cl)ccc5c4)CC3C(N)=O)sc2C1,7.62,,
Cc1cc(S(=O)(=O)NC(C(=O)NO)C2CCOCC2)ccc1F,7.62,,
CCCCC(NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)[NH2+]CC(CC(C)C)NC(=O)C(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)C)C(N)=O,7.62,,
CC1CCN(c2ccc(CO)cc2NC(=O)c2ccc(C#N)o2)CC1,7.62,,CHEMBL400754
CC1CCN(c2ccc(CO)cc2NC(=O)c2ccc(C#N)o2)CC1,7.62,,CHEMBL400754
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(Cc1ccccc1)C(O)C(O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(C)NC(=O)OCc1ccccc1)C(C)C)C(C)C,7.62,,
CNC(=O)CCC(=O)NC(Cc1ccccc1)C(O)CN(CC1CC1)S(=O)(=O)c1cccc(OC)c1,7.62,,
CC[NH+]1CCN(c2nc(Nc3ccccc3)n3ncc(C#N)c3n2)CC1,7.62,,
CC(=NNC(N)=[NH2+])c1ccc(NC(=O)c2cc3cccc([N+](=O)[O-])c3[nH]2)cc1,7.62,,
O=C1CCCCc2cnn3c(NC4CC4)nc(nc23)Nc2cccc(c2)N1,7.62,,CHEMBL404508
CC(NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)[O-],7.62,,
C[NH+](C)Cc1ccc(-c2cnn3c(-c4cccc(NC(=O)c5cccc(C(F)(F)F)c5)c4)ccnc23)cc1,7.62,,
CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC)COC1OC(CO)C(O)C(OC2OC(C)C([NH3+])C(O)C2NC(C)=O)C1O,7.62,,
O=C1NC(=O)C(=Cc2cccc(C(F)(F)F)c2)S1,7.62,,CHEMBL3183803
COc1cccc(CNC(=O)c2nc3sccc3c(=O)[nH]2)c1,7.62,,CHEMBL3337881
O=c1[nH]c2sccc2c2ccccc12,7.62,,CHEMBL3108871
CCC(C)Nc1cc(C(=O)NC2CC3CCC(C2)N3c2ccc(C(=O)C3CC3)cn2)c(C)cc1C(N)=O,7.62,,
Cn1c(=O)cc(OCc2cn(C3CC4C=CC(C3)[N+]4(C)C)nn2)c2ccccc21,7.62,,
CC(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC1CCCCCCCNC(=O)C2CCCN2C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)NC(=O)C2CCCN2C(=O)C(Cc2ccccc2)NC1=O,7.62,,
C[NH+](C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1,7.62,,
CN1C(=[NH2+])NC2(CC(C)(C)Oc3ccc(-c4cccc(Cl)c4)cc32)C1=O,7.62,,
COc1ccc(Cl)cc1NCC(=O)NC1CCC(n2c(=O)[nH]c3ccccc32)CC1,7.62,,
CC(=O)NC1C(O)CC(C(=O)[O-])OC1C(O)C(O)CO,7.62,,
O=C(C=Cc1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,7.62,,CHEMBL2131289
NC(=[NH2+])c1ccc2nc(Cc3nc4ccccc4[nH]3)[nH]c2c1,7.63,,
[NH3+]C(Cn1cc(F)c(=O)[nH]c1=O)C(=O)[O-],7.63,,
CC(C)C1[NH2+]CCc2ccc(NC(=O)c3ccc4cc(C(N)=[NH2+])ccc4c3)cc21,7.63,,
C[N+]1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)C(O)c3ccccc3)C4)cc2)CC1,7.63,,
COC(=O)CCCCCCCCOC1OC(CO)C(O)C(O)C1O,7.63,,
NC(=[NH2+])c1ccc2nc(Cc3nc4ccc(C(N)=[NH2+])cc4[nH]3)[nH]c2c1,7.639999999999999,,
Oc1c(Br)cc(Br)cc1Br,7.639999999999999,"Soft, long, white crystals with a bromine odor. (NTP, 1992) This molecule is a bromophenol that is phenol in which the hydrogens at positions 2, 4 and 6 have been replaced by bromines. It is commonly used as a fungicide and in the preparation of flame retardants. It has a role as an environmental contaminant, a fungicide and a marine metabolite. This molecule is a natural product found in Lanice conchilega, Bos taurus, and other organisms with data available. This molecule is found in crustaceans. This molecule is isolated from molluscs and crustaceans. This molecule is a flavour component of seafood, imparts an intense shrimp-like flavour. This molecule belongs to the family of Bromobenzenes. These are organic compounds containing a chlorine atom attached to a benzene ring.",CHEMBL220087
C=CC[NH+](C)CC=CCOc1ccc2c(-c3ccc(Br)cc3)coc2c1,7.639999999999999,,
Cc1cc(NS(=O)(=O)c2ccccc2)cc(OCCNc2ccncc2)c1,7.639999999999999,,CHEMBL24097
Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1,7.639999999999999,This molecule is a pyrazolopyridine.,CHEMBL185238
COc1ccccc1COCCCOc1ccc(N2C(=O)C[NH2+]CC2COc2ccc3c(c2)NCCC3)cc1,7.639999999999999,,
O=S(=O)(Nc1cc(-c2cccs2)nn1-c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,7.639999999999999,,CHEMBL208472
NS(=O)(=O)c1ccc(NC2OC(CO)C(O)C(O)C2O)cc1,7.639999999999999,,
O=C([O-])CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O,7.639999999999999,,
CCn1ccc2c(N3CCCC3=O)cc(C(=O)NC(Cc3ccccc3)C(O)C[NH2+]Cc3cccc(OC)c3)cc21,7.639999999999999,,
CCCCNS(=O)(=O)c1ccccc1,7.639999999999999,"This molecule is a sulfonamide that is benzenesulfonamide substituted by a butyl group at the nitrogen atom. It has been isolated from the plant Prunus africana and has been shown to exhibit antiandrogenic activity. It has a role as a neurotoxin and a plant metabolite. This molecule is a natural product found in Streptomyces, Pseudomonas, and other organisms with data available. N-Butyl benzenesulfonamide (NBBS), a plasticizer used commercially in the polymerization of polyamide compounds. It is neurotoxic and has been found to induce spastic myelopathy in rabbits.",CHEMBL479880
Cc1o[nH]c(=O)c1CC([NH3+])C(=O)[O-],7.639999999999999,,
NC(=[NH2+])NCCCC(NC(=O)C(CC=CCNC(=O)Cc1ccc(C2C=CC=CC2)cc1)NC(=O)CC1C=CC(C2C=CCCC2)CC1)C(=O)NC(CC1C=CC(=O)CC1)C(=O)NCCC1CCCCC1,7.639999999999999,,
O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1,7.639999999999999,,
COc1cc2c(NC3CC[N+](C)CC3)nc(N3CCC[N+](C)CC3)nc2cc1OCCC[N+](C)C,7.639999999999999,,
COc1ccc2[nH]n(CC3(C)NC(=O)NC3=O)c(=O)c2c1,7.639999999999999,,CHEMBL1078396
CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,7.639999999999999,"This molecule is an orally bioavailable, small molecule and dual kinase inhibitor of human epidermal growth factor receptors 1 (EGFR/ErbB1) and 2 (HER2/ErbB2), with potential antineoplastic activity. EGFR/HER2 kinase inhibitor TAK-285 binds to and inhibits EGFR and HER2, which may result in the inhibition of tumor growth and angiogenesis, and tumor regression in EGFR/HER2-expressing tumors. This agent may be active against EGFR/HER2-expressing tumor cells that are resistant to trastuzumab. EGFR and HER2, receptor tyrosine kinases overexpressed in a variety of tumor cell types, play major roles in tumor cell proliferation and tumor vascularization. In addition, TAK-285 appears to pass the blood brain barrier (BBB) and does not appear to be a substrate for efflux pumps.",CHEMBL1614725
CSCCC(NC(=O)NC(CCCCNC(=O)c1ccc(I)cc1)C(=O)[O-])C(=O)[O-],7.639999999999999,,
O=c1ccn(-c2cccc(C(F)(F)F)c2)nc1-c1ccnn1-c1ccccc1,7.639999999999999,,
CC1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)NC(=[NH2+])OCC1(F)F,7.639999999999999,,
CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,7.639999999999999,,CHEMBL3112862
CC(=O)NC(Cc1cccnc1)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(=O)NC(CCC(C)C)C(=O)NC(CC(=O)[O-])C(C)=O)CC(C)C,7.639999999999999,,
CCc1sc(-c2ccc(OC)c(OCCF)c2)nc1CSc1nc(N)cc(N)n1,7.639999999999999,,CHEMBL2426598
CCOC(=O)n1ccc2ccc(C(=O)Nc3cc(C(=O)NC4C=C4)ccc3C)cc21,7.639999999999999,,
CCC(C)C1NC(=O)C(Cc2c[nH]cn2)NC(=O)C(C(C)CC)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])CSSCC(C(=O)[O-])NC(=O)C(C(C)O)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(Cc2ccccc2)NC(=O)C(C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C2CCCN2C(=O)CNC1=O,7.639999999999999,,
Oc1c(Cl)cc(Cl)cc1Cl,7.639999999999999,"This molecule appears as yellow to pinkish-orange needles or orange fluffy solid. Strong phenolic odor. (NTP, 1992) This molecule is a trichlorophenol with phenolic substituents on positions 2, 4 and 6. It has a role as a carcinogenic agent. It is a conjugate acid of a This moleculeate. This molecule is no longer used in the United States and only very low levels have been detected in ambient air. Limited information is available on the acute (short-term) and chronic (long-term) effects of 2,4,6-trichlorophenol in humans. The only available human study reported respiratory effects, such as cough, chronic bronchitis, chest wheezing, altered pulmonary function, and pulmonary lesions from chronic exposure to 2,4,6-trichlorophenol via inhalation. There are no studies available on the reproductive, developmental, or carcinogenic effects of 2,4,6-trichlorophenol in humans. 2,4,6- Trichlorophenol has been shown to be carcinogenic in animals, producing lymphomas, leukemia, and liver cancer via oral exposure. EPA has classified 2,4,6-trichlorophenol as a Group B2, probable human carcinogen. This molecule is a synthetic, colorless crystalline solid that is slightly soluble in water and soluble in organic solvents. It has been used primarily in pesticide formulations and as a wood preservative, although most uses have been cancelled in the US. When heated to decomposition, 2,4,6-trichlorophenol emits toxic and corrosive fumes of hydrochloric acid and other toxic gases. Exposure of humans to 2,4,6-trichrophenol via inhalation has been reported to cause respiratory effects, altered pulmonary function and pulmonary lesions. It is reasonably anticipated to be a human carcinogen. (NCI05) This molecule is a chlorinated phenol that has been used as a fungicide, herbicide, insecticide, antiseptic, defoliant, and glue preservative. It is a yellow solid with a strong, sweet odour. It decomposes on heating to produce toxic and corrosive fumes including hydrogen chloride and chlorine. The technical grade of this substance may contain polychlorinated dibenzodioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), and other contaminants. It is an environmental pollutant that has been found in fresh water lakes such as the Great Lakes. (L158)",CHEMBL309917
O=C(CC1(S(=O)(=O)c2ccc(Oc3ccccc3)cc2)CCOCC1)NO,7.639999999999999,,CHEMBL1235735
CC(C)CC(NC(=O)OCc1ccccc1)C(=O)NCC(O)CNC(=O)C(CC(C)C)NC(=O)OCc1ccccc1,7.66,,
Nc1nccc2ccc(CN3CCC(NS(=O)(=O)c4cc5ncccc5s4)C3=O)cc12,7.66,,
CC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(N)=O)NC(=O)CNC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(C(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1cnc[nH]1)C(=O)[O-])C(C)O)C(C)C,7.66,,
CC(=O)NC(Cc1ccc(N(C(=O)C(=O)[O-])c2ccccc2C(=O)[O-])c2ccccc12)C(=O)NCCCCCOc1cc2ccccc2cc1C(=O)[O-],7.66,,
O=C1Nc2ccccc2C1=C1Nc2ccccc2C1=NO,7.66,,
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,7.66,"This molecule is an oral multi-kinase inhibitor that is used in the therapy of advanced renal cell, liver and thyroid cancer. This molecule has been associated with a low rate of transient elevations in serum aminotransferase levels during therapy that are generally mild and asymptomatic. This molecule has also been linked to rare instances of clinically apparent liver injury which can be severe and even fatal. This molecule is a member of the class of phenylureas that is urea in which one of the nitrogens is substituted by a 4-chloro-3-trifluorophenyl group while the other is substituted by a phenyl group which, in turn, is substituted at the para position by a [2-(methylcarbamoyl)pyridin-4-yl]oxy group. It has a role as an antineoplastic agent, an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor, a tyrosine kinase inhibitor, an angiogenesis inhibitor, an anticoronaviral agent and a ferroptosis inducer. It is a pyridinecarboxamide, a member of monochlorobenzenes, an aromatic ether, a member of (trifluoromethyl)benzenes and a member of phenylureas. This molecule is a bi-aryl urea and an oral multikinase inhibitor. It targets cell surface tyrosine kinase receptors and downstream intracellular kinases that are implicated in tumour cell proliferation and tumour angiogenesis. First approved by the FDA and European Commission in 2007 for the treatment of hepatocellular carcinoma, sorafenib is also indicated to treat renal carcinoma and differentiated thyroid carcinoma. This molecule is a Kinase Inhibitor. The mechanism of action of sorafenib is as a Protein Kinase Inhibitor. This molecule is a synthetic compound targeting growth signaling and angiogenesis. This molecule blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis. This molecule is a natural product found in Aspergillus ochraceus, Curvularia lunata, and Asimina triloba with data available. This molecule is a drug approved for the treatment of advanced renal cell carcinoma (primary kidney cancer). It has also received 'Fast Track' designation by the FDA for the treatment of advanced hepatocellular carcinoma (primary liver cancer), and has since performed well in Phase III trials.
Sorafenib is a small molecular inhibitor of Raf kinase, PDGF (platelet-derived growth factor), VEGF receptor 2 & 3 kinases and c Kit the receptor for Stem cell factor. A growing number of drugs target most of these pathways. The originality of Sorafenib lays in its simultaneous targeting of the Raf/Mek/Erk pathway.",CHEMBL1336
CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1,7.66,,CHEMBL194176
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(CO)Cc1ccccc1)C(C)C,7.66,,
NC(=[NH2+])c1ccc(C2C3C(=O)N(Cc4ccc(F)cc4)C(C(F)F)C3C3CCC[NH+]32)cc1,7.66,,
CCCCCCCCSCC(O)C(F)(F)F,7.66,,
N=CC1(NC(=O)C2CC(S(=O)(=O)c3ccccc3Cl)CN2C(=O)C2(c3ccc(Cl)cc3)CC2)CC1,7.66,,
CCC(Cc1c(I)cc(I)c(O)c1I)C(=O)[O-],7.66,,
N=CC1(NC(=O)C2CC(S(=O)(=O)c3ccccc3Cl)CN2C(=O)C2(c3ccc(Cl)cc3)CC2)CC1,7.66,,
Cn1nc(C(=O)NC2CC3CCCC(C2)[NH+]3C)c2ccccc21,7.66,,
CC(C)CCn1nc(-c2cccs2)c(O)c(C2=Nc3ccc(NS(C)(=O)=O)cc3S(=O)(=O)N2)c1=O,7.66,,CHEMBL401825
O=C(Nc1cccc(C(F)(F)F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1,7.66,,CHEMBL472193
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CC(C)C)NC(=O)C([NH3+])C(C)C)C(=O)NC(CCC(=O)[O-])C(=O)NC(C)C(=O)[O-],7.66,,
CC1CCCCCCCCC(=O)N(C)C(C)C(=O)NC(C(O)C[NH2+]Cc2cccc(C(C)C)c2)C1,7.66,,
CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12,7.66,,CHEMBL234085
Cc1[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c(C)c1C(N)=O,7.66,,
Cc1ccccc1-n1ncc2c(=O)[nH]c(CC(C)C(F)(F)F)nc21,7.66,,
O=C([O-])c1cccc(-c2cnc(C(O)CCc3ccc(-c4ccccc4)cc3)o2)n1,7.66,,
CC1SCc2ncnc(N3CCN(C(=O)C([NH3+])Cc4c[nH]c5ccccc45)CC3)c21,7.66,,
C[NH+](C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O,7.66,,
CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)C[NH2+]C1CC(C2CC2)Oc2ccc(CC(C)(C)C)cc21,7.66,,
CCOC(=O)c1c(NC(=O)Cc2cccs2)sc2c1CCN(C(=O)OCC)C2,7.66,,CHEMBL1922946
O=C1N=C(N2CC[NH+](Cc3ccc(B(O)O)cc3)CC2)SC1=Cc1ccc(Cl)c(Cl)c1,7.66,,
CNC(=O)NC(=[NH2+])NCCCC(NC(=O)Cn1nncc1CON=Cc1ccnc2ccccc12)C(=O)N(Cc1ccccc1)Cc1ccccc1,7.66,,
CC(=O)NC1CCc2ccc(Oc3cnc4[nH]cc(C(=O)NC(C)C5CC5)c4n3)cc21,7.66,,
COCCCNC(=O)c1nc(-c2ccc(S(=O)(=O)N3CC[N+](C)CC3)cc2)cnc1N,7.66,,
COCCOC1COCCOCC1OCCOC,7.66,,
CCC([NH2+]C(C)CC(=O)NCC[NH3+])c1ccc(Cl)c(Oc2ccccc2)c1F,7.66,,
CNc1nc(C)c(-c2nc(Nc3ccc(C)c(S(=O)(=O)N4CCOCC4)c3)ncc2C#N)s1,7.66,,CHEMBL2312189
CC(=O)N1c2ccc(-c3ccc(C(=O)[O-])cc3)cc2C(Nc2ccc(Cl)cc2)CC1C,7.66,,
CN(C)C(=O)c1ccc(Nc2cc3c(cn2)cc(-c2cnco2)n3C(=O)OC(C)(C)C)c(Cl)c1,7.66,,CHEMBL3109940
Cc1ccc(Cl)cc1-c1c(C(N)=O)cc(-c2ccnc(Nc3ccc(N4CC[NH+](C)CC4)cc3)n2)n1C,7.66,,
CC(C)[NH+]1CCCC1C(=O)N1CCC(n2cnc3cnc4[nH]ccc4c32)CC1,7.66,,
NC(=O)Cn1cnc2c(Br)c(Br)c(Br)c(Br)c21,7.66,,CHEMBL594576
O=C(NCC(COC(=O)c1cc(O)c(O)c(O)c1)OC(=O)c1cc(O)c(O)c(O)c1)Oc1cccc(C(F)(F)F)c1,7.66,,
O=C(NCC(COC(=O)c1cc(O)c(O)c(O)c1)OC(=O)c1cc(O)c(O)c(O)c1)Oc1cccc(C(F)(F)F)c1,7.66,,
CC1(C)CNC(=[N+]2CCN(c3ncnc4sc(CC(F)(F)F)cc34)CC2)S1,7.66,,
CC(C)CC(NC(=O)C(C)NC(=O)C(Cc1ccc(Cl)c(Cl)c1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)C(C)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)[O-])NC(=O)CCCCCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)[O-])c1)C(C)O)C(N)=O,7.66,,
[NH3+]C(Cc1c[nH]cn1)C(=O)[O-],7.66,,
[NH3+]C(Cc1c[nH]cn1)C(=O)[O-],7.66,,
O=C(Nc1cccc(S(=O)(=O)N2CCN(c3ccccn3)CC2)c1)Nc1nccs1,7.66,,
Cc1cc(Nc2cc(NC(=O)c3c(Cl)cccc3Cl)ccn2)nc(NC(C)CO)n1,7.66,,
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(CO)Cc1ccccc1)C(C)C,7.66,,
CC1CCC(O)C1NC(=O)C(Cc1ccccc1)CC(O)C[NH+]1CCN(C(=O)C=Cc2cccnc2)CC1C(=O)NC(C)(C)C,7.67,,
CSCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C([NH3+])C(C)C)C(C)O)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CCCC[NH3+])C(=O)[O-],7.67,,
CC(C)CC(NC(=O)CNC(=O)C(C)NC(=O)C(C)NC(=O)CNC(=O)CNC(=O)C(CCC(N)=O)NC(=O)C(C)NC(=O)C([NH3+])C(C)C)C(=O)NC(C)C=O,7.679999999999999,,
CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,7.679999999999999,,
CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2=O,7.679999999999999,,
C[N+](C)(C)CCCCCCCCCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21,7.679999999999999,,
CCc1c2[nH]c(c1C)Cc1[nH]c(c(CCC(=O)[O-])c1C)Cc1[nH]c(c(C)c1CCC(=O)[O-])Cc1[nH]c(c(C)c1CC)C2,7.679999999999999,,
NC(=[NH2+])c1cc2cc(-c3cccc(OC4CCCC4)c3O)[nH]c2cc1Cl,7.679999999999999,,
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,7.679999999999999,"This molecule is a nonsteroidal antiinflammatory drug (NSAID) with selectively for inhibition of cycloxgenase-2 (Cox-2), which is widely used in the therapy of arthritis. This molecule has been linked to rare instances of idiosyncratic drug induced liver disease. This molecule is a member of the class of pyrazoles that is 1H-pyrazole which is substituted at positions 1, 3 and 5 by 4-sulfamoylphenyl, trifluoromethyl and p-tolyl groups, respectively. A cyclooxygenase-2 inhibitor, it is used in the treatment of arthritis. It has a role as a cyclooxygenase 2 inhibitor, a geroprotector, a non-steroidal anti-inflammatory drug and a non-narcotic analgesic. It is a member of toluenes, a sulfonamide, a member of pyrazoles and an organofluorine compound. This molecule is a nonsteroidal anti-inflammatory drug (NSAID) which is known for its decreased risk of causing gastrointestinal bleeding compared to other NSAIDS. It is used to manage symptoms of various types of arthritis pain and in familial adenomatous polyposis (FAP) to reduce precancerous polyps in the colon. It is marketed by Pfizer under the brand name Celebrex, and was initially granted FDA approval in 1998.   Interestingly, selective COX-2 inhibitors (especially celecoxib), have been evaluated as potential cancer chemopreventive and therapeutic drugs in clinical trials for a variety of malignancies. This molecule is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of celecoxib is as a Cyclooxygenase Inhibitor. This molecule is a nonsteroidal anti-inflammatory drug (NSAID) with a diaryl-substituted pyrazole structure. This molecule selectively inhibits cyclo-oxygenase-2 activity (COX-2); COX-2 inhibition may result in apoptosis and a reduction in tumor angiogenesis and metastasis. This molecule is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer under the brand name Celebrex. In some countries, it is branded Celebra. This molecule is available by prescription in capsule form.",CHEMBL118
C=CCN(C(=O)c1cc(Cl)cc(OCCCONC(N)=[NH2+])c1)C1CCCC1,7.679999999999999,,
CCCCS(=O)(=O)NC(CO)C(=O)NC(C)C(=O)NCc1ccc(C(N)=[NH2+])cc1,7.679999999999999,,
CCOC(=O)c1c(C)nn(-c2cccc([N+](=O)[O-])c2)c1C,7.679999999999999,,CHEMBL1230564
Cc1cc(C)[n+](CCc2ccc(S(N)(=O)=O)cc2)c(C)c1,7.679999999999999,,CHEMBL1184499
C[NH+]1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,7.679999999999999,,
COC(=O)c1c(O)cccc1OCCCCCNC(=O)C(Cc1ccc(C2CC(=O)NS2(=O)=O)c(Cl)c1)NS(=O)(=O)c1ccccc1,7.679999999999999,,
[NH3+]C1CC([NH+]2CCn3c(nnc3C(F)(F)F)C2)CCC1c1cc(F)c(F)cc1F,7.679999999999999,,
CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(C[NH+]2CCOCC2)cc1,7.679999999999999,,
CCNC(=O)c1noc(-c2cc(Cl)c(O)cc2O)c1-c1ccc(C[NH+]2CCOCC2)cc1,7.679999999999999,,
c1ccc(-c2ncc(-c3ccn[nH]3)s2)cc1,7.679999999999999,,
CC(C)n1nc(C#Cc2cccc(O)c2)c2c(N)ncnc21,7.679999999999999,,CHEMBL1213120
[NH3+]C(CS)C(=O)[O-],7.679999999999999,,
COC(=O)c1ccc2c(c1)NC(=O)C2=C(Nc1ccc(N(C)C(=O)C[NH+]2CC[NH+](C)CC2)cc1)c1ccccc1,7.679999999999999,,
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,7.679999999999999,,
CCOc1ccc(-c2nc3cc(-c4nc5ccc(N6CC[NH+](C)CC6)cc5[nH]4)ccc3[nH]2)cc1,7.679999999999999,,
Cc1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1O,7.679999999999999,,
CC[NH+](CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C,7.679999999999999,,
CC(C)C1CCC(O)C(O)C(O)C1,7.679999999999999,,
CNC(=O)c1nc(-c2cccc(-c3nnn[nH]3)c2)cnc1N,7.679999999999999,,CHEMBL2152125
CC(=O)NC1C(NC(N)=[NH2+])CC(C(=O)[O-])OC1C(O)C(O)CO,7.679999999999999,,
COc1ccc(NC(=O)C(C)Nc2nc3c(cnn3-c3ccccc3C)c(=O)[nH]2)cc1,7.679999999999999,,
Cc1cc(=O)[nH]c2cc(-c3ccc(C(=O)[O-])cc3Cl)ccc12,7.679999999999999,,
CC(C(=O)NCc1ccc(C(N)=[NH2+])nc1)N(C)C(=O)C(CC1CCCCC1)[NH2+]CC(=O)[O-],7.69,,
[NH2+]=C1NC2(c3cc(NC(=O)c4ccc(F)cn4)ccc3F)COCC2CS1,7.69,,
CC(C)C(NC(=O)c1ccc(C(=O)N2CCOCC2)cc1)C(=O)N1CCCC1C(=O)NC(C(C)C)C(O)C(F)(F)C(F)(F)F,7.7,,
CCCCC(NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)C)C(N)=O,7.7,,
CC(C)CC(NC(=O)CNC(=O)C(CCC(N)=O)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)CNC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)C)C(=O)[O-],7.7,,
CC(=O)NC(CC1CCCCC1)C(O)CC(C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)C(C)C,7.7,,
CC(O)C(C=O)C1N=C(C(=O)[O-])C(SC2C[NH2+]C(C(=O)N(C)C)C2)C1C,7.7,,
CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(=O)[O-])NC(=O)C1CCCN1C(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C([NH3+])Cc1ccc(O)cc1)C(C)C)C(=O)NC(CO)C(N)=O,7.7,,
OC1C[NH+]2CCCC(O)C2C1O,7.7,,
CC(C)(ON=C(C(=O)NCB(O)O)c1csc(N)n1)C(=O)[O-],7.7,,
CC(C)(C)OC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)C(=O)NC(CCC(N)=O)C(=O)NC(Cc1ccccc1)C(N)=O,7.7,,
CSCCC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCC(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(CCCC[NH3+])NC(=O)C(C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C([NH3+])CCCC[NH3+])C(C)O)C(=O)NC(CC(=O)[O-])C(=O)NC(CO)C(N)=O,7.7,,
Cc1onc(C(=O)[O-])c1CC([NH3+])C(=O)[O-],7.7,,
O=C1N(Cc2ccc(CO)cc2)C(Cc2ccccc2)C(O)C(O)C(Cc2ccccc2)N1Cc1ccc(CO)cc1,7.7,,
[NH3+]C(Cn1oc(=O)[nH]c1=O)C(=O)[O-],7.7,,
[NH3+]C(Cn1oc(=O)[nH]c1=O)C(=O)[O-],7.7,,
O=C([O-])C(CO)Nc1ccc([N+](=O)[O-])cc1[N+](=O)[O-],7.7,,
CC(=O)NC(Cc1ccccc1)C(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(C)C(=O)N(C)C(C)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)[O-])C(C)C,7.7,,
CCCCCC(CC(=O)NO)C(=O)NC(C(=O)N1CCCC1C(=O)[O-])C(C)C,7.7,,
CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21,7.7,"This molecule is a member of the class of pyrazolopyrimidine that is pyrazolo[3,4-d]pyrimidin-4-amine bearing additional tert-butyl and 4-chlorophenyl substituents at positions 1 and 3 respectively. It is a potent ATP-competitive inhibitor of the Src family of protein tyrosine kinases. It has a role as an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, a beta-adrenergic antagonist and a geroprotector. It is a pyrazolopyrimidine, an aromatic amine and a member of monochlorobenzenes.",CHEMBL406845
Nc1nc2ccccc2c(=O)[nH]1,7.7,"This molecule is a member of the class of quinazolines that is 1,2,3,4-tetrahydroquinazoline in which the hydrogens at positions 2 and 4 have been replaced by imino and oxo groups, respectively.",CHEMBL6993
COc1ccc(-c2c(S(C)(=O)=O)ccc(C(=O)C3C=NN(C(C)(C)C)C3=O)c2C)cc1,7.7,,
NC1=CCCN1Cc1[nH]c(=O)[nH]c(=O)c1Cl,7.7,,
NC(=[NH2+])c1ccc(CNC(=O)C(CO)NC(=O)C(CO)NS(=O)(=O)Cc2ccccc2)cc1,7.7,,
O=C1C(c2ccc(O)cc2)=C(Br)c2ccc(O)cc21,7.7,,CHEMBL190467
CC(C)(C)c1cc(O)c(C(C)(C)C)cc1O,7.7,"This molecule is a member of the class of hydroquinones that is benzene-1,4-diol substituted by tert-butyl groups at position 2 and 5.",CHEMBL480626
CCc1nn(-c2c(Cl)cc(Cl)cc2Cl)c2nc(Cc3ccc(O)c(O)c3)[nH]c(=O)c12,7.7,,CHEMBL425181
CC(C)c1cnc(Nc2ccc(S(N)(=O)=O)cc2)s1,7.7,,
CC(C)CNC(=O)c1ccc(Oc2nc(Oc3cccc(C(N)=[NH2+])c3)c(F)c(N(C(C)C)C(C)C)c2F)c(C(=O)[O-])c1,7.7,,
NC(=[NH2+])NCc1ccccc1CCCCCCCCCC(=O)NC(CCCC[NH3+])C(=O)NO,7.7,,
CC1CCC([NH2+]Cc2ccc3c(c2)Cc2c-3n[nH]c2-c2ccc(C(=O)[O-])cc2)CC1,7.7,,
CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(=O)[O-])NC(=O)CNC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CCC(N)=O)NC(=O)C(C)NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)C(C)[NH3+])C(C)O)C(=O)[O-],7.7,,
CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(C)C)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(NC(=O)C(CC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CC(N)=O)C(C)CC)C(C)O)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],7.7,,
CCc1nc(N)nc(N)c1-c1ccc2c(c1)N(CCNC(C)=O)C(=O)C(C)(C)O2,7.7,,CHEMBL240355
CN1C(=O)N(c2cc(Cl)cc(Cl)c2)C(=O)C12C[NH+](Cc1cc(C(=O)[O-])cs1)CC2c1ccc(C#N)cc1,7.7,,
O=C(Cc1ccc(O)cc1)Nc1ncc(-c2ccc(O)cc2)nc1Cc1ccccc1,7.7,,
COc1ccccc1-c1c[nH]c2ncc(-c3cncc(C(=O)N(C)C)c3)cc12,7.7,,CHEMBL1235103
Clc1ccc(C2(c3ccc(-c4ncnc5nc[nH]c45)cc3)CC[NH2+]CC2)cc1,7.7,,
O=C(NO)C(Cc1ccc2ccccc2c1)NS(=O)(=O)c1ccc2ccccc2c1,7.7,,
O=C1c2cccc3c(NCCO)ccc(c23)C(=O)N1c1cccc(Br)c1,7.7,,CHEMBL559638
O=c1[nH]nc2cc(CO)c3ccc(-c4ccc[nH]4)cc3n12,7.7,,CHEMBL2012881
O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,7.7,"This molecule appears as cream-colored needles (from pyridine) or yellow powder. Odorless. (NTP, 1992) This molecule is an organic heterotetracyclic compound resulting from the formal dimerisation of gallic acid by oxidative aromatic coupling with intramolecular lactonisation of both carboxylic acid groups of the resulting biaryl. It is found in many fruits and vegetables, including raspberries, strawberries, cranberries, and pomegranates. It has a role as an antioxidant, a food additive, a plant metabolite, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, an EC 1.14.18.1 (tyrosinase) inhibitor, an EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor, an EC 2.4.1.1 (glycogen phosphorylase) inhibitor, an EC 2.5.1.18 (glutathione transferase) inhibitor, an EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor, an EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor, an EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor, a skin lightening agent, a fungal metabolite, an EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor and a geroprotector. It is an organic heterotetracyclic compound, a cyclic ketone, a lactone, a member of catechols and a polyphenol. It is functionally related to a gallic acid. This molecule is present in several fruits such as cranberries, strawberries, raspberries, and pomegranates. In pomegranates, there are several therapeutic compounds but ellagic acid is the most active and abundant. This molecule is also present in vegetables. This molecule is an investigational drug studied for treatment of Follicular Lymphoma (phase 2 trial), protection from brain injury of intrauterine growth restricted babies (phase 1 and 2 trial), improvement of cardiovascular function in adolescents who are obese (phase 2 trial), and topical treatment of solar lentigines. This molecule's therapeutic action mostly involves antioxidant and anti-proliferative effects. This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Lophostemon confertus, Geranium carolinianum, and other organisms with data available.",CHEMBL6246
Cc1cccc(C)c1Nc1ncc(-c2ccccc2)[n+]2c[nH]cc12,7.7,,
CC(C)(C)CN(C(=O)CCC(=O)N1CCCC(C(=O)[O-])C1)c1ccc(Cl)cc1C(O)c1ccccc1Cl,7.7,,
[NH3+]C(CCC(=O)Nc1ccc(OCc2ccccc2)cc1)C(=O)[O-],7.7,,
CSCC1OC(n2cnc3c2N=CNCC3O)C(O)C1O,7.7,,
CC(C)(C)c1nc2c3c(c4cc(F)ccc4c2[nH]1)C(=O)N=CC3,7.7,,
CC(C)CC([NH3+])C(=O)[O-],7.7,,
CCOC(Cc1ccc(OCc2csc(-c3ccc(Cl)cc3)n2)cc1C)C(=O)[O-],7.7,,
Cc1[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c(C)c1C(N)=O,7.7,,
CC(C=CC1C(C)CCCC1(C)C)CC=CC(C)CCO,7.7,,
Oc1cc(Cl)c(Cl)cc1O,7.7,,CHEMBL1230231
CN1C(=[NH2+])NC(c2ccc(OC(F)(F)F)cc2)(c2ccc(F)c(-c3cncnc3)c2)C1=O,7.7,,
O=C([O-])c1cccc(-c2cnc(C(O)CCCCCCc3ccccc3)o2)n1,7.7,,
CN1C(=[NH2+])NC(c2ccncc2)(c2cccc(-c3cc(F)ccc3F)c2)C1=O,7.7,,
O=C(NC1CCC(c2cccc(F)c2F)CN(CC(F)(F)F)C1=O)N1CCC(n2c(=O)[nH]c3ncccc32)CC1,7.7,,
[NH3+]CCCCC(NC(=O)C(Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(N2Cc3ccccc3NC2=O)CC1)C(=O)N1CCN(c2ccncc2)CC1,7.7,,
Cc1cc(C(=O)[O-])ccc1NC(=O)C(C1CCCCC1)n1c(-c2ccc(Cl)cc2)nc2cc(F)c(F)cc21,7.7,,
O=C([O-])C=Cc1ccc(NC(=O)C2(NC(=O)c3ccc4c(C5CCCCC5)c5n(c4c3)CC(=O)Nc3ccccc3-5)CCCC2)cc1,7.7,,
Nc1nc(-c2ccc3c(N)[nH]nc3c2)cc(N2CCOC(C(=O)Nc3ccccc3)C2)n1,7.7,,
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1cccnc1,7.7,,CHEMBL2377864
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1ccccc1[N+](=O)[O-],7.7,,CHEMBL2377825
CC1Cc2cc(F)ccc2S(=O)(=O)N(CC(O)C(Cc2ccccc2)NC(=O)OC(C)(C)C)C1,7.7,,
CC(NC(=O)c1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]C2CC2)cc(N(C)S(C)(=O)=O)c1)c1ccccc1,7.7,,
CC(C)(C)c1nc(-c2cnc3ccccc3c2)c(-c2ccncc2)[nH]1,7.7,,CHEMBL2030517
C[NH+](C)CCNS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3cccnc3)n2)cc1,7.7,,
c1ccc(-c2nc(-n3cnnc3)c3ccccc3n2)cc1,7.7,,CHEMBL3988703
Oc1ccccc1-c1nc(Nc2ccccc2Cl)c2ccccc2n1,7.7,,CHEMBL3989129
C[NH+]1CCN(c2ccc(N=C3CC(=O)N(c4ccc(Cl)cc4)N=C3c3nnc[nH]3)cc2)CC1,7.7,,
Nc1nonc1-c1nc2ccccc2n1CC1CC1,7.7,,CHEMBL1078930
O=C(NO)C1C(c2ccccc2)C1c1ccc(-c2cnco2)cc1,7.7,,
COC(=O)NC(C(=O)N[NH+](CCCC1(O)Cc2ccc(cc2)CC=CCNC(=O)C(C(C)C)NC1=O)Cc1ccc(-c2cccnc2)cc1)C(C)(C)C,7.7,,
Cc1ccc(Cl)cc1-c1[nH]c(-c2ccnc(N)n2)cc1C(N)=O,7.7,,CHEMBL3330104
Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)NC4C5CC6CC4CC(O)(C6)C5)n3)c2)cn1,7.7,,CHEMBL4103500
CN(c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1)S(=O)(=O)c1ccccc1,7.7,,CHEMBL203682
NC(=[NH2+])c1cccc(CC(NS(=O)(=O)c2cccc(-c3ccc(Cl)cc3Cl)c2)C(=O)N2CCC(CC[NH3+])CC2)c1,7.7,,
COc1ccc(-c2nsc(C)c2C(=O)NC(=[NH2+])NCc2cc(C)c(NC(C)=O)c(Cl)c2)cc1,7.7,,
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1ccccc1[N+](=O)[O-],7.7,,CHEMBL2377825
NC(=O)CCC(NC(=O)CNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CO)NC(=O)CNC(=O)CNC(=O)C(Cc1c[nH]cn1)NC(=O)C1CCC[NH2+]1)C(=O)N1CCCC1C(=O)[O-],7.7,,
N#CC(c1ccc(F)cc1)c1cccc(C(F)(F)F)n1,7.7,,
OCC1CC(O)CC[NH+]1CCc1ccc(Nc2nc(-c3ccc(Cl)c(Cl)c3)cs2)cc1,7.7,,
[NH3+]CC1(c2cccc(Cl)c2)CCC(N2CCCCC2=O)CC1,7.7,,
CCC[NH+](Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccc(S(=O)(=O)CC)cc2)cc1,7.7,,
COc1ccc2c(c1)C1CC1(C(=O)N1C3CCC1C[NH+](C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21,7.7,,
COc1cc(Nc2nc3cccc(-c4c(F)cccc4OC)c3o2)cc(OC)c1OC,7.7,,CHEMBL3297945
Cc1cn(-c2cc3c(c(CC(C)C)c2)C(=O)NCC3)c2c1C(=O)CC(C)(C)C2,7.7,,CHEMBL3235352
O=C(Nc1nc2cc3c(cc2[nH]1)OC(F)(F)O3)c1csc(NC(=O)c2ccccc2OC(F)(F)F)n1,7.7,,CHEMBL3337845
O=C([O-])C(S)=Cc1c(Cl)ccc(Cl)c1Cl,7.7,,
COc1ccc(S(=O)(=O)NCC(=O)NO)cc1,7.71,,CHEMBL83508
CCn1c(-c2nonc2N)nc2cnc(Br)cc21,7.71,,
CC(=O)NC1C(O)CC(O)(C(=O)[O-])OC1C(O)C(O)CO,7.71,,
O=S1(=O)N(Cc2ccccc2)C(COc2ccccc2)C(O)C(O)C(COc2ccccc2)N1Cc1ccccc1,7.72,,
Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CC[NH2+]CC2)n1,7.72,,
O=C([O-])C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(N2CCC(c3ccccc3)CC2)cc1,7.72,,
NS(=O)(=O)c1ccc(C(=O)NCCOCCOCCNC(=O)C[NH3+])cc1,7.72,,
COc1cc(C(F)(F)C(=O)N2CCCCC2C(=O)OC(CCCc2ccccc2)CCCc2cccnc2)cc(OC)c1OC,7.72,,
OCC1C[NH2+]CC(O)C1O,7.72,,
CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,7.72,This molecule is a 21-hydroxy steroid.,CHEMBL1393513
Oc1ccc2c(c1)CCN(c1ccccc1)C2c1ccc(OCC[NH+]2CCCCC2)cc1,7.72,,
CC(C)CC(NC(=O)OCc1ccccc1)C(=O)NC1CCN(C=N)C1,7.72,,
Cc1cc(N=Nc2cc(S(=O)(=O)[O-])c(C)cc2C)c(N)cc1O,7.72,,
CCNc1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]Cc2cccc(OC)c2)cc2c1CCCS(=O)(=O)N2C,7.72,,
CCCCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,7.72,,
O=C(Nc1ccccc1)Nc1ccccc1,7.72,"This molecule is an off-white powder. (NTP, 1992) This molecule is a member of the class of phenylureas that is urea in which one of the hydrogens of each amino group is replaced by a phenyl group. It is present in coconut milk (Cocos nucifera). It has a role as a plant metabolite and a cytokinin.",CHEMBL354676
CS(=O)(=O)c1ccc(-c2noc(C(CC3CC3)C([NH3+])C(=O)N3CCC(F)C3)n2)c(F)c1,7.72,,
CC(COC(=O)Cc1ccc(O)c(O)c1)(C(Nc1c(C=O)cc2ccccn12)C(=O)[O-])[SH+](=O)[O-].CC=CC1CCCCC1.OCC1OC(OC2C(CO)OC(OCCCCCCC3CCCCC3)C(O)C2O)C(O)C(O)C1O,7.72,,
COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(CC(O)CO)CC1,7.72,,CHEMBL3349342
Cc1c(O)cccc1C(=O)NC(CSc1ccccc1)C(O)C[NH+]1CC2CCCCC2CC1C(=O)NC(C)(C)C,7.72,,
COC(Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)c2ccsc12)C(=O)[O-],7.72,,
CSCC(NC(=O)Cc1ccc(-c2ccccc2)cc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccccc1)C(=O)NCCc1ccccc1,7.72,,
CC12CC34C=CC(=O)C(C)(CCC(=O)Nc5c(O)ccc(C(=O)[O-])c5O)C3C(CC1C4)O2,7.72,,
CCNC(=O)c1n[nH]c(-c2cc(Cl)c(O)cc2O)c1-c1ccc(OC)cc1,7.72,"This molecule is an aromatic amide obtained by formal condensation of the carboxy group of 5-(5-chloro-2,4-dihydroxyphenyl)-4-(4-methoxyphenyl)pyrazole-3-carboxylic acid with the amino group of ethylamine. It has a role as a Hsp90 inhibitor. It is a member of pyrazoles, a member of resorcinols, a member of monochlorobenzenes, a monomethoxybenzene and an aromatic amide.",CHEMBL365617
C=C(CCC12OC(C(=O)[O-])C(O)(C(=O)[O-])C(C(=O)[O-])(O1)C(OC(=O)C=CC(C)CC(C)CC)C2O)C(OC(C)=O)C(C)Cc1ccccc1,7.72,,
O=C(Nc1cccc(Oc2ccc(Nc3ncnc4ccn(CCOCCO)c34)cc2Cl)c1)NC1CCCCC1,7.72,,CHEMBL2322330
COc1cc(CCc2ccccc2)c(C(=O)[O-])c(O)c1CC=C(C)CCC=C(C)C,7.72,,
CC1CC2OC2C=CC=CC(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1,7.72,This molecule is a macrocyclic antifungal antibiotic that inhibits signal-dependent transcriptional activation and induces differentiation in leukemia. (NCI),CHEMBL3972342
CCCCCCCC=CC=CC(=O)NC(C(=O)NC1CC(O)CCNC(=O)CCC(C)NC1=O)C(C)O,7.72,,
CC(NC(=O)C[NH+]1CCc2cccc3c2C1C[NH2+]C3O)C(=O)N1CCC(c2ccc(F)cc2)CC1,7.72,,
CC(NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O,7.72,,
O=C(NCCCNc1nc(Nc2cccc(C[NH+]3CCOCC3)c2)ncc1C1CC1)C1CCC1,7.72,,
N#Cc1ccc(C(=O)Nc2ccc(F)c(C3(CF)CC(C(F)(F)F)OC(=[NH2+])N3)c2)nc1,7.72,,
COc1cc(Cl)cc(C[NH2+]CCCNC(=O)Nc2ccsc2)c1,7.72,,
CC(C)(C)c1ccc(S(=O)(=O)NCc2ccc(C(=O)Nc3cccnc3)cc2)cc1,7.72,,CHEMBL3105156
CC[NH+](CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,7.73,,
NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)CCc1ccc(-c2ccccc2)cc1,7.73,,
COc1ccc(S(=O)(=O)N2CC(C)(C)CN(S(=O)(=O)c3ccc(OC)cc3)C2C(=O)NO)cc1,7.74,,CHEMBL115727
COc1ccc(S(=O)(=O)N2CCN(C(=O)OCc3ccccc3)CC2C(=O)NO)cc1,7.74,,CHEMBL332134
CNS(=O)(=O)Nc1ccc(-c2ccccc2)n(CC(=O)NC(C(C)C)C(O)C(F)(F)F)c1=O,7.74,,
O=C1C(NS(=O)(=O)c2cc3ncccc3s2)CCN1Cc1cc2ccncc2[nH]1,7.74,,
C[NH+](CC=CCOc1ccc(C(=O)c2ccc(Br)cc2)cc1)C1CC1,7.74,,
COC(=O)C(NC(=O)C(NC(=O)CCC(O)C(Cc1ccccc1)NC(=O)C(C)NC(=O)C(C)[NH3+])C(C)C)C(C)C,7.74,,
[NH3+]CCCCC([NH2+]C(CCc1ccccc1)C(=O)[O-])C(=O)N1CC=CC1C(=O)[O-],7.74,,
Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(CC(C)C)NC(=O)c1cccc(N)c1,7.74,,
NC(=[NH2+])c1cccc(CN2CCN(S(=O)(=O)c3cc4ccc(Cl)cc4s3)CC2=O)c1,7.74,,
CC(=N)N1CCC(Oc2ccc3nc(C)n(Cc4ccc5ccc(C(N)=[NH2+])cc5c4)c3c2)CC1,7.74,,
CCCCOc1ccc(C(C)[NH2+]CCC[NH2+]CCC(c2ccccc2)c2ccccc2)cc1OCCCC,7.74,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(OS(=O)(=O)O)cc1)C(=O)NC(CC(C)C)C(=O)[O-],7.74,,
CCOc1ccccc1Sc1ccc(-c2ccnc(N3CCN(C(C)=O)CC3)c2)cc1[N+](=O)[O-],7.74,,CHEMBL1233907
CC(C)C(NC(=O)C(Cc1ccccc1)CC(O)C(Cc1ccccc1)NC(=O)OC(C)(C)C)c1ncc[nH]1,7.74,,
CC(C)CC(NC(=O)C(O)C([NH3+])Cc1ccccc1)C(=O)[O-],7.74,,
CNC(=O)C(Cc1c(F)c(F)c(F)c(F)c1F)NC(=O)Nc1nnc(S)s1,7.74,,
O=C(c1ncc(-c2ccncc2)cn1)N1CCN(S(=O)(=O)c2cc3cc(Cl)ccc3[nH]2)CC1,7.74,,
[NH3+]C(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,7.74,,
Cc1cccc(-c2c[nH]nn2)c1,7.74,,CHEMBL194853
COc1ccc(C(=O)NCC2CCN(c3ccncc3)CC2)cc1OCCc1ccc(Cl)cc1Cl,7.74,,CHEMBL96434
COc1ccc2c(nc(NC(=O)c3cccnc3)n3ccnc23)c1OC,7.74,,
O=NC(=O)CN(CCO)S(=O)(=O)c1ccc(-c2ccccc2)cc1,7.74,,
[NH3+]C(COc1cncc(-c2ccc3n[nH]cc3c2)c1)Cc1c[nH]c2ccccc12,7.74,,
Clc1ccc(C2(c3ccc(-c4cn[nH]c4)cc3)CC[NH2+]CC2)cc1,7.74,,
COc1cccc(OC)c1-c1cc2cnc(N)nc2nc1N,7.74,,CHEMBL1234133
CC(NC(=O)C(CC(=O)NO)Cc1ccccc1)C(=O)O,7.74,,CHEMBL16046
CC(C)(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21,7.74,,CHEMBL1231371
CC(=O)c1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n1C,7.74,,CHEMBL1169814
NS(=O)(=O)c1ccc(CCNC(=O)Cc2ccc(O)c(Cl)c2)cc1,7.74,,CHEMBL606453
Cc1ccc(-c2c(C[NH3+])c(CC(C)C)nc(C)c2C(=O)[O-])cc1,7.74,,
CCCCN(C)C(=O)n1cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C[NH2+]Cc2cccc(OC)c2)c2cc(C#N)ccc21,7.74,,
CC(C)(C)c1cc(C(=O)N2CCNC(=O)CC2)c(NC(=O)Nc2cccc3ccccc23)s1,7.74,,CHEMBL1929215
COc1ccc(NC(=O)c2cccc3c(N)nc(C)nc23)cn1,7.74,,
Cc1c(C2CCCN(c3nccc(-c4cc5ccccc5s4)n3)C2)c2cccnc2n1CC#N,7.74,,CHEMBL1761455
NC(=O)C(CCC(=O)[O-])NC(=O)CCc1ccc(-c2ccc(-c3ccccc3)cc2)cc1,7.74,,
COc1cc(OC)c(S(=O)(=O)N(c2ccccc2)c2ccc(N)cc2)cc1NC(=O)CCC(=O)[O-],7.74,,
CN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(N4CCC(O)CC4)cc3)ncc21,7.74,This molecule is a member of piperidines.,CHEMBL4649424
CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N,7.74,,CHEMBL2152252
CC(C)c1ccc(-c2nccnc2N2CCN(S(=O)(=O)c3cccc(-c4cnc(N)nc4)c3)CC2)cc1,7.74,,CHEMBL2152126
OCC#Cc1ccc(OC2OC(CO)C(O)C(O)C2O)cc1,7.74,,
OCC#Cc1ccc(OC2OC(CO)C(O)C(O)C2O)cc1,7.74,,
COc1cccc(Cc2nnc(-c3sc4ccccc4c3OC3CC[NH2+]CC3)o2)c1,7.74,,
C=CCNC(=O)C(NC(=O)C(O)(CCC[NH+](Cc1ccc(-c2cccnc2)cc1)NC(=O)C(NC(=O)OC)C(C)(C)C)Cc1ccc(CC=C)cc1)C(C)C,7.74,,
O=C(NS(=O)(=O)c1ccccc1)c1ccc2c(C3CCCCC3)c(-c3ccoc3)n(CC(=O)N3CCOCC3)c2c1,7.74,,
Nc1ncnc2c(C[NH+]3CC(O)C(O)C3CO)c[nH]c12,7.74,,
CCCOc1ccc(C(=O)C[NH+]2CC[NH+](C)CC2)cc1-c1nc(C(C)C)c(Br)c(=O)[nH]1,7.74,,
CCOc1cc(C(C)(C)C)ccc1C1=NC(C)(c2ccc(Cl)cc2)C(C)(c2ccc(Cl)cc2)N1C(=O)N1CC[NH+](CCCS(C)(=O)=O)CC1,7.74,,
Cc1cc(=O)[nH]c2cc(-c3ccc(C(=O)NCC[NH+]4CCOCC4)cc3Cl)ccc12,7.74,,
O=C(CCCCCNC(=O)CCCCC1SCC2NC(=O)NC21)NCCCCCC(=O)C1=C2C3=C4C1[Fe+10]2341567C2=C1C5C6=C27,7.74,,
NC(=O)c1ncc(NC2CCC[NH2+]C2)c2nc(-c3ccc(Cl)cc3)cn12,7.74,,
C[NH2+]C(C)C(=O)NC1C(=O)N(Cc2c(OC)ccc3cc(C(=O)[O-])ccc23)c2ccccc2OC12CCOCC2,7.74,,
C[NH2+]C1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21,7.74,,
Nc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1,7.74,,CHEMBL3781415
CC(=CC=CC(C)=CC(=O)[O-])C=C1CCCc2c(C)cccc21,7.74,,
CC(=O)NC(C(=O)NC(C=O)CC(=O)[O-])C(C)C,7.75,,
C[NH2+]C1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)NC(C)C)n3)c(OC)c2)C1,7.75,,
O=C(NCc1ccc(OC(F)(F)F)c(F)c1)C1CN(c2nc3nc(C4CC4)ncc3s2)CCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1,7.75,,
Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,7.75,"This molecule is an organic heterotricyclic compound that is pyrido[3',2':4,5]furo[3,2-d]pyrimidine substituted at positions 2 and 4 by 3-hydroxyphenyl and morpholin-4-yl groups respectively. A dual-kinase inhibitor with anti-cancer properties. It has a role as an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor, a mTOR inhibitor and an antineoplastic agent. It is a member of morpholines, a member of phenols, an organic heterotricyclic compound, a tertiary amino compound and an aromatic amine. This molecule is an inhibitor of p110α of class I PI3K.",CHEMBL573339
CC(O)C(NC(=O)C(Cc1ccccc1)NC(=O)CCCNC(N)=[NH2+])C(=O)NC(Cc1ccccc1)C(=O)[O-],7.76,,
Cc1cc2nc3c(=O)[nH]c(=O)[nH]c3[n+](C)c2cc1C,7.76,,
CC(NC(=O)C1CCC[NH2+]1)C(=O)NCC(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(C(=O)[O-])C(C)C,7.76,,
Cc1cc(-c2cc(-c3ccccc3)[nH]c(=O)n2)ccc1O,7.76,,CHEMBL501724
CCn1c(-c2nonc2N)nc2cnc(C)cc21,7.76,,
Cc1nc(N)c2ccc(-c3cccc(S(=O)(=O)NC(=O)C([NH3+])C(C)O)c3)cc2n1,7.76,,
O=C([O-])CCCNC(=O)c1ccc(C2CCC(c3ccccc3)CC2O)cc1,7.769999999999999,,
O=C(Nc1ccc(I)cc1)NC1CCCCC1,7.769999999999999,This molecule is a member of the class of phenylureas that is urea in which a hydrogen attached to one nitrogen is replaced by a cyclohexyl group and a hydrogen attached to the other nitrogen is replaced by a p-iodophenyl group. It is an organoiodine compound and a member of phenylureas.,CHEMBL1231797
Cc1onc(O)c1CC([NH3+])C(=O)[O-],7.769999999999999,,
O=C(Cc1cccs1)NC(B(O)O)c1cccc(C(=O)[O-])c1,7.769999999999999,,
CCC(C)C(NS(=O)(=O)Cc1cccc(C(=O)[O-])c1)C(=O)NC(CCC(N)=[NH2+])C(=O)NCc1ccc(C(N)=[NH2+])cc1,7.769999999999999,,
CN(C)c1ccc(O)c(C(=O)c2ccc(C(=O)NC3CCC[NH2+]CC3NC(=O)c3ccncc3)cc2)c1,7.769999999999999,,
Cc1ccc(NS(=O)(=O)c2cccc3ccccc23)c(O)c1CC(=O)NCc1ccc(C(N)=[NH2+])cc1,7.769999999999999,,
CCC(C)C1NC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C([NH3+])CC(N)=O)CSCC(=O)NCCCC(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CC(C)C)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-])NC(=O)C(C(C)O)NC1=O,7.769999999999999,,
O=[N+]([O-])c1ccc2c(c1)C[NH2+]C(CO)C2,7.769999999999999,,
CC(C(=O)N1CCOCC1)N1CCC(NS(=O)(=O)CCc2ccc(Cl)s2)C1=O,7.769999999999999,,
COc1ccc(S(=O)(=O)N(CC(=O)N=O)CC(C)C)cc1,7.769999999999999,,
O=C([O-])CC1CC(c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N(CC2CC2)C1=O,7.769999999999999,,
Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1,7.769999999999999,,CHEMBL245549
CC(=O)c1cc(F)c(Cl)cc1NCC(=O)Nc1ccccc1C(=O)[O-],7.769999999999999,,
Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,7.769999999999999,"This molecule was the first thiazolidinedione approved for use in the United States and was licensed for use in type 2 diabetes in 1997, but withdrawn 3 years later because of the frequency of liver injury including acute liver failure associated with its use. This molecule is a member of chromanes and a thiazolidinone. It has a role as a hypoglycemic agent, an antioxidant, a vasodilator agent, an anticonvulsant, an anticoagulant, a platelet aggregation inhibitor, an antineoplastic agent, an EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor and a ferroptosis inhibitor. This molecule was withdrawn in 2000 due to risk of hepatotoxicity. It was superseded by [pioglitazone] and [rosiglitazone]. This molecule is an orally-active thiazolidinedione with antidiabetic and hepatotoxic properties and potential antineoplastic activity.  This molecule activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis.  This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation. (NCI04) This molecule was withdrawn in 2000 due to risk of hepatotoxicity. It was superseded by pioglitazone and rosiglitazone.",CHEMBL408
Cc1ncc(-c2ccnc(Nc3ccc(N4CCN(C(=O)CO)CC4)cc3)n2)n1C(C)C,7.769999999999999,,CHEMBL477786
[NH3+]C(CCC(=O)Nc1ccc(OCC(O)c2ccccc2)cc1)C(=O)[O-],7.769999999999999,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,7.769999999999999,,
CSCC(NC(=O)NC(CCC(=O)[O-])C(=O)[O-])C(=O)[O-],7.769999999999999,,
O=C([O-])C[NH+](CC(=O)[O-])C(Cc1ccc(NC(S)=NC(CO)(CO)CO)cc1)C[NH+](CC(=O)[O-])C1CCCCC1[NH+](CC(=O)[O-])CC(=O)[O-],7.769999999999999,,
O=C1Cc2cc(Nc3ncc(C(F)(F)F)c(NCc4ccccc4S(=O)(=O)N4CCCC4)n3)ccc2N1,7.769999999999999,,CHEMBL529889
C[NH2+]C(C)Cc1ccc2c(c1)OCO2,7.769999999999999,,
O=C(NC1c2ccccc2CC1O)C(Cc1cccc(O)c1)C([NH2+]CC1CC1)C(=O)NO,7.769999999999999,,
CCN(CC)C(=O)C1CCCN(c2cc(-c3c(N)nn4cccnc34)ncn2)C1,7.769999999999999,,CHEMBL584934
COc1cc2ncc3c(N)nc(-c4cncc(OCC([NH3+])Cc5ccccc5)c4)cc3c2cc1OC,7.769999999999999,,
COCc1cc2cc(c1)C(=O)NC(C(O)C[NH2+]C1(c3cccc(C(C)C)c3)CC1)Cc1cccc(c1)OCCCCN2,7.769999999999999,,
NC=C1NN(c2cccc(C(F)(F)F)c2)C(=O)N(CCC[N+]2CCCCC2)C1=O,7.769999999999999,,
COc1cc2cncnc2cc1OCCc1ccc2ccccc2n1,7.769999999999999,,CHEMBL1738857
CS(=O)(=O)Nc1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cn1,7.769999999999999,,CHEMBL1825096
CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,7.769999999999999,"This molecule is an orally bioavailable, small molecule and dual kinase inhibitor of human epidermal growth factor receptors 1 (EGFR/ErbB1) and 2 (HER2/ErbB2), with potential antineoplastic activity. EGFR/HER2 kinase inhibitor TAK-285 binds to and inhibits EGFR and HER2, which may result in the inhibition of tumor growth and angiogenesis, and tumor regression in EGFR/HER2-expressing tumors. This agent may be active against EGFR/HER2-expressing tumor cells that are resistant to trastuzumab. EGFR and HER2, receptor tyrosine kinases overexpressed in a variety of tumor cell types, play major roles in tumor cell proliferation and tumor vascularization. In addition, TAK-285 appears to pass the blood brain barrier (BBB) and does not appear to be a substrate for efflux pumps.",CHEMBL1614725
Nc1cc(Cn2c(C(=O)[O-])c(-n3c(=O)[nH]c4cscc4c3=O)c3cc(C(F)(F)F)ccc32)ccn1,7.769999999999999,,
NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1,7.769999999999999,,
O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCC(O)CO)cc2C3=O)ccc1F)c1ccccc1,7.769999999999999,,
C[NH2+]C(C)C(=O)NC(C(=O)N1CCCC1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1,7.769999999999999,,
O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccc(Br)cc12,7.769999999999999,,CHEMBL2035603
COC(=O)NC(C(=O)N[NH+](CCCC1(O)Cc2ccc(cc2)CC=CCNC(=O)C(C(C)C)NC1=O)Cc1ccc(C2C=CCS2)cc1)C(C)(C)C,7.769999999999999,,
COC(C)C(=O)NC(Cc1ccc2c(c1)OCO2)C(O)C[NH2+]C1CC2(CCC2)Oc2ncc(CC(C)(C)C)cc21,7.769999999999999,,
Cn1c(=O)c2c(-c3ccccc3Br)c(C[NH3+])c(N)nc2n(C)c1=O,7.769999999999999,,
CCC(CC)OC1CC(C(=O)[O-])CC([NH3+])C1NC(C)=O,7.769999999999999,,
CC(NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O,7.769999999999999,,
CCOc1cc(C(Nc2ccc3cnccc3c2)C(=O)NS(=O)(=O)c2cccc(S(N)(=O)=O)c2)ccc1OC(C)C,7.769999999999999,,CHEMBL2431608
CCc1ccc2c(c1)C([NH2+]CC(O)C1Cc3cccc(c3)CCCCCCC(=O)N1)CC1(CCC1)O2,7.769999999999999,,
CCCC=CCCOC1OC(CO)C(O)C(O)C1O,7.769999999999999,,
CCCCNc1ncc(-c2ccccn2)c(NC2CCC(O)CC2)n1,7.769999999999999,,
O=c1c2ccccc2oc2c(Cc3ccc(O)cc3)[nH]c(-c3cccs3)c12,7.769999999999999,,CHEMBL4210889
CCOc1cc(C(Nc2ccc3c(N)nccc3c2)C(=O)NCc2ccccc2S(=O)(=O)C(C)C)ccc1OC(C)C,7.769999999999999,,CHEMBL3114841
Nc1ncnc2ccc(-c3ccnc(F)c3)nc12,7.769999999999999,,CHEMBL3262590
CC#CC1CN(S(=O)(=O)c2ccc(N)nc2)CCN1c1ccc(S(=N)(=O)C(F)(F)F)cc1,7.769999999999999,,
COC1CCN(c2nccc(Nc3cc4c(ccn4C4CCCC4)cn3)n2)CC1,7.769999999999999,,CHEMBL3354189
COc1ccc(OCCN2CC(C(O)CO)C3CCCC(C2=O)N3S(=O)(=O)c2cc(Cl)cc(Cl)c2)cc1OC,7.769999999999999,,
CC(C)CC1NC(=O)CC(O)C(CC(C)C)NC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)C2CCC[NH2+]2)CSSCCNC(=O)CNC1=O,7.769999999999999,,
CC(C)CC(=O)NC(C(=O)NC(C(=O)NC(CC(C)C)C(O)CC(=O)NC(C)C(=O)NC(CC(C)C)C(O)CC(=O)[O-])C(C)C)C(C)C,7.769999999999999,,
CC1CN(C(=O)C(C)(O)C(F)(F)F)C(C)CN1C(=O)c1ccc(C#N)cc1,7.78,,
CC(C)n1c(CCC(O)CC(O)CC(=O)[O-])c(-c2ccc(F)cc2)c2c3ccccc3n(-c3ccccc3)c(=O)c21,7.78,,
CCCc1sc(-c2ccc(OC)c(OCCF)c2)nc1CSc1nc(N)cc(N)n1,7.78,,CHEMBL2426558
Cc1cc(C)nc(SCC(=O)c2ccc(S(N)(=O)=O)c(Cl)c2)n1,7.78,,CHEMBL2443204
NS(=O)(=O)c1ccc(C(=O)CSc2ncccn2)cc1Cl,7.78,,CHEMBL2443188
CC(C)CC(NC(=O)C(NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C)[NH3+])C(C)O)C(C)O)C(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)[O-],7.79,,
CC(C)CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCC[NH3+])NC(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)C(CC1CCCCC1)NC(=O)C(CC(=O)[O-])NC(=O)C(CO)NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CCCC[NH3+])C(=O)[O-],7.79,,
CC1[NH2+]C(C[NH3+])C(O)C(O)C1O,7.79,,
CCCCCC(CCCCC)Sc1[nH]nnc1C(=O)[O-],7.8,,
CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)CC)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,7.8,,
Cc1nc2ccc3ccc(CNc4ccc5c(c4)CN(C(CCC(=O)[O-])C(=O)[O-])C5=O)cc3c2c(=O)[nH]1,7.8,,
CCCCOc1ccc(S(=O)(=O)N2CC(NS(C)(=O)=O)CC2C(=O)NO)cc1,7.8,,
CC(=O)Nc1nc(C)c(-c2ccc(Cl)c(S(=O)(=O)NCCO)c2)s1,7.8,,
CCc1ccc(NS(=O)(=O)c2ccc(F)cc2)c(C(=O)[O-])c1C,7.8,,
NS(=O)(=O)c1ccc(NC(=O)c2ccccc2S)cc1,7.8,,CHEMBL386049
CC(=O)N(C)C1CCC(C(C)C([NH3+])C(=O)N2CCC(F)C2)CC1,7.8,,
C[NH+](C)Cc1nccn1-c1ccc(-c2ccc3c(C(N)=O)nn(-c4ccc5onc(N)c5c4)c3c2F)c(F)c1,7.8,,
COC(=O)NC(C(=O)N[NH+](CCC(O)(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O)Cc1ccc(-c2ccccn2)cc1)C(C)(C)C,7.8,,
CC(NC(=O)CCCCCNC(=O)C1OC(n2cnc3c(N)ncnc32)C(O)C1O)C(=O)NCCCCCC(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(N)=O,7.8,,
CC(=O)Nc1nnc(S(N)(=O)=O)s1,7.8,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
CSCCC1NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CO)NC(=O)C(CC(=O)[O-])NC(=O)C(C)NC(=O)CNC(=O)C([NH3+])CSSCC(C(=O)[O-])NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC1=O,7.8,,
CC(C(=O)N(C)C)N(CC(F)(F)F)c1ccc(C#N)c(C(F)(F)F)c1,7.8,,CHEMBL549725
C[NH+]1CCC(N(Cc2ccccc2C(F)(F)F)c2ccc(C#N)c(Cl)c2)C1,7.8,,
Cc1ccccc1CN(c1ccc(C#N)c(Cl)c1)C1CCN(S(C)(=O)=O)C1,7.8,,
O=c1n(C2CCOCC2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1,7.8,,CHEMBL1644639
C[NH+]1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccc(Cl)cc2)cn3Cc2ccc(S(C)(=O)=O)cc2)CC1,7.8,,
NS(=O)(=O)c1cccc(Nc2ncc3ccc4sc(-c5ccccc5)cc4c3n2)c1,7.8,,
CC(C)CC(NC(=O)C([NH3+])Cc1c[nH]cn1)C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CCC(N)=O)C(=O)NCC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-])C(C)C,7.8,,
NS(=O)(=O)c1ccc(C(=O)NCC(F)(F)F)cc1,7.8,,CHEMBL451234
Cc1ccc(C(=O)NC2CC2)cc1-c1ccn2c(C(C)(C)C)nnc2c1,7.8,,CHEMBL2087500
O=C1NCC(c2c[nH]c3cc(Br)ccc23)=NC1c1c[nH]c2cc(Br)ccc12,7.8,,
O=C([O-])c1ccc(Nc2nccc(Nc3ccccc3F)n2)cc1,7.8,,
NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1,7.8,,CHEMBL179583
Cc1ccc(C(=O)NC2CC2)cc1-n1cnc2ccc(N3CC[NH+](C)CC3)cc2c1=O,7.8,,
O=C(NO)c1c[nH]c(NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)[nH+]c1=O,7.8,,
COc1cc2nccc(Oc3ccc4oc(Nc5ccc(Cl)cc5)nc4c3)c2cc1OC,7.8,,CHEMBL3809422
COc1cc(Nc2nccc(N3CCCC(C(=O)NCc4cccc(OC(F)(F)F)c4)C3)n2)cc(OC)c1OC,7.8,,
NC(=O)c1cc2cc(Br)c(C(F)(F)F)nc2nc1N,7.8,,CHEMBL2163365
FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncccc34)cn2)cc1,7.8,,CHEMBL4224714
NC(=O)c1cc2c(-c3ccc(C(=O)NCc4ccnc(Cl)c4)s3)cccc2s1,7.8,,
COCCNC(=O)c1ccc(-c2ccc3c(C)cc(=O)[nH]c3c2)c(Cl)c1,7.8,,CHEMBL2381639
Cn1ccnc1C[NH+]1CCC2(CCN(c3ccc(-c4ccccc4)cc3)C2=O)CC1,7.8,,
Nc1nccnc1C(=O)Nc1cnccc1N1CCCC([NH3+])C1,7.8,,
O=C([O-])C=Cc1ccc(O)cc1,7.8,,
CN1C(=[NH2+])NC(CCC2CCCCC2)(CC2CCCC(NC(=O)Nc3ccccc3)C2)C1=O,7.8,,
COC1CCN(c2nccc(Nc3cc4c(cn3)cc(-c3cn[nH]c3)n4C(C)C)n2)CC1,7.8,,CHEMBL3354187
Cc1ccc(C(=O)Nc2ccc(C[NH+]3CC[NH+](C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,7.8,,
COc1ccc(OCCN2CC(C(O)CO)C3CCCC(C2=O)N3S(=O)(=O)c2cc(Cl)cc(Cl)c2)cc1OC,7.8,,
Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1,7.809999999999999,,CHEMBL2153434
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C1CC=CN1C(=O)C(C)NC(=O)C1CCC[NH2+]1)C(=O)NCC(=O)[O-],7.809999999999999,,
CCCC(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],7.82,,
CC(C)C(NC(=O)Cn1c(-c2ccc(N)cc2)ncc(NS(C)(=O)=O)c1=O)C(O)C(F)(F)F,7.82,,
CN1C(=O)C(O)c2cc(S(=O)(=O)N3CCCC3COc3ccccc3)ccc21,7.82,,
Oc1ccc(CCNc2nc(SCCCc3ccc(Cl)cc3)nc(N3CC[NH2+]CC3)n2)cc1,7.82,,
C=C(OC1C=CC=C(C(=O)[O-])C1O)C(=O)[O-],7.82,,
Nc1nc(N)c(CCCC(c2ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc2)C(O)(O)C(F)(F)F)c(=O)[nH]1,7.82,,
O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1,7.82,This molecule is an indolocarbazole. This molecule is a specific inhibitor of CHK1.,CHEMBL304428
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,7.82,,
CC(C)(ON=C(C(=O)NCB(O)O)c1csc(N)n1)C(=O)[O-],7.82,,
CC(C)COC(=O)NC(C(=O)NC(CC1CC1)C(=O)NC(CC1CC1)C(O)C(=O)NCC(=O)NC(C(=O)[O-])c1ccccc1)C1CCCCC1,7.82,,
CC(NC(=O)c1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]C2CC2)cc(N(C)S(C)(=O)=O)c1)c1ccccc1,7.82,,
CCCCC(NC(=O)OC1CN(C(=O)Nc2c(C)noc2C)CC1(C)C)C(O)C(=O)NC(C)c1ccccc1,7.82,,
COc1ccc(CN2C(=O)C3C(C2C(C)C)C2CCC[NH+]2C3c2ccc(C(N)=[NH2+])cc2)cc1,7.82,,
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CC[NH2+]CC4)cn3)nc2n(C2CCCC2)c1=O,7.82,,
CC(C)COC(=O)NC(C(=O)NN(CC1CC1)C(=O)NC(CC1CC1)C(O)C(=O)NCC(=O)NC(C(=O)[O-])c1ccccc1)C1CCCCC1,7.82,,
CC(C(=O)N1CCOCC1)N1CCC(NS(=O)(=O)c2cc3ccc(Cl)cc3s2)C1=O,7.82,,
OCC1OC(NC2=NC3C(S2)C(O)C(O)C3(O)CO)C(O)C(O)C1O,7.82,,
CCCC1(CCc2ccccc2)CC(O)=C(C(CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,7.82,,
CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(Cl)cc4Cl)nc23)cc1,7.82,,
N#CC1=C(c2cc(Cl)cc(Cl)c2)C(=O)N2CCCC12Cc1ccc(C#N)cc1,7.82,,
CC(C)(C)OC(=O)NC(C(=O)N1CC2C(C1C(=O)NC(CC1CCC1)C(O)C(N)=O)C2(C)C)C1CCCCC1,7.82,,
Cc1cc(C[N+]2CCN(c3c(Br)cnc4nc(-c5ccc(N6CC[N+](C)CC6)cc5)[nH]c34)CC2)no1,7.82,,
CS(=O)(=O)N1CC(C(=O)Nc2ccc(Cl)cc2)C(C(=O)Nc2ccc(-n3ccccc3=O)cc2F)C1,7.82,,
CC([NH2+]CC(O)C(Cc1ccccc1)NC(=O)c1cccc(N(c2ccccc2)S(C)(=O)=O)c1)C(=O)NC1CCCCC1,7.82,,
COc1cc(O)c(C(=O)N2Cc3ccccc3C2)cc1C(C)C,7.82,,CHEMBL1215468
Cn1c2cc(C(=O)NCC[NH+]3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O,7.82,,
C=Cc1nc2c(N)ncnc2n1C1OC(C[NH+](C)CCCCO[NH3+])C(O)C1O,7.82,,
C[S+](O)c1ccc(-c2nc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1,7.82,,
O=C(NCc1ccc(Cl)cc1Cl)N1CCC(Oc2ncccn2)CC1,7.82,,CHEMBL589136
CS(=O)(=O)N1CC[N+](Cc2cc3nc(-c4cccc(CO)c4)nc(N4CCOCC4)c3s2)CC1,7.82,,
Cc1cc(Nc2nn(C3CCOCC3)c(=O)c3cc(C[N+]4CC[N+](C)CC4)ccc23)n[nH]1,7.82,,
COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(C[NH2+]C(C)C(C)(C)C)cc3)s2)cc1C(=O)N1CCN(C(C)=O)CC1,7.82,,
NS(=O)(=O)c1ccc(NC(=O)Nc2cccc([N+](=O)[O-])c2)cc1,7.82,,CHEMBL1614844
Nc1ncnc2c1c(Cc1cccc3ccccc13)nn2CC1CC[NH2+]CC1,7.82,,
[NH3+]C1CCC(C(=O)Nc2cc3cc[nH]c(=O)c3cc2Cl)CC1,7.82,,
C=CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,7.82,,
CC(C)c1nc(CN(C)C(=O)NC(C(=O)NC(Cc2ccccc2)CC(O)C(Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,7.82,,
CC(NC(=O)c1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]C2CC2)cc(N(C)S(C)(=O)=O)c1)c1ccccc1,7.82,,
O=C([O-])c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1,7.82,,
CS(=O)(=O)NC(=O)c1c(C2C=CC=NC2=O)c2c3occc3ccc2n1Cc1cc(F)ccc1F,7.82,,
CCc1cncnc1N1CC[NH+](Cc2nc3ccc(C(F)(F)F)cc3[nH]2)CC1,7.82,,
Cn1cc(C(N)=O)cc1-c1ccnc(Nc2cc(N3CC[NH+](C)CC3)ccc2OC(F)(F)F)n1,7.82,,
Cc1cc(C[NH+]2CCN(c3c(Br)cnc4[nH]c(-c5cncn5C)nc34)CC2)no1,7.82,,
COc1ccc(-n2c(SCCCN3C(=O)c4cccc5cccc(c45)C3=O)nnc2-c2ccncc2)cc1,7.82,,CHEMBL4303453
COc1cc(-c2cncc(-c3ccc(N4CC[NH2+]CC4)cc3)c2)cc(OC)c1OC,7.82,,
O=C(Nc1ccc(F)cc1)c1cnn2c(O)cc(C3CC[NH2+]CC3)nc12,7.82,,
O=C(Nc1cccnc1)c1ccc2c(c1)ncn2CC1CCN(C(=O)c2ccccc2)CC1,7.82,,CHEMBL3116399
CC(C)CC(NC(=O)OCc1ccccc1)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(O)C(C)CO,7.82,,
O=C(NCc1ccc(S(=O)(=O)c2cccc(C(F)(F)F)c2)cc1)c1cnc2[nH]ncc2c1,7.82,,CHEMBL3260358
CC(=CC=CC(C)=CC(=O)[O-])C=C1CCCc2cc(C)ccc21,7.82,,
Cc1onc(C(=O)[O-])c1CC([NH3+])C(=O)[O-],7.83,,
CN(C)c1ccc(C(=O)NCCCCCCC(=O)N=O)cc1,7.83,,
CC1OC(OC2C(CO)OC(OC3C(CO)=CC([NH2+]C4C(C)OC(OC5C(CO)OC(OC6C(CO)OC(O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,7.83,,
CC(C)n1c(CCC(O)CC(O)CC(=O)[O-])c(-c2ccc(F)cc2)c(-c2ccc(F)cc2)c1C(=O)Nc1ccccc1,7.84,,
NS(=O)(=O)OCCCCCCCCOS(N)(=O)=O,7.84,,CHEMBL182455
COc1ccc(S(=O)(=O)N(CCOC2OC(CO)C(O)C(O)C2O)CC(=O)NO)cc1,7.84,,
CC1OC(OC2C(CO)OC(OC3C(CO)=CC([NH2+]C4C(C)OC(OC5C(CO)OC(OC6C(CO)OC(O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,7.84,,
[NH3+]CCCC[NH2+]CCC[NH3+],7.84,,
O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1,7.84,,CHEMBL3218011
CCC(CC)OC1C=C(C(=O)[O-])CC([NH3+])C1NC(C)=O,7.84,,
CCCCC(NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)C)C(N)=O,7.849999999999999,,
O=C([O-])CNS(=O)(=O)c1ccc(N2CCC(c3ccccc3)CC2)cc1,7.849999999999999,,
NS(=O)(=O)c1ccc(C(=O)NCCOCCOCCNC(=O)C([NH3+])Cc2ccccc2)cc1,7.849999999999999,,
[NH2+]=C(NO)N1CCC(CNC(=O)C2CCC3CN(S(=O)(=O)Cc4ccccc4)CC(=O)N32)CC1,7.849999999999999,,
NC(=[NH2+])NCCCC([NH3+])C(=O)[O-],7.849999999999999,,
[NH3+]CCCCC([NH3+])C(=O)[O-],7.849999999999999,,
COc1cc(-c2ccccc2)c(O)c(-c2cc3cc(C(N)=[NH2+])ccc3[nH]2)c1,7.849999999999999,,
NC(=[NH2+])NCCCC(C=O)NC(=O)CN1C(=O)C(NS(=O)(=O)Cc2ccccc2)N=C(c2ccccc2)c2ccccc21,7.849999999999999,,
N#CCc1cc(O)cc2cc(-c3ccc(O)cc3)oc12,7.849999999999999,,CHEMBL184151
CC(C)C(NC(=O)N(C)Cc1ccccn1)C(=O)NC(Cc1ccccc1)C(O)C(O)C(CC1CCCCC1)NC(=O)C(NC(=O)N(C)Cc1ccccn1)C(C)C,7.849999999999999,,
CC(C)c1cc(C(C)C)c(S(=O)(=O)NC(Cc2cccc(C(N)=[NH2+])c2)C(=O)N2CCN(C(=O)C3CCN(C(N)=[NH2+])CC3)CC2)c(C(C)C)c1,7.849999999999999,,
CC(=O)OC1(C(C)=O)CCC2C3C=C(Cl)C4=CC(=O)C5CC5C4(C)C3CCC21C,7.849999999999999,,
Cc1cc2[nH][nH]c(=O)[n+]2c2cc(-c3ccncc3)ccc12,7.849999999999999,,
COc1ccc2ncc(C#N)c(CC[N+]3CCC([NH2+]Cc4cc5c(cn4)OCS5)CC3)c2c1,7.849999999999999,,
COCCON=Cc1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1,7.849999999999999,,
N#CN=C1SCCN1Cc1ccc(Cl)nc1,7.849999999999999,,
CCCN(CCC)C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C2CC(Cc3ccccc3)CC[NH2+]2)c1,7.849999999999999,,
O=C([O-])CCC(NC(=O)NC(CSCc1ccc(F)cc1)C(=O)[O-])C(=O)[O-],7.849999999999999,,
NS(=O)(=O)Oc1ccc2c(c1)S(=O)(=O)C(CC1CCCCCC1)=C2,7.849999999999999,,CHEMBL476937
CC(C)CCn1nc(N2CCCC2)c(O)c(C2=Nc3ccc(NS(C)(=O)=O)cc3S(=O)(=O)N2)c1=O,7.849999999999999,,CHEMBL515012
COc1cc2nccc(Oc3ccc(-c4c[nH+]c(Nc5ccc(F)cc5)n(C)c4=O)cc3F)c2cc1OC,7.849999999999999,,
[NH3+]Cc1ccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5ccccc5Oc5ccccc5)c4)c3c2)cc1,7.849999999999999,,
COc1cnc2c(NCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1,7.849999999999999,,CHEMBL566875
CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CC[N+](C)CC4)cc3OC)ncc2Cl)c1,7.849999999999999,,
CN1C(=[NH2+])NC(c2ccc(OC(F)F)cc2)(c2ccc(F)c(C#CCCCF)c2)C1=O,7.849999999999999,,
Cn1cc(-c2ccc3ncc(Cc4ccc5ncccc5c4)n3n2)cn1,7.849999999999999,,CHEMBL1738731
CC(=O)NC1C([NH2+]OC(=O)Nc2ccccc2)OC(CO)C(O)C1O,7.849999999999999,,
Cc1c(C[N+]2CCN(C(=O)C(C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,7.849999999999999,,
CNC(=O)c1cn(-c2cc3c(=O)n(NS(C)(=O)=O)c(=O)[nH]c3cc2C(F)(F)F)cn1,7.849999999999999,,CHEMBL1940324
C[NH2+]C(C)C(=O)NC(C(=O)N1CCCC1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1,7.849999999999999,,
Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1,7.849999999999999,"This molecule is a member of the class of imidazoles that is 1H-imidazole which is substituted at positions 1, 4, and 5 by cyclohexyl, p-fluorophenyl, and 2-aminopyrimidin-4-yl groups, respectively. It is a selective inhibitor of the delta- and epsilon-isoforms of casein kinase 1 (CK1delta and CK1epsilon). It has a role as an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor. It is a member of imidazoles, an aminopyrimidine and a member of monofluorobenzenes. It is a conjugate base of a This molecule(2+).",CHEMBL1951415
CC(C)(C)c1ccc(C(=O)Nc2c[n+]3cc(-n4ccnc4)ccc3[nH]2)cc1,7.849999999999999,,
O=c1[nH]c2ccccc2c2ccccc12,7.849999999999999,"This molecule is a member of the class of phenanthridines that is phenanthridine with an oxo substituent at position 6. A poly(ADP-ribose) polymerase (PARP) inhibitor, it has been shown to exhibit immunosuppressive activity. It has a role as a mutagen, an immunosuppressive agent and an EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor. It is a lactam and a member of phenanthridines.",CHEMBL45245
C[NH2+]Cc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,7.849999999999999,,
Cc1c(CN(C)C(=O)CCc2cnc3c(c2)CCC(=O)N3)oc2ccccc12,7.849999999999999,,
CCCCn1c(-c2c(C)ccc3n[nH]cc23)c[n+]2c3c(=O)[nH]c(=O)n(C)c3[nH]c12,7.849999999999999,,
COc1cc(-c2cnc3[nH]cc(C(=O)NC(C)C)c3n2)cc(OC)c1OC,7.849999999999999,,CHEMBL2348850
C[NH+](C)CCC(CSc1ccccc1)Nc1ccc(S(=O)(=O)NC2=NS(=O)(=O)c3cc(N4CC[NH+](Cc5ccccc5-c5ccc(Cl)cc5)CC4)ccc32)cc1[N+](=O)[O-],7.849999999999999,,
OCc1cc(-c2c[nH]nc2-c2ccc(F)cc2)ccn1,7.849999999999999,,
CC(C)(C)C1Cc2cc(F)ccc2S(=O)(=O)N(CC(O)C(Cc2ccccc2)NC(=O)OC2CCOC2)C1,7.849999999999999,,
Cc1cc(C)c(Nc2nc(Nc3ccc(C#N)cc3)nc(OCCC[NH+]3CCOCC3)n2)c(C)c1,7.849999999999999,,
CC1[NH2+]C(C#Cc2ccccc2)C(O)C1O,7.849999999999999,,
CC1CCCC(CC2Cc3cc(O)cc(O)c3C(=O)O2)O1,7.849999999999999,,
COc1ccc(CC(NC(=O)C(C)NC(=O)C[NH+]2CCOCC2)C(=O)NC(Cc2ccccc2)C(O)C(C)CO)cc1,7.849999999999999,,
Nc1cccc(C(=O)NC(C(=O)NO)c2ccc(-n3cccn3)cc2)c1,7.849999999999999,,CHEMBL3359699
CN1C(=[NH2+])NC(CCC2CCCCC2)(CC2CCCC(Nc3ccc4ccccc4n3)C2)C1=O,7.849999999999999,,
CC(C)(O)c1cn(-c2ccc(-c3cccc(S(C)(=O)=O)c3)cc2)c(C(C)(C)c2ccccc2Cl)n1,7.849999999999999,,CHEMBL3360975
Cc1cc(NS(=O)(=O)c2ccccc2Cl)c2ccccc2c1Oc1ncccc1-c1ccnc(NC2CCC([NH3+])CC2)n1,7.849999999999999,,
CCSC(NC(=O)C(Cc1ccccc1)NS(=O)(=O)N1CCOCC1)C(=O)NC(CC1CCCCC1)C(O)C(O)CC(C)C,7.86,,
CCNC(=O)C1OC(n2cnc3c(N)ncnc32)C(O)C1O,7.86,This molecule is a purine nucleoside.,CHEMBL277076
CC(C)(c1ccccc1)c1ccc(O)cc1,7.86,This molecule is a diarylmethane. This molecule is a natural product found in Panax ginseng with data available.,CHEMBL194805
CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,7.87,,
CC(C)c1c(C(=O)NCc2ccccc2)nc(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)[O-],7.87,,
CC(C)CC(NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])CO)C(=O)[O-],7.88,,
CCCOc1ccc(S(=O)(=O)N2CC[N+](C)CC2)cc1-c1nc(CC)c(Br)c(=O)[nH]1,7.88,,
COc1cc(Cc2cnc(N)nc2N)cc(C=CC(=O)N2N=Cc3ccccc3C2C(C)C)c1OC,7.88,,
CC(C)CC(NC(=O)c1ccncc1)C(=O)NCC(O)CNS(=O)(=O)c1ccc(Oc2ccccc2)cc1,7.889999999999999,,
COc1ccc(S(=O)(=O)N(Cc2cccnc2)C(C(=O)NO)C(C)C)cc1,7.889999999999999,,CHEMBL3827444
CC=CCC(C)(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,7.889999999999999,,
CC(=O)NC(Cc1cccc(C(=O)[O-])c1O)B(O)O,7.889999999999999,,
CC(C)CC(NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(N)=O)NC(=O)CNC(=O)C1CCCN1C(=O)C(C)NC(=O)C([NH3+])Cc1ccccc1)C(=O)[O-],7.889999999999999,,
NC(=[NH2+])c1cc2cc(-c3cccc(-c4ccccc4)c3O)[nH]c2cc1Cl,7.889999999999999,,
CCC(C)C(NC(=O)CNC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)[O-])NC(=O)C[NH3+])C(C)CC)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CC(=O)[O-])C(=O)[O-])C(C)C,7.889999999999999,,
O=C([O-])CCC(CSc1ccc(Cc2ccccc2)cc1)NC(=O)CCCCCCc1ccccc1,7.889999999999999,,
CC(C)CC(NC(=O)N1CCOCC1)C(=O)NC(CCc1ccccc1)CCS(=O)(=O)c1ccccc1,7.889999999999999,,
CC=CCC(C)C(O)C(C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)C(C)CC(C)C)C(C)C)[NH+](C)OO,7.889999999999999,,
CC(O)C(CCc1cccc(Cl)c1Cl)n1cnc(C(N)=O)c1,7.889999999999999,,
CCC(=C(c1ccc(O)cc1)c1ccc(OCC[NH+](C)C)cc1)c1ccccc1,7.889999999999999,,
CC(=O)NC(=[NH2+])NCCCC1NC(=O)C(CCCC(=O)[O-])NC(=O)C(Cc2c[nH]cn2)N2C(=O)C(CC2O)NC(=O)C2CCCN2C1=O,7.889999999999999,,
NC(=[NH2+])c1cccc(-n2nc(C(F)(F)F)cc2C(=O)Nc2ccc(-n3cnc4ccccc43)cc2F)c1,7.889999999999999,,
CC(Nc1nccc(-c2c(-c3ccc(F)cc3)c(=O)n(C3CC[NH2+]CC3)n2C)n1)c1ccccc1,7.889999999999999,,
[NH3+]CC1CCCN1C(=O)C([NH3+])Cc1ccc(-c2ccccc2)cc1,7.889999999999999,,
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(NC(=O)COc1cccnc1)C(C)(C)S(C)(=O)=O,7.889999999999999,,
CN(CCCCC(=O)[O-])c1ccc(C=Cc2ccc([N+](=O)[O-])cc2)cc1,7.889999999999999,,
COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CC[NH+](C)CC4)cc3)c2C1)c1ccccc1,7.889999999999999,,
N#Cc1ccccc1Cn1c(N2CCCC([NH3+])C2)[nH+]c2ccccc2c1=O,7.889999999999999,,
COc1nc2[nH]cc(C(=O)C(=O)N3CCC(O)C3)c2cc1C(=O)N1CCn2c(cnc2-c2ccc(F)cc2F)C1,7.889999999999999,,CHEMBL244172
CCNc1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]C(C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1,7.889999999999999,,
CCn1cc2c3c(cc(C(=O)NC(Cc4ccccc4)C(O)(O)C[NH2+]C4CCOCC4)cc31)N(C)S(=O)(=O)CC2,7.889999999999999,,
CCNc1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]C(C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1,7.889999999999999,,
CC(C)C1C[NH2+]C(C(=O)[O-])C1CC(=O)[O-],7.889999999999999,,
CC(C[N+](C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N,7.889999999999999,,
O=C([O-])COc1c(C(=O)[O-])sc(-c2cccc(N(C(=O)c3ccccc3)C3CCCCC3)c2)c1Br,7.889999999999999,,
CCCCC(CN(O)C=O)C(=O)N1CCCC1c1nc2ccccc2o1,7.889999999999999,,
O=C(C1CC([NH+]2CCN(c3ncccn3)CC2)C[NH2+]1)N1CCC(F)(F)C1,7.889999999999999,,
CC(=O)NC1C(O)OC(CO)C(OC2OC(CO)C(OC3OC(COC4OC(COC5OC(CO)C(O)C(O)C5OC5OC(CO)C(O)C(O)C5O)C(O)C(OC5OC(CO)C(O)C(O)C5O)C4O)C(O)C(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4O)C3O)C(O)C2NC(C)=O)C1O,7.889999999999999,,
CCC(C)(C)C1C(O)=C(C2=CS(=O)(=O)c3cc(NS(C)(=O)=O)ccc3N2)C(=O)N1Cc1ccc(F)c(C)c1,7.889999999999999,,
NC(=[NH2+])c1ccc(N=NNc2ccc(C(N)=[NH2+])cc2)cc1,7.889999999999999,,
CC1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3C=C3)[nH]n2)c2cccn2n1,7.889999999999999,,
COc1ccc2c(c1)C(CC(=O)NC(C(=O)NC(CCc1ccccc1)C(=O)NCc1ccc(C)cc1)C(C)O)CC2=O,7.889999999999999,,
Cc1ccccc1CNC(=O)C(CCc1ccccc1)NC(=O)C(NC(=O)c1ccc(OCc2ccccc2)cc1)C(C)O,7.889999999999999,,
CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C,7.889999999999999,This molecule has been investigated for the treatment of Psoriasis.,CHEMBL1230065
CCCCCNC(=O)c1ccc(S(N)(=O)=O)cc1,7.889999999999999,,CHEMBL149507
O=C([O-])c1ccc(Nc2nccc(Nc3ccccc3Br)n2)cc1,7.889999999999999,,
Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1,7.889999999999999,"This molecule is a member of the class of imidazoles that is 1H-imidazole which is substituted at positions 1, 4, and 5 by cyclohexyl, p-fluorophenyl, and 2-aminopyrimidin-4-yl groups, respectively. It is a selective inhibitor of the delta- and epsilon-isoforms of casein kinase 1 (CK1delta and CK1epsilon). It has a role as an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor. It is a member of imidazoles, an aminopyrimidine and a member of monofluorobenzenes. It is a conjugate base of a This molecule(2+).",CHEMBL1951415
O=C(NOCCO)c1ccc2n[nH]cc2c1Nc1ccc(I)cc1F,7.889999999999999,,
C=C1C(O)CC(=CC=C2CCCC3(C)C2CCC3C(C)CC#CC(O)CC23CC4CC(CC(C4)C2)C3)CC1O,7.889999999999999,,
N=Cc1nc(N2CCOCC2)nc(N(Cc2ccc(Cl)cc2)C2CCCCC2)n1,7.889999999999999,,
OCCC1CC1c1cncc(OCC2CC[NH2+]2)c1,7.889999999999999,,
[NH3+]CC(NC(=O)CC1CNC(=O)c2cc(-c3ccnc(F)c3)cn21)c1ccccc1,7.889999999999999,,
CCC(C)C1NC(=O)C(C)(NC(=O)C(CCC(N)=O)NC(=O)C2CCCN2C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C([NH3+])CCCNC(N)=[NH2+])CCCC=CCC=CC(C)(C(=O)NC(Cc2c[nH]cn2)C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)[O-])C(C)C)C(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C(CC(C)C)NC1=O,7.889999999999999,,
CSCCC([NH3+])C(=O)[O-],7.889999999999999,,
CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)CC[Si](C)(C)C)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccccc1,7.889999999999999,,CHEMBL2030861
[NH3+]C(C(=O)[O-])C1CCC1C(=O)[O-],7.889999999999999,,
COc1ccc(S(=O)(=O)N2Cc3cc(-c4ccc(C=O)o4)ccc3N(Cc3cncn3C)CC2Cc2ccc(O)cc2)cc1,7.889999999999999,,
CN(O)C(=O)CCC(CC([NH3+])C(=O)[O-])C(=O)[O-],7.889999999999999,,
CC1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)NC(=[NH2+])OC(C(F)(F)F)C1F,7.889999999999999,,
C[NH2+]Cc1cc(-c2cn(C)nc2-c2ccc(F)cc2)ccn1,7.889999999999999,,
CC(=CC=CC(C)=CC(=O)[O-])C=C1CCC(C)c2ccccc21,7.889999999999999,,
Cc1cc2c(C3=CCC=NC3=O)c(C(=O)[O-])n(Cc3cnc4ccccc4c3)c2cc1F,7.889999999999999,,
COc1cccc(-c2cc(F)ccc2C2Cc3nc(N)nc(C)c3C(=O)N2)n1,7.889999999999999,,
N#Cc1ncc2nc1OCCCCCOc1cc(NCc3ccncc3)c(Cl)cc1NC(=O)N2,7.9,,CHEMBL220035
CC(=NNC(N)=[NH2+])c1ccc2[nH]c(C(=O)Nc3ccc4cc[nH]c4c3)cc2c1,7.9,,
CCc1c(C(=O)Nc2ccc(-c3ccccc3)cc2)c2c(n1CCC(O)CC(O)CC(=O)[O-])CCCCC2,7.9,,
Cc1cccc(CC(NC(=O)c2cc(C(C)(C)C)nn2C)C(=O)NCC=N)c1,7.9,,
Cc1cc(NCC(O)(C(F)(F)F)C(F)(F)F)c2cnn(-c3cccc(C(=O)NC(C)C(N)=O)c3)c2c1,7.9,,
CCCCCCCC=CC=CC(=O)NC(C(=O)NC1C=CCCNC(=O)CCC(C(C)C)NC1=O)C(C)O,7.9,,
O=C1N(Cc2ccccc2)C(COc2ccccc2)C(O)C(O)C(COc2ccccc2)N1Cc1ccccc1,7.91,,
CSCCC(NC(=O)C(CC(=O)[O-])NC(C)=O)C(=O)NC(CCC(N)=O)C(=O)NC(CO)CC(=O)[O-],7.91,,
CC(C)n1c(CCC(O)CC(O)CC(=O)[O-])c(-c2ccc(F)cc2)c(-c2ccc(F)cc2)c1C(=O)Nc1ccccc1,7.91,,
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,7.91,,
CCCC(NC(=O)C1C2CCCC2CN1C(=O)C(NC(=O)C(NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(O)C(=O)NC1CC1,7.91,,
Cc1cccc(C(CCC([NH3+])C(=O)[O-])(c2ccccc2)c2ccccc2)c1,7.91,,
CC(C)CC(NC(=O)C(CO)NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C[NH3+])C(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CS)C(=O)NC(Cc1ccccc1)C(=O)[O-],7.92,,
CCC(C)C(NC(=O)C1CCC[NH+]1CC(O)C1Cc2ccc(cc2)OCCCC(=O)NC(CC(N)=O)C(=O)N1)C(=O)NC(C(N)=O)C(C)C,7.92,,
CC1=CC(C(=O)NC2CCC(c3cnc(N)[nH]3)CC2)n2c(=O)n(CC(c3ccccc3)c3ccccc3)c(=O)n2C1,7.92,,
CC(C)CC(NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C([NH3+])CCCC[NH3+])C(C)C)C(=O)[O-],7.92,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCN2C(=O)C([NH2+]CC(=O)[O-])C2CCCCC2)cc1,7.92,,
[NH3+]CCNc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O,7.92,,
C[NH2+]C(C)C(=O)NC(C(=O)N1CCCC1C(=O)NC1CCCc2ccccc21)C(C)(C)C,7.92,,
CC(C)(C)n1nc(-c2ccc(Cl)cc2Cl)c(C(=O)c2ccc(S(C)(=O)=O)cc2Cl)c1O,7.92,,CHEMBL1230467
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,7.92,,
Cc1ccc(S(=O)(=O)NC(=O)Nc2ccc(S(N)(=O)=O)cc2)cc1,7.92,,CHEMBL78755
COC(=O)NC(C(=O)N[NH+](Cc1ccc(-c2ccccn2)cc1)CC(O)(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O)C(C)(C)C,7.92,,
C#CC1CCC(C=N)N1C(=O)C([NH3+])C1CCCC1,7.92,,
N#Cc1ccc2c(-c3cc4cc(C[NH+]5CCC(C[NH3+])CC5)ccc4[nH]3)n[nH]c2c1,7.92,,
CC(NC(=O)c1cc(-c2nnc(C(C)([NH3+])Cc3ccccc3)o2)cc(N(C)S(C)(=O)=O)c1)c1ccc(F)cc1,7.92,,
OCC1OC(OC2C[NH+]3C(CO)C(O)C(O)C3C2O)C(O)C(O)C1O,7.92,,
COc1cc2ncnc(N3CCC(Oc4ccc5ccccc5c4)C3)c2cc1OC,7.92,,
O=c1[nH]cnc2c(C3[NH2+]C(CO)C(O)C3O)c[nH]c12,7.92,,
O=C(Nc1ccccc1)Nc1c[nH]nc1-c1nc2cc(C[NH+]3CCOCC3)ccc2[nH]1,7.92,,
Clc1ccc(C[N+]2CCN(c3c(Br)cnc4[nH]c(-c5ccc(C[N+]6CCOCC6)cc5)nc34)CC2)cc1,7.92,,
Cc1nc2c3ccccc3nc(SCc3nc4ccccc4[nH]3)n2n1,7.92,,CHEMBL1641615
N=CC1(NC(=O)C2CC(S(=O)(=O)c3ccccc3Cl)CN2C(=O)C2(c3ccc(Br)cc3)CC2)CC1,7.92,,
Cc1ccc(C(=O)NC2C=C2)cc1-c1ccc(C(=O)NCC2C=C2)cc1,7.92,,
Cc1ccc(COC2CC(C(=O)NC(CCCC[NH3+])C(O)c3nc4ccccc4o3)N(C(=O)C(CCc3ccccc3)NC(=O)OCc3ccccc3)C2)cc1,7.92,,
CC1(C)CC(NC(=S)Nc2ccc(S(N)(=O)=O)cc2Cl)CC(C)(C)[NH+]1O,7.92,,
COc1cc(NC(=O)c2cccc(-n3ncc4cc(Nc5ccccc5F)ccc43)c2)cc(OC)c1OC,7.92,,CHEMBL1233748
COc1ccc2sc3c(c2c1)NCC(C[NH3+])NC3=O,7.92,,
COc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)CCC(=O)N2C,7.92,,CHEMBL1230645
C=C1C(=O)OC(COC)C2(C)C1=C(O)C(=O)C1C3CCC(=O)C3(C)CC(OC(C)=O)C12,7.92,,
CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1,7.92,,CHEMBL522387
CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)C[NH2+]C1(c2cccc(C(C)(C)C)c2)CCc2[nH]ncc2C1,7.92,,
CCCc1cc(-c2cc(C(=O)N(C)C)cc(C(F)(F)F)c2)nc(C=N)n1,7.92,,
NS(=O)(=O)c1ccc(-n2nncc2C2=C3C4=C5[C]2[Ru+10]5342678[C]3C2=C6C7=C38)cc1,7.92,,
CSc1ccccc1Nc1nc(N2CC[NH2+]CC2)nc2c(NCC3CC3)ncnc12,7.92,,
COc1cc2ncnc(N3CCCC(c4ccccc4)C3)c2cc1OCCc1ccc2ccccc2n1,7.92,,CHEMBL1819131
Nc1nc(NC2CCCCC2)sc1C(O)c1ccc2ccccc2c1,7.92,,
NS(=O)(=O)c1ccc(C(=O)CSc2ncccn2)cc1,7.92,,CHEMBL2011156
C=C1C(O)CC(=CC=C2CCCC3(C)C2CCC3C(C)CC#CC(O)CC23CC4CC(CC(C4)C2)C3)CC1O,7.92,,
COC(c1ccccc1)C1NC(=O)C(C)NC(=O)C(CC(C)CO)N(C)C(=O)C(C(O)c2cn(C(C)(C)C(C)O)c3ccccc23)NC(=O)C(C(C)C=C(C)C)NC(=O)C(CC(C)C)N(C)C(=O)C(C(C)C)NC1=O,7.92,,
COc1cccc(CNC(=O)c2nc3ccccc3c(=O)[nH]2)c1,7.92,,CHEMBL3337869
COC(=O)NC(C(=O)N[NH+](CCCC1(Cc2ccccc2)C(=O)N(C2c3ccccc3CC2O)CC1O)Cc1ccc(-c2ccncc2)cc1)C(C)(C)C,7.92,,
CCOc1ccccc1-c1ccc(-c2nc3ccncc3c(O)c2C#N)cc1,7.92,,CHEMBL1957361
Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,7.92,,CHEMBL1998585
CNC1=NC(C)C(c2nc(Nc3cccc(O)c3)ncc2C#N)S1,7.92,,
Cn1cc(Br)cc1C(=O)Nc1n[nH]c2c1CN(C(=O)NC(C[NH+]1CCCC1)c1ccccc1)C21CC1,7.92,,
Nc1n[n+]2c(Cc3ccc4c(c3)OCO4)nc3cc(NCCO)ccc3c2[nH]1,7.92,,
CC(=O)Nc1nnc(S(N)(=O)=O)s1,7.92,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
O=C1OCC(OC2OCC(OC3OCC(O)C(O)C3O)C(O)C2O)C(O)C1O,7.92,,
CCC(CO)N1C(=O)C(CC(=O)[O-])CC(c2cccc(Cl)c2)C1c1ccc(Cl)cc1,7.92,,
Cc1cc(NC(=O)c2c[nH][n+]3cccnc23)n(-c2cccc(Cl)c2)n1,7.92,,
CCC(C)C(NC(=O)C(Cc1cnc[nH]1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(N)=O)C(C)CC)C(C)O)C(=O)NC(CC(N)=O)C(=O)[O-],7.92,,
CC1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)CC(C(F)(F)F)OC(=[NH2+])N1,7.92,,
Cc1ccc(-c2cnc(C(O)CCCCCCc3ccccc3)o2)nc1,7.92,,
COc1ncc2cc(C(=O)Nc3cc(C(=O)NC(CC[NH3+])c4cccc(Cl)c4)ccc3Cl)c(=O)[nH]c2n1,7.92,,
Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3c(c2)OCC3CC(=O)[O-])c1,7.92,,
Cc1cn(C2CCC[NH+](Cc3ccc(C(=O)[O-])c(Oc4cccc(Cl)c4)c3F)C2)c(=O)[nH]c1=O,7.92,,
CC(=O)Nc1sc(S(N)(=O)=O)n[n+]1C,7.929999999999999,,
Nc1nccc2scc(-c3ccc4c(ccn4C(=O)Cc4ccccc4)c3)c12,7.929999999999999,,
CC(C)CC(NC(=O)N1CC[NH2+]CC1)C(=O)NC(CCc1ccccc1)CCS(=O)(=O)c1ccccc1,7.94,,
CS(=O)c1ccc(-c2nc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1,7.94,,
CC(=O)Nc1sc(S(N)(=O)=O)n[n+]1C,7.94,,
c1ccc2nc(COc3ccc(-c4n[nH]cc4Cc4ccncc4)cc3)ccc2c1,7.94,,CHEMBL562317
COc1ccc(S(=O)(=O)N2Cc3cc(-c4ccc(CO)o4)ccc3N(Cc3cncn3C)CC2Cc2ccc(O)cc2)cc1,7.94,,
CC(C)C(NC(=O)C(CO)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccccc1)NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)[O-],7.95,,
CC[NH+]1CC[NH+](Cc2ccc(-c3cc4c(NC(C)c5ccccc5)ncnc4[nH]3)cc2)CC1,7.95,,
C=CC(=O)OC1CCC(C)(O)C(C2(C)OC2CC=C(C)C)C1OC,7.95,,
CC(=O)OC1C(COS(N)(=O)=O)OC(O)C(O)C1OC(C)=O,7.95,,
CCCCC(CN(O)C=O)C(=O)C(NC(=O)Nc1ccc(C)cn1)C(C)C,7.95,,
CCC(CC)OC1CC(C(=O)[O-])CC([NH3+])C1NC(C)=O,7.95,,
NS(=O)(=O)c1ccc(C(=O)CSc2ncccn2)cc1Cl,7.95,,CHEMBL2443188
CCCCC(NC(=O)C(Cc1ccccc1)NC(=O)N1CCOCC1)C(=O)NC(CC1CCCCC1)C(O)(O)C(F)(F)C(=O)NC,7.96,,
CNC(=O)c1cccc(CN2C(COc3ccccc3)C(O)C(O)C(COc3ccccc3)N(Cc3ccccc3)S2(=O)=O)c1,7.96,,
N#C[NH+]=C1N(Cc2ccc(CO)cc2)C(Cc2ccccc2)C(O)C(O)C(Cc2ccccc2)N1Cc1ccc(CO)cc1,7.96,,
Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)C[NH+]1CCC(S(=O)(=O)c2ccncc2)CC1C(=O)NC(C)(C)C,7.96,,
Cn1cc(CNC(=O)C2C=CCN2C(=O)C(CC2CCCCC2)[NH2+]CC(=O)[O-])cc1C(N)=[NH2+],7.96,,
NC(=[NH2+])c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3O)cc2c1,7.96,,
NC(=[NH2+])c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3O)cc2c1,7.96,,
NC(=[NH2+])c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3O)cc2c1,7.96,,
NC(=O)c1cn(C(CO)CCn2ccc3ccc(NC(=O)CCCCc4ccccc4)cc32)cn1,7.96,,
COc1ccc(C2(C#N)CCC(C(=O)[O-])CC2)cc1OC1CCCC1,7.96,,
CC(O)C(CCc1cccc2ccccc12)n1cnc(C(N)=O)c1,7.96,,
Cc1ccc(NC(=O)c2ccc(C[NH+]3CCC([NH+](C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1,7.96,,
CC([NH3+])C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)NC(CC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)[O-],7.96,,
CC[NH+]1CC[NH+](Cc2ccc(-c3cc4c(NC(C)c5ccccc5)ncnc4[nH]3)cc2)CC1,7.96,,
CCCCC([NH3+])C(Cc1ccsc1)NC(=O)c1cc(NCC2CC2C)nc(N(C)S(C)(=O)=O)c1,7.96,,
O=c1[nH]cnc2c(C3[NH2+]C(CO)C(O)C3O)c[nH]c12,7.96,,
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(Cc1ccccc1)C(O)C(O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(C)NC(=O)OCc1ccccc1)C(C)C)C(C)C,7.96,,
CCCN(CCC)C(=O)c1cc(C(N)=O)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C[NH2+]Cc2cccc(OC)c2)c1,7.96,,
CN(C(=O)CCC(C1CCCCC1)N1Cc2cc(Oc3ccccc3)ccc2N=C1N)C1CCCCC1,7.96,,
COCc1cc(O)cc2c1OC(c1ccc(O)cc1)C1CCCC21,7.96,,
CC(CS)C(=O)N1CCCC1C(=O)[O-],7.96,,
Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CC[NH+](CCO)CC2)n1,7.96,,
Nc1ncnc2c1ncn2C1OC(COS(=O)(=O)NC(=O)C([NH3+])CCCC[NH3+])C(O)C1O,7.96,,
FC(F)(F)c1cccc(-c2nnc3ccc(NC4CCCCC4)nn23)c1,7.96,,CHEMBL494360
CC(C)Nc1ccc2cnn(-c3cncc(-n4ccc(CC(=O)[O-])c4)n3)c2c1,7.96,,
COC(=O)NC(C(=O)NC(Cc1ccccc1)C(O)C[NH+](Cc1ccc(-c2ccccn2)cc1)NC(=O)C(NC(=O)OC)C(C)(C)C)C(C)(C)C,7.96,,
CN(c1ccccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,7.96,This molecule is a sulfonamide.,CHEMBL472212
Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CC[NH+](CCO)CC2)n1,7.96,,
CC(Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccc(F)cc1,7.96,,
C=CCC(NC(=O)NC(CCCCNC(=O)c1ccc(I)cc1)C(=O)[O-])C(=O)[O-],7.96,,
NS(=O)(=O)c1nnc(NC(=O)C23CC4CC(CC(C4)C2)C3)s1,7.96,,CHEMBL1209038
O=C1N=CCc2cc(NC(=O)C3C[NH2+]CC3c3ccc(Cl)cc3)c(Cl)cc21,7.96,,
CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2cccc(CC(N)=O)c2)n1,7.96,,CHEMBL1271376
CNc1ncnc2c1ncn2C1OC(C=CCNC(=O)c2cc(-c3ccc(F)cc3)cc(O)c2O)C(F)C1O,7.96,,
OCCOCCn1ccc2ncnc(Nc3cnc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,7.96,,CHEMBL1614726
Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)C(=O)N1CSC(C)(C)C1C(=O)NC1c2ccccc2CC1O,7.96,,
CC(F)(F)CNC(=O)n1cc2nc(N)nc(-c3c(Cl)cc(Cl)cc3OCCn3cccn3)c2c1,7.96,,
CCCC(Cc1cc2cc(-c3ccccc3C)ccc2nc1N)C(=O)NCC1CCCCC1,7.96,,CHEMBL1821819
COc1ccc2nc(C)c3c(C)nc(-c4cnccc4C)n3c2n1,7.96,,CHEMBL1916091
O=c1[nH]c(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,7.96,,
COc1cc(C)c2nc3[nH]nc(C)c3c(N3CC[NH2+]CC3)c2c1,7.96,,
CCC(O)(CC)c1cc(OCC[N+]2CCOCC2)c2cc(-c3[nH]nc4ccsc34)[nH]c2c1,7.96,,
COCCCn1ccc2cc(-c3cc(-c4ccccc4)cc(=O)n3O)cnc21,7.96,,CHEMBL2203964
CC(C)(C)NC(=O)Cc1ccc(Nc2nc(-c3ccccc3)nc3c2S(=O)(=O)CCC3)cc1,7.96,,CHEMBL2385758
Oc1ccc(Cc2nnc3ncc(-c4ccc(F)cc4)nn23)cc1,7.96,,CHEMBL2170957
CNc1nc(C)c(-c2nc(Nc3cccc(O)c3)ncc2C#N)s1,7.96,,CHEMBL2312188
CC(c1nc2c(cnn2C2CCCC2)c(=O)[nH]1)[NH+]1CC(Oc2ccccc2)C1,7.96,,
CCCCCCCC(=O)OC1C(OC(=O)C(C)CC)C(C)C2C1C(C)(OC(C)=O)CC(OC(O)CCC)C1(OC(O)CCC)C2OC(O)C1(C)O,7.96,,
O=c1[nH]c(-c2ccc(F)cc2)c(-c2ccc(-c3nnn[nH]3)cc2)cc1O,7.96,,CHEMBL2443239
O=c1[nH]c(-c2ccc(-c3nn[nH]n3)cc2)c(-c2ccc(F)cc2)cc1O,7.96,,
Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)n[nH]c1=O,7.96,"This molecule is an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) intended to be administered in combination with other antiretroviral medicines. This molecule is available by itself or as a combination product of doravirine (100 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg).  This molecule is formally indicated for the treatment of HIV-1 infection in adult patients with no prior antiretroviral treatment experience, further expanding the possibility and choice of therapeutic treatments available for the management of HIV-1 infection. This molecule is a nonnucleoside reverse transcriptase inhibitor used in combination with other antiretroviral agents in the therapy of human immunodeficiency virus (HIV) infection. This molecule is associated with a low rate of transient serum aminotransferase elevations during therapy but has not been implicated in cases of clinically apparent acute liver injury. This molecule is a Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor. The mechanism of action of doravirine is as a Non-Nucleoside Reverse Transcriptase Inhibitor. This molecule is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults and children who weigh at least 77 lb (35 kg) and who meet certain requirements, as determined by a health care provider. Doravirine is always used in combination with other HIV medicines. This molecule is a pyridinone non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1), that is used to treat HIV infection. Upon oral administration, doravirine non-competitively inhibits HIV-1 reverse transcriptase (RT), thereby inhibiting HIV-1 viral replication.",CHEMBL2364608
O=C([O-])CCC(NC(=O)NC(CCCCNC(=O)c1ccccc1OCCNC(=O)CCOCCO)C(=O)[O-])C(=O)[O-],7.96,,
CCCS(=O)(=O)Nc1ccc(F)c(N(C)c2ccc3ncn(C)c(=O)c3c2)c1F,7.96,,CHEMBL3236466
NS(=O)(=O)OC1CCN(S(=O)(=O)C2OC(CO)C(O)C(O)C2O)CC1,7.96,,
Nc1ccc(C(=O)NC(C(=O)NO)c2ccc(-n3cccn3)cc2)cc1,7.96,,CHEMBL3359700
CCN1C(C)=C(C(=O)OC(C)C)C(c2ccccc2Cl)C(C(=O)[O-])=C1C(=O)[O-],7.97,,
C=NC(=O)OC1CCC(C)(O)C(C2(C)OC2CC=C(C)C)C1OC,7.97,,
COc1ccc(S(=O)(=O)N2Cc3cc(C#N)ccc3N(Cc3cncn3C)CC2Cc2ccc(OS(=O)(=O)C(F)(F)F)cc2)cc1,7.98,,
CC(NC(=O)C([NH3+])C(C)C)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CO)C(=O)[O-],7.99,,
CCC(C)CCC(=O)Nc1ccc(S(N)(=O)=O)cc1,7.99,,
CC(=O)Nc1ccc(N2C(=O)C3C4CCC(NC(=O)OCC(=O)[O-])(CC4)C3C2=O)cc1,8.0,,
CNC(=O)C(F)(F)C(O)C(CC(C)C)NC(=O)C(NC(=O)C(NC(=O)CC(C)C)C(C)C)C(C)C,8.0,,
CC(C)CC(NC(=O)OCc1ccccc1)C(=O)N[NH2+]C(O)c1csc(C(CC(C)C)NC(=O)OCc2ccccc2)n1,8.0,,
NC(=[NH2+])NCCCC(NC(=O)C1CCC2CCC([NH3+])(Cc3ccccc3)C(=O)N21)C(O)c1nc2ccccc2s1,8.0,,
O=C([O-])C1Cc2ccccc2CN1S(=O)(=O)c1ccc(-c2ccccc2)cc1,8.0,,
CCC(C)(C)C(=O)C(=O)N1CCCCC1C(=O)OC(CCc1ccccc1)c1ccccc1,8.0,,
O=C1N=c2ccc3ncsc3c2=C1CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1,8.0,,
CCCCCC(CC(=O)NO)C(=O)NC(C(=O)N1CCCC1CO)C(C)C,8.0,,CHEMBL67311
CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1CC(CO)C(O)C(O)C1O,8.0,,
CC(=O)N1CC(O)CC1C(O)[NH2+]C(CCCNC(N)=[NH2+])C(O)c1nc2ccccc2s1,8.0,,
COC(=O)c1cc(CC(NC(C)=O)C(=O)NC2CCCCN(Cc3ccc(-c4ccccc4)cc3)C2=O)ccc1C(F)(C(=O)[O-])C(=O)[O-],8.0,,
[NH3+]C(CCC(=O)NC(CSC(=O)N(O)c1ccc(I)cc1)C(=O)NCC(=O)[O-])C(=O)[O-],8.0,,
COC(=O)C1(O)CC2OC1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,8.0,This molecule is a natural product found in Streptomyces longisporoflavus with data available.,CHEMBL1591330
COc1ccc(S(=O)(=O)N(CC(=O)NO)CC(C)C)cc1,8.0,,CHEMBL311932
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,8.0,,
CC(C)CC(NC(=O)C(O)COS(=O)(=O)O)C(=O)NC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC2CCC(O)N(C2=O)C(CC(C)C)C(=O)N(C)C(Cc2ccc(O)cc2)C(=O)NC(C(C)C)C(=O)OC1C,8.0,,
CS(=O)(=O)c1cc(Cl)c(-c2cc(Cl)c(S(C)(=O)=O)cc2Cl)cc1Cl,8.0,,
CCCCCC=CCC=CCC=CCC=CCCCC(=O)[O-],8.0,,
C[NH+](C)CCCn1cc(C2C(=O)NC(=O)C2c2c[nH]c3ccccc23)c2ccccc21,8.0,,
COc1ccc(S(=O)(=O)N(CC(=O)N=O)CC(C)C)cc1,8.0,,
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,8.0,,
CCCCNC(=O)C(NC(=O)C1CC(=O)CC1C(O)C(CC(C)C)NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(C)=O)C(C)C,8.0,,
NC(=[NH2+])c1ccc(C2C3C(=O)N(Cc4ccc5c(c4)OCO5)C(C4CC4)C3C3CCC[NH+]32)cc1,8.0,,
O=C([O-])c1c(NS(=O)(=O)c2ccccc2)ccc2c1CCCC2,8.0,,
COc1ccc(S(=O)(=O)N(CC(=O)NO)CC(C)C)cc1,8.0,,CHEMBL311932
CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,8.0,,
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(CO)Cc1ccccc1)C(C)C,8.0,,
CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCOCC3)ccc2C)n1,8.0,,CHEMBL219158
Brc1cnn2c(NCc3cccnc3)cc(-c3ccccc3)nc12,8.0,,CHEMBL249530
CCc1cnn2c(NCc3cnc(N)nc3)cc(-c3c(F)cccc3F)nc12,8.0,,
NC(=[NH2+])Nc1ncc(Cl)c2ccc(S(=O)(=O)N3CCCC3C(=O)[O-])cc12,8.0,,
O=C(C[NH+]1CC(O)C(NC(=O)c2ccc(Cl)s2)C1)Nc1ccc(-n2ccccc2=O)cc1F,8.0,,
O=C(Nc1c[nH]nc1-c1nc2ccc(C[NH+]3CCOCC3)cc2[nH]1)c1ccc(F)cc1,8.0,,
Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1,8.0,,CHEMBL298445
NS(=O)(=O)N1CC(C(=O)Nc2ccc(Cl)cc2)C(C(=O)Nc2ccc(-n3ccccc3=O)cc2F)C1,8.0,,
CC(C)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CCCN1C(=O)CNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C([NH3+])CCC(=O)[O-])C(N)=O,8.0,,
CC(=O)NC1C(O)OC(CO)C(O)C1O,8.0,"This molecule is a N-acyl-hexosamine. This molecule is under investigation for the other of GNE Myopathy. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655).",CHEMBL83479
CC#CCOc1ccc(S(=O)(=O)CCCS)cc1,8.0,,CHEMBL402747
CC(C)CC(NC(=O)C(O)CC(=O)[O-])C(=O)NCCCCNC(N)=[NH2+],8.0,,
CC(C)CCn1c(=O)c(C2=Nc3ccc(NS(C)(=O)=O)cc3S(=O)(=O)N2)c(O)c2cccn21,8.0,,CHEMBL401974
CC(C)(C)CCN1C(=O)C(C2=Nc3ccc(NS(C)(=O)=O)cc3S(=O)(=O)N2)=C(O)C2CCC[NH+]21,8.0,,
CC(C)CCn1nc(-c2cccs2)c(O)c(C2=CS(=O)(=O)c3cc(NS(C)(=O)=O)ccc3N2)c1=O,8.0,,CHEMBL456104
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,8.0,,
CC(C)(C)C1C(O)=C(C2=NS(=O)(=O)c3c(CNS(C)(=O)=O)cccc32)C(=O)N1Cc1ccc(F)c(Cl)c1,8.0,,
CC(=O)OC(C(=O)Nc1cccc2c1C(=O)C(=O)NC2=O)c1cccc(Cl)c1,8.0,,
Cc1nnc(-c2ccc(-c3cc(C(=O)NC4CC4)ccc3C)c(C)c2)o1,8.0,"This molecule is a member of the class of biphenyls that is biphenyl in which one of the phenyl groups is substituted at positions 2and 4 by a methyl and a 5-methyl-1,3,4-oxadiazol-2-yl groups, respectively, while the other phenyl group is substituted at positions 2 and 5 by a methyl and an N-(cyclopropyl)aminocarbohyl group, respectively. An inhibitor of p38-alpha MAP kinase. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of biphenyls, a member of 1,3,4-oxadiazoles, a monocarboxylic acid amide, a member of cyclopropanes and a ring assembly.",CHEMBL522579
O=C1N=CN2NC(Sc3ccc(F)cc3F)=CC=C2C1c1c(Cl)cccc1Cl,8.0,,
O=S(=O)(Nc1cc(Cl)c(Oc2cnc3ccccc3c2)c(Cl)c1)c1ccc(Cl)cc1Cl,8.0,"This molecule is expected to lower blood glucose in type II diabetic patients by improving the body’s ability to respond to insulin. T131 is a selective modulator of PPARg (peroxisome proliferator activated receptor gamma), a receptor involved in regulating the body’s ability to respond to insulin. T131 is not structurally related to the thiazolidinedione class of PPARg agonists, which includes Actos and Avandia.",CHEMBL1236924
C[NH2+]C(C)Cc1ccccc1,8.0,,
[NH3+]C(CCC(=O)NC(CSC1(SCCCCCCO)C=CC([N+](=O)[O-])c2nonc21)C(=O)NCC(=O)[O-])C(=O)[O-],8.0,,
Cc1ccc(NC(=O)c2ccc(C[NH+]3CC[NH+](C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,8.0,,
NS(=O)(=O)OCC1CC(n2ccc3c(NC4CCc5ccccc54)ncnc32)CC1O,8.0,This molecule is a member of indanes.,CHEMBL1991973
CC(=O)Nc1nnc(S(N)(=O)=O)s1,8.0,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,8.0,,
Cc1ccccc1C1CCCN1C(=O)c1cc(Cl)c(O)cc1O,8.0,,CHEMBL450227
Cn1cnc(S(=O)(=O)N(Cc2ccc(-c3cccc(S(C)(=O)=O)c3)cc2)Cc2c(F)cccc2Cl)c1,8.0,,CHEMBL1092952
CNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3-c2ccccc2)c1,8.0,,CHEMBL410668
O=C([O-])c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12,8.0,,
CCCC(C(=O)Nc1ccc(S(N)(=O)=O)cc1)C(C)(C)C,8.0,,CHEMBL1083383
CC1CCC(NC(=O)OC(C)(C)C)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1,8.0,,
CCCn1c(=O)c2nc(-c3ccc(OCC(=O)NCC[NH3+])cc3)[nH]c2n(CCC)c1=O,8.0,,
CCC(C)C([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-])C(C)O,8.0,,
CN1C(=[NH2+])NC(c2ccsc2)(c2cccc(-c3cccnc3)c2)C1=O,8.0,,
CC[NH+]1CC2(COC(=O)c3ccccc3N3C(=O)CC(C)C3=O)CCC(OC)C34C5CC6C(OC)CC(O)(C5C6OC)C(O)(C(OC)C23)C14,8.0,,
C[N+]1=C(C=CCc2cc[n+](CCCS(=O)(=O)[O-])c3ccccc23)C(C)(C)c2ccccc21,8.0,,
CC(C)Nc1ccc2nnc(C(C)c3c[nH]c4ncccc34)n2n1,8.0,,
[NH3+]Cc1cccc(C2CCN(C(=O)c3ccc(C#Cc4ccccc4F)o3)CC2)c1,8.0,,
Cc1ccc(C(=O)N(C)C(c2nc3cc(Cl)ccc3c(=O)n2Cc2ccccc2)C(C)C)cc1,8.0,,
[NH3+]CC(O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1,8.0,,
Cc1ccc(C(=O)N(CCC[NH3+])C(C2=C(Cc3ccccc3)C(O)c3ccc(Cl)cc3O2)C(C)C)cc1,8.0,,
CCCCOc1cncc(-c2nnc3c(C)nc4ccc(C[NH+]5CCOCC5)cc4n23)c1,8.0,,
CCCCCC(CC(=O)NO)C(=O)NC(C(=O)N1CCCC1CO)C(C)C,8.0,,CHEMBL67311
Cc1nc2cnc3[nH]ccc3c2n1C1CC[NH2+]CC1,8.0,,
CCC(=O)N1CCCC(n2nc(-c3cccc(C(=O)Nc4ccc(C(C)C)cc4)c3)c3c(N)ncnc32)C1,8.0,,
Cc1cc(C)nc(Sc2c(F)c(F)c(S(N)(=O)=O)c(F)c2F)n1,8.0,,CHEMBL2333410
CCOc1cc(C(Nc2ccc3c(N)nccc3c2)C(=O)NS(=O)(=O)c2ccccc2)ccc1OC(C)C,8.0,,CHEMBL2431589
O=C(NCc1ccc(S(=O)(=O)C2CC[NH+](C3CCOCC3)CC2)cc1)n1cc2ccncc2c1,8.0,,
Cc1cc(C)nc(SCC(=O)c2ccc(S(N)(=O)=O)c(Cl)c2)n1,8.0,,CHEMBL2443204
O=C(NCc1ccc(S(=O)(=O)c2cc(F)cc(F)c2)cc1)c1ccn2ccnc2c1,8.0,,
CCNC(=O)Nc1cc(-c2nc(C(F)(F)F)cs2)c(-c2cncc(C(=O)[O-])c2)cn1,8.0,,
CCNC(=O)Nc1cc(-c2nc(C(F)(F)F)cs2)c(-c2cncc(C3N=NC(=O)O3)c2)cn1,8.0,,
CCNC(=O)Nc1nc2cc(-c3cncnc3)c(OCC3CCOC3)nc2s1,8.0,,CHEMBL3263596
Cc1ncc([N+](=O)[O-])n1CCNS(N)(=O)=O,8.0,"This molecule has been used in trials studying the treatment of Solid Tumors and Head and Neck Neoplasms. This molecule is an orally bioavailable, nitroimidazole-based sulfamide, carbonic anhydrase IX (CAIX) inhibitor with potential antineoplastic activity. Upon administration, CAIX inhibitor DTP348 inhibits tumor-associated CAIX, a hypoxia-inducible transmembrane glycoprotein that catalyzes the reversible reaction and rapid interconversion of carbon dioxide and water to carbonic acid, protons, and bicarbonate ions. This prevents the acidification of the tumor's extracellular microenvironment and decreases the intracellular pH. This results in increased cell death in CAIX-expressing, hypoxic tumors. In addition, DTP348, through its nitroimidazole moiety, is able to sensitize hypoxic tumor cells to irradiation. CAIX is overexpressed in various tumors and plays a key role in intra- and extracellular pH regulation, cancer cell progression, survival, migration and invasion.",CHEMBL3087323
CC(=O)NC(CO)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(C(=O)NC(C)C(=O)NC(C(=O)NC(CCC(=O)[O-])C(=O)NC(CC(N)=O)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)[O-])C(C)C)C(C)C,8.0,,
CC(C)CC(NC(=O)C(C)NC(=O)C(CC(N)=O)NC(=O)C(CCC(=O)[O-])NC(=O)C(NC(=O)C(C)NC(=O)C(NC(=O)C(Cc1c[nH]cn1)NC(=O)C([NH3+])CO)C(C)C)C(C)C)C(=O)[O-],8.0,,
NC(=[NH2+])c1ccc(Oc2cc(Oc3ccc(C(N)=[NH2+])cc3)cc(C(=O)NC3CCC([NH3+])CC3)c2)cc1,8.0,,
CC(=CC=CC(C)=CC(=O)[O-])C=C1CCCc2cccc(C)c21,8.0,,
COc1c(C[NH+]2CCCC(n3cc(C)c(=O)[nH]c3=O)C2)ccc(C(=O)[O-])c1Oc1cccc(Cl)c1,8.0,,
c1cc(Nc2ncnn3cc(-c4cn[nH]c4)cc23)ccn1,8.0,,
OCC1OC(O)C(O)C(O)C1O,8.0,,
OCC1OC(O)C(O)C(O)C1O,8.0,,
Cn1nnc(-c2o[nH]c(=O)c2CC([NH3+])C(=O)[O-])n1,8.01,,
CC(O)C(CCOc1ccc2ccccc2c1)n1cnc(C(N)=O)c1,8.01,,
Cc1cc2nc3[nH]c(=O)[nH]c(=O)c3nc2cc1C,8.01,"This molecule is a compound showing blue fluorescence, formed by a photolysis of riboflavin in acid or neutral solution. It has a role as a plant metabolite. It is functionally related to an alloxazine. It is a tautomer of a 7,8-dimethylisoalloxazine. This molecule is a natural product found in Streptomyces, Zea mays, and other organisms with data available.",CHEMBL1234101
NS(=O)(=O)c1ccc(-n2cc(C3=C4C5=C6[C]3[Ru+10]6453789[C]4C3=C7C8=C49)nn2)cc1,8.01,,
C=C(CCC12OC(C(=O)[O-])C(O)(C(=O)[O-])C(C(=O)[O-])(O1)C(OC(=O)C=CC(C)CC(C)CC)C2O)C(OC(C)=O)C(C)Cc1ccccc1,8.01,,
CNc1cc(-c2cccnc2Oc2ccc(Nc3nc4c(F)c(F)ccc4[nH]3)cc2)ccn1,8.01,,
CCCCC(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(=O)[O-],8.019999999999998,,
OCC1C(O)C(O)C(O)c2nc(CCc3ccccc3)cn21,8.019999999999998,,
CCC(=O)c1c(-c2ccccc2)c2cc(Cl)ccc2c(=O)n1Cc1ccc(C(=O)[O-])cc1,8.019999999999998,,
C[N+]1Cc2nc(C(=O)NC3CCCCC3NC(=O)c3cc4ccc(Cl)cc4cn3)sc2C1,8.019999999999998,,
Cn1cnc2c(C=N)nc(-c3ccc(OCCC[N+]4CC[N+](C)CC4)c(C(F)(F)F)c3)cc21,8.019999999999998,,
CN1C(=O)N(c2ccc(C=N)c(C(F)(F)F)c2)C(=O)C1(C)c1ccc(O)cc1,8.019999999999998,,
CN1C(=[NH2+])NC2(C1=O)c1cc(-c3cccnc3F)ccc1OC1CCOCC12,8.019999999999998,,
COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C,8.019999999999998,,CHEMBL1522313
CCC(C)NC(=O)c1cc(N)cc(-c2cnc(NC(C)C)c(=O)n2CC(=O)NCc2ccc(C(N)=[NH2+])cc2C(=O)Nc2ccncc2)c1,8.029999999999998,,
COc1cc(Cc2cnc(N)nc2N)cc(C=CC(=O)N2[NH2+]Cc3ccccc3C2CCC(F)(F)F)c1OC,8.029999999999998,,
CC(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CSCC(=O)Nc1ccc(C2c3ccc(O)cc3Oc3cc(O)ccc32)c(C(=O)[O-])c1)C(N)=O)C(C)O)C(C)O,8.04,,
CCCCCC[NH+](C)CC(O)C(CC(=O)[O-])NC(=O)C(CC)n1cc(C(C)(C)C)nc(NCc2nonc2C)c1=O,8.04,,
CC(=O)NC(C(=O)NC(CCCC[NH3+])C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CSCC(=O)Nc1ccc(C2c3ccc(O)cc3Oc3cc(O)ccc32)c(C(=O)[O-])c1)C(N)=O)C(C)O)C(C)O,8.04,,
O=C([O-])Cc1ccn(-c2cncc(-n3ncc4ccc(NC5CCCC5)cc43)n2)c1,8.04,,
CC(C)C1C(C(=O)N2CCCC2C(=O)N(C)C)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21,8.04,,
CCCCCCNC(=O)Oc1ccc(CC2CN(Cc3cncn3C)c3ccc(C#N)cc3CN2S(=O)(=O)c2ccc(OC)cc2)cc1,8.04,,
CC[NH2+]C1CC(C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,8.04,,
COc1ccc(-c2nc(C(C)Sc3nc(N)cc(N)n3)c(C)s2)cc1OCCNS(C)(=O)=O,8.04,,
CC(=O)NC(C(=O)NC(Cc1ccccc1)C(O)C[NH+](CC1CCCCC1)NC(=O)C(NC(C)=O)C(C)C)C(C)C,8.05,,
CC(C)CC(O)C(O)C(CC1CCCCC1)NC(=O)C(CC1CC1)CC(O)C(O)Cc1ccccc1,8.05,,
O=C([O-])C(Cc1ccc2c(c1)OCO2)C(Cc1ccc2c(c1)OCO2)C(=O)[O-],8.05,,
O=C1Nc2ccc(-c3cnco3)cc2C1=CNc1ccc2c(c1)CS(=O)(=O)C2,8.05,,
Cc1cc(C)cc(CNC(=O)c2cc3c(C)cccc3n2Cc2cccc(C(N)=[NH2+])c2)c1,8.05,,
O=CC1C=NC(C(=O)[O-])=CSC1c1cn2c(n1)COCC2,8.05,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(OS(=O)(=O)O)cc1)C(=O)NC(CC(C)C)C(=O)[O-],8.05,,
CCC(C)C(NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C1CCC[NH2+]1)C(C)C)C(=O)N1CCCC1C(=O)NC(CCSC)C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)[O-])C(=O)NCC(=O)[O-],8.05,,
CCCCCCCCC=CCCCCCCCC(=O)[O-],8.05,,
O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,8.05,"This molecule is a 7-hydroxyisoflavone with additional hydroxy groups at positions 5 and 4'. It is a phytoestrogenic isoflavone with antioxidant properties. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a phytoestrogen, a plant metabolite, a geroprotector and a human urinary metabolite. It is a conjugate acid of a genistein(1-). An isoflavonoid derived from soy products. It inhibits protein-tyrosine kinase and topoisomerase-II (DNA topoisomerases, type II) activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines.  Additionally, genistein has antihelmintic activity. It has been determined to be the active ingredient in Felmingia vestita, which is a plant traditionally used against worms. It has shown to be effective in the treatment of common liver fluke, pork trematode and poultry cestode.  Further, genistein is a phytoestrogen which has selective estrogen receptor modulator properties. It has been investigated in clinical trials as an alternative to classical hormone therapy to help prevent cardiovascular disease in postmenopausal women.    Natural sources of genistein include tofu, fava beans, soybeans, kudzu, and lupin. This molecule is a soy-derived isoflavone and phytoestrogen with antineoplastic activity. This molecule binds to and inhibits protein-tyrosine kinase, thereby disrupting signal transduction and inducing cell differentiation.  This agent also inhibits topoisomerase-II, leading to DNA fragmentation and apoptosis, and induces G2/M cell cycle arrest.  This molecule exhibits antioxidant, antiangiogenic, and immunosuppressive activities. (NCI04) This molecule is a natural product found in Salvia hispanica, Glycine soja, and other organisms with data available. This molecule is one of several known isoflavones. Isoflavones compounds, such as genistein and daidzein, are found in a number of plants, but soybeans and soy products like tofu and textured vegetable protein are the primary food source. This molecule is a natural bioactive compound derived from legumes and has drawn because of its potentially beneficial effects on some human degenerative diseases. It has a weak estrogenic effect and is a well-known non-specific tyrosine kinase inhibitor at pharmacological doses. Epidemiological studies show that genistein intake is inversely associated with the risk of cardiovascular diseases. Data suggests a protective role of genistein in cardiovascular events. However, the mechanisms of the genistein action on vascular protective effects are unclear. Past extensive studies exploring its hypolipidemic effect resulted in contradictory data. This molecule also is a relatively poor antioxidant. However, genistein protects against pro-inflammatory factor-induced vascular endothelial barrier dysfunction and inhibits leukocyte-endothelium interaction, thereby modulating vascular inflammation, a major event in the pathogenesis of atherosclerosis. This molecule exerts a non-genomic action by targeting on important signaling molecules in vascular endothelial cells (ECs). This molecule rapidly activates endothelial nitric oxide synthase and production of nitric oxide in ECs. This genistein effect is novel since it is independent of its known effects, but mediated by the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) cascade. This molecule directly stimulates the plasma membrane-associated adenylate cyclases, leading to activation of the cAMP signaling pathway. In addition, genistein activates peroxisome proliferator-activated receptors, ligand-activated nuclear receptors important to normal vascular function. Furthermore, genistein reduces reactive oxygen species (ROS) by attenuating the expression of ROS-producing enzymes. These findings reveal the roles for genistein in the regulation of vascular function and provide a basis for further investigating its therapeutic potential for inflammatory-related vascular disease.  (A3190).",CHEMBL44
O=C([O-])c1ccc(-c2cc(F)cc(F)c2)cc1,8.05,,
COC(=O)NC(C(=O)N[NH+](Cc1ccccc1)CC(O)(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O)C(C)C,8.05,,
O=C1c2ccccc2C(=O)N1CCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccc(F)cc1Cl,8.05,,CHEMBL221595
NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,8.05,,CHEMBL319467
O=C(NCCCCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,8.05,,CHEMBL457189
C[N+](C)(C)CCCN1C(=O)C2C(C1=O)C(c1cc(-c3ccc(Cl)s3)on1)[NH+]1CCCC21,8.05,,
NC(=O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1,8.05,This molecule is an aminopyrimidine and a member of benzamides. It has a role as a protein kinase inhibitor.,CHEMBL242237
Cc1ccccc1-n1c(Cn2nc(-c3ccc(O)c(F)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O,8.05,,CHEMBL1213085
O=C(Nc1ccc(Cl)cc1)C1C[NH+](CC(F)(F)F)CC1C(=O)Nc1ccc(-n2ccccc2=O)cc1F,8.05,,
c1ccc2oc(C3=NCCN3)cc2c1,8.05,This molecule is a member of benzofurans.,CHEMBL404505
Oc1ccc(-c2cc[nH]n2)cc1-c1nc(NC2CC[NH2+]C2)c2ccccc2n1,8.05,,
CC(C)C1C[NH2+]C(C(=O)[O-])C1CC(=O)[O-],8.05,,
C[NH+](C)C1CCc2cc(N3CCC(NS(=O)(=O)c4ccc5cc(Cl)ccc5c4)C3=O)ccc21,8.05,,
COc1ccccc1-c1c[nH]c2ncc(-c3cncc(C(=O)N(C)C)c3)cc12,8.05,,CHEMBL1235103
CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21,8.05,"This molecule is a member of the class of pyrazolopyrimidine that is pyrazolo[3,4-d]pyrimidin-4-amine bearing additional tert-butyl and 4-chlorophenyl substituents at positions 1 and 3 respectively. It is a potent ATP-competitive inhibitor of the Src family of protein tyrosine kinases. It has a role as an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, a beta-adrenergic antagonist and a geroprotector. It is a pyrazolopyrimidine, an aromatic amine and a member of monochlorobenzenes.",CHEMBL406845
NC(=[NH2+])NCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)CCCCCNC(=O)C(CCCC[NH3+])NC(=O)CCCCCNC(=O)C1OC(n2cnc3c(N)ncnc32)C(O)C1O)C(N)=O,8.05,,
COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1,8.05,"This molecule is a member of the class of quinolines that is 7-methoxyquinoline substituted at position 4 by a (6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy group. AMG exhibits antitumour activity, particularly in prostate cancer. It has a role as a c-Met tyrosine kinase inhibitor and an antineoplastic agent. It is a member of quinolines, an aromatic ether and a triazolopyridazine. This molecule has been used in trials studying the treatment of Cancer, Tumors, Oncology, Prostate Cancer, and Oncology Patients, among others. This molecule is a selective small-molecule inhibitor of the proto-oncogene c-Met with potential antineoplastic activity. c-Met inhibitor AMG 208 inhibits the ligand-dependent and ligand-independent activation of c-Met, inhibiting its tyrosine kinase activity, which may result in cell growth inhibition in tumors that overexpress c-Met. C-Met encodes the hepatocyte growth factor receptor tyrosine kinase, plays an important role in epithelial cell proliferation and has been shown to be overexpressed in a variety of cancers.",CHEMBL496102
Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(C(=O)NC(C)CO)s3)n2)c1,8.05,,
COC(=O)C(C#N)=C(Nc1cccc2c(Cl)c[nH]c12)NC1CCCCN(CC(=O)N2CCCC2)C1=O,8.05,,
CC(C)CC(NC(=O)C(CC(N)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCC(=O)[O-])NC(=O)C(C)NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C([NH3+])C(C)O)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N1CCCC1C(=O)[O-],8.05,,
COc1ccc2c(CC(=O)Nc3ccc(S(N)(=O)=O)cc3)cc(=O)oc2c1,8.05,,CHEMBL477822
Nc1ncnc2c1c(Cc1cccc3ccccc13)nn2CC1CC[NH2+]CC1,8.05,,
CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2cccc(CC(N)=O)c2)n1,8.05,,CHEMBL1271376
Cc1cc(Nc2cc(C3CCC[NH2+]C3)nc3c(-c4cnn(C)c4)cnn23)sn1,8.05,,
NS(=O)(=O)c1ccc(NC(=O)Cc2ccccc2)cc1,8.05,,CHEMBL574782
CCOCCN(CC(O)C[N+]1CCCC2(CCc3c(ccc4[nH]ncc34)O2)C1)S(=O)(=O)c1c(C)cccc1C,8.05,,
CC(C)([NH3+])CNc1nc(-c2ccncc2)cc2cnccc12,8.05,,
c1ccc(-c2cncc(N3CCC[NH2+]CC3)c2)cc1,8.05,,
Cn1c(-c2ccnc(Nc3cc(N4CC[N+](C)CC4)ccc3OC(F)(F)F)n2)cc2c1CCNC2=O,8.05,,
Cc1ccc(NC(=O)c2ccoc2)cc1-n1cnc2ccc(N3CC[NH+](C)CC3)cc2c1=O,8.05,,
CC(=O)N(O)CCCC1NC(=O)CNC(=O)CNC(=O)CNC(=O)C(CCCN(O)C(C)=O)NC(=O)C(CCCN(O)C(C)=O)NC1=O,8.05,,
CC(C)(C)OC(=O)NCc1cn(C2CC(C(=O)N3CCCC3C=N)N(C(=O)CCCc3ccccc3)C2)nn1,8.05,,
CC(=O)NCC1CCN(c2c(Cl)cnc3[nH]c(-c4cn(C)nc4C)nc23)C1,8.05,,
COc1ccc(S(=O)(=O)N(CC(C)C)CC(O)C(Cc2ccccc2)NC(=O)OC2COC3OC4OCCC4C23)cc1,8.05,,
COc1c(-c2nc3cc(NS(C)(=O)=O)ccc3o2)cc(C2=CCC=NC2=O)cc1C(C)(C)C,8.05,,
Cc1cc(C)c(Nc2ncnc(Nc3ccc(C#N)cc3)n2)c(C)c1,8.05,,CHEMBL71728
CCC(CS(=O)(=O)C(C)(C)C)N1C(=O)C(CC(=O)[O-])OC(c2cccc(Cl)c2)C1c1ccc(Cl)cc1,8.05,,
Cn1cc(C2=C(c3cn(CCCSC(N)=[NH2+])c4ccccc34)C(=O)NC2=O)c2ccccc21,8.05,,
CCCc1sc(-c2ccc(OC)c(O)c2)nc1CSc1nc(N)cc(N)n1,8.05,,CHEMBL2426568
C=C1CCC(OC2CC(O)(C(C)NC(=O)c3[nH]c(C)c(Cl)c3Cl)C(O)C(C)O2)C2C=CC(C)C(C(O)=C3C(=O)C(C(C)C)N(C4OC(C)C(OC(N)=O)C(OC(C)=O)C4OC)C3=O)C12,8.05,,
CC(C)CC(NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)C(C)NC(=O)C(C)NC(=O)C(C)[NH3+])C(=O)NC(CO)C(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCC[NH3+])C(=O)O,8.06,,
O=c1ccc2c([nH]1)CCCC2[NH2+]CCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2,8.06,,
CNC(=O)c1cc(Oc2ccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)[nH]c3c2)ccn1,8.06,,CHEMBL394826
NS(=O)(=O)c1nnc(NS(=O)(=O)c2ccccc2)s1,8.06,,CHEMBL73962
CCC(NC(=O)c1ccc(OCc2ccccn2)c(C(F)(F)F)c1Cl)C(O)C(N)=O,8.06,,
O=C([O-])C1CCCN1C(=O)CCCCC(=O)N1CCCC1C(=O)[O-],8.06,,
O=C([O-])c1ccccc1C1c2ccc(O)cc2Oc2cc(O)ccc21,8.06,,
CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CC[NH+](C)CC4)cc3OC)nc2N1C1CCCC1,8.06,,
CC(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC1CSSCC(C(=O)NC(CCC(N)=O)C(=O)NC(Cc2ccccc2)C(=O)NC(C(=O)NC(CCC(=O)[O-])C(N)=O)C(C)C)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(=O)[O-])NC(=O)C(C(C)C)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C2CCCN2C(=O)C(CC(=O)[O-])NC(=O)C(CC(=O)[O-])NC1=O,8.07,,
CCCCCCCCC=CCCCCCCCC(=O)[O-],8.07,,
Nc1nc2[nH]cc(CCc3ccc(C(=O)NC(CCc4nnn[nH]4)C(=O)[O-])cc3)c2c(=O)[nH]1,8.07,,
CC(O)C(CCc1cccc2nc(-c3ccc(Cl)cc3)oc12)n1cnc(C(N)=O)c1,8.07,,
O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21,8.07,,CHEMBL226403
O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21,8.07,,CHEMBL226403
CC(C)c1noc(C2CCN(C(=O)NC3CC3c3ccccc3)CC2)n1,8.07,,
CC(C)Cn1c(=O)n(C)c(=O)c2nc[nH]c21,8.07,This molecule is a 3-isobutyl-1-methylxanthine. It is functionally related to a 9H-xanthine. It is a tautomer of a 3-isobutyl-1-methyl-7H-xanthine.,CHEMBL275084
Cc1ccc(CC([NH3+])CNc2nnc(-c3ccc4n[nH]cc4c3)s2)cc1,8.07,,
Cc1ccc(C(=O)Nc2ccc(C[N+]3CC[N+](C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,8.07,,
O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21,8.07,,CHEMBL226403
CCC(O)(CC)c1ccc2cc(-c3[nH]nc4cc(-c5ccccc5)sc34)[nH]c2c1,8.07,,
COc1ccc2c(c1)CC[NH2+]C2c1ccc(S(N)(=O)=O)cc1,8.07,,
CC(=O)NC(Cc1ccccc1)C(O)C[NH2+]C1CC(C)(C)Oc2sc(CC(C)(C)C)cc21,8.07,,
CC(C)CC(NC(=O)C(CC(=O)[O-])NC(=O)CNC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(Cc1c[nH]cn1)NC=O)C(=O)NCC(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CC(C)C)C(=O)NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(N)=O,8.07,,
COC(=O)C(NC(=O)C(NC(=O)CCC(O)C(Cc1ccccc1)NC(=O)C(C)NC(=O)C(C)[NH3+])C(C)C)C(C)C,8.08,,
Oc1ccc(C2Oc3ccc(O)cc3C3CC(F)(F)CC32)cc1,8.08,,
O=C([O-])c1ccccc1NC(=O)N1CCC(c2ccccc2C(F)(F)F)CC1,8.08,,
CC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(=O)[O-])NC(=O)C(C)NC(=O)C([NH3+])CC(=O)[O-])C(=O)[O-],8.08,,
CCC(CC)C(NC(C)=O)C1C(NC(N)=[NH2+])CC(C(=O)[O-])C1O,8.08,,
NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)CCc1cc(-c2ccc(-c3cccc(Cl)c3)cc2)no1,8.08,,
CC(C)(C)CNC(=O)Cc1ccc(Nc2nc(-c3ccccc3)ncc2C(N)=O)cc1,8.08,,CHEMBL2442472
Cc1cc2ccccc2c(-c2ccc(C(=O)NCC[N+]3CCOCC3)cc2)n1,8.08,,
CCC(CC)Oc1cc(C(=O)[O-])cc(N)c1NC(C)=O,8.08,,
C[NH+](C)Cc1ccc(C2CC2C(=O)Nc2nc3ccc(-c4cccnc4)cc3s2)cc1,8.08,,
CC1=C(C(=O)NC(C)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CC2CCCCC2)C(O)C(C)CO)Cc2ccccc21,8.08,,
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(CO)Cc1ccccc1)C(C)C,8.08,,
Nc1c2c(nc3ccccc13)CCCC2,8.09,"This molecule is an oral acetylcholinesterase inhibitor previously used for therapy of Alzheimer disease. This molecule therapy is associated with a very high rate of serum aminotransferase elevations during therapy and has been linked to several instances of clinically apparent, acute liver injury. This molecule is a member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease. It has a role as an EC 3.1.1.7 (acetylcholinesterase) inhibitor. It is a member of acridines and an aromatic amine. It is a conjugate base of a tacrine(1+). A centerally active cholinesterase inhibitor that has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. Tacrine has been discontinued for the United States market. This molecule is a Cholinesterase Inhibitor. The mechanism of action of tacrine is as a Cholinesterase Inhibitor. This molecule is only found in individuals that have used or taken this drug. It is a centerally active cholinesterase inhibitor that has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. The mechanism of tacrine is not fully known, but it is suggested that the drug is an anticholinesterase agent which reversibly binds with and inactivates cholinesterases. This inhibits the hydrolysis of acetylcholine released from functioning cholinergic neurons, thus leading to an accumulation of acetylcholine at cholinergic synapses. The result is a prolonged effect of acetylcholine.",CHEMBL95
CC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NC(CCCCC[NH3+])B(O)O,8.09,,
Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCCNC1=O,8.09,,
CC(Oc1cc(-c2cnn(C3CC[NH2+]CC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,8.09,,
CC1C[NH+](Cc2ccc(F)cc2)C(C)CN1C(=O)c1cc2c(C(=O)C(=O)N(C)C)cn(C)c2cc1Cl,8.09,,
Cc1nn(-c2cccc(-c3n[nH]c(=O)[nH]3)c2)c2c1CCN(c1ccc(-c3ccccc3C[N+]3CCCC3)cc1)C2=O,8.09,,
CC1(C)C[n+]2c(CSC(=NC3CCCCC3)NC3CCCCC3)csc2N1,8.09,,
O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCOCC4)c3c2)cnc1Cl)c1ccc(F)cc1,8.09,,CHEMBL1738719
CS(=O)(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC1CCN(C(N)=[NH2+])CC1,8.09,,
COc1cc(Cc2cnc(N)nc2N)cc(C=CC(=O)N2[NH2+]Cc3ccccc3C2CC(C)C)c1OC,8.09,,
O=C([O-])c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1,8.09,,
CC(=O)Nc1cn2cc(-c3cnc(N)c(C(F)(F)F)c3)ccc2n1,8.09,,CHEMBL2418954
C[NH+]1CCN(C(=O)C(CNC(=O)c2ccc(Cl)s2)NS(=O)(=O)c2cc(F)cc(N3CCCCC3=O)c2Cl)CC1,8.09,,
CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2=O,8.099999999999998,,
CCNC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,8.099999999999998,,
CC(C)CC(NC(=O)CNC(=O)C(CCC(N)=O)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)CNC(=O)C([NH3+])CCCNC(N)=[NH2+])C(C)C)C(=O)[O-],8.099999999999998,,
NC(=[NH2+])c1ccc2nc(-c3ncccc3O)[nH]c2c1,8.099999999999998,,
O=C([O-])c1cccc(O)c1O,8.099999999999998,,
CCC(NC(=O)CC(O)C(CC(C)C)NC(=O)C(NC(=O)C(Cc1cccc2ccccc12)NC(C)=O)C(C)C)C(=O)NC(Cc1cccc2ccccc12)C(N)=O,8.099999999999998,,
Nc1nc2ccc(S(=O)(=O)Nc3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc3)cc2c(=O)[nH]1,8.099999999999998,,
O=C([O-])Cc1cccc(OCCC[NH+](Cc2cccc(C(F)(F)F)c2Cl)CC(c2ccccc2)c2ccccc2)c1,8.099999999999998,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C([NH3+])CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CCC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(OS(=O)(=O)O)cc1)C(=O)NC(CC(C)C)C(=O)[O-],8.099999999999998,,
CCOc1ccc(C=CC(=O)OC)cc1CC(=O)NC(C(=O)NC(CC(=O)[O-])C(O)CSCc1c(F)cccc1Cl)C(C)C,8.099999999999998,,
CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O,8.099999999999998,"This molecule is a pyrimidone that is uracil which is substituted at positions 1, 5 and 6 by ethoxymethyl, isopropyl, and benzyl groups, respectively. A non-nucleoside inhibitor of HIV-1 reverse transcriptase, emivirine was an unsuccessful experimental agent for the treatment of HIV. It has a role as a HIV-1 reverse transcriptase inhibitor and an antiviral drug. It is functionally related to a uracil. This molecule has been used in trials studying the treatment of HIV Infections. This molecule is a non-nucleoside reverse transcriptase inhibitor. This molecule has a structure typical of a nucleoside analog but has been shown to bind directly to the reverse transcriptase and act as an NNRTI. However, it is no longer in development due to the fact that it causes an increasingly rapid breakdown of other drugs metabolized by the cytochrome P450 enzyme.",CHEMBL35033
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,8.099999999999998,,
Cc1cccc2c(=O)[nH]c(CCC[NH+]3CC=C(c4ccc(F)cc4)CC3)nc12,8.099999999999998,,
Cc1cc(CNC(=O)c2cc(C(=O)NCc3ccc(F)c(C)c3)ncn2)ccc1F,8.099999999999998,,CHEMBL514794
CCC1C2C(C(=O)N1Cc1ccc3c(c1)OCO3)C(c1ccc(C(N)=[NH2+])cc1)[NH+]1CCCC21,8.099999999999998,,
CC#CCOc1ccc(S(=O)(=O)N2CCSC(C)(C)C2C(=O)NO)cc1,8.099999999999998,,CHEMBL382975
O=C1NC(=O)C(=Cc2ccc3nccnc3c2)S1,8.099999999999998,,CHEMBL3182407
Cc1nc(C)c(-c2n[nH]c3c2C(=O)c2c(NC(=O)N[NH+]4CC[NH+](C)CC4)cccc2-3)s1,8.099999999999998,,
CC(C)C1C2C(C(=O)N1Cc1ccc(Cl)cc1)C(c1ccc(C(N)=[NH2+])cc1)[NH+]1CCCC21,8.099999999999998,,
O=C1Nc2cncc(n2)OCCCCCOc2ccc(Cl)cc2N1,8.099999999999998,,CHEMBL223512
Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O,8.099999999999998,,CHEMBL459850
CC(CCc1ccc(O)cc1)NC(=O)Cc1c(-c2ccccc2)[nH]c2cc(OCC[NH+]3CCCCC3)ccc12,8.099999999999998,,
N#Cc1cnn2c(Nc3ccccc3)nc(NCC3CCCCC3)nc12,8.099999999999998,,CHEMBL438303
CCCN(CCC)C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C[NH2+]Cc2cccc(OC)c2)c1,8.099999999999998,,
CSCCC(NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(CCC(N)=O)C(=O)NC(C=O)CC(=O)[O-],8.099999999999998,,
CCCN(CCC)C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C2CC(OCC)CC[NH2+]2)c1,8.099999999999998,,
CC(C)CNC(=O)C(C)[NH2+]CC(Cc1ccccc1)NC(=O)c1cc(C(=O)NC(C)c2ccc(F)cc2)cc(N(C)S(C)(=O)=O)c1,8.099999999999998,,
CCC[NH+]1CCC(c2nc3c(C(N)=O)cccc3[nH]2)CC1,8.099999999999998,,
O=C(C[NH+]1CCC(NC(=O)c2ccc(Cl)s2)C1)Nc1ccc(-n2ccccc2=O)cc1F,8.099999999999998,,
CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CC[N+](C)CC1)C2(C)C,8.099999999999998,,
CC(C)Nc1ccc2cnn(-c3cncc(-n4ccc(CC(=O)[O-])c4)n3)c2c1,8.099999999999998,,
CCOc1ccc2nc(S(N)(=O)=O)sc2c1,8.099999999999998,"This molecule is a sulfonamide that is 1,3-benzothiazole-2-sulfonamide which is substituted by an ethoxy group at position 6. A carbonic anhydrase inhibitor, it has been used in the treatment of glaucoma, and as a diuretic. It has a role as an EC 4.2.1.1 (carbonic anhydrase) inhibitor, a diuretic and an antiglaucoma drug. It is a member of benzothiazoles, a sulfonamide and an aromatic ether. This molecule is a sulfonamide used as diuretic and in glaucoma. It inhibits carbonic anhydrase activity in proximal renal tubules to decrease reabsorption of water, sodium, potassium, bicarbonate. Its pharmacological activity thus confers the risk for hypokalemia. This molecule is a sulfonamide and carbonic anhydrase (CA) inhibitor with diuretic and anti-glaucoma activity. In the eye, ethoxzolamide inhibits CA, thereby decreasing the secretion of aqueous humor. This may relieve intraocular pressure. Also, this agent prevents reabsorption of bicarbonate and sodium in the proximal convoluted tubule thereby producing a mild diuresis.",CHEMBL18
Cn1cnc2cc(C#N)c(-c3ccccc3Cl)c(C[NH3+])c21,8.099999999999998,,
COc1ccc(S(=O)(=O)N(CC(=O)NO)CC(O)CO)cc1,8.099999999999998,,
COc1cc2ncc3c(N)nc(-c4cncc(OCC([NH3+])Cc5ccccc5)c4)cc3c2cc1OC,8.099999999999998,,
C=Cc1cc(N(C)C)nc(S(C)(=O)=O)n1,8.099999999999998,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C([NH3+])CCC(=O)[O-])C(C)O)C(=O)NC(CO)C(=O)[O-],8.099999999999998,,
O=c1[nH]c(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,8.099999999999998,,
CCCN(CCC)C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C[NH2+]Cc2cccc(OC)c2)c1,8.099999999999998,,
Nc1cc(Oc2ccc(Nc3ncccc3C(=O)Nc3ccc(F)cc3F)cc2F)ccn1,8.099999999999998,,CHEMBL1097142
C[NH+](C)CCNC(=O)NCC1CCC2C(c3ccccc3)Nc3ccc(C(F)(F)F)cc3C2O1,8.099999999999998,,
CC1(NC(=O)NC(C(=O)N2CC3C(C2C(=O)NC(CC2CCC2)C(O)C(N)=O)C3(C)C)C(C)(C)C)CCCCC1,8.099999999999998,,
C[N+]1CCN(C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(CCc2ccccc2)CCS(=O)(=O)c2ccccc2)CC1,8.099999999999998,,
CC=C(C)C(=O)OC1CC2C(=C1C)C1OC(=O)C(C)(O)C1(O)C(OC(=O)CCCCCCCCCCC)CC2(C)OC(C)=O,8.099999999999998,,
COc1ccc(S(=O)(=O)N(CCO)CC(=O)NO)cc1,8.099999999999998,,CHEMBL1234724
CSc1ccccc1Nc1nc(N2CC3(C[NH2+]C3)C2)nc2c(NCC3CC3)ncnc12,8.099999999999998,,
CC(=O)NC1(CC(C)C)CCN(C(CCc2ccccc2)C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C2Cc3ccccc3C[NH2+]2)C1=O,8.099999999999998,,
Cc1cc2c(C3C=CC=NC3=O)c(C(=O)NS(=O)(=O)C3CC3)n(Cc3cc(F)ccc3F)c2cc1F,8.099999999999998,,
CCOC(=O)NC1CCC2C(C1)CC1C(=O)OC(C)C1C2CCc1ccc(-c2cccc(F)c2)cn1,8.099999999999998,,
[NH3+]CC(Oc1cnc(-c2ccoc2)c(-c2c[nH]c3ncccc23)c1)c1ccccc1,8.099999999999998,,
NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1cc(C(F)(F)F)ccc1Cl,8.099999999999998,,CHEMBL3330125
CC1C[NH+](Cc2ncccn2)CC1c1nc(=O)c2cnn(C3CCOCC3)c2[nH]1,8.099999999999998,,
CSCCC([NH3+])C(=O)[O-],8.099999999999998,,
CCn1c(=O)c(-c2ccc(-c3cncs3)cc2Cl)cc2cnc(Nc3ccc(N4CC[NH+](C)CC4)cc3)nc21,8.099999999999998,,
CC(C)COc1ccc2c(c1)C1(COC(=[NH2+])N1)c1cc(-c3cncnc3)ccc1O2,8.099999999999998,,
Cc1cc(C)c(S(=O)(=O)N2CCC(C(=O)NC3CCCCCC3)CC2)c(C)c1,8.099999999999998,,CHEMBL469792
COc1cnc(-c2cnc3ccccc3c2)nc1-c1cc2c([nH]1)CCNC2=O,8.099999999999998,,CHEMBL2203552
CCCc1scc(-c2cn[nH]c2)c1CC(NC1=NC(C)(C)Cc2cc(Cl)ccc21)C(=O)[O-],8.099999999999998,,
COc1ccccc1NC(=O)c1ccc(NC(=O)CCc2nc3ccccc3c(=O)[nH]2)cc1,8.099999999999998,,CHEMBL2314698
C[NH+](C)CCC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(NC(CO)c4ccccc4)c23)c1,8.099999999999998,,
Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2[nH]cnc2n1,8.099999999999998,,
Cc1cccc(-c2nc(C(=O)[O-])c(-c3cccc(Cl)c3)n2-c2cc(Cl)ccc2C)c1,8.099999999999998,,
CCCn1cnc2c1CCC(CCC[NH3+])(C(=O)[O-])C2,8.099999999999998,,
O=C([O-])c1cc2c(-c3cccc4ccccc34)nccc2n1Cc1noc(-c2ccccc2)n1,8.099999999999998,,
CC(C=CC=C(C)Cc1cccc2ccc(C)cc12)=CC(=O)[O-],8.099999999999998,,
c1ccc(-c2cc3c(Nc4ccncc4)ncnn3c2)cc1,8.099999999999998,,CHEMBL3326742
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NCC(=O)NC(CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)[O-])C(C)C)C(C)O,8.099999999999998,,
CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NCC(=O)NC(CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(C(=O)[O-])C(C)C)C(C)O,8.099999999999998,,
O=C1NC(=O)C(CNC(=O)c2cc3cc(Cl)ccc3o2)(c2nccs2)N1,8.099999999999998,,
O=C(c1ccc(OCC[NH+]2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,8.109999999999998,,
Cn1c(CCC(=O)Nc2ccc3ccn(CCC(CO)n4cnc(C(N)=O)c4)c3c2)nc2ccccc21,8.109999999999998,,
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,8.109999999999998,,
COc1cc(N2CC[NH+](C)CC2)ccc1Nc1ncc(Cl)c(Nc2cccc3c2C(=O)N(C)C3)n1,8.109999999999998,,
COc1ccccc1Nc1ncc(Cl)c(Nc2ccc(N3CCC([NH+]4CCCCC4)CC3)c3c2C(=O)N(C)C3)n1,8.109999999999998,,
[NH3+]C(CC1(C(=O)[O-])CC2OCC(O)C(O)C2O1)C(=O)[O-],8.109999999999998,,
[NH3+]C(CC1(C(=O)[O-])CC2OCC(O)C(O)C2O1)C(=O)[O-],8.109999999999998,,
Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,8.109999999999998,"This molecule is a member of the class of pyrrolopyrimidines that is 7H-pyrrolo[2,3-d]pyrimidine substituted by amino, 4-phenoxyphenyl, and cyclopentyl groups at positions 4, 5 and 7, respectively. It is a potent inhibitor of Lck that inhibits Lck (64-509) and LckCD isoforms (IC50 of less than 1 and 2 nM, respectively). It has a role as a geroprotector and an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor. It is a primary amino compound, a pyrrolopyrimidine, an aromatic amine, an aromatic ether and a member of cyclopentanes.",CHEMBL47940
CC(C)CCNC(=O)C1C[NH2+]CC([N+]2CC(=O)N(c3ccccc3Cl)CC2(C)C)C1,8.109999999999998,,
O=C1N=C(Nc2ccccc2)N=C1Cc1ccc2c(c1)OCO2,8.109999999999998,,CHEMBL1738733
CCCNC(=O)C(NC(=O)C(O)(CCC[NH+](Cc1ccc(-c2ccncc2)cc1)NC(=O)C(NC(=O)OC)C(C)(C)C)Cc1ccc(CCC)cc1)C(C)C,8.109999999999998,,
CNC(=O)OC1COc2ccc(N3CC[NH+](C4COC4)CC3)cc2C1NC(=O)c1ccc(F)cc1,8.109999999999998,,
c1cn2cc(-c3ccc4c[nH]nc4c3)nc(Nc3ccc(N4CCOCC4)cc3)c2n1,8.109999999999998,,
Cc1ccc(C(=O)Nc2ccc(C[NH+]3CC[NH+](C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,8.109999999999998,,
Cc1ccc(C(=O)Nc2ccc(C[NH+]3CC[NH+](C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,8.109999999999998,,
NC(=O)c1cn(C(CO)CCn2ccc3ccc(NC(=O)NCc4ccccc4)cc32)cn1,8.12,,
CC(C)C(NS(=O)(=O)c1ccc2c(c1)sc1ccccc12)C(=O)[O-],8.12,,
COc1ccc(-c2snnc2-c2cc(Cl)c(O)cc2O)cc1,8.12,"This molecule is a member of the class of thiadiazoles that is 1,2,3-thiadiazole substituted at positions 4 and 5 by 2,4-dihydroxy-4-chlorophenyl and 4-methoxyphenyl groups respectively. It has a role as a Hsp90 inhibitor. It is a member of thiadiazoles, a member of resorcinols, a member of monochlorobenzenes and a monomethoxybenzene.",CHEMBL454733
CCC(C)C([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(CCCC[NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-])C(C)O,8.12,,
Nc1nc2ccc(C(=O)c3ccccc3)cc2n1CC1CC[NH2+]CC1,8.12,,
O=C(c1ccc(F)cc1)C1CC[NH+](CC(=O)N(Cc2nc3c(c(=O)[nH]2)COCC3)Cc2cccs2)CC1,8.12,,
CC(=O)NCCOc1ccccc1NC(=O)NCCCCC(NC(=O)NC(CCC(=O)[O-])C(=O)[O-])C(=O)[O-],8.12,,
C[NH+]1CCCC1c1cccnc1,8.13,,
NC(=O)CC1CCCc2sc3nc(C(=O)NCc4ccc5c(c4)NC(=O)CO5)[nH]c(=O)c3c21,8.13,,CHEMBL460899
Cc1ccsc1CNC(=O)C(CCc1ccccc1)NC(=O)C(NC(=O)c1ccc(OCc2ccccc2)cc1)C(C)O,8.13,,
C[N+]1CCc2nc(C(=O)Nc3ccccc3NC(=O)c3cc4cc(Cl)ccc4[nH]3)sc2C1,8.13,,
N#Cc1c(O)c2c(-c3ccc(-c4ccccc4O)cc3)c(Cl)sc2[nH]c1=O,8.13,,CHEMBL3957427
COC(=O)c1ccc(CN2C(COc3ccccc3)C(O)C(O)C(COc3ccccc3)N(Cc3ccc(CO)cc3)S2(=O)=O)cc1,8.14,,
c1ccc(CC2CN(c3cc(-c4ccncc4)c(-c4ccc5ccccc5c4)nn3)CC[NH2+]2)cc1,8.14,,
NS(=O)(=O)c1ccc2[nH]c(C(=O)N[NH3+])c(-c3ccccc3)c2c1,8.14,,
O=C(CC(Cc1ccc(-c2ccc3c(c2)OCO3)cc1)C(=O)NC1c2ccccc2CC1O)NO,8.14,,
CCCc1[nH]c(C)c2c(C)nc3ccc(OC)nc3[n+]12,8.14,,
CC1(C)C[n+]2c(CSC(=NC3CCCCC3)NC3CCCCC3)csc2N1,8.14,,
CC1(C)C[n+]2c(CSC(=NC3CCCCC3)NC3CCCCC3)csc2N1,8.14,,
NS(=O)(=O)c1ccc(C(=O)NCC(F)(F)C(F)(F)F)cc1,8.14,,CHEMBL75113
CCCCCCCOC1OC(CO)C(O)C(O)C1O,8.14,,
CCC1(CC)CC(C(=O)NCc2ccc(C(N)=[NH2+])cc2)n2c1c(Cl)nc(NC1CCC1)c2=O,8.14,,
CS(=O)(=O)NCCC1CCN(c2ncnc3cc(C(N)=O)sc23)CC1,8.14,,CHEMBL2338810
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N=C4,8.15,,
CCC(C)(C)C(=O)C(=O)N1CCCCC1C(=O)OC(CCc1ccccc1)C1CCCCC1,8.15,,
CCCCC(CN(O)C=O)C(=O)NC(C(=O)N(C)C)C(C)(C)C,8.15,,
CC(Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1,8.15,,CHEMBL280752
Cc1cc(C)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,8.15,,CHEMBL299001
CSCCC([NH3+])C(=O)NS(=O)(=O)OCC1OC(n2cnc3c(N)ncnc32)C(O)C1O,8.15,,
CCCn1c(C2CC[NH+](C)CC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CC2)n1,8.15,,
COc1ccc(-c2c(S(C)(=O)=O)ccc(C(=O)C3C=NN(C(C)(C)C)C3=O)c2C)cc1,8.15,,
C=C(C)C1C[NH2+]C(C(=O)[O-])C1CC(=O)[O-],8.15,,
C[NH+]1CC[NH+](CCCOc2ccccc2Nc2nc(C=N)nc3c2ncn3C2CCCC2)CC1,8.15,,
O=C(NC1c2ccccc2CC1O)C(OCc1cccc(F)c1)C(O)C(O)C(OCc1cccc(F)c1)C(=O)NC1c2ccccc2CC1O,8.15,,
COc1cc(-c2ccc3c(c2)NC(=O)C3=Cc2ccc[nH]2)ccc1O,8.15,,
CS(=O)(=O)N1CCC(C2c3ccc(Cl)cc3C(N3CC[NH2+]CC3)=Cc3cccnc32)CC1,8.15,,
NC(=O)c1nn(-c2ccc(S(N)(=O)=O)cc2)c2c1CCc1[nH]ncc1-2,8.15,,CHEMBL361862
NC(=[NH2+])NCc1ccccc1CCCCCCCCCC(=O)NC(CCCC[NH3+])C(=O)NO,8.15,,
CC(O)C1C(=O)C2C3c4c[nH]c5cccc(c45)CC3C(C)(C)N2C1=O,8.15,,
CN(C)C(=O)C(NC(=O)CNC(=O)C(O)C(CC1CC1)NC(=O)C1C2C(CN1C(=O)C(NC(=O)OC(C)(C)C)C(C)(C)C)C2(C)C)c1ccccc1,8.15,,
CC=CC(=O)CC1CCC(C)C(CC(=O)NCC(O)C(C)C(=O)NCCCC2OC3(CCCC(CCC(C)C=C(C)C(C)O)O3)CCC2C)O1,8.15,,
OCC1=CC([NH2+]C2CC(CO)C(O)C(O)C2O)C(O)C(O)C1O,8.15,,
NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1,8.15,This molecule is an organic molecular entity.,CHEMBL328560
Cc1ccccc1-n1c(Cn2nc(C#CCO)c3c(N)ncnc32)nc2cccc(C)c2c1=O,8.15,,CHEMBL1213116
NC(=O)Nc1sc(-c2ccccc2)cc1C(=O)NC1CCC[NH2+]C1,8.15,,
COc1cc(OC)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl,8.15,,CHEMBL207994
CC(C)CC(NC(=O)C(O)C([NH3+])Cc1ccccc1)C(=O)[O-],8.15,,
CC1CN(c2ccc(Nc3ncc4c(=O)c(C(N)=O)cn(-c5ccc6c(c5)CCC6)c4n3)cc2)CC(C)[NH2+]1,8.15,,
[NH3+]CCc1cnc[nH]1,8.15,,
Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(N4CC[NH+](C)CC4)cc3)nc2n2c3ccccc3nc12,8.15,,
NS(=O)(=O)c1nnc(NS(=O)(=O)c2ccccc2)s1,8.15,,CHEMBL73962
Cc1nc2c(N)ncnc2n1C1OC(C[NH+](C)CCO[NH3+])C(O)C1O,8.15,,
CC(=O)Nc1nc(-c2ccc3nccnc3c2)c(-c2ccc(F)c(C)n2)[nH]1,8.15,,
CCc1cc(CCC2(C3CCCC3)CC(O)=C(Cc3nc4nc(C)cc(C)n4n3)C(=O)O2)cc(CC)n1,8.15,,CHEMBL490671
Cn1c(=O)cc(N2CCCC([NH3+])C2)n(Cc2ccccc2C#N)c1=O,8.15,,
CC1(C)CN=C2C(O)c3cc(S(=O)(=O)N4CCCC4COc4ccccc4)ccc3N2C1,8.15,,
O=C(NCCC(c1ccccc1)c1ccccc1)c1cccnc1,8.15,,CHEMBL560537
Cc1cnc(Nc2ccccc2)nc1-c1c[nH]c(C(=O)NC(CO)c2ccccc2)c1,8.15,,
COc1ccc(N2CC[NH+](C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2,8.15,,
c1cc(-c2ccnc3ccc(-c4cnc5[nH]ncc5c4)cc23)ccn1,8.15,,
O=C(c1ccc(F)nc1)N1CCCC1c1nc(Nc2cc(C3CC3)[nH]n2)c2cccn2n1,8.15,,
CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCC[NH+](C)C)n1,8.15,,
Cc1nc(N)nc2c1nc(-c1cn[nH]c1)c(=O)n2C(C)C,8.15,,CHEMBL1234917
Nc1nc(-c2c(Cl)cc(Cl)cc2OCCCC(F)(F)F)c2cn(C(=O)NC3CCC3)cc2n1,8.15,,
N#Cc1csc(NC(=O)CN2C(=O)CCc3ccccc32)c1-c1ncn[nH]1,8.15,,CHEMBL1682015
CCC(O)(CC)c1ccc2c(-c3ccc(OC)cc3)c(-c3n[nH]c4ccsc34)[nH]c2c1,8.15,,CHEMBL2017555
O=c1[nH]c(-c2ccc(NCC3CC[NH2+]CC3)cc2Cl)nc2c1oc1ccc(Br)cc12,8.15,,
CNc1nc(C)c(-c2nc(Nc3cccc(N4CCCN(C(C)=O)CC4)c3)ncc2C#N)s1,8.15,,CHEMBL2348651
CNc1nc(C)c(-c2nc(Nc3cccc(N4CCC[NH2+]CC4)c3)ncc2C#N)s1,8.15,,
N#CC1(c2cccc(C(=O)Nc3cc(Oc4ccc5nc(NC(=O)C6CC6)sc5n4)ccc3F)c2Cl)CC1,8.15,,CHEMBL2063743
CCCS(=O)(=O)Nc1ccc(F)c(-c2cc3cnc(NCCCO)nc3n(C)c2=O)c1F,8.15,,CHEMBL2023498
CC1CCC(C(=O)N(c2cc(C#CC(C)(C)C)sc2C(=O)[O-])[NH+](C)C)CC1,8.15,,
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(O)[NH2+]C4,8.15,,
O=S(=O)(c1ccc(NC(=S)NCc2cccnc2)cc1)N1CCCCC1,8.15,,CHEMBL1586371
COc1ccc(-c2ccc(C(=O)NC(CO)C(C)(C)C)cc2C(=O)[O-])c(C(=O)Nc2ccc3c(N)nccc3c2)n1,8.15,,
Cc1ccc(C(=O)NC2C=C2)cc1NC(=O)c1cnc(-c2ccccc2Cl)s1,8.15,,
N#CCOC(=O)c1ccc(-c2cc(=O)c3ccccc3o2)cc1,8.15,,CHEMBL2431803
Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CC[NH2+]CC2)n1,8.15,,
Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CC[NH2+]CC2)n1,8.15,,
Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CC[NH2+]CC2)n1,8.15,,
C[NH+](C)C1CCN(C(=O)C(CNC(=O)c2ccc(Cl)s2)NS(=O)(=O)c2cccc(N3CCCCC3=O)c2OC(F)F)C1,8.15,,
CC1COCC[NH+]1CC1CN(S(=O)(=O)c2cccs2)CCN1c1ccc(C(C)(O)C(F)(F)F)cc1,8.15,,
C[NH+](C)CCNc1cc[n+]2[nH]cc(-c3cn[nH]c3)c2n1,8.15,,
CC(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC1(C)CCCCCCC=CCCCC(C)(C(=O)NC(CO)C(=O)NC(C)C(=O)NC(C)C(=O)[O-])NC(=O)C(CC2CCC2)NC(=O)C(CCC(N)=O)NC(=O)C(C)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CCC(=O)[O-])NC1=O)C(C)O,8.15,,
CCOc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)cnc2c1,8.15,,CHEMBL3109011
CC(O)(c1ccc(-c2ccc(S(=O)(=O)c3ccc(N)nc3)nc2Nc2ccccc2)nc1)C(F)(F)F,8.15,,CHEMBL3578087
O=c1cc(N2CCOCC2)[nH+]c2n1CCC(C(F)(F)F)N2c1cc(F)cc(F)c1,8.15,,
CC(C)OCCN1C2=[NH+]C(=[N+]3CCOCC3)CC(=O)N2CCC1C(F)(F)F,8.15,,
CCN1C(C)=C(C(=O)OC(C)C)C(c2ccccc2Cl)C(C(=O)[O-])=C1C(=O)[O-],8.16,,
CCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1OC(CO)C(O)C(O)C1O)C(O)C(O)CCCCC,8.16,,
O=C(Nc1cccc(Oc2ccc(Nc3ncnc4ccn(CCOCCO)c34)cc2Cl)c1)NC1CCCCC1,8.16,,CHEMBL2322330
COc1cc(Cc2cnc(N)nc2N)cc(C=CC(=O)N2[NH2+]Cc3ccccc3C2CC(C)C)c1OC,8.16,,
COC(=O)c1ccc(NC(=O)NCC2CCC(C(=O)N3CCCC3C=N)[NH2+]2)cc1,8.17,,
[NH3+]C1Cn2c(nc3cnccc32)CC1c1cc(F)c(F)cc1F,8.17,,
CCC(O)CC(=O)NC(CC(N)=O)C(=O)NC(CCC(N)=O)C(=O)NC(CO)CC(C)C,8.17,,
COc1cc2c(cc1OC)C1CC([NH3+])C(N3CC(CF)CC3=O)C[NH+]1CC2,8.17,,
CCCCCCNC(=O)c1ccc(S(N)(=O)=O)cc1,8.17,,CHEMBL72963
CC(C)CC(=O)CCC(=O)N1CC[NH+](Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,8.17,,
Cc1ccc(C(=O)Nc2ccon2)cc1-n1cnc2ccc(N3CC[NH+](C)CC3)cc2c1=O,8.17,,
CC1CCN(C(=O)C(CC(=O)NCC2CCCN(C(N)=[NH2+])C2)NS(=O)(=O)c2ccc3ccccc3c2)C(C(=O)[O-])C1,8.17,,
CCC(CC)Nc1cc(C)nc(Oc2c(C)cc(C)cc2C)c1C,8.17,,CHEMBL270948
COc1ccc(-c2nc(C(C)Sc3nc(N)cc(N)n3)c(C)s2)cc1OCCF,8.17,,CHEMBL3358094
NC(=[NH2+])c1ccc(CC(NC(=O)CNS(=O)(=O)c2ccc3ccccc3c2)C(=O)N2CCCCC2)cc1,8.179999999999998,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,8.179999999999998,,
CC1C(=O)NCCCN1C(=O)CC([NH3+])Cc1cc(F)c(F)cc1F,8.179999999999998,,
CC(CC(O)C(COCc1cc(F)cc(F)c1)NC(=O)c1cc(C(=O)NC(C)c2ccccc2)cc(N(C)S(C)(=O)=O)c1)C(=O)NC(C(=O)NCc1ccccc1)C(C)C,8.179999999999998,,
[NH3+]CCCCC([NH2+]C(CCc1ccccc1)C(=O)[O-])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-],8.179999999999998,,
CC1(C)C[n+]2c(CSC(=NC3CCCCC3)NC3CCCCC3)csc2N1,8.179999999999998,,
[NH3+]CC1(O)CN(C(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C1,8.179999999999998,,
Cn1cc(-c2ccnc(C3COCC[NH2+]3)c2)c(-c2ccc(F)cc2)n1,8.179999999999998,,
COc1ccc(CC(NC(=O)C(C)NC(=O)C[NH+]2CCOCC2)C(=O)NC(CC2CCCCC2)C(O)C(C)CO)cc1,8.179999999999998,,
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N=C4,8.189999999999998,,
CC([NH3+])C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(B(O)O)C(C)C,8.189999999999998,,
C=CC[NH+](C)CCCCCCOc1ccc(C(=O)c2ccc(Br)cc2)c(F)c1,8.189999999999998,,
COC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(B(O)O)C(C)C,8.189999999999998,,
CC(=O)NC(C(=O)NC(CC(=O)[O-])C(=O)NC(C(=O)NC(C)C(=O)NC(C=O)CC(=O)[O-])C(C)C)C(C)C,8.189999999999998,,
O=C([O-])c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)[NH2+]C3)cc1,8.189999999999998,,
N=CC1(NC(=O)C2CC(S(=O)(=O)c3ccccc3Cl)CN2C(=O)C2(c3ccc(I)cc3)CC2)CC1,8.189999999999998,,
Cn1cncc1C(O)(c1ccc(Cl)cc1)c1cc2cc(C(=O)N[NH+]3CCOCC3)cc(-c3ccccc3)c2o1,8.189999999999998,,
C[NH+]1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1,8.189999999999998,,
CC(C)Nc1nc2ccc(-c3ocnc3-c3ccccc3F)cc2s1,8.189999999999998,,CHEMBL257341
COc1cc(Nc2ncnc(-c3cccnc3Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)n2)cc(OC)c1OC,8.189999999999998,,
Cc1cc2cc(NC(NC#N)=[NH+]C3CCCCN(CC(=O)N4CCCC4)C3=O)ccc2o1,8.189999999999998,,
Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O,8.189999999999998,,CHEMBL1738710
CC(C)(C)C1Cc2cc(F)ccc2S(=O)(=O)N(CC(O)C(Cc2ccccc2)NC(=O)OC2CCOC2)C1,8.189999999999998,,
CCCCCCCCCCNC(=O)NC1CCCCC1,8.199999999999998,,CHEMBL67158
CCC1C[NH2+]Cc2ccc(NC(=O)c3ccc4cc(C(N)=[NH2+])ccc4c3)cc21,8.199999999999998,,
Cc1n[nH]c2ccc(-c3cncc(OCC([NH3+])Cc4c[nH]c5ccccc45)c3)cc12,8.199999999999998,,
Cc1[nH]nc2ccc(-c3cncc(OCC([NH3+])Cc4c[nH]c5ccccc45)c3)cc12,8.199999999999998,,
[NH3+]C(CCO)(CCO)CCO,8.199999999999998,,
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,8.199999999999998,This molecule is a member of morpholines.,CHEMBL458997
Nc1ncnc2[nH]cnc12,8.199999999999998,"This molecule is the parent compound of the 6-aminopurines, composed of a purine having an amino group at C-6. It has a role as a human metabolite, a Daphnia magna metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a purine nucleobase and a member of 6-aminopurines. It derives from a hydride of a 9H-purine. A purine base and a fundamental unit of adenine nucleotides. This molecule is a purine nucleobase with an amine group attached to the carbon at position 6. This molecule is the precursor for adenosine and deoxyadenosine nucleosides. This molecule is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). This molecule is a metabolite found in or produced by Saccharomyces cerevisiae. This molecule is a natural product found in Streptomyces piomogenus, Bridelia balansae, and other organisms with data available. This molecule is a purine base. This molecule is found in both DNA and RNA. This molecule is a fundamental component of adenine nucleotides. This molecule forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose; it forms adenosine triphosphate (ATP), a nucleotide, when three phosphate groups are added to adenosine. Adenosine triphosphate is used in cellular metabolism as one of the basic methods of transferring chemical energy between chemical reactions. Purine inborn errors of metabolism (IEM) are serious hereditary disorders, which should be suspected in any case of neonatal fitting, failure to thrive, recurrent infections, neurological deficit, renal disease, self-mutilation and other manifestations. Investigation usually starts with uric acid (UA) determination in urine and plasma. (OMIM 300322, 229600, 603027, 232400, 232600, 232800, 201450, 220150, 232200, 162000, 164050, 278300).  (A3372, A3373).",CHEMBL226345
COc1cc(Nc2nccc(Nc3ccc4c(C)[nH]nc4c3)n2)cc(OC)c1OC,8.199999999999998,,
CCCCC(CC(O)(O)C(CCCC)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)CC)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O,8.199999999999998,,
COc1ccc(F)cc1C(C)(C)CC(O)(CNc1cc(C)cc2c1cnn2-c1cccc(C(=O)N2CCCC2C(N)=O)c1)C(F)(F)F,8.199999999999998,,
CC1CC(NC(=O)OC(C)(C)C)CN(c2cc(-c3ccc4c(N)[nH]nc4c3)nc(N)n2)C1,8.199999999999998,,
CCC(C)C1NC(=O)C(C)n2cc(nn2)C2CCCN2C(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(CCCC[NH3+])NC(=O)C(C(C)O)NC(=O)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C[NH3+])CSSCC(C(=O)NC(Cc2ccccc2)C(=O)[O-])NC1=O,8.199999999999998,,
CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-c4cn[nH]c4)ccc3n2)cc1,8.199999999999998,,CHEMBL3330167
CC(C)(O)C1CC[NH+](Cc2ccc3nc(-c4cccc5n[nH]cc45)nc(N4CCOCC4)c3n2)CC1,8.199999999999998,,
O=[N+]([O-])c1cccc(CNc2nc(C(F)(F)F)nc3ncc(-c4cnn(C5CC[NH2+]CC5)c4)cc23)c1,8.199999999999998,,
CC(=O)NC(CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(=O)[O-])C(C)O)C(C)C,8.199999999999998,,
Cn1c(CNC(=O)C2C=CCN2C(=O)C(CC2CCCCC2)[NH2+]CC(=O)[O-])ccc1C(N)=[NH2+],8.21,,
O=CC1=CN=C(C(=O)[O-])CSC1c1cn2c(n1)COCC2,8.21,,
O=C(NC1CCC(O)CC1)c1ccc2c(c1)Cc1c(-c3ccc(-c4ccc(O)cc4)cc3)n[nH]c1-2,8.21,,
O=c1[nH]cnc2c(C3[NH2+]C(CO)C(O)C3O)c[nH]c12,8.21,,
O=c1[nH]cnc2c(C3[NH2+]C(CO)C(O)C3O)c[nH]c12,8.21,,
COc1cc2nccc(Oc3ccc(NC(=O)C4C(=O)N(c5ccccc5)[N+](C)=C4C)cc3F)c2cc1OC,8.21,,
O=C([O-])c1ccc(Nc2nccc(Nc3ccccc3C(=O)[O-])n2)cc1,8.21,,
Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21,8.21,,CHEMBL1254007
Cc1n[nH]c(C)c1CCCOc1cc(C(=O)[O-])ccc1F,8.21,,
CS(=O)(=O)CCCOc1cccc2c1cnn2-c1ccnc(NC2CCC(O)CC2)n1,8.21,,
CC(Oc1cccc2ccccc12)C(=O)Nc1ccc2oc(-c3ccncc3)nc2c1,8.21,,CHEMBL2348818
CN(Cc1cnc2[nH]c(=[NH2+])[nH]c(=[NH2+])c2n1)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,8.22,,
CNC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)C(CSc1cccs1)C(=O)NO,8.22,,CHEMBL3827321
CCOc1ccnc(CCNC(=S)Nc2ccc(C#N)cn2)c1F,8.22,,
COc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)c1,8.22,,CHEMBL134022
O=C(NCCOCCOCCNC(=O)c1cc2cc(Cl)ccc2[nH]1)c1cc2cc(Cl)ccc2[nH]1,8.22,,CHEMBL434025
NC(=[NH2+])c1ccc(CC(NC(=O)CNS(=O)(=O)c2ccc3ccccc3c2)C(=O)N2CCCCC2)cc1,8.22,,
O=C(CC[NH+]1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,8.22,,
NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,8.22,,CHEMBL319467
COc1c(C)c2c(c(O)c1CC=C(C)CCC(=O)[O-])C(=O)OC2,8.22,,
CC(C)CC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)NC(CO)Cc1ccc(O)cc1,8.22,,
NC(=O)c1ccc(S(=O)(=O)Nc2ccc3nc(N)[nH]c(=O)c3c2)cc1,8.22,,
CC(C)c1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O,8.22,"This molecule is a pyrimidone that is uracil which is substituted at positions 1, 5, and 6 by benzyloxymethyl, isopropyl, and benzyl groups, respectively. It is functionally related to a uracil.",CHEMBL436546
CCC(C)C(NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C1CCC[NH2+]1)C(C)C)C(=O)N1CCCC1C(=O)NC(CCSC)C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)[O-])C(=O)NCC(=O)NC(C)C(=O)NC(C(=O)[O-])C(C)O,8.22,,
C[NH+]1CC[NH+](CCn2cnc3c(NC4CCCCC4)nc(C=N)nc32)CC1,8.22,,
CC(NC(=O)C(CO)NS(=O)(=O)Cc1ccccc1)C(=O)NCc1ccc(C(N)=[NH2+])cc1,8.22,,
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(CO)Cc1ccccc1)C(C)C,8.22,,
NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3[nH]cnc3n2)cc1,8.22,,
CC(C=CC=C(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)=CC(=O)[O-],8.22,,
CC(C(=O)N1CCOCC1)N1CCC(NS(=O)(=O)c2ccc3cc(Cl)ccc3c2)C1=O,8.22,,
COc1ccc(S(=O)(=O)C(CC(=O)[O-])C(F)F)cc1,8.22,,
CC(C)CC(=O)NC(C(=O)NC(C(=O)NC(CC(C)C)C(O)CC(=O)NC(C)C(=O)NC(CC(C)C)C(O)CC(=O)[O-])C(C)C)C(C)C,8.22,,
CCCCNC(=O)C(C)CC(O)C([NH3+])CC(C)(C)CC(=O)N1CC(C(=O)OC)Cc2ccccc21,8.22,,
O=C(Cn1cnc(NC(=O)c2ccc(Cl)s2)n1)Nc1ccc(-n2ccccc2=O)cc1F,8.22,,CHEMBL564248
COc1cc(Nc2ncnc(-n3c(Nc4ccccc4)nc4ccccc43)n2)cc(OC)c1OC,8.22,,CHEMBL271131
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,8.22,,
Cc1cncc2cccc(S(=O)(=O)N3CCC[NH2+]CC3C)c12,8.22,,
O=C(Nc1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1)c1ccccc1Cl,8.22,,CHEMBL523991
CC(C)CCn1c(=O)c(C2=NS(=O)(=O)c3cc(OCC(N)=O)ccc3N2)c(O)c2ccccc21,8.22,,CHEMBL560922
CS(=O)(=O)c1ccc(C(CCNC(=O)c2ccc(C#N)cc2)c2ccc(F)cc2)cc1,8.22,,CHEMBL556716
NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCC[NH2+]4)cc3F)nc12,8.22,,
COc1ccc2[nH]n(CC3(c4ccccc4)NC(=O)NC3=O)c(=O)c2c1,8.22,,CHEMBL1087293
CC=C(C)C(=O)OC1C(C)=C2C(C1OC(=O)CCCCCCC)C(C)(OC(C)=O)CC(OC(=O)CCCc1ccc(O)c(CCCCCCNC(=O)OC(C)(C)C)c1)C1(O)C2OC(=O)C1(C)O,8.22,,
Nc1cc2c3c(c4c5ccccc5n5c4c2[n+](c1)[Ru+7]51(Cl)([C]=O)[NH+]Cc2cccc[n+]21)C(=O)NC3=O,8.22,,
COc1ccc(S(=O)(=O)N2Cc3cc(C#N)ccc3N(Cc3cncn3C)CC2Cc2ccccc2)cc1,8.22,,
CC1=C(C(=O)OCCO)C(c2ccc(C#N)cc2)NC(=O)N1c1cccc(C(F)(F)F)c1,8.22,,
OC1CCC(Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n(C4CCOC4)c3n2)CC1,8.22,,
CNC(=O)CC1NC(=O)c2csc(n2)-c2ccc(-c3nc(N(CCCCC(=O)[O-])C(=O)OC4CCC(C(=O)[O-])CC4)cs3)nc2-c2csc(n2)-c2csc(n2)C(C(O)c2ccccc2)NC(=O)CNC(=O)c2nc(sc2COC)C(C(C)C)NC(=O)c2nc1sc2C,8.22,,
CC1COc2c1ccc1c2c(C2C=CC=NC2=O)c(C(=O)NS(C)(=O)=O)n1Cc1cc(F)ccc1F,8.22,,
CCOc1ccc2cc(-c3nn(CC(C(C)C)[NH+](C)C)c4ncnc(N)c34)ccc2c1,8.22,,
Fc1ccc(-c2cnc3nnc(Cc4ccc5ncccc5c4)n3n2)cc1,8.22,,CHEMBL2170967
FC(F)(F)Oc1cccc(-n2nnc3ccc(NCC4CC[NH2+]CC4)nc32)c1,8.22,,
CNc1nc(C)c(-c2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2C#N)s1,8.22,,CHEMBL2312183
CC(C)c1ccc(-c2cc(=O)c3ccccc3o2)cc1,8.22,,CHEMBL2431867
N=CC1(NC(=O)C2CC(S(=O)(=O)c3ccccc3C(F)(F)F)C[NH2+]2)CC1,8.22,,
CN(C)C(=O)c1ccc(Nc2cc3c(cn2)cc(-c2cnn(C)c2)n3C(=O)OC(C)(C)C)c(Cl)c1,8.22,,CHEMBL3109933
CN(C)C(=O)c1ccc(Nc2cc3c(cn2)cc(-c2cnn(C)c2)n3C(=O)OC(C)(C)C)c(Cl)c1,8.22,,CHEMBL3109933
COc1cnc2c(NCc3nnc4ccc(-c5cc(C)ns5)nn34)ccnc2c1,8.22,,CHEMBL566685
Nc1[nH]nc2ccc(-c3ccc(NS(=O)(=O)c4cccc(Cl)c4)cc3)cc12,8.22,,
COc1ccc(S(=O)(=O)N2Cc3cc(C#N)ccc3N(Cc3cncn3C)CC2Cc2ccc(OC(=O)NCc3ccccc3)cc2)cc1,8.22,,
CN1C(=[NH2+])NC2(c3cc(-c4cccc(C#N)c4)cs3)CN(c3ncccc3C#N)CC2C1=O,8.22,,
CCc1[nH]c2nc(Sc3cnc4ncc(=O)[nH]c4c3)nc(N3CCC([NH3+])C3)c2c1Cl,8.22,,
CCC(=O)NCC(NC(=O)C(NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCCC[NH3+])C(C)C)C(=O)NC(CCSC)C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)[O-])C(C)C)C(C)C,8.22,,
CC12CCC(O)CC1CCC1C2CC(O)C2(C)C(C3=CC(=O)OC3)CCC12O,8.22,,
Cn1cc(-c2ccnc3c2OCC[NH2+]C3)c(-c2ccc(F)cc2)n1,8.22,,
C[NH2+]C(C)C(=O)NC1CN(C(=O)c2ccc(N)cc2)c2ccccc2N(Cc2c(OC)ccc3ccccc23)C1=O,8.22,,
COCCN1Cc2nc(C)c(C[NH3+])c(-c3ccc(Cl)cc3Cl)c2C1=O,8.22,,
COc1cc(C(N)=O)ccc1NC(=O)C1[NH2+]C(CC(C)(C)C)C2(C(=O)Nc3cc(Cl)sc32)C1c1cccc(Cl)c1F,8.22,,
Cc1ccc(C(=O)Nc2ccc(C[NH+]3CC[NH+](C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,8.22,,
O=C(Cc1ccccc1)NC(Cc1cccc(C(=O)[O-])c1)B(O)O,8.23,,
O=C(Nc1c[nH]nc1-c1nc2ccccc2[nH]1)c1ccccc1,8.23,,CHEMBL522891
Cc1cc(Nc2cc(N3CC[NH+](C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)[nH]n1,8.23,,
COc1ccc(S(=O)(=O)NC(CO)C(=O)NO)cc1,8.23,,
COCCOc1ccc(Nc2ncc(Cl)c(NC3CC3)n2)cc1,8.23,,
COc1cc2c(cc1OC)C(=O)C(CC1CC[NH+](Cc3ccccc3)CC1)C2,8.24,,
CC(=O)Nc1nnc(S(N)(=O)=O)s1,8.24,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
CNS(=O)(=O)Cc1ccc(NN=C2C(=O)Nc3ccc4ncsc4c32)cc1,8.24,,
CC(=O)CCC1C(=O)NC(C(C)C)C(=O)NC(Cc2cccc(O)c2)C(=O)N2CCCC([NH2+]2)C(=O)OC(C(C)=CCO)CC=CC=CC(O)C(C)C1O,8.24,,
O=C(NC(Cc1ccccc1)C(O)CC1(Cc2ccccc2)NC=C(C2CNC(=O)c3ccccc32)C1=O)OC1CCOC1,8.24,,
Oc1ccc(-c2cc3cc(O)ccc3o2)cc1,8.24,,CHEMBL367588
CC(=O)Nc1nnc(S(N)(=O)=O)s1,8.24,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
COC(COS(=O)(=O)[O-])C(=O)NC(C(=O)N1C(C(=O)NCCC2=CCN(C(N)=[NH2+])C2)CC2CC(O)C(O)CC21)C(Cl)C(C)C,8.24,,
O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,8.24,"This molecule is a selective inhibitor of phosphodiesterase-4 (PDE-4) that has unique antiinflammatory activity and is used to treat and prevent exacerbations of chronic obstructive pulmonary disease (COPD). This molecule has not been linked to significant serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury. This molecule is a benzamide obtained by formal condensation of the carboxy group of 3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzoic acid with the amino group of 3,5-dichloropyridin-4-amine. Used for treatment of bronchial asthma and chronic obstructive pulmonary disease. It has a role as a phosphodiesterase IV inhibitor and an anti-asthmatic drug. It is a member of benzamides, a chloropyridine, an aromatic ether, an organofluorine compound and a member of cyclopropanes. This molecule is a highly selective phosphodiesterase-4 (PDE4) inhibitor. PDE4 is a major cyclic-3',5′-adenosinemonophosphate (cyclic AMP, cAMP)-metabolizing enzyme expressed on nearly all immune and pro-inflammatory cells, in addition to structural cells like those of the smooth muscle or epithelium. The resultant increase in intracellular cAMP induced by roflumilast's inhibition of PDE4 is thought to mediate its disease-modifying effects, although its precise mechanism of action has yet to be elucidated.  The oral formulation of roflumilast is indicated to manage chronic obstructive pulmonary disease. It was first approved by the EMA in July 2010, and by the FDA in January 2018. This molecule topical cream is indicated to treat plaque psoriasis. The cream formulation was first approved by the FDA in July 2022 and by Health Canada in April 2023. On December 15, 2023, the FDA approved a new topical foam formulation of roflumilast for the treatment of seborrheic dermatitis in patients aged 9 years and older. This molecule is a Phosphodiesterase 4 Inhibitor. The mechanism of action of roflumilast is as a Phosphodiesterase 4 Inhibitor. This molecule is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3',5'-adenosine monophosphate (cAMP) and cAMP-mediated signaling. cAMP prevents phosphorylation of spleen tyrosine kinase (SYK) and abrogates activation of the PI3K/AKT/mTOR signaling pathway, which may result in the induction of apoptosis. PDE4, a member of the PDE superfamily that hydrolyses cAMP and 3',5'-cyclic guanosine monophosphate (cGMP) to their inactive 5' monophosphates, is upregulated in a variety of cancers and may contribute to chemoresistance; it also plays a key role in inflammation, especially in inflammatory airway diseases.",CHEMBL193240
CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1,8.24,"This molecule is a member of the class of benzamides obtained by formal condensation of the carboxy group of 3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1-yl}-4-methylbenzoic acid with the amino group of methylamine. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor and an anti-inflammatory agent. It is a member of benzamides, an organofluorine compound, a pyridone, an organobromine compound and an aromatic ether. This molecule has been investigated for the treatment of Osteoarthritis.",CHEMBL1088751
C[C]1O[Fe+7]2345O[C](C)N(CCCC6NC(=O)C(CCC[N+](=C(C)O2)O3)NC(=O)CNC(=O)CNC(=O)CNC(=O)C(CCCN1O4)NC6=O)O5,8.24,,
N#Cc1cccc(CC(NC(=O)C2CCCN2C(=O)C([NH3+])Cc2ccccc2)B(O)O)c1,8.25,,
NC(=[NH2+])c1ccc2nc(Cc3nc4ccccc4[nH]3)[nH]c2c1,8.25,,
NS(=O)(=O)c1ccc(C(=O)NCc2ccccc2)cc1,8.25,"This molecule is a secondary carboxamide resulting from the formal condensation of the carboxy group of 4-sulfamoylbenzoic acid with the amino group of 1-phenylmethanamine. It is a potent inhibitor of carbonic anhydrase II. It has a role as an EC 4.2.1.1 (carbonic anhydrase) inhibitor and a fungal metabolite. It is a secondary carboxamide, a member of benzamides, a sulfonamide and a member of benzenes.",CHEMBL302715
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4O,8.25,,
CC(=CC=CC(C)C(=O)[O-])C1C[NH2+]C(C(=O)[O-])C1CC(=O)[O-],8.25,,
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCC[NH+]1CCOCC1,8.25,,
O=C(C1CC([NH+]2CCC(c3cc(C(F)(F)F)nn3-c3ccccc3)CC2)C[NH2+]1)N1CCSC1,8.25,,
COc1ccc(C(C)=O)c(O)c1C1CC1NC(=S)Nc1ccc(C#N)cn1,8.26,,
CCCCOc1ncc(C(C)=O)cc1-c1nc2c(CC)n(C3C[NH+](CC)C3)nc2c(=O)[nH]1,8.26,,
CC(C)(c1ccc(O)cc1)c1ccc(O)cc1,8.26,"This molecule appears as white to light brown flakes or powder. Has a weak medicine odor. Sinks in water. (USCG, 1999) These molecules is a bisphenol that is 4,4'-methanediyldiphenol in which the methylene hydrogens are replaced by two methyl groups. It has a role as a xenoestrogen, an environmental contaminant, a xenobiotic and an endocrine disruptor. This molecule is a diphenylmethane derivative with two hydroxyphenyl groups. This molecule (BPA) is a colorless solid that is used in the synthesis of commercial plastics, including polycarbonates and epoxy resins, which are incorporated into a wide variety of consumer goods. Ingested BPA may exhibit estrogenic effects. Exposure to BPA may increase the risk of certain cancers. This molecule is an organic compound with two phenol functional groups. It is a difunctional building block of several important plastics and plastic additives. With an annual production of 2-3 million metric tonnes, it is an important monomer in the production of polycarbonate. It is a potential food contaminant arising from its use in reusable polycarbonate food containers such as water carboys, baby bottles and kitchen utensils.



Suspected of being hazardous to humans since the 1930s, concerns about the use of bisphenol A in consumer products were regularly reported in the news media in 2008 after several governments issued reports questioning its safety, and some retailers removed baby bottles and other children's products made from it from their shelves.",CHEMBL418971
O=C(Nc1ccccc1S(=O)(=O)Nc1ccc(Cl)cn1)c1ccc(-n2ccccc2=O)cc1,8.26,,CHEMBL402761
CC(C)CC(NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC1CCCCC1)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NC(C=O)C(C)O,8.26,,
COC(C)C(=O)NC(Cc1cccc(-c2nccs2)c1)C(O)C[NH2+]C1CC2(CCC2)Oc2ncc(CC(C)(C)C)cc21,8.26,,
CC(=O)NC1C(=NOC(=O)Nc2ccccc2)OC(CO)C(O)C1O,8.269999999999998,,
O=C(c1cc(Cl)c(O)cc1O)N1CCCC1c1ccc(C[NH+]2CCC(F)(F)C2)cc1,8.269999999999998,,
CCNC(=O)Nc1sc2ccccc2c1C(=O)N1CCC([N+]2CCCC3(C2)CC(C)(C)OC3=O)CC1,8.269999999999998,,
COC(=O)NC(C(=O)N[NH+](CCCC1(O)Cc2ccc(cc2)CC=CCNC(=O)C(C(C)C)NC1=O)Cc1ccc(-c2ccncc2)cc1)C(C)(C)C,8.269999999999998,,
CC#Cc1cncc(-c2cccc(C3(C4CC4)NC(=[NH2+])N(C)C3=O)c2)c1,8.269999999999998,,
CCC([NH2+]C)C(=O)NC1C(=O)N2C(CCC1CO)CCC2C(=O)NC(c1ccccc1)c1cn(CCCCc2ccc(CCCCn3cc(C(NC(=O)C4CCC5CCC(CO)C(NC(=O)C(CC)[NH2+]C)C(=O)N54)c4ccccc4)nn3)cc2)nn1,8.269999999999998,,
Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCCNC1=O,8.269999999999998,,
CCOc1cc(C(=O)[O-])nc2c(NC(=O)c3cc(O)c4cccc(NC(=O)c5cc(O)c6cccc(NC(=O)c7cc(OCC(C)C)c8cccc(NC(=O)NCCCCOc9cccc(CNC(=O)c%10ccc(S(N)(=O)=O)cc%10)c9)c8n7)c6n5)c4n3)cccc12,8.269999999999998,,
Cc1nc(N)ncc1-c1nc(N2CCOCC2)c2sc(C[N+]3CCN(S(C)(=O)=O)CC3)cc2n1,8.279999999999998,,
O=C(NCc1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1)c1ccc(F)nc1,8.279999999999998,,CHEMBL1222855
CCc1nc(CC(C)(C)C)c(C[NH3+])c(-c2ccc(C)cc2)c1CC(=O)[O-],8.279999999999998,,
Cc1ccc(-c2ccc(CCC(=O)NC(CCC(=O)[O-])C(N)=O)cc2)s1,8.279999999999998,,
O=C(CCC(NC(=O)c1ccc(C#Cc2ccccc2)cc1)C(=O)NO)NCCCO,8.279999999999998,,
CCCCNc1ncc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)c(NC2CCC(O)CC2)n1,8.279999999999998,,
C#CCC(NC(=O)NC(CCCCNC(=O)c1ccc(I)cc1)C(=O)[O-])C(=O)[O-],8.279999999999998,,
O=C(NC(CCCCNC(=O)c1ccc(I)cc1)C(=O)[O-])NC(Cc1ccco1)C(=O)[O-],8.279999999999998,,
CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,8.29,This molecule is a corticosteroid hormone.,CHEMBL125608
Cc1c(N)nc(C(CC(N)=O)[NH2+]CC([NH3+])C(N)=O)nc1C(=O)NC(C(=O)NC(C)C(O)C(C)C(=O)NC(C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)C(C)O)C(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)c1cnc[nH]1,8.29,,
O=C([O-])CCCCC1SCC2NC(=O)NC21,8.29,,
Cn1cc(-c2ccc(=O)n(C)c2)c(COc2ccc(-c3ccc4ccccc4n3)cc2)n1,8.29,,
CC(C)(C)NC(=O)C1CCCC[NH+]1CC(O)C1Cc2ccc(cc2)OCCCC(=O)NC(CC(N)=O)C(=O)N1,8.3,,
COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,8.3,"This molecule is a parenterally administered folate antagonist that is used as a second line therapy for severe Pneumocystis jirovecii (previously carinii) pneumonia. This molecule therapy has been associated with transient, mild serum enzyme elevations during therapy, but has not been convincingly linked to instances of acute, clinically apparent liver injury. This molecule is a member of quinazolines. It has a role as an antifungal drug. A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against pneumocystis pneumonia in AIDS patients. Myelosuppression is its dose-limiting toxic effect. This molecule is a methotrexate derivative with potential antineoplastic activity.  This molecule inhibits the enzyme dihydrofolate reductase, thereby preventing the synthesis of purine nucleotides and thymidylate, with subsequent inhibition of DNA and RNA synthesis.  This molecule also exhibits antiviral activity. (NCI04) A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against pneumocystis pneumonia in AIDS patients. Myelosuppression is its dose-limiting toxic effect. [PubChem]",CHEMBL119
CCOc1ccnc(CCNC(=S)Nc2ccc(Cl)cn2)c1F,8.3,,
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4O,8.3,,
O=C(NC1C[NH2+]CCCC1OC(=O)c1ccc(O)cc1)c1ccc(O)cc1,8.3,,
O=CC(CC(=O)[O-])NC(=O)c1ccc(CNC(=O)c2ccc(Nc3cnc4ccccc4n3)cc2)nc1,8.3,,
O=C(CC1Sc2ccccc2NC1=O)NO,8.3,,CHEMBL37719
COc1ccc(O)c(C(=O)c2ccc(C(=O)OC3CCC[NH2+]CC3NC(=O)c3ccncc3)cc2)c1F,8.3,,
C[NH2+]C(C)C(=O)NC(C(=O)N1CC(Oc2ccccc2)CC1C(=O)NC1CCCc2ccccc21)C(C)(C)C,8.3,,
C[NH2+]C(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC1CCC([NH3+])CC1,8.3,,
Oc1ccc2nc(-c3cccc4c(O)cccc34)oc2c1,8.3,,CHEMBL185918
O=C1Nc2cc(Br)ccc2C1=C1Nc2ccccc2C1=NO,8.3,,
Cc1nc(CN2CCN(C(C(=O)NC(Cc3ccccc3)C(O)CN(CC(C)C)S(=O)(=O)c3ccc(C=NO)cc3)C(C)C)C2=O)cs1,8.3,,
CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12,8.3,,CHEMBL194322
[NH3+]C(CCCCB(O)O)C(=O)[O-],8.3,,
COC(=O)NC(C(=O)N[NH+](Cc1ccc(-c2cccnc2)cc1)CC(O)(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O)C(C)(C)C,8.3,,
CSCCC([NH3+])C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NCC(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(C)C(=O)[O-],8.3,,
[NH3+]C(CCC(=O)NCC(=O)NCC(=O)[O-])C(=O)[O-],8.3,,
CCCN(CCC)C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C[NH2+]Cc2cccc(I)c2)c1,8.3,,
ON=Cc1ccc(-c2ccc(O)cc2)c2ccccc12,8.3,,
CC(c1ccc[nH]1)C1C(=O)Nc2ccc(NC(N)=O)cc21,8.3,,
N#Cc1cnn2c(Nc3ccccc3)nc(NCc3ccc(Cl)cc3)nc12,8.3,,CHEMBL230347
CCCN(CCC)C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C2CC(OCc3ccccc3)C[NH2+]2)c1,8.3,,
CC1(c2nc3c(C(N)=O)cccc3[nH]2)CCC[NH2+]1,8.3,,
COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCC[NH+]1CCOCC1,8.3,,
CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CC[NH+](C)CC4)cc3OC)nc2N1C1CCCC1,8.3,,
COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CC[NH+](C)CC4)cc3)c2C1)c1ccccc1,8.3,,
CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,8.3,This molecule is a 21-hydroxy steroid.,CHEMBL1730629
O=C([O-])c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,8.3,,
NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)NC1CCC[NH2+]C1,8.3,,
O=C1N=CCC=C1c1c(C(=O)[O-])n(Cc2cc3c(=O)[nH]cnc3cc2F)c2cc(F)c3ccoc3c12,8.3,,
Cc1oc(-c2ccccc2)nc1CCOc1cccc(Cc2nn(-c3ccccc3)nc2CC(=O)[O-])c1,8.3,,
N=CC1CC2CC2N1C(=O)C([NH3+])C12CC3CC(CC(O)(C3)C1)C2,8.3,,
CCCN(CCC)C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C2[NH2+]CN(Cc3ccccc3)C2=O)c1,8.3,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,8.3,,
Cc1cccc(Nc2nc(NC3CCCCC3[NH3+])ncc2C(N)=O)c1,8.3,,
Cc1ccc(-c2ccc3c(ccc4sc5c(c43)NCC(C)NC5=O)n2)cn1,8.3,,
Cn1c(=O)c2c(nc(N3CCCC([NH3+])C3)n2Cc2ccccc2C#N)n(C)c1=O,8.3,,
N#Cc1ccccc1Cn1c(N2CCCC([NH3+])C2)[nH+]cc(Br)c1=O,8.3,,
CS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)C=C(c1c(O)c3cc(F)ccc3n(Cc3ccc(F)cc3)c1=O)N2,8.3,,CHEMBL497075
O=c1[nH]c2cc(C[NH+]3CCCC3)ccc2n2cccc12,8.3,,
CC1(c2nc3cccc(C(N)=O)c3[nH]2)CCC[NH2+]1,8.3,,
Cc1cc(CN2C(=O)C(C3=NS(=O)(=O)c4c3ccc3c4CN(S(C)(=O)=O)CC3)=C(O)C2C(C)(C)C)ccc1F,8.3,,
CC(C)CCN1C(=O)C(C2=NS(=O)(=O)c3cc(NS(C)(=O)=O)ccc3N2)C(O)n2ccnc21,8.3,,
CC1(C)OC2COC3(COS(N)(=O)=O)OC(C)(C)OC3C2O1,8.3,,
CCNc1ncnc2c1ncn2C1OC(C=CCNC(=O)c2cc(-c3ccc(F)cc3)cc(O)c2O)C(O)C1O,8.3,,
O=c1[nH]c(C[NH+]2CCC(O)C2)nc2c1sc1ccc(Cl)cc12,8.3,,
CC(C)(C)c1nc2c3c(c4cc(F)ccc4c2[nH]1)C(=O)N=CC3,8.3,,
COc1ccc2c(Nc3c(Cl)cncc3Cl)cc(=O)oc2c1OC1CCCC1,8.3,,CHEMBL1096812
[NH3+]CC(Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3[nH]ccc23)CC1,8.3,,
Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CC[NH+](CCO)CC2)n1,8.3,,
Cn1cc(-c2cnn3c(N)c(Br)c(C4CCCC([NH3+])C4)nc23)cn1,8.3,,
C[N+]1CC(C2CCC3C(C2)[NH2+]C2C(C(N)=O)C[NH2+]C([NH2+]C4CCCCC4)C32)C[NH2+]1,8.3,,
CCC(C)C1(NC(C)=O)CC[N+](C(CCc2ccccc2)C(=O)NC(Cc2ccccc2)C(O)C[NH2+]Cc2cccc(OC)c2)C1O,8.3,,
CCc1ccc2c(c1)c(-c1ccc[nH]c1=O)c(C(=O)[O-])n2Cc1cccc([N+](=O)[O-])c1,8.3,,
C=CCNC(=O)C(NC(=O)C(O)(CCC[NH+](Cc1ccc(Br)cc1)NC(=O)C(NC(=O)OC)C(C)(C)C)Cc1ccccc1)C(C)(C)C,8.3,,
c1cnc2cc3c(cc2n1)C1C[NH2+]CC3C1,8.3,,
Cc1ccccc1C(CC(=O)[O-])NC(=O)c1cc(OCC(O)C(C)(C)C)n(-c2ccccc2F)n1,8.3,,
CC(C)CC(NC(=O)C1(C)CCCC=CCCCC(C)(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CO)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])CCCC[NH3+])C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)N1)C(N)=O,8.3,,
Nc1n[n+]2c(Cc3ccc4c(c3)OCO4)nc3cccc(F)c3c2[nH]1,8.3,,
CC(=O)NC(Cc1ccc(F)cc1)C(O)C[NH2+]C1CC2(CCC2)Oc2ncc(CC(C)(C)C)cc21,8.3,,
CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5cccc(F)c5)cc4)c3n2)c1,8.3,,CHEMBL2177836
COc1cc(Cc2cnc(N)nc2N)cc(C=CC(=O)N2[NH2+]Cc3ccccc3C2c2ccccc2)c1OC,8.3,,
CCNC(=O)c1cc2c(-n3ccc(C(F)(F)F)n3)c(-c3cncc(C(=O)[O-])c3)cnc2[nH]1,8.3,,
C=CCNS(=O)(=O)c1cccc(C(=O)Nc2nc3cc(C[NH+]4CCCCC4)ccc3n2C2CCC(CO)CC2)c1,8.3,,
CCc1[nH]c2nc(Sc3cncnc3)nc(N3CC4C([NH3+])C4C3)c2c1Cl,8.3,,
COc1ccc(S(=O)(=O)N2Cc3cc(C#N)ccc3N(Cc3cncn3C)CC2Cc2ccc(OC(=O)NCc3ccccc3)cc2)cc1,8.3,,
CCN(CC)C(=O)Oc1ccc(CC2CN(Cc3cncn3C)c3ccc(C#N)cc3CN2S(=O)(=O)c2ccc(OC)cc2)cc1,8.3,,
COc1cnc(COc2ccc(F)c(F)c2)cc1-c1cc2c([nH]1)CCNC2=O,8.3,,CHEMBL2203563
CCC1C(=O)N(C)c2cnc(-n3ccnc3-c3ccccc3)nc2N1C1CC=CC1,8.3,,
CCC1C(=O)N(C)c2cnc(-n3ccnc3-c3cscn3)nc2N1C1CCCC1,8.3,,
Cc1nc(NC(=O)N2CCCC2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,8.3,,
COc1ccc(-c2ccc(C(=O)NC(CO)C(C)(C)C)cc2C(=O)[O-])c(C(=O)Nc2ccc(C(N)=[NH2+])cc2)n1,8.3,,
CCCc1sc(-c2ccc(OC)c(OCCNS(C)(=O)=O)c2)nc1CSc1nc(N)cc(N)n1,8.3,,CHEMBL2426574
CC(C)(C)CC1[NH2+]C(C(=O)Nc2ccc(C(N)=O)cc2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12,8.3,,
Nc1nc(NC2C=C2)cc(-c2cccc(Cl)c2Cl)n1,8.3,,
C[NH+]1CCN(c2ccc(-c3ccncc3-c3cc(F)c(O)c(F)c3)cc2)CC1,8.3,,
Cc1cn(-c2cc3c(c(C4CCCC4)c2)C(=O)NCC3)c2c1C(=O)CC(C)(C)C2,8.3,,CHEMBL3235353
Cc1nc(-c2nc3cc(Cl)ccc3[nH]2)c(C)c(-c2ccccc2)c1C(OC(C)(C)C)C(=O)[O-],8.3,,
CC#CC1CN(S(=O)(=O)c2ccc(N)nc2)CCN1c1ccc(C(O)(CCCC)C(F)(F)F)cc1,8.3,,
Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cccnc3)CC2)cn1,8.3,,CHEMBL3319549
CCC(c1cccc(C2C=C2)n1)N1C(=O)C(C)(CC(=O)[O-])CC(c2cccc(Cl)c2)C1c1ccc(Cl)cc1,8.3,,
Cn1ccnc1C1(CNC(=O)c2cc3cc(Cl)ccc3o2)NC(=O)NC1=O,8.3,,
CC(C)CC(NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(=O)[O-])C(=O)NC(CC(=O)[O-])C(=O)O,8.31,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,8.31,,
CC(=O)Nc1nnc(S(N)(=O)=O)s1,8.31,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
C[N+]1CCN(S(=O)(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4cccnc4)n3)cc2)CC1,8.31,,
Cc1cc(C)c(S(=O)(=O)NC(C)CNc2cccc3c2cnn3-c2ccc(F)cc2)c(C)c1,8.31,,
COc1cc2nncc(-c3cnc(N4CCC(C(C)(C)O)CC4)c(C)c3)c2cc1OC,8.31,,CHEMBL1956250
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,8.32,,
Cc1nc(COc2ccc(CC(NC(=O)OC3COC4OCCC34)C(O)CN(CC(C)C)S(=O)(=O)c3ccc4c(c3)OCO4)cc2)cs1,8.32,,
C=C1CCC(O)CC1CCC1CCCC2(C)C(C(C)CCCC(C)C)CCC12,8.32,,
CN(C)C(=O)C(C1CCC(c2ccc3ncnn3c2)CC1)C([NH3+])C(=O)N1CCC(F)(F)C1,8.32,,
Nc1nc(Cl)cc(-c2cc(OCC[N+]3CCOCC3)c(Cl)cc2Cl)n1,8.32,,
CCOc1ccc(-c2snnc2-c2cc(Cl)c(O)cc2O)cc1,8.32,"This molecule is a member of the class of thiadiazoles that is 1,2,3-thiadiazole substituted at positions 4 and 5 by 2,4-dihydroxy-4-chlorophenyl and 4-methoxyphenyl groups respectively. It has a role as a Hsp90 inhibitor. It is a member of monochlorobenzenes, an aromatic ether, a member of resorcinols and a member of thiadiazoles.",CHEMBL517583
CCNC(=O)C1OC(n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(C(=O)NCCNC(=O)NC4CCN(c5ccccn5)CC4)nc32)C(O)C1O,8.32,,
CCCS(=O)(=O)Nc1ccc(F)c(C(=O)Nc2cnc3[nH]nc(OC)c3c2)c1F,8.32,,CHEMBL1822067
CCc1cccc(C(SCC[NH3+])(c2ccccc2)c2cccc(O)c2)c1,8.32,,
O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cccc1Cl,8.32,,CHEMBL2387224
[NH2+]=c1ccn(C2OC(CO)C(O)C2O)c(=O)[nH]1,8.32,,
Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1,8.32,,CHEMBL2401983
CC1[NH2+]C(c2cn(-c3ccccc3)nn2)C(O)C1O,8.32,,
C=CCN1C(=O)N(CC=C)C(Cc2ccccc2)C(O)C(O)C1Cc1ccccc1,8.33,,
CC(C=CC(=O)C=O)NC(=O)C(Cc1ccccc1)NC(=O)OCc1ccccc1,8.33,,
OC(CCCCCCc1ccccc1)c1ncc(-c2ccccn2)o1,8.33,,CHEMBL177495
Cc1nc2ccccc2n1CCNC(=O)CC(C(=O)NC(CO)CC(=O)[O-])C(C)C,8.33,,
Cc1ccc(CNC(=O)C(CCc2ccccc2)NC(=O)C(CC(=O)NCC(C)(C)C)NC(=O)c2cc(C)on2)cc1,8.33,,
O=C(CN1CCCC(NS(=O)(=O)c2ccc3cc(Cl)ccc3c2)C1=O)N1CC2CC(C1)c1cccc(=O)n1C2,8.33,,
CC1C=CC(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)C(=O)N1c1ccc(F)cc1,8.33,,
COc1ccc(Cc2nn3c(C(CCCc4ccccc4)C(C)O)nc(C)c3c(=O)[nH]2)cc1OC,8.33,,
CCC(C)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(CO)NC(=O)CNC(=O)C[NH3+])C(C)C)C(C)C)C(C)CC)C(C)C)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)[O-])C(C)CC,8.33,,
CC(C)=CC[NH+]1Cc2c(Cl)ccc3[nH]c(=S)n(c23)CC1C,8.34,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc2c(c1)OCO2,8.34,,
FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,8.34,"This molecule is a triamino-1,3,5-triazine that is 1,3,5-triazine in which two of the hydrogens have been replaced by morpholin-4-yl groups while the third hydrogen has been replaced by a 2-(difluoromethyl)benzimidazol-1-yl group. It is an inhibitor of phosphatidylinositol 3-kinase. It has a role as an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor and an antineoplastic agent. It is a member of morpholines, a member of benzimidazoles, a triamino-1,3,5-triazine and an organofluorine compound. This molecule has been used in trials studying the treatment of Neoplasms. This molecule is an orally available, s-triazine derivative, ATP-competitive phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. PI3K inhibitor ZSTK474 inhibits all four PI3K isoforms. Inhibiting the activation of the PI3K/AKT kinase (or protein kinase B) signaling pathway results in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents. This agent does not induce apoptosis but rather induces strong G(0)/G(1) arrest, which might contribute to its favorable efficacy in tumor cells.",CHEMBL586702
CNC(=O)C(NC(=O)C(O)(CCC[NH+](Cc1ccc(-c2ccccc2)cc1)NC(=O)C(NC(=O)OC)C(C)(C)C)Cc1ccccc1)C(C)(C)C,8.34,,
CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,8.34,"This molecule is an aromatic amide. This molecule has been investigated for the basic science of Malignant Solid Tumour. This molecule is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. MET tyrosine kinase inhibitor BMS-777607 binds to c-Met protein, or hepatocyte growth factor receptor (HGFR), preventing binding of hepatocyte growth factor (HGF) and disrupting the MET signaling pathway; this agent may induce cell death in tumor cells expressing c-Met. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays an important role in tumor cell proliferation, survival, invasion, and metastasis, and in tumor angiogenesis.",CHEMBL460702
O=CNC1CCCCC1,8.34,This molecule is a member of the class of formamides that is cyclohexane substituted by a formamido group. It has a role as a mouse metabolite. It is a member of formamides and an alicyclic compound. It is functionally related to a formamide. This molecule is a natural product found in Vitis vinifera and Euglena gracilis with data available.,CHEMBL46778
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCC[NH+]3CCOCC3)c3ccccc23)cc1,8.34,,
O=c1ccc2c([nH]1)CCCC2[NH2+]CCCCCCCCCCCC[NH2+]C1CCCc2[nH]c(=O)ccc21,8.349999999999998,,
CCNC(=O)c1noc(-c2cc(Cl)c(O)cc2O)c1-c1ccc(OC)cc1,8.349999999999998,,CHEMBL252124
CC(=O)NCC1[NH2+]C(C)C(O)C(O)C1O,8.349999999999998,,
CC(C)c1c(S(=O)(=O)N2CCOCC2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)[O-],8.349999999999998,,
CCCCCC(CC(=O)NO)C(=O)NC(C(=O)N1CCCC1CO)C(C)C,8.349999999999998,,CHEMBL67311
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,8.349999999999998,,CHEMBL195725
N#Cc1cccc(-n2cc(-c3ccc(S(N)(=O)=O)s3)nn2)c1,8.349999999999998,,CHEMBL2414070
O=C(c1ccc(Oc2nccnc2N2CCOCC2)cc1)c1nc2ccccc2[nH]1,8.349999999999998,,CHEMBL3086091
CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(Cc1ccccc1)C(O)C(Cc1ccccc1)NC(=O)C(NC(=O)OCc1ccccc1)C(C)C,8.349999999999998,,
NC(=[NH2+])N1CCCC(CC(CO)NC(=O)CN2CCCC(NS(=O)(=O)Cc3ccccc3)C2=O)C1,8.359999999999998,,
O=C(NCc1c(F)cccc1Cl)C(OCc1ccccc1)C(O)C(O)C(OCc1ccccc1)C(=O)NC1c2ccccc2CC1O,8.359999999999998,,
Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,8.359999999999998,,CHEMBL476351
O=[N+]([O-])c1cccc(-c2cc(Cc3ccncc3)cc3cccnc23)c1,8.359999999999998,,CHEMBL127944
Cc1cc(-c2ncn(CC3CCC(C(=O)[O-])CC3)n2)cc(C(=O)NCc2ccc(F)cc2)n1,8.359999999999998,,
OC(c1ncc(-c2ccccn2)o1)C1CCc2cc(Oc3ccccc3)ccc2C1,8.359999999999998,,
CN(CC1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C5CC[NH2+]CC5)c4)cc3c(=O)c2c1,8.359999999999998,,
Cc1cc(C(=O)NS(=O)(=O)c2ccc(NC(CC[NH+](C)C)CSc3ccccc3)c([N+](=O)[O-])c2)ccc1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)[O-])nn12,8.359999999999998,,
c1ccc(C[NH+]2CCC(n3cnc4cnc5[nH]ccc5c43)CC2)cc1,8.359999999999998,,
N#Cc1cccc(-c2csc(Nc3cc(F)ccc3O)n2)c1,8.359999999999998,,
CCCCC(NC(=O)C(C)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)[NH2+]CC(CC(C)C)NC(=O)C(NC(=O)C([NH3+])CCCNC(C)=[NH2+])C(C)C)C(=O)[O-],8.359999999999998,,
CC1OC(c2cccc(O)c2O)=NC1C(=O)N(CCCNC(=O)c1cccc(O)c1O)CCCNC(=O)c1cccc(O)c1O,8.359999999999998,,
N#CNC(Nc1ccncc1)=[NH+]Cc1ccc(S(=O)(=O)c2cccc(OC(F)(F)F)c2)cc1,8.359999999999998,,
O=c1ncc2nc(Sc3ccc(F)cc3F)c(C3C=CNC=C3)cc2n1-c1c(Cl)cccc1Cl,8.37,,
CN(C)C(=O)C(c1ccc(-c2ccc3ncnn3c2)cc1)C([NH3+])C(=O)N1CCC(F)C1,8.37,,
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,8.37,,
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,8.37,,
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,8.37,,
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,8.37,,
O=C(C1CCCN1C(=O)OCc1ccccc1)N1CCCCC1CO,8.37,,
CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1,8.37,,CHEMBL508307
[NH3+]CCc1c[nH]c2ccc(O)cc12,8.37,,
[NH3+]Cc1cc(Cl)cc(Oc2c(Cl)ccc3c2nnn3Cc2[nH]nc3ncccc23)c1Cl,8.37,,
CCCCNc1ncc2c(-c3ccc(F)cc3)nn(CC3CCC([NH3+])CC3)c2n1,8.37,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCN2C(=O)C([NH2+]CC(N)=O)C2CCCCC2)cc1,8.37,,
Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(C[NH+]3CCCC3CO)cc2)c1,8.37,,
NC(=[NH2+])NCCCNC(=O)C1CCCCN1C(=O)C(CC1CCCCC1)[NH2+]CC(=O)[O-],8.38,,
Cc1cnc(NCC(F)(F)c2ccccn2)c(=O)n1CC(=O)NCc1ncccc1F,8.38,,CHEMBL141889
CS(=O)(=O)c1ccc2c(c1)nc1n2CC([NH3+])C(c2cc(F)c(F)cc2F)C1,8.38,,
C[NH+](C)CCC(CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3cc(N4CC[NH+](Cc5ccccc5-c5ccc(Cl)cc5)CC4)ccc23)cc1[N+](=O)[O-],8.38,,
COC(=O)NC(C(=O)N[NH+](CCCC1(O)Cc2ccc(cc2)CC=CCNC(=O)C(C(C)(C)C)NC1=O)Cc1ccc(Br)cc1)C(C)(C)C,8.38,,
COC(=O)NC(C(=O)N[NH+](CCCC1(Cc2ccccc2)C(=O)N(C2c3ccccc3CC2O)CC1O)Cc1ccc(-c2ccccc2)cc1)C(C)(C)C,8.38,,
CCC(C(=O)OC(C)(C)C)N1C(=O)C(CC(=O)[O-])CC(c2cccc(Cl)c2)C1c1ccc(Cl)cc1,8.38,,
CC(O)(C#Cc1ccc2ccn(-c3nc(N)ncc3Cl)c2c1)c1nccs1,8.38,,
CC(C)(C)OC(=O)NC(CC[NH2+]C(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccccc1)C(N)=O)Cc1ccccc1,8.39,,
C=Cc1cc(O)cc2nc(-c3ccc(O)c(F)c3)oc12,8.39,This molecule is an estrogen receptor beta agonist.,CHEMBL450940
CONC(=O)c1cn(C2CCCCC2)c2nc(Nc3ccc(CC[NH+]4CCCC4)cc3)ncc2c1=O,8.39,,
COc1nc2cccnc2n1-c1ccc(Nc2ccc(C)cn2)cc1,8.39,,CHEMBL3287662
C[NH+]1CCN(c2ccc(-c3cnc4[nH]c5cnc(C(=O)[O-])cc5c4c3)cc2)CC1,8.39,,
CC(=O)NC1C(NC(N)=[NH2+])C=C(C(=O)[O-])OC1C(O)C(O)CO,8.4,,
COC(=O)C(NC(=O)C(NC(=O)CCC(O)C(Cc1ccccc1)NC(=O)C(C)NC(=O)C(C)[NH3+])C(C)C)C(C)C,8.4,,
CCC(C)C1NC(=O)C([NH2+]CC(O)C(Cc2ccccc2)NC(=O)OC(C)(C)C)Cc2ccc(cc2)OCCCNC1=O,8.4,,
CC1(C)CCC(C)(C)c2cc(C(=NO)c3ccc4cc(C(=O)[O-])ccc4c3)ccc21,8.4,,
CC(C)CC1NC(=O)CC(O)C(CC(C)C)NC(=O)C(NC(=O)C(Cc2cccc3ccccc23)Cc2cccc3ccccc23)CCC(=O)NCc2cccc(c2)CNC1=O,8.4,,
CC(C)CC(NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(N)=O)NC(=O)CNC(=O)C1CCCN1C(=O)C(C)NC(=O)C([NH3+])Cc1ccccc1)C(=O)[O-],8.4,,
CC1OC(C(NC(=O)C([NH3+])Cc2ccc(O)cc2)C(=O)[O-])C(O)C(O)C1O,8.4,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCN2C(=O)C([NH2+]CC(=O)[O-])C2CCCCC2)cc1,8.4,,
CCC(C)C1NC(=O)C([NH2+]CC(O)C(Cc2ccccc2)NC(=O)OC(C)(C)C)Cc2ccc(cc2)OCCCNC1=O,8.4,,
O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,8.4,"This molecule is an organic heterotetracyclic compound that is 1,3-dihydro-2H-1-benzazepin-2-one which shares its 4-5 bond with the 3-2 bond of 5-nitro-1H-indole. It has a role as an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor, an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor, an EC 2.7.11.26 (tau-protein kinase) inhibitor, an antineoplastic agent, an apoptosis inducer and an anti-HIV-1 agent. It is a C-nitro compound, an organic heterotetracyclic compound and a member of caprolactams. It is functionally related to a paullone.",CHEMBL50894
N#Cc1ccc(Cn2cncc2C[NH+]2CCN(c3cccc(Cl)c3)C(=O)C2)cc1,8.4,,
COc1ccc2c3c1OC1CC(O)C=CC31CC[N+](CCCCCCCCN1C(=O)c3ccccc3C1=O)=C2,8.4,,
O=C(NC1c2ccccc2CC1O)C(OCc1cccc(F)c1F)C(O)C(O)C(OCc1cccc(F)c1F)C(=O)NC1c2ccccc2CC1O,8.4,,
COc1cc(C(Nc2ccc(C(N)=[NH2+])cc2)C(=O)NC(C(=O)[O-])c2ccccc2)ccc1OCc1ccccc1,8.4,,
CC(C)CCN(CC(O)C1Cc2ccc(cc2)OCCCC(=O)NC(C(C)C)C(=O)N1)S(=O)(=O)c1ccccc1,8.4,,
COc1ccc(S(=O)(=O)N(CC(C)C)CC(O)C(Cc2ccccc2)n2cc(CNC(=O)c3ccc(CNC(=O)OC(C)(C)C)cc3)nn2)cc1,8.4,,
[NH3+]C(Cn1cc(F)c(=O)[nH]c1=O)C(=O)[O-],8.4,,
CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2ccccc2)n1,8.4,,CHEMBL63071
CC(C(=O)N1CCOCC1)N1CCC(NS(=O)(=O)c2ccc(-c3ccc(Cl)s3)s2)C1=O,8.4,,
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,8.4,,
CS(=O)(=O)c1cccc(-c2cc(N3CCC(c4cc(F)c(F)cc4F)C([NH3+])C3)ncn2)c1,8.4,,
COc1cc2ncnc(N3CCC(Oc4cnc5ccccc5n4)C3)c2cc1OC,8.4,,
NC(=O)Nc1ccc2c(c1)C(=Cc1cc(-c3cccc(C(=O)NCC[NH+]4CCCCC4)c3)c[nH]1)C(=O)N2,8.4,,
O=C([O-])COc1c(C(=O)[O-])sc(-c2cccc(NC3CCN(S(=O)(=O)Cc4ccccc4)CC3)c2)c1Br,8.4,,
COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3ccc(Cl)cc3)c2cc1OC,8.4,,CHEMBL270548
CC(C(=O)N1CCOCC1)N1CCC(NS(=O)(=O)C=Cc2ccc(Cl)s2)C1=O,8.4,,
C[NH2+]C(C)C(=O)NC(CCCC[NH3+])C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)O,8.4,,
Cc1cc(Nc2cc(N3CC[NH+](C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)[nH]n1,8.4,,
O=C1C(NS(=O)(=O)c2ccc3cc(Cl)ccc3c2)CCN1c1ccc(C2CCC[NH2+]2)cc1F,8.4,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)C([NH3+])Cc2ccccc2)cc1,8.4,,
CC(=O)Nc1ccc(OCC(C)(O)C(=O)Nc2ccc([N+](=O)[O-])c(C(F)(F)F)c2)cc1,8.4,,CHEMBL2136499
Nc1nc(N)c2c(OCC3CC[NH+](Cc4ccccc4F)CC3)cccc2n1,8.4,,
CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4,8.4,This molecule is an aurora kinase inhibitor.,CHEMBL223147
CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCC[NH2+]C3)c21,8.4,,
CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2C)n1,8.4,,CHEMBL468612
COc1cc(N2CC[NH+](C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1,8.4,,
COC(=O)NC(C(=O)NC(Cc1ccccc1)C(O)C[NH+](Cc1ccc(-c2ccccn2)cc1)NC(=O)C(NC(=O)OC)C(C)(C)C)C(C)(C)C,8.4,,
CNc1nc2c(CC[NH2+]CC3CCCCC3)c3[nH]c(=[NH2+])[nH]c(=O)c3cc2[nH]1,8.4,,
COc1cccc(Nc2c(C(N)=O)cnc3ccc(S(C)(=O)=O)cc23)c1,8.4,,CHEMBL462150
C=CCOc1cc(COc2ccc(C(F)(F)F)cc2)ccc1Sc1ccc(OCC(=O)[O-])c(C)c1C,8.4,,
Cc1cc2cc([NH+]=C(NC(=O)c3cccnc3)NC3CCCCN(CC(=O)N4CCCC4)C3=O)ccc2o1,8.4,,
N=Cc1nc(CCC[N+]2CCCCC2)cc(-c2cccc(C(F)(F)F)c2)n1,8.4,,
Cc1cc(Nc2nccn3c(-c4cn[nH]c4)cnc23)sn1,8.4,,CHEMBL1234822
O=C([O-])c1cc(F)c(NC(=O)C(C2CCCCC2)n2c(-c3ccc(Cl)cc3)nc3cc(F)c(F)cc32)c(F)c1,8.4,,
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1,8.4,"This molecule is a member of the class of ureas that is urea in which one of the nitrogens bears a 3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl substituent, while the other bears a 2-fluoro-4-{[2-(methylcarbamoyl)pyridin-4-yl]oxy}phenyl substituent. It has a role as a tyrosine kinase inhibitor. It is a member of quinolines, a pyridinecarboxamide, a member of pyrazoles, an organofluorine compound and a member of phenylureas. This molecule has been used in trials studying the treatment of Chronic Myeloid Leukemia. It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent. This molecule is an orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity. Upon oral administration, rebastinib binds to and inhibits the Bcr-Abl fusion oncoprotein by changing the conformation of the folded protein to disallow ligand-dependent and ligand-independent activation; in addition, this agent binds to and inhibits Src family kinases LYN, HCK and FGR and the receptor tyrosine kinases TIE-2 and VEGFR-2. This molecule may exhibit more potent activity against T315I Bcr-Abl gatekeeper mutant kinases than other Bcr-Abl kinase inhibitors. The TIE-2 and VEGFR-2 receptor tyrosine kinases regulate angiogenesis, respectively, while the Src family kinases Abl, LYN, and HCK Src regulate a variety of cellular responses including differentiation, division, adhesion, and the stress response.",CHEMBL1738757
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1,8.4,,
O=C1NCC2(CC[NH2+]CC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21,8.4,,
Cc1ccc(C(=O)NC2C=C2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12,8.4,,
NS(=O)(=O)c1cc2ccccc2s1,8.4,,CHEMBL313338
CNC(=O)c1cccc(C)c1Nc1nc(N2CCN(c3ccccc3Cl)CC2)nc(N2CSCC2C(=O)NCC(=O)NO)n1,8.4,,
COCCN1Cc2c(nc(C)c(C[NH3+])c2-c2ccc(Cl)cc2Cl)C1=O,8.4,,
Cc1[nH]c(C(=O)NC2CCN(c3ncc(C(=O)[O-])s3)CC2F)c(Cl)c1Cl,8.4,,
O=C1CCC(=O)NC(CC2CCCCC2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCCNC(=O)c2cnccn2)C(=O)NCCC(C(=O)[O-])N1,8.4,,
Cc1c[n+]2c(-c3cnn(CC(=O)Nc4cc[nH+]cc4F)c3)c[nH]c2c(Nc2cc(C[NH+]3CCCC(C)C3)ns2)n1,8.4,,
OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,8.4,"This molecule is a member of quinolines. This molecule has been used in trials studying the treatment of Neoplasms. This molecule is an orally bioavailabe, small-molecule tyrosine kinase inhibitor with potential antineoplastic activity. MET tyrosine kinase inhibitor PF-04217903 selectively binds to and inhibits c-Met, disrupting the c-Met signaling pathway, which may result in the inhibition of tumor cell growth, migration and invasion of tumor cells, and the induction of death in tumor cells expressing c-Met. The receptor tyrosine kinase c-Met, also known as hepatocyte growth factor (HGF) receptor, is overexpressed or mutated in many tumor cell types, playing an important role in tumor cell proliferation, survival, invasion, and metastasis and angiogenesis.",CHEMBL2001019
N#Cc1ccc(-c2cnc3nnc(Cc4c[nH]c5ncccc45)n3n2)cc1,8.4,,CHEMBL2170968
NC(=O)Nc1snc(SC2CCCCc3ccccc32)c1C(N)=O,8.4,,CHEMBL211168
CC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C(CCCC[NH3+])NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CO)NC(=O)C[NH3+])C(=O)NCC(=O)[O-],8.4,,
CNc1nc(C)c(-c2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2C#N)s1,8.4,,CHEMBL2312183
CC(CO)Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)ncc1Br,8.4,,
Cc1csc2c(Nc3cn(C)cn3)nc(NC(C)c3ncc(F)cn3)nc12,8.4,,
COc1ccc(F)cc1C(C)Oc1cc(-c2cnnn2C)cnc1N,8.4,,
COc1ccc(Nc2ncc(C[N+]3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,8.4,,
CC(C)CCCCCC=CC=CC(=O)NC(C(=O)NC1CC(O)CCNC(=O)CCC(C)NC1=O)C(C)O,8.4,,
O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccccc1,8.4,,CHEMBL2380845
CCNC(=O)c1ccc(C(=O)NCCC2CCN(c3ncnc4cc(C(N)=O)sc34)CC2)s1,8.4,,CHEMBL2332039
CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc6nnsc56)cc34)cn2)CC1,8.4,,CHEMBL2407759
COCC(Oc1cc(CC2C[S+](O)CC([NH2+]Cc3cccc(C(C)(C)C)c3)C2O)cc(F)c1N)C(F)(F)F,8.4,,
CC#CC1CN(S(=O)(=O)c2ccc(N)nc2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,8.4,,CHEMBL3114183
CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(NC4CCC(O)CC4)c3)c2C1,8.4,,
COc1cc(Nc2nc3cccc(-c4cccc5nc[nH]c45)c3o2)cc(OC)c1OC,8.4,,
[NH3+]C1CCCCC1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1,8.4,,
CC1C(=O)NN=C2COc3cc(-c4ccccc4)c(N(C)C4(C)C[NH+](C)C4)cc3N21,8.4,,
[NH2+]=C1NC2(CO1)c1cc(-c3cccnc3F)ccc1Oc1c(F)cc(C3C=COCC3)cc12,8.4,,
O=C(Nc1cn[nH]c1-c1ccccn1)c1nn(C2CC[NH2+]CC2)cc1Cl,8.4,,
COC1C(OC(N)=O)C(O)C(Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C,8.4,This molecule is a natural product found in Actinoalloteichus cyanogriseus and Streptomyces niveus with data available.,CHEMBL35025
CCOC(=O)c1[nH]cc2c1N=C1CCCC(=O)C1C2c1ccc(Sc2nc3ccccc3[nH]2)o1,8.4,,
Oc1c(Br)c(Br)c(Br)c(Br)c1Br,8.41,"This molecule is a light brown powder. Insoluble in water. (NTP, 1992)",CHEMBL1235157
NS(=O)(=O)c1ccc(C(=O)NCc2c(F)cccc2F)cc1,8.41,,
NS(=O)(=O)c1ccc(C(=O)NCc2c(F)cc(F)cc2F)cc1,8.41,,
NS(=O)(=O)c1ccc(C(=O)NCc2cc(F)c(F)c(F)c2)cc1,8.41,,
COC1C=CC(C)C2OC(O)(C(C)C(=O)OC(c3ccccc3)CCCCC1OC)C(OC)C(O)C2C,8.41,,
CC12CCC(O)C=C1CCC1C2CCC2(C)C(O)CCC12,8.41,,
CCC1(c2cccc(O)c2)CCCC[NH+](CCCCCCCCC[NH3+])C1,8.41,,
CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)Nc4ccon4)ccc3C)c2c1C,8.41,,CHEMBL1230070
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,8.41,,
CC[N+](CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C,8.41,,
CC(=O)NCCOc1cc(Br)ccc1NC(=O)NCCCCC(NC(=O)NC(CCC(=O)[O-])C(=O)[O-])C(=O)[O-],8.41,,
O=C(Nc1nc2ccccc2[nH]1)c1cccc(CN2C(=O)N(Cc3cccc(C(=O)Nc4nc5ccccc5[nH]4)c3)C(Cc3ccccc3)C(O)C(O)C2Cc2ccccc2)c1,8.42,,
CC1(C)SC(C(NC(=O)Cc2ccccc2)C(=O)NCc2ccccc2)[NH2+]C1C(=O)NC(Cc1ccccc1)C(O)CC(=O)NCc1nc2ccccc2[nH]1,8.42,,
NS(=O)(=O)c1ccc(C(=O)NCc2ccc(F)c(F)c2F)cc1,8.42,,CHEMBL66907
CC(C)(C)c1cc(C(=O)[O-])ccc1OCC1CCC(C(=O)N2CCCC2C=N)[NH2+]1,8.42,,
Nc1ncnc2c(C[NH+]3CC(O)C(CO)C3)c[nH]c12,8.42,,
CC(C)(O)C1CC[NH+](Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1,8.42,,
O=CN1CCN(c2nc(-c3ccccc3)ns2)CC1,8.42,,
O=C([O-])C(Cc1ccccc1)C(Cc1ccc2c(c1)OCO2)C(=O)[O-],8.429999999999998,,
COc1ccc(S(=O)(=O)NCC(O)C(Cc2ccccc2)[NH2+]Cc2cc(Cl)ccc2-n2cnnn2)cc1,8.429999999999998,,
O=C(Nc1ccc(Cl)cn1)C1C[NH+](CC(F)F)CC1C(=O)Nc1ccc(-n2ccccc2=O)cc1F,8.429999999999998,,
[NH3+]Cc1ccc2c(c1)C1(CCN(C(=O)c3ccc(C#Cc4ccccc4)o3)CC1)CO2,8.429999999999998,,
CCCCCC=CCCC=CCCCCC(O)CCCC(=O)[O-],8.429999999999998,,
CC1=CCN(Cc2[nH]nc3ncccc23)C(=O)C1Oc1cc(Cl)cc(C#N)c1,8.429999999999998,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,8.429999999999998,,
CC(=O)Nc1cc(-c2sc(C3CC[NH+](C4CC4)CC3)nc2-c2cccc(NS(=O)(=O)c3cc(F)ccc3F)c2F)ccn1,8.429999999999998,,
Oc1ccc(F)cc1Nc1nc(-c2ccncc2)cs1,8.429999999999998,,
NC(=[NH2+])N1CCCC(C(=O)NCC2CCCN2C(=O)C(CO)NS(=O)(=O)c2ccc3ccccc3c2)C1,8.439999999999998,,
CCC1CC(C)C2(NC1=O)OC(CC(O)C(C)CCC=CC=C(C)C1CC=CC=CC(O)C(C)C(O)C(CCC(C)=O)C(=O)NC(C(C)C)C(=O)NC(Cc3cccc(O)c3)C(=O)N3CCCC([NH2+]3)C(=O)O1)C(C)C(O)C2C,8.439999999999998,,
NC(=O)c1[nH]c2ccc(Br)cc2c1S(=O)(=O)N1CCCC1,8.439999999999998,,CHEMBL253629
CC(=O)NC1C[NH2+]C(CO)C(O)C1O,8.439999999999998,,
CNC(=O)C(NC(=O)C(O)(CCC[NH+](Cc1ccc(-c2ccsc2)cc1)NC(=O)C(NC(=O)OC)C(C)(C)C)Cc1ccccc1)C(C)(C)C,8.439999999999998,,
CC(CCN1CC=C(c2ccccc2)CC1=O)(C(=O)NO)S(C)(=O)=O,8.439999999999998,,
CCOc1cc2c(-c3ccc(C)c(S(N)(=O)=O)c3)[nH]nc2cc1-c1cnn(C)c1,8.439999999999998,,
CC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,8.439999999999998,,CHEMBL1077458
CC(C)CC(NC(=O)C([NH3+])Cc1ccccc1)C(=O)NC(CO)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCC[NH3+])C(=O)[O-],8.449999999999998,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)[O-])NC(=O)C[NH3+])C(=O)N1CC=CC1C(=O)NCC(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C)C(=O)[O-],8.46,,
CC(C)CC(C(=O)NCC(O)CNS(=O)(=O)c1ccccn1)c1cccc(-c2ccccc2)c1,8.46,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)[O-])NC(=O)CC=CCNC(=O)CC=CCNC(=O)CCCCC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(C)=O)C(=O)N1CCCC1C(N)=O,8.46,,
N#Cc1ccc2cc1Oc1ccc3cccc(c3c1)N1CCC([NH2+]Cc3cncn3C2)C1=O,8.46,,
Oc1ccc(-c2noc3cc(O)ccc23)c(O)c1,8.46,,CHEMBL360410
COc1ccccc1Nc1nc(C=N)nc2c1ncn2C1CCCC1,8.46,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(C)C)[NH2+]CC(Cc1ccccc1)NC(=O)C(NC(=O)C([NH3+])Cc1ccccc1)C(C)C)C(N)=O,8.46,,
COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1,8.46,,
CCC(C)Nc1ncc(C(=O)Nc2cc(C(=O)NC)ccc2C)s1,8.46,,
CC1(C)SCN(C(=O)C(O)C(Cc2ccccc2)NC(=O)COc2c(F)cccc2F)C1C(=O)NC1c2ccccc2CC1O,8.46,,
O=C(C(O)CS(=O)(=O)c1ccc2cc(Cl)ccc2c1)N1CCC(N2CCCNC2=O)CC1,8.46,,
CC=C(C)C(=O)OC1CC2C(C1C)C1OC(=O)C(C)(O)C1(O)C(OC(=O)CCC)CC2(C)OC(C)=O,8.46,,
CC(CC(C)(CS(=O)(=O)N1CCC(OCc2ccc(Cl)cc2Cl)CC1)N(O)C=O)c1ncc(F)cn1,8.46,,
COc1ccc(S(=O)(=O)N(CC(C)C)CC(O)C(Cc2ccccc2)NC(=O)OC2COC3OC4OCCC4C23)cc1,8.46,,
C[NH2+]C(C)C(=O)NC(C(=O)N1CC2CC3CC3[NH+]2CC1C(=O)NC1CCOc2ccccc21)C1CCCCC1,8.46,,
O=C(c1ccc(OCC[NH+]2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,8.47,,
CC1CC2C[NH+]1CCn1[nH]c3c(cccc3c1=O)C1Nc3c(cccc3O2)NC1=O,8.47,,
CS(=O)(=O)c1cccc(-c2cc(N3CC([NH3+])C(c4cc(F)c(F)cc4F)C3)ncn2)c1,8.47,,
CCCC(CCC)C(=O)NC1Cc2ccc(S(N)(=O)=O)cc2C1,8.47,,CHEMBL381730
Cc1cccc(Cc2nn(C(C)(C)C)c3ncnc(N)c23)c1,8.47,,CHEMBL1236661
CSc1nc(N)nc(-c2c(Cl)cc3c4c(cccc24)COC3)n1,8.47,,CHEMBL1834096
O=C([O-])c1cccc(-c2ccc3c(c2)C(=NNc2nc4ccccc4s2)CCC3)n1,8.47,,
NS(=O)(=O)c1ccc(C(=O)NCc2ccc(F)cc2)cc1,8.48,,
NS(=O)(=O)c1ccc(C(=O)NCc2ccc(F)cc2F)cc1,8.48,,
O=C(NC1c2ccccc2CC1O)C(OCc1cc(F)ccc1F)C(O)C(O)C(OCc1cc(F)ccc1F)C(=O)NC1c2ccccc2CC1O,8.48,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,8.48,,
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(Cc1ccccc1)C(O)C(O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(C)NC(=O)OCc1ccccc1)C(C)C)C(C)C,8.48,,
CC(C)(C)NC(=O)C1C[NH+](Cc2cccnc2)CC[NH+]1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O,8.48,,
COC(=O)NC(C(=O)N[NH+](CCCC(O)(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O)Cc1ccc(Br)cc1)C(C)(C)C,8.48,,
CCNC(=O)NCc1ccccc1Sc1ccc2nnc(C(C)C)n2c1,8.48,,CHEMBL1938764
CCc1ccc2ccccc2c1CNC(=O)c1c(OC)cc(O)c2c1OC1=CC(O)=C(C(C)=O)C(=O)C12C,8.48,,
CC(C)CC(NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCC(=O)[O-])NC(=O)C(C)NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C([NH3+])C(C)O)C(=O)NC(C=O)CO,8.48,,
CC(C)c1ccccc1NC(=O)Nc1ccc(S(N)(=O)=O)cc1,8.48,,CHEMBL1615280
CC1(CS(=O)(=O)N2CCN(c3ncc(OCc4cccc(C#N)c4)cn3)CC2)NC(=O)NC1=O,8.48,,
COc1cc2c(cc1OCCC[NH+]1CCCC1)NC(=[NH2+])C21CCC1,8.48,,
COCCNc1nc2ccc(C#CC3(O)CCCCC3)cc2n1-c1ccnc(N)n1,8.48,,CHEMBL3128042
O=C(NC1c2ccccc2CC1O)C(OCc1ccccc1F)C(O)C(O)C(OCc1ccccc1F)C(=O)NC1c2ccccc2CC1O,8.49,,
Oc1c(Cl)cc(-c2cc(Cl)c(O)c(Cl)c2)cc1Cl,8.49,"This molecule is a member of the class of hydroxybiphenyls formed formally by chlorination of biphenyl-4,4'-diol at C-3, -3', -5 and -5'. It is a dichlorobenzene and a member of hydroxybiphenyls. It is functionally related to a biphenyl-4,4'-diol and a 3,3',5,5'-tetrachlorobiphenyl.",CHEMBL83116
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,8.49,,
N#Cc1ccc(N2C(=O)C3C(O)CCN3C2=O)c2ccccc12,8.49,,CHEMBL218914
[NH3+]C1CN(CCc2ccc3c(c2)OCO3)C(=O)CC1c1cc(F)c(F)cc1F,8.49,,
Cc1ccc(C(=O)NC2CC2)cc1N=C1CC(=O)N(C)c2c1cnn2-c1ccc(F)cc1F,8.49,,
CN1C(=O)C(F)C(Nc2ccc(I)cc2F)=C2C(=O)N(CC(O)CO)CN=C21,8.49,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,8.49,,CHEMBL195725
CCCS(=O)(=O)Nc1ccc(F)c(NC(=O)c2csc3c(N)ncnc23)c1F,8.49,,CHEMBL2047876
COc1ccc(S(=O)(=O)N(CC(C)C)CC(O)C(Cc2ccccc2)NC(=O)OC2COC3OC4OCCC4C23)cc1,8.49,,
CC[NH2+]C1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,8.49,,
COC(C(O)CO)C1OC(C(=O)[O-])CC(NC(N)=[NH2+])C1NC(C)=O,8.49,,
O=c1oc2c(c(O)c1C(c1cccc(NS(=O)(=O)c3ccccc3)c1)C1CC1)CCCCCC2,8.49,,
CCn1ncc2c(NC3CCOCC3)c(C(=O)NCc3ccccc3)cnc21,8.5,,CHEMBL521203
CC1CCC(C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1,8.5,,
O=C(NCCCc1ccccc1)NC1CCCCC1,8.51,,CHEMBL1231909
COc1ccc(S(=O)(=O)N2CN(Cc3ccccc3)C(=O)CC2C(=O)NO)cc1,8.51,,
COc1ccc(S(=O)(=O)N2CN(Cc3ccccc3)C(=O)CC2C(=O)NO)cc1,8.51,,
CCC1C=C(C)C(O)C(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)=CC3CCC(Oc4ccc5c(ccn5C)c4)C(OC)C3)C(C)C(O)CC1=O)C(C)CC2OC,8.51,,
CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NOC)ccc3C)c2c1C,8.51,"This molecule is a solid. This compound belongs to the pyrrolotriazines. These are compounds containing a pyrrolotriazine moiety, which consists of a pyrrole ring fused to a triazine ring. This molecule is known to target mitogen-activated protein kinase 14.",CHEMBL252128
C[NH+](C)Cc1nccn1-c1ccc(N2CCC(NS(=O)(=O)C=Cc3ccc(Cl)s3)C2=O)c(F)c1,8.51,,
COCCOC(CC(O)C(COc1cc(F)cc(F)c1)NC(=O)c1cc(C(=O)NC(C)c2ccccc2)cc(N(C)S(C)(=O)=O)c1)C(=O)NC(C(=O)NCc1ccccc1)C(C)C,8.51,,
COC(C(O)CO)C1OC(C(=O)[O-])CC(NC(N)=[NH2+])C1NC(C)=O,8.51,,
c1cncc(N2CCC[NH2+]CC2)c1,8.51,,
Clc1ccccc1Nc1ccnc(Nc2ccc(-c3nnn[nH]3)cc2)n1,8.51,,CHEMBL2170416
COC(=O)NC(C(=O)N[NH+](CCCC1(O)Cc2ccc(cc2)CC=CCNC(=O)C(C(C)C)NC1=O)Cc1ccc(Br)cc1)C(C)(C)C,8.51,,
COc1cc(CCc2cc(Nc3ccnc(NCc4cc(C)no4)n3)n[nH]2)cc(OC)c1,8.51,,CHEMBL2088096
CCC(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(O)C[NH2+]C1Cc2ccc(cc2)OCCCNC(=O)C(C(C)CC)NC1=O)C(C)C,8.519999999999998,,
CON=C1CC(C(=O)NO)N(S(=O)(=O)c2ccc(OC)cc2)C1,8.519999999999998,,
CC1(C)CCC(C)(C)c2cc(C(=O)c3ccc4cc(C(=O)[O-])ccc4c3)ccc21,8.519999999999998,,
Cc1nc2cccc(F)c2c(N)c1CSCc1cccc(C(O)C(F)(F)F)c1,8.519999999999998,,CHEMBL325766
CC12CCC3c4ccc(O)cc4CCC3C1CC(CCCCCCCCC(=O)OCC1OC(n3cnc4c(N)ncnc43)C(O)C1O)C2O,8.519999999999998,,
[NH3+]C(Cc1ccc(O)cc1)C(=O)NC(C(=O)[O-])C1C(O)C(O)(CO)C(O)C[NH+]1O,8.519999999999998,,
C=C1C(O)C2OC3(CCC(C=CC(C)C4CC(C)=CC5(OC(CC(C)(O)C(=O)[O-])CCC5O)O4)O3)CCC2OC1C(O)CC(C)C1OC2(CCCCO2)CCC1C,8.519999999999998,,
O=C1CN(S(=O)(=O)c2cc3ccc(Cl)cc3s2)CCN1Cc1cc2cnccc2n1CCO,8.519999999999998,,CHEMBL157813
CC(=O)NC(Cc1ccc(C(C(=O)[O-])C(=O)[O-])c(C(=O)[O-])c1)C(=O)NC1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O,8.519999999999998,,
NS(=O)(=O)c1ccc(Nc2nccc(-c3c[nH]c4cccc[n+]34)n2)cc1,8.519999999999998,,
COc1cc[nH]c1C=C1C(=O)Nc2ccc(F)c(C#CC(O)C([NH3+])C(C)O)c21,8.519999999999998,,
CC(=O)NC(CC(=O)[O-])C(=O)NC1CCc2cccc3c2N(C1=O)C(C(=O)NC(CC(=O)[O-])C(O)CSCc1ccccc1)C3,8.519999999999998,,
CCC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(C)NC(=O)C1CCC[NH2+]1)C(=O)N1CCCC1C=O,8.519999999999998,,
[NH3+]C(C(=O)N1CCCC1C(=O)NCc1cc(Cl)ccc1Cl)C(c1ccccc1)c1ccccc1,8.519999999999998,,
C[NH+](C)CCCNS(=O)(=O)c1ccc(Nc2nccc(-c3c[nH]c4cccn[n+]34)n2)cc1,8.519999999999998,,
CC(NC(=O)C(CO)NS(=O)(=O)CCc1ccccc1)C(=O)NC(CO)CCCNC(N)=[NH2+],8.519999999999998,,
CS(=O)(=O)CC[NH2+]Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,8.519999999999998,,
C[NH+](C)CCCC(=O)Nc1cc(C(=O)[O-])cc(-c2n[nH]c3cc(Nc4ccccc4Cl)ccc23)c1,8.519999999999998,,
CC(C)[NH+]1CCC(NC(=O)c2cc3ccccc3n2Cc2cc(-c3ccc(Cl)s3)on2)CC1,8.519999999999998,,
CC(C)[NH+]1CCC(NC(=O)c2cc3ccccc3n2CC(=O)Nc2ccc(Cl)cc2)CC1,8.519999999999998,,
O=c1c(NCCc2ccccn2)ncc(Cl)n1CC[NH2+]Cc1csc2ccc(Cl)cc12,8.519999999999998,,
CCOC(=O)NC(CCCC[NH3+])C(O)c1noc(Cc2ccc(C(=O)NC3Cc4ccccc4C3)cc2)n1,8.519999999999998,,
COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N,8.519999999999998,"This molecule is an orally bioavailable diaminopyrimidine compound and a cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. CDKs are ATP-dependent serine/threonine kinases that are important regulators of cell cycle progression and are frequently overexpressed in cancerous cells. R547 selectively binds to and inhibits CDKs, especially CDK1/cyclin B, CDK2/cyclin E, and CDK4/cyclin D1. The inhibition of CDKs results in cell cycle arrest, inhibition of tumor cell proliferation, and induction of apoptosis. By inhibiting CDK activity, R547 also reduces phosphorylation of the retinoblastoma (Rb) protein, thereby preventing activation of transcription factor E2F and leading to further suppression of tumor cell proliferation.",CHEMBL384304
Cn1c(=O)c2c(nc(N3CCCC([NH3+])C3)n2Cc2ccccc2C#N)n(C)c1=O,8.519999999999998,,
COc1ccc(-c2c(C(=O)NS(=O)(=O)c3ccccc3)n(Cc3cccc(C(F)(F)F)c3)c3ccccc23)cc1,8.519999999999998,,CHEMBL376627
CN(C)c1nc2ccc1CCCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2,8.519999999999998,,CHEMBL1231352
Cc1c(O)cccc1C(=O)NC(CSc1ccccc1)C(O)C[NH+]1CC2CCCCC2CC1C(=O)NC(C)(C)C,8.519999999999998,,
CCCN(CCC)C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C2CC(Oc3ccccc3)C[NH2+]2)c1,8.519999999999998,,
CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(OCC5CCC[NH+]5C)c4)nc3c2)ccn1,8.519999999999998,,
CCCCNC(=O)C(C)CC(O)C([NH3+])CC(C)COC(=O)c1cn(Cc2ccccc2)c2ccccc12,8.519999999999998,,
C=CC1C(OC2OC(CO)C(O)C(O)C2O)OC=C(C(=O)OC)C1CC[NH2+]CCc1c[nH]c2ccccc12,8.519999999999998,,
CCNc1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]Cc2cccc(C(F)(F)F)c2)cc(N2CCCCS2(=O)=O)c1,8.519999999999998,,
O=C(Nc1ccc(F)cc1)c1[nH]ncc1NC(=O)c1c(F)cccc1F,8.519999999999998,,
COC1C[NH+](CC(=O)Nc2ccc(-n3ccccc3=O)cc2F)CC1NC(=O)c1ccc(Cl)s1,8.519999999999998,,
COC1CC(C)Cc2cc(O)cc(c2)NC(=O)C(C)=CCCC(C)C(OC(N)=O)C(C)=CC(C)C1O,8.519999999999998,,
O=C(Nc1c[nH]nc1-c1nc2cc(C[NH+]3CCOCC3)ccc2[nH]1)NC1CC1,8.519999999999998,,
COc1cc(O)ccc1C=C1CCCN=C1c1cccnc1,8.519999999999998,,
CS(=O)(=O)N1CC[NH+](Cc2cc3nc(-c4cccc5n[nH]cc45)nc(N4CCOCC4)c3s2)CC1,8.519999999999998,,
Cc1cc(Nc2nc(NC(C)c3ncc(F)cn3)ncc2Cl)[nH]n1,8.519999999999998,,
COC1Cc2nc(-c3cc(F)ccc3O)nc(NC3C[NH2+]CC3C(C)(C)O)c2CC1OC,8.519999999999998,,
CCNc1cc(C(=O)NC(Cc2ccccc2)C(O)C[NH2+]C(C)C(=O)NC2CCCCC2)cc(N(c2ccccc2)S(C)(=O)=O)c1,8.519999999999998,,
CCCN(CCC)C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C2[NH2+]CCN(Cc3ccccc3)C2=O)c1,8.519999999999998,,
Cc1cc(-c2cc(-c3ccccc3)[nH]c(=O)n2)ccc1O,8.519999999999998,,CHEMBL501724
N#Cc1cc(Cl)cc(Oc2c(Br)ccc(Cc3n[nH]c4nnccc34)c2F)c1,8.519999999999998,,CHEMBL456649
CC(C)(C)C1C(O)=C(C2=NS(=O)(=O)c3c(CNS(C)(=O)=O)cccc32)C(=O)N1Cc1ccc(F)cc1,8.519999999999998,,
CNc1ncnc2c1ncn2C1OC(C=CCNC(=O)c2cc(-c3ccc(F)cc3)cc(O)c2O)C(O)C1O,8.519999999999998,,
O=C1C=C(c2ccc(F)cc2)C=C(C(=O)NCC=CC2OC(n3cnc4c(NCCO)ncnc43)C(O)C2O)C1=O,8.519999999999998,,
Cc1ccc2c(c1)CCCN2C(=O)SCC(=O)Nc1ccc(S(N)(=O)=O)cc1Cl,8.519999999999998,,CHEMBL1078535
Cc1oc(-c2ccccc2)nc1CCCc1ccc(CC(C(=O)[O-])n2nccn2)cc1,8.519999999999998,,
CC(C)CC([NH3+])C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(CO)C(=O)[O-])C(C)O)C(C)O,8.519999999999998,,
CCCCCCCCC=CCCCCCCCC(O)c1nnc(-c2ccccn2)o1,8.519999999999998,,
CCCN(CCC)C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C2CN(S(=O)(=O)c3ccccc3)CC[NH2+]2)c1,8.519999999999998,,
C[N+]1CC2(CNC(=O)c3c2[nH]c2c3ccc3cnc(-c4ccccc4F)cc32)C1,8.519999999999998,,
CC(=O)Nc1nnc(S(N)(=O)=O)s1,8.519999999999998,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
CC1OC(OC2CC(O)C3(CO)C4C(O)CC5(C)C(C6=CC(=O)OC6)CCC5(O)C4CCC3(O)C2)C(O)C(O)C1O,8.519999999999998,"This molecule appears as odorless, white crystals or crystalline powder as an octahydrate. Used to produce rapid digitalization in acute congestive heart failure. Also recommended in treatment of atrial or nodal paroxysmal tachycardia and atrial flutter. (EPA, 1998) This molecule is a cardenolide glycoside.",CHEMBL1720907
CC(C)c1cnn2c(NCc3ccccc3)cc(NC(CO)C(O)CO)nc12,8.519999999999998,,
Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnn(-c2ccccc2)c1N,8.519999999999998,,CHEMBL1234931
NC(=O)c1cnc(NC2CCC[NH2+]C2)c2cc(-c3ccc(Cl)cc3)sc12,8.519999999999998,,
CCOC(=O)c1sc2cnccc2c1Nc1ccc2c(c1)CCC2[NH2+]O,8.519999999999998,,
c1cc(-c2nn(C3CC[NH2+]CC3)cc2-c2ccc3c(c2)Cc2cn[nH]c2-3)ccn1,8.519999999999998,,
Cc1ccc(F)cc1Oc1c(C(=O)N2CC[NH2+]CC2)c2ccnc(Cc3ccccc3)c2n1-c1ccccc1,8.519999999999998,,
CCCC1(CCc2ccccc2)CC(=O)C(C(CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,8.519999999999998,,
CC(=O)NC1C([NH2+]OC(=O)Nc2ccccc2)OC(CO)C(O)C1O,8.519999999999998,,
COc1ccccc1N1Cc2c(nc(C)c(C[NH3+])c2-c2ccc(Cl)cc2Cl)C1=O,8.519999999999998,,
COc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1,8.519999999999998,,CHEMBL1785020
O=C([O-])c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1,8.519999999999998,,
[NH3+]CCCC[NH3+],8.519999999999998,,
CC(=O)Nc1ccc2c(c1)c(-c1cc(NC3CC3)n3ncc(C#N)c3n1)cn2CCC(=O)[O-],8.519999999999998,,
COc1ccc2c(c1C[N+]1CC[NH2+]CC1)OC(=Cc1[nH]nc3ccccc13)C2=O,8.519999999999998,,
CC(C)CCN(C(C(=O)NO)C(C)C)S(=O)(=O)c1ccc2ccccc2c1,8.519999999999998,,
COC1CN(c2nc(-c3ncnn3C)c(C(=O)[O-])s2)CCC1NC(=O)c1[nH]c(C)c(Cl)c1Br,8.519999999999998,,
N#[N+2]=NC1CC(C(=O)N2CCCC2C=N)N(C(=O)CCCc2ccccc2)C1,8.519999999999998,,
Cn1cc(-c2cc3cnc(Nc4ccc(-c5cncn5C)cc4Cl)cc3n2C(=O)OC(C)(C)C)cn1,8.519999999999998,,CHEMBL3109945
CC(C)Oc1cccc(C=C2SC(=O)NC2=O)c1N1CCCC([NH3+])C1,8.519999999999998,,
O=C(Nc1[nH]nc2ccc(-c3ccc(NS(=O)(=O)c4cccc(Cl)c4)cc3)cc12)c1ccco1,8.519999999999998,,
O=S(=O)(NCB(O)O)c1ccc(-c2nn[nH]n2)c(Cl)c1,8.519999999999998,,
COC(=O)C1CCC(n2c(NC(=O)c3ccccc3)nc3ccc(C[NH+]4CCCCC4)cc32)CC1,8.519999999999998,,
COCCCCC1(CNC(=O)C2C[NH2+]CC(NS(=O)(=O)c3ccc(C)cc3)C2)c2ccccc2Oc2ccccc21,8.519999999999998,,
[NH3+]C1(C(=O)NC(CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,8.519999999999998,,
CN1C(=[NH2+])NC2(c3cc(-c4cccc(C#N)c4)cs3)CN(C(=O)c3ccccc3)CC2C1=O,8.519999999999998,,
COc1cccnc1N1CC2C(=O)N(C)C(=[NH2+])NC2(c2cc(-c3cccc(C#N)c3)cs2)C1,8.519999999999998,,
N#CC=Cc1cc(Cl)cc(Oc2ccc(Cl)cc2OCCn2ccc(=O)[nH]c2=O)c1,8.519999999999998,,
O=C(Nc1ccccc1N1CC[NH2+]CC1)c1csc(-n2ncc3ccccc32)n1,8.519999999999998,,
CS(=O)(=O)C1CCN(c2cccc3c2ccn3-c2ccnc(NC3CCC(O)CC3)n2)CC1,8.519999999999998,,
C=CC1(F)CN(C2CCCC2)c2nc(Nc3ccc(C(=O)N[NH+]4CC[NH+](C)CC4)cc3OC)ncc2N(C)C1=O,8.519999999999998,,
CNc1nc(C)nc(N2CCC(C(=O)NCc3ccccc3C(F)(F)F)CC2)n1,8.519999999999998,,CHEMBL2392714
Nc1ccc(CNC(=O)Nc2ccc(S(=O)(=O)c3ccccc3)cc2)cn1,8.519999999999998,,CHEMBL2393183
CC1Oc2ccc(C[NH+]3CC=C(c4ccc(Cl)cc4)CC3)cc2NC1=O,8.519999999999998,,
Cc1cccc(Cc2nn(C(C)(C)C)c3ncnc(N)c23)c1,8.519999999999998,,CHEMBL1236661
Cc1cn(-c2cc(F)c(C(N)=O)c(NC3CCOC3)c2)c2c1C(=O)CC(C)(C)C2,8.519999999999998,,
NC(=[NH2+])c1cccc(COc2cc(OCc3cccc(C(N)=[NH2+])c3)cc(C(=O)NC3CCC([NH3+])CC3)c2)c1,8.519999999999998,,
O=C([O-])C1C2CCC(CC2)C1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,8.519999999999998,,
CC(O)CC1OCC(C2CCCCC2)N(c2cc(C#CC(C)(C)C)sc2C(=O)[O-])C1=O,8.519999999999998,,
O=c1cc(N2CCOCC2)[nH+]c2n1CCC(C(F)(F)F)N2CC(O)c1ccccc1,8.519999999999998,,
COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OCC(=O)NCc2ccccc2)c1OC,8.519999999999998,,CHEMBL3315083
O=C([O-])Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1,8.529999999999998,,
CCCCCC(S)C(=O)NC(Cc1ccccc1)C(=O)NC(C)C(=O)[O-],8.54,,
CCCOCCn1c(=O)c(=NCC[NH+]2CCOCC2)[nH]c2ccc(-c3ccc(OC)nc3)nc21,8.54,,
CC1(c2nc3cccc(C(N)=O)c3[nH]2)CCC[NH2+]1,8.54,,
CC(C)([NH3+])c1cc(NC(=O)C2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1,8.54,,
CCCc1nc(C)c2c(C)nc3cc(OCc4ccc5ccccc5n4)ccc3n12,8.54,,
CC(O)C([NH3+])C(=O)NS(=O)(=O)c1cccc(-c2ccc3c(N)ncnc3c2)c1,8.54,,
[NH3+]C1CCCCC1Nc1ccn2ncc(-c3ccc4ccccc4c3)c2n1,8.54,,
CC1OC(OC2CC(O)C3(CO)C4C(O)CC5(C)C(C6=CC(=O)OC6)CCC5(O)C4CCC3(O)C2)C(O)C(O)C1O,8.55,"This molecule appears as odorless, white crystals or crystalline powder as an octahydrate. Used to produce rapid digitalization in acute congestive heart failure. Also recommended in treatment of atrial or nodal paroxysmal tachycardia and atrial flutter. (EPA, 1998) This molecule is a cardenolide glycoside.",CHEMBL1720907
CC[NH+]1CC2(COC(=O)c3ccccc3N3C(=O)CC(C)C3=O)CCC(OC)C34C5CC6C(OC)CC(O)(C5C6OC)C(O)(C(OC)C23)C14,8.55,,
Cn1cncc1C(O)(c1ccc(C#N)cc1)c1cc2cc([N+](=O)[O-])cc(-c3cccc(C#N)c3)c2o1,8.55,,CHEMBL473148
O=C(CC1CCC(O)C2C(O)C(O)C[NH+]12)c1ccccc1,8.55,,
COc1ccc(Nc2ncnc(-c3cccnc3Nc3cc(NC(=O)c4ccc(C[NH+]5CC[NH+](C)CC5)cc4)ccc3C)n2)cc1,8.55,,
CS(=O)(=O)c1cccc(Oc2cccc(-c3ccnc4c(C(F)(F)F)cccc34)c2)c1,8.55,,CHEMBL593241
CSCCC([NH3+])C(=O)NC(Cc1c[nH]cn1)C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)[O-])C(C)O,8.55,,
CC(C)n1nc(-c2ccc3cc(OCc4cccc(Cl)c4)ccc3c2)c2c(N)ncnc21,8.55,,CHEMBL2078817
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,8.56,,
CC1CC2OC2C=CC=CC(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1,8.57,This molecule is a macrocyclic antifungal antibiotic that inhibits signal-dependent transcriptional activation and induces differentiation in leukemia. (NCI),CHEMBL3972342
CSCC1[NH2+]C(c2c[nH]c3c(=O)[nH]cnc23)C(O)C1O,8.57,,
N#Cc1cc(-c2ccc(O)c(F)c2)cc2ccc(O)cc12,8.57,,CHEMBL192154
C[NH+]1CC[NH+](CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,8.57,,
Oc1ccc(C2Oc3ccc(O)cc3C3CCCC32)cc1,8.57,,
Cc1c(O)cccc1C(=O)NC(CSc1ccccc1)C(O)C[NH+]1CC2CCCCC2CC1C(=O)NC(C)(C)C,8.57,,
[NH3+]CCCCC(NC(=O)C([NH3+])CO)C(=O)NCC(=O)NC(CCC[N+](=O)C=O)C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC1CCCNC(=O)C(CO)NC(=O)C(CCC[N+](=O)C=O)NC1=O,8.57,,
[NH3+]C1CCCCNC(=O)C(CO)NC(=O)C(CCC[N+](=O)C=O)NC1=O.[NH3+]CCCCC(NC(=O)C([NH3+])CO)C(=O)NCC=O,8.57,,
Cc1nc(Nc2n[nH]c3c2CN(C(=O)NC(C[NH+](C)C)c2ccccc2)C3(C)C)c2sccc2n1,8.57,,
Cc1nn(C)c(C)c1Cc1nnc(-c2sc3ccccc3c2OC2CC[NH2+]CC2)o1,8.57,,
Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,8.57,"This molecule is a member of the class of triazolopyridazines that is 6-(1-methylpyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazine-3-thiol in which the thiol hydrogen is replaced by a quinolin-6-yl group. It has a role as a c-Met tyrosine kinase inhibitor and a nephrotoxic agent. It is a member of quinolines, a triazolopyridazine, a member of pyrazoles, a biaryl and an aryl sulfide. A MET receptor tyrosine kinase inhibitor. This molecule is an orally bioavailable small molecule, c-Met inhibitor with potential antineoplastic activity. MET receptor tyrosine kinase inhibitor SGX523 specifically binds to c-Met protein, or hepatocyte growth factor receptor (HGFR), preventing binding of hepatocyte growth factor (HGF) and disrupting the MET signaling pathway; this agent may induce cell death in tumor cells expressing c-Met. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays an important role in tumor cell proliferation, survival, invasion, and metastasis, and in tumor angiogenesis.",CHEMBL1236107
Cc1ccc(C(=O)CC2CCC(O)C3C(O)C(O)C[NH+]23)cc1,8.57,,
CC(C)(C)c1ccc(C(=O)CC2CCC(O)C3C(O)C(O)C[NH+]23)cc1,8.57,,
COc1ccc(CCNC(=O)c2ccc(S(N)(=O)=O)cc2)cc1OC,8.57,,CHEMBL2048917
C=C1C(O)CC(=CC=C2CCCC3(C)C2CCC3C(C)CCCO)CC1O,8.57,,
C[NH2+]C(C)C(=O)NC(C(=O)N1CC2CCC[NH+]2CC1C(=O)NC1CCCc2ccccc21)C1CCCCC1,8.57,,
[NH2+]=c1[nH]c(=O)c2nc(CNc3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc3)cnc2[nH]1,8.57,,
COCCN(CC1CCC[NH+](C2Cc3ccccc3C2)C1)C(=O)c1ccc2ccccc2c1,8.57,,
CC(C)C(=O)CN1C2=[N+]=C(N3CCOCC3C)CC(=O)N2CCC1C(F)(F)F,8.57,,
CC1OC(c2cccc(O)c2O)[NH2+]C1C(=O)NCCCN(CCCNC(=O)c1cccc(O)c1O)C(=O)C1[NH2+]C(c2cccc(O)c2O)OC1C,8.58,,
COCC1OC(OC2C(CO)OC(OC3C(O)C4[NH+]=C(N(C)C)OC4C3CO)C(NC(C)=O)C2O)C(NC(C)=O)C(O)C1O,8.59,,
O=c1ncc2c(-c3ccc(F)cc3F)cc(N3CC[NH2+]CC3)cc2n1-c1c(Cl)cccc1Cl,8.59,,
CN(C(=O)N1CC(c2cc(F)ccc2F)=CC1c1ccccc1)C1CC[NH2+]CC1,8.59,,
CNc1nccc(-c2ccc(C(=O)NC(C[NH3+])Cc3ccc(Cl)cc3Cl)s2)n1,8.59,,
[NH3+]C(CC(=O)N1CCCNC(=O)C1CC(F)(F)F)Cc1cc(F)c(F)cc1F,8.59,,
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCC[NH+]1CCOCC1,8.59,,
[NH3+]C(CC1=C2C(=O)NOC2CCC=C1)C(=O)[O-],8.59,,
CCCCCCCCOS(N)(=O)=O,8.59,,CHEMBL24261
CC(C)(O)C1CC[NH+](Cc2ccc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1,8.59,,
CCOc1ccc2cc(-c3nn(CC4CC[NH+](C)CC4)c4ncnc(N)c34)ccc2c1,8.59,,
CC(=O)N1CCC(c2nc3ccccc3nc2OC2CN(c3ccc4ccccc4n3)C2)CC1,8.59,,CHEMBL3356684
O=C(Nc1nccs1)c1cccc(CN2C(=O)N(Cc3cccc(C(=O)Nc4nccs4)c3)C(Cc3ccccc3)C(O)C(O)C2Cc2ccccc2)c1,8.599999999999998,,
O=C1Nc2ccc(Cl)cc2C(C#CC2CC2)(C(F)(F)F)O1,8.599999999999998,,CHEMBL59507
Oc1ccc(-c2ccc3c(Cl)c(O)ccc3c2)cc1,8.599999999999998,,CHEMBL364092
CC(C)CC1NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCC(N)=O)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCC(=O)[O-])NC(=O)C2CCCN2C(=O)C(Cc2ccc(O)cc2)NC(=O)C(CC(=O)[O-])NC(=O)C(NC(=O)C(C)NC(=O)CNC(=O)C([NH3+])CCCC[NH3+])CSSCC(C(=O)NC(C)C(=O)NC(C)C(=O)O)NC1=O,8.599999999999998,,
CC(O)(COc1ccc([N+](=O)[O-])cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,8.599999999999998,,
O=C(C=Cc1ccc(Sc2ccccc2OCc2cccnc2)c(C(F)(F)F)c1C(F)(F)F)N1CCOCC1,8.599999999999998,,
C[NH+](CCCOc1ccc(Cc2ccccc2)cc1)CCC(=O)[O-],8.599999999999998,,
CC(C)c1cccc(C[NH2+]CC(O)C(Cc2ccccc2)NC(=O)C2CCCC(C(C)(C)N3CCCCC3=O)C2)c1,8.599999999999998,,
CN1C(=O)N(c2cc(Cl)cc(Cl)c2)C(=O)C12CN(c1ccc(C(=O)[O-])cn1)CC2c1ccc(C#N)cc1,8.599999999999998,,
NC(=[NH2+])NCCCC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC(Cc1cccc2ccccc12)C(=O)NC1CSSCC(C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCC(=O)N2CCCC2C(=O)[O-])NC(=O)C(CCCNC(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc2ccc(O)cc2)NC(=O)C2CCCN2C(=O)C2CCCN2C(=O)C(CCCC[NH3+])NC(=O)C(CCC(N)=O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,8.599999999999998,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,8.599999999999998,,CHEMBL195725
CCOc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1,8.599999999999998,,CHEMBL1785021
COc1ccc2cc(-c3nn(CC4CC[NH2+]CC4)c4ncnc(N)c34)ccc2c1,8.599999999999998,,
NC(=O)C(CCC(=O)[O-])NC(=O)c1ccc(-c2cc(-c3ccccc3)cs2)cc1,8.599999999999998,,
Cc1cc(CNc2ncc(Br)c(Nc3cc(CCc4ccccc4)n[nH]3)n2)on1,8.599999999999998,,
O=C(Nc1ccnc(NC(=O)C2CC2F)c1)c1c(Cl)cccc1Cl,8.599999999999998,,
COc1cc(-c2n[nH]c3ccc(CC(C#N)C(=O)NC(C)(C)CO)cc23)cc(OC)c1OC,8.599999999999998,,
CCc1ccc2c(c1)C([NH2+]CC(O)C1Cc3cccc(c3)CCCCn3cc(ccc3=O)C(=O)N1)CC1(CCC1)O2,8.599999999999998,,
CC12CCC(=O)C=C1CCC1C2C(=O)CC2(C)C(C(=O)CO)CCC12,8.599999999999998,,
CC1=C(C(=O)NC(C)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(Cc2ccccc2)C(O)C(C)CO)Cc2ccccc21,8.599999999999998,,
CC#Cc1cncc(-c2cccc(C3(c4cc(C)c(=O)n(CC)c4)NC(=[NH2+])c4c(F)cccc43)c2)c1,8.609999999999998,,
CNC(=O)C[NH2+]C(C(=O)N1CCC1C(=O)NCc1ccc(C(N)=[NH2+])cc1)C1CCCCC1,8.609999999999998,,
NC(=[NH2+])NCCCC(NC(=O)C1CC[NH+]2CCC([NH3+])(Cc3ccccc3)C(=O)N12)C(O)c1nccs1,8.62,,
NC(=O)CC1CC(C2=CNC(Cc3ccccc3)(CC(O)C(Cc3ccccc3)NC(=O)OC3CCOC3)C2=O)c2ccccc21,8.62,,
COC(=O)NC(C(=O)N[NH+](Cc1ccc(Br)cc1)CC(O)(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O)C(C)(C)C,8.62,,
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CC[NH+](C)CC4)ccc3OCC)nc12,8.62,,
Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2nc(NCC[NH+]3CCOCC3)ncc2c1,8.62,,
COc1cc(Nc2nccc(Nc3cnc4ccccc4c3)n2)ccc1N1CCOCC1,8.62,"This molecule is a member of the class of aminopyrimidines that is pyrimidine-2,4-diamine substituted at positions N-2 and N-4 by 3-methoxy-4-(morpholin-4-yl)phenyl and quinolin-3-yl groups respectively. It has a role as an insulin-like growth factor receptor 1 antagonist. It is a member of morpholines, a monomethoxybenzene, an aminoquinoline, an aminopyrimidine, a tertiary amino compound and a secondary amino compound.",CHEMBL1738698
NS(=O)(=O)c1ccc(C(=O)NCC(F)(F)C(F)(F)C(F)(F)F)cc1,8.62,,CHEMBL309012
NS(=O)(=O)c1ccc(-c2cn(-c3cccc4ccccc34)nn2)s1,8.62,,CHEMBL2414068
COc1ccc2c(c1)C=C1Cn3c-2c(C2CCCCC2)c2ccc(cc23)C(=O)NS(=O)(=O)N(C)CCCCN(C)C1=O,8.62,,CHEMBL2043027
OCC1OC(OC2C(CO)OC(OCCCCCCC3CCCCC3)C(O)C2O)C(O)C(O)C1O,8.62,,
CC(O)C1CCN(c2nccnc2Oc2ccc(Nc3nc4ccccc4s3)cc2)CC1,8.62,,CHEMBL2206223
O=c1ccn(C2OC(CO)C(O)C2O)c(=O)[nH]1,8.62,"This molecule is a pyrimidine nucleoside. This molecule is a natural product found in Homo sapiens, Apium graveolens, and other organisms with data available.",CHEMBL68846
CC(=O)NC1C(O)CC(C(=O)[O-])OC1C(O)C(O)CO,8.62,,
OCC1CCN(c2nccnc2OC2CN(c3ccc4ccccc4n3)C2)CC1,8.62,,CHEMBL2180767
O=NC(=O)CNS(=O)(=O)c1ccc(-c2ccccc2)cc1,8.63,,
O=C(NCC[N+]1CCOCC1)c1ccc(-c2nccc3ccccc23)cc1,8.63,,
NS(=O)(=O)c1ccc(C(=O)NCc2ccccc2F)cc1,8.64,,
CC(NC(=O)C(Cc1ccccc1)NC(=O)C(S)Cc1ccccc1)C(=O)[O-],8.64,,
CN(C)C(=O)C(C1CCC(c2cccc3ncnn23)CC1)C([NH3+])C(=O)N1CCC(F)C1,8.64,,
COc1ccc(-n2cnc3ccc(-c4n[nH]c(=S)o4)cc32)cc1,8.64,,CHEMBL1230134
C=C(C)COc1ccc(C2C3=C(CC(C)(C)CS3(=O)=O)Nc3c(O)cccc3N2C(=O)c2nc(C)oc2C)c(F)c1,8.64,,
NS(=O)(=O)c1cc2ccccc2o1,8.64,,CHEMBL165346
CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F,8.64,"This molecule is a member of the class of coumarins that is 4-methyl-7-[(pyrimidin-2-yl)oxy]coumarin carrying an additional [2-[(methylaminosulfonyl)amino]-3-fluoropyridin-4-yl]methyl substituent at position 3. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor and an antineoplastic agent. It is an aryloxypyrimidine, a member of coumarins, a member of pyridines, an organofluorine compound and a member of sulfamides. This molecule is under investigation in clinical trial NCT03875820 (Phase I Trial of VS-6063 and RO5126766.). This molecule is an orally bioavailable inhibitor of the serine/threonine protein kinases Raf and mitogen-activated protein kinase kinase (MAP2K, MAPK/ERK kinase, or MEK), with potential antineoplastic activity. Upon oral administration, avutometinib specifically targets, binds to and inhibits the kinase activities of Raf and MEK, resulting in the inhibition of Raf/MEK-mediated signal transduction pathways. This results in the inhibition of Raf/MEK-dependent tumor cell proliferation and survival. The RAS/RAF/MEK/extracellular signal-regulated kinase (ERK) signaling pathway is often dysregulated in human cancers and plays a key role in tumor cell proliferation, differentiation and survival.",CHEMBL3264002
CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)CNC(=O)C[NH3+])C(=O)NC(CC(C)C)C(=O)[O-],8.64,,
COc1[nH]nc2ncc(NC(=O)c3c(F)ccc(NC(=O)c4cccc(C(C)(C)C#N)c4)c3F)cc12,8.64,,
O=C1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O,8.64,,
CC(NC(=O)C1(S(C)=O)C(C)C1(Cl)Cl)c1ccc(Br)cc1,8.64,,
CC(=O)SC1CC2=CC(=O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,8.65,This molecule is a steroid lactone.,CHEMBL1562223
Cc1cccc2scc(Cn3c(SCCCC(=O)[O-])nc4ccccc43)c12,8.65,,
NS(=O)(=O)c1ccc(C(=O)NCc2cc(F)ccc2F)cc1,8.66,,
N#CC1=C(c2cccc3ccccc23)CN(C(=O)Cc2cncn2Cc2ccc(C#N)cc2)CC1,8.66,,CHEMBL30059
CC#CCOc1ccc(S(=O)(=O)CC2(C(=O)NO)CCN(S(=O)(=O)c3c(C)noc3C)CC2)cc1,8.66,,CHEMBL234567
CONC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)NC(C)c4ccccc4)c(C)c23)c1,8.66,,
[NH3+]C1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,8.66,,
CN(C(=O)N1CC(c2cc(F)ccc2F)=CC1(CO)c1ccccc1)C1CC[NH+](C)CC1F,8.66,,
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,8.66,,
CS(=O)(=O)c1ccccc1-c1ccc(N2CCc3c(C(F)(F)F)nn(-c4cccc(-c5n[nH]c(=O)[nH]5)c4)c3C2=O)cc1,8.66,,CHEMBL578474
Cc1nc2nc(C(=O)N3CCOCC3)cn2c(-c2ccc(Cl)cc2Cl)c1C[NH3+],8.66,,
Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1,8.66,"This molecule is a catechol-O-methyltransferase inhibitor used in the therapy of Parkinson disease as adjunctive therapy in combination with levodopa and carbidopa. This molecule has been associated with serum enzyme elevations during treatment and with several instances of clinically apparent acute liver injury, which can be severe and even fatal. This molecule is benzophenone substituted on one of the phenyl rings at C-3 and C-4 by hydroxy groups and at C-5 by a nitro group, and on the other phenyl ring by a methyl group at C-4. It is an inhibitor of catechol O-methyltransferase. It has a role as an EC 2.1.1.6 (catechol O-methyltransferase) inhibitor and an antiparkinson drug. It is a member of benzophenones, a member of 2-nitrophenols and a member of catechols. This molecule is a drug that inhibits the enzyme catechol-O-methyl transferase (COMT). It is used in the treatment of Parkinson's disease as an adjunct to levodopa/carbidopa medication. It is a yellow, odorless, non-hygroscopic, crystalline compound. This molecule is associated with a risk of hepatotoxicity. This molecule is a Catechol-O-Methyltransferase Inhibitor. The mechanism of action of tolcapone is as a Catechol O-Methyltransferase Inhibitor. This molecule is a benzophenone derivative and a catechol-O-methyltransferase (COMT) inhibitor. This molecule selectively and reversibly inhibits COMT, an enzyme that catalyzes the metabolism of biologically active catechols and their hydroxylated metabolites by transferring the methyl group of S-adenosyl-L-methionine to the phenolic group of catechol-containing substrates. When given in conjunction with a peripheral dopa decarboxylase inhibitor and levodopa, tolcapone may prevent the metabolism of levodopa to 3-methoxy-4-hydroxy- L-phenylalanine (3-OMD) in the brain and peripheral tissues leading to increased bioavailability and enhancement of delivery to the central nervous system (CNS) of levodopa. This molecule is a drug that inhibits the enzyme catechol-O-methyl transferase (COMT). It is used in the treatment of Parkinson's disease as an adjunct to levodopa/carbidopa medication. It is a yellow, odorless, non-hygroscopic, crystalline compound. This molecule is associated with a risk of hepatotoxicity.",CHEMBL1324
[NH3+]Cc1cc(Cl)cc(Oc2c(Cl)ccc3c2nnn3Cc2[nH]nc3ncccc23)c1Cl,8.66,,
CCOc1cncc(N2CCC[NH2+]CC2)c1,8.66,,
N#CC1(c2cccc(C(=O)Nc3cc(Oc4ccc5nc(NC(=O)C6CC6)sc5n4)ccc3F)c2Cl)CC1,8.66,,CHEMBL2063743
O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCC[NH2+]1,8.66,,
COc1nc2cccnc2n1C1CC(Nc2nc3ccccc3s2)C1,8.66,,CHEMBL3287905
CC(CCc1ccc(-c2ccc(OCCC[NH+]3CCOCC3)cc2)cc1)(C(=O)NO)S(C)(=O)=O,8.67,,
Cc1c(N2C(=O)C3C(O)CCN3C2=O)ccc(C#N)c1Cl,8.679999999999998,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc2c(c1)OCO2,8.679999999999998,,
N#Cc1cc(Cl)cc(Oc2cc(Cl)cc(OCC(=O)Nc3ccc(S(N)(=O)=O)cc3Cl)c2)c1,8.679999999999998,,CHEMBL255689
C[NH+]1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1,8.679999999999998,,
O=c1[nH]c(Cc2ccccc2)nc2c1cnn2C1CCCC1,8.679999999999998,,CHEMBL572934
Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,8.679999999999998,"This molecule is a nonnucleoside reverse transcriptase inhibitor used in combination with other agents in the therapy of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). This molecule has been associated with transient serum aminotransferase elevations and with hypersensitivity reactions that can be associated with liver injury including acute liver failure. This molecule is an aminopyrimidine that consists of 2,6-diaminopyrimidine bearing a bromo substituent at position 5, a 4-cyano-2,6-dimethylphenoxy substituent at position 4 and having a 4-cyanophenyl substituent attached to the 2-amino group. NNRTI of HIV-1, binds directly to RT and blocks RNA-dependent and DNA-dependent DNA polymerase activities It has a role as a HIV-1 reverse transcriptase inhibitor and an antiviral agent. It is a dinitrile, an organobromine compound, an aminopyrimidine and an aromatic ether. This molecule is an antiretroviral agent more specifically classified as a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI). Etraverine is used clinically for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. On January 18, 2007, the FDA granted accelerated approved for the use of etravirine 100mg tablets in the treatment of adult HIV-1 infection documented to be resistant to therapy with other NNRTIs and antiretroviral agents. On March 26, 2012, approval was extended for use in treatment-experienced pediatric patients 6 to 18 years of age, weighing at least 16 kg. Etravarine must always be used in combination with other antiretroviral drugs.   This molecule exerts its effects via direct inhibition of the reverse transcriptase enzyme of human immunodeficiency virus type 1 (HIV-1), and consequently blocks DNA-dependent and RNA-dependent polymerase activity. This molecule does not inhibit human DNA polymerase alpha, beta or gamma.   Common side effects of use include mild to moderate rash within the first 6 weeks of therapy, nausea, diarrhea and peripheral neuropathy. Patients are advised to immediately contact their healthcare provider if a rash develops.   In 2009, postmarketing case reports of Stevens-Johnson Syndrome, toxic epidermal necrolysis, erythema multiforme, and other hypersensitivity reactions lead to a revision of etravirine's ""Warnings and Precautions,"" as well as notification of health care providers.   In 2013, reports of Autoimmune disorders (such as Graves’ disease, polymyositis, and Guillain-Barré syndrome) in the setting of immune reconstitution, as well as more in depth information about the development of rashes in patients taking etravirine, lead to a modification of etravirine's monograph. This molecule is a Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor. The mechanism of action of etravirine is as a Non-Nucleoside Reverse Transcriptase Inhibitor, and Cytochrome P450 3A Inducer, and Cytochrome P450 2C9 Inhibitor, and Cytochrome P450 2C19 Inhibitor, and P-Glycoprotein Inhibitor. This molecule is a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor. This molecule is designed to be active against HIV isolates with mutations that confer resistance to the two most commonly prescribed first-generation NNRTIs. It can bind the enzyme reverse transcriptase (RT) in multiple conformations, both for native and mutant RT, thereby blocking the enzymatic activity of RT. &nbsp;",CHEMBL308954
CC(O)C(NC(=O)N1CCC(c2ccc(C#Cc3ccccc3)cc2)CC1)C(=O)NO,8.679999999999998,,
C[N+]1CCN(C(=O)NC(Cc2ccccc2)C(=O)NC(CCc2ccccc2)CCS(=O)(=O)c2ccccc2)CC1,8.679999999999998,,
C[NH2+]C(C)C(=O)NC(C(=O)N1CC2CCC[NH+]2CC1C(=O)NC1CCOc2ccccc21)C1CCCCC1,8.679999999999998,,
CC(C)C(C(=O)NC(Cc1ccccc1)CC(O)C(Cc1ccccc1)NC(=O)C1CN(c2ccccc2)C(=O)O1)N1CCCNC1=O,8.689999999999998,,
NS(=O)(=O)C(F)(F)F,8.699999999999998,,CHEMBL67511
CCCN(CCc1ccccc1)C(=O)C1OC(C(=O)[O-])=CC([NH3+])C1NC(C)=O,8.699999999999998,,
CC(C)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CC(=O)[O-])NC(=O)OCc1ccccc1)C(=O)NC(C=O)CC(=O)[O-],8.699999999999998,,
NS(=O)(=O)c1ccc(C(=O)NCc2c(F)c(F)c(F)c(F)c2F)cc1,8.699999999999998,,
CC(C)CC(NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])Cc1c[nH]c2ccccc12)C(=O)NC(CCC(=O)[O-])C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)[O-],8.699999999999998,,
CC(C)CC(NC(=O)C(CCc1ccc(-c2ccc(F)cc2)cc1)CC(CCCCN1Cc2ccccc2C1=O)C(=O)[O-])C(=O)Nc1ccccc1,8.699999999999998,,
CC(C)C(NC(=O)c1ccc2ccccc2n1)C(=O)NC(Cc1ccccc1)C(O)C[NH+]1CCC(SCc2cccnc2)CC1C(=O)NC(C)(C)C,8.699999999999998,,
CC12CCC3c4ccc(O)cc4CCC3C1CCC2O,8.699999999999998,This molecule is a steroid. It has a role as an estrogen. This molecule is a natural product found in Punica granatum with data available.,CHEMBL412
COc1ccc(S(=O)(=O)N(Cc2cccnc2)C(C(=O)N=O)C(C)C)cc1,8.699999999999998,,
CC12CCC(O)CC1CCC1C2CCC2(C)C(C3=CC(=O)OC3)CCC12O,8.699999999999998,,
NC(=O)OC1Cc2ccccc2C1C1=CNC(Cc2ccccc2)(CC(O)C(Cc2ccccc2)NC(=O)OC2CCOC2)C1=O,8.699999999999998,,
NC(=O)OC1Cc2ccccc2C1C1=CNC(Cc2ccccc2)(CC(O)C(Cc2ccccc2)NC(=O)OC2CCOC2)C1=O,8.699999999999998,,
Cc1c(O)cccc1C(=O)NC(CSc1ccccc1)C(O)C[NH+]1CC2CCCCC2CC1C(=O)NC(C)(C)C,8.699999999999998,,
Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1,8.699999999999998,,CHEMBL298445
CCCCNC(=O)C(CC(O)C(CC1CCCCC1)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(Cc1ccccc1)CS(=O)(=O)C(C)(C)C)C(C)C,8.699999999999998,,
COc1ccc(O)c(C(=O)c2ccc(C(=O)NC3CCC[NH2+]CC3NC(=O)c3ccncc3)cc2)c1F,8.699999999999998,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,8.699999999999998,,CHEMBL195725
CC(NC(=O)C(CO)NS(=O)(=O)Cc1ccccc1)C(=O)NCc1ccc(NC(N)=[NH2+])cc1,8.699999999999998,,
CC(=Cc1ccc(C(=O)[O-])cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C,8.699999999999998,,
[NH3+]C(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-],8.699999999999998,,
NC(=[NH2+])c1ccc2nc(-c3cc(C(CC(=O)[O-])C(=O)[O-])cc(-c4cc(CNC(N)=O)ccc4O)c3O)[nH]c2c1,8.699999999999998,,
Cc1cc(C)cc(Oc2c(CSCc3ccco3)c(C)[nH]c(=O)c2I)c1,8.699999999999998,,CHEMBL567204
CC(C(=O)Nc1cc(C2CC2)n[nH]1)c1ccc(N2CCNC2=O)cc1,8.699999999999998,,
O=C(Cn1c(Cl)cnc(NCCc2ccccn2)c1=O)NCc1csc2ccc(Cl)cc12,8.699999999999998,,
CC(=O)C1CCC2C3CCC4CC(OC(=O)CCC(=O)[O-])CCC4(C)C3CCC12C,8.699999999999998,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,8.699999999999998,,
[NH3+]C(C(=O)N1CC(c2cc(F)ccc2F)=CC1c1ccccc1)C1CC1,8.699999999999998,,
CCC(NC(=O)CC(O)C(CC(C)C)NC(=O)C(NC(=O)C(Cc1cccc2ccccc12)NC(C)=O)C(C)C)C(=O)NC(Cc1cccc2ccccc12)C(N)=O,8.699999999999998,,
CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)[O-],8.699999999999998,,
CC(=O)Nc1nnc(S(N)(=O)=O)s1,8.699999999999998,"This molecule appears as white to yellowish-white fine crystalline powder. No odor or taste. (NTP, 1992) This molecule is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. This molecule is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) This molecule is a Carbonic Anhydrase Inhibitor. The mechanism of action of acetazolamide is as a Carbonic Anhydrase Inhibitor. This molecule is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. This molecule is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. This molecule reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. This molecule also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.",CHEMBL20
CCCCCS(=O)(=O)CC(NC(=O)c1cccnc1)C(=O)NC(Cc1cc(F)cc(F)c1)C(O)C[NH2+]Cc1cccc(CC)c1,8.699999999999998,,
Cc1[nH]c2ccccc2c1C1=C(c2c(C)n(CCC[NH+](C)C)c3ccccc23)C(=O)NC1=O,8.699999999999998,,
CN1C(=O)c2nc(N3CCCC([NH3+])C3)n(Cc3ccccc3C#N)c2C1=O,8.699999999999998,,
CC(=CS(=O)(=O)NC1CCN(C(C)C(=O)N2CCOCC2)C1=O)c1ccc(Cl)s1,8.699999999999998,,
CCc1c(-c2ccccc2)c(-c2ccccc2)nn1-c1ccccc1-c1cccc(OCC(=O)[O-])c1,8.699999999999998,,
[NH3+]C(CC(=O)[O-])C(=O)[O-],8.699999999999998,,
CC(C)c1ccccc1Nc1n[nH]c(SCc2cccs2)n1,8.699999999999998,,
O=C(NC(CO)c1ccc(F)c(Cl)c1)c1cc(-c2[nH]ncc2-c2cccc(Cl)c2)c[nH]1,8.699999999999998,,CHEMBL220054
O=C1NC(=O)C(c2ccc(Oc3ccccc3)cc2)([NH+]2CCN(c3ncccn3)CC2)C(=O)N1,8.699999999999998,,
c1ccc(C2([NH+]3CCCCC3)CCCCC2)cc1,8.699999999999998,,
CC(=O)C1N=[N+](c2cc(C)ccc2F)CC1(CCC[NH+]1CCN(C(C)=O)CC1)c1ccccc1,8.699999999999998,,
CC(=CS(=O)(=O)NC1CCN(C(C)C(=O)N2CCOCC2)C1=O)c1ccc(Cl)s1,8.699999999999998,,
[NH3+]C(Cc1ccc(OCc2ccccc2)cc1)CN(O)C(=O)CCCCC(=O)[O-],8.699999999999998,,
CCc1cn2c3c(cc(C(=O)NC(Cc4ccccc4)C(O)C[NH2+]Cc4cccc(C(F)(F)F)c4)cc13)N(C)S(=O)(=O)CC2,8.699999999999998,,
COc1ccc(S(=O)(=O)N(Cc2cccnc2)C(C(=O)NO)C(C)C)cc1,8.699999999999998,,CHEMBL3827444
Cc1ncc(-c2nc(Nc3ccc(C(=O)N4CCC([NH+](C)C)C4)cc3)ncc2F)n1C(C)C,8.699999999999998,,
CCc1cn2c3c(cc(C(=O)NC(Cc4ccccc4)C(O)C[NH2+]Cc4cccc(OC)c4)cc13)N(C)S(=O)(=O)CC2,8.699999999999998,,
CC(Oc1cc(-c2cnn(C3CC[NH2+]CC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,8.699999999999998,,
CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(S(C)(=O)=O)CC3)nc1-2,8.699999999999998,,
CC(c1ccc(N2CCC(NS(=O)(=O)C=Cc3ccc(Cl)s3)C2=O)c(F)c1)[NH+](C)C,8.699999999999998,,
CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,8.699999999999998,,
Cc1ccc(CO)cc1N(c1ccnc(Nc2cc(N3CCOCC3)cc(S(C)(=O)=O)c2)n1)C(C)C,8.699999999999998,,CHEMBL1738764
O=C1C2C(C(=O)N1CCC[N+]1(CCO)CCCC1)C(c1cc(-c3ccc(Cl)s3)on1)[NH+]1CCCC21,8.699999999999998,,
C[NH+](C)C1CCc2cc(N3CCC(NS(=O)(=O)c4ccc5cc(Cl)ccc5c4)C3=O)ccc21,8.699999999999998,,
O=C1C(NS(=O)(=O)c2ccc3cc(Cl)ccc3c2)CCN1c1ccc(C2CCC[NH2+]2)cc1F,8.699999999999998,,
C[NH+]1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4ccc5c(C(N)=O)nn(CCO)c5c4n3)c2)CC1,8.699999999999998,,
CC(C)Oc1ccc2c(c1)c1c3c(c4cc(F)c[n+]5c4c1n2[Ru+7]512(N=C=S)[S+]4[CH]C[S+]1CC[S+]2CC4)C(=O)NC3=O,8.699999999999998,,
Cc1ccc(C(=O)Nc2cc(CCC[NH+](C)C)cc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1,8.699999999999998,,
CC(Oc1cccc2nc(N)nc(N)c12)c1cccc(Cl)c1,8.699999999999998,,CHEMBL398416
[NH3+]CCc1c[nH]c2ccc(O)cc12,8.699999999999998,,
NS(=O)(=O)c1nnc(-c2ccccc2Cl)s1,8.699999999999998,,CHEMBL360356
CNc1nccc(-c2cccnc2Oc2c(C)cc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1,8.699999999999998,,CHEMBL458023
COC(C)(C)CCn1nc(Nc2c(C)cccc2C)c2cnc(Nc3ccc(N4CC[NH2+]CC4)cc3)nc21,8.699999999999998,,
CC(C)CC(CC(=O)NCC(=O)NC(CC(=O)[O-])C(=O)NC(C)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(N)=[NH2+])C(N)=O)NC(=O)C(CCCC[NH3+])NC(=O)C1CCCC1NC(=O)C(CC(C)C)NC(=O)C1CCCC1NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C1CCCC1NC(=O)C(C)NC(=O)C1C[NH2+]CC1[NH3+],8.699999999999998,,
CNc1nc2c(CC[NH2+]CC3CCCC3)c3[nH]c(=[NH2+])[nH]c(=O)c3cc2[nH]1,8.699999999999998,,
CCCNc1ncnc2c1ncn2C1OC(C=CCNC(=O)c2cc(-c3ccc(F)cc3)cc(O)c2O)C(O)C1O,8.699999999999998,,
Cn1nc(C(C)(C)C)cc1C(=O)NC(Cc1cccc(-c2nnc(C[NH3+])o2)c1)C(=O)NCC=N,8.699999999999998,,
Cc1cnc(Nc2ccccc2)nc1-c1c[nH]c(C(=O)NC(CO)c2ccccc2)c1,8.699999999999998,,
Cc1cnc(Nc2ccccc2Cl)nc1-c1c[nH]c(C(=O)NC(CO)c2ccccc2)c1,8.699999999999998,,
Cc1ccc(C(=O)Nc2ccc(C[NH+]3CC[NH+](C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,8.699999999999998,,
COc1ccc(C2=NNC(=O)C2=NNc2ccc(Cl)cc2)cc1OC,8.699999999999998,,
O=C(NCc1ccc(Cn2c(C(F)(F)F)nc3ccccc32)s1)C(O)C(O)C(=O)N1CCCC1c1cccc(Cl)c1,8.699999999999998,,
COc1cc2c(nc1OC)c(-c1cc3c(Cl)ccnc3[nH]1)cn2C,8.699999999999998,,
Cc1c(F)cccc1Cc1c(C(=O)N2CC[NH2+]CC2)c2c(C)c(O)ccc2n1-c1ccccc1,8.699999999999998,,
C=CC1CC1(NC(=O)C1CC(Oc2nccc3ccc(Br)cc23)CN1C(=O)C(C)NC(=O)CC)C(=O)NS(=O)(=O)C1CC1,8.699999999999998,,
CCC([NH2+]C)C(=O)NC1C(=O)N2C(CCC1CC[NH2+]Cc1ccccc1)CCC2C(=O)NC(c1ccccc1)c1ccccc1,8.699999999999998,,
NC(=O)Nc1sc(-c2ccc(Cl)cc2)cc1C(=O)NC1CCC[NH2+]C1,8.699999999999998,,
COC(=O)c1oc2cnccc2c1Nc1ccc2c(c1)CCC2=NO,8.699999999999998,,
O=C(NC(COc1ccc2[nH]c(=O)[nH]c2c1)c1ccccc1)c1cccn(Cc2ccc(F)c(F)c2)c1=O,8.699999999999998,,
CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,8.699999999999998,,CHEMBL1615189
NS(=O)(=O)c1nc2ccccc2s1,8.699999999999998,This molecule is a member of benzothiazoles and a sulfonamide.,CHEMBL168552
Cc1ncc(CCC[N+](C)C)cc1Nc1ncc2c(n1)-c1ccc(Cl)cc1N=C(S)C2,8.699999999999998,,
[NH3+]CCCCCC(C[SeH5])C(=O)[O-],8.699999999999998,,
CC(C)[NH+]1CCC(NS(=O)(=O)CCNC(=O)c2ccc(Cl)s2)CC1,8.699999999999998,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCN2C(=O)C([NH2+]CC(=O)[O-])C2CCCCC2)cc1,8.699999999999998,,
CCOCC(Oc1cc(CC2CS(=O)(=O)CC([NH2+]Cc3cccc(C(C)(C)C)c3)C2O)cc(F)c1N)C(F)(F)F,8.699999999999998,,
CCOCC(Oc1cc(CC2CS(=O)(=O)CC([NH2+]Cc3cccc(C(C)(C)C)c3)C2O)cc(F)c1N)C(F)(F)F,8.699999999999998,,
CC1CCC(C(=O)N(c2cc(C#CC(C)(C)C)sc2C(=O)[O-])C(C)C)CC1,8.699999999999998,,
Cc1nc(N)nc(-c2cc(C3CCOCC3)cnc2Nc2cnc(Cl)c(NS(C)(=O)=O)c2)n1,8.699999999999998,,CHEMBL2206907
CCc1[nH]c2nc(Sc3cnc4nccnc4c3)nc(N3CCC([NH3+])C3)c2c1Cl,8.699999999999998,,
CCc1[nH]c2nc(Sc3ccc4c(c3)C(=O)NC4)nc(N3CCC([NH3+])C3)c2c1Cl,8.699999999999998,,
Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NC3CC3)ncc2c1,8.699999999999998,,
COc1cc(C(=O)NC2CC[NH+](C)CC2)c(F)cc1Nc1ncc2c(n1)N(C1CCCC1)CC(F)(F)C(=O)N2C,8.699999999999998,,
N#CC1CCCC1Nc1nc(-c2cn[nH]c2)nc2c(=O)[nH]ccc12,8.699999999999998,,
CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,8.699999999999998,This molecule is a pyrazolopyrimidine. It has a role as a tyrosine kinase inhibitor.,CHEMBL573578
CC(C)(C)c1cccc(C[NH2+]C2C[S+](O)CC(Cc3cc(F)c(N)c(OC(C(F)(F)F)C(F)(F)F)c3)C2O)c1,8.699999999999998,,
CC1(C)OC(=O)N(C2CCC(c3cnc(N)c(-c4ncccn4)c3)CC2)C1c1ccccc1,8.699999999999998,,
C=CC1CC1(NC(=O)C1CC(Oc2nccc3cc(OC)ccc23)CN1C(=O)C(NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,8.699999999999998,,
N#CNC(Nc1ccncc1)=[NH+]CCCCCCOc1ccc(Cl)cc1,8.699999999999998,,
O=C(NCc1ccc(S(=O)(=O)c2cccc(C(F)(F)F)c2)cc1)c1cnc2[nH]ncc2c1,8.699999999999998,,CHEMBL3260358
CCC(CS(=O)(=O)C(C)(C)C)N1C(=O)C(CC(=O)[O-])OC(c2cccc(Cl)c2)C1c1ccc(Cl)cc1,8.699999999999998,,
CCCn1cnc(CCNC(=O)Nc2nc3ccc(-c4cncc(OC)c4)cc3s2)c1,8.699999999999998,,CHEMBL3356900
CCCc1sc(-c2ccc(OCCO)c(OCCO)c2)nc1CSc1nc(N)cc(N)n1,8.699999999999998,,CHEMBL2426567
NS(=O)(=O)OC1CCN(S(=O)(=O)C2OC(CO)C(O)C(O)C2O)C1,8.699999999999998,,
CC(C)(C)COc1ccc2c(c1)C1(COC(=[NH2+])N1)c1cc(-c3cncnc3)ccc1O2,8.699999999999998,,
Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)C=CC[N+](C)C)cc2n2cncc12,8.71,,
Cc1cc2c(cc1C(=O)CCC(=O)[O-])C(C(C)C)C(C)C2(C)C,8.72,,
COc1ccc(S(=O)(=O)N(Cc2cccnc2)C(C(=O)NO)C(C)C)cc1,8.72,,CHEMBL3827444
CC(C)CC(NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C([NH3+])Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(CC(=O)[O-])C(=O)[O-],8.72,,
C=NC1=NC2C(O)C(OC3OC(CO)C(OC4OC(CO)C(O)C(O)C4NC(C)=O)C(O)C3NC(C)=O)C(CO)C2O1,8.72,,
NC(=O)N1CCC(CC(=O)N2CCC(C3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1,8.72,,
N#Cc1cc(O)cc2cc(-c3ccc(O)cc3)oc12,8.72,,CHEMBL363498
OC(CCCCCCc1ccccc1)c1nc(-c2ccccn2)co1,8.72,,
CC(=O)NC1C(NC(N)=[NH2+])C=C(C(=O)[O-])OC1C(O)C(O)CO,8.72,,
NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)CCc1ccc(-c2cc(-c3ccccc3)cs2)cc1,8.72,,
C=CC1CC1(NC(=O)C1CC(Oc2cc(-c3csc(NC(=O)C(C)C)n3)nc3cc(OC)ccc23)CN1C(=O)C(NC(=O)OC1CCCC1)C(C)(C)C)C(=O)[O-],8.72,,
Nc1nc(NCCc2ccc(O)cc2)nc2nc(-c3ccco3)nn12,8.72,"This molecule is a diamino-1,3,5-triazine.",CHEMBL113142
NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)CCc1ccc(-c2cc(-c3ccccc3)cs2)cc1,8.72,,
CC(C)(O)c1ccc2cc(-c3[nH]nc4ccsc34)[nH]c2c1,8.72,,
Cc1ccc(NC(=O)c2ccc(C[NH+]3CC[NH+](C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,8.72,,
O=C1NCC2c3c(cccc31)CCN2C(=O)C1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)CC1,8.72,,CHEMBL2323222
COc1cc(C2Nc3ccc(C(N)=[NH2+])cc3C3c4ccccc4CC23)c(-c2ccc(C(=O)[O-])cc2)cc1O,8.72,,
CC(O)c1nc2cnc3[nH]ccc3c2n1C1CCC(C#N)CC1,8.72,,
COc1ccc(-c2cc3c(C)nc(N)nc3n(C3CCC(OCCO)CC3)c2=O)cn1,8.72,,
C[NH2+]C1CC(C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,8.73,,
CCC(C)C1NC(=O)C([NH2+]CC(O)C(Cc2ccc(O)cc2)NC(=O)C(C(C)C)N2CCCC2=O)Cc2ccc(cc2)OCCCNC1=O,8.74,,
CCC(C(=O)N1CCCCC1C(=O)OC(CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)[O-])c1)c1cc(OC)c(OC)c(OC)c1,8.74,,
CC(C)(C)NC(=O)C1C[NH+](Cc2cccnc2)CC[NH+]1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O,8.74,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)C(CC2CCCCC2)[NH2+]CC(=O)[O-])cn1,8.74,,
Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(CC(O)C(O)C(O)CO)c2cc1C,8.74,"This molecule is a natural product found in Aspergillus unilateralis, Syzygium, and Eremothecium gossypii with data available.",CHEMBL511565
O=S(=O)(c1ccc2c(c1)C[NH2+]C(CF)C2)N1CCSCC1,8.74,,
COc1cccc(C[NH2+]CC(O)C(Cc2ccccc2)NC(=O)c2cc(C(=O)NC(C)c3ccccc3)cc(N(C)S(C)(=O)=O)c2)c1,8.74,,
O=C([O-])c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,8.74,,
O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,8.74,,CHEMBL509101
Nc1nc(NCCc2ccc(O)cc2)nc2nc(-c3ccco3)nn12,8.74,"This molecule is a diamino-1,3,5-triazine.",CHEMBL113142
COc1cc(F)c(CC(=O)N2CCN(c3nc(Nc4cc(C)n[nH]4)c4cccn4n3)CC2)c(F)c1,8.74,,CHEMBL1615027
CC(=O)Nc1ccc2c(c1)OCCc1cc(C(=O)N(C)c3ccccc3Cl)sc1-2,8.74,,CHEMBL1796273
NS(=O)(=O)c1ccc(C(=O)NCC(F)(F)C(F)(F)C(F)(F)C(F)(F)F)cc1,8.74,,
COC(C(O)CO)C1OC(C(=O)[O-])CC(NC(N)=[NH2+])C1NC(C)=O,8.74,,
Cc1nc2cnc3[nH]ccc3c2n1C1CCCC(O)C1,8.74,,
N#Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1,8.74,,CHEMBL2387124
C=C1C(O)CC(=CC=C2CCCC3(C)C2CCC3C(C)C(CCCC)CC(O)(CC)CC)CC1O,8.75,,
C[NH2+]C1CN(c2cccc(OC)c2)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,8.769999999999998,,
CC(C)CCN(CC(O)C1Cc2ccc(cc2)OCCCCCC(=O)NC(C(C)C)C(=O)N1)S(=O)(=O)c1ccc(N)cc1,8.769999999999998,,
OCC1C(O)C(O)C(O)c2nc(-c3ccccc3)cn21,8.769999999999998,,
[NH3+]CCc1c[nH]cn1,8.769999999999998,,
CCOc1ccc(-c2ccc(C(=O)CC(CCN3C(=O)c4ccccc4C3=O)C(=O)[O-])cc2)cc1,8.769999999999998,,
OCC1C(O)C(O)C(O)c2nc(-c3ccccc3)cn21,8.769999999999998,,
CC(COc1ccc(C2Oc3ccc(O)cc3SC2c2ccc(O)cc2)cc1)[NH+]1CCCC1,8.769999999999998,,
COc1ccc(S(=O)(=O)N(CC(C)C)CC(O)C(Cc2ccccc2)n2cc(COC(=O)NC3c4ccccc4CC3O)nn2)cc1,8.769999999999998,,
Cn1c(C#N)ccc1-c1ccc2c(c1)C(C)(C)OC(=S)N2,8.769999999999998,"This molecule is an investigational non-steroidal progestin. It is a high affinity, high efficacy agonist of the progesterone receptor (PR) with a much more selective binding profile relative to most conventional progestins. Because of this tanaproget may prove to produce fewer side effects in comparison. It is currently in the process of being developed for clinical use as a contraceptive by Ligand Pharmaceuticals. An analog of tanaproget, 4-fluoropropyltanaproget (18F), has been developed as a radiotracer for imaging of the PR in positron emission tomography.",CHEMBL539163
CC[NH+]1CC[NH+](Cc2ccc(-c3cc4c(NC(C)c5ccccc5)ncnc4[nH]3)cc2)CC1,8.769999999999998,,
CC12CCC3c4ccc(O)cc4CCC3C1CCC2O,8.769999999999998,This molecule is a steroid. It has a role as an estrogen. This molecule is a natural product found in Punica granatum with data available.,CHEMBL412
CCC(C)C1NC(=O)C2CSSCC(NC(=O)C[NH3+])C(=O)NC(CSSCC(C(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)[O-])NC(=O)C3CCCN3C(=O)C(CC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC1=O)C(=O)NC(CO)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N2,8.769999999999998,,
COC(=O)NC(C(=O)N[NH+](CCC(O)(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O)Cc1ccc(-c2ccccn2)cc1)C(C)(C)C,8.769999999999998,,
CC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc2ccc3nnc(-c4ccccc4SCCO)n3c2)n(-c2ccc(O)c(Cl)c2)n1,8.769999999999998,"This molecule has been used in trials studying the treatment of Asthma, Pulmonary Disease, Chronic Obstructive, and Chronic Obstructive Pulmonary Disease (COPD).",CHEMBL1938400
CC(O)(COc1ccc(Cl)c(F)c1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,8.769999999999998,,
NC(=[NH2+])NCCCC(NC(=O)C(CC(=O)NO)Cc1ccc2ccccc2c1)C(=O)NCC(=O)NCC(N)=O,8.769999999999998,,
COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc32)c1C,8.769999999999998,"This molecule is a member of the class of 2-aminopurines that is 2-aminopurine which is substituted by a chlorine at position 6 and by a (4-methoxy-3,5-dimethylpyridin-2-yl)methyl group at position 9. It has a role as a Hsp90 inhibitor and an antineoplastic agent. It is a member of pyridines, a member of 2-aminopurines, an organochlorine compound and an aromatic ether. This molecule has been investigated for the treatment of Tumors and Lymphoma. This molecule is an orally active inhibitor of heat shock protein 90 (HSP90) with potential antineoplastic activity. HSP90, a chaperon protein upregulated in a variety of tumor cells, regulates the folding and degradation of many oncogenic signaling proteins. HSP90 inhibitor BIIB021 specifically blocks active HSP90, thereby inhibiting its chaperon function and promoting the degradation of oncogenic signaling proteins involved in tumor cell proliferation and survival. As a result, CNF2024 has the potential to inhibit the growth of a wide range of cancer cells in both solid tumors and blood-based cancers.",CHEMBL467399
CC(C)CC(NC(=O)N1CCOCC1)C(=O)NC(CCc1ccccc1)CCS(=O)(=O)c1ccccc1,8.769999999999998,,
Cc1nc2ccc(C(=O)NCc3ccccc3)cc2n2c(-c3ccccc3)nnc12,8.769999999999998,,
CC1(n2cnc3cnc4[nH]ccc4c32)CCN(S(C)(=O)=O)CC1,8.769999999999998,,CHEMBL2152409
C[N+](CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)CC1OC(n2cnc3c(N)ncnc32)C(O)C1O,8.769999999999998,,
CC#Cc1cncc(-c2cc(Cl)c(C3(C)CC(=O)N(C)C(=[NH2+])N3)s2)c1,8.769999999999998,,
COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc(-c2c[nH]c(=O)[nH]c2=O)c1,8.769999999999998,,CHEMBL3341771
COc1cc(-c2cc3c(c(=O)o2)CC2(O)C(C)(CCC4(O)C(C)(C)C=CC(=O)C42C)O3)cc(OC)c1OC,8.769999999999998,,
CC(=O)NC1C(NC(N)=[NH2+])C=C(C(=O)[O-])OC1C(O)C(O)CO,8.779999999999998,,
CC(=O)NC(CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CO)CC(=O)[O-])C(C)C,8.8,,
CC(C)CC(NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C([NH3+])CCC(=O)[O-])C(C)C)C(O)CC(C)C(=O)NC(C)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccccc1)C(=O)[O-],8.8,,
NS(=O)(=O)c1ccc(C(=O)NCc2cccc(F)c2F)cc1,8.8,,
CCCn1c(C2CC[NH2+]CC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1,8.8,,
O=C(NC1c2ccccc2CC1O)C(OCc1ccc(F)cc1F)C(O)C(O)C(OCc1ccc(F)cc1F)C(=O)NC1c2ccccc2CC1O,8.8,,
CCN1C(C)=C(C(=O)OC(C)C)C(c2ccccc2Cl)C(C(=O)[O-])=C1C(=O)[O-],8.8,,
CCC(C)C(NC(=O)C(CCCC[NH3+])NC(=O)C(NC(=O)C(C)NC(=O)C(CC(N)=O)NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(CCCC[NH3+])NC(=O)C([NH3+])CCCC[NH3+])C(C)O)C(C)C)C(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)[O-],8.8,,
CC(=O)C1N=[N+]2c3cc(F)ccc3OCC2C1(CCC[NH+]1CCN(C(C)=O)CC1)c1ccccc1,8.8,,
CC(C)(C)Sc1c(CC(C)(C)C(=O)[O-])n(Cc2ccc(Cl)cc2)c2ccc(OCc3ccc4ccccc4n3)cc12,8.8,,
O=C(NC(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-])c1ccc2c(c1)C1(OC2=O)c2ccc(O)cc2Oc2cc(O)ccc21,8.8,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,8.8,,
CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12,8.8,,CHEMBL234085
Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12,8.8,,CHEMBL1197798
Nc1nc(N)c2cc(CNc3cc(Cl)ccc3Cl)cnc2n1,8.8,,CHEMBL145979
COc1[nH]nc2ncc(NC(=O)c3c(F)ccc(NS(=O)(=O)c4ccccc4)c3F)cc12,8.8,,
CC(C)CC(CC(C)C)NC(=O)C1C[NH2+]CC([N+]2CC(=O)N(c3ccccc3Cl)CC2(C)C)C1,8.8,,
CCCOc1ccc(S(=O)(=O)N2CC[NH+](C)CC2)cc1-c1nc(O)c(CC)c(CC)n1,8.8,,
COc1ccccc1-n1c(-c2cc(O)ccc2C)c[n+]2c3c(=O)[nH]c(=O)n(C)c3[nH]c12,8.8,,
N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12,8.8,"This molecule is a member of the class of benzothiazoles that is 1,3-benzothiazole substituted by (cyclopropanecarbonyl)amino, 4-fluoro-3-{2-[3-(trifluoromethyl)phenyl]acetamido}phenoxy, and cyano groups at positions 2, 6 and 7, respectively. It is a potent pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAF(V600E), BRAF(WT), respectively. It has a role as a necroptosis inhibitor, a B-Raf inhibitor, an EC 2.7.11.26 (tau-protein kinase) inhibitor, an antineoplastic agent and an apoptosis inducer. It is a member of monofluorobenzenes, a member of benzothiazoles, an aromatic ether, a secondary carboxamide, a member of (trifluoromethyl)benzenes, a nitrile and a cyclopropylcarboxamide.",CHEMBL3125890
CCC(=O)N(CCCCC(NC(=O)NC(CCC(=O)[O-])C(=O)[O-])C(=O)[O-])Cc1ccc(Br)cc1,8.8,,
C[NH+](C)CC(=O)Nc1ccc2c(c1O)C(=O)C1=C(O)C3(O)C(=O)C(C(N)=O)=C(O)C([NH+](C)C)C3CC1C2,8.81,,
Clc1ccc2c(c1Cl)C[NH2+]CC2,8.81,,
CC1CC([NH3+])c2cc(S(N)(=O)=O)sc2S1(=O)=O,8.82,,
NS(=O)(=O)c1ccc(C(=O)NCc2c(F)c(F)c(F)c(F)c2F)cc1,8.82,,
CC(C)(C)OC(=O)NC(CC[NH2+]C(Cc1ccccc1)C(=O)NC(CCC(=O)[O-])C(=O)NC(Cc1ccccc1)C(N)=O)Cc1ccccc1,8.82,,
c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,8.82,"These molecules is a secondary amino compound consisting of two molecules of tacrine that are linked together through their exocyclic amino groups by a heptane-1,7-diyl chain. These molecules is an acetylcholinesterase (AChE)inhibitor (IC50 0.40 nM, >1,000 times more potent than tacrine). It has also been found to protect against H2O2 -induced apoptosis in rat pheochromocytoma cells. It has a role as an EC 3.1.1.7 (acetylcholinesterase) inhibitor, a neuroprotective agent, an EC 1.14.13.39 (nitric oxide synthase) inhibitor and an apoptosis inhibitor. It is functionally related to a tacrine.",CHEMBL32823
[NH3+]C(COc1cncc(-c2ccc3c(c2)C(Cc2ccc[nH]2)C(=O)N3)c1)Cc1c[nH]c2ccccc12,8.82,,
CCCCC12CCC(=O)C(Br)=C1c1ccc(O)cc1C2,8.82,,CHEMBL209851
O=c1cc(C(F)(F)F)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,8.82,An androgen receptor modulator.,CHEMBL436784
O=C(NCCNC(=O)c1ccc(Cl)s1)c1ccc(-n2ccccc2=O)cc1,8.82,,CHEMBL232566
CC(C)c1c(C(=O)N(C)C(C)c2ccccc2)nn(-c2ccc(F)cc2)c1CCC(O)CC(O)CC(=O)[O-],8.82,,
C[NH+]1CCC(C=N)(NC(=O)C(CC2CCCCC2)NC(=O)N2CCOCC2)CC1,8.82,,
CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,8.82,This molecule is a member of indoles.,CHEMBL1084546
[NH3+]C(CC1(C(=O)[O-])CC2OCC(O)CC2O1)C(=O)[O-],8.82,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,8.82,,CHEMBL195725
O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCC(O)CO)cc21,8.82,,
CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(CO)Cc1ccccc1)C(C)C,8.82,,
O=C([O-])c1nc(-c2ccc3cccc(N=Nc4nc5ccccc5s4)c3c2)sc1CCCCc1ccccc1,8.82,,
N#CCC(=O)N1CCCC(n2nnc3cnc4[nH]ccc4c32)C1,8.82,,
CCC(CC)OC1CC(C(=O)[O-])=CC([NH3+])C1NC(C)=O,8.82,,
CC1(c2ccccc2)CC(c2cccc(-c3ccc(C(N)=O)cc3C(=O)[O-])c2)Nc2ccc(C(N)=[NH2+])cc21,8.82,,
CC1COCC[N+]1=C1CC(=O)N2CCC(C(F)(F)F)N(Cc3cncc(Cl)c3)C2=[NH+]1,8.82,,
CC12CCC3c4ccc(O)cc4CCC3C1CCC2O,8.83,This molecule is a steroid. It has a role as an estrogen. This molecule is a natural product found in Punica granatum with data available.,CHEMBL412
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)C1CN(c2ccccc2O)C(=O)O1)S(=O)(=O)c1ccc2c(c1)OCO2,8.83,,
CCc1c(N2CCOCC2=O)cccc1S(=O)(=O)NC(Cc1cc(-c2ccc(Cl)s2)on1)C(=O)N1CCC(OC)CC1,8.84,,
O=C(NC1c2ccccc2CC1O)C(CC(O)C(OCc1ccccc1)C(=O)NC1c2ccccc2CC1O)OCc1ccccc1,8.849999999999998,,
Oc1ccc2cc(-c3noc4cc(O)ccc34)ccc2c1,8.849999999999998,,CHEMBL187105
CC(C)(C)NC(=O)C1C[NH+](Cc2cccnc2)CC[NH+]1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O,8.849999999999998,,
O=S(=O)(Nc1ccc(Cl)cc1)c1ccc2c(c1)C[NH2+]C(CO)C2,8.849999999999998,,
CC(C)CC(NC(=O)C(CC(N)=O)NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(C=O)CC(=O)[O-],8.849999999999998,,
CC(O)(COc1c(F)c(F)c(F)c(F)c1F)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,8.849999999999998,,
Cc1ccc(C(=O)Nc2cccc(N3CCOCC3)c2)cc1-c1ccc2c(C3CC[NH2+]CC3)noc2c1,8.849999999999998,,
O=C(NC1CC1)c1ccc(Cl)c(Nc2nncc3c2cnn3-c2c(F)cccc2F)c1,8.849999999999998,,CHEMBL1082158
Cn1ncc2c(NCCCS(C)(=O)=O)nc(-c3cccc4[nH]ncc34)nc21,8.849999999999998,,
O=C(Nc1ccncn1)c1oc2cnccc2c1Nc1ccc2c(O)cccc2c1,8.849999999999998,,CHEMBL1614960
Oc1cc(Nc2c(-c3ncccn3)oc3cnccc23)ccc1Cl,8.849999999999998,,CHEMBL1614963
CCCOC1C[NH2+]C(C(O)C(Cc2cc(F)cc(F)c2)NC(=O)C(CCc2ccccc2)N2CCC(CC(C)C)(NC(C)=O)C2=O)C1,8.849999999999998,,
Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)c2)n(C)n1,8.849999999999998,,CHEMBL2348996
CC(C)C(CC(O)C([NH3+])C[N+]1CC(=O)N(c2ccccc2Cl)CC1(C)C)C(=O)NCC(C)(C)C(N)=O,8.849999999999998,,
COc1cn(-c2cccc(C(F)(F)F)c2)nc(-c2ccnn2-c2ccccc2)c1=O,8.849999999999998,,
N#Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3F)c2)c(Cl)c1,8.849999999999998,,
CC(NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C,8.849999999999998,,
CC(C)(O)Cn1cc(-c2ccc3c(c2)OCCc2sc(-c4ncnn4CC(F)(F)F)nc2-3)cn1,8.849999999999998,,CHEMBL2381379
CCC([NH2+]C)C(=O)NC(C(=O)N1CC2Cc3ccccc3N2CC1C(=O)NC1CCOc2ccccc21)C1CCCCC1,8.849999999999998,,
NC(=[NH2+])c1csc(CNC(=O)C2C=CCN2C(=O)C(CC2CCCCC2)[NH2+]CC(=O)[O-])n1,8.859999999999998,,
COCCOCCOCCOCCOCc1cn(CCCCC(NC(=O)NC(CCC(=O)[O-])C(=O)[O-])C(=O)[O-])nn1,8.87,,
CC(=NNC(N)=[NH2+])c1ccc(NC(=O)c2c[nH]c3ccccc23)cc1,8.87,,
N#Cc1cc(Cl)cc(Oc2cc(OCc3[nH]nc4ccccc34)ccc2Cl)c1,8.87,,
CC(=O)NC1C(NC(N)=[NH2+])CC(C(=O)[O-])OC1C(O)C(O)CO,8.87,,
COC(C(O)CO)C1OC(C(=O)[O-])=CC(NC(N)=[NH2+])C1NC(C)=O,8.88,,
COCCCN1CC([NH3+])c2cc(S(N)(=O)=O)sc2S1(=O)=O,8.89,,
CC(C)C(NC(=O)C(CO)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccccc1)NC(=O)C(CCCC[NH3+])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)[O-],8.89,,
O=c1[nH]cnc2c(C[NH+]3CC(O)C(CO)C3)c[nH]c12,8.89,,
NC(=[NH2+])c1ccc(CN2CCN(S(=O)(=O)c3cc4ccc(Cl)cc4s3)CC2=O)cc1,8.89,,
O=C1COc2ccc(Cl)cc2CNC(=O)C2CCCN2C(=O)C(C2CCCCC2)NC(=O)CCN1,8.89,,
CC(COc1ccc(C2Oc3ccc(O)cc3SC2c2ccc(O)cc2)cc1)[NH+]1CCCC1,8.89,,
CC(C)C(NS(=O)(=O)c1ccc(-c2ccc(NC(=O)c3cc4ccccc4o3)cc2)cc1)C(=O)[O-],8.89,,
CC(=O)NC(CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(C=O)CC(=O)[O-])C(C)C,8.89,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,8.89,,
CC([NH3+])C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(B(O)O)C(C)C,8.89,,
O=S(=O)(Nc1ccc(Cl)cc1)c1ccc2c(c1)C[NH2+]CC2,8.89,,
O=C1C(NS(=O)(=O)c2ccc3cc(Cl)ccc3c2)CCN1c1ccc2c(c1F)CC[NH2+]C2,8.89,,
C[NH2+]C1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,8.89,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,8.89,,CHEMBL195725
C[NH2+]CC(CC1CCCCC1)NC(=O)N1CCCC(C(O)(CCCNC(C)=O)c2cccc(Cl)c2)C1,8.89,,
Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1,8.89,,CHEMBL1800911
CCOc1ccc2cc(-c3nn(CC4CC[NH2+]CC4)c4ncnc(N)c34)ccc2c1,8.89,,
Brc1ccc(N2CCC[NH2+]CC2)cn1,8.89,,
COc1cccc(C2OC(CC(=O)N3CCC(CC(=O)[O-])CC3)c3cccn3-c3ccc(Cl)cc32)c1OC,8.89,,
Cc1cc(C)c2cc1C(=O)NCCCOc1cccc(c1)Sc1cc-2nc(N)n1,8.89,,CHEMBL1939374
O=C(NC1CCC(Oc2ccc(C(=O)[O-])cc2)CC1)NC12CC3CC(CC(C3)C1)C2,8.89,,
Cc1ccc(C(=O)Nc2ccc(C[NH+]3CC[NH+](C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,8.89,,
Cc1ccc(Cl)c2c1NC(=O)C2[NH2+]NC(=O)C(C)c1ccc(O)cc1,8.89,,
CC1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21,8.89,,CHEMBL4303155
O=C([O-])c1cccc(CS(=O)(=O)NCB(O)O)c1,8.89,,
CCOC1CC2CN(C(=O)C(NC(=O)C(C)[NH2+]C)C3CCC(F)(F)CC3)C(C(=O)NC3CCOc4ccccc43)C[NH+]2C1,8.89,,
CC(C)CC1NC(=O)c2c1c1c3ccccc3n(CCCC[NH3+])c1c1[nH]c3ccccc3c21,8.89,,
NC(=[NH2+])NCCCC([NH3+])C(=O)[O-],8.89,,
C[NH+]1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1,8.89,,
COc1cccc(N2C(C[NH+]3CCOCC3)Cc3cc(S(N)(=O)=O)sc3S2(=O)=O)c1,8.9,,
CC([NH2+]C(CCc1ccccc1)C(=O)[O-])C(=O)N1CC=CC1C(=O)[O-],8.9,,
C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21CC,8.91,,
CCCNC(=O)C[NH2+]C(C(=O)N1CCC1C(=O)NCc1ccc(C(N)=[NH2+])cc1)C1CCCCC1,8.91,,
CC(c1ccccc1)N(C)C(=O)CC(Cc1csc(N)n1)C(=O)NC(CC1CCCCC1)C(O)C1CC(C)(C)N(C)C1=O,8.92,,
CNC(=O)C(NC(=O)C(OCc1ccc(-c2ccsc2)cc1)C(O)C(O)C(OCc1ccc(-c2ccsc2)cc1)C(=O)NC(C(=O)NC)C(C)C)C(C)C,8.92,,
COC1C(OC(=O)c2ccc(C)[nH]2)C(O)C(Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2Cl)OC1(C)C,8.92,This molecule is a natural product found in Streptomyces albidoflavus and Streptomyces hygroscopicus with data available.,CHEMBL1172192
Cn1cncc1CC([NH2+]Cc1ccc(C#N)cc1)C(=O)N1CCC(C#N)=C(c2cccc3ccccc23)C1,8.92,,
CN1CC(=O)N2C(Cc3c([nH]c4ccccc34)C2c2ccc3c(c2)OCO3)C1=O,8.92,This molecule is a member of beta-carbolines.,CHEMBL1671905
O=C(Nc1c[nH]nc1-c1nc2ccc(C[NH+]3CCOCC3)cc2[nH]1)NC1CC1,8.92,,
CCC(CC)C(NC(C)=O)C1C(NC(N)=[NH2+])CC(C(=O)[O-])C1O,8.92,,
Cc1ccccc1CNC(=O)C(Cc1ccncc1)NC(=O)C(CC(=O)NCC(C)(C)C)NC(=O)C(=O)c1c[nH]c2ccccc12,8.92,,
O=S(=O)(NCB(O)O)c1ccc(-c2nnn[nH]2)cc1,8.92,,CHEMBL3613795
N#CCC(=O)N1CCCC(n2cnc3cnc4[nH]ccc4c32)C1,8.92,,
CC(C)NC(=O)C1CCC(n2c(NC(=O)c3ccc(F)cc3)nc3ccc(C[NH+]4CCC(C(C)(C)O)CC4)cc32)CC1,8.92,,
Cc1cn(C2CCC[NH+](C(CC(C)C)c3ccc(C(=O)[O-])c(Oc4cccc(Cl)c4)c3)C2)c(=O)[nH]c1=O,8.92,,
COc1ccc(S(=O)(=O)N(CC(C)C)CC(O)C(Cc2ccccc2)NC(=O)OC2COC3OC4OCCC4C23)cc1,8.92,,
CCC([NH2+]C)C(=O)NC(C(=O)N1CC2CCC[NH+]2CC1C(=O)NC1CCOc2ccccc21)C1CCCCC1,8.92,,
CCOc1ccc2cc(-c3nn(CC4CC[NH2+]CC4)c4ncnc(N)c34)ccc2c1,8.92,,
CC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(=O)[O-])NC(=O)C(C)NC(=O)C([NH3+])CC(=O)[O-])C(=O)[O-],8.92,,
NS(=O)(=O)c1cc2c(s1)S(=O)(=O)N(c1cccc(O)c1)C(C[NH+]1CCOCC1)C2,8.939999999999998,,
Cc1cc(-c2nnc(N)nc2-c2ccccc2)cc(C)n1,8.939999999999998,,CHEMBL2024115
CN(C)C(=O)C[NH2+]C(C(=O)N1CCC1C(=O)NCc1ccc(C(N)=[NH2+])cc1)C1CCCCC1,8.939999999999998,,
CCCCCCC(C(C)O)n1cnc2c(N)ncnc21,8.949999999999998,,
CC(=O)NC1C(NC(N)=[NH2+])CC(C(=O)[O-])OC1C(O)C(O)CO,8.949999999999998,,
C[NH2+]C(Cc1ccccc1)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(O)c1nc2ccc(C(=O)[O-])cc2s1,8.96,,
CC(CS)C(=O)N1CCCC1C(=O)[O-],8.96,,
N#Cc1ccc2cc1Oc1ccc3cccc(c3c1)N1CCC([NH2+]CCc3cncn3C2)C1=O,8.96,,
CCCC[NH+](CCC1CCCCC1)Cc1ccc(C(=O)NC(CCSC)C(=O)[O-])c(-c2ccccc2C)c1,8.96,,
O=C1CN(S(=O)(=O)C=Cc2ccc(Cl)s2)CCN1Cc1cc2cnccc2[nH]1,8.96,,
Ic1cccc(CNc2c3c(nc4ccccc24)CCCC3)c1,8.96,,
CC(C)CC(NC(=O)c1cc(C(=O)NC(C)c2ccccc2)cc(N(C)S(C)(=O)=O)c1)C(O)CC(C)C(=O)NC(C(=O)NC(C)C)C(C)C,8.96,,
Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCCNC1=O,8.96,,
NS(=O)(=O)c1nnc(-c2ccccc2Cl)s1,8.96,,CHEMBL360356
N#Cc1c[nH]c(C(=O)Nc2ccc(C3CC[NH2+]CC3)cc2C2=CCCCC2)n1,8.96,,
NS(=O)(=O)c1ccc(C(=O)NCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)cc1,8.96,,
Nc1nc(N)c2nc(CN3c4ccccc4C=Cc4cc(OCCCC(=O)[O-])ccc43)cnc2n1,8.96,,
COc1cc(Nc2c(C#N)cnc3cc(OCCC[NH+]4CC[NH+](C)CC4)c(OC)cc23)c(Cl)cc1Cl,8.96,,
COc1ccc(-c2nn(CC3CC[NH2+]CC3)c3ncnc(N)c23)cc1C,8.96,,
CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1,8.96,,CHEMBL1988437
Nc1c2c(nc3cc(Cl)ccc13)CC1C=C(CCO)CC2C1,8.96,,
N#Cc1ccc(Cc2cc(O)n3ncc(C(=O)Nc4ccc(F)cc4)c3n2)cc1,8.96,,CHEMBL2387467
CNC(=O)C(F)(F)C(O)(O)C(CC(C)C)NC(=O)C(NC(=O)C(NC(=O)CC(C)C)C(C)C)C(C)C,9.0,,
NC(=[NH2+])NCCCC(CO)NC(=O)CN1CCCC(NS(=O)(=O)Cc2ccccc2)C1=O,9.0,,
CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,9.0,This molecule is a corticosteroid hormone.,CHEMBL125608
CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21C,9.0,,CHEMBL1713571
Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC(Nc2ccccc2C(=O)c2ccccc2)C(=O)[O-])cc1,9.0,,
CCC(C)C(NC(=O)C(NC(=O)CC(O)C(CC(C)C)NC(=O)C(Cc1cnc[nH]1)NC(=O)C(Cc1ccccc1)NC(=O)C1CCC[NH2+]1)C(C)C)C(=O)[O-],9.0,,
COC(=O)C(NC(=O)C(NC(=O)C(Cc1ccccc1)CC(O)C(Cc1ccccc1)NC(=O)C(C)NC(=O)C(C)[NH3+])C(C)C)C(C)C,9.0,,
CCC(C)C(NC(=O)C(C(C)C)C(O)C(O)C(CC1CCCCC1)NC(=O)C(Cc1cnc[nH]1)NC(=O)COc1cccc2ccccc12)C(=O)NCc1ccccn1,9.0,,
Cc1c(C(=O)c2nccn2C)oc2cccc(OCCC[NH2+]Cc3cccnc3)c12,9.0,,
[NH3+]C(Cc1ccc(O)cc1)C(=O)NC(C(=O)[O-])C1C(O)C2(O)COC(C2O)[NH+]1O,9.0,,
CSCC1[NH2+]C(c2c[nH]c3c(N)ncnc23)C(O)C1O,9.0,,
CCC(C)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(CCC(=O)[O-])NC(=O)C(CCC(=O)[O-])NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C([NH3+])CCC(=O)[O-])C(C)CC)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)[O-],9.0,,
C[NH+]1CC[NH+](Cc2csc(C(=O)Nc3ccc(Cl)cc3C(=O)Nc3ccc(Cl)cc3)c2Cl)CC1,9.0,,
Cc1ccnc(CNC(=O)Cn2c(C)cnc(NCC(F)(F)c3ccccn3)c2=O)c1F,9.0,,CHEMBL143824
O=C(Cc1cccs1)NC(B(O)O)c1cccc(C(=O)[O-])c1,9.0,,
CC(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CO)CCCNC(N)=[NH2+],9.0,,
CNC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)C(CSc1cccs1)C(=O)NO,9.0,,CHEMBL3827321
CCCc1[nH]c(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CC[NH+](CC)CC4)ccc3OCC)n[n+]12,9.0,,
Cc1cc2nc(N)n(CCCCC(=O)[O-])c2cc1C,9.0,,
CC(NC(=O)CNC(=O)C([NH3+])CS)C(=O)NC(CCCNC(N)=[NH2+])C(=O)O,9.0,,
CC(C)(C)c1nc2c3cc[nH]c(=O)c3c3cc(F)ccc3c2[nH]1,9.0,,
CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cccc(C)c1,9.0,,CHEMBL177275
C#CC1CCC(C=N)N1C(=O)C[NH2+]C1(C)CCN(c2cc(C(=O)[O-])ccn2)CC1,9.0,,
Nc1ncnc2c(C3[NH2+]C(CO)C(O)C3O)c[nH]c12,9.0,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,9.0,,
CC(CCc1ccc(O)cc1)NC(=O)Cc1c(-c2ccccc2)[nH]c2ccccc12,9.0,,CHEMBL241301
CC(C)N(CCNS(C)(=O)=O)C(=O)C(C)N1CCC(NS(=O)(=O)c2ccc3cc(Cl)ccc3c2)C1=O,9.0,,
COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(OCCC[NH+]4CC[NH+](C)CC4)c(OC)c3)n2)c(OC)c1,9.0,,
[NH3+]CCCO[NH3+],9.0,,
Cc1ccc(C(=O)Nc2cc(CCC[NH+](C)C)cc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1,9.0,,
[NH3+]C(CS(=O)(=O)c1ccc(Oc2ccccc2)cc1)(C(=O)NO)C(F)(F)F,9.0,,
COc1ccc2c(-c3c(C)n(Cc4cc(OC(C)C(=O)[O-])ccc4Cl)c4cc(OC(F)(F)F)ccc34)noc2c1,9.0,,
[NH3+]CCCc1cc2c(C3=CC(=O)CC=C3)c[nH]c(=O)c2c2cc(-c3cn[nH]c3)ccc12,9.0,,
COC(=O)N1CCC(CN(C2Cc3cc(C#N)ccc3N(Cc3cncn3C)C2)S(=O)(=O)c2ccccn2)CC1,9.0,,CHEMBL232104
C[NH+]1CCN(c2ccc(Cc3cc4cnc(C=N)nc4n3C3CCCCC3)cc2)CC1,9.0,,
O=C([O-])C=Cc1cccc(C(NC(=O)Cc2cccs2)B(O)O)c1,9.0,,
CC#CCn1c(N2CCCC([NH3+])C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,9.0,,
COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1,9.0,,CHEMBL478409
CC(=O)Nc1nc2ccc(-c3nn(Cc4cc5ccccc5nc4N4CC[N+](C)CC4)c4ncnc(N)c34)cc2s1,9.0,,
CC(c1ccc(N2CCC(NS(=O)(=O)C=Cc3ccc(Cl)s3)C2=O)c(F)c1)[NH+](C)C,9.0,,
CC(Oc1cc(-c2cnn(C3CC[NH2+]CC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,9.0,,
CCOc1ccc2nc(S(N)(=O)=O)sc2c1,9.0,"This molecule is a sulfonamide that is 1,3-benzothiazole-2-sulfonamide which is substituted by an ethoxy group at position 6. A carbonic anhydrase inhibitor, it has been used in the treatment of glaucoma, and as a diuretic. It has a role as an EC 4.2.1.1 (carbonic anhydrase) inhibitor, a diuretic and an antiglaucoma drug. It is a member of benzothiazoles, a sulfonamide and an aromatic ether. This molecule is a sulfonamide used as diuretic and in glaucoma. It inhibits carbonic anhydrase activity in proximal renal tubules to decrease reabsorption of water, sodium, potassium, bicarbonate. Its pharmacological activity thus confers the risk for hypokalemia. This molecule is a sulfonamide and carbonic anhydrase (CA) inhibitor with diuretic and anti-glaucoma activity. In the eye, ethoxzolamide inhibits CA, thereby decreasing the secretion of aqueous humor. This may relieve intraocular pressure. Also, this agent prevents reabsorption of bicarbonate and sodium in the proximal convoluted tubule thereby producing a mild diuresis.",CHEMBL18
CCOc1ccc2nc(S(N)(=O)=O)sc2c1,9.0,"This molecule is a sulfonamide that is 1,3-benzothiazole-2-sulfonamide which is substituted by an ethoxy group at position 6. A carbonic anhydrase inhibitor, it has been used in the treatment of glaucoma, and as a diuretic. It has a role as an EC 4.2.1.1 (carbonic anhydrase) inhibitor, a diuretic and an antiglaucoma drug. It is a member of benzothiazoles, a sulfonamide and an aromatic ether. This molecule is a sulfonamide used as diuretic and in glaucoma. It inhibits carbonic anhydrase activity in proximal renal tubules to decrease reabsorption of water, sodium, potassium, bicarbonate. Its pharmacological activity thus confers the risk for hypokalemia. This molecule is a sulfonamide and carbonic anhydrase (CA) inhibitor with diuretic and anti-glaucoma activity. In the eye, ethoxzolamide inhibits CA, thereby decreasing the secretion of aqueous humor. This may relieve intraocular pressure. Also, this agent prevents reabsorption of bicarbonate and sodium in the proximal convoluted tubule thereby producing a mild diuresis.",CHEMBL18
CCC(C)C(NC(=O)C(NC(=O)CC(O)C(CC(C)C)NC(=O)C(Cc1cnc[nH]1)NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(Cc1cnc[nH]1)NC(=O)C1CCC[NH2+]1)C(C)C)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CCCC[NH3+])C(=O)[O-],9.0,,
NS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,9.0,,CHEMBL1079267
COc1ccc(Cc2ccc(NC(N)=O)cc2)c(F)c1-c1cccc([N+](=O)[O-])c1,9.0,,CHEMBL1229663
COc1c(C)cc(C(=CCCCc2nnc(C)o2)c2cc(C)c3oc(=O)n(C)c3c2)cc1C(=O)SC,9.0,,
COC1C=CC(C)C2OC(O)(C(C)C(=O)OC(c3ccccc3)CCCCC1OC)C(OC)C(O)C2C,9.0,,
C[NH+](C)Cc1nc2c(sc3ccc(C=CC4CC4)cc32)c(=O)[nH]1,9.0,,
O=C1Nc2ccccc2-c2ccnc3[nH]cc(c23)C1c1ccc(O)cc1,9.0,,CHEMBL584052
Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CC[NH+](CCO)CC2)n1,9.0,,
CCNC(=O)C1c2ccccc2CN1C(=O)c1cc(Cl)c(O)cc1O,9.0,,CHEMBL583865
[NH3+]Cc1nc(NC2CCCCC2)nc(N2CC[NH2+]CC2)n1,9.0,,
O=C([O-])CC(O)(CC(=O)NCCCC(NC(=O)CC(O)(CC(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-],9.0,,
O=C([O-])CC(O)(CC(=O)NCCCC(NC(=O)CC(O)(CC(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-],9.0,,
O=C[Ru+9]12345(C6=C1C2C3=C64)n1c2ccc(O)cc2c2c3c(c4ccc[n+]5c4c21)C(=O)NC3=O,9.0,,
Cc1ncnc2c1ncn2C1OC(C=CCNC(=O)c2cc(-c3ccc(F)cc3)cc(O)c2O)C(O)C1O,9.0,,
CCCc1cc(-c2cc(C(=O)N(CC[N+](C)C)Cc3ccccc3)cc(C(F)(F)F)c2)nc(C=N)n1,9.0,,
NC(=O)c1nnc(NC2CCC[NH2+]C2)c2cc(-c3ccc(Cl)cc3)sc12,9.0,,
[NH3+]C1CCC(Nc2cc(Br)cc3cc(C(=O)[O-])oc23)CC1,9.0,,
CNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12,9.0,,CHEMBL1938654
Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)c(F)c3)nc2C)ccc1OCC(=O)[O-],9.0,,
COc1cc2nccc(Oc3ccc(NC(=O)C4C(=O)N(c5ccccc5)[N+](C)=C4C)cc3F)c2cc1OC,9.0,,
COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)O)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,9.0,,CHEMBL2032028
CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(F)cccc3Cl)n21,9.0,,CHEMBL1945723
COc1cc(C)c2nc3n[nH]c(C)c3c(C[NH+]3CCOCC3)c2c1,9.0,,
CSCCC([NH2+]CC(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(Cc1cnc[nH]1)NC(=O)C1CCC[NH2+]1)C(=O)NC(C)C(=O)NC(Cc1cnc[nH]1)C(=O)[O-],9.0,,
CC[NH+](CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,9.0,,
COCCOc1cnc2ccc(C(C)n3nnc4ccn(-c5cc(C)ns5)c(=O)c43)cc2c1,9.0,,
N=CC1(NC(=O)C2CCCCC2C(=O)N2CCc3[nH]c4ccc(F)cc4c3C2)CC1,9.0,,
COc1ncc(Nc2ncc(C(C)[N+]3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cc1F,9.0,,
CCc1[nH]c2nc(Oc3cncnc3)nc(N3CC4C([NH3+])C4C3)c2c1Cl,9.0,,
CCc1[nH]c2nc(Sc3cnc4ncc(=O)[nH]c4c3)nc(N3CCC([NH3+])C3)c2c1Cl,9.0,,
CCC(CC)(NC(=O)C(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC1(C(=O)NC(c2ccccc2)c2ccccc2)CCCC1,9.0,,
CCC(CC)(NC(=O)C(C)C)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NC1(C(=O)NC(c2ccc(F)cc2)c2ccc(F)cc2)CCCC1,9.0,,
COc1cccc(N2CC3C(=O)N(C)C(=[NH2+])NC3(c3cc(-c4cccc(C#N)c4)cs3)C2)n1,9.0,,
COc1ccc2c(c1)C(=O)N(c1nc(C(=O)Nc3cnccc3N3CC[NH2+]CC3)cs1)C2,9.0,,
O=c1c2cc(CS(=O)(=O)NCc3ccccn3)ccc2ccc2ncc(-c3cnn(C4CC[NH2+]CC4)c3)cc12,9.0,,
O=C(NC1CCCCCCCC2CC2(C(=O)NS(=O)(=O)C2CC2)NC(=O)C2CC(OC(=O)N3CCc4ccccc4C3)CN2C1=O)OC1CCCC1,9.0,,
O=C(Nc1cc(Nc2ccc3c(c2)OCc2ccc(OCC[NH+]4CCOCC4)cc2C3=O)ccc1F)c1ccccc1,9.0,,
COc1c(CCc2ccc(NS(C)(=O)=O)cc2)cc(-c2ccc[nH]c2=O)cc1C(C)(C)C,9.0,,CHEMBL2431456
COc1c(-c2cc3ccc(NS(C)(=O)=O)cc3c(=O)o2)cc(C2=CCC=NC2=O)cc1C(C)(C)C,9.0,,
O=C(NC(CO)c1ccc(F)c(Cl)c1)N1CCc2cnc(NC3CCOCC3)nc2C1,9.0,,
COc1cc(-c2ccc3nc(NC(C)=O)sc3c2)cnc1OC,9.0,,CHEMBL3356889
Cc1cn(C2CCC[NH+](C(CC(C)C)c3ccc(C(=O)[O-])c(Oc4cccc(Cl)c4)c3F)C2)c(=O)[nH]c1=O,9.0,,
Cc1cn(C2CCC[NH+](C(CC(C)C)c3ccc(C(=O)[O-])c(Oc4cccc(Cl)c4)c3F)C2)c(=O)[nH]c1=O,9.0,,
CC1(F)CCCC1Nc1c(C(N)=O)cnn2cccc12,9.0,,
CC1COCC(C)[N+]1=C1CC(=O)N2CCC(C(F)(F)F)N(Cc3ccc(Cl)s3)C2=[NH+]1,9.0,,
O=C(Nc1cnn(-c2cccc(C(=O)Nc3cnn(C4CC[NH2+]C4)c3)c2)c1)Nc1ccccc1Cl,9.0,,
CCC(C)C(NC(=O)C(CC(O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C([NH3+])C(C)C)C(C)C)C(=O)NC(C(=O)[O-])C(C)C,9.0,,
NC(=[NH2+])c1ccc(CNC(=O)C2CCCN2C(=O)C(CC2CCCCC2)[NH2+]CC(=O)[O-])s1,9.01,,
CC(=O)NC(C(=O)NC(Cc1ccccc1)CC(O)C(Cc1ccccc1)NC(=O)C1CN(c2cccc(C(C)=O)c2)C(=O)O1)C(C)C,9.01,,
OC(O)CC1CC(I)C(OC2C=C(I)C(O)CC2)C(I)C1,9.01,,
CCNC(=O)C[NH2+]C(C(=O)N1CCC1C(=O)NCc1ccc(C(N)=[NH2+])cc1)C1CCCCC1,9.01,,
CC(C)C(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)Cc1ccccc1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)NCc1ccc(C(N)=[NH2+])cc1,9.01,,
CSCCC(NC(=O)C(CCC(N)=O)NC(=O)C([NH3+])CC(=O)[O-])C(=O)NC(C=O)CC(=O)[O-],9.03,,
Cn1cc(C=C2Oc3cc(O)cc(O)c3C2=O)c2c(N3CC[N+](C)CC3)ccnc21,9.03,,
C[NH+]1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1,9.03,,
Cc1nc2c(c(-c3ccc(Cl)cc3Cl)c1C[NH3+])C(=O)N(CC(=O)N(C)C)C2,9.03,,
C[NH+](C)CCC(c1ccccc1)n1cc(NC(=O)c2n[nH]c3cc(-c4cn[nH]c4)ccc23)cn1,9.03,,
CC(C)C(NC(=O)C(OCc1ccccc1)C(O)C(O)C(OCc1ccccc1)C(=O)NC(C(=O)NCc1ccccn1)C(C)C)C(=O)NCc1ccccn1,9.04,,
NS(=O)(=O)c1ccc(C(=O)NCc2c(F)cccc2F)cc1,9.04,,
CC12CCC3c4ccc(O)cc4CCC3C1CCC2O,9.04,This molecule is a steroid. It has a role as an estrogen. This molecule is a natural product found in Punica granatum with data available.,CHEMBL412
O=c1c2cccnc2n(-c2cccc([N+](=O)[O-])c2)c(=O)n1Cc1ccncc1,9.04,,CHEMBL1232082
O=c1c2cccnc2n(-c2cccc([N+](=O)[O-])c2)c(=O)n1Cc1ccncc1,9.04,,CHEMBL1232082
NS(=O)(=O)c1ccccc1-c1ccc(NC(=O)c2cc(C(F)(F)F)nn2-c2ccccc2C[NH3+])c(F)c1,9.04,,
O=C([O-])c1ccc2c(c1)nc(Nc1cccc(C(F)(F)F)c1)c1nc(NC3CC3)ncc12,9.04,,
COc1ccc(S(=O)(=O)N(CC2CCC(=O)N2)CC(O)C(Cc2ccccc2)NC(=O)OC2CC3CCOC3C2)cc1,9.04,,
CCC(=O)N1CCC(NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1,9.04,,CHEMBL1258904
CCC(C)C(NC(=O)C(OCC1=CCC=CC1)C(O)C(O)C(OCc1ccccc1)C(=O)NC(C(=O)NC)C(C)CC)C(=O)NC,9.05,,
COC(=O)C(Cc1cccc(C(N)=[NH2+])c1)C(C)NC(=O)c1ccc(-c2cccc(C[NH3+])c2)cc1,9.05,,
CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,9.05,,
Cn1cncc1C(OCc1nc(Cl)c(C#N)cc1-c1cccc(Cl)c1)c1ccc(C#N)cc1,9.05,,CHEMBL288046
COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,9.05,,CHEMBL3560003
N#Cc1ccc(Cn2cncc2C[NH+]2CCN(c3cccc(Cl)c3)C(=O)C2)cc1,9.05,,
CN1CC(=O)N2C(Cc3c([nH]c4ccccc34)C2c2ccc3c(c2)OCO3)C1=O,9.05,This molecule is a member of beta-carbolines.,CHEMBL1671905
CC1OC(n2cc(I)c3c(N)ncnc32)C(O)C1O,9.05,,
CCCCNC(=O)C(C)CC(O)C([NH3+])CC(CNC(=O)c1ccccc1OCCCOC)C(C)C,9.05,,
CC12CCC3c4ccc(O)cc4CCC3C1CC(Cc1cccc(C(N)=O)c1)C2O,9.05,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,9.05,,CHEMBL195725
COC(C(O)CO)C1OC(C(=O)[O-])CC(NC(N)=[NH2+])C1NC(C)=O,9.05,,
CC[N+]1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1,9.05,,
CCC(CC(O)C([NH3+])C[NH+]1CC(=O)N(c2ccccc2Cl)CC1(C)C)C(=O)NC1C2CC3CC1CC(O)(C3)C2,9.05,,
O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)(C2CCCC[NH2+]2)C1,9.05,,
CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc(N5CCOCC5)cc4)nc23)cc1,9.05,,CHEMBL2062803
CC(C)(C)OC(=O)NC1CCC(n2cnc3cnc4[nH]ccc4c32)C1,9.05,,
Nc1ncnc2c(C3[NH2+]C(CO)C(O)C3O)c[nH]c12,9.05,,
CCC(CC)OC1CC(C(=O)[O-])=CC([NH3+])C1NC(C)=O,9.05,,
CCOCCC1(Oc2ccc(Oc3ccc(F)cc3)cc2)C(=O)NC(=O)NC1=O,9.06,"These molecules is a member of the class of barbiturates that is barbituric acid in which the hydrogens at position 5 are replaced by 2-ethoxyethyl and 4-(4-fluorophenoxy)phenoxy groups. It is a potent and selective inhibitor of matrix MMP-13 (metalloproteinase-13, collagenase 3). It has a role as a matrix metalloproteinase inhibitor.",CHEMBL222002
CC1NC(=O)C2CSSCC(NC(=O)C[NH3+])C(=O)NC(CSSCC(C(N)=O)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(Cc3c[nH]c4ccccc34)NC1=O)C(=O)NC(CO)C(=O)NC(CC(=O)[O-])C(=O)N1CCCC1C(=O)NC(CCCNC(N)=[NH2+])C(=O)N2,9.06,,
O=C(C1CCCN1C(=O)CCn1c(=O)c(-c2ccccc2)nc2ccccc21)N1CCCC1,9.06,,
CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCC([NH+]5CC[NH+](CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C,9.06,,
CCc1cc(-c2nc(O)c(C(N)=O)c(=O)[nH]2)nc(C2CCCCC2C(=O)NCc2ccc(Cl)c(Cl)c2)n1,9.06,,
O=c1[nH]cnc2c(C3[NH2+]C(CO)C(O)C3O)c[nH]c12,9.07,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc2c(c1)OCO2,9.07,,
C[NH2+]C1C(O)COC2CC(CC([NH3+])C(=O)[O-])(C(=O)[O-])OC21,9.07,,
CNC(=O)c1ccc(F)cc1C(C)Oc1nc(-c2cccnc2OC)cnc1N,9.07,,
O=C([O-])CCCCC1SCC2NC(=O)NC21,9.07,,
COC(=O)N1CCC2C1CCCC2(O)C#Cc1cccc(C)c1,9.07,,
COc1ccc(Nc2nc(-c3cccc(C(=O)Nc4ccc(C(=O)[O-])cc4)c3)c[n+]3cc[nH]c23)cc1OC,9.07,,
NS(=O)(=O)c1ccc(S(=O)(=O)NCc2cccs2)s1,9.08,,
COc1cc2c(cc1O)CCC1C2CCC2(C)C(O)CCC12,9.08,This molecule is a steroid. It has a role as an estrogen.,CHEMBL23576
CCCCC(NC(=O)OCC1(Cc2ccc(F)cc2)CCC1)C(O)C(=O)Nc1cc[nH]n1,9.08,,
O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,9.08,"This molecule is a selective inhibitor of phosphodiesterase-4 (PDE-4) that has unique antiinflammatory activity and is used to treat and prevent exacerbations of chronic obstructive pulmonary disease (COPD). This molecule has not been linked to significant serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury. This molecule is a benzamide obtained by formal condensation of the carboxy group of 3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzoic acid with the amino group of 3,5-dichloropyridin-4-amine. Used for treatment of bronchial asthma and chronic obstructive pulmonary disease. It has a role as a phosphodiesterase IV inhibitor and an anti-asthmatic drug. It is a member of benzamides, a chloropyridine, an aromatic ether, an organofluorine compound and a member of cyclopropanes. This molecule is a highly selective phosphodiesterase-4 (PDE4) inhibitor. PDE4 is a major cyclic-3',5′-adenosinemonophosphate (cyclic AMP, cAMP)-metabolizing enzyme expressed on nearly all immune and pro-inflammatory cells, in addition to structural cells like those of the smooth muscle or epithelium. The resultant increase in intracellular cAMP induced by roflumilast's inhibition of PDE4 is thought to mediate its disease-modifying effects, although its precise mechanism of action has yet to be elucidated.  The oral formulation of roflumilast is indicated to manage chronic obstructive pulmonary disease. It was first approved by the EMA in July 2010, and by the FDA in January 2018. This molecule topical cream is indicated to treat plaque psoriasis. The cream formulation was first approved by the FDA in July 2022 and by Health Canada in April 2023. On December 15, 2023, the FDA approved a new topical foam formulation of roflumilast for the treatment of seborrheic dermatitis in patients aged 9 years and older. This molecule is a Phosphodiesterase 4 Inhibitor. The mechanism of action of roflumilast is as a Phosphodiesterase 4 Inhibitor. This molecule is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3',5'-adenosine monophosphate (cAMP) and cAMP-mediated signaling. cAMP prevents phosphorylation of spleen tyrosine kinase (SYK) and abrogates activation of the PI3K/AKT/mTOR signaling pathway, which may result in the induction of apoptosis. PDE4, a member of the PDE superfamily that hydrolyses cAMP and 3',5'-cyclic guanosine monophosphate (cGMP) to their inactive 5' monophosphates, is upregulated in a variety of cancers and may contribute to chemoresistance; it also plays a key role in inflammation, especially in inflammatory airway diseases.",CHEMBL193240
Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCCNC1=O,9.08,,
C=C(C)CNC(=O)C1N(C(=O)C(O)C(Cc2ccccc2)NC(=O)COc2c(C)cc(N)cc2C)CSC1(C)C,9.08,,
CCc1cc2c(cc1N1CCC([N+]3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,9.08,,
O=C1c2c(c(C(F)(F)F)nn2-c2cccc(-c3n[nH]c(=O)[nH]3)c2)CCN1c1ccc(-c2ccccc2C[NH+]2CCC(O)C2)cc1,9.08,,
CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OC1CC1CCCCCc1nc3ccc(OC)cc3nc1O2)C(=O)NS(=O)(=O)C1C=C1,9.08,,
CCC(CC)OC1CC(C(=O)[O-])CC([NH3+])C1NC(C)=O,9.08,,
Oc1ccc2c(Cc3ccc(C[NH+]4CCCC4)c(Br)c3)c(-c3ccc(OCC[NH+]4CCCC4)cc3)sc2c1,9.090000000000002,,
Cc1ccccc1CNC(=O)C1N(C(=O)C(O)C(Cc2ccccc2)NC(=O)c2cccc(O)c2C)CSC1(C)C,9.090000000000002,,CHEMBL185500
N=CC1CCCN1C(=O)C1CCC(COc2cc(C(=O)[O-])ccc2Cl)[NH2+]1,9.090000000000002,,
Nc1ncc2cc(-c3c(Br)cccc3Br)c(N)nc2n1,9.090000000000002,,CHEMBL57531
CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C,9.090000000000002,,
NC(=[NH2+])NCCCC(NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)CCCCCCC(=O)N1CCN(c2ncnc3[nH]cnc23)CC1)C(N)=O,9.090000000000002,,
O=C(C1CC(F)(F)CN1C(=O)CCN1C(=O)c2ccccc2C1=O)N1CCCC1,9.090000000000002,,
O[n+]1ccc2c(-c3ccc(F)cc3F)cc(C3CC[NH2+]CC3)nc2c1-c1c(Cl)cccc1Cl,9.090000000000002,,
CCC(C#N)(CC)Nc1nc(NC)nc(-n2cncn2)n1,9.090000000000002,,CHEMBL2402509
O=c1ccc2c([nH]1)CCCC2[NH2+]CCCCCCCCCC[NH2+]C1CCCc2[nH]c(=O)ccc21,9.1,,
Oc1ccc(C2Sc3cc(O)ccc3OC2c2ccc(OCC[NH+]3CCCCC3)cc2)cc1,9.1,,
CCc1c(C)nc(O)c(I)c1Oc1cccc(CCC#N)c1,9.1,,
COc1cc2c(Nc3cnc(NC(=O)c4ccccc4)nc3)ncnc2cc1OCC(O)C[NH+]1CCCCC1,9.1,,
CCCCN(C(=O)Nc1ccc(Cl)cc1)C1(C(=O)Nc2ccc(-c3ccccc3S(C)(=O)=O)cc2F)C=C1,9.1,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc2c(c1)OCO2,9.1,,
CC(C)c1nnc2ccc(Sc3ccccc3CNC(=O)Nc3cc(C(C)(C)C)nn3-c3ccccc3)cn12,9.1,,CHEMBL1938736
OCC1OC2C=CC3OC4C(CC3OC2CC=CC1O)OC1C=CC=COC1C4O,9.1,,
Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2C)cc1C(=O)Nc1cnc(Nc2ccc(N3CC[NH+](C)CC3)cc2)nc1,9.1,,
Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(-c3ccccc3C)nncc2c1,9.1,,CHEMBL492265
O=C(C1=C(c2ccc(CCCOc3c(F)ccc(F)c3Cl)cc2)CC2C[NH2+]CC1[NH2+]2)N(Cc1cccc(Cl)c1Cl)C1CC1,9.1,,
Cc1cccc(C(=O)N2c3cccc(O)c3NC3=C(C2c2ccc(OCc4ccccc4)cc2F)S(=O)(=O)CC(C)(C)C3)n1,9.1,,CHEMBL499447
C[NH+]1CCN(c2ccc(NC(=O)c3ccc(C#N)o3)c(N3CCCCC3)c2)CC1,9.1,,
COc1ccc2c(c1)C(=O)N(CC1(c3ccc(-c4cccnc4)cc3)NC(=O)NC1=O)C2,9.1,,
COCC1CCCN1C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C2CN(S(=O)(=O)c3cccc(C)c3)CC[NH2+]2)c1,9.1,,
CCOc1ccc2nc(S(N)(=O)=O)sc2c1,9.1,"This molecule is a sulfonamide that is 1,3-benzothiazole-2-sulfonamide which is substituted by an ethoxy group at position 6. A carbonic anhydrase inhibitor, it has been used in the treatment of glaucoma, and as a diuretic. It has a role as an EC 4.2.1.1 (carbonic anhydrase) inhibitor, a diuretic and an antiglaucoma drug. It is a member of benzothiazoles, a sulfonamide and an aromatic ether. This molecule is a sulfonamide used as diuretic and in glaucoma. It inhibits carbonic anhydrase activity in proximal renal tubules to decrease reabsorption of water, sodium, potassium, bicarbonate. Its pharmacological activity thus confers the risk for hypokalemia. This molecule is a sulfonamide and carbonic anhydrase (CA) inhibitor with diuretic and anti-glaucoma activity. In the eye, ethoxzolamide inhibits CA, thereby decreasing the secretion of aqueous humor. This may relieve intraocular pressure. Also, this agent prevents reabsorption of bicarbonate and sodium in the proximal convoluted tubule thereby producing a mild diuresis.",CHEMBL18
CCn1ncc2c(NC3CCOCC3)c(-c3nc(CC(=O)N4CCCC4)no3)cnc21,9.1,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,9.1,,
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1,9.1,"This molecule is a member of the class of ureas that is urea in which one of the nitrogens bears a 3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl substituent, while the other bears a 2-fluoro-4-{[2-(methylcarbamoyl)pyridin-4-yl]oxy}phenyl substituent. It has a role as a tyrosine kinase inhibitor. It is a member of quinolines, a pyridinecarboxamide, a member of pyrazoles, an organofluorine compound and a member of phenylureas. This molecule has been used in trials studying the treatment of Chronic Myeloid Leukemia. It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent. This molecule is an orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity. Upon oral administration, rebastinib binds to and inhibits the Bcr-Abl fusion oncoprotein by changing the conformation of the folded protein to disallow ligand-dependent and ligand-independent activation; in addition, this agent binds to and inhibits Src family kinases LYN, HCK and FGR and the receptor tyrosine kinases TIE-2 and VEGFR-2. This molecule may exhibit more potent activity against T315I Bcr-Abl gatekeeper mutant kinases than other Bcr-Abl kinase inhibitors. The TIE-2 and VEGFR-2 receptor tyrosine kinases regulate angiogenesis, respectively, while the Src family kinases Abl, LYN, and HCK Src regulate a variety of cellular responses including differentiation, division, adhesion, and the stress response.",CHEMBL1738757
O=C([O-])c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1,9.1,,
COc1ccc(S(=O)(=O)N(CC2CCC(=O)N2)CC(O)C(Cc2ccccc2)NC(=O)OC2CC3CCOC3C2)cc1,9.1,,
CC(=O)NC1C(=NOC(=O)Nc2ccccc2)OC(CO)C(O)C1O,9.1,,
O=S(=O)(NCB(O)O)c1ccc(-c2nn[nH]n2)nc1,9.1,,
CC(O)C([NH3+])C(=O)NS(=O)(=O)c1cccc(-c2ccc3c(N)nc(Cl)nc3c2)c1,9.1,,
CCC(CC)OC1CC(C(=O)[O-])CC([NH3+])C1NC(C)=O,9.1,,
CNc1cc(-c2cccc(Cl)c2Cl)nc(N)n1,9.1,,CHEMBL3781316
N#Cc1cccc(Cn2cc(NC(=O)c3n[nH]c4cc(-c5cn[nH]c5)ccc34)cn2)c1,9.1,,CHEMBL3263036
[NH3+]C1CCC(CNC(=O)C2C=CCn3c(=O)n(CCS(=O)(=O)c4ccccc4)c(=O)n32)CC1,9.11,,
CC(=O)NC(CC(=O)[O-])C(=O)NC(CCC(=O)[O-])C(=O)NC(C(=O)NC(CC(=O)[O-])C(O)CCCc1ccccc1)C(C)C,9.11,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,9.12,,
C[N+](C)CCCC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3nccc(-c4cccnc4)n3)cc2)c1,9.12,,
O=C1CCc2c(-c3ccc(F)cc3F)cc(C3C=CNC=C3)cc2N1c1c(Cl)cccc1Cl,9.13,,
CCNC(=O)COc1ccc(Cl)cc1CNC(=O)C1CCCN1C(=O)C([NH3+])C1CCCCC1,9.13,,
CCC(=O)NC1c2nc(CCc3ccccc3)cn2C(CO)C(O)C1O,9.13,,
CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3cn(cc13)C(=O)O2)C(=O)NS(=O)(=O)C1CC1,9.13,,
Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,9.14,"This molecule is a member of the class of pyrrolopyrimidines that is 7H-pyrrolo[2,3-d]pyrimidine substituted by amino, 4-phenoxyphenyl, and cyclopentyl groups at positions 4, 5 and 7, respectively. It is a potent inhibitor of Lck that inhibits Lck (64-509) and LckCD isoforms (IC50 of less than 1 and 2 nM, respectively). It has a role as a geroprotector and an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor. It is a primary amino compound, a pyrrolopyrimidine, an aromatic amine, an aromatic ether and a member of cyclopentanes.",CHEMBL47940
CCC(C)C1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(NC(=O)C(NC(=O)C([NH3+])CO)C(C)O)CSC(=O)C(CCSC)NC1=O,9.14,,
Cc1cc(Nc2nc(OC(C)c3ncc(F)cn3)c(F)c(N3CCOCC3)n2)[nH]n1,9.14,,
CC(C)CC(NC(=O)OCc1ccccc1)C(=O)N[NH2+]C(O)[NH2+]NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1,9.15,,
COc1ccc(S(=O)(=O)N2CCCSC(C)(C)C2C(=O)NO)cc1,9.15,,
CC1OC(OC2C(CO)OC(OC3C(CO)=CC([NH2+]C4C(C)OC(OC5C(CO)OC(OC6C(CO)OC(O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1[NH3+],9.15,,
Cc1nc(COc2ccc(CC(NC(=O)OC3COC4OCCC34)C(O)CN(CC(C)C)S(=O)(=O)c3ccc4c(c3)OCO4)cc2)cs1,9.15,,
COCC1CCCN1C(=O)c1cc(C)cc(C(=O)NC(Cc2cc(F)cc(F)c2)C(O)C2CC(Oc3ccccc3)C[NH2+]2)c1,9.15,,
Cc1ccccc1-n1c(Cn2nc(-c3cc(O)cc(F)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O,9.15,,CHEMBL1213084
CC(C)c1cc(C(=O)N2Cc3ccc(C[NH+]4CC[NH+](C)CC4)cc3C2)c(O)cc1O,9.15,,
CC1OC(OC2CC(O)C3(CO)C4C(O)CC5(C)C(C6=CC(=O)OC6)CCC5(O)C4CCC3(O)C2)C(O)C(O)C1O,9.15,"This molecule appears as odorless, white crystals or crystalline powder as an octahydrate. Used to produce rapid digitalization in acute congestive heart failure. Also recommended in treatment of atrial or nodal paroxysmal tachycardia and atrial flutter. (EPA, 1998) This molecule is a cardenolide glycoside.",CHEMBL1720907
CC(C)(C)S(=O)(=O)CC(Cc1ccccc1)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CC1CCCCC1)C(O)C(O)C1CC1,9.15,,
CCCCCCCCCCOS(N)(=O)=O,9.15,,CHEMBL153094
Cc1ccccc1-c1ccc2nc(N)c(CC(C)C(=O)NC3CCOC(C)(C)C3)cc2c1,9.15,,
COc1cc(F)cc2c1nc(C)c1c(C)nc(-c3ccncc3C)n12,9.15,,CHEMBL1916113
Cc1cnccc1-c1nc(C)c2c(C)nc3c(Cl)cc(C(F)(F)F)cc3n12,9.15,,CHEMBL1916132
N=CCNC(=O)C1CC(S(=O)(=O)c2ccccc2)CC1C(=O)N1CCOCC1,9.15,,
CC1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21,9.15,,CHEMBL4303155
C[NH+](C)Cc1ccc(C2CC2C(=O)Nc2nc3ccc(-c4cn[nH]c4)cc3s2)cc1,9.15,,
CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(O)CCl,9.15,,
C[NH+](C)CCC(c1ccccc1)n1cc(NC(=O)c2[nH]nc3c2CCC(C)(C)C3)cn1,9.15,,
Cc1noc(C)c1CCC1CCN(S(=O)(=O)CC(C)(CC(C)c2ncc(F)cn2)N(O)C=O)CC1,9.16,,
O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,9.170000000000002,"This molecule is a selective inhibitor of phosphodiesterase-4 (PDE-4) that has unique antiinflammatory activity and is used to treat and prevent exacerbations of chronic obstructive pulmonary disease (COPD). This molecule has not been linked to significant serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury. This molecule is a benzamide obtained by formal condensation of the carboxy group of 3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzoic acid with the amino group of 3,5-dichloropyridin-4-amine. Used for treatment of bronchial asthma and chronic obstructive pulmonary disease. It has a role as a phosphodiesterase IV inhibitor and an anti-asthmatic drug. It is a member of benzamides, a chloropyridine, an aromatic ether, an organofluorine compound and a member of cyclopropanes. This molecule is a highly selective phosphodiesterase-4 (PDE4) inhibitor. PDE4 is a major cyclic-3',5′-adenosinemonophosphate (cyclic AMP, cAMP)-metabolizing enzyme expressed on nearly all immune and pro-inflammatory cells, in addition to structural cells like those of the smooth muscle or epithelium. The resultant increase in intracellular cAMP induced by roflumilast's inhibition of PDE4 is thought to mediate its disease-modifying effects, although its precise mechanism of action has yet to be elucidated.  The oral formulation of roflumilast is indicated to manage chronic obstructive pulmonary disease. It was first approved by the EMA in July 2010, and by the FDA in January 2018. This molecule topical cream is indicated to treat plaque psoriasis. The cream formulation was first approved by the FDA in July 2022 and by Health Canada in April 2023. On December 15, 2023, the FDA approved a new topical foam formulation of roflumilast for the treatment of seborrheic dermatitis in patients aged 9 years and older. This molecule is a Phosphodiesterase 4 Inhibitor. The mechanism of action of roflumilast is as a Phosphodiesterase 4 Inhibitor. This molecule is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3',5'-adenosine monophosphate (cAMP) and cAMP-mediated signaling. cAMP prevents phosphorylation of spleen tyrosine kinase (SYK) and abrogates activation of the PI3K/AKT/mTOR signaling pathway, which may result in the induction of apoptosis. PDE4, a member of the PDE superfamily that hydrolyses cAMP and 3',5'-cyclic guanosine monophosphate (cGMP) to their inactive 5' monophosphates, is upregulated in a variety of cancers and may contribute to chemoresistance; it also plays a key role in inflammation, especially in inflammatory airway diseases.",CHEMBL193240
Cn1c(=O)n(Cc2ccc(C(=O)[O-])cc2)c(=O)c2cc(C#CCc3ccccc3)ccc21,9.170000000000002,,
O=C(NC1CCCCC1NC(=O)c1ccc2c(Cl)c[nH]c2c1)c1ccc(-n2ccccc2=O)cc1,9.170000000000002,,
NC(=[NH2+])N1CCCC(CNC(=O)CC(NS(=O)(=O)c2ccc3ccccc3c2)C(=O)N(CC(=O)[O-])Cc2ccccc2)C1,9.170000000000002,,
O=C(NC1c2ccccc2CC1O)C(Cc1ccccc1)CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O,9.170000000000002,,
CC(NC(=O)Cc1c(Cl)ccc(NCC(F)(F)c2cccc[n+]2O)[n+]1O)c1cccc(Cl)c1,9.18,,
CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,9.18,,
CC(C)C(=O)N1CCC(NC(=O)Nc2ccc(C(F)(F)F)cc2)CC1,9.18,,CHEMBL3327064
Cn1cncc1C([NH3+])(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,9.19,,
NS(=O)(=O)c1ccc(CCNC(=S)Nc2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)[O-])c2)cc1,9.19,,
O=c1[nH]c2ccc(-c3cn[nH]c3)cc2cc1-c1cc2cc(C[NH+]3CCCCC3)ccc2[nH]1,9.19,,
[NH3+]CCCCC(NC(=O)C([NH3+])CO)C(=O)NCC(=O)NC(CCC[N+](=O)C=O)C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC1CCCCNC(=O)C(CO)NC(=O)C(CCC[N+](=O)C=O)NC1=O,9.19,,
COc1cc(N2CCC([NH+]3CC[NH+](C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,9.19,,
COc1ccc(S(=O)(=O)N(CC2CCC(=O)N2)CC(O)C(Cc2ccccc2)NC(=O)OC2CC3CCOC3C2)cc1,9.19,,
NS(=O)(=O)c1ccc(N2CCCC2=O)c([N+](=O)[O-])c1,9.21,,CHEMBL121291
O=C([O-])Cc1cc(Br)c(Oc2ccc(O)c(C(=O)NCCc3ccccc3)c2)c(Br)c1,9.21,,
NC(=[NH2+])c1ccc2cc(C(=O)Nc3ccc(C[NH3+])cc3)cc(Nc3ncccn3)c2c1,9.21,,
CCC(C)C1NC(=O)C([NH2+]CC(O)CC(Cc2ccccc2)C(=O)NC2c3ccccc3CC2O)Cc2ccc(cc2)OCCCCCNC1=O,9.22,,
CC1(C)CCC(C)(C)c2cc(C(=O)C=Cc3ccc(C(=O)[O-])cc3)ccc21,9.22,,
N#Cc1ccc(S(=O)(=O)Nc2cccc(C(c3c(O)c4c(oc3=O)CCCCCC4)C3CC3)c2)cc1,9.22,,CHEMBL2062136
CC(C)C(=O)c1cnc(C(Cc2ccccc2)CC(O)C(Cc2ccccc2)NC(=O)C(NC(=O)OCc2ccccc2)C(C)C)[nH]1,9.22,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,9.22,,CHEMBL195725
CCC(C)C(NC(=O)C(CCC(N)=O)NC(=O)C1CCC[NH2+]1)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(C=O)Cc1c[nH]c2ccccc12)C(C)O,9.22,,
CCCc1[nH]c(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CC[NH+](CC)CC4)ccc3OCC)n[n+]12,9.22,,
OCC1C(O)C(O)C(O)c2nc(CNc3ccccc3)cn21,9.22,,
CC(C)CCN(CC(O)C1Cc2ccc(cc2)OCCCC(=O)NC(CC(N)=O)C(=O)N1)S(=O)(=O)c1ccccc1,9.22,,
OCC1C(O)C(O)C(O)c2nc(CCc3ccccc3)cn21,9.22,,
CC=CC=C(C)C=CC=C1N(CCS(=O)(=O)[O-])c2ccc(S(=O)(=O)[O-])cc2C1(C)C,9.22,,
CCCC1(CCc2ccccc2)CC(O)=C(C(CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,9.22,,
COCCCOc1cc(CC(CC([NH3+])C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,9.22,,
CCCC(CC1(C(=O)NC(Cc2ncc(-c3ccccc3)o2)C(=O)[O-])CCCC1)C(=O)[O-],9.22,,
COc1nc(Nc2ccc(N3CC[NH2+]CC3)cc2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2F)ccc1C,9.22,,
COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC,9.22,,CHEMBL272198
CC(C)[NH+]1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1,9.22,,
CC(C)(C)Oc1ccc(CC(NC(=O)C(Cc2ccccc2)NC(=O)OCc2ccccc2)C(=O)CO)cc1,9.22,,
CC(C)n1cc(C(=O)c2cncc(NC3COCC3c3ccc(F)cc3)n2)c2c(N)ncnc21,9.22,,
CC(NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(F)ccc34)nc12)C(=O)N1CC(C#N)C1,9.22,,
O=C(NOCC(O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,9.22,This molecule is an aminobenzoic acid.,CHEMBL450775
FC(F)(F)c1ccnc(Nc2cccc(-c3cccc(N4CC[NH2+]CC4)c3)n2)c1,9.22,,
CCC(C)C(NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C([NH3+])CCC(=O)[O-])C(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(C(=O)[O-])C(C)C)C(C)O)C(C)CC,9.22,,
COc1ccc(-c2cccc3[nH]c(Nc4ccc(N5CC[NH+](C)CC5)cc4)n[n+]23)cc1,9.22,,
CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1cccc(Oc2nc3ccccc3[nH]2)c1,9.22,,CHEMBL3393497
COC(CC(CCCC[NH2+]Cc1ccc(F)cc1)C(=O)NO)c1ccc(F)cc1,9.24,,
O=S(=O)([O-])CC[NH2+]C1CCCCC1,9.24,,
Cn1ncnc1C1c2n[nH]c(=O)c3cc(F)cc(c23)NC1c1ccc(F)cc1,9.24,,CHEMBL3765528
CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,9.25,This molecule is a phenylalanine derivative.,CHEMBL3559830
C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O,9.26,,
CC(C)(C)NC(=O)C1C[NH+](Cc2cccnc2)CC[NH+]1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O,9.26,,
[NH3+]Cc1ccc(OCCCc2sc(-c3ccc4c(c3)C(=NNc3nc5ccccc5s3)CCC4)nc2C(=O)[O-])cc1,9.26,,
CC(C)CC(NC(=O)C(Cc1ccc(C[NH3+])cc1)NC(=O)C(Cc1ccccc1)N=[N+2]#N)C(=O)NC(CCS(C)(=O)=O)Cc1ccc(C[NH3+])cc1,9.26,,
CC(C)(C)NC(=O)C1C[NH+](Cc2cccnc2)CC[NH+]1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O,9.27,,
CC(C)c1cc(C(=O)n2cc3ccccc3c2)c(O)cc1O,9.27,,
CC(O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(I)c1,9.27,,
CC(O)C(NC(=O)c1ccc(C#Cc2ccc(C[NH+]3CCOCC3)cc2)cc1)C(=O)NO,9.27,,
CCC(CC)OC1CC(C(=O)[O-])CC([NH3+])C1NC(C)=O,9.27,,
CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21C,9.28,,CHEMBL1713571
CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21C,9.28,,CHEMBL1713571
COCc1cc(O)cc2c1OC(c1ccc(O)cc1)C1CC(F)(F)CC21,9.28,,
O=[N+]([O-])c1cccc(-c2cc(Cc3ccncc3)cc3cccnc23)c1,9.28,,CHEMBL127944
CC1(C)SCN(C(=O)C(O)C(Cc2ccccc2)NC(=O)COc2c(Cl)cccc2Cl)C1C(=O)NC1c2ccccc2CC1O,9.28,,
C=CC1CC1(NC(=O)C1CC(Oc2cc(-c3csc(NC(=O)C(C)C)n3)nc3c(Br)c(OC)ccc23)CN1C(=O)C(NC(=O)OC1CCCC1)C(C)(C)C)C(=O)[O-],9.28,,
Nc1ncnc2c1ncn2C1OC(CNS(=O)(=O)NC(=O)CCCCC2SCC3NC(=O)NC32)C(O)C1O,9.28,,
Cc1cc(C)c2cc1C(=O)NCCCNC(=O)CCSc1cc-2nc(N)n1,9.28,,CHEMBL1939379
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,9.28,"This molecule is an oral multi-kinase inhibitor that is used in the therapy of advanced renal cell, liver and thyroid cancer. This molecule has been associated with a low rate of transient elevations in serum aminotransferase levels during therapy that are generally mild and asymptomatic. This molecule has also been linked to rare instances of clinically apparent liver injury which can be severe and even fatal. This molecule is a member of the class of phenylureas that is urea in which one of the nitrogens is substituted by a 4-chloro-3-trifluorophenyl group while the other is substituted by a phenyl group which, in turn, is substituted at the para position by a [2-(methylcarbamoyl)pyridin-4-yl]oxy group. It has a role as an antineoplastic agent, an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor, a tyrosine kinase inhibitor, an angiogenesis inhibitor, an anticoronaviral agent and a ferroptosis inducer. It is a pyridinecarboxamide, a member of monochlorobenzenes, an aromatic ether, a member of (trifluoromethyl)benzenes and a member of phenylureas. This molecule is a bi-aryl urea and an oral multikinase inhibitor. It targets cell surface tyrosine kinase receptors and downstream intracellular kinases that are implicated in tumour cell proliferation and tumour angiogenesis. First approved by the FDA and European Commission in 2007 for the treatment of hepatocellular carcinoma, sorafenib is also indicated to treat renal carcinoma and differentiated thyroid carcinoma. This molecule is a Kinase Inhibitor. The mechanism of action of sorafenib is as a Protein Kinase Inhibitor. This molecule is a synthetic compound targeting growth signaling and angiogenesis. This molecule blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis. This molecule is a natural product found in Aspergillus ochraceus, Curvularia lunata, and Asimina triloba with data available. This molecule is a drug approved for the treatment of advanced renal cell carcinoma (primary kidney cancer). It has also received 'Fast Track' designation by the FDA for the treatment of advanced hepatocellular carcinoma (primary liver cancer), and has since performed well in Phase III trials.
Sorafenib is a small molecular inhibitor of Raf kinase, PDGF (platelet-derived growth factor), VEGF receptor 2 & 3 kinases and c Kit the receptor for Stem cell factor. A growing number of drugs target most of these pathways. The originality of Sorafenib lays in its simultaneous targeting of the Raf/Mek/Erk pathway.",CHEMBL1336
Oc1ccc2c3c1OC1c4[nH]c5ccccc5c4CC4(O)C(C2)[NH+](CC2CC2)CCC314,9.28,,
COc1cc(Nc2c(C#N)cnc3cc(OCCC[NH+]4CC[NH+](C)CC4)c(OC)cc23)c(Cl)cc1Cl,9.28,,
O=C(NO)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1,9.28,This molecule has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C Virus Infection.,CHEMBL440498
CS(=O)(=O)c1ccc(-c2ccc3cc(O)ccc3c2Oc2ccc(OCC[NH+]3CCCCC3)cc2)cc1,9.29,,
CC(C)CC(O)C(O)C(CC1CCCCC1)NC(=O)C(CC(=O)N(CC(=O)N(C)C)C(C)c1ccccc1)Cc1csc(N)n1,9.3,,
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CC[NH+](C)CC4)ccc3OCC)nc12,9.3,,
CC(C)CC(NC(=O)C(C)NC(=O)CC(O)C(COCc1ccc(Br)cc1)NC(=O)C(NC(=O)c1ccccn1)C(C)C)C(N)=O,9.3,,
CC1C[NH+](CCOc2ccc(C3Oc4ccc(O)cc4SC3c3ccc(O)cc3)cc2)CC1C,9.3,,
CCCCC(CO)NC(=O)OC(Cc1ccccc1)C(C)C,9.3,,
CC[NH+](CC)CC(=O)Nc1ccc(C(F)(F)F)cc1NC(=O)c1ccc(C)c(-c2ccc3nc(NC)ncc3c2)c1,9.3,,
C[N+]1CCN(c2nc3ccccc3cc2Cn2nc(-c3ccc4nc(N)sc4c3)c3c(N)ncnc32)CC1,9.3,,
C[NH+](C)CCC(CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CC[NH+](Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-],9.3,,
C[NH2+]C1C(O)COC2CC(CC([NH3+])C(=O)[O-])(C(=O)[O-])OC21,9.3,,
COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccc(Cl)cc5)cccc4c3)c2cc1OC,9.3,,CHEMBL429743
Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CC[NH+](C)CC3)cc2)nc1,9.3,,
O=C([O-])CCC(NC(=O)NC(Cc1ccc(O)c(I)c1)C(=O)[O-])C(=O)[O-],9.3,,
N=Cc1cc(Cl)cc(Oc2cc(OCc3[nH]nc4ncccc34)ccc2Cl)c1,9.3,,
C[NH2+]C1C(O)COC2CC(CC([NH3+])C(=O)[O-])(C(=O)[O-])OC21,9.3,,
Cc1ccc2n[nH]cc2c1C=Cn1cnc2c(Nc3ccc(P(C)(C)=O)cc3)ncnc21,9.3,,
CS(=O)(=O)c1ccccc1-c1ccc(NC(=O)c2cc(C(F)(F)F)nn2-c2cccc(-c3n[nH]c(=O)[nH]3)c2)c(F)c1,9.3,,CHEMBL591955
COc1cc2c(cc1OC)C1CC([NH3+])C(c3cccc(CF)c3)C[N+]1CC2,9.3,,
Cc1ccc(CNC(=O)C(CCc2ccccc2)NC(=O)C(CCc2ccccc2)NC(=O)C([NH3+])CCc2ccccc2)cc1,9.3,,
CCc1c[nH]c2ncnc(N3CCC([NH3+])(CNC(=O)c4ccc(F)cc4F)C3)c12,9.3,,
CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,9.3,,CHEMBL195725
C=C1C(O)CC(=CC=C2CCCC3(C)C2CCC3C(C)CC#CC(O)C23CC4CC(CC(C4)C2)C3)CC1O,9.3,,
C[NH+]1CCN(C(=O)C(CNC(=O)c2ccc(Cl)s2)NS(=O)(=O)c2cc(F)cc(N3CCCCC3=O)c2Cl)CC1,9.3,,
CC(C)CC(=O)NC(C(=O)NC(C(=O)NC(CC(C)C)C(O)CC(=O)NC(C)C(=O)NC(CC(C)C)C(O)CC(=O)[O-])C(C)C)C(C)C,9.3,,
CC(C)CC(NC(=O)C(O)C([NH3+])Cc1ccccc1)C(=O)[O-],9.3,,
Cc1cn(C2CCCN(S(=O)(=O)c3ccc(O)c(Oc4cccc(Cl)c4)c3)C2)c(=O)[nH]c1=O,9.3,,
